,ONTOLOGY,ID,Description,GeneRatio,BgRatio,RichFactor,FoldEnrichment,zScore,pvalue,p.adjust,qvalue,geneID,Count
GO:0048732,BP,GO:0048732,gland development,56/269,449/18888,0.124721604,8.757403896,19.99633236,1.42E-36,6.45E-33,2.70E-33,CTNNB1/COX2/AR/AURKA/FBXW7/HOXB13/BRCA2/GPX1/VDR/IL6/CCND1/PIK3CA/FASN/NFKB1/VEGFA/SOD2/NCOA1/FGF2/CDH1/NOTCH1/HIF1A/PCNA/MAPK1/TNF/RELA/EZH2/HNF1B/TWSG1/AKT1/ALOX15B/TGFBR1/SMAD3/CAV1/TGFB1/MMP2/CYP1A1/IL10/FOXA1/EGFR/CUL3/WT1/BAX/TGFA/PCSK1/BRAF/SNAI2/SOX2/NKX3-1/GATA3/TP63/FGFR1/MED1/ESR1/IGF2/ID4/CYP19A1,56
GO:0050673,BP,GO:0050673,epithelial cell proliferation,55/269,482/18888,0.114107884,8.012155054,18.74453949,7.44E-34,1.69E-30,7.11E-31,THBS1/CTNNB1/ERBB2/AR/FBXW7/MYC/BRCA2/GPX1/VDR/IL6/CCND1/CDK4/EDNRB/PPARG/BID/SOX11/VEGFA/MMP14/FGF2/NOTCH1/HIF1A/STAT3/HDAC6/MAPK1/TNF/HNF1B/AKT1/TGFBR1/SMAD3/CAV1/TGFB1/SLC39A9/IL10/EGFR/RB1/BAX/TGFA/DAB2IP/KDR/IGF1/TWIST1/SNAI2/SOX2/HRAS/NKX3-1/GATA3/TP63/STAT1/FGFR1/CDKN1A/MED1/SFN/LGR4/ESR1/IGF2,55
GO:0050678,BP,GO:0050678,regulation of epithelial cell proliferation,48/269,407/18888,0.117936118,8.280956861,17.84852711,3.58E-30,5.44E-27,2.28E-27,THBS1/CTNNB1/ERBB2/AR/FBXW7/MYC/BRCA2/GPX1/VDR/CCND1/CDK4/EDNRB/PPARG/BID/SOX11/VEGFA/FGF2/NOTCH1/HIF1A/STAT3/HDAC6/TNF/AKT1/TGFBR1/SMAD3/CAV1/TGFB1/SLC39A9/IL10/EGFR/RB1/BAX/TGFA/DAB2IP/KDR/IGF1/TWIST1/SNAI2/SOX2/HRAS/NKX3-1/GATA3/TP63/STAT1/FGFR1/MED1/SFN/IGF2,48
GO:0097193,BP,GO:0097193,intrinsic apoptotic signaling pathway,42/269,319/18888,0.131661442,9.244688909,17.8506819,2.26E-28,2.57E-25,1.08E-25,TP53/BRCA1/CTNNB1/FBXW7/MYC/BRCA2/GPX1/PTGS2/CASP3/BID/PARP1/KDM1A/CD44/SOD2/HIF1A/PRKCD/TNF/AKT1/MMP9/CAV1/MMP2/IL10/CHEK2/CUL3/BAX/DAB2IP/SNAI1/AIFM1/BNIP3/PMAIP1/SNAI2/HRAS/NKX3-1/TP63/MUC1/MLH1/MSH2/NBN/CDKN1A/SFN/CLU/FHIT,42
GO:2000628,BP,GO:2000628,regulation of miRNA metabolic process,26/269,90/18888,0.288888889,20.28451053,22.04212732,3.75E-27,3.41E-24,1.43E-24,TP53/AR/MYC/NFKB1/PPARG/VEGFA/FGF2/MYB/MALAT1/HIF1A/STAT3/SMARCA4/FOS/TNF/RELA/SMAD3/TGFB1/IL10/FOXA1/EGFR/WT1/MYCN/TWIST1/HRAS/GATA3/ESR1,26
GO:0048545,BP,GO:0048545,response to steroid hormone,41/269,338/18888,0.121301775,8.517278546,16.76202524,2.75E-26,2.09E-23,8.76E-24,SRD5A2/BRCA1/THBS1/AR/HSD3B1/IL6/PTGS2/PIK3CA/CASP3/PARP1/KDM1A/IGF1R/ARID1A/NCOA1/SMARCA4/HDAC6/PCNA/MAPK1/FOS/TNF/RELA/RHOA/CAV1/TGFB1/IL10/FOXA1/EGFR/A2M/HSD3B2/PCSK1/AIFM1/NKX3-1/AKR1C3/TP63/CDKN1A/MED1/UCN/PER1/ESR1/ESR2/CLOCK,41
GO:2000630,BP,GO:2000630,positive regulation of miRNA metabolic process,23/269,67/18888,0.343283582,24.10386728,22.77089965,4.00E-26,2.60E-23,1.09E-23,TP53/AR/MYC/NFKB1/PPARG/FGF2/MYB/MALAT1/HIF1A/STAT3/SMARCA4/FOS/TNF/RELA/SMAD3/TGFB1/IL10/FOXA1/EGFR/WT1/MYCN/HRAS/GATA3,23
GO:0010586,BP,GO:0010586,miRNA metabolic process,26/269,108/18888,0.240740741,16.90375878,19.92247625,7.12E-25,4.05E-22,1.70E-22,TP53/AR/MYC/NFKB1/PPARG/VEGFA/FGF2/MYB/MALAT1/HIF1A/STAT3/SMARCA4/FOS/TNF/RELA/SMAD3/TGFB1/IL10/FOXA1/EGFR/WT1/MYCN/TWIST1/HRAS/GATA3/ESR1,26
GO:1902893,BP,GO:1902893,regulation of miRNA transcription,23/269,75/18888,0.306666667,21.5327881,21.41553772,8.11E-25,4.10E-22,1.72E-22,TP53/AR/MYC/PPARG/VEGFA/FGF2/MYB/HIF1A/STAT3/SMARCA4/FOS/TNF/RELA/SMAD3/TGFB1/IL10/FOXA1/EGFR/WT1/MYCN/TWIST1/GATA3/ESR1,23
GO:0061614,BP,GO:0061614,miRNA transcription,23/269,76/18888,0.302631579,21.24946194,21.26092979,1.15E-24,5.23E-22,2.19E-22,TP53/AR/MYC/PPARG/VEGFA/FGF2/MYB/HIF1A/STAT3/SMARCA4/FOS/TNF/RELA/SMAD3/TGFB1/IL10/FOXA1/EGFR/WT1/MYCN/TWIST1/GATA3/ESR1,23
GO:2001233,BP,GO:2001233,regulation of apoptotic signaling pathway,42/269,396/18888,0.106060606,7.44711051,15.58476361,1.39E-24,5.77E-22,2.42E-22,TP53/BRCA1/THBS1/CTNNB1/AR/FBXW7/MYC/GPX1/PTGS2/IL1B/BID/PARP1/KDM1A/CD44/SOD2/GSTP1/HIF1A/TLR4/PRKCD/TNF/RELA/BMI1/AKT1/MMP9/TGFBR1/CAV1/MMP2/IL10/RB1/BAX/DAB2IP/SNAI1/SERPINE1/IGF1/PMAIP1/SNAI2/NKX3-1/TP63/MUC1/FGFR1/MAL/CLU,42
GO:0071214,BP,GO:0071214,cellular response to abiotic stimulus,38/269,334/18888,0.113772455,7.98860272,15.48903155,2.18E-23,7.65E-21,3.21E-21,TP53/BRCA1/TIMP1/PTEN/MYC/BRCA2/ERCC1/PTGS2/PIK3CA/CASP8/IL1B/NFKB1/CASP3/PARP1/KDM1A/IGF1R/FGF2/MAPK14/MTOR/TLR4/PCNA/PRKCD/MMP9/MMP2/CHEK2/EGFR/BAX/MC1R/BNIP3/SNAI2/MME/HRAS/GATA3/CDKN1A/FBP1/MYD88/CLOCK/MMP1,38
GO:0104004,BP,GO:0104004,cellular response to environmental stimulus,38/269,334/18888,0.113772455,7.98860272,15.48903155,2.18E-23,7.65E-21,3.21E-21,TP53/BRCA1/TIMP1/PTEN/MYC/BRCA2/ERCC1/PTGS2/PIK3CA/CASP8/IL1B/NFKB1/CASP3/PARP1/KDM1A/IGF1R/FGF2/MAPK14/MTOR/TLR4/PCNA/PRKCD/MMP9/MMP2/CHEK2/EGFR/BAX/MC1R/BNIP3/SNAI2/MME/HRAS/GATA3/CDKN1A/FBP1/MYD88/CLOCK/MMP1,38
GO:0140747,BP,GO:0140747,regulation of ncRNA transcription,24/269,97/18888,0.24742268,17.37293527,19.43197396,2.37E-23,7.71E-21,3.23E-21,TP53/AR/MYC/PPARG/VEGFA/FGF2/MYB/HIF1A/STAT3/SMARCA4/MTOR/FOS/TNF/RELA/SMAD3/TGFB1/IL10/FOXA1/EGFR/WT1/MYCN/TWIST1/GATA3/ESR1,24
GO:1902895,BP,GO:1902895,positive regulation of miRNA transcription,20/269,56/18888,0.357142857,25.07700478,21.68840947,2.88E-23,8.73E-21,3.66E-21,TP53/AR/MYC/PPARG/FGF2/MYB/HIF1A/STAT3/SMARCA4/FOS/TNF/RELA/SMAD3/TGFB1/IL10/FOXA1/EGFR/WT1/MYCN/GATA3,20
GO:0051402,BP,GO:0051402,neuron apoptotic process,35/269,292/18888,0.119863014,8.416255029,15.35132149,2.36E-22,6.73E-20,2.82E-20,TP53/CTNNB1/FBXW7/GPX1/CCND1/PIK3CA/CASP8/CASP3/BID/FASLG/PARP1/SOD2/MYB/HIF1A/TNF/RHOA/KRAS/MMP2/IL10/RB1/BAX/KDR/AIFM1/BNIP3/BRAF/HRAS/GATA3/TP63/MSH2/TFAP2A/UCN/UBE2M/MAP2K7/ROCK1/CLU,35
GO:0036293,BP,GO:0036293,response to decreased oxygen levels,36/269,327/18888,0.110091743,7.730159272,14.75631737,1.06E-21,2.83E-19,1.19E-19,TP53/THBS1/COX2/MYC/XRCC1/PTGS2/MAP3K7/PPARG/CASP3/NPEPPS/VEGFA/SOD2/MMP14/MYB/MALAT1/NOTCH1/HIF1A/MTOR/FOS/TNF/AKT1/SMAD3/CAV1/TGFB1/MMP2/CYP1A1/VHL/TWIST1/AIFM1/BNIP3/MIR145/PMAIP1/SOX2/NKX3-1/BNIP3L/PLAU,36
GO:0070482,BP,GO:0070482,response to oxygen levels,37/269,354/18888,0.104519774,7.338920043,14.47144104,1.68E-21,4.26E-19,1.79E-19,TP53/THBS1/COX2/MYC/XRCC1/PTGS2/MAP3K7/PPARG/CASP3/NPEPPS/VEGFA/SOD2/MMP14/MYB/MALAT1/NOTCH1/HIF1A/MTOR/FOS/TNF/AKT1/SMAD3/CAV1/TGFB1/MMP2/CYP1A1/VHL/TWIST1/AIFM1/BNIP3/MIR145/PMAIP1/SOX2/NKX3-1/BNIP3L/CDKN1A/PLAU,37
GO:0051054,BP,GO:0051054,positive regulation of DNA metabolic process,34/269,301/18888,0.112956811,7.931331744,14.57050948,6.73E-21,1.61E-18,6.76E-19,BRCA1/CTNNB1/MYC/XRCC1/ERCC1/IL6/PARP1/IGF1R/ARID1A/FGF2/SMARCA4/SMARCA2/CDK2/PCNA/MAPK1/PRKCD/TNF/AKT1/TGFB1/CBX8/FGFR4/EGFR/WT1/BAX/MEAF6/SMARCE1/HSP90AA1/MLH1/MSH2/NBN/FGFR1/CDKN1A/UCN/MAP2K7,34
GO:0042063,BP,GO:0042063,gliogenesis,36/269,346/18888,0.104046243,7.305670757,14.2288731,7.16E-21,1.63E-18,6.84E-19,TP53/PTEN/CTNNB1/ERBB2/ETV5/IL6/IL1B/SOX11/MMP14/FGF2/MYB/NOTCH1/STAT3/MTOR/TLR4/MAPK1/TNF/RELA/RHOA/KRAS/EZH2/AKT1/TGFB1/ILK/EGFR/RB1/DAB2IP/VIM/CD9/BNIP3/SOX2/HRAS/ID4/MAL/MYD88/CLU,36
GO:0022612,BP,GO:0022612,gland morphogenesis,24/269,125/18888,0.192,13.48139777,16.82854411,1.55E-20,3.36E-18,1.41E-18,AR/FBXW7/HOXB13/VDR/IL6/NFKB1/NOTCH1/TNF/TWSG1/CAV1/TGFB1/MMP2/FOXA1/EGFR/CUL3/BAX/TGFA/SNAI2/NKX3-1/TP63/FGFR1/MED1/ESR1/ID4,24
GO:0009314,BP,GO:0009314,response to radiation,39/269,431/18888,0.090487239,6.353616988,13.5140285,2.28E-20,4.69E-18,1.97E-18,TP53/BRCA1/TIMP1/MYC/BRCA2/GPX1/ERCC1/CCND1/CASP3/PARP1/KDM1A/SOD2/MAPK14/HIF1A/PCNA/PRKCD/FOS/RELA/KRAS/AKT1/MMP9/MMP2/CHEK2/EGFR/TXN/BAX/MC1R/BRAF/SNAI2/MME/HRAS/THBD/GATA3/MSH2/CDKN1A/PER1/MAP2K7/CLOCK/MMP1,39
GO:0001666,BP,GO:0001666,response to hypoxia,34/269,313/18888,0.108626198,7.627255128,14.21087769,2.37E-20,4.69E-18,1.97E-18,TP53/THBS1/COX2/MYC/XRCC1/PTGS2/MAP3K7/PPARG/CASP3/NPEPPS/VEGFA/SOD2/MMP14/MYB/MALAT1/NOTCH1/HIF1A/MTOR/FOS/TNF/SMAD3/CAV1/TGFB1/MMP2/CYP1A1/VHL/TWIST1/AIFM1/BNIP3/MIR145/PMAIP1/NKX3-1/BNIP3L/PLAU,34
GO:0033002,BP,GO:0033002,muscle cell proliferation,31/269,251/18888,0.123505976,8.672047868,14.70752571,2.79E-20,5.30E-18,2.22E-18,THBS1/PTEN/CTNNB1/IL6/PTGS2/MAP3K7/PIK3CA/PPARG/SOD2/IGF1R/FGF2/MYB/NOTCH1/MAPK14/TLR4/FOS/TNF/AKT1/MMP9/TGFBR1/TGFB1/MMP2/IL10/EGFR/IGF1/MIR145/PIM1/STAT1/FGFR1/CDKN1A/MYD88,31
GO:0098781,BP,GO:0098781,ncRNA transcription,25/269,146/18888,0.171232877,12.02322147,16.07150132,4.56E-20,8.30E-18,3.48E-18,TP53/AR/MYC/PPARG/VEGFA/FGF2/MYB/HIF1A/STAT3/SMARCA4/ELL2/MTOR/FOS/TNF/RELA/SMAD3/TGFB1/IL10/FOXA1/EGFR/WT1/MYCN/TWIST1/GATA3/ESR1,25
GO:0048145,BP,GO:0048145,regulation of fibroblast proliferation,21/269,90/18888,0.233333333,16.38364312,17.58344967,5.41E-20,9.48E-18,3.98E-18,TP53/CTNNB1/MYC/CDK4/SOD2/GSTP1/MYB/S100A6/BMI1/LZTS2/CAV1/EGFR/FN1/BAX/DAB2IP/IGF1/SPHK1/HRAS/PAWR/CDKN1A/ESR1,21
GO:0051347,BP,GO:0051347,positive regulation of transferase activity,36/269,376/18888,0.095744681,6.722771494,13.47265259,1.16E-19,1.95E-17,8.18E-18,THBS1/PTEN/ERBB2/FBXW7/MYC/CCND1/MAP3K7/ALK/IL1B/VEGFA/IGF1R/FGF2/TENM1/TLR4/PCNA/MAPK1/PRKCD/TNF/RHOA/BMI1/EZH2/AKT1/PTK2/FGFR4/EGFR/TXN/DAB2IP/KDR/IGF1/HSP90AA1/HRAS/NBN/FGFR1/CDKN1A/MST1R/MAP2K7,36
GO:0043523,BP,GO:0043523,regulation of neuron apoptotic process,30/269,244/18888,0.12295082,8.633067219,14.42460426,1.34E-19,2.18E-17,9.13E-18,TP53/CTNNB1/FBXW7/CCND1/PIK3CA/CASP8/CASP3/FASLG/PARP1/SOD2/MYB/HIF1A/TNF/RHOA/KRAS/MMP2/IL10/BAX/KDR/AIFM1/BRAF/HRAS/GATA3/MSH2/TFAP2A/UCN/UBE2M/MAP2K7/ROCK1/CLU,30
GO:0009411,BP,GO:0009411,response to UV,25/269,154/18888,0.162337662,11.39863854,15.57403114,1.76E-19,2.77E-17,1.16E-17,TP53/TIMP1/MYC/BRCA2/GPX1/ERCC1/CCND1/CASP3/PARP1/KDM1A/MAPK14/PCNA/PRKCD/RELA/AKT1/MMP9/MMP2/EGFR/BAX/MC1R/MME/MSH2/CDKN1A/MAP2K7/MMP1,25
GO:0048144,BP,GO:0048144,fibroblast proliferation,22/269,110/18888,0.2,14.04312268,16.49045765,2.51E-19,3.82E-17,1.60E-17,TP53/CTNNB1/MYC/GPX1/CDK4/SOD2/GSTP1/MYB/S100A6/BMI1/LZTS2/CAV1/EGFR/FN1/BAX/DAB2IP/IGF1/SPHK1/HRAS/PAWR/CDKN1A/ESR1,22
GO:0030522,BP,GO:0030522,intracellular receptor signaling pathway,35/269,369/18888,0.094850949,6.66001753,13.19780319,5.24E-19,7.70E-17,3.23E-17,BRCA1/AR/VDR/MAP3K7/PPARG/PARP1/KDM1A/ARID1A/NCOA1/STAT3/SMARCA4/TLR4/HDAC6/MAPK1/TNF/RELA/RHOA/EZH2/AKT1/ALOX15B/CAV1/FOXA1/TWIST1/SNAI2/PIM1/NKX3-1/AKR1C3/TP63/NFKBIA/MED1/PER1/ESR1/ESR2/MYD88/CLOCK,35
GO:0062197,BP,GO:0062197,cellular response to chemical stress,32/269,311/18888,0.102893891,7.224757647,13.30436973,1.69E-18,2.41E-16,1.01E-16,TP53/ETV5/GPX1/IL6/PTGS2/PIK3CA/CASP3/PARP1/SOD2/MYB/HIF1A/MTOR/HDAC6/PCNA/MAPK1/PRKCD/FOS/RELA/EZH2/AKT1/MMP9/CAV1/MMP2/CBX8/EGFR/TXN/SPHK1/AIFM1/BNIP3/PAWR/FBP1/CAMKK2,32
GO:0048660,BP,GO:0048660,regulation of smooth muscle cell proliferation,25/269,174/18888,0.143678161,10.0884502,14.47640076,3.72E-18,5.14E-16,2.16E-16,THBS1/PTEN/CTNNB1/IL6/PTGS2/MAP3K7/PIK3CA/PPARG/SOD2/IGF1R/FGF2/MYB/TLR4/TNF/AKT1/MMP9/TGFB1/MMP2/IL10/EGFR/IGF1/MIR145/STAT1/CDKN1A/MYD88,25
GO:0032496,BP,GO:0032496,response to lipopolysaccharide,33/269,348/18888,0.094827586,6.658377131,12.80578191,5.77E-18,7.73E-16,3.24E-16,IL6/PTGS2/CDK4/EDNRB/CASP8/IL1B/NFKB1/CASP3/FASLG/SOD2/GSTP1/NOTCH1/MAPK14/TLR4/MAPK1/FOS/TNF/RELA/RHOA/AKT1/MMP9/CYP1A1/IL10/GIT1/DAB2IP/SERPINE1/PCSK1/VIM/THBD/CD274/NFKBIA/MAP2K7/MYD88,33
GO:0048659,BP,GO:0048659,smooth muscle cell proliferation,25/269,178/18888,0.140449438,9.861743453,14.27814324,6.52E-18,8.49E-16,3.56E-16,THBS1/PTEN/CTNNB1/IL6/PTGS2/MAP3K7/PIK3CA/PPARG/SOD2/IGF1R/FGF2/MYB/TLR4/TNF/AKT1/MMP9/TGFB1/MMP2/IL10/EGFR/IGF1/MIR145/STAT1/CDKN1A/MYD88,25
GO:0033674,BP,GO:0033674,positive regulation of kinase activity,31/269,303/18888,0.102310231,7.183775627,13.0428713,7.07E-18,8.94E-16,3.75E-16,THBS1/ERBB2/FBXW7/CCND1/MAP3K7/ALK/IL1B/VEGFA/IGF1R/FGF2/TENM1/TLR4/PRKCD/TNF/RHOA/EZH2/AKT1/PTK2/FGFR4/EGFR/TXN/DAB2IP/KDR/IGF1/HSP90AA1/HRAS/NBN/FGFR1/CDKN1A/MST1R/MAP2K7,31
GO:0010720,BP,GO:0010720,positive regulation of cell development,37/269,454/18888,0.081497797,5.722417831,12.24227128,7.66E-18,9.44E-16,3.96E-16,CTNNB1/AURKA/ETV5/IL6/CASP8/IL1B/KDM1A/SOX11/VEGFA/MMP14/ARID1A/FGF2/MYB/NOTCH1/HIF1A/SMARCA4/SMARCA2/MTOR/HDAC6/FOS/TNF/RELA/RHOA/KRAS/TGFB1/IL10/EGFR/BRD2/BRD4/FN1/RB1/SMARCE1/MIR145/BRAF/MME/GATA3/ID4,37
GO:0032355,BP,GO:0032355,response to estradiol,21/269,115/18888,0.182608696,12.82198157,15.28452028,1.22E-17,1.47E-15,6.14E-16,CTNNB1/GPX1/PTGS2/CASP8/CASP3/IGF1R/NCOA1/NCOA3/STAT3/PCNA/EZH2/TGFB1/MMP2/IL10/FOXA1/EGFR/AIFM1/UCN/ESR1/ESR2/CYP19A1,21
GO:0000302,BP,GO:0000302,response to reactive oxygen species,26/269,203/18888,0.128078818,8.993132749,13.76251951,1.44E-17,1.68E-15,7.06E-16,GPX1/IL6/CASP3/SOD2/GSTP1/MYB/HIF1A/HDAC6/PCNA/MAPK1/PRKCD/FOS/RELA/EZH2/AKT1/MMP9/MMP2/CBX8/EGFR/TXN/SPHK1/AIFM1/BNIP3/STAT1/PAWR/CAMKK2,26
GO:2001234,BP,GO:2001234,negative regulation of apoptotic signaling pathway,28/269,244/18888,0.114754098,8.057529405,13.33698051,1.48E-17,1.69E-15,7.07E-16,BRCA1/THBS1/CTNNB1/AR/GPX1/PTGS2/IL1B/BID/KDM1A/CD44/SOD2/GSTP1/HIF1A/TNF/RELA/BMI1/AKT1/MMP9/TGFBR1/IL10/RB1/BAX/SNAI1/SERPINE1/IGF1/SNAI2/MUC1/CLU,28
GO:0043434,BP,GO:0043434,response to peptide hormone,36/269,438/18888,0.082191781,5.771146305,12.14342119,1.69E-17,1.88E-15,7.87E-16,SRD5A2/TIMP1/PTGS2/MAP3K7/EDNRB/PIK3CA/IL1B/NFKB1/PPARG/PARP1/IGF1R/NCOA1/MAPK14/STAT3/MTOR/MAPK1/PRKCD/FOS/RELA/AKT1/SMAD3/CAV1/PTK2/IL10/BSG/RB1/PCSK1/IRS1/MIR145/BRAF/HRAS/STAT1/CRHR2/FBP1/ROCK1/IGF2,36
GO:0002237,BP,GO:0002237,response to molecule of bacterial origin,33/269,369/18888,0.089430894,6.279445099,12.31039957,3.37E-17,3.66E-15,1.53E-15,IL6/PTGS2/CDK4/EDNRB/CASP8/IL1B/NFKB1/CASP3/FASLG/SOD2/GSTP1/NOTCH1/MAPK14/TLR4/MAPK1/FOS/TNF/RELA/RHOA/AKT1/MMP9/CYP1A1/IL10/GIT1/DAB2IP/SERPINE1/PCSK1/VIM/THBD/CD274/NFKBIA/MAP2K7/MYD88,33
GO:0009416,BP,GO:0009416,response to light stimulus,31/269,321/18888,0.096573209,6.780947087,12.5562541,3.71E-17,3.93E-15,1.65E-15,TP53/TIMP1/MYC/BRCA2/GPX1/ERCC1/CCND1/CASP3/PARP1/KDM1A/MAPK14/HIF1A/PCNA/PRKCD/FOS/RELA/KRAS/AKT1/MMP9/MMP2/EGFR/BAX/MC1R/BRAF/MME/MSH2/CDKN1A/PER1/MAP2K7/CLOCK/MMP1,31
GO:0043491,BP,GO:0043491,phosphatidylinositol 3-kinase/protein kinase B signal transduction,30/269,299/18888,0.100334448,7.045044821,12.6644566,4.28E-17,4.43E-15,1.86E-15,THBS1/PTEN/ERBB2/GPX1/PIK3CA/IGF1R/FGF2/STAT3/MTOR/TNF/AKT1/TGFBR1/TGFB1/PTK2/ILK/EGFR/FN1/TXN/DAB2IP/KDR/IRS1/IGF1/TWIST1/MIR145/NKX3-1/AKR1C3/GATA3/FGFR1/MST1R/IGF2,30
GO:0006979,BP,GO:0006979,response to oxidative stress,34/269,398/18888,0.085427136,5.998318731,12.11369072,4.40E-17,4.46E-15,1.87E-15,TP53/ETV5/GPX1/XRCC1/ERCC1/IL6/PTGS2/CASP3/PARP1/SOD2/MMP14/GSTP1/MYB/HIF1A/HDAC6/PCNA/MAPK1/PRKCD/FOS/RELA/EZH2/AKT1/MMP9/MMP2/CBX8/EGFR/TXN/SPHK1/AIFM1/BNIP3/STAT1/PAWR/UCN/CAMKK2,34
GO:1901654,BP,GO:1901654,response to ketone,26/269,217/18888,0.119815668,8.412930636,13.20126253,7.66E-17,7.58E-15,3.18E-15,SRD5A2/THBS1/AR/HSD3B1/HOXB13/CDK4/PIK3CA/PARP1/IGF1R/NCOA1/HDAC6/PCNA/FOS/RELA/AKT1/CAV1/TGFB1/SLC39A9/EGFR/A2M/HSD3B2/AIFM1/NKX3-1/AKR1C3/CDKN1A/FBP1,26
GO:0010001,BP,GO:0010001,glial cell differentiation,28/269,260/18888,0.107692308,7.561681441,12.80554763,7.95E-17,7.71E-15,3.23E-15,PTEN/CTNNB1/ERBB2/IL6/IL1B/SOX11/FGF2/NOTCH1/STAT3/MTOR/TLR4/MAPK1/TNF/RELA/RHOA/KRAS/AKT1/TGFB1/ILK/EGFR/VIM/BNIP3/SOX2/HRAS/ID4/MAL/MYD88/CLU,28
GO:0048608,BP,GO:0048608,reproductive structure development,30/269,307/18888,0.09771987,6.861460591,12.44571781,8.90E-17,8.45E-15,3.54E-15,SRD5A2/CTNNB1/AR/HOXB13/BRCA2/ERCC1/CASP3/VEGFA/MMP14/NCOA1/NOTCH1/ALOX15B/TGFBR1/MMP2/FOXA1/A2M/WT1/BAX/KDR/SGPL1/NKX3-1/AKR1C3/GATA3/TP63/MSH2/ZFX/LGR4/ESR1/ID4/CYP19A1,30
GO:0050679,BP,GO:0050679,positive regulation of epithelial cell proliferation,26/269,219/18888,0.118721461,8.336100219,13.12520935,9.62E-17,8.95E-15,3.75E-15,CTNNB1/ERBB2/AR/MYC/CCND1/SOX11/VEGFA/FGF2/NOTCH1/HIF1A/STAT3/HDAC6/TNF/AKT1/TGFBR1/IL10/EGFR/TGFA/KDR/IGF1/TWIST1/HRAS/TP63/FGFR1/MED1/IGF2,26
GO:0061458,BP,GO:0061458,reproductive system development,30/269,311/18888,0.096463023,6.773210294,12.33926341,1.27E-16,1.16E-14,4.87E-15,SRD5A2/CTNNB1/AR/HOXB13/BRCA2/ERCC1/CASP3/VEGFA/MMP14/NCOA1/NOTCH1/ALOX15B/TGFBR1/MMP2/FOXA1/A2M/WT1/BAX/KDR/SGPL1/NKX3-1/AKR1C3/GATA3/TP63/MSH2/ZFX/LGR4/ESR1/ID4/CYP19A1,30
GO:0022407,BP,GO:0022407,regulation of cell-cell adhesion,37/269,496/18888,0.074596774,5.237858256,11.49614519,1.38E-16,1.23E-14,5.16E-15,ERBB2/ALOX12/IL6/PIK3CA/IL1B/CASP3/CD44/VEGFA/ARID1A/CDH1/NOTCH1/MAPK14/SMARCA4/SMARCA2/MTOR/PRKCD/TNF/RELA/RHOA/BMI1/TWSG1/AKT1/CAV1/TGFB1/PTK2/IL10/FOXA1/BRD2/BRD4/IGF1/CD9/SMARCE1/SOX2/GATA3/CD274/PAWR/IGF2,37
GO:0001667,BP,GO:0001667,ameboidal-type cell migration,37/269,498/18888,0.074297189,5.216822681,11.46274418,1.57E-16,1.35E-14,5.66E-15,TIMP1/THBS1/PTEN/FBXW7/GPX1/PTGS2/EDNRB/PIK3CA/PPARG/VEGFA/ID1/FGF2/NOTCH1/HIF1A/MTOR/HDAC6/TNF/RHOA/AKT1/MMP9/TGFBR1/TGFB1/PTK2/ILK/MIR200C/FN1/DAB2IP/SNAI1/KDR/SGPL1/TWIST1/MIR145/BRAF/SNAI2/GATA3/FGFR1/ROCK1,37
GO:0071900,BP,GO:0071900,regulation of protein serine/threonine kinase activity,28/269,267/18888,0.104868914,7.363435111,12.58708615,1.60E-16,1.35E-14,5.66E-15,THBS1/PTEN/ERBB2/CCND1/MAP3K7/IL1B/PPARG/VEGFA/GSTP1/FGF2/TENM1/TLR4/PRKCD/TNF/RHOA/EZH2/AKT1/CDK12/EGFR/HHEX/RB1/DAB2IP/HRAS/FGFR1/CDKN1A/CDKN2A/MST1R/MAP2K7,28
GO:0045859,BP,GO:0045859,regulation of protein kinase activity,36/269,470/18888,0.076595745,5.378217195,11.55325745,1.60E-16,1.35E-14,5.66E-15,THBS1/PTEN/ERBB2/FBXW7/CCND1/MAP3K7/IL1B/PPARG/VEGFA/GSTP1/FGF2/TENM1/TLR4/PRKCD/TNF/RHOA/EZH2/AKT1/CAV1/PTK2/CDK12/EGFR/TXN/HHEX/RB1/DAB2IP/IGF1/HSP90AA1/HRAS/FGFR1/CDKN1A/SFN/CDKN2A/MST1R/MAP2K7/CAMKK2,36
GO:0048661,BP,GO:0048661,positive regulation of smooth muscle cell proliferation,19/269,100/18888,0.19,13.34096654,14.87264985,2.06E-16,1.71E-14,7.17E-15,THBS1/IL6/PTGS2/MAP3K7/PIK3CA/IGF1R/FGF2/MYB/TLR4/TNF/AKT1/MMP9/TGFB1/MMP2/IL10/EGFR/IGF1/STAT1/MYD88,19
GO:0008630,BP,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,19/269,102/18888,0.18627451,13.07937896,14.70303488,3.05E-16,2.48E-14,1.04E-14,TP53/BRCA1/BRCA2/BID/KDM1A/CD44/SOD2/TNF/CHEK2/BAX/SNAI1/SNAI2/TP63/MUC1/MLH1/MSH2/CDKN1A/SFN/CLU,19
GO:0097191,BP,GO:0097191,extrinsic apoptotic signaling pathway,26/269,230/18888,0.113043478,7.937417165,12.72355989,3.24E-16,2.55E-14,1.07E-14,BRCA1/THBS1/AR/GPX1/CASP8/IL1B/BID/FASLG/GSTP1/TLR4/TNF/RELA/AKT1/TGFBR1/SMAD3/CAV1/TGFB1/BAX/IFI27/DAB2IP/SERPINE1/IGF1/PMAIP1/SNAI2/FGFR1/MAL,26
GO:0061138,BP,GO:0061138,morphogenesis of a branching epithelium,24/269,189/18888,0.126984127,8.916268366,13.14684898,3.25E-16,2.55E-14,1.07E-14,CTNNB1/AR/MYC/HOXB13/VDR/VEGFA/MMP14/FGF2/NOTCH1/TNF/KRAS/HNF1B/IL10/ILK/FOXA1/WT1/KDR/SNAI2/NKX3-1/TP63/FGFR1/MED1/LGR4/ESR1,24
GO:2001242,BP,GO:2001242,regulation of intrinsic apoptotic signaling pathway,24/269,190/18888,0.126315789,8.869340638,13.10379294,3.67E-16,2.83E-14,1.19E-14,TP53/CTNNB1/FBXW7/MYC/GPX1/PTGS2/BID/PARP1/KDM1A/CD44/SOD2/HIF1A/AKT1/MMP9/CAV1/MMP2/IL10/BAX/SNAI1/PMAIP1/SNAI2/NKX3-1/MUC1/CLU,24
GO:0030879,BP,GO:0030879,mammary gland development,21/269,135/18888,0.155555556,10.92242875,13.90685577,3.73E-16,2.83E-14,1.19E-14,COX2/AR/BRCA2/GPX1/VDR/CCND1/FASN/NFKB1/VEGFA/NCOA1/FGF2/HIF1A/MAPK1/AKT1/CAV1/BAX/TGFA/GATA3/MED1/ESR1/CYP19A1,21
GO:0030856,BP,GO:0030856,regulation of epithelial cell differentiation,23/269,171/18888,0.134502924,9.444205309,13.33270203,3.81E-16,2.85E-14,1.19E-14,CTNNB1/ETV4/VDR/CCND1/IL1B/VEGFA/NCOA3/FGF2/NOTCH1/TNF/KRAS/EZH2/MMP9/ALOX15B/CAV1/MIR200C/SERPINE1/GATA3/TP63/STAT1/MED1/SFN/ROCK1,23
GO:0042060,BP,GO:0042060,wound healing,34/269,430/18888,0.079069767,5.551932221,11.47670313,4.59E-16,3.38E-14,1.42E-14,TIMP1/THBS1/PTEN/ERBB2/ALOX12/GPX1/IL6/PIK3CA/PPARG/CD44/VEGFA/FGF2/MAPK14/HIF1A/MTOR/TLR4/PRKCD/TNF/RHOA/TGFBR1/SMAD3/CAV1/TGFB1/PTK2/ILK/FN1/SERPINE1/KDR/IGF1/CD9/HRAS/THBD/CDKN1A/PLAU,34
GO:0071453,BP,GO:0071453,cellular response to oxygen levels,23/269,177/18888,0.129943503,9.124062756,13.05241451,8.25E-16,5.97E-14,2.50E-14,TP53/MYC/PTGS2/MAP3K7/PPARG/NPEPPS/VEGFA/MALAT1/NOTCH1/HIF1A/MTOR/FOS/AKT1/CAV1/TGFB1/VHL/TWIST1/AIFM1/BNIP3/MIR145/PMAIP1/NKX3-1/BNIP3L,23
GO:0060562,BP,GO:0060562,epithelial tube morphogenesis,30/269,335/18888,0.089552239,6.287965378,11.73771035,9.77E-16,6.96E-14,2.92E-14,CTNNB1/AR/CXCR2/MYC/VDR/CASP3/VEGFA/MMP14/FGF2/NOTCH1/HIF1A/TNF/RHOA/KRAS/HNF1B/LZTS2/SMAD3/TGFB1/ILK/FOXA1/BRD2/WT1/DLC1/KDR/TWIST1/NKX3-1/GATA3/MED1/LGR4/ESR1,30
GO:0009410,BP,GO:0009410,response to xenobiotic stimulus,34/269,444/18888,0.076576577,5.376871295,11.2177862,1.20E-15,8.39E-14,3.52E-14,SRD5A2/TP53/THBS1/CTNNB1/UGT2B17/MYC/GPX1/XRCC1/PTGS2/CCND1/CDK4/IL1B/CASP3/SOD2/GSTP1/CDH1/PCNA/FOS/TNF/RELA/DUSP6/MMP2/CYP1A1/IL10/EGFR/RB1/PCSK1/HSP90AA1/BRAF/NKX3-1/STAT1/CDKN1A/NAT1/FBP1,34
GO:0036294,BP,GO:0036294,cellular response to decreased oxygen levels,22/269,161/18888,0.136645963,9.59468009,13.16400392,1.22E-15,8.39E-14,3.52E-14,TP53/MYC/PTGS2/MAP3K7/PPARG/NPEPPS/VEGFA/MALAT1/NOTCH1/HIF1A/MTOR/FOS/AKT1/TGFB1/VHL/TWIST1/AIFM1/BNIP3/MIR145/PMAIP1/NKX3-1/BNIP3L,22
GO:0071478,BP,GO:0071478,cellular response to radiation,23/269,181/18888,0.127071823,8.92242601,12.8728545,1.36E-15,9.18E-14,3.85E-14,TP53/BRCA1/TIMP1/MYC/BRCA2/ERCC1/PARP1/KDM1A/MAPK14/PCNA/PRKCD/MMP9/MMP2/CHEK2/BAX/MC1R/SNAI2/MME/HRAS/GATA3/CDKN1A/CLOCK/MMP1,23
GO:0001503,BP,GO:0001503,ossification,34/269,446/18888,0.076233184,5.352759765,11.18169323,1.37E-15,9.18E-14,3.85E-14,CTNNB1/VDR/IL6/PTGS2/FASN/PPARG/SOX11/MMP14/FGF2/NOTCH1/MAPK14/HIF1A/MAPK1/TNF/RHOA/TWSG1/AKT1/SMAD3/MMP2/PTK2/ILK/MIR200C/EGFR/GIT1/SNAI1/IGF1/TWIST1/SNAI2/SOX2/TP63/TFAP2A/LGR4/IGF2/ID4,34
GO:0034599,BP,GO:0034599,cellular response to oxidative stress,26/269,248/18888,0.10483871,7.361314306,12.12074166,2.04E-15,1.35E-13,5.66E-14,TP53/ETV5/GPX1/IL6/PARP1/SOD2/MYB/HIF1A/HDAC6/PCNA/MAPK1/PRKCD/FOS/RELA/EZH2/AKT1/MMP9/MMP2/CBX8/EGFR/TXN/SPHK1/AIFM1/BNIP3/PAWR/CAMKK2,26
GO:0001763,BP,GO:0001763,morphogenesis of a branching structure,24/269,206/18888,0.116504854,8.180459812,12.45528405,2.36E-15,1.54E-13,6.44E-14,CTNNB1/AR/MYC/HOXB13/VDR/VEGFA/MMP14/FGF2/NOTCH1/TNF/KRAS/HNF1B/IL10/ILK/FOXA1/WT1/KDR/SNAI2/NKX3-1/TP63/FGFR1/MED1/LGR4/ESR1,24
GO:1901653,BP,GO:1901653,cellular response to peptide,31/269,376/18888,0.082446809,5.789053231,11.2744761,3.15E-15,2.02E-13,8.48E-14,TP53/MAP3K7/PIK3CA/IL1B/NFKB1/PPARG/PARP1/IGF1R/NCOA1/STAT3/MTOR/TLR4/MAPK1/PRKCD/FOS/TNF/RELA/AKT1/CAV1/PTK2/RB1/VIM/IRS1/IGF1/MIR145/HRAS/STAT1/CRHR2/FBP1/ROCK1/IGF2,31
GO:0051896,BP,GO:0051896,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,26/269,253/18888,0.102766798,7.215833786,11.96394503,3.32E-15,2.10E-13,8.80E-14,THBS1/PTEN/GPX1/PIK3CA/IGF1R/FGF2/MTOR/TNF/TGFBR1/TGFB1/PTK2/EGFR/FN1/TXN/DAB2IP/KDR/IRS1/IGF1/TWIST1/MIR145/NKX3-1/AKR1C3/GATA3/FGFR1/MST1R/IGF2,26
GO:0031667,BP,GO:0031667,response to nutrient levels,35/269,490/18888,0.071428571,5.015400956,10.82483051,3.67E-15,2.29E-13,9.61E-14,SRD5A2/TP53/GPX1/VDR/ERCC1/PTGS2/PPARG/SOD2/IGF1R/NCOA1/MAPK14/MTOR/MAPK1/FOS/TNF/RELA/AKT1/CYP1A1/EGFR/A2M/BAX/HSPA5/PCSK1/BNIP3/PMAIP1/SNAI2/SOX2/PIM1/AKR1C3/STAT1/CDKN1A/MED1/UCN/NPRL2/FBP1,35
GO:0034614,BP,GO:0034614,cellular response to reactive oxygen species,21/269,151/18888,0.139072848,9.765085305,12.9979256,3.84E-15,2.37E-13,9.92E-14,IL6/SOD2/MYB/HDAC6/PCNA/MAPK1/PRKCD/FOS/RELA/EZH2/AKT1/MMP9/MMP2/CBX8/EGFR/TXN/SPHK1/AIFM1/BNIP3/PAWR/CAMKK2,21
GO:0043405,BP,GO:0043405,regulation of MAP kinase activity,20/269,134/18888,0.149253731,10.4799423,13.23703116,4.39E-15,2.65E-13,1.11E-13,THBS1/ERBB2/MAP3K7/IL1B/PPARG/VEGFA/GSTP1/FGF2/TENM1/TLR4/PRKCD/TNF/EZH2/CDK12/EGFR/DAB2IP/HRAS/FGFR1/MST1R/MAP2K7,20
GO:0051897,BP,GO:0051897,positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,22/269,171/18888,0.128654971,9.033587687,12.68437075,4.42E-15,2.65E-13,1.11E-13,THBS1/GPX1/PIK3CA/IGF1R/FGF2/MTOR/TNF/TGFBR1/TGFB1/PTK2/EGFR/FN1/TXN/KDR/IRS1/IGF1/NKX3-1/AKR1C3/GATA3/FGFR1/MST1R/IGF2,22
GO:0045860,BP,GO:0045860,positive regulation of protein kinase activity,26/269,257/18888,0.101167315,7.103525089,11.84155311,4.85E-15,2.87E-13,1.20E-13,THBS1/ERBB2/FBXW7/CCND1/MAP3K7/IL1B/VEGFA/FGF2/TENM1/TLR4/PRKCD/TNF/RHOA/EZH2/AKT1/PTK2/EGFR/TXN/DAB2IP/IGF1/HSP90AA1/HRAS/FGFR1/CDKN1A/MST1R/MAP2K7,26
GO:0071456,BP,GO:0071456,cellular response to hypoxia,21/269,154/18888,0.136363636,9.57485637,12.84255431,5.76E-15,3.36E-13,1.41E-13,TP53/MYC/PTGS2/MAP3K7/PPARG/NPEPPS/VEGFA/MALAT1/NOTCH1/HIF1A/MTOR/FOS/TGFB1/VHL/TWIST1/AIFM1/BNIP3/MIR145/PMAIP1/NKX3-1/BNIP3L,21
GO:0009612,BP,GO:0009612,response to mechanical stimulus,24/269,216/18888,0.111111111,7.80173482,12.08455344,6.94E-15,4.00E-13,1.68E-13,THBS1/CTNNB1/ETV1/PTGS2/PIK3CA/CASP8/IL1B/NFKB1/MMP14/IGF1R/FGF2/MAPK14/TLR4/FOS/TNF/RELA/MMP2/PTK2/EGFR/BNIP3/STAT1/NFKBIA/UCN/MYD88,24
GO:0010212,BP,GO:0010212,response to ionizing radiation,20/269,138/18888,0.144927536,10.17617585,13.00409367,7.86E-15,4.48E-13,1.88E-13,TP53/BRCA1/MYC/BRCA2/GPX1/ERCC1/CASP3/PARP1/KDM1A/SOD2/MAPK14/CHEK2/BAX/SNAI2/HRAS/THBD/GATA3/MSH2/CDKN1A/CLOCK,20
GO:0043410,BP,GO:0043410,positive regulation of MAPK cascade,34/269,475/18888,0.071578947,5.025959695,10.68152854,8.83E-15,4.97E-13,2.08E-13,THBS1/CTNNB1/ERBB2/AR/FBXW7/IL6/MAP3K7/IL1B/CD44/VEGFA/IGF1R/FGF2/NOTCH1/TENM1/TLR4/TNF/EZH2/TGFB1/FGFR4/EGFR/TGFA/DAB2IP/KDR/IGF1/SPHK1/BRAF/SOX2/HRAS/FGFR1/MST1R/MAP2K7/ROCK1/IGF2/MYD88,34
GO:0007548,BP,GO:0007548,sex differentiation,27/269,288/18888,0.09375,6.582713755,11.47531423,9.35E-15,5.20E-13,2.18E-13,SRD5A2/CTNNB1/AR/BRCA2/ERCC1/CASP3/VEGFA/MMP14/NCOA1/NOTCH1/TGFBR1/MMP2/A2M/WT1/BAX/KDR/SGPL1/NKX3-1/AKR1C3/GATA3/TP63/MSH2/ZFX/LGR4/ESR1/CYP17A1/CYP19A1,27
GO:0071216,BP,GO:0071216,cellular response to biotic stimulus,26/269,265/18888,0.098113208,6.889079049,11.60446047,1.01E-14,5.56E-13,2.33E-13,TP53/IL6/CDK4/EDNRB/IL1B/NFKB1/GSTP1/NOTCH1/MAPK14/TLR4/MAPK1/TNF/RELA/RHOA/AKT1/MMP9/IL10/GIT1/DAB2IP/HSPA5/SERPINE1/VIM/CD274/NFKBIA/MAP2K7/MYD88,26
GO:1903706,BP,GO:1903706,regulation of hemopoiesis,32/269,424/18888,0.075471698,5.299291576,10.76208422,1.32E-14,7.19E-13,3.01E-13,CTNNB1/ERBB2/FBXW7/MYC/CASP8/MMP14/ARID1A/MYB/MAPK14/HIF1A/STAT3/SMARCA4/SMARCA2/MTOR/TLR4/FOS/TNF/RHOA/TGFB1/IL10/BRD2/BRD4/RB1/MEAF6/SMARCE1/MIR145/BRAF/SNAI2/GATA3/STAT1/NFKBIA/MED1,32
GO:0050727,BP,GO:0050727,regulation of inflammatory response,32/269,425/18888,0.075294118,5.286822655,10.74380956,1.42E-14,7.58E-13,3.18E-13,GPX1/IL6/PTGS2/EDNRB/IL1B/NFKB1/PPARG/GSTP1/MAPK14/STAT3/BAP1/TLR4/PRKCD/TNF/RELA/MMP9/SMAD3/TGFB1/IL10/BRD4/GIT1/RB1/SERPINE1/IGF1/SPHK1/MIR145/GATA3/NFKBIA/ESR1/MYD88/CYP19A1/CLOCK,32
GO:0048762,BP,GO:0048762,mesenchymal cell differentiation,26/269,269/18888,0.096654275,6.786639212,11.48957128,1.45E-14,7.68E-13,3.22E-13,PTEN/CTNNB1/IL6/EDNRB/IL1B/NOTCH1/HIF1A/MTOR/MAPK1/EZH2/TGFBR1/SMAD3/TGFB1/PTK2/FOXA1/FN1/DAB2IP/SNAI1/IGF1/TWIST1/MIR145/SNAI2/GATA3/STAT1/FGFR1/ROCK1,26
GO:1903131,BP,GO:1903131,mononuclear cell differentiation,34/269,484/18888,0.070247934,4.932501767,10.53452478,1.53E-14,8.01E-13,3.36E-13,TP53/CTNNB1/ERBB2/MYC/IL6/FASN/IL1B/PPARG/VEGFA/MMP14/ARID1A/MYB/STAT3/SMARCA4/SMARCA2/MTOR/FOS/RHOA/BMI1/EZH2/TGFB1/IL10/BRD2/BRD4/HHEX/BAX/SMARCE1/BRAF/GATA3/CD8A/MSH2/KLF6/MED1/IFNA1,34
GO:0071902,BP,GO:0071902,positive regulation of protein serine/threonine kinase activity,19/269,127/18888,0.149606299,10.50469807,12.91789197,2.07E-14,1.07E-12,4.50E-13,THBS1/ERBB2/CCND1/MAP3K7/IL1B/VEGFA/FGF2/TENM1/TLR4/TNF/RHOA/EZH2/AKT1/EGFR/DAB2IP/HRAS/FGFR1/MST1R/MAP2K7,19
GO:0050867,BP,GO:0050867,positive regulation of cell activation,30/269,380/18888,0.078947368,5.543337899,10.75391364,2.88E-14,1.47E-12,6.17E-13,THBS1/IL6/PIK3CA/IL1B/MMP14/ARID1A/MYB/SMARCA4/SMARCA2/MTOR/TLR4/TNF/RHOA/BMI1/AKT1/CAV1/TGFB1/IL10/BRD2/BRD4/IGF1/SMARCE1/MIR145/GATA3/CD274/MLH1/MSH2/CDKN1A/IGF2/MYD88,30
GO:0001837,BP,GO:0001837,epithelial to mesenchymal transition,22/269,187/18888,0.117647059,8.260660398,11.99344551,2.93E-14,1.48E-12,6.22E-13,PTEN/CTNNB1/IL6/IL1B/NOTCH1/HIF1A/MTOR/EZH2/TGFBR1/SMAD3/TGFB1/PTK2/FOXA1/DAB2IP/SNAI1/IGF1/TWIST1/MIR145/SNAI2/GATA3/FGFR1/ROCK1,22
GO:0043406,BP,GO:0043406,positive regulation of MAP kinase activity,16/269,82/18888,0.195121951,13.70060749,13.85360048,3.30E-14,1.65E-12,6.93E-13,THBS1/ERBB2/MAP3K7/IL1B/VEGFA/FGF2/TENM1/TLR4/TNF/EZH2/EGFR/DAB2IP/HRAS/FGFR1/MST1R/MAP2K7,16
GO:0001890,BP,GO:0001890,placenta development,20/269,150/18888,0.133333333,9.362081784,12.35884476,4.04E-14,2.00E-12,8.39E-13,VDR/PTGS2/CASP8/PPARG/PARP1/NCOA1/MAPK14/HIF1A/MAPK1/AKT1/PTK2/IL10/BSG/EGFR/SNAI1/PLAC1/MME/MED1/CTSB/IGF2,20
GO:0018105,BP,GO:0018105,peptidyl-serine phosphorylation,26/269,282/18888,0.092198582,6.473779957,11.13178565,4.46E-14,2.18E-12,9.15E-13,PTEN/AURKA/IL6/PTGS2/CD44/VEGFA/MAPK14/TENM1/CDK2/MTOR/HDAC6/SRPK1/MAPK1/PRKCD/TNF/LMTK2/AKT1/TGFBR1/CAV1/EGFR/TXN/BAX/BRAF/UCN/ROCK1/IFNA1,26
GO:0002696,BP,GO:0002696,positive regulation of leukocyte activation,29/269,362/18888,0.080110497,5.625007702,10.67960942,5.46E-14,2.65E-12,1.11E-12,THBS1/IL6/PIK3CA/IL1B/MMP14/ARID1A/SMARCA4/SMARCA2/MTOR/TLR4/TNF/RHOA/BMI1/AKT1/CAV1/TGFB1/IL10/BRD2/BRD4/IGF1/SMARCE1/MIR145/GATA3/CD274/MLH1/MSH2/CDKN1A/IGF2/MYD88,29
GO:0060485,BP,GO:0060485,mesenchyme development,28/269,336/18888,0.083333333,5.851301115,10.78479655,5.72E-14,2.74E-12,1.15E-12,PTEN/CTNNB1/MYC/IL6/EDNRB/IL1B/NOTCH1/HIF1A/MTOR/MAPK1/EZH2/TGFBR1/SMAD3/TGFB1/PTK2/FOXA1/FN1/WT1/DAB2IP/SNAI1/IGF1/TWIST1/MIR145/SNAI2/GATA3/STAT1/FGFR1/ROCK1,28
GO:0044843,BP,GO:0044843,cell cycle G1/S phase transition,25/269,262/18888,0.095419847,6.699963109,11.16714989,6.41E-14,3.04E-12,1.28E-12,TP53/PTEN/RBL2/FBXW7/MYC/CCND1/CDK4/BID/ARID1A/SMARCA4/SMARCA2/CDK2/EZH2/AKT1/CYP1A1/CHEK2/EGFR/CUL3/RB1/SMARCE1/SOX2/MUC1/CDKN1A/CDKN2A/ID4,25
GO:0042542,BP,GO:0042542,response to hydrogen peroxide,17/269,101/18888,0.168316832,11.81846958,13.10319643,6.75E-14,3.17E-12,1.33E-12,GPX1/IL6/CASP3/SOD2/MYB/HDAC6/PCNA/PRKCD/RELA/EZH2/MMP2/CBX8/TXN/SPHK1/AIFM1/BNIP3/STAT1,17
GO:0031960,BP,GO:0031960,response to corticosteroid,20/269,156/18888,0.128205128,9.002001716,12.06280532,8.65E-14,4.02E-12,1.69E-12,HSD3B1/IL6/PTGS2/PIK3CA/CASP3/PARP1/IGF1R/HDAC6/PCNA/FOS/TNF/IL10/EGFR/A2M/HSD3B2/PCSK1/AIFM1/AKR1C3/CDKN1A/UCN,20
GO:1901987,BP,GO:1901987,regulation of cell cycle phase transition,32/269,455/18888,0.07032967,4.938240941,10.22090669,9.36E-14,4.31E-12,1.81E-12,TP53/BRCA1/PTEN/RBL2/AURKA/FBXW7/BRCA2/CCND1/CDK4/BID/ARID1A/XRCC3/MAPK14/SMARCA4/SMARCA2/CDK2/EZH2/AKT1/CYP1A1/CHEK2/EGFR/CUL3/BRD4/RB1/SMARCE1/SOX2/MUC1/MSH2/NBN/CDKN1A/CDKN2A/CLOCK,32
GO:0045785,BP,GO:0045785,positive regulation of cell adhesion,33/269,485/18888,0.068041237,4.777557199,10.1301776,9.48E-14,4.32E-12,1.81E-12,ERBB2/IL6/PIK3CA/IL1B/CD44/VEGFA/ARID1A/SMARCA4/SMARCA2/MTOR/TNF/RELA/RHOA/BMI1/AKT1/SMAD3/CAV1/IL10/ILK/FOXA1/BRD2/BRD4/FN1/OLFM4/KDR/IGF1/SMARCE1/BRAF/SOX2/GATA3/CD274/ROCK1/IGF2,33
GO:0001701,BP,GO:0001701,in utero embryonic development,30/269,401/18888,0.074812968,5.253038408,10.34707804,1.18E-13,5.32E-12,2.23E-12,TP53/CTNNB1/AR/YBX1/BRCA2/CASP8/VEGFA/NCOA1/NOTCH1/HIF1A/BAP1/MAPK1/BMI1/HNF1B/AKT1/TGFBR1/SMAD3/IL10/EGFR/CUL3/SNAI1/IGF1/TWIST1/GATA3/MSH2/NBN/FGFR1/CDKN1A/MED1/IGF2,30
GO:0018209,BP,GO:0018209,peptidyl-serine modification,26/269,294/18888,0.088435374,6.209544041,10.82097565,1.19E-13,5.32E-12,2.23E-12,PTEN/AURKA/IL6/PTGS2/CD44/VEGFA/MAPK14/TENM1/CDK2/MTOR/HDAC6/SRPK1/MAPK1/PRKCD/TNF/LMTK2/AKT1/TGFBR1/CAV1/EGFR/TXN/BAX/BRAF/UCN/ROCK1/IFNA1,26
GO:0010631,BP,GO:0010631,epithelial cell migration,29/269,375/18888,0.077333333,5.430007435,10.4150448,1.35E-13,5.95E-12,2.50E-12,THBS1/PTEN/FBXW7/GPX1/PTGS2/PIK3CA/PPARG/VEGFA/ID1/FGF2/NOTCH1/HIF1A/MTOR/HDAC6/TNF/RHOA/AKT1/MMP9/TGFBR1/TGFB1/PTK2/MIR200C/DAB2IP/SNAI1/KDR/SNAI2/GATA3/FGFR1/ROCK1,29
GO:0043281,BP,GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,20/269,160/18888,0.125,8.776951673,11.8741668,1.41E-13,6.18E-12,2.59E-12,THBS1/MYC/GPX1/CASP8/PPARG/BID/FASLG/CD44/VEGFA/TNF/AKT1/MMP9/SMAD3/DLC1/BAX/AIFM1/PMAIP1/SOX2/NKX3-1/SFN,20
GO:0045786,BP,GO:0045786,negative regulation of cell cycle,30/269,405/18888,0.074074074,5.201156547,10.27281812,1.53E-13,6.59E-12,2.77E-12,TP53/BRCA1/PTEN/CTNNB1/RBL2/BRCA2/PTGS2/CCND1/CASP3/XRCC3/MAPK14/CDK2/TNF/EZH2/ALOX15B/TGFB1/IL10/CHEK2/EGFR/HHEX/RB1/DAB2IP/SOX2/GATA3/MUC1/MSH2/NBN/CDKN1A/CDKN2A/CLOCK,30
GO:0034644,BP,GO:0034644,cellular response to UV,16/269,90/18888,0.177777778,12.48277571,13.12477202,1.53E-13,6.59E-12,2.77E-12,TP53/TIMP1/MYC/ERCC1/PARP1/KDM1A/MAPK14/PCNA/PRKCD/MMP9/MMP2/BAX/MC1R/MME/CDKN1A/MMP1,16
GO:0071222,BP,GO:0071222,cellular response to lipopolysaccharide,23/269,225/18888,0.102222222,7.177596035,11.20468085,1.56E-13,6.65E-12,2.79E-12,IL6/CDK4/EDNRB/IL1B/NFKB1/GSTP1/MAPK14/TLR4/MAPK1/TNF/RELA/RHOA/AKT1/MMP9/IL10/GIT1/DAB2IP/SERPINE1/VIM/CD274/NFKBIA/MAP2K7/MYD88,23
GO:0090132,BP,GO:0090132,epithelium migration,29/269,378/18888,0.076719577,5.386912138,10.35573864,1.65E-13,6.95E-12,2.91E-12,THBS1/PTEN/FBXW7/GPX1/PTGS2/PIK3CA/PPARG/VEGFA/ID1/FGF2/NOTCH1/HIF1A/MTOR/HDAC6/TNF/RHOA/AKT1/MMP9/TGFBR1/TGFB1/PTK2/MIR200C/DAB2IP/SNAI1/KDR/SNAI2/GATA3/FGFR1/ROCK1,29
GO:0001889,BP,GO:0001889,liver development,19/269,143/18888,0.132867133,9.329347233,12.01754391,1.90E-13,7.95E-12,3.33E-12,AURKA/FBXW7/IL6/CCND1/PIK3CA/SOD2/NOTCH1/PCNA/TNF/RELA/EZH2/HNF1B/SMAD3/CYP1A1/IL10/EGFR/CUL3/TGFA/MED1,19
GO:0090130,BP,GO:0090130,tissue migration,29/269,383/18888,0.075718016,5.316586914,10.25828561,2.30E-13,9.52E-12,3.99E-12,THBS1/PTEN/FBXW7/GPX1/PTGS2/PIK3CA/PPARG/VEGFA/ID1/FGF2/NOTCH1/HIF1A/MTOR/HDAC6/TNF/RHOA/AKT1/MMP9/TGFBR1/TGFB1/PTK2/MIR200C/DAB2IP/SNAI1/KDR/SNAI2/GATA3/FGFR1/ROCK1,29
GO:0061008,BP,GO:0061008,hepaticobiliary system development,19/269,146/18888,0.130136986,9.137648317,11.86442875,2.79E-13,1.15E-11,4.80E-12,AURKA/FBXW7/IL6/CCND1/PIK3CA/SOD2/NOTCH1/PCNA/TNF/RELA/EZH2/HNF1B/SMAD3/CYP1A1/IL10/EGFR/CUL3/TGFA/MED1,19
GO:0008406,BP,GO:0008406,gonad development,23/269,233/18888,0.098712446,6.931154969,10.9496203,3.28E-13,1.34E-11,5.60E-12,SRD5A2/AR/BRCA2/ERCC1/CASP3/VEGFA/MMP14/NCOA1/NOTCH1/TGFBR1/MMP2/A2M/WT1/BAX/KDR/SGPL1/NKX3-1/AKR1C3/GATA3/MSH2/ZFX/ESR1/CYP19A1,23
GO:0001649,BP,GO:0001649,osteoblast differentiation,24/269,257/18888,0.093385214,6.557100082,10.78142463,3.34E-13,1.35E-11,5.64E-12,CTNNB1/IL6/FASN/PPARG/SOX11/FGF2/NOTCH1/MAPK14/TNF/TWSG1/AKT1/SMAD3/PTK2/ILK/MIR200C/SNAI1/IGF1/TWIST1/SNAI2/SOX2/TP63/LGR4/IGF2/ID4,24
GO:0000082,BP,GO:0000082,G1/S transition of mitotic cell cycle,23/269,234/18888,0.098290598,6.901534649,10.91858496,3.60E-13,1.44E-11,6.02E-12,TP53/PTEN/RBL2/MYC/CCND1/CDK4/BID/ARID1A/SMARCA4/SMARCA2/CDK2/EZH2/AKT1/CYP1A1/CHEK2/EGFR/CUL3/RB1/SMARCE1/MUC1/CDKN1A/CDKN2A/ID4,23
GO:1901342,BP,GO:1901342,regulation of vasculature development,28/269,362/18888,0.077348066,5.431041919,10.23172286,3.62E-13,1.44E-11,6.02E-12,BRCA1/THBS1/CTNNB1/ERBB2/CXCR2/KLK3/IL6/IL1B/PPARG/FASLG/VEGFA/FGF2/HIF1A/STAT3/TNF/RELA/TGFBR1/TGFB1/IL10/HHEX/DAB2IP/SERPINE1/KDR/SPHK1/TWIST1/MIR145/STAT1/ROCK1,28
GO:0043086,BP,GO:0043086,negative regulation of catalytic activity,31/269,449/18888,0.069042316,4.847848585,9.918635178,3.83E-13,1.51E-11,6.31E-12,TP53/TIMP1/THBS1/PTEN/GPX1/XRCC1/EDNRB/IL1B/NFKB1/PPARG/CD44/VEGFA/GSTP1/NOTCH1/HDAC6/PRKCD/TNF/AKT1/MMP9/CAV1/HHEX/RB1/DAB2IP/SERPINE1/HRAS/MIR130B/CDKN1A/SFN/NPRL2/CDKN2A/ROCK1,31
GO:0014013,BP,GO:0014013,regulation of gliogenesis,17/269,112/18888,0.151785714,10.65772703,12.32145098,3.94E-13,1.54E-11,6.44E-12,TP53/CTNNB1/ETV5/IL6/IL1B/SOX11/MYB/NOTCH1/MTOR/TNF/RELA/KRAS/EZH2/TGFB1/EGFR/RB1/ID4,17
GO:0010821,BP,GO:0010821,regulation of mitochondrion organization,19/269,149/18888,0.127516779,8.953668821,11.71566342,4.06E-13,1.57E-11,6.57E-12,TP53/AURKA/FBXW7/GPX1/PPARG/BID/HIF1A/HDAC6/SQSTM1/AKT1/MMP9/BAX/KDR/IGF1/BNIP3/PMAIP1/BNIP3L/CLU/CAMKK2,19
GO:0007249,BP,GO:0007249,canonical NF-kappaB signal transduction,26/269,311/18888,0.083601286,5.870115588,10.40905078,4.42E-13,1.68E-11,7.03E-12,MAP3K7/EDNRB/CASP8/IL1B/NFKB1/FASLG/PARP1/VEGFA/GSTP1/TLR4/SQSTM1/TNF/RELA/RHOA/AKT1/CAV1/TGFB1/ILK/BRD4/DAB2IP/STAT1/NFKBIA/PER1/ROCK1/ESR1/MYD88,26
GO:0071375,BP,GO:0071375,cellular response to peptide hormone stimulus,26/269,311/18888,0.083601286,5.870115588,10.40905078,4.42E-13,1.68E-11,7.03E-12,MAP3K7/PIK3CA/IL1B/NFKB1/PPARG/PARP1/IGF1R/NCOA1/STAT3/MTOR/MAPK1/PRKCD/FOS/RELA/AKT1/CAV1/PTK2/RB1/IRS1/MIR145/HRAS/STAT1/CRHR2/FBP1/ROCK1/IGF2,26
GO:0045137,BP,GO:0045137,development of primary sexual characteristics,23/269,238/18888,0.096638655,6.78554247,10.79624175,5.15E-13,1.91E-11,8.00E-12,SRD5A2/AR/BRCA2/ERCC1/CASP3/VEGFA/MMP14/NCOA1/NOTCH1/TGFBR1/MMP2/A2M/WT1/BAX/KDR/SGPL1/NKX3-1/AKR1C3/GATA3/MSH2/ZFX/ESR1/CYP19A1,23
GO:0071219,BP,GO:0071219,cellular response to molecule of bacterial origin,23/269,238/18888,0.096638655,6.78554247,10.79624175,5.15E-13,1.91E-11,8.00E-12,IL6/CDK4/EDNRB/IL1B/NFKB1/GSTP1/MAPK14/TLR4/MAPK1/TNF/RELA/RHOA/AKT1/MMP9/IL10/GIT1/DAB2IP/SERPINE1/VIM/CD274/NFKBIA/MAP2K7/MYD88,23
GO:0072593,BP,GO:0072593,reactive oxygen species metabolic process,23/269,238/18888,0.096638655,6.78554247,10.79624175,5.15E-13,1.91E-11,8.00E-12,TP53/BRCA1/THBS1/ALOX12/GPX1/SOD2/GSTP1/MAPK14/HIF1A/TLR4/HDAC6/PRKCD/TNF/RHOA/TGFB1/CYP1A1/EGFR/TXN/BNIP3/PMAIP1/AKR1C3/CDKN1A/TFAP2A,23
GO:0061448,BP,GO:0061448,connective tissue development,25/269,288/18888,0.086805556,6.095105328,10.47303108,5.49E-13,2.02E-11,8.45E-12,TIMP1/CTNNB1/PIK3CA/PPARG/PARP1/CD44/NCOA1/FGF2/NOTCH1/MAPK14/HIF1A/TWSG1/TGFBR1/SMAD3/TGFB1/FOXA1/WT1/RB1/COL11A2/SNAI1/SNAI2/HRAS/GATA3/FGFR1/ID4,25
GO:0002064,BP,GO:0002064,epithelial cell development,22/269,216/18888,0.101851852,7.151590252,10.92945007,5.79E-13,2.11E-11,8.85E-12,AR/HOXB13/GPX1/EDNRB/FASN/IL1B/VEGFA/NOTCH1/HIF1A/TNF/AKT1/FOXA1/SPDEF/VIM/KDR/TP63/CDKN1A/SFN/ROCK1/ESR1/MYD88/CLOCK,22
GO:0050680,BP,GO:0050680,negative regulation of epithelial cell proliferation,20/269,173/18888,0.115606936,8.117411952,11.30393609,6.29E-13,2.27E-11,9.53E-12,THBS1/AR/FBXW7/BRCA2/VDR/PPARG/NOTCH1/TNF/TGFBR1/CAV1/TGFB1/RB1/DAB2IP/SNAI2/SOX2/NKX3-1/GATA3/STAT1/MED1/SFN,20
GO:0001822,BP,GO:0001822,kidney development,26/269,319/18888,0.081504702,5.722902658,10.22561724,7.95E-13,2.85E-11,1.20E-11,CTNNB1/CXCR2/MYC/EDNRB/SOX11/VEGFA/FGF2/NOTCH1/RHOA/EZH2/HNF1B/LZTS2/MMP9/TGFBR1/SMAD3/ILK/WT1/BAX/SGPL1/MME/NKX3-1/GATA3/STAT1/FGFR1/TFAP2A/LGR4,26
GO:0072331,BP,GO:0072331,signal transduction by p53 class mediator,20/269,177/18888,0.11299435,7.933967614,11.1403644,9.69E-13,3.45E-11,1.45E-11,TP53/AURKA/MYC/BRCA2/KDM1A/CD44/MTOR/AKT1/CHEK2/BAX/SNAI1/TWIST1/PMAIP1/SNAI2/TP63/MUC1/MSH2/NBN/CDKN1A/FHIT,20
GO:0048754,BP,GO:0048754,branching morphogenesis of an epithelial tube,19/269,157/18888,0.121019108,8.497430919,11.33864795,1.06E-12,3.70E-11,1.55E-11,CTNNB1/AR/MYC/VDR/VEGFA/MMP14/FGF2/NOTCH1/TNF/KRAS/HNF1B/ILK/FOXA1/WT1/KDR/NKX3-1/MED1/LGR4/ESR1,19
GO:2001236,BP,GO:2001236,regulation of extrinsic apoptotic signaling pathway,19/269,157/18888,0.121019108,8.497430919,11.33864795,1.06E-12,3.70E-11,1.55E-11,BRCA1/THBS1/AR/GPX1/IL1B/BID/GSTP1/TLR4/TNF/RELA/AKT1/TGFBR1/CAV1/SERPINE1/IGF1/PMAIP1/SNAI2/FGFR1/MAL,19
GO:0070661,BP,GO:0070661,leukocyte proliferation,27/269,352/18888,0.076704545,5.385856708,9.983830844,1.19E-12,4.14E-11,1.74E-11,TP53/CTNNB1/ERBB2/IL6/IL1B/CASP3/BID/SOX11/GSTP1/BAP1/TLR4/MAPK1/PRKCD/BMI1/TWSG1/PTK2/IL10/HHEX/BAX/IGF1/CD274/PAWR/CDKN1A/IGF2/IFNA1/MYD88/CLU,27
GO:1903034,BP,GO:1903034,regulation of response to wounding,20/269,179/18888,0.111731844,7.845319931,11.06049167,1.20E-12,4.14E-11,1.74E-11,THBS1/PTEN/ALOX12/IGF1R/FGF2/STAT3/MTOR/PRKCD/TNF/SMAD3/CAV1/PTK2/IL10/GIT1/SERPINE1/CD9/BRAF/HRAS/THBD/PLAU,20
GO:0010717,BP,GO:0010717,regulation of epithelial to mesenchymal transition,17/269,120/18888,0.141666667,9.947211896,11.81813108,1.26E-12,4.30E-11,1.80E-11,PTEN/CTNNB1/IL6/IL1B/NOTCH1/MTOR/EZH2/TGFBR1/SMAD3/TGFB1/PTK2/FOXA1/DAB2IP/SNAI1/TWIST1/MIR145/GATA3,17
GO:0051090,BP,GO:0051090,regulation of DNA-binding transcription factor activity,28/269,381/18888,0.073490814,5.160202558,9.860260897,1.26E-12,4.30E-11,1.80E-11,PTEN/AR/IL6/ALK/IL1B/PPARG/KDM1A/ID1/STAT3/SMARCA4/TLR4/TNF/RELA/AKT1/SMAD3/IL10/FOXA1/RB1/DAB2IP/SPHK1/PIM1/NFKBIA/CDKN2A/ESR1/ESR2/MYD88/CLOCK/CLU,28
GO:0051251,BP,GO:0051251,positive regulation of lymphocyte activation,26/269,328/18888,0.079268293,5.565871793,10.02654028,1.51E-12,5.08E-11,2.13E-11,IL6/PIK3CA/IL1B/MMP14/ARID1A/SMARCA4/SMARCA2/MTOR/TLR4/RHOA/BMI1/AKT1/CAV1/TGFB1/IL10/BRD2/BRD4/IGF1/SMARCE1/GATA3/CD274/MLH1/MSH2/CDKN1A/IGF2/MYD88,26
GO:0072001,BP,GO:0072001,renal system development,26/269,329/18888,0.079027356,5.548954249,10.00487544,1.62E-12,5.41E-11,2.27E-11,CTNNB1/CXCR2/MYC/EDNRB/SOX11/VEGFA/FGF2/NOTCH1/RHOA/EZH2/HNF1B/LZTS2/MMP9/TGFBR1/SMAD3/ILK/WT1/BAX/SGPL1/MME/NKX3-1/GATA3/STAT1/FGFR1/TFAP2A/LGR4,26
GO:0030518,BP,GO:0030518,intracellular steroid hormone receptor signaling pathway,17/269,123/18888,0.138211382,9.704596972,11.64143167,1.90E-12,6.32E-11,2.65E-11,BRCA1/AR/PARP1/KDM1A/ARID1A/SMARCA4/HDAC6/MAPK1/RHOA/FOXA1/NKX3-1/TP63/MED1/PER1/ESR1/ESR2/CLOCK,17
GO:0045787,BP,GO:0045787,positive regulation of cell cycle,26/269,332/18888,0.078313253,5.498813096,9.940409251,1.99E-12,6.56E-11,2.75E-11,AURKA/BRCA2/CCND1/CDK4/MAP3K7/IL1B/IGF1R/XRCC3/TNF/RHOA/EZH2/AKT1/CYP1A1/IL10/FOXA1/EGFR/CUL3/BRD4/RB1/TGFA/IGF1/SPHK1/NKX3-1/FGFR1/MED1/IGF2,26
GO:0051302,BP,GO:0051302,regulation of cell division,20/269,186/18888,0.107526882,7.550065955,10.79040072,2.47E-12,8.08E-11,3.39E-11,YBX1/AURKA/MYC/BRCA2/IL1B/VEGFA/IGF1R/NCOA3/FGF2/RHOA/TGFB1/CUL3/GIT1/TGFA/MIR145/NKX3-1/TP63/SFN/IGF2/FGF3,20
GO:0007162,BP,GO:0007162,negative regulation of cell adhesion,25/269,310/18888,0.080645161,5.662549466,9.949110955,2.83E-12,9.21E-11,3.86E-11,THBS1/PTEN/ERBB2/ALOX12/CASP3/VEGFA/MMP14/CDH1/NOTCH1/PRKCD/RHOA/TWSG1/AKT1/TGFB1/MMP2/PTK2/IL10/DLC1/SERPINE1/CD9/SNAI2/MUC1/CD274/PAWR/CDKN2A,25
GO:1902806,BP,GO:1902806,regulation of cell cycle G1/S phase transition,21/269,211/18888,0.099526066,6.988283796,10.51403689,3.11E-12,1.00E-10,4.21E-11,TP53/PTEN/RBL2/FBXW7/CCND1/BID/ARID1A/SMARCA4/SMARCA2/CDK2/EZH2/AKT1/CYP1A1/CHEK2/EGFR/RB1/SMARCE1/SOX2/MUC1/CDKN1A/CDKN2A,21
GO:0030850,BP,GO:0030850,prostate gland development,12/269,49/18888,0.244897959,17.19566042,13.6441735,3.15E-12,1.01E-10,4.24E-11,CTNNB1/AR/HOXB13/NOTCH1/ALOX15B/MMP2/FOXA1/NKX3-1/TP63/ESR1/ID4/CYP19A1,12
GO:0032102,BP,GO:0032102,negative regulation of response to external stimulus,30/269,456/18888,0.065789474,4.619448249,9.404116835,3.22E-12,1.03E-10,4.30E-11,THBS1/PTEN/ALOX12/GPX1/NFKB1/PPARG/PARP1/GSTP1/FGF2/NOTCH1/MAPK14/STAT3/HDAC6/PRKCD/TNF/SMAD3/TGFB1/IL10/A2M/GIT1/RB1/SERPINE1/IGF1/CD9/MIR145/THBD/GATA3/UCN/CYP19A1/PLAU,30
GO:1904019,BP,GO:1904019,epithelial cell apoptotic process,18/269,147/18888,0.12244898,8.59783021,11.11555944,3.45E-12,1.09E-10,4.58E-11,THBS1/IL6/CASP3/BID/FASLG/IGF1R/TNF/TGFB1/IL10/RB1/BAX/DAB2IP/SERPINE1/KDR/BRAF/AKR1C3/GATA3/ESR1,18
GO:2000116,BP,GO:2000116,regulation of cysteine-type endopeptidase activity,20/269,190/18888,0.105263158,7.391117198,10.64229905,3.67E-12,1.15E-10,4.84E-11,THBS1/MYC/GPX1/CASP8/PPARG/BID/FASLG/CD44/VEGFA/TNF/AKT1/MMP9/SMAD3/DLC1/BAX/AIFM1/PMAIP1/SOX2/NKX3-1/SFN,20
GO:0071383,BP,GO:0071383,cellular response to steroid hormone stimulus,21/269,213/18888,0.098591549,6.922666108,10.44855422,3.73E-12,1.16E-10,4.88E-11,BRCA1/AR/PARP1/KDM1A/IGF1R/ARID1A/SMARCA4/HDAC6/MAPK1/RHOA/FOXA1/EGFR/AIFM1/NKX3-1/AKR1C3/TP63/MED1/PER1/ESR1/ESR2/CLOCK,21
GO:0034612,BP,GO:0034612,response to tumor necrosis factor,23/269,263/18888,0.087452471,6.140528927,10.0906001,4.16E-12,1.29E-10,5.40E-11,TP53/BRCA1/THBS1/PTGS2/MAP3K7/CASP8/NFKB1/CASP3/GSTP1/MAPK14/MAPK1/FOS/TNF/RELA/AKT1/ILK/DAB2IP/SPHK1/NKX3-1/GATA3/STAT1/NFKBIA/MAP2K7,23
GO:0045165,BP,GO:0045165,cell fate commitment,24/269,289/18888,0.083044983,5.831054399,9.947764746,4.22E-12,1.30E-10,5.45E-11,TP53/CTNNB1/AR/IL6/PPARG/CASP3/FGF2/NOTCH1/STAT3/MTOR/RHOA/HNF1B/TGFBR1/FOXA1/SPDEF/BRD2/BRD4/WT1/KDR/BRAF/SOX2/GATA3/FGFR1/NANOG,24
GO:0070141,BP,GO:0070141,response to UV-A,8/269,14/18888,0.571428571,40.12320765,17.60134888,4.25E-12,1.30E-10,5.46E-11,TIMP1/CCND1/AKT1/MMP9/MMP2/EGFR/MME/MMP1,8
GO:2000377,BP,GO:2000377,regulation of reactive oxygen species metabolic process,18/269,149/18888,0.120805369,8.482423093,11.02152384,4.36E-12,1.32E-10,5.55E-11,TP53/BRCA1/THBS1/SOD2/GSTP1/MAPK14/HIF1A/TLR4/HDAC6/PRKCD/TNF/RHOA/TGFB1/EGFR/BNIP3/AKR1C3/CDKN1A/TFAP2A,18
GO:0072091,BP,GO:0072091,regulation of stem cell proliferation,15/269,96/18888,0.15625,10.97118959,11.77268551,6.36E-12,1.92E-10,8.04E-11,TP53/CTNNB1/KDM1A/SOX11/FGF2/NOTCH1/TGFBR1/TGFB1/KDR/SNAI2/PIM1/TP63/FGFR1/NANOG/SFN,15
GO:0009755,BP,GO:0009755,hormone-mediated signaling pathway,20/269,196/18888,0.102040816,7.164858508,10.42804069,6.55E-12,1.95E-10,8.19E-11,BRCA1/AR/PPARG/PARP1/KDM1A/ARID1A/NCOA1/SMARCA4/HDAC6/MAPK1/RELA/RHOA/FOXA1/NKX3-1/TP63/MED1/PER1/ESR1/ESR2/CLOCK,20
GO:0030900,BP,GO:0030900,forebrain development,28/269,408/18888,0.068627451,4.818718565,9.372947942,6.56E-12,1.95E-10,8.19E-11,SRD5A2/PTEN/CTNNB1/HSD3B1/XRCC1/ALK/CASP3/KDM1A/IGF1R/NCOA1/FGF2/CDH1/NOTCH1/HIF1A/RHOA/KRAS/EZH2/TWSG1/EGFR/DLC1/HSD3B2/BAX/DAB2IP/PCSK1/BNIP3/SOX2/FGFR1/ID4,28
GO:0021782,BP,GO:0021782,glial cell development,17/269,133/18888,0.127819549,8.974928026,11.0936258,6.93E-12,2.05E-10,8.59E-11,PTEN/ERBB2/IL6/IL1B/SOX11/TLR4/MAPK1/TNF/KRAS/AKT1/ILK/EGFR/VIM/HRAS/ID4/MAL/CLU,17
GO:0048511,BP,GO:0048511,rhythmic process,24/269,297/18888,0.080808081,5.67398896,9.758745356,7.55E-12,2.22E-10,9.31E-11,TP53/PTEN/FBXW7/PPARG/CASP3/PARP1/ID1/IGF1R/NCOA1/NOTCH1/MTOR/PCNA/TNF/EZH2/MMP2/EGFR/A2M/SGPL1/TWIST1/PER1/LGR4/ESR1/ID4/CLOCK,24
GO:0051384,BP,GO:0051384,response to glucocorticoid,17/269,134/18888,0.126865672,8.907950952,11.04202852,7.83E-12,2.29E-10,9.59E-11,HSD3B1/IL6/PTGS2/PIK3CA/CASP3/IGF1R/HDAC6/PCNA/FOS/TNF/IL10/EGFR/A2M/HSD3B2/PCSK1/CDKN1A/UCN,17
GO:0050769,BP,GO:0050769,positive regulation of neurogenesis,22/269,246/18888,0.089430894,6.279445099,10.01818469,7.96E-12,2.30E-10,9.66E-11,CTNNB1/ETV5/IL6/IL1B/KDM1A/SOX11/VEGFA/FGF2/MYB/NOTCH1/HIF1A/MTOR/HDAC6/TNF/RELA/KRAS/TGFB1/EGFR/FN1/BRAF/MME/ID4,22
GO:0045765,BP,GO:0045765,regulation of angiogenesis,26/269,353/18888,0.073654391,5.171688238,9.510040284,7.99E-12,2.30E-10,9.66E-11,BRCA1/THBS1/CTNNB1/ERBB2/CXCR2/KLK3/IL6/IL1B/PPARG/FASLG/VEGFA/FGF2/HIF1A/STAT3/TNF/RELA/IL10/HHEX/DAB2IP/SERPINE1/KDR/SPHK1/TWIST1/MIR145/STAT1/ROCK1,26
GO:0061180,BP,GO:0061180,mammary gland epithelium development,13/269,67/18888,0.194029851,13.62392498,12.44199187,9.49E-12,2.72E-10,1.14E-10,AR/BRCA2/GPX1/VDR/CCND1/FGF2/HIF1A/MAPK1/AKT1/BAX/GATA3/MED1/ESR1,13
GO:1901990,BP,GO:1901990,regulation of mitotic cell cycle phase transition,26/269,356/18888,0.073033708,5.128106595,9.451357929,9.67E-12,2.75E-10,1.15E-10,TP53/BRCA1/PTEN/RBL2/AURKA/CCND1/CDK4/BID/ARID1A/XRCC3/SMARCA4/SMARCA2/CDK2/EZH2/AKT1/CYP1A1/CHEK2/EGFR/CUL3/BRD4/RB1/SMARCE1/MUC1/NBN/CDKN1A/CDKN2A,26
GO:0048146,BP,GO:0048146,positive regulation of fibroblast proliferation,12/269,54/18888,0.222222222,15.60346964,12.91698345,1.10E-11,3.11E-10,1.30E-10,MYC/CDK4/MYB/S100A6/BMI1/EGFR/FN1/IGF1/SPHK1/HRAS/CDKN1A/ESR1,12
GO:0060251,BP,GO:0060251,regulation of glial cell proliferation,11/269,42/18888,0.261904762,18.38980351,13.56092084,1.15E-11,3.25E-10,1.36E-10,TP53/ETV5/IL6/IL1B/SOX11/MYB/NOTCH1/TNF/KRAS/EGFR/RB1,11
GO:0001558,BP,GO:0001558,regulation of cell growth,28/269,418/18888,0.066985646,4.703438217,9.20320829,1.17E-11,3.26E-10,1.37E-10,TP53/BRCA1/ERBB2/VEGFA/MMP14/CDH1/BAP1/SMARCA4/SMARCA2/MTOR/HDAC6/AKT1/TGFBR1/SMAD3/TGFB1/EGFR/FN1/WT1/RB1/MEAF6/IGF1/SPHK1/CDKN1A/UCN/SFN/CDKN2A/FBP1/ESR2,28
GO:0052547,BP,GO:0052547,regulation of peptidase activity,24/269,304/18888,0.078947368,5.543337899,9.598904815,1.24E-11,3.44E-10,1.44E-10,TIMP1/THBS1/MYC/GPX1/CASP8/PPARG/BID/FASLG/CD44/VEGFA/STAT3/TNF/AKT1/MMP9/SMAD3/CAV1/DLC1/BAX/SERPINE1/AIFM1/PMAIP1/SOX2/NKX3-1/SFN,24
GO:0070371,BP,GO:0070371,ERK1 and ERK2 cascade,25/269,332/18888,0.075301205,5.287320285,9.47310264,1.27E-11,3.52E-10,1.47E-10,ERBB2/FBXW7/MYC/IL1B/CD44/GSTP1/FGF2/NOTCH1/TLR4/MAPK1/TNF/DUSP6/PSCA/TGFB1/FGFR4/MIR200C/EGFR/FN1/DAB2IP/KDR/IGF1/MIR145/BRAF/HRAS/MAP2K7,25
GO:0044703,BP,GO:0044703,multi-organism reproductive process,20/269,204/18888,0.098039216,6.883883665,10.15602324,1.37E-11,3.76E-10,1.58E-10,TIMP1/AR/VDR/PTGS2/IL1B/PARP1/VEGFA/KLK14/FOS/AKT1/MMP9/MMP2/CYP1A1/BSG/TAC1/THBD/MED1/UCN/CTSB/ESR1,20
GO:0001836,BP,GO:0001836,release of cytochrome c from mitochondria,12/269,55/18888,0.218181818,15.31977019,12.78312672,1.39E-11,3.79E-10,1.59E-10,TP53/GPX1/BID/SOD2/AKT1/MMP9/BAX/IGF1/BNIP3/PMAIP1/SFN/CLU,12
GO:0043525,BP,GO:0043525,positive regulation of neuron apoptotic process,13/269,69/18888,0.188405797,13.22902861,12.23200611,1.41E-11,3.82E-10,1.60E-10,TP53/CTNNB1/FBXW7/CASP8/CASP3/FASLG/MYB/TNF/MMP2/BAX/AIFM1/TFAP2A/UBE2M,13
GO:0043401,BP,GO:0043401,steroid hormone mediated signaling pathway,17/269,139/18888,0.122302158,8.587521061,10.79189495,1.43E-11,3.84E-10,1.61E-10,BRCA1/AR/PARP1/KDM1A/ARID1A/SMARCA4/HDAC6/MAPK1/RHOA/FOXA1/NKX3-1/TP63/MED1/PER1/ESR1/ESR2/CLOCK,17
GO:0052548,BP,GO:0052548,regulation of endopeptidase activity,23/269,280/18888,0.082142857,5.767711099,9.660921484,1.51E-11,4.04E-10,1.69E-10,TIMP1/THBS1/MYC/GPX1/CASP8/PPARG/BID/FASLG/CD44/VEGFA/STAT3/TNF/AKT1/MMP9/SMAD3/DLC1/BAX/SERPINE1/AIFM1/PMAIP1/SOX2/NKX3-1/SFN,23
GO:0050767,BP,GO:0050767,regulation of neurogenesis,27/269,393/18888,0.06870229,4.823973439,9.207960096,1.56E-11,4.14E-10,1.74E-10,TP53/PTEN/CTNNB1/ETV5/IL6/IL1B/KDM1A/SOX11/VEGFA/FGF2/MYB/CDH1/NOTCH1/HIF1A/MTOR/HDAC6/TNF/RELA/KRAS/EZH2/TGFB1/EGFR/FN1/RB1/BRAF/MME/ID4,27
GO:0051091,BP,GO:0051091,positive regulation of DNA-binding transcription factor activity,21/269,230/18888,0.091304348,6.410990787,9.924019805,1.63E-11,4.32E-10,1.81E-10,PTEN/AR/IL6/ALK/IL1B/PPARG/STAT3/SMARCA4/TLR4/TNF/RELA/AKT1/SMAD3/IL10/FOXA1/SPHK1/ESR1/ESR2/MYD88/CLOCK/CLU,21
GO:0048568,BP,GO:0048568,embryonic organ development,29/269,455/18888,0.063736264,4.475280853,9.019387556,1.64E-11,4.32E-10,1.81E-10,TP53/CTNNB1/ERCC1/CASP8/SOX11/VEGFA/MMP14/NCOA1/NOTCH1/HIF1A/MAPK1/TNF/BMI1/HNF1B/AKT1/TGFBR1/SMAD3/TGFB1/IL10/EGFR/A2M/SNAI1/KDR/TWIST1/GATA3/FGFR1/TFAP2A/MED1/IGF2,29
GO:0046660,BP,GO:0046660,female sex differentiation,16/269,121/18888,0.132231405,9.284709208,10.98884333,1.72E-11,4.52E-10,1.89E-10,SRD5A2/BRCA2/CASP3/VEGFA/MMP14/NOTCH1/MMP2/A2M/WT1/BAX/KDR/SGPL1/TP63/ZFX/ESR1/CYP19A1,16
GO:2000045,BP,GO:2000045,regulation of G1/S transition of mitotic cell cycle,19/269,185/18888,0.102702703,7.211333266,10.2045654,2.00E-11,5.20E-10,2.18E-10,TP53/PTEN/RBL2/CCND1/BID/ARID1A/SMARCA4/SMARCA2/CDK2/EZH2/AKT1/CYP1A1/CHEK2/EGFR/RB1/SMARCE1/MUC1/CDKN1A/CDKN2A,19
GO:0097305,BP,GO:0097305,response to alcohol,22/269,259/18888,0.084942085,5.964260596,9.669168674,2.20E-11,5.70E-10,2.39E-10,BRCA1/CTNNB1/HSD3B1/CDK4/CASP8/PARP1/SOD2/IGF1R/CDH1/HDAC6/FOS/TNF/AKT1/TGFBR1/TGFB1/A2M/HSD3B2/AIFM1/AKR1C3/CDKN1A/FBP1/MYD88,22
GO:0071482,BP,GO:0071482,cellular response to light stimulus,16/269,123/18888,0.130081301,9.133738326,10.87797163,2.22E-11,5.73E-10,2.40E-10,TP53/TIMP1/MYC/ERCC1/PARP1/KDM1A/MAPK14/PCNA/PRKCD/MMP9/MMP2/BAX/MC1R/MME/CDKN1A/MMP1,16
GO:0007584,BP,GO:0007584,response to nutrient,18/269,164/18888,0.109756098,7.706591713,10.36821346,2.24E-11,5.74E-10,2.41E-10,GPX1/VDR/ERCC1/PTGS2/PPARG/SOD2/IGF1R/NCOA1/MTOR/RELA/CYP1A1/EGFR/A2M/SNAI2/PIM1/AKR1C3/STAT1/MED1,18
GO:2001235,BP,GO:2001235,positive regulation of apoptotic signaling pathway,17/269,143/18888,0.118881119,8.347310682,10.60066609,2.26E-11,5.76E-10,2.41E-10,TP53/THBS1/FBXW7/MYC/BID/TLR4/PRKCD/TNF/TGFBR1/CAV1/MMP2/BAX/DAB2IP/PMAIP1/NKX3-1/TP63/MAL,17
GO:0043122,BP,GO:0043122,regulation of canonical NF-kappaB signal transduction,23/269,286/18888,0.08041958,5.646710167,9.517617245,2.32E-11,5.84E-10,2.45E-10,MAP3K7/EDNRB/CASP8/IL1B/FASLG/PARP1/VEGFA/GSTP1/TLR4/SQSTM1/TNF/RELA/RHOA/CAV1/TGFB1/ILK/BRD4/DAB2IP/STAT1/NFKBIA/PER1/ESR1/MYD88,23
GO:0043542,BP,GO:0043542,endothelial cell migration,23/269,286/18888,0.08041958,5.646710167,9.517617245,2.32E-11,5.84E-10,2.45E-10,THBS1/FBXW7/GPX1/PTGS2/PIK3CA/PPARG/VEGFA/ID1/FGF2/NOTCH1/HIF1A/TNF/RHOA/AKT1/TGFBR1/TGFB1/PTK2/MIR200C/DAB2IP/KDR/SNAI2/GATA3/FGFR1,23
GO:0030098,BP,GO:0030098,lymphocyte differentiation,28/269,432/18888,0.064814815,4.551011979,8.974384532,2.53E-11,6.35E-10,2.66E-10,TP53/CTNNB1/ERBB2/IL6/IL1B/MMP14/ARID1A/MYB/STAT3/SMARCA4/SMARCA2/MTOR/RHOA/BMI1/EZH2/TGFB1/IL10/BRD2/BRD4/HHEX/BAX/SMARCE1/BRAF/GATA3/CD8A/MSH2/KLF6/IFNA1,28
GO:0016049,BP,GO:0016049,cell growth,30/269,496/18888,0.060483871,4.2469121,8.807980508,2.63E-11,6.56E-10,2.75E-10,TP53/BRCA1/CTNNB1/ERBB2/AURKA/VEGFA/MMP14/CDH1/BAP1/SMARCA4/SMARCA2/MTOR/HDAC6/AKT1/TGFBR1/SMAD3/TGFB1/EGFR/FN1/WT1/RB1/MEAF6/IGF1/SPHK1/CDKN1A/UCN/SFN/CDKN2A/FBP1/ESR2,30
GO:0042770,BP,GO:0042770,signal transduction in response to DNA damage,19/269,188/18888,0.10106383,7.096258799,10.09720029,2.65E-11,6.56E-10,2.75E-10,TP53/BRCA1/BRCA2/CCND1/BID/KDM1A/CD44/MAPK14/CDK2/CHEK2/SNAI1/TWIST1/PMAIP1/SNAI2/MUC1/MSH2/NBN/CDKN1A/CLOCK,19
GO:0044706,BP,GO:0044706,multi-multicellular organism process,20/269,212/18888,0.094339623,6.62411447,9.898277007,2.78E-11,6.84E-10,2.87E-10,TIMP1/AR/VDR/PTGS2/IL1B/PARP1/VEGFA/KLK14/FOS/AKT1/MMP9/MMP2/CYP1A1/BSG/TAC1/THBD/MED1/UCN/CTSB/ESR1,20
GO:0032963,BP,GO:0032963,collagen metabolic process,15/269,107/18888,0.140186916,9.843310287,11.02622499,3.19E-11,7.79E-10,3.26E-10,IL6/MMP14/MYB/NOTCH1/HIF1A/MMP9/TGFB1/MMP2/CBX8/VIM/MIR145/MMP7/UCN/CTSB/MMP1,15
GO:0001819,BP,GO:0001819,positive regulation of cytokine production,30/269,500/18888,0.06,4.212936803,8.751840458,3.21E-11,7.79E-10,3.26E-10,BRCA1/THBS1/IL6/PTGS2/MAP3K7/CASP8/IL1B/MYB/MAPK14/HIF1A/STAT3/TLR4/TNF/RELA/ALOX15B/SMAD3/TGFB1/IL10/SERPINE1/SPHK1/TWIST1/MIR145/HSP90AA1/HRAS/GATA3/STAT1/CD274/UCN/MYD88/CLU,30
GO:0033135,BP,GO:0033135,regulation of peptidyl-serine phosphorylation,16/269,126/18888,0.126984127,8.916268366,10.7163199,3.23E-11,7.79E-10,3.26E-10,PTEN/IL6/PTGS2/CD44/VEGFA/TENM1/HDAC6/TNF/AKT1/CAV1/EGFR/TXN/BAX/BRAF/UCN/IFNA1,16
GO:0072089,BP,GO:0072089,stem cell proliferation,16/269,126/18888,0.126984127,8.916268366,10.7163199,3.23E-11,7.79E-10,3.26E-10,TP53/CTNNB1/BRCA2/KDM1A/SOX11/FGF2/NOTCH1/TGFBR1/TGFB1/KDR/SNAI2/PIM1/TP63/FGFR1/NANOG/SFN,16
GO:0010718,BP,GO:0010718,positive regulation of epithelial to mesenchymal transition,12/269,59/18888,0.203389831,14.2811417,12.28081652,3.37E-11,8.05E-10,3.38E-10,CTNNB1/IL6/IL1B/NOTCH1/MTOR/EZH2/TGFBR1/SMAD3/TGFB1/PTK2/SNAI1/TWIST1,12
GO:0002573,BP,GO:0002573,myeloid leukocyte differentiation,21/269,239/18888,0.087866109,6.169572724,9.667301856,3.38E-11,8.05E-10,3.38E-10,CTNNB1/FBXW7/MYC/FASN/CASP8/PPARG/PARP1/VEGFA/MAPK14/BAP1/MTOR/TLR4/FOS/TNF/MMP9/TGFB1/RB1/MIR145/GATA3/MED1/MYD88,21
GO:0021543,BP,GO:0021543,pallium development,19/269,191/18888,0.09947644,6.984799237,9.992168756,3.50E-11,8.31E-10,3.48E-10,SRD5A2/PTEN/CTNNB1/HSD3B1/XRCC1/ALK/CASP3/KDM1A/IGF1R/NCOA1/HIF1A/RHOA/EZH2/EGFR/HSD3B2/BAX/DAB2IP/BNIP3/ID4,19
GO:0042445,BP,GO:0042445,hormone metabolic process,21/269,240/18888,0.0875,6.143866171,9.63959096,3.65E-11,8.62E-10,3.62E-10,SRD5A2/HSD3B1/UGT2B17/EDNRB/NFKB1/IGF1R/HIF1A/CYP1A1/FOXA1/HSD3B2/PCSK1/SGPL1/MME/AKR1C3/GATA3/MED1/CTSB/RBP1/ESR1/CYP17A1/CYP19A1,21
GO:0030099,BP,GO:0030099,myeloid cell differentiation,28/269,439/18888,0.063781321,4.478444589,8.863604891,3.69E-11,8.67E-10,3.64E-10,CTNNB1/FBXW7/MYC/FASN/CASP8/PPARG/CASP3/PARP1/VEGFA/MYB/MAPK14/HIF1A/STAT3/BAP1/MTOR/TLR4/HDAC6/FOS/TNF/MMP9/TGFB1/RB1/MIR145/GATA3/STAT1/NFKBIA/MED1/MYD88,28
GO:0014009,BP,GO:0014009,glial cell proliferation,12/269,60/18888,0.2,14.04312268,12.16282795,4.16E-11,9.71E-10,4.07E-10,TP53/ETV5/IL6/IL1B/SOX11/MYB/NOTCH1/TNF/KRAS/EGFR/RB1/CLU,12
GO:0050863,BP,GO:0050863,regulation of T cell activation,26/269,382/18888,0.068062827,4.779073162,8.968920131,4.65E-11,1.07E-09,4.51E-10,CTNNB1/ERBB2/IL6/PIK3CA/IL1B/CASP3/BID/ARID1A/SMARCA4/SMARCA2/MTOR/RHOA/BMI1/TWSG1/AKT1/CAV1/IL10/BRD2/BRD4/IGF1/SMARCE1/BRAF/GATA3/CD274/PAWR/IGF2,26
GO:1903037,BP,GO:1903037,regulation of leukocyte cell-cell adhesion,26/269,382/18888,0.068062827,4.779073162,8.968920131,4.65E-11,1.07E-09,4.51E-10,ERBB2/IL6/PIK3CA/IL1B/CASP3/CD44/ARID1A/SMARCA4/SMARCA2/MTOR/TNF/RELA/RHOA/BMI1/TWSG1/AKT1/CAV1/IL10/BRD2/BRD4/IGF1/SMARCE1/GATA3/CD274/PAWR/IGF2,26
GO:0009895,BP,GO:0009895,negative regulation of catabolic process,25/269,353/18888,0.07082153,4.972777152,9.056590186,4.79E-11,1.10E-09,4.62E-10,TP53/TIMP1/YBX1/PIK3CA/ALK/IL1B/MAPK14/STAT3/RILP/MTOR/TNF/RELA/AKT1/SMAD3/IL10/EGFR/GIT1/PKP1/PKP3/DAB2IP/VHL/FBP1/ROCK1/MYD88/FHIT,25
GO:0022409,BP,GO:0022409,positive regulation of cell-cell adhesion,24/269,325/18888,0.073846154,5.185152988,9.147625798,5.01E-11,1.15E-09,4.81E-10,IL6/PIK3CA/IL1B/CD44/ARID1A/SMARCA4/SMARCA2/MTOR/TNF/RELA/RHOA/BMI1/AKT1/CAV1/IL10/FOXA1/BRD2/BRD4/IGF1/SMARCE1/SOX2/GATA3/CD274/IGF2,24
GO:0060740,BP,GO:0060740,prostate gland epithelium morphogenesis,9/269,26/18888,0.346153846,24.30540463,14.2931814,5.33E-11,1.21E-09,5.09E-10,AR/HOXB13/NOTCH1/MMP2/FOXA1/NKX3-1/TP63/ESR1/ID4,9
GO:0090398,BP,GO:0090398,cellular senescence,15/269,111/18888,0.135135135,9.488596403,10.78111617,5.46E-11,1.24E-09,5.18E-10,TP53/PTEN/YBX1/BRCA2/IGF1R/MAPK14/CDK2/PRKCD/TWIST1/HRAS/TP63/PAWR/CDKN1A/CDKN2A/MAP2K7,15
GO:0033138,BP,GO:0033138,positive regulation of peptidyl-serine phosphorylation,14/269,93/18888,0.150537634,10.57009234,11.12028433,5.48E-11,1.24E-09,5.18E-10,IL6/PTGS2/CD44/VEGFA/TENM1/HDAC6/TNF/AKT1/CAV1/EGFR/TXN/BRAF/UCN/IFNA1,14
GO:0001704,BP,GO:0001704,formation of primary germ layer,16/269,131/18888,0.122137405,8.57595278,10.45853061,5.88E-11,1.32E-09,5.53E-10,CTNNB1/LAMB3/MMP14/HNF1B/TWSG1/MMP9/SMAD3/MMP2/MIR200C/BRD3/FN1/SNAI1/MIR145/SOX2/FGFR1/NANOG,16
GO:0008544,BP,GO:0008544,epidermis development,26/269,387/18888,0.067183463,4.717328031,8.881129887,6.19E-11,1.38E-09,5.79E-10,CTNNB1/YBX1/ALOX12/HOXB13/ETV4/VDR/LAMB3/CASP3/NCOA3/FGF2/NOTCH1/KLK14/TNF/RELA/EZH2/ALOX15B/EGFR/SNAI1/AKR1C3/TP63/FGFR1/CDKN1A/MED1/SFN/LGR4/ROCK1,26
GO:0007159,BP,GO:0007159,leukocyte cell-cell adhesion,27/269,419/18888,0.064439141,4.524633798,8.769579639,6.70E-11,1.49E-09,6.24E-10,ERBB2/IL6/PIK3CA/IL1B/CASP3/CD44/ARID1A/SMARCA4/SMARCA2/MTOR/TNF/RELA/RHOA/BMI1/TWSG1/AKT1/CAV1/IL10/BRD2/BRD4/IGF1/SMARCE1/GATA3/CD274/PAWR/ROCK1/IGF2,27
GO:0048863,BP,GO:0048863,stem cell differentiation,21/269,248/18888,0.084677419,5.94567694,9.423409947,6.77E-11,1.50E-09,6.28E-10,TP53/CTNNB1/EDNRB/FGF2/NOTCH1/MAPK14/HIF1A/STAT3/MAPK1/EZH2/HNF1B/CDK12/FOXA1/A2M/FN1/TWIST1/SNAI2/TP63/FGFR1/MED1/ESR1,21
GO:0044772,BP,GO:0044772,mitotic cell cycle phase transition,28/269,451/18888,0.062084257,4.359284201,8.678993133,6.92E-11,1.52E-09,6.39E-10,TP53/BRCA1/PTEN/RBL2/AURKA/MYC/CCND1/CDK4/BID/ARID1A/XRCC3/SMARCA4/SMARCA2/CDK2/EZH2/AKT1/CYP1A1/CHEK2/EGFR/CUL3/BRD4/RB1/SMARCE1/MUC1/NBN/CDKN1A/CDKN2A/ID4,28
GO:0062012,BP,GO:0062012,regulation of small molecule metabolic process,24/269,331/18888,0.072507553,5.0911623,9.025811845,7.32E-11,1.60E-09,6.73E-10,TP53/BRCA1/PTGS2/IL1B/NFKB1/PPARG/PARP1/HIF1A/STAT3/MTOR/TNF/AKT1/CAV1/FGFR4/GIT1/SNAI1/IRS1/IGF1/TWIST1/PMAIP1/SNAI2/AKR1C3/FBP1/IGF2,24
GO:0007369,BP,GO:0007369,gastrulation,19/269,200/18888,0.095,6.670483271,9.690208303,7.82E-11,1.70E-09,7.15E-10,TP53/CTNNB1/LAMB3/MMP14/HNF1B/TWSG1/MMP9/SMAD3/MMP2/IL10/MIR200C/CUL3/BRD3/FN1/SNAI1/MIR145/SOX2/FGFR1/NANOG,19
GO:1902894,BP,GO:1902894,negative regulation of miRNA transcription,9/269,27/18888,0.333333333,23.40520446,14.0032193,7.90E-11,1.71E-09,7.19E-10,PPARG/VEGFA/HIF1A/TNF/RELA/SMAD3/TGFB1/TWIST1/ESR1,9
GO:2001243,BP,GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,15/269,114/18888,0.131578947,9.238896498,10.6052893,8.06E-11,1.74E-09,7.30E-10,CTNNB1/GPX1/PTGS2/BID/KDM1A/CD44/SOD2/HIF1A/AKT1/MMP9/IL10/SNAI1/SNAI2/MUC1/CLU,15
GO:0071496,BP,GO:0071496,cellular response to external stimulus,24/269,335/18888,0.071641791,5.030372302,8.946227768,9.39E-11,2.02E-09,8.46E-10,TP53/VDR/PTGS2/CASP8/IL1B/NFKB1/IGF1R/NCOA1/FGF2/MTOR/TLR4/MAPK1/FOS/EGFR/HSPA5/BNIP3/PMAIP1/SNAI2/PIM1/AKR1C3/CDKN1A/MED1/NPRL2/MYD88,24
GO:0045862,BP,GO:0045862,positive regulation of proteolysis,24/269,336/18888,0.071428571,5.015400956,8.92652947,9.98E-11,2.14E-09,8.95E-10,PTEN/AURKA/FBXW7/MYC/CASP8/IL1B/PPARG/BID/FASLG/MMP14/STAT3/TNF/AKT1/SMAD3/CAV1/PTK2/FGFR4/DLC1/BAX/DAB2IP/AIFM1/PMAIP1/NKX3-1/CLU,24
GO:0070372,BP,GO:0070372,regulation of ERK1 and ERK2 cascade,23/269,308/18888,0.074675325,5.243373727,9.024917503,1.03E-10,2.20E-09,9.21E-10,ERBB2/FBXW7/IL1B/CD44/GSTP1/FGF2/NOTCH1/TLR4/TNF/DUSP6/PSCA/TGFB1/FGFR4/MIR200C/EGFR/FN1/DAB2IP/KDR/IGF1/MIR145/BRAF/HRAS/MAP2K7,23
GO:0060512,BP,GO:0060512,prostate gland morphogenesis,9/269,28/18888,0.321428571,22.5693043,13.72852134,1.15E-10,2.41E-09,1.01E-09,AR/HOXB13/NOTCH1/MMP2/FOXA1/NKX3-1/TP63/ESR1/ID4,9
GO:0090594,BP,GO:0090594,inflammatory response to wounding,9/269,28/18888,0.321428571,22.5693043,13.72852134,1.15E-10,2.41E-09,1.01E-09,TIMP1/IL6/PPARG/HIF1A/STAT3/TLR4/TNF/TGFB1/GIT1,9
GO:2000629,BP,GO:2000629,negative regulation of miRNA metabolic process,9/269,28/18888,0.321428571,22.5693043,13.72852134,1.15E-10,2.41E-09,1.01E-09,PPARG/VEGFA/HIF1A/TNF/RELA/SMAD3/TGFB1/TWIST1/ESR1,9
GO:0021700,BP,GO:0021700,developmental maturation,24/269,341/18888,0.070381232,4.941861352,8.82919589,1.35E-10,2.82E-09,1.18E-09,PTEN/CTNNB1/AURKA/HOXB13/BRCA2/EDNRB/PPARG/KDM1A/DEFB1/VEGFA/HIF1A/BAP1/HDAC6/RHOA/MMP2/FOXA1/RB1/DAB2IP/KDR/IGF1/GATA3/FGFR1/CDKN1A/ROCK1,24
GO:0001655,BP,GO:0001655,urogenital system development,12/269,66/18888,0.181818182,12.76647516,11.50972427,1.36E-10,2.82E-09,1.18E-09,CTNNB1/AR/HOXB13/NOTCH1/ALOX15B/MMP2/FOXA1/NKX3-1/TP63/ESR1/ID4/CYP19A1,12
GO:0010332,BP,GO:0010332,response to gamma radiation,11/269,52/18888,0.211538462,14.85330283,12.02375485,1.44E-10,2.97E-09,1.25E-09,TP53/MYC/BRCA2/GPX1/PARP1/KDM1A/SOD2/CHEK2/BAX/HRAS/CDKN1A,11
GO:0072332,BP,GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,13/269,83/18888,0.156626506,10.99762619,10.97182131,1.62E-10,3.33E-09,1.40E-09,TP53/MYC/BRCA2/KDM1A/CD44/CHEK2/BAX/PMAIP1/TP63/MUC1/MSH2/CDKN1A/FHIT,13
GO:0051960,BP,GO:0051960,regulation of nervous system development,28/269,468/18888,0.05982906,4.200934134,8.428189767,1.63E-10,3.33E-09,1.40E-09,TP53/PTEN/CTNNB1/ETV5/IL6/IL1B/KDM1A/SOX11/VEGFA/FGF2/MYB/CDH1/NOTCH1/HIF1A/MTOR/HDAC6/TNF/RELA/KRAS/EZH2/AKT1/TGFB1/EGFR/FN1/RB1/BRAF/MME/ID4,28
GO:0070301,BP,GO:0070301,cellular response to hydrogen peroxide,12/269,67/18888,0.179104478,12.57593076,11.4091011,1.63E-10,3.33E-09,1.40E-09,IL6/MYB/HDAC6/PCNA/PRKCD/RELA/EZH2/CBX8/TXN/SPHK1/AIFM1/BNIP3,12
GO:0098727,BP,GO:0098727,maintenance of cell number,18/269,186/18888,0.096774194,6.79505936,9.54662336,1.84E-10,3.74E-09,1.57E-09,CTNNB1/MYC/ARID1A/NCOA3/NOTCH1/STAT3/SMARCA4/SMARCA2/EZH2/HNF1B/IGF1/SMARCE1/MIR145/BRAF/SOX2/ZHX2/TP63/NANOG,18
GO:0008585,BP,GO:0008585,female gonad development,14/269,102/18888,0.137254902,9.637437131,10.51349906,1.96E-10,3.97E-09,1.66E-09,BRCA2/CASP3/VEGFA/MMP14/NOTCH1/MMP2/A2M/WT1/BAX/KDR/SGPL1/ZFX/ESR1/CYP19A1,14
GO:0090068,BP,GO:0090068,positive regulation of cell cycle process,21/269,263/18888,0.079847909,5.60656989,9.04246533,2.02E-10,4.08E-09,1.71E-09,AURKA/CCND1/CDK4/IL1B/IGF1R/XRCC3/TNF/RHOA/EZH2/AKT1/CYP1A1/EGFR/CUL3/BRD4/RB1/TGFA/IGF1/SPHK1/FGFR1/MED1/IGF2,21
GO:0051962,BP,GO:0051962,positive regulation of nervous system development,22/269,294/18888,0.074829932,5.254229573,8.836649479,2.57E-10,5.16E-09,2.16E-09,CTNNB1/ETV5/IL6/IL1B/KDM1A/SOX11/VEGFA/FGF2/MYB/NOTCH1/HIF1A/MTOR/HDAC6/TNF/RELA/KRAS/TGFB1/EGFR/FN1/BRAF/MME/ID4,22
GO:0070663,BP,GO:0070663,regulation of leukocyte proliferation,21/269,267/18888,0.078651685,5.522576333,8.945806305,2.67E-10,5.34E-09,2.24E-09,CTNNB1/ERBB2/IL6/IL1B/CASP3/BID/SOX11/GSTP1/TLR4/MAPK1/BMI1/TWSG1/PTK2/IL10/HHEX/IGF1/CD274/PAWR/CDKN1A/IGF2/MYD88,21
GO:0055123,BP,GO:0055123,digestive system development,16/269,145/18888,0.110344828,7.747929753,9.804251777,2.75E-10,5.47E-09,2.29E-09,CTNNB1/EDNRB/SOX11/NOTCH1/HIF1A/TNF/HNF1B/SMAD3/CYP1A1/SPDEF/EGFR/RB1/TP63/CDKN1A/LGR4/IGF2,16
GO:0071356,BP,GO:0071356,cellular response to tumor necrosis factor,20/269,241/18888,0.082987552,5.827021858,9.06489453,2.80E-10,5.54E-09,2.32E-09,TP53/BRCA1/THBS1/MAP3K7/CASP8/NFKB1/GSTP1/MAPK14/MAPK1/FOS/TNF/RELA/AKT1/ILK/DAB2IP/SPHK1/NKX3-1/GATA3/STAT1/NFKBIA,20
GO:0002065,BP,GO:0002065,columnar/cuboidal epithelial cell differentiation,15/269,125/18888,0.12,8.425873606,10.01223131,3.05E-10,6.01E-09,2.52E-09,CTNNB1/FASN/SOX11/FGF2/NOTCH1/HIF1A/AKT1/CAV1/TGFB1/FOXA1/SPDEF/SERPINE1/TP63/CDKN1A/CLOCK,15
GO:0046777,BP,GO:0046777,protein autophosphorylation,18/269,192/18888,0.09375,6.582713755,9.345468532,3.10E-10,6.09E-09,2.56E-09,AURKA/ALK/VEGFA/IGF1R/MTOR/LMTK2/AKT1/CAV1/PTK2/CDK12/CHEK2/FGFR4/EGFR/KDR/PIM1/NBN/FGFR1/CAMKK2,18
GO:0046545,BP,GO:0046545,development of primary female sexual characteristics,14/269,106/18888,0.132075472,9.273760258,10.26749267,3.31E-10,6.47E-09,2.71E-09,BRCA2/CASP3/VEGFA/MMP14/NOTCH1/MMP2/A2M/WT1/BAX/KDR/SGPL1/ZFX/ESR1/CYP19A1,14
GO:0010632,BP,GO:0010632,regulation of epithelial cell migration,22/269,298/18888,0.073825503,5.183703001,8.750013801,3.33E-10,6.47E-09,2.71E-09,THBS1/PTEN/FBXW7/PTGS2/PPARG/VEGFA/FGF2/NOTCH1/HIF1A/MTOR/HDAC6/TNF/RHOA/AKT1/MMP9/TGFB1/PTK2/MIR200C/DAB2IP/KDR/GATA3/FGFR1,22
GO:0071695,BP,GO:0071695,anatomical structure maturation,21/269,271/18888,0.077490775,5.441062292,8.851076921,3.51E-10,6.81E-09,2.86E-09,CTNNB1/AURKA/HOXB13/BRCA2/EDNRB/PPARG/KDM1A/DEFB1/VEGFA/HIF1A/BAP1/HDAC6/RHOA/MMP2/FOXA1/RB1/KDR/IGF1/GATA3/FGFR1/CDKN1A,21
GO:1902105,BP,GO:1902105,regulation of leukocyte differentiation,23/269,328/18888,0.070121951,4.923655816,8.616250052,3.59E-10,6.92E-09,2.90E-09,CTNNB1/ERBB2/FBXW7/MYC/CASP8/MMP14/ARID1A/SMARCA4/SMARCA2/MTOR/TLR4/FOS/TNF/RHOA/TGFB1/IL10/BRD2/BRD4/RB1/SMARCE1/MIR145/BRAF/GATA3,23
GO:0048638,BP,GO:0048638,regulation of developmental growth,23/269,330/18888,0.06969697,4.893815478,8.577213216,4.04E-10,7.77E-09,3.26E-09,PTEN/AR/MIR25/PIK3CA/VEGFA/FGF2/CDH1/NOTCH1/MAPK14/STAT3/HDAC6/HNF1B/DUSP6/AKT1/TGFBR1/FN1/WT1/IGF1/SGPL1/PIM1/FGFR1/CDKN1A/IGF2,23
GO:0010038,BP,GO:0010038,response to metal ion,24/269,360/18888,0.066666667,4.681040892,8.475924422,4.09E-10,7.82E-09,3.28E-09,THBS1/ERCC1/PTGS2/CASP8/CASP3/PARP1/SOD2/CDH1/HIF1A/PCNA/MAPK1/FOS/AKT1/MMP9/CAV1/CYP1A1/BSG/EGFR/PCSK1/BNIP3/BRAF/AKR1C3/TFAP2A/FBP1,24
GO:0033143,BP,GO:0033143,regulation of intracellular steroid hormone receptor signaling pathway,12/269,73/18888,0.164383562,11.54229261,10.84735464,4.63E-10,8.83E-09,3.70E-09,BRCA1/AR/PARP1/KDM1A/SMARCA4/HDAC6/RHOA/FOXA1/TP63/MED1/PER1/CLOCK,12
GO:0090199,BP,GO:0090199,regulation of release of cytochrome c from mitochondria,10/269,44/18888,0.227272727,15.95809395,11.93975736,4.71E-10,8.90E-09,3.73E-09,TP53/GPX1/BID/AKT1/MMP9/BAX/IGF1/BNIP3/PMAIP1/CLU,10
GO:1990776,BP,GO:1990776,response to angiotensin,10/269,44/18888,0.227272727,15.95809395,11.93975736,4.71E-10,8.90E-09,3.73E-09,PTGS2/MAP3K7/NFKB1/IGF1R/PRKCD/RELA/SMAD3/CAV1/MIR145/ROCK1,10
GO:1903039,BP,GO:1903039,positive regulation of leukocyte cell-cell adhesion,21/269,277/18888,0.075812274,5.323205347,8.712451001,5.25E-10,9.88E-09,4.14E-09,IL6/PIK3CA/IL1B/CD44/ARID1A/SMARCA4/SMARCA2/MTOR/TNF/RELA/RHOA/BMI1/AKT1/CAV1/BRD2/BRD4/IGF1/SMARCE1/GATA3/CD274/IGF2,21
GO:0030330,BP,GO:0030330,"DNA damage response, signal transduction by p53 class mediator",12/269,74/18888,0.162162162,11.38631568,10.76009889,5.46E-10,1.02E-08,4.29E-09,TP53/BRCA2/KDM1A/CD44/CHEK2/SNAI1/TWIST1/PMAIP1/SNAI2/MUC1/NBN/CDKN1A,12
GO:0072073,BP,GO:0072073,kidney epithelium development,16/269,152/18888,0.105263158,7.391117198,9.50910386,5.57E-10,1.04E-08,4.36E-09,CTNNB1/CXCR2/MYC/EDNRB/VEGFA/FGF2/NOTCH1/HNF1B/LZTS2/SMAD3/ILK/WT1/GATA3/STAT1/FGFR1/LGR4,16
GO:0042113,BP,GO:0042113,B cell activation,21/269,278/18888,0.075539568,5.304057126,8.689738201,5.61E-10,1.04E-08,4.37E-09,TP53/ERCC1/IL6/CASP8/CASP3/MMP14/TLR4/PRKCD/BMI1/EZH2/TGFB1/IL10/HHEX/BAX/MLH1/MSH2/NBN/PAWR/CDKN1A/KLF6/IFNA1,21
GO:0031099,BP,GO:0031099,regeneration,18/269,200/18888,0.09,6.319405204,9.090255983,6.05E-10,1.12E-08,4.70E-09,AURKA/GPX1/IL6/CCND1/IGF1R/NOTCH1/PCNA/TNF/EZH2/MMP2/IL10/EGFR/IGF1/CD9/BRAF/SOX2/CDKN1A/MED1,18
GO:0045604,BP,GO:0045604,regulation of epidermal cell differentiation,11/269,59/18888,0.186440678,13.09104656,11.18035841,6.09E-10,1.12E-08,4.71E-09,ETV4/VDR/NCOA3/FGF2/NOTCH1/EZH2/ALOX15B/TP63/MED1/SFN/ROCK1,11
GO:0048565,BP,GO:0048565,digestive tract development,15/269,133/18888,0.112781955,7.919054141,9.624838907,7.38E-10,1.36E-08,5.68E-09,CTNNB1/EDNRB/SOX11/NOTCH1/HIF1A/TNF/HNF1B/SMAD3/CYP1A1/SPDEF/EGFR/RB1/TP63/CDKN1A/LGR4,15
GO:0045667,BP,GO:0045667,regulation of osteoblast differentiation,16/269,156/18888,0.102564103,7.201601373,9.348749564,8.20E-10,1.50E-08,6.29E-09,CTNNB1/IL6/PPARG/SOX11/FGF2/NOTCH1/TNF/TWSG1/SMAD3/PTK2/ILK/MIR200C/IGF1/TWIST1/SNAI2/TP63,16
GO:0060537,BP,GO:0060537,muscle tissue development,26/269,438/18888,0.059360731,4.168050109,8.063254478,8.99E-10,1.64E-08,6.87E-09,CTNNB1/MIR25/GPX1/SOX11/VEGFA/FGF2/NOTCH1/MAPK14/MTOR/FOS/RHOA/KRAS/TGFBR1/SMAD3/CAV1/TGFB1/WT1/RB1/IGF1/TWIST1/MIR145/PIM1/FGFR1/MED1/IGF2/FGF3,26
GO:0048469,BP,GO:0048469,cell maturation,18/269,205/18888,0.087804878,6.16527337,8.937712677,9.03E-10,1.64E-08,6.87E-09,CTNNB1/AURKA/HOXB13/BRCA2/EDNRB/PPARG/KDM1A/DEFB1/VEGFA/HIF1A/BAP1/HDAC6/FOXA1/RB1/KDR/GATA3/FGFR1/CDKN1A,18
GO:1904035,BP,GO:1904035,regulation of epithelial cell apoptotic process,14/269,115/18888,0.12173913,8.547987716,9.758716893,9.95E-10,1.80E-08,7.54E-09,THBS1/IL6/FASLG/IGF1R/TNF/TGFB1/RB1/BAX/SERPINE1/KDR/BRAF/AKR1C3/GATA3/ESR1,14
GO:0048147,BP,GO:0048147,negative regulation of fibroblast proliferation,9/269,35/18888,0.257142857,18.05544344,12.13909354,1.08E-09,1.94E-08,8.14E-09,TP53/MYC/SOD2/GSTP1/LZTS2/CAV1/BAX/DAB2IP/PAWR,9
GO:0045936,BP,GO:0045936,negative regulation of phosphate metabolic process,24/269,378/18888,0.063492063,4.458134183,8.163266702,1.09E-09,1.96E-08,8.20E-09,TP53/PTEN/IL1B/PPARG/PARP1/GSTP1/STAT3/PRKCD/TNF/DUSP6/AKT1/CAV1/TGFB1/GIT1/HHEX/RB1/BAX/DAB2IP/CDKN1A/SFN/NPRL2/CDKN2A/FBP1/ROCK1,24
GO:0001659,BP,GO:0001659,temperature homeostasis,17/269,183/18888,0.092896175,6.522761899,9.023654588,1.13E-09,2.00E-08,8.37E-09,GPX1/PTGS2/EDNRB/IL1B/KDM1A/VEGFA/ID1/IGF1R/NOTCH1/STAT3/SMARCA4/TLR4/SQSTM1/TNF/CAV1/RB1/LGR4,17
GO:0007565,BP,GO:0007565,female pregnancy,17/269,183/18888,0.092896175,6.522761899,9.023654588,1.13E-09,2.00E-08,8.37E-09,TIMP1/AR/VDR/PTGS2/IL1B/PARP1/VEGFA/FOS/AKT1/MMP9/MMP2/BSG/THBD/MED1/UCN/CTSB/ESR1,17
GO:0043534,BP,GO:0043534,blood vessel endothelial cell migration,17/269,183/18888,0.092896175,6.522761899,9.023654588,1.13E-09,2.00E-08,8.37E-09,THBS1/FBXW7/GPX1/PTGS2/PPARG/VEGFA/ID1/FGF2/NOTCH1/HIF1A/TNF/RHOA/AKT1/TGFB1/MIR200C/KDR/FGFR1,17
GO:0010563,BP,GO:0010563,negative regulation of phosphorus metabolic process,24/269,379/18888,0.063324538,4.446371296,8.146473441,1.15E-09,2.03E-08,8.51E-09,TP53/PTEN/IL1B/PPARG/PARP1/GSTP1/STAT3/PRKCD/TNF/DUSP6/AKT1/CAV1/TGFB1/GIT1/HHEX/RB1/BAX/DAB2IP/CDKN1A/SFN/NPRL2/CDKN2A/FBP1/ROCK1,24
GO:0061041,BP,GO:0061041,regulation of wound healing,15/269,138/18888,0.108695652,7.632131889,9.398780682,1.24E-09,2.18E-08,9.16E-09,THBS1/PTEN/ALOX12/FGF2/MTOR/PRKCD/TNF/SMAD3/CAV1/PTK2/SERPINE1/CD9/HRAS/THBD/PLAU,15
GO:0045428,BP,GO:0045428,regulation of nitric oxide biosynthetic process,11/269,63/18888,0.174603175,12.259869,10.76008184,1.28E-09,2.23E-08,9.37E-09,PTGS2/IL1B/SOD2/TLR4/TNF/AKT1/SMAD3/CAV1/IL10/HSP90AA1/CLU,11
GO:0035994,BP,GO:0035994,response to muscle stretch,8/269,25/18888,0.32,22.46899628,12.91087918,1.34E-09,2.34E-08,9.79E-09,CTNNB1/PIK3CA/NFKB1/MAPK14/FOS/RELA/PTK2/NFKBIA,8
GO:0048872,BP,GO:0048872,homeostasis of number of cells,22/269,322/18888,0.068322981,4.797340045,8.26090649,1.43E-09,2.48E-08,1.04E-08,CXCR2/IL6/CASP3/VEGFA/MYB/NOTCH1/MAPK14/HIF1A/STAT3/BAP1/HDAC6/KRAS/EZH2/AKT1/RB1/BAX/PMAIP1/GATA3/STAT1/MED1/ZFX/LGR4,22
GO:0043524,BP,GO:0043524,negative regulation of neuron apoptotic process,16/269,162/18888,0.098765432,6.934875396,9.11855574,1.43E-09,2.48E-08,1.04E-08,CTNNB1/CCND1/PIK3CA/SOD2/HIF1A/RHOA/KRAS/IL10/BAX/KDR/BRAF/HRAS/MSH2/UCN/ROCK1/CLU,16
GO:0045216,BP,GO:0045216,cell-cell junction organization,18/269,213/18888,0.084507042,5.933713807,8.703880188,1.67E-09,2.89E-08,1.21E-08,CTNNB1/IL1B/VEGFA/CDH1/TNF/RHOA/TGFBR1/SMAD3/CAV1/TGFB1/SLC39A9/FSCN1/EPB41L3/PKP3/SNAI1/CD9/SNAI2/ROCK1,18
GO:0048771,BP,GO:0048771,tissue remodeling,17/269,188/18888,0.090425532,6.349284189,8.859990304,1.71E-09,2.93E-08,1.23E-08,TP53/TIMP1/CTNNB1/VDR/IL6/NFKB1/PPARG/MMP14/HIF1A/CAV1/TGFB1/MMP2/CYP1A1/EGFR/BAX/LGR4/ROCK1,17
GO:1903035,BP,GO:1903035,negative regulation of response to wounding,13/269,100/18888,0.13,9.12802974,9.795451585,1.75E-09,2.99E-08,1.25E-08,THBS1/PTEN/ALOX12/FGF2/STAT3/PRKCD/TNF/SMAD3/GIT1/SERPINE1/CD9/THBD/PLAU,13
GO:2001237,BP,GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,13/269,100/18888,0.13,9.12802974,9.795451585,1.75E-09,2.99E-08,1.25E-08,BRCA1/THBS1/AR/GPX1/IL1B/GSTP1/TNF/RELA/AKT1/TGFBR1/SERPINE1/IGF1/SNAI2,13
GO:1904951,BP,GO:1904951,positive regulation of establishment of protein localization,22/269,326/18888,0.067484663,4.738476977,8.184093464,1.80E-09,3.05E-08,1.28E-08,ERBB2/FBXW7/PTGS2/IL1B/PPARG/NPEPPS/CDH1/MAPK14/HIF1A/BAP1/TENM1/TLR4/PRKCD/TNF/SMAD3/TGFB1/EGFR/PCSK1/IGF1/HSP90AA1/HRAS/SFN,22
GO:0045682,BP,GO:0045682,regulation of epidermis development,11/269,65/18888,0.169230769,11.88264226,10.56394338,1.81E-09,3.05E-08,1.28E-08,ETV4/VDR/NCOA3/FGF2/NOTCH1/EZH2/ALOX15B/TP63/MED1/SFN/ROCK1,11
GO:0080164,BP,GO:0080164,regulation of nitric oxide metabolic process,11/269,65/18888,0.169230769,11.88264226,10.56394338,1.81E-09,3.05E-08,1.28E-08,PTGS2/IL1B/SOD2/TLR4/TNF/AKT1/SMAD3/CAV1/IL10/HSP90AA1/CLU,11
GO:0007160,BP,GO:0007160,cell-matrix adhesion,19/269,241/18888,0.078838174,5.535670765,8.517752419,1.87E-09,3.15E-08,1.32E-08,THBS1/PTEN/CTNNB1/CD44/VEGFA/MMP14/RHOA/SMAD3/PTK2/MSLN/ILK/FN1/DLC1/SERPINE1/KDR/LYVE1/CDKN2A/ROCK1/PLAU,19
GO:0090399,BP,GO:0090399,replicative senescence,7/269,17/18888,0.411764706,28.91231139,13.83892192,1.89E-09,3.17E-08,1.33E-08,TP53/ERCC1/CHEK2/SERPINE1/MME/CDKN1A/CDKN2A,7
GO:0033598,BP,GO:0033598,mammary gland epithelial cell proliferation,8/269,26/18888,0.307692308,21.60480412,12.6369058,1.91E-09,3.19E-08,1.34E-08,BRCA2/GPX1/CCND1/MAPK1/BAX/GATA3/MED1/ESR1,8
GO:0018108,BP,GO:0018108,peptidyl-tyrosine phosphorylation,20/269,269/18888,0.074349442,5.220491701,8.379931506,1.93E-09,3.19E-08,1.34E-08,TP53/ERBB2/FBXW7/IL6/ALK/CD44/VEGFA/IGF1R/MTOR/PRKCD/TNF/CAV1/TGFB1/PTK2/FGFR4/EGFR/TGFA/KDR/IGF1/FGFR1,20
GO:0032868,BP,GO:0032868,response to insulin,20/269,269/18888,0.074349442,5.220491701,8.379931506,1.93E-09,3.19E-08,1.34E-08,PIK3CA/IL1B/PPARG/PARP1/IGF1R/NCOA1/MAPK14/MTOR/MAPK1/PRKCD/FOS/RELA/AKT1/IL10/RB1/IRS1/HRAS/STAT1/FBP1/IGF2,20
GO:0031100,BP,GO:0031100,animal organ regeneration,11/269,66/18888,0.166666667,11.70260223,10.46906563,2.14E-09,3.54E-08,1.48E-08,AURKA/IL6/CCND1/NOTCH1/PCNA/TNF/EZH2/IL10/EGFR/CDKN1A/MED1,11
GO:0018212,BP,GO:0018212,peptidyl-tyrosine modification,20/269,271/18888,0.073800738,5.181964087,8.334691879,2.19E-09,3.60E-08,1.51E-08,TP53/ERBB2/FBXW7/IL6/ALK/CD44/VEGFA/IGF1R/MTOR/PRKCD/TNF/CAV1/TGFB1/PTK2/FGFR4/EGFR/TGFA/KDR/IGF1/FGFR1,20
GO:0035987,BP,GO:0035987,endodermal cell differentiation,10/269,51/18888,0.196078431,13.76776733,10.97421927,2.22E-09,3.64E-08,1.53E-08,CTNNB1/LAMB3/MMP14/HNF1B/MMP9/MMP2/BRD3/FN1/SOX2/NANOG,10
GO:0046620,BP,GO:0046620,regulation of organ growth,13/269,102/18888,0.12745098,8.949048764,9.675591901,2.25E-09,3.67E-08,1.54E-08,PTEN/MIR25/FGF2/NOTCH1/MAPK14/DUSP6/AKT1/TGFBR1/WT1/IGF1/PIM1/FGFR1/IGF2,13
GO:0001654,BP,GO:0001654,eye development,24/269,393/18888,0.061068702,4.28797639,7.917302743,2.36E-09,3.84E-08,1.61E-08,CTNNB1/FASLG/SOX11/VEGFA/FGF2/NOTCH1/HIF1A/STAT3/SMARCA4/TWSG1/TGFBR1/SMAD3/CYP1A1/EGFR/WT1/BAX/VIM/KDR/TWIST1/SOX2/ZHX2/GATA3/TFAP2A/MED1,24
GO:0003180,BP,GO:0003180,aortic valve morphogenesis,9/269,38/18888,0.236842105,16.6300137,11.59244206,2.40E-09,3.88E-08,1.63E-08,NOTCH1/RHOA/TGFB1/RB1/SNAI1/TWIST1/SNAI2/GATA3/ROCK1,9
GO:0045637,BP,GO:0045637,regulation of myeloid cell differentiation,18/269,218/18888,0.082568807,5.797619454,8.56369791,2.43E-09,3.92E-08,1.64E-08,CTNNB1/FBXW7/MYC/CASP8/MYB/MAPK14/HIF1A/STAT3/MTOR/TLR4/FOS/TNF/TGFB1/RB1/MIR145/STAT1/NFKBIA/MED1,18
GO:0008625,BP,GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,12/269,84/18888,0.142857143,10.03080191,9.97057701,2.48E-09,3.98E-08,1.67E-08,BRCA1/THBS1/GPX1/CASP8/BID/FASLG/TNF/BAX/DAB2IP/SERPINE1/PMAIP1/MAL,12
GO:0046209,BP,GO:0046209,nitric oxide metabolic process,12/269,84/18888,0.142857143,10.03080191,9.97057701,2.48E-09,3.98E-08,1.67E-08,PTGS2/IL1B/SOD2/TLR4/TNF/AKT1/SMAD3/CAV1/CYP1A1/IL10/HSP90AA1/CLU,12
GO:0007492,BP,GO:0007492,endoderm development,12/269,85/18888,0.141176471,9.912792478,9.898950184,2.85E-09,4.54E-08,1.90E-08,CTNNB1/LAMB3/MMP14/NOTCH1/HNF1B/MMP9/SMAD3/MMP2/BRD3/FN1/SOX2/NANOG,12
GO:2001057,BP,GO:2001057,reactive nitrogen species metabolic process,12/269,85/18888,0.141176471,9.912792478,9.898950184,2.85E-09,4.54E-08,1.90E-08,PTGS2/IL1B/SOD2/TLR4/TNF/AKT1/SMAD3/CAV1/CYP1A1/IL10/HSP90AA1/CLU,12
GO:0150063,BP,GO:0150063,visual system development,24/269,397/18888,0.060453401,4.244772597,7.853780765,2.88E-09,4.58E-08,1.92E-08,CTNNB1/FASLG/SOX11/VEGFA/FGF2/NOTCH1/HIF1A/STAT3/SMARCA4/TWSG1/TGFBR1/SMAD3/CYP1A1/EGFR/WT1/BAX/VIM/KDR/TWIST1/SOX2/ZHX2/GATA3/TFAP2A/MED1,24
GO:0072577,BP,GO:0072577,endothelial cell apoptotic process,11/269,68/18888,0.161764706,11.35840805,10.28530361,2.98E-09,4.72E-08,1.98E-08,THBS1/FASLG/TNF/TGFB1/IL10/DAB2IP/SERPINE1/KDR/BRAF/AKR1C3/GATA3,11
GO:0021761,BP,GO:0021761,limbic system development,14/269,125/18888,0.112,7.864148699,9.254863219,3.02E-09,4.72E-08,1.98E-08,SRD5A2/PTEN/CTNNB1/HSD3B1/XRCC1/ALK/CASP3/IGF1R/NCOA1/EZH2/HSD3B2/BAX/FGFR1/ID4,14
GO:0045444,BP,GO:0045444,fat cell differentiation,19/269,248/18888,0.076612903,5.379421993,8.344477263,3.02E-09,4.72E-08,1.98E-08,GPX1/IL6/PTGS2/LAMB3/CCND1/PPARG/SOD2/MAPK14/RNASEL/HDAC6/TNF/AKT1/SMAD3/TGFB1/BNIP3/SNAI2/PIM1/MED1/ID4,19
GO:0010810,BP,GO:0010810,regulation of cell-substrate adhesion,18/269,221/18888,0.081447964,5.718918737,8.48165935,3.02E-09,4.72E-08,1.98E-08,THBS1/PTEN/VEGFA/MMP14/NOTCH1/RHOA/SMAD3/PTK2/ILK/FN1/OLFM4/DLC1/SERPINE1/KDR/BRAF/CDKN2A/ROCK1/PLAU,18
GO:0045616,BP,GO:0045616,regulation of keratinocyte differentiation,9/269,39/18888,0.230769231,16.20360309,11.42389292,3.08E-09,4.80E-08,2.01E-08,ETV4/VDR/NCOA3/NOTCH1/EZH2/ALOX15B/TP63/MED1/ROCK1,9
GO:0048009,BP,GO:0048009,insulin-like growth factor receptor signaling pathway,10/269,53/18888,0.188679245,13.24822894,10.73267237,3.30E-09,5.11E-08,2.14E-08,AR/ERCC1/PIK3CA/IGF1R/MAPK1/AKT1/IRS1/IGF1/NKX3-1/IGF2,10
GO:0006935,BP,GO:0006935,chemotaxis,26/269,466/18888,0.055793991,3.91760933,7.665335407,3.31E-09,5.11E-08,2.14E-08,THBS1/CXCR2/IL6/EDNRB/IL1B/DEFB1/VEGFA/FGF2/NOTCH1/MAPK14/HDAC6/MAPK1/PRKCD/RHOA/SMAD3/TGFB1/MMP2/PTK2/IL10/BSG/SERPINE1/KDR/HRAS/FGFR1/CYP19A1/PLAU,26
GO:0016055,BP,GO:0016055,Wnt signaling pathway,26/269,466/18888,0.055793991,3.91760933,7.665335407,3.31E-09,5.11E-08,2.14E-08,PTEN/CTNNB1/CCND1/EDNRB/NFKB1/FGF2/CTNND1/NOTCH1/MAPK14/SMARCA4/RHOA/HNF1B/LZTS2/SMAD3/CAV1/TGFB1/ILK/EGFR/CUL3/HHEX/DAB2IP/SNAI1/MIR145/SNAI2/SOX2/LGR4,26
GO:0060742,BP,GO:0060742,epithelial cell differentiation involved in prostate gland development,6/269,11/18888,0.545454545,38.29942548,14.87344087,3.44E-09,5.29E-08,2.22E-08,CTNNB1/AR/HOXB13/NOTCH1/FOXA1/TP63,6
GO:0031334,BP,GO:0031334,positive regulation of protein-containing complex assembly,17/269,197/18888,0.086294416,6.059215368,8.579845472,3.49E-09,5.36E-08,2.25E-08,TP53/BID/VEGFA/TENM1/MTOR/TLR4/TNF/RHOA/TGFB1/FSCN1/GIT1/BAX/DAB2IP/HSP90AA1/MYD88/MMP1/CLU,17
GO:0046651,BP,GO:0046651,lymphocyte proliferation,21/269,308/18888,0.068181818,4.787428185,8.055200678,3.56E-09,5.44E-08,2.28E-08,TP53/CTNNB1/ERBB2/IL6/IL1B/CASP3/BID/SOX11/TLR4/PRKCD/BMI1/TWSG1/IL10/BAX/IGF1/CD274/PAWR/CDKN1A/IGF2/IFNA1/MYD88,21
GO:0042330,BP,GO:0042330,taxis,26/269,468/18888,0.055555556,3.90086741,7.638101878,3.62E-09,5.50E-08,2.31E-08,THBS1/CXCR2/IL6/EDNRB/IL1B/DEFB1/VEGFA/FGF2/NOTCH1/MAPK14/HDAC6/MAPK1/PRKCD/RHOA/SMAD3/TGFB1/MMP2/PTK2/IL10/BSG/SERPINE1/KDR/HRAS/FGFR1/CYP19A1/PLAU,26
GO:0198738,BP,GO:0198738,cell-cell signaling by wnt,26/269,468/18888,0.055555556,3.90086741,7.638101878,3.62E-09,5.50E-08,2.31E-08,PTEN/CTNNB1/CCND1/EDNRB/NFKB1/FGF2/CTNND1/NOTCH1/MAPK14/SMARCA4/RHOA/HNF1B/LZTS2/SMAD3/CAV1/TGFB1/ILK/EGFR/CUL3/HHEX/DAB2IP/SNAI1/MIR145/SNAI2/SOX2/LGR4,26
GO:0010165,BP,GO:0010165,response to X-ray,8/269,28/18888,0.285714286,20.06160382,12.13240962,3.70E-09,5.59E-08,2.34E-08,TP53/BRCA2/ERCC1/CASP3/THBD/GATA3/MSH2/CDKN1A,8
GO:0045606,BP,GO:0045606,positive regulation of epidermal cell differentiation,8/269,28/18888,0.285714286,20.06160382,12.13240962,3.70E-09,5.59E-08,2.34E-08,ETV4/VDR/NCOA3/FGF2/NOTCH1/ALOX15B/MED1/SFN,8
GO:0046661,BP,GO:0046661,male sex differentiation,16/269,173/18888,0.092485549,6.493929561,8.725507115,3.75E-09,5.64E-08,2.36E-08,SRD5A2/CTNNB1/AR/ERCC1/MMP14/NCOA1/TGFBR1/WT1/BAX/SGPL1/NKX3-1/AKR1C3/GATA3/MSH2/LGR4/ESR1,16
GO:0048880,BP,GO:0048880,sensory system development,24/269,403/18888,0.05955335,4.181574991,7.760048113,3.87E-09,5.80E-08,2.43E-08,CTNNB1/FASLG/SOX11/VEGFA/FGF2/NOTCH1/HIF1A/STAT3/SMARCA4/TWSG1/TGFBR1/SMAD3/CYP1A1/EGFR/WT1/BAX/VIM/KDR/TWIST1/SOX2/ZHX2/GATA3/TFAP2A/MED1,24
GO:0045429,BP,GO:0045429,positive regulation of nitric oxide biosynthetic process,9/269,40/18888,0.225,15.79851301,11.26146501,3.92E-09,5.86E-08,2.46E-08,PTGS2/IL1B/SOD2/TLR4/TNF/AKT1/SMAD3/HSP90AA1/CLU,9
GO:0008637,BP,GO:0008637,apoptotic mitochondrial changes,13/269,107/18888,0.121495327,8.530868916,9.389815846,4.09E-09,6.07E-08,2.55E-08,TP53/GPX1/BID/SOD2/AKT1/MMP9/BAX/IGF1/BNIP3/PMAIP1/BNIP3L/SFN/CLU,13
GO:0071479,BP,GO:0071479,cellular response to ionizing radiation,11/269,70/18888,0.157142857,11.0338821,10.10905911,4.10E-09,6.07E-08,2.55E-08,TP53/BRCA1/BRCA2/KDM1A/MAPK14/CHEK2/SNAI2/HRAS/GATA3/CDKN1A/CLOCK,11
GO:2000379,BP,GO:2000379,positive regulation of reactive oxygen species metabolic process,11/269,70/18888,0.157142857,11.0338821,10.10905911,4.10E-09,6.07E-08,2.55E-08,TP53/THBS1/SOD2/GSTP1/MAPK14/TLR4/PRKCD/TGFB1/EGFR/AKR1C3/CDKN1A,11
GO:0090287,BP,GO:0090287,regulation of cellular response to growth factor stimulus,23/269,373/18888,0.061662198,4.329649083,7.806753682,4.30E-09,6.34E-08,2.66E-08,TP53/THBS1/CTNNB1/IL1B/PPARG/SOX11/VEGFA/FGF2/NOTCH1/HIF1A/TWSG1/SMAD3/TGFB1/ILK/MIR200C/HHEX/DAB2IP/HSPA5/PEG10/KDR/MIR145/GATA3/FGFR1,23
GO:1901796,BP,GO:1901796,regulation of signal transduction by p53 class mediator,13/269,108/18888,0.12037037,8.451879389,9.334893232,4.59E-09,6.74E-08,2.83E-08,TP53/AURKA/MYC/KDM1A/CD44/MTOR/AKT1/CHEK2/SNAI1/TWIST1/PMAIP1/SNAI2/MUC1,13
GO:0030857,BP,GO:0030857,negative regulation of epithelial cell differentiation,10/269,55/18888,0.181818182,12.76647516,10.5038238,4.83E-09,7.08E-08,2.97E-08,CTNNB1/CCND1/VEGFA/NOTCH1/KRAS/EZH2/MMP9/CAV1/TP63/STAT1,10
GO:1904407,BP,GO:1904407,positive regulation of nitric oxide metabolic process,9/269,41/18888,0.219512195,15.41318343,11.10478567,4.96E-09,7.24E-08,3.04E-08,PTGS2/IL1B/SOD2/TLR4/TNF/AKT1/SMAD3/HSP90AA1/CLU,9
GO:0045931,BP,GO:0045931,positive regulation of mitotic cell cycle,14/269,130/18888,0.107692308,7.561681441,9.023458117,5.05E-09,7.35E-08,3.08E-08,AURKA/BRCA2/CCND1/CDK4/AKT1/CYP1A1/FOXA1/EGFR/CUL3/BRD4/RB1/SPHK1/NKX3-1/FGFR1,14
GO:0001935,BP,GO:0001935,endothelial cell proliferation,17/269,202/18888,0.084158416,5.90923479,8.43161504,5.11E-09,7.41E-08,3.11E-08,THBS1/PPARG/VEGFA/MMP14/FGF2/HIF1A/STAT3/TNF/AKT1/TGFBR1/CAV1/SLC39A9/IL10/KDR/STAT1/FGFR1/IGF2,17
GO:0032943,BP,GO:0032943,mononuclear cell proliferation,21/269,315/18888,0.066666667,4.681040892,7.918890609,5.30E-09,7.67E-08,3.22E-08,TP53/CTNNB1/ERBB2/IL6/IL1B/CASP3/BID/SOX11/TLR4/PRKCD/BMI1/TWSG1/IL10/BAX/IGF1/CD274/PAWR/CDKN1A/IGF2/IFNA1/MYD88,21
GO:0043010,BP,GO:0043010,camera-type eye development,22/269,346/18888,0.063583815,4.464576573,7.817886836,5.41E-09,7.80E-08,3.27E-08,CTNNB1/SOX11/VEGFA/FGF2/NOTCH1/HIF1A/STAT3/SMARCA4/TWSG1/TGFBR1/SMAD3/CYP1A1/EGFR/WT1/BAX/VIM/KDR/TWIST1/ZHX2/GATA3/TFAP2A/MED1,22
GO:0002067,BP,GO:0002067,glandular epithelial cell differentiation,11/269,72/18888,0.152777778,10.72738538,9.939812044,5.59E-09,8.03E-08,3.37E-08,CTNNB1/FASN/FGF2/NOTCH1/HIF1A/AKT1/CAV1/FOXA1/SPDEF/TP63/CLOCK,11
GO:0045927,BP,GO:0045927,positive regulation of growth,19/269,258/18888,0.073643411,5.170917265,8.108013346,5.79E-09,8.29E-08,3.48E-08,ERBB2/VEGFA/MMP14/FGF2/NOTCH1/MAPK14/MTOR/AKT1/TGFBR1/EGFR/FN1/WT1/IGF1/SPHK1/PIM1/FGFR1/UCN/SFN/IGF2,19
GO:2000648,BP,GO:2000648,positive regulation of stem cell proliferation,10/269,56/18888,0.178571429,12.53850239,10.39380798,5.81E-09,8.30E-08,3.48E-08,CTNNB1/KDM1A/SOX11/FGF2/TGFBR1/TGFB1/KDR/TP63/FGFR1/NANOG,10
GO:0010721,BP,GO:0010721,negative regulation of cell development,20/269,288/18888,0.069444444,4.876084263,7.967323212,6.22E-09,8.86E-08,3.72E-08,TP53/PTEN/CTNNB1/ERBB2/FBXW7/MYC/IL6/EDNRB/IL1B/SOX11/VEGFA/CDH1/NOTCH1/TLR4/HDAC6/TNF/RB1/IGF1/SNAI2/ID4,20
GO:0043588,BP,GO:0043588,skin development,21/269,318/18888,0.066037736,4.636880129,7.861692435,6.27E-09,8.90E-08,3.73E-08,CTNNB1/ALOX12/ETV4/VDR/CASP3/NCOA3/NOTCH1/TNF/RELA/EZH2/ALOX15B/EGFR/SNAI1/AKR1C3/TP63/CDKN1A/MED1/SFN/LGR4/ROCK1/MYD88,21
GO:0001818,BP,GO:0001818,negative regulation of cytokine production,23/269,381/18888,0.060367454,4.238737816,7.676260805,6.42E-09,9.09E-08,3.81E-08,THBS1/IL6/NFKB1/CASP3/GSTP1/TLR4/TNF/EZH2/TWSG1/TGFB1/IL10/MIR200C/CUL3/FN1/GIT1/IGF1/TWIST1/MC1R/MIR145/GATA3/CD274/FGFR1/LGR4,23
GO:0030858,BP,GO:0030858,positive regulation of epithelial cell differentiation,11/269,73/18888,0.150684932,10.58043489,9.857663675,6.50E-09,9.17E-08,3.84E-08,CTNNB1/ETV4/VDR/NCOA3/FGF2/NOTCH1/ALOX15B/MIR200C/SERPINE1/MED1/SFN,11
GO:0035265,BP,GO:0035265,organ growth,16/269,180/18888,0.088888889,6.241387856,8.492749693,6.66E-09,9.36E-08,3.93E-08,PTEN/AR/MIR25/FGF2/NOTCH1/MAPK14/DUSP6/AKT1/TGFBR1/WT1/IGF1/PIM1/FGFR1/ESR1/IGF2/CYP19A1,16
GO:0008209,BP,GO:0008209,androgen metabolic process,8/269,30/18888,0.266666667,18.72416357,11.67771885,6.81E-09,9.51E-08,3.99E-08,SRD5A2/HSD3B1/HSD3B2/SGPL1/MED1/ESR1/CYP17A1/CYP19A1,8
GO:0097421,BP,GO:0097421,liver regeneration,8/269,30/18888,0.266666667,18.72416357,11.67771885,6.81E-09,9.51E-08,3.99E-08,AURKA/IL6/CCND1/PCNA/TNF/EZH2/IL10/EGFR,8
GO:0043535,BP,GO:0043535,regulation of blood vessel endothelial cell migration,15/269,156/18888,0.096153846,6.751501287,8.670235624,6.83E-09,9.52E-08,3.99E-08,THBS1/FBXW7/PTGS2/PPARG/VEGFA/FGF2/NOTCH1/HIF1A/TNF/RHOA/AKT1/TGFB1/MIR200C/KDR/FGFR1,15
GO:0032869,BP,GO:0032869,cellular response to insulin stimulus,17/269,206/18888,0.082524272,5.794492367,8.316565494,6.87E-09,9.54E-08,4.00E-08,PIK3CA/IL1B/PPARG/PARP1/IGF1R/NCOA1/MTOR/MAPK1/PRKCD/RELA/AKT1/RB1/IRS1/HRAS/STAT1/FBP1/IGF2,17
GO:1903829,BP,GO:1903829,positive regulation of protein localization,26/269,483/18888,0.053830228,3.77972246,7.438520167,6.95E-09,9.63E-08,4.04E-08,ERBB2/FBXW7/PTGS2/PIK3CA/IL1B/PPARG/PARP1/NPEPPS/CDH1/MAPK14/HIF1A/BAP1/TENM1/TLR4/SQSTM1/PRKCD/TNF/AKT1/SMAD3/TGFB1/EGFR/PCSK1/IGF1/HSP90AA1/HRAS/SFN,26
GO:0001936,BP,GO:0001936,regulation of endothelial cell proliferation,16/269,181/18888,0.08839779,6.20690505,8.460505785,7.21E-09,9.95E-08,4.17E-08,THBS1/PPARG/VEGFA/FGF2/HIF1A/STAT3/TNF/AKT1/TGFBR1/CAV1/SLC39A9/IL10/KDR/STAT1/FGFR1/IGF2,16
GO:0010594,BP,GO:0010594,regulation of endothelial cell migration,18/269,234/18888,0.076923077,5.401201029,8.142778149,7.45E-09,1.03E-07,4.30E-08,THBS1/FBXW7/PTGS2/PPARG/VEGFA/FGF2/NOTCH1/HIF1A/TNF/RHOA/AKT1/TGFB1/PTK2/MIR200C/DAB2IP/KDR/GATA3/FGFR1,18
GO:0014015,BP,GO:0014015,positive regulation of gliogenesis,11/269,74/18888,0.148648649,10.43745604,9.777091645,7.54E-09,1.03E-07,4.34E-08,ETV5/IL6/IL1B/MYB/NOTCH1/MTOR/TNF/RELA/KRAS/TGFB1/EGFR,11
GO:0003176,BP,GO:0003176,aortic valve development,9/269,43/18888,0.209302326,14.69629117,10.80733444,7.79E-09,1.06E-07,4.46E-08,NOTCH1/RHOA/TGFB1/RB1/SNAI1/TWIST1/SNAI2/GATA3/ROCK1,9
GO:0019827,BP,GO:0019827,stem cell population maintenance,16/269,182/18888,0.087912088,6.172801177,8.428503456,7.80E-09,1.06E-07,4.46E-08,CTNNB1/MYC/ARID1A/NCOA3/NOTCH1/STAT3/SMARCA4/SMARCA2/HNF1B/SMARCE1/MIR145/BRAF/SOX2/ZHX2/TP63/NANOG,16
GO:0002460,BP,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,23/269,385/18888,0.05974026,4.194698981,7.612348944,7.82E-09,1.06E-07,4.46E-08,ERCC1/IL6/MAP3K7/IL1B/NOTCH1/STAT3/MTOR/TLR4/PRKCD/TNF/TGFB1/IL10/BRD2/BRD4/HRAS/GATA3/CD8A/CD274/MLH1/MSH2/NBN/MYD88/CLU,23
GO:0043123,BP,GO:0043123,positive regulation of canonical NF-kappaB signal transduction,17/269,208/18888,0.081730769,5.738776094,8.260167891,7.95E-09,1.08E-07,4.52E-08,MAP3K7/EDNRB/CASP8/IL1B/FASLG/PARP1/VEGFA/TLR4/TNF/RELA/RHOA/CAV1/TGFB1/ILK/BRD4/DAB2IP/MYD88,17
GO:0060070,BP,GO:0060070,canonical Wnt signaling pathway,21/269,323/18888,0.06501548,4.565101799,7.767927685,8.26E-09,1.12E-07,4.68E-08,PTEN/CTNNB1/EDNRB/NFKB1/FGF2/CTNND1/NOTCH1/MAPK14/LZTS2/SMAD3/CAV1/TGFB1/ILK/EGFR/HHEX/DAB2IP/SNAI1/MIR145/SNAI2/SOX2/LGR4,21
GO:0072594,BP,GO:0072594,establishment of protein localization to organelle,25/269,454/18888,0.055066079,3.866498534,7.431035107,8.77E-09,1.18E-07,4.96E-08,TP53/FBXW7/BRCA2/PTGS2/BID/NPEPPS/CDH1/NOTCH1/MAPK14/STAT3/BAP1/SQSTM1/PRKCD/AKT1/SMAD3/TGFB1/BAX/HSPA5/AIFM1/HSP90AA1/BNIP3L/CDKN1A/NFKBIA/MED1/CLU,25
GO:0010575,BP,GO:0010575,positive regulation of vascular endothelial growth factor production,8/269,31/18888,0.258064516,18.12015829,11.46652379,9.06E-09,1.22E-07,5.11E-08,BRCA1/IL6/PTGS2/IL1B/HIF1A/STAT3/RELA/TGFB1,8
GO:0051781,BP,GO:0051781,positive regulation of cell division,12/269,94/18888,0.127659574,8.963695325,9.303543792,9.23E-09,1.24E-07,5.19E-08,YBX1/IL1B/VEGFA/IGF1R/FGF2/RHOA/TGFB1/CUL3/TGFA/NKX3-1/IGF2/FGF3,12
GO:0042771,BP,GO:0042771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,9/269,44/18888,0.204545455,14.36228456,10.66596025,9.67E-09,1.29E-07,5.40E-08,TP53/BRCA2/KDM1A/CD44/CHEK2/TP63/MUC1/MSH2/CDKN1A,9
GO:0045840,BP,GO:0045840,positive regulation of mitotic nuclear division,9/269,44/18888,0.204545455,14.36228456,10.66596025,9.67E-09,1.29E-07,5.40E-08,AURKA/IL1B/TNF/CUL3/RB1/TGFA/IGF1/SPHK1/IGF2,9
GO:0006606,BP,GO:0006606,protein import into nucleus,15/269,161/18888,0.093167702,6.541827334,8.488115439,1.05E-08,1.40E-07,5.86E-08,TP53/PTGS2/CDH1/NOTCH1/MAPK14/STAT3/SQSTM1/PRKCD/AKT1/SMAD3/TGFB1/HSP90AA1/CDKN1A/NFKBIA/MED1,15
GO:0007517,BP,GO:0007517,muscle organ development,22/269,359/18888,0.061281337,4.30290667,7.594461588,1.06E-08,1.40E-07,5.86E-08,CTNNB1/ETV1/GPX1/SOX11/NOTCH1/MAPK14/FOS/RHOA/KRAS/TGFBR1/SMAD3/CAV1/TGFB1/WT1/RB1/IGF1/TWIST1/MIR145/MED1/FRG1/IGF2/FGF3,22
GO:0031589,BP,GO:0031589,cell-substrate adhesion,22/269,359/18888,0.061281337,4.30290667,7.594461588,1.06E-08,1.40E-07,5.86E-08,THBS1/PTEN/CTNNB1/CD44/VEGFA/MMP14/NOTCH1/RHOA/SMAD3/PTK2/MSLN/ILK/FN1/OLFM4/DLC1/SERPINE1/KDR/BRAF/LYVE1/CDKN2A/ROCK1/PLAU,22
GO:1905952,BP,GO:1905952,regulation of lipid localization,16/269,186/18888,0.086021505,6.040052764,8.302846006,1.07E-08,1.40E-07,5.89E-08,THBS1/IL6/IL1B/NFKB1/PPARG/FASLG/MYB/PRKCD/TNF/AKT1/CAV1/MIR145/NKX3-1/MIR130B/NFKBIA/CYP19A1,16
GO:0003007,BP,GO:0003007,heart morphogenesis,19/269,269/18888,0.07063197,4.959467116,7.86165821,1.15E-08,1.50E-07,6.30E-08,TP53/CTNNB1/SOX11/VEGFA/NOTCH1/HIF1A/MTOR/TGFBR1/SMAD3/TGFB1/PTK2/ILK/DLC1/SNAI1/TWIST1/SNAI2/PIM1/GATA3/MED1,19
GO:0006809,BP,GO:0006809,nitric oxide biosynthetic process,11/269,77/18888,0.142857143,10.03080191,9.544324384,1.16E-08,1.51E-07,6.35E-08,PTGS2/IL1B/SOD2/TLR4/TNF/AKT1/SMAD3/CAV1/IL10/HSP90AA1/CLU,11
GO:0061045,BP,GO:0061045,negative regulation of wound healing,11/269,77/18888,0.142857143,10.03080191,9.544324384,1.16E-08,1.51E-07,6.35E-08,THBS1/PTEN/ALOX12/FGF2/PRKCD/TNF/SMAD3/SERPINE1/CD9/THBD/PLAU,11
GO:0001706,BP,GO:0001706,endoderm formation,10/269,60/18888,0.166666667,11.70260223,9.980271812,1.17E-08,1.52E-07,6.39E-08,CTNNB1/LAMB3/MMP14/HNF1B/MMP9/MMP2/BRD3/FN1/SOX2/NANOG,10
GO:0045684,BP,GO:0045684,positive regulation of epidermis development,8/269,32/18888,0.25,17.55390335,11.26497089,1.19E-08,1.55E-07,6.50E-08,ETV4/VDR/NCOA3/FGF2/NOTCH1/ALOX15B/MED1/SFN,8
GO:0043467,BP,GO:0043467,regulation of generation of precursor metabolites and energy,14/269,140/18888,0.1,7.021561338,8.595578566,1.33E-08,1.71E-07,7.19E-08,TP53/PIK3CA/HIF1A/STAT3/MTOR/TNF/RHOA/AKT1/GIT1/IRS1/IGF1/BNIP3/FBP1/IGF2,14
GO:0003179,BP,GO:0003179,heart valve morphogenesis,10/269,61/18888,0.163934426,11.51075629,9.882976822,1.38E-08,1.78E-07,7.48E-08,NOTCH1/MTOR/RHOA/TGFB1/RB1/SNAI1/TWIST1/SNAI2/GATA3/ROCK1,10
GO:0006913,BP,GO:0006913,nucleocytoplasmic transport,21/269,333/18888,0.063063063,4.428011655,7.586009485,1.41E-08,1.81E-07,7.58E-08,TP53/PTGS2/IL1B/CDH1/NOTCH1/MAPK14/STAT3/SQSTM1/PRKCD/AKT1/LZTS2/SMAD3/TGFB1/TXN/HHEX/IFI27/HSP90AA1/CDKN1A/NFKBIA/MED1/SFN,21
GO:0051169,BP,GO:0051169,nuclear transport,21/269,333/18888,0.063063063,4.428011655,7.586009485,1.41E-08,1.81E-07,7.58E-08,TP53/PTGS2/IL1B/CDH1/NOTCH1/MAPK14/STAT3/SQSTM1/PRKCD/AKT1/LZTS2/SMAD3/TGFB1/TXN/HHEX/IFI27/HSP90AA1/CDKN1A/NFKBIA/MED1/SFN,21
GO:0002757,BP,GO:0002757,immune response-activating signaling pathway,26/269,500/18888,0.052,3.651211896,7.221736672,1.41E-08,1.81E-07,7.58E-08,MAP3K7/PIK3CA/NFKB1/PARP1/TLR4/SQSTM1/MAPK1/PRKCD/TNF/RELA/AKT1/CAV1/PTK2/MIR200C/BAX/DAB2IP/BRAF/HRAS/GATA3/CD8A/CD274/PAWR/NFKBIA/LGR4/ESR1/MYD88,26
GO:1902107,BP,GO:1902107,positive regulation of leukocyte differentiation,16/269,190/18888,0.084210526,5.912893759,8.180805165,1.45E-08,1.84E-07,7.71E-08,CASP8/MMP14/ARID1A/SMARCA4/SMARCA2/FOS/TNF/RHOA/TGFB1/IL10/BRD2/BRD4/RB1/SMARCE1/MIR145/GATA3,16
GO:1903708,BP,GO:1903708,positive regulation of hemopoiesis,16/269,190/18888,0.084210526,5.912893759,8.180805165,1.45E-08,1.84E-07,7.71E-08,CASP8/MMP14/ARID1A/SMARCA4/SMARCA2/FOS/TNF/RHOA/TGFB1/IL10/BRD2/BRD4/RB1/SMARCE1/MIR145/GATA3,16
GO:0031331,BP,GO:0031331,positive regulation of cellular catabolic process,24/269,432/18888,0.055555556,3.90086741,7.331290284,1.49E-08,1.89E-07,7.93E-08,YBX1/IL6/MAP3K7/IL1B/MALAT1/HIF1A/MTOR/SQSTM1/PRKCD/TNF/MIR200C/BAX/KDR/IRS1/IGF1/TWIST1/BNIP3/MIR145/BNIP3L/MLH1/MIR130B/NPRL2/ROCK1/CAMKK2,24
GO:0010657,BP,GO:0010657,muscle cell apoptotic process,12/269,98/18888,0.12244898,8.59783021,9.06397473,1.49E-08,1.89E-07,7.93E-08,TP53/ALOX12/CXCR2/PPARG/SOD2/IGF1R/IGF1/BNIP3/MIR145/HSP90AA1/CDKN2A/ESR1,12
GO:0072088,BP,GO:0072088,nephron epithelium morphogenesis,11/269,79/18888,0.139240506,9.77685756,9.396133895,1.53E-08,1.93E-07,8.10E-08,CTNNB1/MYC/VEGFA/FGF2/HNF1B/LZTS2/ILK/WT1/GATA3/STAT1/LGR4,11
GO:0051170,BP,GO:0051170,import into nucleus,15/269,166/18888,0.090361446,6.344784342,8.313570121,1.60E-08,2.01E-07,8.42E-08,TP53/PTGS2/CDH1/NOTCH1/MAPK14/STAT3/SQSTM1/PRKCD/AKT1/SMAD3/TGFB1/HSP90AA1/CDKN1A/NFKBIA/MED1,15
GO:0021537,BP,GO:0021537,telencephalon development,19/269,275/18888,0.069090909,4.851260561,7.732866537,1.64E-08,2.05E-07,8.62E-08,SRD5A2/PTEN/CTNNB1/HSD3B1/XRCC1/ALK/CASP3/KDM1A/IGF1R/NCOA1/HIF1A/RHOA/EZH2/EGFR/HSD3B2/BAX/DAB2IP/BNIP3/ID4,19
GO:0007265,BP,GO:0007265,Ras protein signal transduction,13/269,120/18888,0.108333333,7.60669145,8.726600697,1.68E-08,2.09E-07,8.78E-08,TP53/FGF2/NOTCH1/CDK2/SQSTM1/KRAS/RB1/DAB2IP/IGF1/HRAS/CDKN1A/CDKN2A/FBP1,13
GO:0001657,BP,GO:0001657,ureteric bud development,12/269,99/18888,0.121212121,8.51098344,9.006209035,1.68E-08,2.09E-07,8.78E-08,CTNNB1/MYC/VEGFA/FGF2/HNF1B/LZTS2/SMAD3/ILK/WT1/GATA3/FGFR1/LGR4,12
GO:0045926,BP,GO:0045926,negative regulation of growth,18/269,247/18888,0.072874494,5.116927291,7.828283129,1.73E-08,2.16E-07,9.05E-08,TP53/BRCA1/PTEN/MIR25/CDH1/HIF1A/SMARCA4/SMARCA2/HDAC6/ALOX15B/SMAD3/TGFB1/WT1/RB1/CDKN1A/CDKN2A/FBP1/ESR2,18
GO:0048806,BP,GO:0048806,genitalia development,9/269,47/18888,0.191489362,13.44554299,10.26810397,1.79E-08,2.21E-07,9.27E-08,SRD5A2/CTNNB1/AR/WT1/BAX/TP63/LGR4/ESR1/CYP19A1,9
GO:1902175,BP,GO:1902175,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,9/269,47/18888,0.191489362,13.44554299,10.26810397,1.79E-08,2.21E-07,9.27E-08,CTNNB1/FBXW7/GPX1/PARP1/SOD2/HIF1A/AKT1/MMP2/IL10,9
GO:1905314,BP,GO:1905314,semi-lunar valve development,9/269,47/18888,0.191489362,13.44554299,10.26810397,1.79E-08,2.21E-07,9.27E-08,NOTCH1/RHOA/TGFB1/RB1/SNAI1/TWIST1/SNAI2/GATA3/ROCK1,9
GO:0030324,BP,GO:0030324,lung development,16/269,193/18888,0.082901554,5.820983493,8.091536889,1.81E-08,2.22E-07,9.33E-08,CTNNB1/FBXW7/SOX11/VEGFA/MMP14/FGF2/NOTCH1/MAPK1/TNF/KRAS/FOXA1/SPDEF/EGFR/KDR/MME/FGFR1,16
GO:0050878,BP,GO:0050878,regulation of body fluid levels,22/269,370/18888,0.059459459,4.174982417,7.413522345,1.82E-08,2.24E-07,9.40E-08,THBS1/COX2/ALOX12/VDR/IL6/CCND1/EDNRB/PIK3CA/VEGFA/NCOA1/MAPK14/HIF1A/TLR4/PRKCD/CAV1/ILK/EGFR/SERPINE1/CD9/THBD/MED1/PLAU,22
GO:0060541,BP,GO:0060541,respiratory system development,17/269,220/18888,0.077272727,5.425751943,7.936499025,1.84E-08,2.25E-07,9.44E-08,CTNNB1/FBXW7/SOX11/VEGFA/MMP14/FGF2/NOTCH1/MAPK1/TNF/KRAS/FOXA1/SPDEF/EGFR/WT1/KDR/MME/FGFR1,17
GO:0045930,BP,GO:0045930,negative regulation of mitotic cell cycle,18/269,248/18888,0.072580645,5.09629452,7.805010921,1.85E-08,2.25E-07,9.45E-08,TP53/BRCA1/PTEN/CTNNB1/RBL2/CCND1/XRCC3/CDK2/TNF/EZH2/IL10/CHEK2/EGFR/RB1/MUC1/MSH2/NBN/CDKN1A,18
GO:0072009,BP,GO:0072009,nephron epithelium development,13/269,121/18888,0.107438017,7.543826231,8.679735093,1.85E-08,2.26E-07,9.47E-08,CTNNB1/MYC/EDNRB/VEGFA/FGF2/NOTCH1/HNF1B/LZTS2/ILK/WT1/GATA3/STAT1/LGR4,13
GO:0072080,BP,GO:0072080,nephron tubule development,12/269,100/18888,0.12,8.425873606,8.949251875,1.88E-08,2.28E-07,9.54E-08,CTNNB1/MYC/VEGFA/FGF2/NOTCH1/HNF1B/LZTS2/ILK/WT1/GATA3/STAT1/LGR4,12
GO:0072163,BP,GO:0072163,mesonephric epithelium development,12/269,100/18888,0.12,8.425873606,8.949251875,1.88E-08,2.28E-07,9.54E-08,CTNNB1/MYC/VEGFA/FGF2/HNF1B/LZTS2/SMAD3/ILK/WT1/GATA3/FGFR1/LGR4,12
GO:0072164,BP,GO:0072164,mesonephric tubule development,12/269,100/18888,0.12,8.425873606,8.949251875,1.88E-08,2.28E-07,9.54E-08,CTNNB1/MYC/VEGFA/FGF2/HNF1B/LZTS2/SMAD3/ILK/WT1/GATA3/FGFR1/LGR4,12
GO:0051893,BP,GO:0051893,regulation of focal adhesion assembly,10/269,63/18888,0.158730159,11.14533546,9.695018634,1.91E-08,2.30E-07,9.63E-08,THBS1/PTEN/VEGFA/MMP14/RHOA/SMAD3/PTK2/DLC1/KDR/ROCK1,10
GO:0090109,BP,GO:0090109,regulation of cell-substrate junction assembly,10/269,63/18888,0.158730159,11.14533546,9.695018634,1.91E-08,2.30E-07,9.63E-08,THBS1/PTEN/VEGFA/MMP14/RHOA/SMAD3/PTK2/DLC1/KDR/ROCK1,10
GO:0072028,BP,GO:0072028,nephron morphogenesis,11/269,81/18888,0.135802469,9.535453669,9.253133131,2.00E-08,2.39E-07,1.00E-07,CTNNB1/MYC/VEGFA/FGF2/HNF1B/LZTS2/ILK/WT1/GATA3/STAT1/LGR4,11
GO:0002360,BP,GO:0002360,T cell lineage commitment,8/269,34/18888,0.235294118,16.5213208,10.88794294,2.01E-08,2.39E-07,1.00E-07,TP53/IL6/STAT3/MTOR/RHOA/BRD2/BRD4/BRAF,8
GO:0043276,BP,GO:0043276,anoikis,8/269,34/18888,0.235294118,16.5213208,10.88794294,2.01E-08,2.39E-07,1.00E-07,MAP3K7/PIK3CA/NOTCH1/MTOR/AKT1/CAV1/PTK2/SNAI2,8
GO:0090183,BP,GO:0090183,regulation of kidney development,8/269,34/18888,0.235294118,16.5213208,10.88794294,2.01E-08,2.39E-07,1.00E-07,MYC/VEGFA/EZH2/HNF1B/WT1/GATA3/STAT1/LGR4,8
GO:0071559,BP,GO:0071559,response to transforming growth factor beta,20/269,309/18888,0.064724919,4.544699895,7.551391713,2.04E-08,2.42E-07,1.02E-07,TP53/THBS1/MAP3K7/PPARG/PARP1/SOX11/ID1/IGF1R/STAT3/FOS/TWSG1/TGFBR1/SMAD3/CAV1/TGFB1/PTK2/HSPA5/PEG10/MIR145/ROCK1,20
GO:0030217,BP,GO:0030217,T cell differentiation,20/269,310/18888,0.064516129,4.530039573,7.532521776,2.15E-08,2.55E-07,1.07E-07,TP53/CTNNB1/ERBB2/IL6/IL1B/ARID1A/MYB/STAT3/SMARCA4/SMARCA2/MTOR/RHOA/BMI1/TGFB1/BRD2/BRD4/SMARCE1/BRAF/GATA3/CD8A,20
GO:0008631,BP,GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,10/269,64/18888,0.15625,10.97118959,9.604183696,2.24E-08,2.64E-07,1.11E-07,CTNNB1/FBXW7/GPX1/PARP1/SOD2/HIF1A/PRKCD/AKT1/MMP2/IL10,10
GO:0034504,BP,GO:0034504,protein localization to nucleus,20/269,311/18888,0.064308682,4.515473529,7.513731823,2.27E-08,2.68E-07,1.12E-07,TP53/PTGS2/PARP1/CDH1/NOTCH1/MAPK14/STAT3/MTOR/SQSTM1/PRKCD/AKT1/LZTS2/SMAD3/TGFB1/TXN/HHEX/HSP90AA1/CDKN1A/NFKBIA/MED1,20
GO:0030323,BP,GO:0030323,respiratory tube development,16/269,197/18888,0.081218274,5.702790935,7.975390761,2.42E-08,2.84E-07,1.19E-07,CTNNB1/FBXW7/SOX11/VEGFA/MMP14/FGF2/NOTCH1/MAPK1/TNF/KRAS/FOXA1/SPDEF/EGFR/KDR/MME/FGFR1,16
GO:0050870,BP,GO:0050870,positive regulation of T cell activation,18/269,253/18888,0.071146245,4.995577237,7.690499468,2.51E-08,2.94E-07,1.23E-07,IL6/PIK3CA/IL1B/ARID1A/SMARCA4/SMARCA2/MTOR/RHOA/BMI1/AKT1/CAV1/BRD2/BRD4/IGF1/SMARCE1/GATA3/CD274/IGF2,18
GO:0030225,BP,GO:0030225,macrophage differentiation,10/269,65/18888,0.153846154,10.80240206,9.515338074,2.61E-08,3.04E-07,1.28E-07,CASP8/PARP1/VEGFA/TLR4/MMP9/TGFB1/RB1/MIR145/GATA3/MYD88,10
GO:1905330,BP,GO:1905330,regulation of morphogenesis of an epithelium,10/269,65/18888,0.153846154,10.80240206,9.515338074,2.61E-08,3.04E-07,1.28E-07,CTNNB1/AR/VEGFA/FGF2/TNF/SNAI2/GATA3/FGFR1/LGR4/ESR1,10
GO:0001952,BP,GO:0001952,regulation of cell-matrix adhesion,13/269,125/18888,0.104,7.302423792,8.49749513,2.75E-08,3.20E-07,1.34E-07,THBS1/PTEN/VEGFA/MMP14/RHOA/SMAD3/PTK2/DLC1/SERPINE1/KDR/CDKN2A/ROCK1/PLAU,13
GO:0001823,BP,GO:0001823,mesonephros development,12/269,104/18888,0.115384615,8.101801544,8.72912306,2.95E-08,3.39E-07,1.42E-07,CTNNB1/MYC/VEGFA/FGF2/HNF1B/LZTS2/SMAD3/ILK/WT1/GATA3/FGFR1/LGR4,12
GO:0032642,BP,GO:0032642,regulation of chemokine production,12/269,104/18888,0.115384615,8.101801544,8.72912306,2.95E-08,3.39E-07,1.42E-07,IL6/IL1B/GSTP1/HIF1A/TLR4/TNF/ALOX15B/TGFB1/IL10/TWIST1/SNAI2/MYD88,12
GO:0061326,BP,GO:0061326,renal tubule development,12/269,104/18888,0.115384615,8.101801544,8.72912306,2.95E-08,3.39E-07,1.42E-07,CTNNB1/MYC/VEGFA/FGF2/NOTCH1/HNF1B/LZTS2/ILK/WT1/GATA3/STAT1/LGR4,12
GO:0008584,BP,GO:0008584,male gonad development,14/269,149/18888,0.093959732,6.597440184,8.244965525,2.95E-08,3.39E-07,1.42E-07,SRD5A2/AR/ERCC1/MMP14/NCOA1/TGFBR1/WT1/BAX/SGPL1/NKX3-1/AKR1C3/GATA3/MSH2/ESR1,14
GO:0060252,BP,GO:0060252,positive regulation of glial cell proliferation,7/269,24/18888,0.291666667,20.4795539,11.47749701,3.09E-08,3.55E-07,1.49E-07,ETV5/IL6/IL1B/MYB/TNF/KRAS/EGFR,7
GO:0046546,BP,GO:0046546,development of primary male sexual characteristics,14/269,150/18888,0.093333333,6.553457249,8.207802532,3.21E-08,3.68E-07,1.54E-07,SRD5A2/AR/ERCC1/MMP14/NCOA1/TGFBR1/WT1/BAX/SGPL1/NKX3-1/AKR1C3/GATA3/MSH2/ESR1,14
GO:1904385,BP,GO:1904385,cellular response to angiotensin,8/269,36/18888,0.222222222,15.60346964,10.54163661,3.27E-08,3.73E-07,1.56E-07,MAP3K7/NFKB1/IGF1R/PRKCD/RELA/CAV1/MIR145/ROCK1,8
GO:0032602,BP,GO:0032602,chemokine production,12/269,105/18888,0.114285714,8.024641529,8.675925047,3.28E-08,3.74E-07,1.57E-07,IL6/IL1B/GSTP1/HIF1A/TLR4/TNF/ALOX15B/TGFB1/IL10/TWIST1/SNAI2/MYD88,12
GO:0060675,BP,GO:0060675,ureteric bud morphogenesis,10/269,67/18888,0.149253731,10.4799423,9.343319542,3.53E-08,4.01E-07,1.68E-07,CTNNB1/MYC/VEGFA/FGF2/HNF1B/LZTS2/ILK/WT1/GATA3/LGR4,10
GO:0002262,BP,GO:0002262,myeloid cell homeostasis,15/269,177/18888,0.084745763,5.95047571,7.953614215,3.79E-08,4.29E-07,1.80E-07,CXCR2/IL6/CASP3/VEGFA/MYB/MAPK14/HIF1A/STAT3/BAP1/HDAC6/RB1/BAX/GATA3/STAT1/MED1,15
GO:0032612,BP,GO:0032612,interleukin-1 production,13/269,129/18888,0.100775194,7.075992046,8.323129738,4.02E-08,4.53E-07,1.90E-07,IL6/CASP8/GSTP1/STAT3/TLR4/TNF/RELA/SMAD3/IL10/GIT1/IGF1/SPHK1/MYD88,13
GO:0032652,BP,GO:0032652,regulation of interleukin-1 production,13/269,129/18888,0.100775194,7.075992046,8.323129738,4.02E-08,4.53E-07,1.90E-07,IL6/CASP8/GSTP1/STAT3/TLR4/TNF/RELA/SMAD3/IL10/GIT1/IGF1/SPHK1/MYD88,13
GO:0006919,BP,GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,10/269,68/18888,0.147058824,10.3258255,9.26000851,4.08E-08,4.57E-07,1.92E-07,CASP8/PPARG/BID/FASLG/TNF/SMAD3/DLC1/BAX/AIFM1/NKX3-1,10
GO:0072171,BP,GO:0072171,mesonephric tubule morphogenesis,10/269,68/18888,0.147058824,10.3258255,9.26000851,4.08E-08,4.57E-07,1.92E-07,CTNNB1/MYC/VEGFA/FGF2/HNF1B/LZTS2/ILK/WT1/GATA3/LGR4,10
GO:0150116,BP,GO:0150116,regulation of cell-substrate junction organization,10/269,68/18888,0.147058824,10.3258255,9.26000851,4.08E-08,4.57E-07,1.92E-07,THBS1/PTEN/VEGFA/MMP14/RHOA/SMAD3/PTK2/DLC1/KDR/ROCK1,10
GO:0042552,BP,GO:0042552,myelination,14/269,154/18888,0.090909091,6.38323758,8.062469854,4.49E-08,5.01E-07,2.10E-07,PTEN/CTNNB1/ERBB2/MTOR/MAPK1/TNF/AKT1/ILK/EPB41L3/CD9/HRAS/ID4/MAL/CLU,14
GO:0038127,BP,GO:0038127,ERBB signaling pathway,13/269,131/18888,0.099236641,6.967961633,8.238714159,4.84E-08,5.38E-07,2.26E-07,ERBB2/PIK3CA/FASLG/MAPK1/AKT1/MMP9/TGFB1/PTK2/EGFR/TGFA/DAB2IP/BRAF/NRG4,13
GO:0048708,BP,GO:0048708,astrocyte differentiation,11/269,88/18888,0.125,8.776951673,8.789238832,4.84E-08,5.38E-07,2.26E-07,IL6/IL1B/NOTCH1/STAT3/TLR4/MAPK1/TNF/KRAS/EGFR/VIM/ID4,11
GO:0019216,BP,GO:0019216,regulation of lipid metabolic process,20/269,326/18888,0.061349693,4.307706343,7.241071171,4.96E-08,5.50E-07,2.31E-07,BRCA1/FBXW7/PTGS2/ALK/IL1B/NFKB1/PPARG/IGF1R/MTOR/PRKCD/TNF/AKT1/CAV1/FGFR4/SNAI1/IRS1/SPHK1/TWIST1/SNAI2/AKR1C3,20
GO:0032965,BP,GO:0032965,regulation of collagen biosynthetic process,8/269,38/18888,0.210526316,14.7822344,10.22198424,5.15E-08,5.68E-07,2.38E-07,IL6/MYB/NOTCH1/TGFB1/CBX8/VIM/MIR145/UCN,8
GO:0071392,BP,GO:0071392,cellular response to estradiol stimulus,8/269,38/18888,0.210526316,14.7822344,10.22198424,5.15E-08,5.68E-07,2.38E-07,IGF1R/NCOA3/MMP2/IL10/EGFR/AIFM1/ESR1/ESR2,8
GO:0007043,BP,GO:0007043,cell-cell junction assembly,14/269,156/18888,0.08974359,6.301401201,7.991721684,5.28E-08,5.77E-07,2.42E-07,CTNNB1/IL1B/CDH1/TNF/RHOA/CAV1/SLC39A9/FSCN1/EPB41L3/PKP3/SNAI1/CD9/SNAI2/ROCK1,14
GO:0007272,BP,GO:0007272,ensheathment of neurons,14/269,156/18888,0.08974359,6.301401201,7.991721684,5.28E-08,5.77E-07,2.42E-07,PTEN/CTNNB1/ERBB2/MTOR/MAPK1/TNF/AKT1/ILK/EPB41L3/CD9/HRAS/ID4/MAL/CLU,14
GO:0008366,BP,GO:0008366,axon ensheathment,14/269,156/18888,0.08974359,6.301401201,7.991721684,5.28E-08,5.77E-07,2.42E-07,PTEN/CTNNB1/ERBB2/MTOR/MAPK1/TNF/AKT1/ILK/EPB41L3/CD9/HRAS/ID4/MAL/CLU,14
GO:0032368,BP,GO:0032368,regulation of lipid transport,14/269,156/18888,0.08974359,6.301401201,7.991721684,5.28E-08,5.77E-07,2.42E-07,THBS1/IL1B/NFKB1/PPARG/FASLG/MYB/PRKCD/AKT1/CAV1/MIR145/NKX3-1/MIR130B/NFKBIA/CYP19A1,14
GO:0046622,BP,GO:0046622,positive regulation of organ growth,9/269,53/18888,0.169811321,11.92340605,9.571778814,5.41E-08,5.89E-07,2.47E-07,FGF2/NOTCH1/MAPK14/AKT1/WT1/IGF1/PIM1/FGFR1/IGF2,9
GO:0050670,BP,GO:0050670,regulation of lymphocyte proliferation,17/269,237/18888,0.071729958,5.036562985,7.516476424,5.50E-08,5.98E-07,2.51E-07,CTNNB1/ERBB2/IL6/IL1B/CASP3/BID/SOX11/TLR4/BMI1/TWSG1/IL10/IGF1/CD274/PAWR/CDKN1A/IGF2/MYD88,17
GO:0051216,BP,GO:0051216,cartilage development,16/269,209/18888,0.076555024,5.375357962,7.645209241,5.54E-08,5.99E-07,2.51E-07,TIMP1/CTNNB1/CD44/FGF2/MAPK14/HIF1A/TWSG1/TGFBR1/SMAD3/TGFB1/RB1/COL11A2/SNAI1/SNAI2/GATA3/FGFR1,16
GO:0032611,BP,GO:0032611,interleukin-1 beta production,12/269,110/18888,0.109090909,7.659885096,8.42011195,5.56E-08,5.99E-07,2.51E-07,IL6/CASP8/GSTP1/STAT3/TLR4/TNF/RELA/SMAD3/GIT1/IGF1/SPHK1/MYD88,12
GO:0032651,BP,GO:0032651,regulation of interleukin-1 beta production,12/269,110/18888,0.109090909,7.659885096,8.42011195,5.56E-08,5.99E-07,2.51E-07,IL6/CASP8/GSTP1/STAT3/TLR4/TNF/RELA/SMAD3/GIT1/IGF1/SPHK1/MYD88,12
GO:0071347,BP,GO:0071347,cellular response to interleukin-1,12/269,110/18888,0.109090909,7.659885096,8.42011195,5.56E-08,5.99E-07,2.51E-07,IL6/MAP3K7/IL1B/NFKB1/HIF1A/RELA/MMP2/DAB2IP/NKX3-1/NFKBIA/MAP2K7/MYD88,12
GO:0044346,BP,GO:0044346,fibroblast apoptotic process,7/269,26/18888,0.269230769,18.9042036,10.9806302,5.74E-08,6.16E-07,2.59E-07,TP53/MYC/PIK3CA/CASP3/BID/CUL3/TP63,7
GO:0008202,BP,GO:0008202,steroid metabolic process,20/269,329/18888,0.060790274,4.268426345,7.188508983,5.77E-08,6.19E-07,2.59E-07,SRD5A2/AMACR/HSD3B1/UGT2B17/EDNRB/NFKB1/IGF1R/TNF/CYP1A1/FGFR4/HSD3B2/SNAI1/SGPL1/SNAI2/AKR1C3/FGFR1/MED1/ESR1/CYP17A1/CYP19A1,20
GO:0042176,BP,GO:0042176,regulation of protein catabolic process,21/269,362/18888,0.05801105,4.073281439,7.096516922,5.93E-08,6.34E-07,2.66E-07,TIMP1/AURKA/FBXW7/GPX1/IL1B/CDH1/RILP/CDK2/TNF/RELA/AKT1/SMAD3/CAV1/IL10/CHEK2/EGFR/DAB2IP/HSP90AA1/ROCK1/CLU/FHIT,21
GO:0060828,BP,GO:0060828,regulation of canonical Wnt signaling pathway,18/269,268/18888,0.067164179,4.715974033,7.36426967,6.07E-08,6.47E-07,2.71E-07,CTNNB1/NFKB1/FGF2/CTNND1/NOTCH1/MAPK14/LZTS2/SMAD3/CAV1/TGFB1/ILK/EGFR/HHEX/DAB2IP/MIR145/SNAI2/SOX2/LGR4,18
GO:0050900,BP,GO:0050900,leukocyte migration,22/269,396/18888,0.055555556,3.90086741,7.012340301,6.10E-08,6.48E-07,2.72E-07,THBS1/CXCR2/IL6/EDNRB/IL1B/VEGFA/MMP14/MAPK1/TNF/RHOA/AKT1/MMP2/PTK2/IL10/BSG/SERPINE1/CD9/GATA3/LYVE1/ROCK1/MYD88/CYP19A1,22
GO:2000146,BP,GO:2000146,negative regulation of cell motility,22/269,396/18888,0.055555556,3.90086741,7.012340301,6.10E-08,6.48E-07,2.72E-07,TIMP1/THBS1/PTEN/PPARG/FGF2/CDH1/NOTCH1/STAT3/TNF/RHOA/AKT1/ALOX15B/TGFBR1/TGFB1/MIR200C/DLC1/DAB2IP/SERPINE1/MIR145/BRAF/GATA3/CYP19A1,22
GO:0043280,BP,GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,12/269,111/18888,0.108108108,7.590877122,8.370878828,6.15E-08,6.52E-07,2.73E-07,MYC/CASP8/PPARG/BID/FASLG/TNF/SMAD3/DLC1/BAX/AIFM1/PMAIP1/NKX3-1,12
GO:0040013,BP,GO:0040013,negative regulation of locomotion,23/269,431/18888,0.053364269,3.747004891,6.934209614,6.29E-08,6.65E-07,2.79E-07,TIMP1/THBS1/PTEN/PPARG/FGF2/CDH1/NOTCH1/STAT3/HDAC6/TNF/RHOA/AKT1/ALOX15B/TGFBR1/TGFB1/MIR200C/DLC1/DAB2IP/SERPINE1/MIR145/BRAF/GATA3/CYP19A1,23
GO:0030520,BP,GO:0030520,intracellular estrogen receptor signaling pathway,9/269,54/18888,0.166666667,11.70260223,9.466608916,6.41E-08,6.76E-07,2.83E-07,BRCA1/AR/PARP1/ARID1A/FOXA1/TP63/MED1/ESR1/ESR2,9
GO:0002285,BP,GO:0002285,lymphocyte activation involved in immune response,16/269,212/18888,0.075471698,5.299291576,7.566627454,6.76E-08,7.11E-07,2.98E-07,TP53/ERCC1/IL6/MYB/STAT3/MTOR/TLR4/TGFB1/IL10/BRD2/BRD4/GATA3/MLH1/MSH2/NBN/IFNA1,16
GO:0006694,BP,GO:0006694,steroid biosynthetic process,15/269,185/18888,0.081081081,5.693157842,7.710363308,6.82E-08,7.16E-07,3.00E-07,SRD5A2/AMACR/HSD3B1/NFKB1/IGF1R/TNF/CYP1A1/FGFR4/HSD3B2/SNAI1/SNAI2/AKR1C3/MED1/CYP17A1/CYP19A1,15
GO:0010660,BP,GO:0010660,regulation of muscle cell apoptotic process,11/269,91/18888,0.120879121,8.487601618,8.60594585,6.89E-08,7.20E-07,3.02E-07,TP53/ALOX12/CXCR2/PPARG/SOD2/IGF1R/IGF1/BNIP3/MIR145/CDKN2A/ESR1,11
GO:0033273,BP,GO:0033273,response to vitamin,11/269,91/18888,0.120879121,8.487601618,8.60594585,6.89E-08,7.20E-07,3.02E-07,GPX1/VDR/PTGS2/SOD2/IGF1R/RELA/CYP1A1/EGFR/SNAI2/PIM1/MED1,11
GO:0032944,BP,GO:0032944,regulation of mononuclear cell proliferation,17/269,241/18888,0.070539419,4.952968579,7.423468198,7.02E-08,7.32E-07,3.07E-07,CTNNB1/ERBB2/IL6/IL1B/CASP3/BID/SOX11/TLR4/BMI1/TWSG1/IL10/IGF1/CD274/PAWR/CDKN1A/IGF2/MYD88,17
GO:0010822,BP,GO:0010822,positive regulation of mitochondrion organization,10/269,72/18888,0.138888889,9.752168525,8.943298404,7.16E-08,7.42E-07,3.11E-07,TP53/AURKA/BID/HIF1A/MMP9/BAX/KDR/BNIP3/PMAIP1/CAMKK2,10
GO:0042698,BP,GO:0042698,ovulation cycle,10/269,72/18888,0.138888889,9.752168525,8.943298404,7.16E-08,7.42E-07,3.11E-07,CASP3/IGF1R/NCOA1/NOTCH1/PCNA/MMP2/EGFR/A2M/SGPL1/ESR1,10
GO:1903053,BP,GO:1903053,regulation of extracellular matrix organization,10/269,72/18888,0.138888889,9.752168525,8.943298404,7.16E-08,7.42E-07,3.11E-07,IL6/PPARG/NOTCH1/TGFBR1/SMAD3/TGFB1/FSCN1/FGFR4/RB1/MIR145,10
GO:0071560,BP,GO:0071560,cellular response to transforming growth factor beta stimulus,19/269,302/18888,0.062913907,4.41753859,7.196202677,7.30E-08,7.54E-07,3.16E-07,TP53/THBS1/MAP3K7/PPARG/PARP1/SOX11/ID1/IGF1R/STAT3/FOS/TWSG1/TGFBR1/SMAD3/CAV1/TGFB1/PTK2/HSPA5/PEG10/MIR145,19
GO:0046890,BP,GO:0046890,regulation of lipid biosynthetic process,15/269,187/18888,0.080213904,5.632268453,7.651763922,7.87E-08,8.11E-07,3.40E-07,BRCA1/FBXW7/PTGS2/IL1B/NFKB1/IGF1R/MTOR/PRKCD/TNF/AKT1/FGFR4/SNAI1/SPHK1/SNAI2/AKR1C3,15
GO:0051385,BP,GO:0051385,response to mineralocorticoid,8/269,40/18888,0.2,14.04312268,9.925637096,7.91E-08,8.13E-07,3.41E-07,HSD3B1/PARP1/IGF1R/HDAC6/FOS/HSD3B2/AIFM1/CDKN1A,8
GO:1901988,BP,GO:1901988,negative regulation of cell cycle phase transition,18/269,273/18888,0.065934066,4.629600882,7.260861108,8.03E-08,8.24E-07,3.46E-07,TP53/BRCA1/PTEN/RBL2/BRCA2/CCND1/XRCC3/MAPK14/CDK2/EZH2/CHEK2/RB1/SOX2/MUC1/MSH2/NBN/CDKN1A/CLOCK,18
GO:0003170,BP,GO:0003170,heart valve development,10/269,73/18888,0.136986301,9.618577176,8.867972707,8.20E-08,8.36E-07,3.50E-07,NOTCH1/MTOR/RHOA/TGFB1/RB1/SNAI1/TWIST1/SNAI2/GATA3/ROCK1,10
GO:0060420,BP,GO:0060420,regulation of heart growth,10/269,73/18888,0.136986301,9.618577176,8.867972707,8.20E-08,8.36E-07,3.50E-07,MIR25/FGF2/NOTCH1/MAPK14/DUSP6/TGFBR1/WT1/IGF1/PIM1/FGFR1,10
GO:0071260,BP,GO:0071260,cellular response to mechanical stimulus,10/269,73/18888,0.136986301,9.618577176,8.867972707,8.20E-08,8.36E-07,3.50E-07,PTGS2/CASP8/IL1B/NFKB1/IGF1R/FGF2/TLR4/EGFR/BNIP3/MYD88,10
GO:1901888,BP,GO:1901888,regulation of cell junction assembly,16/269,215/18888,0.074418605,5.225347973,7.489522262,8.22E-08,8.36E-07,3.50E-07,THBS1/PTEN/CTNNB1/IL1B/VEGFA/MMP14/TNF/RHOA/SMAD3/CAV1/PTK2/DLC1/SNAI1/KDR/SNAI2/ROCK1,16
GO:0035270,BP,GO:0035270,endocrine system development,13/269,137/18888,0.094890511,6.66279543,7.995735033,8.25E-08,8.37E-07,3.51E-07,IL6/FGF2/CDH1/MAPK1/AKT1/TGFBR1/SMAD3/WT1/PCSK1/BRAF/SOX2/GATA3/CLOCK,13
GO:0038083,BP,GO:0038083,peptidyl-tyrosine autophosphorylation,6/269,17/18888,0.352941176,24.78198119,11.79110451,8.56E-08,8.67E-07,3.64E-07,ALK/VEGFA/IGF1R/CAV1/EGFR/KDR,6
GO:1904705,BP,GO:1904705,regulation of vascular associated smooth muscle cell proliferation,11/269,93/18888,0.11827957,8.305072551,8.488369905,8.66E-08,8.75E-07,3.67E-07,PTEN/MAP3K7/PPARG/SOD2/FGF2/TNF/MMP9/MMP2/IL10/IGF1/CDKN1A,11
GO:0010761,BP,GO:0010761,fibroblast migration,9/269,56/18888,0.160714286,11.28465215,9.264347834,8.90E-08,8.96E-07,3.76E-07,THBS1/FGF2/AKT1/TGFB1/PTK2/ILK/SGPL1/MIR145/BRAF,9
GO:0007179,BP,GO:0007179,transforming growth factor beta receptor signaling pathway,17/269,245/18888,0.069387755,4.872103786,7.3324918,8.91E-08,8.96E-07,3.76E-07,TP53/THBS1/MAP3K7/PPARG/PARP1/SOX11/ID1/STAT3/FOS/TWSG1/TGFBR1/SMAD3/TGFB1/PTK2/HSPA5/PEG10/MIR145,17
GO:0070555,BP,GO:0070555,response to interleukin-1,13/269,138/18888,0.094202899,6.614514304,7.956655486,8.99E-08,9.03E-07,3.79E-07,IL6/MAP3K7/IL1B/NFKB1/HIF1A/RELA/MMP2/DAB2IP/PCSK1/NKX3-1/NFKBIA/MAP2K7/MYD88,13
GO:2000278,BP,GO:2000278,regulation of DNA biosynthetic process,12/269,115/18888,0.104347826,7.326846614,8.179915926,9.15E-08,9.16E-07,3.84E-07,TP53/CTNNB1/MYC/FGF2/PCNA/MAPK1/TNF/FGFR4/MEAF6/HSP90AA1/CDKN1A/MAP2K7,12
GO:0021766,BP,GO:0021766,hippocampus development,11/269,94/18888,0.117021277,8.216720715,8.430894762,9.68E-08,9.65E-07,4.05E-07,SRD5A2/PTEN/HSD3B1/XRCC1/ALK/CASP3/IGF1R/NCOA1/EZH2/HSD3B2/ID4,11
GO:1902807,BP,GO:1902807,negative regulation of cell cycle G1/S phase transition,11/269,94/18888,0.117021277,8.216720715,8.430894762,9.68E-08,9.65E-07,4.05E-07,TP53/PTEN/RBL2/CCND1/CDK2/EZH2/CHEK2/RB1/SOX2/MUC1/CDKN1A,11
GO:1904018,BP,GO:1904018,positive regulation of vasculature development,15/269,190/18888,0.078947368,5.543337899,7.565431693,9.71E-08,9.66E-07,4.05E-07,BRCA1/THBS1/CXCR2/IL1B/VEGFA/FGF2/HIF1A/STAT3/TGFBR1/TGFB1/IL10/SERPINE1/KDR/SPHK1/TWIST1,15
GO:0001101,BP,GO:0001101,response to acid chemical,13/269,139/18888,0.09352518,6.56692787,7.917961652,9.80E-08,9.73E-07,4.08E-07,PIK3CA/CASP3/VEGFA/IGF1R/MTOR/PCNA/TNF/RELA/MMP2/EGFR/CUL3/AIFM1/MYD88,13
GO:0033044,BP,GO:0033044,regulation of chromosome organization,17/269,247/18888,0.068825911,4.832653553,7.287740352,1.00E-07,9.93E-07,4.16E-07,TP53/CTNNB1/MYC/XRCC1/ERCC1/PARP1/ARID1A/XRCC3/SMARCA4/SMARCA2/CDK2/MAPK1/CUL3/RB1/SMARCE1/NBN/MAP2K7,17
GO:0071887,BP,GO:0071887,leukocyte apoptotic process,12/269,116/18888,0.103448276,7.263684143,8.133604028,1.01E-07,9.96E-07,4.18E-07,TP53/CXCR2/IL6/CASP3/FASLG/HIF1A/AKT1/IL10/CHEK2/BAX/CD274/CDKN2A,12
GO:0071901,BP,GO:0071901,negative regulation of protein serine/threonine kinase activity,11/269,95/18888,0.115789474,8.130228918,8.374264486,1.08E-07,1.06E-06,4.46E-07,PTEN/IL1B/PPARG/GSTP1/PRKCD/AKT1/HHEX/RB1/DAB2IP/CDKN1A/CDKN2A,11
GO:1990874,BP,GO:1990874,vascular associated smooth muscle cell proliferation,11/269,95/18888,0.115789474,8.130228918,8.374264486,1.08E-07,1.06E-06,4.46E-07,PTEN/MAP3K7/PPARG/SOD2/FGF2/TNF/MMP9/MMP2/IL10/IGF1/CDKN1A,11
GO:0030111,BP,GO:0030111,regulation of Wnt signaling pathway,20/269,342/18888,0.058479532,4.106176221,6.967764604,1.09E-07,1.07E-06,4.47E-07,CTNNB1/NFKB1/FGF2/CTNND1/NOTCH1/MAPK14/SMARCA4/HNF1B/LZTS2/SMAD3/CAV1/TGFB1/ILK/EGFR/HHEX/DAB2IP/MIR145/SNAI2/SOX2/LGR4,20
GO:0040029,BP,GO:0040029,epigenetic regulation of gene expression,16/269,220/18888,0.072727273,5.106590064,7.36416059,1.13E-07,1.11E-06,4.64E-07,TP53/BRCA1/MYC/GPX1/PIK3CA/CDKN2B-AS1/KDM1A/ARID1A/SMARCA4/CDK2/HDAC6/BMI1/EZH2/MBD2/RB1/IGF2,16
GO:0051345,BP,GO:0051345,positive regulation of hydrolase activity,24/269,482/18888,0.049792531,3.496213115,6.672751092,1.17E-07,1.15E-06,4.81E-07,MYC/CASP8/PPARG/BID/FASLG/STAT3/MTOR/PCNA/PRKCD/TNF/RHOA/EZH2/AKT1/SMAD3/EGFR/DLC1/BAX/AIFM1/PMAIP1/HRAS/NKX3-1/FGFR1/ROCK1/ESR1,24
GO:0007044,BP,GO:0007044,cell-substrate junction assembly,11/269,96/18888,0.114583333,8.045539033,8.318457348,1.21E-07,1.18E-06,4.93E-07,THBS1/PTEN/VEGFA/MMP14/RHOA/SMAD3/PTK2/FN1/DLC1/KDR/ROCK1,11
GO:0051222,BP,GO:0051222,positive regulation of protein transport,17/269,251/18888,0.067729084,4.755639153,7.19966303,1.26E-07,1.23E-06,5.16E-07,PTGS2/IL1B/PPARG/CDH1/MAPK14/HIF1A/TENM1/TLR4/PRKCD/TNF/SMAD3/TGFB1/EGFR/PCSK1/IGF1/HSP90AA1/SFN,17
GO:0006702,BP,GO:0006702,androgen biosynthetic process,5/269,10/18888,0.5,35.10780669,12.96747013,1.34E-07,1.30E-06,5.46E-07,SRD5A2/HSD3B1/HSD3B2/MED1/CYP17A1,5
GO:0060525,BP,GO:0060525,prostate glandular acinus development,5/269,10/18888,0.5,35.10780669,12.96747013,1.34E-07,1.30E-06,5.46E-07,HOXB13/NOTCH1/FOXA1/TP63/ESR1,5
GO:0003158,BP,GO:0003158,endothelium development,13/269,143/18888,0.090909091,6.38323758,7.766910445,1.37E-07,1.32E-06,5.56E-07,CTNNB1/GPX1/EDNRB/FASN/IL1B/VEGFA/NOTCH1/TNF/RHOA/MIR200C/KDR/ROCK1/MYD88,13
GO:0072078,BP,GO:0072078,nephron tubule morphogenesis,10/269,77/18888,0.12987013,9.118910829,8.580580036,1.38E-07,1.33E-06,5.57E-07,CTNNB1/MYC/VEGFA/FGF2/HNF1B/LZTS2/ILK/WT1/GATA3/LGR4,10
GO:0030336,BP,GO:0030336,negative regulation of cell migration,21/269,381/18888,0.05511811,3.870151919,6.802660769,1.41E-07,1.35E-06,5.68E-07,TIMP1/THBS1/PTEN/PPARG/FGF2/CDH1/NOTCH1/STAT3/TNF/RHOA/AKT1/ALOX15B/TGFBR1/TGFB1/MIR200C/DLC1/DAB2IP/SERPINE1/MIR145/BRAF/CYP19A1,21
GO:0060135,BP,GO:0060135,maternal process involved in female pregnancy,9/269,59/18888,0.152542373,10.71085628,8.979442192,1.42E-07,1.37E-06,5.73E-07,AR/VDR/PTGS2/PARP1/AKT1/BSG/MED1/CTSB/ESR1,9
GO:0007595,BP,GO:0007595,lactation,8/269,43/18888,0.186046512,13.06336993,9.518845044,1.44E-07,1.37E-06,5.75E-07,COX2/VDR/CCND1/VEGFA/NCOA1/HIF1A/CAV1/MED1,8
GO:0010712,BP,GO:0010712,regulation of collagen metabolic process,8/269,43/18888,0.186046512,13.06336993,9.518845044,1.44E-07,1.37E-06,5.75E-07,IL6/MYB/NOTCH1/TGFB1/CBX8/VIM/MIR145/UCN,8
GO:0032768,BP,GO:0032768,regulation of monooxygenase activity,8/269,43/18888,0.186046512,13.06336993,9.518845044,1.44E-07,1.37E-06,5.75E-07,VDR/IL1B/NFKB1/HIF1A/TNF/AKT1/EGFR/MIR130B,8
GO:0031330,BP,GO:0031330,negative regulation of cellular catabolic process,16/269,224/18888,0.071428571,5.015400956,7.266579319,1.45E-07,1.38E-06,5.78E-07,TP53/TIMP1/YBX1/PIK3CA/MAPK14/STAT3/MTOR/AKT1/IL10/GIT1/PKP1/PKP3/VHL/FBP1/ROCK1/MYD88,16
GO:0045664,BP,GO:0045664,regulation of neuron differentiation,15/269,196/18888,0.076530612,5.373643881,7.398148116,1.46E-07,1.39E-06,5.82E-07,ETV5/EDNRB/ALK/SOX11/NCOA1/FGF2/NOTCH1/RHOA/FOXA1/SOX2/ZHX2/FGFR1/MED1/ROCK1/ID4,15
GO:0010948,BP,GO:0010948,negative regulation of cell cycle process,19/269,316/18888,0.060126582,4.221824855,6.942175453,1.48E-07,1.41E-06,5.90E-07,TP53/BRCA1/PTEN/RBL2/BRCA2/CCND1/XRCC3/MAPK14/CDK2/EZH2/CHEK2/RB1/DAB2IP/SOX2/MUC1/MSH2/NBN/CDKN1A/CLOCK,19
GO:0060993,BP,GO:0060993,kidney morphogenesis,11/269,98/18888,0.112244898,7.881344359,8.209229432,1.49E-07,1.42E-06,5.94E-07,CTNNB1/MYC/VEGFA/FGF2/HNF1B/LZTS2/ILK/WT1/GATA3/STAT1/LGR4,11
GO:0034329,BP,GO:0034329,cell junction assembly,23/269,453/18888,0.050772627,3.565031143,6.642011553,1.54E-07,1.46E-06,6.10E-07,THBS1/PTEN/CTNNB1/IL1B/VEGFA/MMP14/CDH1/TNF/RHOA/SMAD3/CAV1/SLC39A9/PTK2/FSCN1/EPB41L3/FN1/DLC1/PKP3/SNAI1/KDR/CD9/SNAI2/ROCK1,23
GO:0007254,BP,GO:0007254,JNK cascade,14/269,171/18888,0.081871345,5.74864671,7.497720544,1.67E-07,1.57E-06,6.60E-07,MAP3K7/IL1B/NFKB1/IGF1R/GSTP1/TLR4/TNF/SMAD3/EGFR/DAB2IP/HRAS/PER1/MAP2K7/MYD88,14
GO:1902230,BP,GO:1902230,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,7/269,30/18888,0.233333333,16.38364312,10.13564666,1.69E-07,1.59E-06,6.68E-07,BID/KDM1A/CD44/SNAI1/SNAI2/MUC1/CLU,7
GO:0045598,BP,GO:0045598,regulation of fat cell differentiation,13/269,146/18888,0.089041096,6.252075164,7.65735617,1.75E-07,1.64E-06,6.89E-07,IL6/PTGS2/PPARG/SOD2/MAPK14/HDAC6/TNF/AKT1/SMAD3/TGFB1/SNAI2/PIM1/ID4,13
GO:0045618,BP,GO:0045618,positive regulation of keratinocyte differentiation,6/269,19/18888,0.315789474,22.17335159,11.09868235,1.83E-07,1.72E-06,7.20E-07,ETV4/VDR/NCOA3/NOTCH1/ALOX15B/MED1,6
GO:0048010,BP,GO:0048010,vascular endothelial growth factor receptor signaling pathway,9/269,61/18888,0.147540984,10.35968066,8.800651873,1.92E-07,1.79E-06,7.50E-07,IL1B/VEGFA/MAPK14/HIF1A/PTK2/MIR200C/HHEX/DAB2IP/KDR,9
GO:0051785,BP,GO:0051785,positive regulation of nuclear division,9/269,61/18888,0.147540984,10.35968066,8.800651873,1.92E-07,1.79E-06,7.50E-07,AURKA/IL1B/TNF/CUL3/RB1/TGFA/IGF1/SPHK1/IGF2,9
GO:0045446,BP,GO:0045446,endothelial cell differentiation,12/269,123/18888,0.097560976,6.850303745,7.824131492,1.93E-07,1.80E-06,7.54E-07,CTNNB1/GPX1/EDNRB/FASN/IL1B/VEGFA/NOTCH1/TNF/MIR200C/KDR/ROCK1/MYD88,12
GO:0071241,BP,GO:0071241,cellular response to inorganic substance,16/269,229/18888,0.069868996,4.905894385,7.147818378,1.96E-07,1.82E-06,7.63E-07,PTGS2/PARP1/CDH1/CDK2/MAPK1/FOS/AKT1/MMP9/CYP1A1/EGFR/AIFM1/BNIP3/BRAF/AKR1C3/TFAP2A/FBP1,16
GO:0002534,BP,GO:0002534,cytokine production involved in inflammatory response,10/269,80/18888,0.125,8.776951673,8.37842796,1.99E-07,1.84E-06,7.73E-07,IL6/MAPK14/HIF1A/STAT3/BAP1/TLR4/TNF/EZH2/PER1/MYD88,10
GO:1900015,BP,GO:1900015,regulation of cytokine production involved in inflammatory response,10/269,80/18888,0.125,8.776951673,8.37842796,1.99E-07,1.84E-06,7.73E-07,IL6/MAPK14/HIF1A/STAT3/BAP1/TLR4/TNF/EZH2/PER1/MYD88,10
GO:0050728,BP,GO:0050728,negative regulation of inflammatory response,15/269,201/18888,0.074626866,5.239971148,7.263912288,2.03E-07,1.87E-06,7.86E-07,GPX1/NFKB1/PPARG/GSTP1/MAPK14/STAT3/PRKCD/SMAD3/IL10/GIT1/RB1/IGF1/MIR145/GATA3/CYP19A1,15
GO:0031348,BP,GO:0031348,negative regulation of defense response,18/269,291/18888,0.06185567,4.343233817,6.908301039,2.09E-07,1.93E-06,8.08E-07,GPX1/NFKB1/PPARG/PARP1/GSTP1/MAPK14/STAT3/PRKCD/SMAD3/TGFB1/IL10/A2M/GIT1/RB1/IGF1/MIR145/GATA3/CYP19A1,18
GO:0043200,BP,GO:0043200,response to amino acid,12/269,124/18888,0.096774194,6.79505936,7.781896915,2.11E-07,1.94E-06,8.14E-07,PIK3CA/CASP3/IGF1R/MTOR/PCNA/TNF/RELA/MMP2/EGFR/CUL3/AIFM1/MYD88,12
GO:0031400,BP,GO:0031400,negative regulation of protein modification process,22/269,426/18888,0.051643192,3.626158438,6.589702438,2.17E-07,1.99E-06,8.35E-07,PTEN/CTNNB1/IL1B/PPARG/GSTP1/HDAC6/SQSTM1/PRKCD/TNF/RELA/DUSP6/AKT1/CAV1/TGFB1/HHEX/RB1/BAX/DAB2IP/CDKN1A/SFN/CDKN2A/ROCK1,22
GO:0045861,BP,GO:0045861,negative regulation of proteolysis,16/269,231/18888,0.069264069,4.863419109,7.101275502,2.20E-07,2.02E-06,8.47E-07,TP53/TIMP1/THBS1/GPX1/CD44/VEGFA/HDAC6/TNF/AKT1/MMP9/IL10/SERPINE1/SFN/ROCK1/PLAU/FHIT,16
GO:0046824,BP,GO:0046824,positive regulation of nucleocytoplasmic transport,9/269,62/18888,0.14516129,10.19258904,8.714332304,2.21E-07,2.02E-06,8.47E-07,PTGS2/IL1B/CDH1/MAPK14/PRKCD/SMAD3/TGFB1/HSP90AA1/SFN,9
GO:2000351,BP,GO:2000351,regulation of endothelial cell apoptotic process,9/269,62/18888,0.14516129,10.19258904,8.714332304,2.21E-07,2.02E-06,8.47E-07,THBS1/FASLG/TNF/TGFB1/SERPINE1/KDR/BRAF/AKR1C3/GATA3,9
GO:0035148,BP,GO:0035148,tube formation,13/269,149/18888,0.087248322,6.126194456,7.550825945,2.22E-07,2.02E-06,8.47E-07,CTNNB1/CASP3/VEGFA/FGF2/NOTCH1/HIF1A/HNF1B/TGFB1/BRD2/DLC1/DAB2IP/TWIST1/GATA3,13
GO:0061333,BP,GO:0061333,renal tubule morphogenesis,10/269,81/18888,0.12345679,8.668594245,8.313386285,2.24E-07,2.04E-06,8.55E-07,CTNNB1/MYC/VEGFA/FGF2/HNF1B/LZTS2/ILK/WT1/GATA3/LGR4,10
GO:0000077,BP,GO:0000077,DNA damage checkpoint signaling,12/269,125/18888,0.096,6.740698885,7.740127041,2.30E-07,2.09E-06,8.76E-07,TP53/BRCA1/BRCA2/CCND1/MAPK14/CDK2/CHEK2/MUC1/MSH2/NBN/CDKN1A/CLOCK,12
GO:0022408,BP,GO:0022408,negative regulation of cell-cell adhesion,15/269,203/18888,0.073891626,5.188345816,7.211464246,2.31E-07,2.09E-06,8.76E-07,ERBB2/ALOX12/CASP3/VEGFA/CDH1/NOTCH1/PRKCD/TWSG1/AKT1/TGFB1/PTK2/IL10/CD9/CD274/PAWR,15
GO:0042692,BP,GO:0042692,muscle cell differentiation,22/269,428/18888,0.051401869,3.609213772,6.562890414,2.35E-07,2.12E-06,8.90E-07,CTNNB1/YBX1/GPX1/EDNRB/CASP3/KDM1A/VEGFA/SOD2/MMP14/NOTCH1/MAPK14/MTOR/KRAS/EZH2/AKT1/TGFB1/WT1/RB1/IGF1/CD9/MIR145/IGF2,22
GO:0016331,BP,GO:0016331,morphogenesis of embryonic epithelium,13/269,150/18888,0.086666667,6.08535316,7.51596216,2.40E-07,2.16E-06,9.07E-07,CTNNB1/AR/CASP3/SOX11/HIF1A/HNF1B/TGFB1/BRD2/DLC1/TWIST1/GATA3/TP63/TFAP2A,13
GO:0071492,BP,GO:0071492,cellular response to UV-A,5/269,11/18888,0.454545455,31.9161879,12.32807441,2.43E-07,2.19E-06,9.18E-07,TIMP1/MMP9/MMP2/MME/MMP1,5
GO:0002768,BP,GO:0002768,immune response-regulating cell surface receptor signaling pathway,20/269,360/18888,0.055555556,3.90086741,6.679505511,2.48E-07,2.23E-06,9.33E-07,MAP3K7/PIK3CA/NFKB1/TLR4/SQSTM1/MAPK1/PRKCD/RELA/PTK2/MIR200C/BAX/DAB2IP/BRAF/HRAS/GATA3/CD8A/PAWR/NFKBIA/MAP2K7/MYD88,20
GO:0031346,BP,GO:0031346,positive regulation of cell projection organization,20/269,360/18888,0.055555556,3.90086741,6.679505511,2.48E-07,2.23E-06,9.33E-07,PIK3CA/ALK/KDM1A/VEGFA/IGF1R/TENM1/MTOR/HDAC6/EZH2/KATNB1/TGFBR1/FSCN1/MIR200C/FN1/DAB2IP/HSP90AA1/BRAF/HRAS/FGFR1/MIEN1,20
GO:0070849,BP,GO:0070849,response to epidermal growth factor,8/269,46/18888,0.173913043,12.21141102,9.150717433,2.49E-07,2.23E-06,9.35E-07,ERBB2/MAPK1/FOS/AKT1/EGFR/DAB2IP/SNAI2/MED1,8
GO:0150115,BP,GO:0150115,cell-substrate junction organization,11/269,103/18888,0.106796117,7.498754827,7.949185284,2.50E-07,2.23E-06,9.36E-07,THBS1/PTEN/VEGFA/MMP14/RHOA/SMAD3/PTK2/FN1/DLC1/KDR/ROCK1,11
GO:0007405,BP,GO:0007405,neuroblast proliferation,10/269,82/18888,0.12195122,8.562879681,8.249456858,2.52E-07,2.25E-06,9.43E-07,TP53/CTNNB1/KDM1A/VEGFA/FGF2/NOTCH1/HIF1A/NBN/FGFR1/ID4,10
GO:0010634,BP,GO:0010634,positive regulation of epithelial cell migration,14/269,177/18888,0.079096045,5.55377733,7.316264177,2.55E-07,2.27E-06,9.53E-07,THBS1/PTGS2/VEGFA/FGF2/HIF1A/MTOR/HDAC6/AKT1/MMP9/TGFB1/PTK2/KDR/GATA3/FGFR1,14
GO:0055093,BP,GO:0055093,response to hyperoxia,6/269,20/18888,0.3,21.06468401,10.79105343,2.59E-07,2.28E-06,9.58E-07,SOD2/CAV1/MMP2/CYP1A1/BNIP3/CDKN1A,6
GO:0060749,BP,GO:0060749,mammary gland alveolus development,6/269,20/18888,0.3,21.06468401,10.79105343,2.59E-07,2.28E-06,9.58E-07,AR/CCND1/VEGFA/HIF1A/TGFA/ESR1,6
GO:0061377,BP,GO:0061377,mammary gland lobule development,6/269,20/18888,0.3,21.06468401,10.79105343,2.59E-07,2.28E-06,9.58E-07,AR/CCND1/VEGFA/HIF1A/TGFA/ESR1,6
GO:1903376,BP,GO:1903376,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,6/269,20/18888,0.3,21.06468401,10.79105343,2.59E-07,2.28E-06,9.58E-07,CTNNB1/FBXW7/PARP1/HIF1A/MMP2/IL10,6
GO:1901889,BP,GO:1901889,negative regulation of cell junction assembly,7/269,32/18888,0.21875,15.35966543,9.771786728,2.73E-07,2.40E-06,1.01E-06,THBS1/PTEN/IL1B/MMP14/TNF/DLC1/ROCK1,7
GO:2001056,BP,GO:2001056,positive regulation of cysteine-type endopeptidase activity,12/269,127/18888,0.094488189,6.634546146,7.657945355,2.74E-07,2.41E-06,1.01E-06,MYC/CASP8/PPARG/BID/FASLG/TNF/SMAD3/DLC1/BAX/AIFM1/PMAIP1/NKX3-1,12
GO:0010469,BP,GO:0010469,regulation of signaling receptor activity,11/269,104/18888,0.105769231,7.426651415,7.899267633,2.76E-07,2.42E-06,1.02E-06,FBXW7/PPARG/NCOA3/HIF1A/HDAC6/PRKCD/TNF/PSCA/IL10/SERPINE1/PLAU,11
GO:0022617,BP,GO:0022617,extracellular matrix disassembly,9/269,64/18888,0.140625,9.874070632,8.547445989,2.93E-07,2.56E-06,1.07E-06,IL6/MMP14/MMP9/TGFB1/MMP2/FSCN1/FGFR4/MMP7/MMP1,9
GO:2001244,BP,GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,9/269,64/18888,0.140625,9.874070632,8.547445989,2.93E-07,2.56E-06,1.07E-06,TP53/FBXW7/MYC/BID/CAV1/MMP2/BAX/PMAIP1/NKX3-1,9
GO:0046683,BP,GO:0046683,response to organophosphorus,12/269,128/18888,0.09375,6.582713755,7.617516132,2.99E-07,2.61E-06,1.09E-06,PTGS2/IL1B/KDM1A/FOS/RELA/BSG/WT1/BRAF/THBD/STAT1/PER1/FBP1,12
GO:0010950,BP,GO:0010950,positive regulation of endopeptidase activity,13/269,153/18888,0.08496732,5.96603251,7.413236906,3.02E-07,2.62E-06,1.10E-06,MYC/CASP8/PPARG/BID/FASLG/STAT3/TNF/SMAD3/DLC1/BAX/AIFM1/PMAIP1/NKX3-1,13
GO:0016525,BP,GO:0016525,negative regulation of angiogenesis,13/269,153/18888,0.08496732,5.96603251,7.413236906,3.02E-07,2.62E-06,1.10E-06,THBS1/CTNNB1/KLK3/PPARG/FASLG/TNF/RELA/HHEX/DAB2IP/SERPINE1/MIR145/STAT1/ROCK1,13
GO:0045639,BP,GO:0045639,positive regulation of myeloid cell differentiation,11/269,105/18888,0.104761905,7.355921402,7.85000878,3.04E-07,2.64E-06,1.11E-06,CASP8/MAPK14/HIF1A/STAT3/FOS/TNF/TGFB1/RB1/MIR145/STAT1/MED1,11
GO:0002429,BP,GO:0002429,immune response-activating cell surface receptor signaling pathway,19/269,332/18888,0.057228916,4.018363416,6.669262978,3.18E-07,2.75E-06,1.15E-06,MAP3K7/PIK3CA/NFKB1/TLR4/SQSTM1/MAPK1/PRKCD/RELA/PTK2/MIR200C/BAX/DAB2IP/BRAF/HRAS/GATA3/CD8A/PAWR/NFKBIA/MYD88,19
GO:0030198,BP,GO:0030198,extracellular matrix organization,19/269,332/18888,0.057228916,4.018363416,6.669262978,3.18E-07,2.75E-06,1.15E-06,IL6/PPARG/MMP14/NOTCH1/TNF/MMP9/TGFBR1/SMAD3/CAV1/TGFB1/MMP2/FSCN1/FGFR4/WT1/RB1/COL11A2/MIR145/MMP7/MMP1,19
GO:0051098,BP,GO:0051098,regulation of binding,16/269,238/18888,0.067226891,4.72037737,6.94249393,3.30E-07,2.85E-06,1.19E-06,AURKA/PPARG/KDM1A/SOX11/PRKCD/AKT1/MMP9/IL10/TXN/RB1/BAX/IGF1/TWIST1/GATA3/CDKN1A/ROCK1,16
GO:0043062,BP,GO:0043062,extracellular structure organization,19/269,333/18888,0.057057057,4.006296259,6.652775496,3.33E-07,2.87E-06,1.20E-06,IL6/PPARG/MMP14/NOTCH1/TNF/MMP9/TGFBR1/SMAD3/CAV1/TGFB1/MMP2/FSCN1/FGFR4/WT1/RB1/COL11A2/MIR145/MMP7/MMP1,19
GO:0002532,BP,GO:0002532,production of molecular mediator involved in inflammatory response,11/269,106/18888,0.103773585,7.286525917,7.801393409,3.35E-07,2.88E-06,1.21E-06,IL6/MAPK14/HIF1A/STAT3/BAP1/TLR4/TNF/EZH2/SERPINE1/PER1/MYD88,11
GO:0097306,BP,GO:0097306,cellular response to alcohol,11/269,106/18888,0.103773585,7.286525917,7.801393409,3.35E-07,2.88E-06,1.21E-06,BRCA1/CTNNB1/CDK4/SOD2/IGF1R/CDH1/FOS/AKT1/AIFM1/AKR1C3/FBP1,11
GO:0010573,BP,GO:0010573,vascular endothelial growth factor production,9/269,65/18888,0.138461538,9.722161853,8.466732773,3.36E-07,2.88E-06,1.21E-06,BRCA1/IL6/PTGS2/IL1B/HIF1A/STAT3/TNF/RELA/TGFB1,9
GO:0002366,BP,GO:0002366,leukocyte activation involved in immune response,18/269,301/18888,0.059800664,4.198940335,6.724564948,3.44E-07,2.94E-06,1.23E-06,TP53/ERCC1/IL6/MYB/STAT3/MTOR/TLR4/TNF/TGFB1/IL10/BRD2/BRD4/GATA3/MLH1/MSH2/NBN/IFNA1/MYD88,18
GO:0045229,BP,GO:0045229,external encapsulating structure organization,19/269,334/18888,0.056886228,3.99430136,6.636352085,3.48E-07,2.97E-06,1.25E-06,IL6/PPARG/MMP14/NOTCH1/TNF/MMP9/TGFBR1/SMAD3/CAV1/TGFB1/MMP2/FSCN1/FGFR4/WT1/RB1/COL11A2/MIR145/MMP7/MMP1,19
GO:0009743,BP,GO:0009743,response to carbohydrate,16/269,239/18888,0.066945607,4.700626837,6.920315973,3.49E-07,2.98E-06,1.25E-06,THBS1/GPX1/ERCC1/PTGS2/PIK3CA/IL1B/CASP3/SOD2/IGF1R/HIF1A/SMARCA4/TNF/HNF1B/SMAD3/PCSK1/FBP1,16
GO:2000181,BP,GO:2000181,negative regulation of blood vessel morphogenesis,13/269,155/18888,0.083870968,5.889051445,7.346259137,3.51E-07,2.98E-06,1.25E-06,THBS1/CTNNB1/KLK3/PPARG/FASLG/TNF/RELA/HHEX/DAB2IP/SERPINE1/MIR145/STAT1/ROCK1,13
GO:0032964,BP,GO:0032964,collagen biosynthetic process,8/269,48/18888,0.166666667,11.70260223,8.923783155,3.52E-07,2.98E-06,1.25E-06,IL6/MYB/NOTCH1/TGFB1/CBX8/VIM/MIR145/UCN,8
GO:0048041,BP,GO:0048041,focal adhesion assembly,10/269,85/18888,0.117647059,8.260660398,8.06401762,3.55E-07,3.00E-06,1.26E-06,THBS1/PTEN/VEGFA/MMP14/RHOA/SMAD3/PTK2/DLC1/KDR/ROCK1,10
GO:0051591,BP,GO:0051591,response to cAMP,10/269,85/18888,0.117647059,8.260660398,8.06401762,3.55E-07,3.00E-06,1.26E-06,KDM1A/FOS/RELA/BSG/WT1/BRAF/THBD/STAT1/PER1/FBP1,10
GO:2000134,BP,GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,10/269,85/18888,0.117647059,8.260660398,8.06401762,3.55E-07,3.00E-06,1.26E-06,TP53/PTEN/RBL2/CCND1/CDK2/EZH2/CHEK2/RB1/MUC1/CDKN1A,10
GO:0042359,BP,GO:0042359,vitamin D metabolic process,6/269,21/18888,0.285714286,20.06160382,10.50502562,3.58E-07,3.01E-06,1.26E-06,NFKB1/TNF/CYP1A1/SNAI1/SNAI2/FGFR1,6
GO:0033673,BP,GO:0033673,negative regulation of kinase activity,14/269,182/18888,0.076923077,5.401201029,7.171266944,3.59E-07,3.02E-06,1.26E-06,PTEN/IL1B/PPARG/GSTP1/PRKCD/AKT1/CAV1/HHEX/RB1/DAB2IP/CDKN1A/SFN/NPRL2/CDKN2A,14
GO:0060538,BP,GO:0060538,skeletal muscle organ development,14/269,182/18888,0.076923077,5.401201029,7.171266944,3.59E-07,3.02E-06,1.26E-06,CTNNB1/GPX1/SOX11/NOTCH1/MAPK14/FOS/RHOA/KRAS/CAV1/TGFB1/WT1/RB1/TWIST1/IGF2,14
GO:0051223,BP,GO:0051223,regulation of protein transport,22/269,440/18888,0.05,3.510780669,6.405306615,3.76E-07,3.15E-06,1.32E-06,IL6/PTGS2/IL1B/PPARG/CDH1/MAPK14/HIF1A/TENM1/TLR4/PRKCD/TNF/SMAD3/TGFB1/EGFR/TXN/IFI27/PCSK1/IRS1/IGF1/HSP90AA1/SFN/CLOCK,22
GO:0042446,BP,GO:0042446,hormone biosynthetic process,9/269,66/18888,0.136363636,9.57485637,8.38774834,3.84E-07,3.21E-06,1.35E-06,SRD5A2/HSD3B1/NFKB1/IGF1R/HIF1A/HSD3B2/MED1/CYP17A1/CYP19A1,9
GO:1901343,BP,GO:1901343,negative regulation of vasculature development,13/269,157/18888,0.082802548,5.814031681,7.280441935,4.07E-07,3.40E-06,1.42E-06,THBS1/CTNNB1/KLK3/PPARG/FASLG/TNF/RELA/HHEX/DAB2IP/SERPINE1/MIR145/STAT1/ROCK1,13
GO:0030656,BP,GO:0030656,regulation of vitamin metabolic process,5/269,12/18888,0.416666667,29.25650558,11.76883693,4.12E-07,3.43E-06,1.44E-06,NFKB1/TNF/SNAI1/SNAI2/AKR1C3,5
GO:0035272,BP,GO:0035272,exocrine system development,8/269,49/18888,0.163265306,11.46377361,8.815296133,4.15E-07,3.44E-06,1.44E-06,TNF/TWSG1/TGFB1/EGFR/SNAI2/NKX3-1/FGFR1/IGF2,8
GO:0048546,BP,GO:0048546,digestive tract morphogenesis,8/269,49/18888,0.163265306,11.46377361,8.815296133,4.15E-07,3.44E-06,1.44E-06,CTNNB1/SOX11/NOTCH1/HIF1A/HNF1B/SMAD3/EGFR/TP63,8
GO:0002263,BP,GO:0002263,cell activation involved in immune response,18/269,305/18888,0.059016393,4.143872265,6.653288456,4.18E-07,3.46E-06,1.45E-06,TP53/ERCC1/IL6/MYB/STAT3/MTOR/TLR4/TNF/TGFB1/IL10/BRD2/BRD4/GATA3/MLH1/MSH2/NBN/IFNA1/MYD88,18
GO:0007435,BP,GO:0007435,salivary gland morphogenesis,7/269,34/18888,0.205882353,14.4561557,9.439264699,4.26E-07,3.52E-06,1.48E-06,TNF/TWSG1/TGFB1/EGFR/SNAI2/NKX3-1/FGFR1,7
GO:0042098,BP,GO:0042098,T cell proliferation,15/269,213/18888,0.070422535,4.944761506,6.95920616,4.29E-07,3.53E-06,1.48E-06,TP53/CTNNB1/ERBB2/IL6/IL1B/CASP3/BID/BMI1/TWSG1/IL10/BAX/IGF1/CD274/PAWR/IGF2,15
GO:0051348,BP,GO:0051348,negative regulation of transferase activity,15/269,213/18888,0.070422535,4.944761506,6.95920616,4.29E-07,3.53E-06,1.48E-06,PTEN/XRCC1/IL1B/PPARG/GSTP1/PRKCD/AKT1/CAV1/HHEX/RB1/DAB2IP/CDKN1A/SFN/NPRL2/CDKN2A,15
GO:0000723,BP,GO:0000723,telomere maintenance,13/269,158/18888,0.082278481,5.777234013,7.247957276,4.38E-07,3.59E-06,1.51E-06,TP53/CTNNB1/MYC/BRCA2/XRCC1/ERCC1/PARP1/XRCC3/PCNA/MAPK1/HSP90AA1/NBN/MAP2K7,13
GO:0072006,BP,GO:0072006,nephron development,13/269,158/18888,0.082278481,5.777234013,7.247957276,4.38E-07,3.59E-06,1.51E-06,CTNNB1/MYC/EDNRB/VEGFA/FGF2/NOTCH1/HNF1B/LZTS2/ILK/WT1/GATA3/STAT1/LGR4,13
GO:1905953,BP,GO:1905953,negative regulation of lipid localization,9/269,67/18888,0.134328358,9.431948066,8.310428765,4.38E-07,3.59E-06,1.51E-06,THBS1/IL6/NFKB1/PPARG/TNF/AKT1/MIR145/MIR130B/NFKBIA,9
GO:0009791,BP,GO:0009791,post-embryonic development,10/269,87/18888,0.114942529,8.070760159,7.945380716,4.43E-07,3.63E-06,1.52E-06,ERCC1/VEGFA/SOD2/MTOR/TGFBR1/BAX/KDR/SGPL1/GATA3/ZFX,10
GO:0009615,BP,GO:0009615,response to virus,21/269,409/18888,0.051344743,3.605202643,6.402408575,4.54E-07,3.71E-06,1.55E-06,IL6/IL1B/NFKB1/MAPK14/HIF1A/RNASEL/TNF/RELA/SMAD3/BAX/IFI27/BNIP3/HSP90AA1/PMAIP1/GATA3/STAT1/BNIP3L/MST1R/IFNA1/MYD88/CLU,21
GO:0036480,BP,GO:0036480,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,6/269,22/18888,0.272727273,19.14971274,10.2381299,4.86E-07,3.96E-06,1.66E-06,CTNNB1/FBXW7/PARP1/HIF1A/MMP2/IL10,6
GO:0030521,BP,GO:0030521,androgen receptor signaling pathway,8/269,50/18888,0.16,11.23449814,8.709908879,4.88E-07,3.96E-06,1.66E-06,AR/KDM1A/ARID1A/SMARCA4/HDAC6/MAPK1/RHOA/NKX3-1,8
GO:0035094,BP,GO:0035094,response to nicotine,8/269,50/18888,0.16,11.23449814,8.709908879,4.88E-07,3.96E-06,1.66E-06,GPX1/NFKB1/CASP3/IGF1R/MAPK1/TNF/RELA/MMP2,8
GO:0043154,BP,GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,8/269,50/18888,0.16,11.23449814,8.709908879,4.88E-07,3.96E-06,1.66E-06,THBS1/GPX1/CD44/VEGFA/TNF/AKT1/MMP9/SFN,8
GO:0007173,BP,GO:0007173,epidermal growth factor receptor signaling pathway,11/269,110/18888,0.1,7.021561338,7.61307738,4.89E-07,3.96E-06,1.66E-06,ERBB2/PIK3CA/FASLG/AKT1/MMP9/TGFB1/PTK2/EGFR/TGFA/DAB2IP/BRAF,11
GO:0031570,BP,GO:0031570,DNA integrity checkpoint signaling,12/269,134/18888,0.089552239,6.287965378,7.383690778,4.92E-07,3.97E-06,1.67E-06,TP53/BRCA1/BRCA2/CCND1/MAPK14/CDK2/CHEK2/MUC1/MSH2/NBN/CDKN1A/CLOCK,12
GO:0001892,BP,GO:0001892,embryonic placenta development,10/269,88/18888,0.113636364,7.979046975,7.887474845,4.94E-07,3.98E-06,1.67E-06,CASP8/NCOA1/HIF1A/MAPK1/AKT1/IL10/EGFR/SNAI1/MED1/IGF2,10
GO:0035019,BP,GO:0035019,somatic stem cell population maintenance,9/269,68/18888,0.132352941,9.293242948,8.234713408,4.99E-07,4.02E-06,1.68E-06,MYC/STAT3/HNF1B/MIR145/BRAF/SOX2/ZHX2/TP63/NANOG,9
GO:0009913,BP,GO:0009913,epidermal cell differentiation,16/269,246/18888,0.06504065,4.566869163,6.768429897,5.15E-07,4.14E-06,1.74E-06,CTNNB1/ETV4/VDR/CASP3/NCOA3/FGF2/NOTCH1/EZH2/ALOX15B/AKR1C3/TP63/FGFR1/CDKN1A/MED1/SFN/ROCK1,16
GO:0030218,BP,GO:0030218,erythrocyte differentiation,12/269,135/18888,0.088888889,6.241387856,7.346107169,5.33E-07,4.28E-06,1.79E-06,CASP3/VEGFA/MYB/MAPK14/HIF1A/STAT3/BAP1/HDAC6/RB1/GATA3/STAT1/MED1,12
GO:0045445,BP,GO:0045445,myoblast differentiation,11/269,111/18888,0.099099099,6.958304029,7.567466381,5.36E-07,4.29E-06,1.80E-06,GPX1/ARID1A/NOTCH1/MAPK14/SMARCA4/SMARCA2/TNF/TGFB1/RB1/IGF1/SMARCE1,11
GO:2000027,BP,GO:2000027,regulation of animal organ morphogenesis,10/269,89/18888,0.112359551,7.889394762,7.830475843,5.49E-07,4.39E-06,1.84E-06,CTNNB1/AR/VEGFA/FGF2/TNF/WT1/SNAI2/GATA3/FGFR1/LGR4,10
GO:0048645,BP,GO:0048645,animal organ formation,9/269,69/18888,0.130434783,9.158558267,8.1605447,5.67E-07,4.52E-06,1.90E-06,CTNNB1/AR/FGF2/NOTCH1/MAPK1/WT1/PIM1/TP63/FGFR1,9
GO:0032200,BP,GO:0032200,telomere organization,14/269,189/18888,0.074074074,5.201156547,6.977021003,5.69E-07,4.53E-06,1.90E-06,TP53/CTNNB1/MYC/BRCA2/XRCC1/ERCC1/PARP1/XRCC3/PCNA/MAPK1/EZH2/HSP90AA1/NBN/MAP2K7,14
GO:0006302,BP,GO:0006302,double-strand break repair,18/269,312/18888,0.057692308,4.050900772,6.53143686,5.82E-07,4.63E-06,1.94E-06,TP53/BRCA1/BRCA2/XRCC1/ERCC1/PARP1/KDM1A/ARID1A/XRCC3/SMARCA4/SMARCA2/CHEK2/MEAF6/SMARCE1/TWIST1/MLH1/MSH2/NBN,18
GO:0048592,BP,GO:0048592,eye morphogenesis,13/269,162/18888,0.080246914,5.634586259,7.120744804,5.84E-07,4.63E-06,1.94E-06,CTNNB1/FASLG/SOX11/VEGFA/FGF2/NOTCH1/HIF1A/STAT3/BAX/KDR/TWIST1/ZHX2/TFAP2A,13
GO:0045833,BP,GO:0045833,negative regulation of lipid metabolic process,11/269,112/18888,0.098214286,6.896176314,7.522416731,5.87E-07,4.64E-06,1.95E-06,BRCA1/FBXW7/ALK/IL1B/NFKB1/TNF/AKT1/SNAI1/SPHK1/SNAI2/AKR1C3,11
GO:0046822,BP,GO:0046822,regulation of nucleocytoplasmic transport,11/269,112/18888,0.098214286,6.896176314,7.522416731,5.87E-07,4.64E-06,1.95E-06,PTGS2/IL1B/CDH1/MAPK14/PRKCD/SMAD3/TGFB1/TXN/IFI27/HSP90AA1/SFN,11
GO:0030308,BP,GO:0030308,negative regulation of cell growth,14/269,190/18888,0.073684211,5.173782039,6.950058222,6.06E-07,4.79E-06,2.01E-06,TP53/BRCA1/CDH1/SMARCA4/SMARCA2/HDAC6/SMAD3/TGFB1/WT1/RB1/CDKN1A/CDKN2A/FBP1/ESR2,14
GO:0007178,BP,GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,21/269,417/18888,0.050359712,3.536038084,6.294453777,6.22E-07,4.90E-06,2.06E-06,TP53/THBS1/MAP3K7/PPARG/PARP1/SOX11/ID1/NOTCH1/MAPK14/STAT3/FOS/TWSG1/TGFBR1/SMAD3/TGFB1/PTK2/ILK/HSPA5/PEG10/KDR/MIR145,21
GO:0043627,BP,GO:0043627,response to estrogen,9/269,70/18888,0.128571429,9.027721721,8.087867941,6.42E-07,5.04E-06,2.11E-06,AR/MMP14/CAV1/MMP2/HSP90AA1/MME/GATA3/ESR1/ESR2,9
GO:2000573,BP,GO:2000573,positive regulation of DNA biosynthetic process,9/269,70/18888,0.128571429,9.027721721,8.087867941,6.42E-07,5.04E-06,2.11E-06,CTNNB1/MYC/FGF2/PCNA/MAPK1/TNF/FGFR4/HSP90AA1/MAP2K7,9
GO:0062014,BP,GO:0062014,negative regulation of small molecule metabolic process,11/269,113/18888,0.097345133,6.835148205,7.477916203,6.42E-07,5.04E-06,2.11E-06,TP53/BRCA1/NFKB1/PARP1/STAT3/AKT1/GIT1/SNAI1/SNAI2/AKR1C3/FBP1,11
GO:0043254,BP,GO:0043254,regulation of protein-containing complex assembly,21/269,418/18888,0.050239234,3.527578663,6.281145125,6.47E-07,5.06E-06,2.12E-06,TP53/BID/VEGFA/TENM1/MTOR/TLR4/HDAC6/PRKCD/TNF/RHOA/TGFB1/FSCN1/GIT1/RB1/BAX/DAB2IP/HSPA5/HSP90AA1/MYD88/MMP1/CLU,21
GO:0042326,BP,GO:0042326,negative regulation of phosphorylation,18/269,316/18888,0.056962025,3.999623547,6.463390747,7.00E-07,5.47E-06,2.30E-06,PTEN/IL1B/PPARG/GSTP1/PRKCD/DUSP6/AKT1/CAV1/TGFB1/HHEX/RB1/BAX/DAB2IP/CDKN1A/SFN/NPRL2/CDKN2A/ROCK1,18
GO:0060688,BP,GO:0060688,regulation of morphogenesis of a branching structure,8/269,53/18888,0.150943396,10.59858315,8.410885256,7.76E-07,6.05E-06,2.54E-06,CTNNB1/AR/VEGFA/TNF/SNAI2/FGFR1/LGR4/ESR1,8
GO:1902692,BP,GO:1902692,regulation of neuroblast proliferation,8/269,53/18888,0.150943396,10.59858315,8.410885256,7.76E-07,6.05E-06,2.54E-06,TP53/CTNNB1/KDM1A/VEGFA/FGF2/NOTCH1/HIF1A/ID4,8
GO:0002052,BP,GO:0002052,positive regulation of neuroblast proliferation,7/269,37/18888,0.189189189,13.28403496,8.989885564,7.85E-07,6.10E-06,2.56E-06,CTNNB1/KDM1A/VEGFA/FGF2/NOTCH1/HIF1A/ID4,7
GO:0007431,BP,GO:0007431,salivary gland development,7/269,37/18888,0.189189189,13.28403496,8.989885564,7.85E-07,6.10E-06,2.56E-06,TNF/TWSG1/TGFB1/EGFR/SNAI2/NKX3-1/FGFR1,7
GO:0141091,BP,GO:0141091,transforming growth factor beta receptor superfamily signaling pathway,20/269,388/18888,0.051546392,3.619361515,6.266209275,8.09E-07,6.27E-06,2.63E-06,TP53/THBS1/MAP3K7/PPARG/PARP1/SOX11/ID1/NOTCH1/STAT3/FOS/TWSG1/TGFBR1/SMAD3/TGFB1/PTK2/ILK/HSPA5/PEG10/KDR/MIR145,20
GO:0032722,BP,GO:0032722,positive regulation of chemokine production,9/269,72/18888,0.125,8.776951673,7.946784763,8.20E-07,6.33E-06,2.66E-06,IL6/IL1B/HIF1A/TLR4/TNF/ALOX15B/TGFB1/TWIST1/MYD88,9
GO:0051341,BP,GO:0051341,regulation of oxidoreductase activity,9/269,72/18888,0.125,8.776951673,7.946784763,8.20E-07,6.33E-06,2.66E-06,VDR/IL1B/NFKB1/HIF1A/HDAC6/TNF/AKT1/EGFR/MIR130B,9
GO:0010952,BP,GO:0010952,positive regulation of peptidase activity,13/269,167/18888,0.077844311,5.465886072,6.967561453,8.26E-07,6.37E-06,2.67E-06,MYC/CASP8/PPARG/BID/FASLG/STAT3/TNF/SMAD3/DLC1/BAX/AIFM1/PMAIP1/NKX3-1,13
GO:0090200,BP,GO:0090200,positive regulation of release of cytochrome c from mitochondria,6/269,24/18888,0.25,17.55390335,9.753682093,8.56E-07,6.58E-06,2.76E-06,TP53/BID/MMP9/BAX/BNIP3/PMAIP1,6
GO:2001026,BP,GO:2001026,regulation of endothelial cell chemotaxis,6/269,24/18888,0.25,17.55390335,9.753682093,8.56E-07,6.58E-06,2.76E-06,THBS1/VEGFA/FGF2/NOTCH1/KDR/FGFR1,6
GO:1904645,BP,GO:1904645,response to amyloid-beta,8/269,54/18888,0.148148148,10.40231309,8.316484071,9.00E-07,6.91E-06,2.90E-06,PARP1/IGF1R/TLR4/TNF/MMP9/MMP2/MIR200C/IGF1,8
GO:0050921,BP,GO:0050921,positive regulation of chemotaxis,12/269,142/18888,0.084507042,5.933713807,7.093217446,9.19E-07,7.03E-06,2.95E-06,THBS1/CXCR2/IL6/VEGFA/FGF2/MAPK1/SMAD3/TGFB1/PTK2/SERPINE1/KDR/FGFR1,12
GO:0060326,BP,GO:0060326,cell chemotaxis,18/269,322/18888,0.055900621,3.9250964,6.363387938,9.19E-07,7.03E-06,2.95E-06,THBS1/CXCR2/IL6/EDNRB/IL1B/VEGFA/FGF2/NOTCH1/MAPK1/PRKCD/MMP2/PTK2/IL10/BSG/SERPINE1/KDR/FGFR1/CYP19A1,18
GO:2000036,BP,GO:2000036,regulation of stem cell population maintenance,9/269,73/18888,0.123287671,8.656719458,7.878281739,9.24E-07,7.05E-06,2.96E-06,MYC/ARID1A/NCOA3/SMARCA4/SMARCA2/HNF1B/SMARCE1/MIR145/TP63,9
GO:0002520,BP,GO:0002520,immune system development,14/269,197/18888,0.07106599,4.989942068,6.76648134,9.38E-07,7.14E-06,3.00E-06,TP53/CTNNB1/ERCC1/MAPK1/TGFBR1/SMAD3/TGFB1/IL10/BRAF/GATA3/CD274/MLH1/MSH2/NBN,14
GO:0043516,BP,GO:0043516,"regulation of DNA damage response, signal transduction by p53 class mediator",7/269,38/18888,0.184210526,12.9344551,8.851526421,9.51E-07,7.22E-06,3.03E-06,TP53/KDM1A/CD44/SNAI1/TWIST1/PMAIP1/SNAI2,7
GO:1902229,BP,GO:1902229,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,7/269,38/18888,0.184210526,12.9344551,8.851526421,9.51E-07,7.22E-06,3.03E-06,BID/KDM1A/CD44/SNAI1/SNAI2/MUC1/CLU,7
GO:0010506,BP,GO:0010506,regulation of autophagy,19/269,357/18888,0.053221289,3.736965418,6.275284851,9.54E-07,7.23E-06,3.03E-06,TP53/FBXW7/MAP3K7/PIK3CA/CASP3/HIF1A/STAT3/MTOR/HDAC6/SQSTM1/AKT1/IL10/VHL/KDR/BNIP3/BNIP3L/NPRL2/ROCK1/CAMKK2,19
GO:0014074,BP,GO:0014074,response to purine-containing compound,12/269,143/18888,0.083916084,5.892219305,7.058471534,9.90E-07,7.49E-06,3.14E-06,PTGS2/IL1B/KDM1A/FOS/RELA/BSG/WT1/BRAF/THBD/STAT1/PER1/FBP1,12
GO:0042303,BP,GO:0042303,molting cycle,11/269,118/18888,0.093220339,6.545523281,7.263247687,9.93E-07,7.49E-06,3.14E-06,CTNNB1/PTGS2/NOTCH1/TNF/RELA/EGFR/SNAI1/TP63/PER1/LGR4/CLOCK,11
GO:0042633,BP,GO:0042633,hair cycle,11/269,118/18888,0.093220339,6.545523281,7.263247687,9.93E-07,7.49E-06,3.14E-06,CTNNB1/PTGS2/NOTCH1/TNF/RELA/EGFR/SNAI1/TP63/PER1/LGR4/CLOCK,11
GO:0007519,BP,GO:0007519,skeletal muscle tissue development,13/269,170/18888,0.076470588,5.369429259,6.878581794,1.01E-06,7.60E-06,3.19E-06,CTNNB1/GPX1/SOX11/NOTCH1/MAPK14/FOS/RHOA/KRAS/CAV1/TGFB1/RB1/TWIST1/IGF2,13
GO:0043409,BP,GO:0043409,negative regulation of MAPK cascade,13/269,170/18888,0.076470588,5.369429259,6.878581794,1.01E-06,7.60E-06,3.19E-06,MYC/IL1B/PPARG/IGF1R/GSTP1/TLR4/PRKCD/DUSP6/PSCA/CAV1/MIR200C/DAB2IP/PER1,13
GO:0090316,BP,GO:0090316,positive regulation of intracellular protein transport,10/269,95/18888,0.105263158,7.391117198,7.506197402,1.01E-06,7.60E-06,3.19E-06,PTGS2/IL1B/CDH1/MAPK14/TENM1/PRKCD/SMAD3/TGFB1/HSP90AA1/SFN,10
GO:0034101,BP,GO:0034101,erythrocyte homeostasis,12/269,144/18888,0.083333333,5.851301115,7.02405323,1.07E-06,8.00E-06,3.35E-06,CASP3/VEGFA/MYB/MAPK14/HIF1A/STAT3/BAP1/HDAC6/RB1/GATA3/STAT1/MED1,12
GO:0050920,BP,GO:0050920,regulation of chemotaxis,15/269,229/18888,0.065502183,4.599275986,6.586704223,1.08E-06,8.04E-06,3.37E-06,THBS1/CXCR2/IL6/VEGFA/FGF2/NOTCH1/HDAC6/MAPK1/SMAD3/TGFB1/PTK2/SERPINE1/KDR/FGFR1/CYP19A1,15
GO:0006469,BP,GO:0006469,negative regulation of protein kinase activity,13/269,171/18888,0.076023392,5.338029088,6.849389268,1.08E-06,8.07E-06,3.38E-06,PTEN/IL1B/PPARG/GSTP1/PRKCD/AKT1/CAV1/HHEX/RB1/DAB2IP/CDKN1A/SFN/CDKN2A,13
GO:0031647,BP,GO:0031647,regulation of protein stability,18/269,326/18888,0.055214724,3.876935708,6.298048877,1.10E-06,8.18E-06,3.43E-06,TP53/PTEN/AURKA/FBXW7/CASP3/CTNND1/MTOR/HDAC6/MAPK1/PRKCD/SMAD3/CHEK2/CUL3/VHL/IGF1/HSP90AA1/PIM1/CLU,18
GO:0006312,BP,GO:0006312,mitotic recombination,6/269,25/18888,0.24,16.85174721,9.532816081,1.11E-06,8.28E-06,3.47E-06,BRCA2/XRCC1/ERCC1/XRCC3/MLH1/MSH2,6
GO:0072576,BP,GO:0072576,liver morphogenesis,6/269,25/18888,0.24,16.85174721,9.532816081,1.11E-06,8.28E-06,3.47E-06,FBXW7/IL6/TNF/CUL3/TGFA/MED1,6
GO:0071248,BP,GO:0071248,cellular response to metal ion,14/269,200/18888,0.07,4.915092937,6.690446699,1.12E-06,8.34E-06,3.50E-06,PTGS2/PARP1/CDH1/MAPK1/FOS/AKT1/MMP9/CYP1A1/EGFR/BNIP3/BRAF/AKR1C3/TFAP2A/FBP1,14
GO:0002685,BP,GO:0002685,regulation of leukocyte migration,15/269,230/18888,0.065217391,4.579279134,6.564571704,1.14E-06,8.41E-06,3.53E-06,THBS1/CXCR2/IL6/VEGFA/MMP14/MAPK1/TNF/RHOA/AKT1/PTK2/SERPINE1/CD9/LYVE1/MYD88/CYP19A1,15
GO:0043388,BP,GO:0043388,positive regulation of DNA binding,7/269,39/18888,0.179487179,12.6028024,8.718273652,1.15E-06,8.47E-06,3.55E-06,PPARG/MMP9/TXN/RB1/IGF1/TWIST1/GATA3,7
GO:0045058,BP,GO:0045058,T cell selection,8/269,56/18888,0.142857143,10.03080191,8.134887685,1.20E-06,8.86E-06,3.71E-06,IL6/STAT3/MTOR/RHOA/BRD2/BRD4/BRAF/GATA3,8
GO:0035924,BP,GO:0035924,cellular response to vascular endothelial growth factor stimulus,9/269,76/18888,0.118421053,8.315006848,7.680394047,1.31E-06,9.63E-06,4.04E-06,PIK3CA/VEGFA/NOTCH1/MAPK14/RELA/AKT1/DAB2IP/KDR/SPHK1,9
GO:0010639,BP,GO:0010639,negative regulation of organelle organization,19/269,365/18888,0.052054795,3.655059327,6.156649827,1.33E-06,9.77E-06,4.10E-06,TP53/BRCA1/GPX1/XRCC1/ERCC1/PIK3CA/PPARG/PARP1/XRCC3/MTOR/HDAC6/PRKCD/AKT1/KATNB1/DLC1/IGF1/BNIP3/NBN/CLU,19
GO:0002042,BP,GO:0002042,cell migration involved in sprouting angiogenesis,10/269,98/18888,0.102040816,7.164858508,7.354484134,1.35E-06,9.94E-06,4.17E-06,THBS1/FBXW7/PTGS2/VEGFA/FGF2/NOTCH1/RHOA/AKT1/MIR200C/KDR,10
GO:0010742,BP,GO:0010742,macrophage derived foam cell differentiation,7/269,40/18888,0.175,12.28773234,8.589809177,1.37E-06,1.00E-05,4.21E-06,NFKB1/PPARG/ALOX15B/TGFB1/STAT1/MIR130B/NFKBIA,7
GO:0042307,BP,GO:0042307,positive regulation of protein import into nucleus,7/269,40/18888,0.175,12.28773234,8.589809177,1.37E-06,1.00E-05,4.21E-06,PTGS2/CDH1/MAPK14/PRKCD/SMAD3/TGFB1/HSP90AA1,7
GO:0150077,BP,GO:0150077,regulation of neuroinflammatory response,7/269,40/18888,0.175,12.28773234,8.589809177,1.37E-06,1.00E-05,4.21E-06,IL6/PTGS2/IL1B/TNF/MMP9/IGF1/SPHK1,7
GO:0014706,BP,GO:0014706,striated muscle tissue development,16/269,265/18888,0.060377358,4.239433261,6.383319854,1.38E-06,1.01E-05,4.23E-06,MIR25/VEGFA/FGF2/NOTCH1/MAPK14/MTOR/TGFBR1/SMAD3/TGFB1/WT1/IGF1/TWIST1/PIM1/FGFR1/MED1/FGF3,16
GO:0002363,BP,GO:0002363,alpha-beta T cell lineage commitment,6/269,26/18888,0.230769231,16.20360309,9.3243546,1.43E-06,1.04E-05,4.37E-06,IL6/STAT3/MTOR/RHOA/BRD2/BRD4,6
GO:0043536,BP,GO:0043536,positive regulation of blood vessel endothelial cell migration,9/269,77/18888,0.116883117,8.207019746,7.616835688,1.46E-06,1.06E-05,4.46E-06,THBS1/PTGS2/VEGFA/FGF2/HIF1A/AKT1/TGFB1/KDR/FGFR1,9
GO:0045088,BP,GO:0045088,regulation of innate immune response,21/269,440/18888,0.047727273,3.35119973,5.998196245,1.47E-06,1.07E-05,4.49E-06,MAP3K7/CASP8/PPARG/PARP1/TLR4/SQSTM1/TNF/RELA/AKT1/CAV1/TGFB1/MIR200C/A2M/DAB2IP/HSP90AA1/CD274/NFKBIA/MED1/LGR4/ESR1/MYD88,21
GO:0060419,BP,GO:0060419,heart growth,10/269,99/18888,0.101010101,7.0924862,7.305328883,1.49E-06,1.08E-05,4.52E-06,MIR25/FGF2/NOTCH1/MAPK14/DUSP6/TGFBR1/WT1/IGF1/PIM1/FGFR1,10
GO:0007623,BP,GO:0007623,circadian rhythm,14/269,205/18888,0.068292683,4.795212621,6.567032861,1.51E-06,1.09E-05,4.55E-06,TP53/PTEN/FBXW7/PPARG/PARP1/ID1/MTOR/TNF/EZH2/EGFR/PER1/LGR4/ID4/CLOCK,14
GO:0010763,BP,GO:0010763,positive regulation of fibroblast migration,5/269,15/18888,0.333333333,23.40520446,10.4340647,1.51E-06,1.09E-05,4.55E-06,THBS1/AKT1/TGFB1/PTK2/MIR145,5
GO:0033599,BP,GO:0033599,regulation of mammary gland epithelial cell proliferation,5/269,15/18888,0.333333333,23.40520446,10.4340647,1.51E-06,1.09E-05,4.55E-06,BRCA2/GPX1/CCND1/BAX/GATA3,5
GO:0036446,BP,GO:0036446,myofibroblast differentiation,5/269,15/18888,0.333333333,23.40520446,10.4340647,1.51E-06,1.09E-05,4.55E-06,PARP1/TGFBR1/TGFB1/RB1/MIR145,5
GO:0043518,BP,GO:0043518,"negative regulation of DNA damage response, signal transduction by p53 class mediator",5/269,15/18888,0.333333333,23.40520446,10.4340647,1.51E-06,1.09E-05,4.55E-06,KDM1A/CD44/SNAI1/TWIST1/SNAI2,5
GO:0033157,BP,GO:0033157,regulation of intracellular protein transport,12/269,149/18888,0.080536913,5.654948729,6.856686365,1.53E-06,1.10E-05,4.61E-06,PTGS2/IL1B/CDH1/MAPK14/TENM1/PRKCD/SMAD3/TGFB1/TXN/IFI27/HSP90AA1/SFN,12
GO:0050768,BP,GO:0050768,negative regulation of neurogenesis,12/269,149/18888,0.080536913,5.654948729,6.856686365,1.53E-06,1.10E-05,4.61E-06,TP53/PTEN/CTNNB1/IL6/IL1B/SOX11/CDH1/NOTCH1/HDAC6/TNF/RB1/ID4,12
GO:0061005,BP,GO:0061005,cell differentiation involved in kidney development,8/269,58/18888,0.137931034,9.684912191,7.962211743,1.58E-06,1.13E-05,4.74E-06,CTNNB1/EDNRB/NOTCH1/MMP9/WT1/GATA3/STAT1/LGR4,8
GO:0072132,BP,GO:0072132,mesenchyme morphogenesis,8/269,58/18888,0.137931034,9.684912191,7.962211743,1.58E-06,1.13E-05,4.74E-06,MYC/NOTCH1/TGFBR1/SMAD3/SNAI1/TWIST1/SNAI2/FGFR1,8
GO:0030216,BP,GO:0030216,keratinocyte differentiation,13/269,177/18888,0.073446328,5.157078949,6.67891414,1.59E-06,1.14E-05,4.77E-06,ETV4/VDR/CASP3/NCOA3/NOTCH1/EZH2/ALOX15B/AKR1C3/TP63/CDKN1A/MED1/SFN/ROCK1,13
GO:0051101,BP,GO:0051101,regulation of DNA binding,9/269,78/18888,0.115384615,8.101801544,7.554415883,1.63E-06,1.16E-05,4.85E-06,PPARG/KDM1A/SOX11/MMP9/TXN/RB1/IGF1/TWIST1/GATA3,9
GO:0010762,BP,GO:0010762,regulation of fibroblast migration,7/269,41/18888,0.170731707,11.98803155,8.465842122,1.63E-06,1.16E-05,4.85E-06,THBS1/FGF2/AKT1/TGFB1/PTK2/MIR145/BRAF,7
GO:0032570,BP,GO:0032570,response to progesterone,7/269,41/18888,0.170731707,11.98803155,8.465842122,1.63E-06,1.16E-05,4.85E-06,THBS1/IGF1R/NCOA1/FOS/RELA/CAV1/TGFB1,7
GO:0060421,BP,GO:0060421,positive regulation of heart growth,7/269,41/18888,0.170731707,11.98803155,8.465842122,1.63E-06,1.16E-05,4.85E-06,FGF2/NOTCH1/MAPK14/WT1/IGF1/PIM1/FGFR1,7
GO:0090077,BP,GO:0090077,foam cell differentiation,7/269,41/18888,0.170731707,11.98803155,8.465842122,1.63E-06,1.16E-05,4.85E-06,NFKB1/PPARG/ALOX15B/TGFB1/STAT1/MIR130B/NFKBIA,7
GO:1903146,BP,GO:1903146,regulation of autophagy of mitochondrion,7/269,41/18888,0.170731707,11.98803155,8.465842122,1.63E-06,1.16E-05,4.85E-06,TP53/FBXW7/HIF1A/HDAC6/BNIP3/BNIP3L/CAMKK2,7
GO:0002824,BP,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,11/269,125/18888,0.088,6.178973978,6.982758952,1.76E-06,1.25E-05,5.22E-06,IL6/MAP3K7/IL1B/TNF/TGFB1/BRD2/BRD4/GATA3/CD274/MLH1/MSH2,11
GO:0032755,BP,GO:0032755,positive regulation of interleukin-6 production,10/269,101/18888,0.099009901,6.952040929,7.209038292,1.79E-06,1.26E-05,5.29E-06,IL6/IL1B/STAT3/TLR4/TNF/RELA/TGFB1/TWIST1/UCN/MYD88,10
GO:0036296,BP,GO:0036296,response to increased oxygen levels,6/269,27/18888,0.222222222,15.60346964,9.127146698,1.82E-06,1.28E-05,5.37E-06,SOD2/CAV1/MMP2/CYP1A1/BNIP3/CDKN1A,6
GO:0031669,BP,GO:0031669,cellular response to nutrient levels,15/269,239/18888,0.062761506,4.40683766,6.370918796,1.83E-06,1.29E-05,5.40E-06,TP53/VDR/IGF1R/NCOA1/MTOR/MAPK1/FOS/HSPA5/PMAIP1/SNAI2/PIM1/AKR1C3/CDKN1A/MED1/NPRL2,15
GO:0097529,BP,GO:0097529,myeloid leukocyte migration,15/269,239/18888,0.062761506,4.40683766,6.370918796,1.83E-06,1.29E-05,5.40E-06,THBS1/CXCR2/IL6/EDNRB/IL1B/VEGFA/MMP14/MAPK1/MMP2/PTK2/BSG/SERPINE1/CD9/MYD88/CYP19A1,15
GO:0071364,BP,GO:0071364,cellular response to epidermal growth factor stimulus,7/269,42/18888,0.166666667,11.70260223,8.346105898,1.94E-06,1.36E-05,5.69E-06,ERBB2/FOS/AKT1/EGFR/DAB2IP/SNAI2/MED1,7
GO:2000177,BP,GO:2000177,regulation of neural precursor cell proliferation,10/269,102/18888,0.098039216,6.883883665,7.16187041,1.96E-06,1.37E-05,5.74E-06,TP53/CTNNB1/KDM1A/VEGFA/FGF2/NOTCH1/HIF1A/RHOA/ILK/ID4,10
GO:1903036,BP,GO:1903036,positive regulation of response to wounding,9/269,80/18888,0.1125,7.899256506,7.432851076,2.02E-06,1.41E-05,5.93E-06,THBS1/IGF1R/MTOR/PTK2/SERPINE1/BRAF/HRAS/THBD/PLAU,9
GO:1903320,BP,GO:1903320,regulation of protein modification by small protein conjugation or removal,15/269,241/18888,0.062240664,4.370266393,6.329183976,2.03E-06,1.42E-05,5.95E-06,PTEN/CTNNB1/FBXW7/KDM1A/HIF1A/SQSTM1/RELA/BMI1/AKT1/TGFBR1/CAV1/CUL3/HSPA5/SPHK1/HSP90AA1,15
GO:0042129,BP,GO:0042129,regulation of T cell proliferation,13/269,181/18888,0.071823204,5.043110353,6.569499195,2.05E-06,1.42E-05,5.97E-06,CTNNB1/ERBB2/IL6/IL1B/CASP3/BID/BMI1/TWSG1/IL10/IGF1/CD274/PAWR/IGF2,13
GO:0001658,BP,GO:0001658,branching involved in ureteric bud morphogenesis,8/269,60/18888,0.133333333,9.362081784,7.79771567,2.06E-06,1.42E-05,5.97E-06,CTNNB1/MYC/VEGFA/FGF2/HNF1B/ILK/WT1/LGR4,8
GO:0046686,BP,GO:0046686,response to cadmium ion,8/269,60/18888,0.133333333,9.362081784,7.79771567,2.06E-06,1.42E-05,5.97E-06,ERCC1/SOD2/PCNA/MAPK1/FOS/AKT1/MMP9/EGFR,8
GO:0097300,BP,GO:0097300,programmed necrotic cell death,8/269,60/18888,0.133333333,9.362081784,7.79771567,2.06E-06,1.42E-05,5.97E-06,TP53/CASP8/FASLG/PARP1/TNF/CAV1/BAX/AIFM1,8
GO:1905517,BP,GO:1905517,macrophage migration,8/269,60/18888,0.133333333,9.362081784,7.79771567,2.06E-06,1.42E-05,5.97E-06,THBS1/EDNRB/MMP14/MAPK1/MMP2/PTK2/CD9/CYP19A1,8
GO:0006109,BP,GO:0006109,regulation of carbohydrate metabolic process,13/269,182/18888,0.071428571,5.015400956,6.542648689,2.18E-06,1.51E-05,6.31E-06,TP53/NFKB1/HIF1A/STAT3/MTOR/AKT1/TGFB1/GIT1/IRS1/IGF1/PMAIP1/FBP1/IGF2,13
GO:0002761,BP,GO:0002761,regulation of myeloid leukocyte differentiation,11/269,128/18888,0.0859375,6.034154275,6.869016232,2.23E-06,1.54E-05,6.45E-06,CTNNB1/FBXW7/MYC/CASP8/MTOR/TLR4/FOS/TNF/TGFB1/RB1/MIR145,11
GO:0006970,BP,GO:0006970,response to osmotic stress,9/269,81/18888,0.111111111,7.80173482,7.37363944,2.25E-06,1.55E-05,6.50E-06,TP53/PTGS2/CASP3/MTOR/TNF/BAX/HSP90AA1/FBP1/MAP2K7,9
GO:0043369,BP,GO:0043369,"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment",6/269,28/18888,0.214285714,15.04620287,8.940186163,2.29E-06,1.57E-05,6.59E-06,IL6/STAT3/MTOR/BRD2/BRD4/BRAF,6
GO:0051961,BP,GO:0051961,negative regulation of nervous system development,12/269,155/18888,0.077419355,5.436047488,6.66557813,2.33E-06,1.60E-05,6.70E-06,TP53/PTEN/CTNNB1/IL6/IL1B/SOX11/CDH1/NOTCH1/HDAC6/TNF/RB1/ID4,12
GO:0010574,BP,GO:0010574,regulation of vascular endothelial growth factor production,8/269,61/18888,0.131147541,9.208605034,7.718326925,2.34E-06,1.60E-05,6.73E-06,BRCA1/IL6/PTGS2/IL1B/HIF1A/STAT3/RELA/TGFB1,8
GO:0045739,BP,GO:0045739,positive regulation of DNA repair,11/269,129/18888,0.085271318,5.987377885,6.831903807,2.41E-06,1.65E-05,6.91E-06,BRCA1/XRCC1/PARP1/ARID1A/SMARCA4/SMARCA2/PCNA/CBX8/EGFR/MEAF6/SMARCE1,11
GO:0090049,BP,GO:0090049,regulation of cell migration involved in sprouting angiogenesis,9/269,82/18888,0.109756098,7.706591713,7.315432922,2.49E-06,1.70E-05,7.13E-06,THBS1/FBXW7/PTGS2/VEGFA/FGF2/NOTCH1/RHOA/MIR200C/KDR,9
GO:2000142,BP,GO:2000142,regulation of DNA-templated transcription initiation,9/269,82/18888,0.109756098,7.706591713,7.315432922,2.49E-06,1.70E-05,7.13E-06,TP53/MYC/ERCC1/CDK4/NFKB1/HNF1B/TWIST1/NFKBIA/MED1,9
GO:0090257,BP,GO:0090257,regulation of muscle system process,15/269,245/18888,0.06122449,4.298915105,6.247060847,2.49E-06,1.70E-05,7.13E-06,MIR25/PTGS2/PPARG/PARP1/NOTCH1/RHOA/SMAD3/CAV1/MIR200C/IGF1/SPHK1/MIR145/HSP90AA1/UCN/ROCK1,15
GO:2000241,BP,GO:2000241,regulation of reproductive process,14/269,214/18888,0.065420561,4.593544801,6.354636709,2.50E-06,1.71E-05,7.15E-06,TIMP1/CTNNB1/AR/AURKA/EDNRB/DEFB1/VEGFA/NOTCH1/WT1/BAX/SNAI1/IGF1/NKX3-1/ESR1,14
GO:0090596,BP,GO:0090596,sensory organ morphogenesis,16/269,278/18888,0.057553957,4.041186382,6.140047101,2.57E-06,1.75E-05,7.34E-06,CTNNB1/FASLG/SOX11/VEGFA/FGF2/NOTCH1/HIF1A/STAT3/MAPK1/BAX/KDR/TWIST1/ZHX2/GATA3/FGFR1/TFAP2A,16
GO:0050864,BP,GO:0050864,regulation of B cell activation,11/269,130/18888,0.084615385,5.941321132,6.795179662,2.59E-06,1.76E-05,7.39E-06,IL6/CASP3/MMP14/TLR4/BMI1/TGFB1/IL10/MLH1/MSH2/PAWR/CDKN1A,11
GO:1901873,BP,GO:1901873,regulation of post-translational protein modification,15/269,246/18888,0.06097561,4.28143984,6.226804098,2.62E-06,1.78E-05,7.46E-06,PTEN/CTNNB1/FBXW7/KDM1A/HIF1A/SQSTM1/RELA/BMI1/AKT1/TGFBR1/CAV1/CUL3/HSPA5/SPHK1/HSP90AA1,15
GO:0070374,BP,GO:0070374,positive regulation of ERK1 and ERK2 cascade,14/269,215/18888,0.065116279,4.572179476,6.331766729,2.64E-06,1.79E-05,7.51E-06,FBXW7/CD44/FGF2/NOTCH1/TLR4/TNF/TGFB1/FGFR4/EGFR/KDR/IGF1/BRAF/HRAS/MAP2K7,14
GO:0032731,BP,GO:0032731,positive regulation of interleukin-1 beta production,8/269,62/18888,0.129032258,9.060079146,7.640742752,2.65E-06,1.79E-05,7.52E-06,IL6/CASP8/STAT3/TLR4/TNF/RELA/SMAD3/MYD88,8
GO:0014002,BP,GO:0014002,astrocyte development,7/269,44/18888,0.159090909,11.17066577,8.118366008,2.69E-06,1.81E-05,7.59E-06,IL6/IL1B/TLR4/TNF/KRAS/EGFR/VIM,7
GO:0060443,BP,GO:0060443,mammary gland morphogenesis,7/269,44/18888,0.159090909,11.17066577,8.118366008,2.69E-06,1.81E-05,7.59E-06,AR/VDR/NFKB1/CAV1/BAX/MED1/ESR1,7
GO:0051146,BP,GO:0051146,striated muscle cell differentiation,17/269,313/18888,0.054313099,3.813627564,6.033284732,2.74E-06,1.84E-05,7.74E-06,YBX1/GPX1/CASP3/VEGFA/MMP14/NOTCH1/MAPK14/MTOR/KRAS/EZH2/AKT1/TGFB1/WT1/RB1/IGF1/CD9/IGF2,17
GO:0001570,BP,GO:0001570,vasculogenesis,9/269,83/18888,0.108433735,7.61374121,7.258201635,2.76E-06,1.85E-05,7.76E-06,CTNNB1/FBXW7/VEGFA/NOTCH1/CAV1/TGFB1/WT1/KDR/SGPL1,9
GO:0050871,BP,GO:0050871,positive regulation of B cell activation,9/269,83/18888,0.108433735,7.61374121,7.258201635,2.76E-06,1.85E-05,7.76E-06,IL6/MMP14/TLR4/BMI1/TGFB1/IL10/MLH1/MSH2/CDKN1A,9
GO:0150076,BP,GO:0150076,neuroinflammatory response,9/269,83/18888,0.108433735,7.61374121,7.258201635,2.76E-06,1.85E-05,7.76E-06,IL6/PTGS2/IL1B/TNF/MMP9/EGFR/IGF1/SPHK1/CLU,9
GO:0048709,BP,GO:0048709,oligodendrocyte differentiation,10/269,106/18888,0.094339623,6.62411447,6.979360323,2.78E-06,1.86E-05,7.81E-06,PTEN/CTNNB1/ERBB2/SOX11/NOTCH1/MTOR/BNIP3/ID4/MAL/CLU,10
GO:0002821,BP,GO:0002821,positive regulation of adaptive immune response,11/269,131/18888,0.083969466,5.895967536,6.758836524,2.80E-06,1.87E-05,7.84E-06,IL6/MAP3K7/IL1B/TNF/TGFB1/BRD2/BRD4/GATA3/CD274/MLH1/MSH2,11
GO:1901201,BP,GO:1901201,regulation of extracellular matrix assembly,6/269,29/18888,0.206896552,14.52736829,8.762588895,2.85E-06,1.90E-05,7.96E-06,PPARG/NOTCH1/TGFBR1/SMAD3/TGFB1/MIR145,6
GO:0003012,BP,GO:0003012,muscle system process,21/269,459/18888,0.045751634,3.212479044,5.767851597,2.87E-06,1.91E-05,8.01E-06,MIR25/PTGS2/EDNRB/PIK3CA/IL1B/PPARG/PARP1/NOTCH1/MTOR/TNF/RHOA/EZH2/SMAD3/CAV1/MIR200C/IGF1/SPHK1/MIR145/HSP90AA1/UCN/ROCK1,21
GO:0002700,BP,GO:0002700,regulation of production of molecular mediator of immune response,13/269,187/18888,0.069518717,4.881299326,6.411283469,2.94E-06,1.95E-05,8.20E-06,KLK3/IL6/MAP3K7/IL1B/TLR4/TNF/TGFB1/IL10/TWIST1/GATA3/MLH1/MSH2/MYD88,13
GO:0045766,BP,GO:0045766,positive regulation of angiogenesis,13/269,187/18888,0.069518717,4.881299326,6.411283469,2.94E-06,1.95E-05,8.20E-06,BRCA1/THBS1/CXCR2/IL1B/VEGFA/FGF2/HIF1A/STAT3/IL10/SERPINE1/KDR/SPHK1/TWIST1,13
GO:0032757,BP,GO:0032757,positive regulation of interleukin-8 production,8/269,63/18888,0.126984127,8.916268366,7.564892225,3.00E-06,1.99E-05,8.33E-06,IL6/IL1B/STAT3/TLR4/TNF/RELA/SERPINE1/MYD88,8
GO:2000117,BP,GO:2000117,negative regulation of cysteine-type endopeptidase activity,8/269,63/18888,0.126984127,8.916268366,7.564892225,3.00E-06,1.99E-05,8.33E-06,THBS1/GPX1/CD44/VEGFA/TNF/AKT1/MMP9/SFN,8
GO:1901655,BP,GO:1901655,cellular response to ketone,10/269,107/18888,0.093457944,6.562206858,6.935202123,3.03E-06,2.01E-05,8.41E-06,AR/CDK4/IGF1R/FOS/AKT1/SLC39A9/EGFR/AIFM1/AKR1C3/FBP1,10
GO:0051412,BP,GO:0051412,response to corticosterone,5/269,17/18888,0.294117647,20.65165099,9.743287108,3.04E-06,2.01E-05,8.41E-06,HSD3B1/HDAC6/FOS/HSD3B2/CDKN1A,5
GO:0044773,BP,GO:0044773,mitotic DNA damage checkpoint signaling,9/269,84/18888,0.107142857,7.523101434,7.201916931,3.06E-06,2.02E-05,8.45E-06,TP53/BRCA1/CCND1/CDK2/CHEK2/MUC1/MSH2/NBN/CDKN1A,9
GO:0033574,BP,GO:0033574,response to testosterone,7/269,45/18888,0.155555556,10.92242875,8.009929175,3.14E-06,2.07E-05,8.67E-06,SRD5A2/THBS1/AR/HOXB13/IGF1R/SLC39A9/NKX3-1,7
GO:0048593,BP,GO:0048593,camera-type eye morphogenesis,11/269,133/18888,0.082706767,5.80730637,6.687265115,3.24E-06,2.13E-05,8.94E-06,CTNNB1/SOX11/VEGFA/NOTCH1/HIF1A/STAT3/BAX/KDR/TWIST1/ZHX2/TFAP2A,11
GO:0001885,BP,GO:0001885,endothelial cell development,8/269,64/18888,0.125,8.776951673,7.490708283,3.39E-06,2.22E-05,9.31E-06,GPX1/EDNRB/FASN/IL1B/VEGFA/TNF/ROCK1/MYD88,8
GO:0034142,BP,GO:0034142,toll-like receptor 4 signaling pathway,8/269,64/18888,0.125,8.776951673,7.490708283,3.39E-06,2.22E-05,9.31E-06,MAP3K7/TLR4/SQSTM1/RELA/MIR200C/DAB2IP/NFKBIA/MYD88,8
GO:0002702,BP,GO:0002702,positive regulation of production of molecular mediator of immune response,11/269,134/18888,0.082089552,5.763968263,6.652023229,3.49E-06,2.28E-05,9.58E-06,KLK3/IL6/MAP3K7/IL1B/TLR4/TGFB1/IL10/GATA3/MLH1/MSH2/MYD88,11
GO:0031571,BP,GO:0031571,mitotic G1 DNA damage checkpoint signaling,6/269,30/18888,0.2,14.04312268,8.593574471,3.52E-06,2.29E-05,9.61E-06,TP53/CCND1/CDK2/CHEK2/MUC1/CDKN1A,6
GO:0044819,BP,GO:0044819,mitotic G1/S transition checkpoint signaling,6/269,30/18888,0.2,14.04312268,8.593574471,3.52E-06,2.29E-05,9.61E-06,TP53/CCND1/CDK2/CHEK2/MUC1/CDKN1A,6
GO:1900017,BP,GO:1900017,positive regulation of cytokine production involved in inflammatory response,6/269,30/18888,0.2,14.04312268,8.593574471,3.52E-06,2.29E-05,9.61E-06,IL6/HIF1A/STAT3/TLR4/TNF/MYD88,6
GO:0045601,BP,GO:0045601,regulation of endothelial cell differentiation,7/269,46/18888,0.152173913,10.68498465,7.904853158,3.66E-06,2.38E-05,9.98E-06,CTNNB1/IL1B/VEGFA/NOTCH1/TNF/MIR200C/ROCK1,7
GO:0048483,BP,GO:0048483,autonomic nervous system development,7/269,46/18888,0.152173913,10.68498465,7.904853158,3.66E-06,2.38E-05,9.98E-06,CTNNB1/EDNRB/SOX11/FN1/GATA3/TP63/TFAP2A,7
GO:0000075,BP,GO:0000075,cell cycle checkpoint signaling,13/269,191/18888,0.068062827,4.779073162,6.309507685,3.72E-06,2.41E-05,1.01E-05,TP53/BRCA1/BRCA2/CCND1/XRCC3/MAPK14/CDK2/CHEK2/MUC1/MSH2/NBN/CDKN1A/CLOCK,13
GO:0038061,BP,GO:0038061,non-canonical NF-kappaB signal transduction,11/269,135/18888,0.081481481,5.721272202,6.617135102,3.75E-06,2.43E-05,1.02E-05,MAP3K7/IL1B/NFKB1/TLR4/TNF/RELA/RHOA/AKT1/EGFR/SPHK1/NFKBIA,11
GO:0010812,BP,GO:0010812,negative regulation of cell-substrate adhesion,8/269,65/18888,0.123076923,8.641921647,7.418127472,3.82E-06,2.47E-05,1.04E-05,THBS1/PTEN/MMP14/NOTCH1/RHOA/DLC1/SERPINE1/CDKN2A,8
GO:0030307,BP,GO:0030307,positive regulation of cell growth,12/269,163/18888,0.073619632,5.169247611,6.425693878,3.93E-06,2.54E-05,1.06E-05,ERBB2/VEGFA/MMP14/MTOR/AKT1/TGFBR1/EGFR/FN1/IGF1/SPHK1/UCN/SFN,12
GO:0034250,BP,GO:0034250,positive regulation of amide metabolic process,12/269,163/18888,0.073619632,5.169247611,6.425693878,3.93E-06,2.54E-05,1.06E-05,THBS1/CNBP/ERBB2/YBX1/IL6/CASP3/MTOR/PRKCD/TNF/RELA/UCN/CLU,12
GO:0071897,BP,GO:0071897,DNA biosynthetic process,13/269,192/18888,0.067708333,4.754182156,6.284504767,3.94E-06,2.54E-05,1.06E-05,TP53/CTNNB1/MYC/FGF2/PCNA/MAPK1/TNF/FGFR4/MEAF6/SPHK1/HSP90AA1/CDKN1A/MAP2K7,13
GO:0032370,BP,GO:0032370,positive regulation of lipid transport,9/269,87/18888,0.103448276,7.263684143,7.038473103,4.10E-06,2.64E-05,1.11E-05,IL1B/PPARG/FASLG/MYB/PRKCD/CAV1/NKX3-1/NFKBIA/CYP19A1,9
GO:2000811,BP,GO:2000811,negative regulation of anoikis,5/269,18/18888,0.277777778,19.50433705,9.440680216,4.16E-06,2.67E-05,1.12E-05,PIK3CA/NOTCH1/CAV1/PTK2/SNAI2,5
GO:0001938,BP,GO:0001938,positive regulation of endothelial cell proliferation,10/269,111/18888,0.09009009,6.325730935,6.764053934,4.23E-06,2.72E-05,1.14E-05,VEGFA/FGF2/HIF1A/STAT3/AKT1/TGFBR1/IL10/KDR/FGFR1/IGF2,10
GO:0006775,BP,GO:0006775,fat-soluble vitamin metabolic process,7/269,47/18888,0.14893617,10.45764455,7.802960276,4.25E-06,2.72E-05,1.14E-05,NFKB1/TNF/CYP1A1/SNAI1/SNAI2/FGFR1/RBP1,7
GO:0006953,BP,GO:0006953,acute-phase response,7/269,47/18888,0.14893617,10.45764455,7.802960276,4.25E-06,2.72E-05,1.14E-05,IL6/PTGS2/EDNRB/IL1B/TNF/A2M/FN1,7
GO:1901224,BP,GO:1901224,positive regulation of non-canonical NF-kappaB signal transduction,8/269,66/18888,0.121212121,8.51098344,7.347089696,4.29E-06,2.74E-05,1.15E-05,MAP3K7/IL1B/TLR4/TNF/RELA/RHOA/EGFR/SPHK1,8
GO:0035767,BP,GO:0035767,endothelial cell chemotaxis,6/269,31/18888,0.193548387,13.59011872,8.432450994,4.31E-06,2.75E-05,1.15E-05,THBS1/VEGFA/FGF2/NOTCH1/KDR/FGFR1,6
GO:1903055,BP,GO:1903055,positive regulation of extracellular matrix organization,6/269,31/18888,0.193548387,13.59011872,8.432450994,4.31E-06,2.75E-05,1.15E-05,IL6/TGFBR1/SMAD3/TGFB1/FSCN1/RB1,6
GO:0071466,BP,GO:0071466,cellular response to xenobiotic stimulus,13/269,194/18888,0.067010309,4.705169969,6.235012598,4.41E-06,2.80E-05,1.17E-05,TP53/UGT2B17/MYC/IL1B/GSTP1/PCNA/CYP1A1/EGFR/RB1/BRAF/NKX3-1/NAT1/FBP1,13
GO:0071706,BP,GO:0071706,tumor necrosis factor superfamily cytokine production,13/269,194/18888,0.067010309,4.705169969,6.235012598,4.41E-06,2.80E-05,1.17E-05,THBS1/IL6/GSTP1/STAT3/TLR4/TGFB1/IL10/IGF1/TWIST1/MC1R/CD274/MYD88/CLU,13
GO:1903555,BP,GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,13/269,194/18888,0.067010309,4.705169969,6.235012598,4.41E-06,2.80E-05,1.17E-05,THBS1/IL6/GSTP1/STAT3/TLR4/TGFB1/IL10/IGF1/TWIST1/MC1R/CD274/MYD88/CLU,13
GO:0044774,BP,GO:0044774,mitotic DNA integrity checkpoint signaling,9/269,88/18888,0.102272727,7.181142278,6.985710857,4.51E-06,2.86E-05,1.20E-05,TP53/BRCA1/CCND1/CDK2/CHEK2/MUC1/MSH2/NBN/CDKN1A,9
GO:1905954,BP,GO:1905954,positive regulation of lipid localization,10/269,112/18888,0.089285714,6.269251195,6.722577691,4.59E-06,2.90E-05,1.22E-05,IL1B/NFKB1/PPARG/FASLG/MYB/PRKCD/CAV1/NKX3-1/NFKBIA/CYP19A1,10
GO:0046328,BP,GO:0046328,regulation of JNK cascade,11/269,138/18888,0.079710145,5.596896719,6.514530289,4.65E-06,2.94E-05,1.23E-05,IL1B/IGF1R/GSTP1/TLR4/TNF/EGFR/DAB2IP/HRAS/PER1/MAP2K7/MYD88,11
GO:1901991,BP,GO:1901991,negative regulation of mitotic cell cycle phase transition,13/269,195/18888,0.066666667,4.681040892,6.210519059,4.67E-06,2.95E-05,1.24E-05,TP53/BRCA1/PTEN/RBL2/CCND1/XRCC3/CDK2/EZH2/CHEK2/RB1/MUC1/NBN/CDKN1A,13
GO:0055021,BP,GO:0055021,regulation of cardiac muscle tissue growth,8/269,67/18888,0.119402985,8.383953837,7.277537988,4.81E-06,3.03E-05,1.27E-05,MIR25/FGF2/NOTCH1/MAPK14/TGFBR1/IGF1/PIM1/FGFR1,8
GO:0035850,BP,GO:0035850,epithelial cell differentiation involved in kidney development,7/269,48/18888,0.145833333,10.23977695,7.704085805,4.91E-06,3.09E-05,1.30E-05,CTNNB1/EDNRB/NOTCH1/MMP9/WT1/GATA3/STAT1,7
GO:2000378,BP,GO:2000378,negative regulation of reactive oxygen species metabolic process,7/269,48/18888,0.145833333,10.23977695,7.704085805,4.91E-06,3.09E-05,1.30E-05,TP53/BRCA1/HIF1A/HDAC6/RHOA/BNIP3/TFAP2A,7
GO:0002221,BP,GO:0002221,pattern recognition receptor signaling pathway,15/269,259/18888,0.057915058,4.066541316,5.97287444,4.93E-06,3.09E-05,1.30E-05,MAP3K7/PARP1/TLR4/SQSTM1/TNF/RELA/AKT1/CAV1/MIR200C/DAB2IP/CD274/NFKBIA/LGR4/ESR1/MYD88,15
GO:0042180,BP,GO:0042180,cellular ketone metabolic process,14/269,227/18888,0.061674009,4.330478358,6.067803977,4.98E-06,3.12E-05,1.31E-05,SRD5A2/BRCA1/PTGS2/EDNRB/IL1B/PPARG/AKT1/CAV1/FGFR4/IRS1/TWIST1/AKR1C3/CYP17A1/CYP19A1,14
GO:0061351,BP,GO:0061351,neural precursor cell proliferation,12/269,167/18888,0.071856287,5.045433297,6.311581766,5.05E-06,3.16E-05,1.33E-05,TP53/CTNNB1/KDM1A/VEGFA/FGF2/NOTCH1/HIF1A/RHOA/ILK/NBN/FGFR1/ID4,12
GO:0070498,BP,GO:0070498,interleukin-1-mediated signaling pathway,6/269,32/18888,0.1875,13.16542751,8.278602567,5.24E-06,3.27E-05,1.37E-05,IL6/MAP3K7/IL1B/RELA/NFKBIA/MYD88,6
GO:0010611,BP,GO:0010611,regulation of cardiac muscle hypertrophy,8/269,68/18888,0.117647059,8.260660398,7.209418307,5.39E-06,3.36E-05,1.41E-05,MIR25/PPARG/PARP1/NOTCH1/SMAD3/IGF1/MIR145/ROCK1,8
GO:0031396,BP,GO:0031396,regulation of protein ubiquitination,13/269,198/18888,0.065656566,4.61011603,6.138023674,5.52E-06,3.44E-05,1.44E-05,PTEN/CTNNB1/FBXW7/KDM1A/SQSTM1/BMI1/AKT1/TGFBR1/CAV1/CUL3/HSPA5/SPHK1/HSP90AA1,13
GO:0030540,BP,GO:0030540,female genitalia development,5/269,19/18888,0.263157895,18.477793,9.161538347,5.57E-06,3.47E-05,1.45E-05,SRD5A2/BAX/TP63/ESR1/CYP19A1,5
GO:0030195,BP,GO:0030195,negative regulation of blood coagulation,7/269,49/18888,0.142857143,10.03080191,7.60807679,5.66E-06,3.51E-05,1.47E-05,THBS1/ALOX12/PRKCD/SERPINE1/CD9/THBD/PLAU,7
GO:0061028,BP,GO:0061028,establishment of endothelial barrier,7/269,49/18888,0.142857143,10.03080191,7.60807679,5.66E-06,3.51E-05,1.47E-05,EDNRB/FASN/IL1B/VEGFA/TNF/ROCK1/MYD88,7
GO:0070266,BP,GO:0070266,necroptotic process,7/269,49/18888,0.142857143,10.03080191,7.60807679,5.66E-06,3.51E-05,1.47E-05,TP53/CASP8/FASLG/PARP1/TNF/CAV1/AIFM1,7
GO:0051092,BP,GO:0051092,positive regulation of NF-kappaB transcription factor activity,11/269,141/18888,0.078014184,5.47781381,6.414889093,5.72E-06,3.54E-05,1.48E-05,AR/ALK/IL1B/STAT3/TLR4/TNF/RELA/SPHK1/MYD88/CLOCK/CLU,11
GO:0001933,BP,GO:0001933,negative regulation of protein phosphorylation,16/269,296/18888,0.054054054,3.795438561,5.826559772,5.74E-06,3.55E-05,1.49E-05,PTEN/IL1B/PPARG/GSTP1/PRKCD/DUSP6/AKT1/CAV1/TGFB1/HHEX/RB1/BAX/DAB2IP/CDKN1A/SFN/CDKN2A,16
GO:0030193,BP,GO:0030193,regulation of blood coagulation,8/269,69/18888,0.115942029,8.140940682,7.142679347,6.02E-06,3.71E-05,1.56E-05,THBS1/ALOX12/PRKCD/CAV1/SERPINE1/CD9/THBD/PLAU,8
GO:0022412,BP,GO:0022412,cellular process involved in reproduction in multicellular organism,21/269,482/18888,0.043568465,3.059186475,5.504513505,6.12E-06,3.77E-05,1.58E-05,PTEN/CTNNB1/AURKA/BRCA2/ETV5/ERCC1/PIK3CA/DEFB1/SMARCA2/MTOR/SRPK1/AKT1/TGFBR1/WT1/BAX/IGF1/CD9/MLH1/MSH2/ZFX/IGF2,21
GO:0062013,BP,GO:0062013,positive regulation of small molecule metabolic process,11/269,142/18888,0.077464789,5.439237656,6.38230737,6.12E-06,3.77E-05,1.58E-05,PTGS2/IL1B/PPARG/MTOR/TNF/AKT1/IRS1/IGF1/TWIST1/PMAIP1/IGF2,11
GO:0002218,BP,GO:0002218,activation of innate immune response,16/269,298/18888,0.053691275,3.769965819,5.793250414,6.26E-06,3.85E-05,1.61E-05,MAP3K7/PARP1/TLR4/SQSTM1/TNF/RELA/AKT1/CAV1/MIR200C/DAB2IP/HSP90AA1/CD274/NFKBIA/LGR4/ESR1/MYD88,16
GO:0002062,BP,GO:0002062,chondrocyte differentiation,10/269,116/18888,0.086206897,6.053070119,6.561581097,6.29E-06,3.86E-05,1.62E-05,CTNNB1/MAPK14/HIF1A/TWSG1/TGFBR1/SMAD3/TGFB1/RB1/SNAI2/FGFR1,10
GO:0017145,BP,GO:0017145,stem cell division,6/269,33/18888,0.181818182,12.76647516,8.131478875,6.33E-06,3.88E-05,1.63E-05,ETV5/NCOA3/NOTCH1/BMI1/CUL3/MIR145,6
GO:1900047,BP,GO:1900047,negative regulation of hemostasis,7/269,50/18888,0.14,9.830185874,7.514790983,6.51E-06,3.98E-05,1.67E-05,THBS1/ALOX12/PRKCD/SERPINE1/CD9/THBD/PLAU,7
GO:0007281,BP,GO:0007281,germ cell development,18/269,371/18888,0.04851752,3.406687442,5.627309314,6.74E-06,4.12E-05,1.73E-05,CTNNB1/AURKA/BRCA2/ETV5/ERCC1/PIK3CA/DEFB1/SMARCA2/MTOR/SRPK1/AKT1/WT1/BAX/IGF1/MLH1/MSH2/ZFX/IGF2,18
GO:1900180,BP,GO:1900180,regulation of protein localization to nucleus,11/269,144/18888,0.076388889,5.363692689,6.31805963,7.00E-06,4.28E-05,1.79E-05,PTGS2/PARP1/CDH1/MAPK14/MTOR/PRKCD/AKT1/LZTS2/SMAD3/TGFB1/HSP90AA1,11
GO:0007589,BP,GO:0007589,body fluid secretion,9/269,93/18888,0.096774194,6.79505936,6.733760292,7.14E-06,4.35E-05,1.82E-05,COX2/VDR/CCND1/VEGFA/NCOA1/HIF1A/CAV1/EGFR/MED1,9
GO:0050886,BP,GO:0050886,endocrine process,9/269,93/18888,0.096774194,6.79505936,6.733760292,7.14E-06,4.35E-05,1.82E-05,EDNRB/IL1B/PPARG/RHOA/NKX3-1/GATA3/FGFR1/UCN/CYP19A1,9
GO:0023061,BP,GO:0023061,signal release,21/269,487/18888,0.04312115,3.02777799,5.449336503,7.16E-06,4.36E-05,1.83E-05,IL6/PTGS2/EDNRB/IL1B/PPARG/SOX11/MYB/HIF1A/TNF/HNF1B/SNCG/EGFR/GIT1/IRS1/BRAF/NKX3-1/GATA3/FGFR1/UCN/CYP19A1/CLOCK,21
GO:0016241,BP,GO:0016241,regulation of macroautophagy,12/269,173/18888,0.069364162,4.870447171,6.147078144,7.26E-06,4.41E-05,1.85E-05,TP53/FBXW7/MAP3K7/PIK3CA/CASP3/HIF1A/MTOR/HDAC6/AKT1/KDR/BNIP3/BNIP3L,12
GO:0007088,BP,GO:0007088,regulation of mitotic nuclear division,10/269,118/18888,0.084745763,5.95047571,6.483884284,7.33E-06,4.44E-05,1.86E-05,AURKA/IL1B/XRCC3/TNF/CUL3/RB1/TGFA/IGF1/SPHK1/IGF2,10
GO:0010633,BP,GO:0010633,negative regulation of epithelial cell migration,10/269,118/18888,0.084745763,5.95047571,6.483884284,7.33E-06,4.44E-05,1.86E-05,THBS1/PTEN/PPARG/FGF2/NOTCH1/TNF/RHOA/TGFB1/MIR200C/DAB2IP,10
GO:0010224,BP,GO:0010224,response to UV-B,5/269,20/18888,0.25,17.55390335,8.902908981,7.35E-06,4.45E-05,1.86E-05,MAPK14/RELA/MME/MSH2/CDKN1A,5
GO:2001238,BP,GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,7/269,51/18888,0.137254902,9.637437131,7.424095891,7.45E-06,4.50E-05,1.89E-05,THBS1/BID/TLR4/TNF/CAV1/PMAIP1/MAL,7
GO:0014743,BP,GO:0014743,regulation of muscle hypertrophy,8/269,71/18888,0.112676056,7.911618409,7.013150984,7.47E-06,4.50E-05,1.89E-05,MIR25/PPARG/PARP1/NOTCH1/SMAD3/IGF1/MIR145/ROCK1,8
GO:0032091,BP,GO:0032091,negative regulation of protein binding,8/269,71/18888,0.112676056,7.911618409,7.013150984,7.47E-06,4.50E-05,1.89E-05,AURKA/KDM1A/PRKCD/AKT1/IL10/BAX/CDKN1A/ROCK1,8
GO:1900046,BP,GO:1900046,regulation of hemostasis,8/269,71/18888,0.112676056,7.911618409,7.013150984,7.47E-06,4.50E-05,1.89E-05,THBS1/ALOX12/PRKCD/CAV1/SERPINE1/CD9/THBD/PLAU,8
GO:0030212,BP,GO:0030212,hyaluronan metabolic process,6/269,34/18888,0.176470588,12.3909906,7.990586454,7.59E-06,4.55E-05,1.91E-05,IL1B/NFKB1/CD44/FGF2/TGFB1/LYVE1,6
GO:1901797,BP,GO:1901797,negative regulation of signal transduction by p53 class mediator,6/269,34/18888,0.176470588,12.3909906,7.990586454,7.59E-06,4.55E-05,1.91E-05,KDM1A/CD44/SNAI1/TWIST1/SNAI2/MUC1,6
GO:1902176,BP,GO:1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,6/269,34/18888,0.176470588,12.3909906,7.990586454,7.59E-06,4.55E-05,1.91E-05,CTNNB1/GPX1/SOD2/HIF1A/AKT1/IL10,6
GO:0051346,BP,GO:0051346,negative regulation of hydrolase activity,13/269,204/18888,0.06372549,4.474524382,5.99728893,7.63E-06,4.57E-05,1.92E-05,TIMP1/THBS1/GPX1/CD44/VEGFA/TNF/AKT1/MMP9/DAB2IP/SERPINE1/HRAS/SFN/ROCK1,13
GO:0031668,BP,GO:0031668,cellular response to extracellular stimulus,15/269,269/18888,0.055762082,3.915368776,5.788565026,7.78E-06,4.65E-05,1.95E-05,TP53/VDR/IGF1R/NCOA1/MTOR/MAPK1/FOS/HSPA5/PMAIP1/SNAI2/PIM1/AKR1C3/CDKN1A/MED1/NPRL2,15
GO:0097194,BP,GO:0097194,execution phase of apoptosis,9/269,94/18888,0.095744681,6.722771494,6.685596702,7.80E-06,4.65E-05,1.95E-05,TP53/IL6/CASP8/CASP3/FASLG/AKT1/DLC1/BAX/AIFM1,9
GO:1900182,BP,GO:1900182,positive regulation of protein localization to nucleus,9/269,94/18888,0.095744681,6.722771494,6.685596702,7.80E-06,4.65E-05,1.95E-05,PTGS2/PARP1/CDH1/MAPK14/PRKCD/AKT1/SMAD3/TGFB1/HSP90AA1,9
GO:0042368,BP,GO:0042368,vitamin D biosynthetic process,4/269,10/18888,0.4,28.08624535,10.29793797,7.90E-06,4.70E-05,1.97E-05,NFKB1/TNF/SNAI1/SNAI2,4
GO:0060768,BP,GO:0060768,regulation of epithelial cell proliferation involved in prostate gland development,4/269,10/18888,0.4,28.08624535,10.29793797,7.90E-06,4.70E-05,1.97E-05,CTNNB1/AR/NOTCH1/NKX3-1,4
GO:0043500,BP,GO:0043500,muscle adaptation,10/269,119/18888,0.084033613,5.900471713,6.445702463,7.91E-06,4.70E-05,1.97E-05,MIR25/IL1B/PPARG/PARP1/NOTCH1/EZH2/SMAD3/IGF1/MIR145/ROCK1,10
GO:0140895,BP,GO:0140895,cell surface toll-like receptor signaling pathway,8/269,72/18888,0.111111111,7.80173482,6.950271122,8.30E-06,4.93E-05,2.07E-05,MAP3K7/TLR4/SQSTM1/RELA/MIR200C/DAB2IP/NFKBIA/MYD88,8
GO:0010823,BP,GO:0010823,negative regulation of mitochondrion organization,7/269,52/18888,0.134615385,9.452101802,7.335867937,8.51E-06,5.03E-05,2.11E-05,TP53/GPX1/PPARG/AKT1/IGF1/BNIP3/CLU,7
GO:1904707,BP,GO:1904707,positive regulation of vascular associated smooth muscle cell proliferation,7/269,52/18888,0.134615385,9.452101802,7.335867937,8.51E-06,5.03E-05,2.11E-05,MAP3K7/FGF2/TNF/MMP9/MMP2/IL10/IGF1,7
GO:0002718,BP,GO:0002718,regulation of cytokine production involved in immune response,10/269,120/18888,0.083333333,5.851301115,6.407952909,8.52E-06,5.03E-05,2.11E-05,IL6/MAP3K7/IL1B/TLR4/TNF/TGFB1/IL10/TWIST1/GATA3/MYD88,10
GO:0035710,BP,GO:0035710,"CD4-positive, alpha-beta T cell activation",10/269,120/18888,0.083333333,5.851301115,6.407952909,8.52E-06,5.03E-05,2.11E-05,IL6/MYB/STAT3/MTOR/TWSG1/BRD2/BRD4/BRAF/GATA3/CD274,10
GO:0001893,BP,GO:0001893,maternal placenta development,6/269,35/18888,0.171428571,12.03696229,7.855481343,9.06E-06,5.33E-05,2.24E-05,VDR/PTGS2/PARP1/AKT1/BSG/CTSB,6
GO:0033146,BP,GO:0033146,regulation of intracellular estrogen receptor signaling pathway,6/269,35/18888,0.171428571,12.03696229,7.855481343,9.06E-06,5.33E-05,2.24E-05,BRCA1/AR/PARP1/FOXA1/TP63/MED1,6
GO:0032732,BP,GO:0032732,positive regulation of interleukin-1 production,8/269,73/18888,0.109589041,7.694861741,6.888590771,9.21E-06,5.41E-05,2.27E-05,IL6/CASP8/STAT3/TLR4/TNF/RELA/SMAD3/MYD88,8
GO:0045661,BP,GO:0045661,regulation of myoblast differentiation,8/269,73/18888,0.109589041,7.694861741,6.888590771,9.21E-06,5.41E-05,2.27E-05,ARID1A/NOTCH1/MAPK14/SMARCA4/SMARCA2/TNF/TGFB1/SMARCE1,8
GO:0002295,BP,GO:0002295,T-helper cell lineage commitment,5/269,21/18888,0.238095238,16.71800319,8.662336477,9.53E-06,5.57E-05,2.34E-05,IL6/STAT3/MTOR/BRD2/BRD4,5
GO:0032495,BP,GO:0032495,response to muramyl dipeptide,5/269,21/18888,0.238095238,16.71800319,8.662336477,9.53E-06,5.57E-05,2.34E-05,NOTCH1/MAPK14/RELA/VIM/NFKBIA,5
GO:0097709,BP,GO:0097709,connective tissue replacement,5/269,21/18888,0.238095238,16.71800319,8.662336477,9.53E-06,5.57E-05,2.34E-05,TIMP1/PPARG/HIF1A/TGFB1/ROCK1,5
GO:0050819,BP,GO:0050819,negative regulation of coagulation,7/269,53/18888,0.132075472,9.273760258,7.249991698,9.68E-06,5.66E-05,2.37E-05,THBS1/ALOX12/PRKCD/SERPINE1/CD9/THBD/PLAU,7
GO:0002687,BP,GO:0002687,positive regulation of leukocyte migration,11/269,149/18888,0.073825503,5.183703001,6.162546786,9.71E-06,5.66E-05,2.37E-05,THBS1/CXCR2/IL6/VEGFA/MMP14/MAPK1/TNF/RHOA/PTK2/SERPINE1/LYVE1,11
GO:0006367,BP,GO:0006367,transcription initiation at RNA polymerase II promoter,11/269,149/18888,0.073825503,5.183703001,6.162546786,9.71E-06,5.66E-05,2.37E-05,TP53/MYC/ERCC1/CDK4/NFKB1/ARID1A/SMARCA4/HNF1B/NFKBIA/MED1/ESR1,11
GO:0002367,BP,GO:0002367,cytokine production involved in immune response,10/269,122/18888,0.081967213,5.755378146,6.333715784,9.87E-06,5.74E-05,2.41E-05,IL6/MAP3K7/IL1B/TLR4/TNF/TGFB1/IL10/TWIST1/GATA3/MYD88,10
GO:0014823,BP,GO:0014823,response to activity,8/269,74/18888,0.108108108,7.590877122,6.828069911,1.02E-05,5.91E-05,2.48E-05,IL6/PIK3CA/SOD2/HIF1A/FOS/TNF/MMP2/IL10,8
GO:0050818,BP,GO:0050818,regulation of coagulation,8/269,74/18888,0.108108108,7.590877122,6.828069911,1.02E-05,5.91E-05,2.48E-05,THBS1/ALOX12/PRKCD/CAV1/SERPINE1/CD9/THBD/PLAU,8
GO:0051881,BP,GO:0051881,regulation of mitochondrial membrane potential,8/269,74/18888,0.108108108,7.590877122,6.828069911,1.02E-05,5.91E-05,2.48E-05,BID/PARP1/SOD2/BAX/KDR/BNIP3/PMAIP1/BNIP3L,8
GO:0060260,BP,GO:0060260,regulation of transcription initiation by RNA polymerase II,8/269,74/18888,0.108108108,7.590877122,6.828069911,1.02E-05,5.91E-05,2.48E-05,TP53/MYC/ERCC1/CDK4/NFKB1/HNF1B/NFKBIA/MED1,8
GO:0045834,BP,GO:0045834,positive regulation of lipid metabolic process,10/269,123/18888,0.081300813,5.708586454,6.297211421,1.06E-05,6.13E-05,2.57E-05,PTGS2/IL1B/PPARG/IGF1R/MTOR/PRKCD/TNF/AKT1/IRS1/TWIST1,10
GO:0046879,BP,GO:0046879,hormone secretion,16/269,311/18888,0.051446945,3.612378824,5.583519186,1.07E-05,6.17E-05,2.59E-05,IL6/IL1B/PPARG/SOX11/MYB/HIF1A/TNF/HNF1B/EGFR/IRS1/NKX3-1/GATA3/FGFR1/UCN/CYP19A1/CLOCK,16
GO:0048265,BP,GO:0048265,response to pain,6/269,36/18888,0.166666667,11.70260223,7.725762868,1.07E-05,6.18E-05,2.59E-05,THBS1/EDNRB/MTOR/AKT1/TAC1/UCN,6
GO:1905332,BP,GO:1905332,positive regulation of morphogenesis of an epithelium,6/269,36/18888,0.166666667,11.70260223,7.725762868,1.07E-05,6.18E-05,2.59E-05,CTNNB1/AR/VEGFA/FGF2/GATA3/LGR4,6
GO:0031214,BP,GO:0031214,biomineral tissue development,12/269,180/18888,0.066666667,4.681040892,5.964481119,1.09E-05,6.25E-05,2.62E-05,VDR/PTGS2/NOTCH1/HIF1A/SMAD3/TGFB1/IGF1/TWIST1/FGFR1/TFAP2A/LGR4/ROCK1,12
GO:0010951,BP,GO:0010951,negative regulation of endopeptidase activity,10/269,124/18888,0.080645161,5.662549466,6.261105721,1.14E-05,6.55E-05,2.75E-05,TIMP1/THBS1/GPX1/CD44/VEGFA/TNF/AKT1/MMP9/SERPINE1/SFN,10
GO:0002758,BP,GO:0002758,innate immune response-activating signaling pathway,15/269,278/18888,0.053956835,3.788612233,5.630108881,1.15E-05,6.61E-05,2.77E-05,MAP3K7/PARP1/TLR4/SQSTM1/TNF/RELA/AKT1/CAV1/MIR200C/DAB2IP/CD274/NFKBIA/LGR4/ESR1/MYD88,15
GO:0035296,BP,GO:0035296,regulation of tube diameter,11/269,152/18888,0.072368421,5.081393074,6.072551861,1.17E-05,6.71E-05,2.82E-05,GPX1/PTGS2/EDNRB/SOD2/TNF/RHOA/CAV1/MMP2/EGFR/UCN/ROCK1,11
GO:0097746,BP,GO:0097746,blood vessel diameter maintenance,11/269,152/18888,0.072368421,5.081393074,6.072551861,1.17E-05,6.71E-05,2.82E-05,GPX1/PTGS2/EDNRB/SOD2/TNF/RHOA/CAV1/MMP2/EGFR/UCN/ROCK1,11
GO:0001660,BP,GO:0001660,fever generation,4/269,11/18888,0.363636364,25.53295032,9.782707946,1.23E-05,6.99E-05,2.93E-05,PTGS2/EDNRB/IL1B/TNF,4
GO:0031650,BP,GO:0031650,regulation of heat generation,4/269,11/18888,0.363636364,25.53295032,9.782707946,1.23E-05,6.99E-05,2.93E-05,PTGS2/EDNRB/IL1B/TNF,4
GO:0033148,BP,GO:0033148,positive regulation of intracellular estrogen receptor signaling pathway,4/269,11/18888,0.363636364,25.53295032,9.782707946,1.23E-05,6.99E-05,2.93E-05,AR/PARP1/FOXA1/MED1,4
GO:0060767,BP,GO:0060767,epithelial cell proliferation involved in prostate gland development,4/269,11/18888,0.363636364,25.53295032,9.782707946,1.23E-05,6.99E-05,2.93E-05,CTNNB1/AR/NOTCH1/NKX3-1,4
GO:0035150,BP,GO:0035150,regulation of tube size,11/269,153/18888,0.071895425,5.048181354,6.04307913,1.25E-05,7.10E-05,2.98E-05,GPX1/PTGS2/EDNRB/SOD2/TNF/RHOA/CAV1/MMP2/EGFR/UCN/ROCK1,11
GO:0033144,BP,GO:0033144,negative regulation of intracellular steroid hormone receptor signaling pathway,6/269,37/18888,0.162162162,11.38631568,7.601068354,1.27E-05,7.18E-05,3.01E-05,BRCA1/SMARCA4/RHOA/TP63/PER1/CLOCK,6
GO:0055023,BP,GO:0055023,positive regulation of cardiac muscle tissue growth,6/269,37/18888,0.162162162,11.38631568,7.601068354,1.27E-05,7.18E-05,3.01E-05,FGF2/NOTCH1/MAPK14/IGF1/PIM1/FGFR1,6
GO:0071404,BP,GO:0071404,cellular response to low-density lipoprotein particle stimulus,6/269,37/18888,0.162162162,11.38631568,7.601068354,1.27E-05,7.18E-05,3.01E-05,PPARG/TLR4/AKT1/TGFB1/CD9/MYD88,6
GO:0008286,BP,GO:0008286,insulin receptor signaling pathway,10/269,126/18888,0.079365079,5.572667729,6.190059244,1.31E-05,7.43E-05,3.11E-05,PIK3CA/IL1B/IGF1R/MAPK1/PRKCD/RELA/AKT1/IRS1/HRAS/IGF2,10
GO:0002833,BP,GO:0002833,positive regulation of response to biotic stimulus,18/269,390/18888,0.046153846,3.240720618,5.374487788,1.33E-05,7.51E-05,3.15E-05,KLK3/MAP3K7/PARP1/TLR4/SQSTM1/TNF/RELA/AKT1/CAV1/MIR200C/DAB2IP/HSP90AA1/CD274/NFKBIA/MED1/LGR4/ESR1/MYD88,18
GO:0006282,BP,GO:0006282,regulation of DNA repair,13/269,215/18888,0.060465116,4.245595228,5.752888962,1.34E-05,7.57E-05,3.17E-05,BRCA1/XRCC1/PARP1/KDM1A/ARID1A/SMARCA4/SMARCA2/PCNA/CBX8/EGFR/MEAF6/SMARCE1/TWIST1,13
GO:0034284,BP,GO:0034284,response to monosaccharide,13/269,215/18888,0.060465116,4.245595228,5.752888962,1.34E-05,7.57E-05,3.17E-05,THBS1/GPX1/PTGS2/PIK3CA/CASP3/SOD2/IGF1R/HIF1A/SMARCA4/TNF/HNF1B/SMAD3/PCSK1,13
GO:0048738,BP,GO:0048738,cardiac muscle tissue development,14/269,248/18888,0.056451613,3.963784626,5.647145552,1.36E-05,7.68E-05,3.22E-05,MIR25/VEGFA/FGF2/NOTCH1/MAPK14/MTOR/TGFBR1/TGFB1/WT1/IGF1/PIM1/FGFR1/MED1/FGF3,14
GO:0045669,BP,GO:0045669,positive regulation of osteoblast differentiation,8/269,77/18888,0.103896104,7.295128663,6.653091341,1.37E-05,7.72E-05,3.24E-05,CTNNB1/IL6/SOX11/FGF2/ILK/MIR200C/IGF1/TP63,8
GO:0070231,BP,GO:0070231,T cell apoptotic process,7/269,56/18888,0.125,8.776951673,7.005427537,1.40E-05,7.87E-05,3.30E-05,TP53/FASLG/HIF1A/AKT1/CHEK2/BAX/CD274,7
GO:0003300,BP,GO:0003300,cardiac muscle hypertrophy,9/269,101/18888,0.089108911,6.256836836,6.367015701,1.40E-05,7.87E-05,3.30E-05,MIR25/PPARG/PARP1/NOTCH1/EZH2/SMAD3/IGF1/MIR145/ROCK1,9
GO:0010596,BP,GO:0010596,negative regulation of endothelial cell migration,9/269,101/18888,0.089108911,6.256836836,6.367015701,1.40E-05,7.87E-05,3.30E-05,THBS1/PPARG/FGF2/NOTCH1/TNF/RHOA/TGFB1/MIR200C/DAB2IP,9
GO:1901617,BP,GO:1901617,organic hydroxy compound biosynthetic process,14/269,249/18888,0.0562249,3.947865813,5.628277915,1.43E-05,7.99E-05,3.35E-05,SRD5A2/AMACR/ALOX12/NFKB1/TNF/ALOX15B/FGFR4/SNAI1/SPHK1/MC1R/SNAI2/AKR1C3/GATA3/CYP19A1,14
GO:0010661,BP,GO:0010661,positive regulation of muscle cell apoptotic process,6/269,38/18888,0.157894737,11.0866758,7.481068603,1.49E-05,8.28E-05,3.47E-05,TP53/CXCR2/PPARG/SOD2/BNIP3/CDKN2A,6
GO:0032885,BP,GO:0032885,regulation of polysaccharide biosynthetic process,6/269,38/18888,0.157894737,11.0866758,7.481068603,1.49E-05,8.28E-05,3.47E-05,NFKB1/AKT1/TGFB1/IRS1/IGF1/IGF2,6
GO:0055094,BP,GO:0055094,response to lipoprotein particle,6/269,38/18888,0.157894737,11.0866758,7.481068603,1.49E-05,8.28E-05,3.47E-05,PPARG/TLR4/AKT1/TGFB1/CD9/MYD88,6
GO:0070316,BP,GO:0070316,regulation of G0 to G1 transition,6/269,38/18888,0.157894737,11.0866758,7.481068603,1.49E-05,8.28E-05,3.47E-05,ARID1A/SMARCA4/SMARCA2/DAB2IP/SMARCE1/MED1,6
GO:0010827,BP,GO:0010827,regulation of glucose transmembrane transport,8/269,78/18888,0.102564103,7.201601373,6.59684386,1.51E-05,8.41E-05,3.52E-05,IL1B/MAPK14/RNASEL/TNF/AKT1/IRS1/IGF1/BRAF,8
GO:0032677,BP,GO:0032677,regulation of interleukin-8 production,9/269,102/18888,0.088235294,6.195495298,6.323963246,1.52E-05,8.46E-05,3.55E-05,IL6/IL1B/STAT3/TLR4/TNF/RELA/IL10/SERPINE1/MYD88,9
GO:0072574,BP,GO:0072574,hepatocyte proliferation,5/269,23/18888,0.217391304,15.26426378,8.227432516,1.54E-05,8.53E-05,3.58E-05,FBXW7/IL6/TNF/TGFA/MED1,5
GO:0072575,BP,GO:0072575,epithelial cell proliferation involved in liver morphogenesis,5/269,23/18888,0.217391304,15.26426378,8.227432516,1.54E-05,8.53E-05,3.58E-05,FBXW7/IL6/TNF/TGFA/MED1,5
GO:0001541,BP,GO:0001541,ovarian follicle development,7/269,57/18888,0.122807018,8.622970065,6.927944576,1.58E-05,8.75E-05,3.67E-05,VEGFA/MMP14/MMP2/BAX/KDR/ZFX/ESR1,7
GO:0060986,BP,GO:0060986,endocrine hormone secretion,7/269,57/18888,0.122807018,8.622970065,6.927944576,1.58E-05,8.75E-05,3.67E-05,IL1B/PPARG/NKX3-1/GATA3/FGFR1/UCN/CYP19A1,7
GO:0098773,BP,GO:0098773,skin epidermis development,10/269,129/18888,0.07751938,5.443070805,6.086290842,1.61E-05,8.91E-05,3.74E-05,CTNNB1/ALOX12/NOTCH1/TNF/RELA/EGFR/SNAI1/TP63/SFN/LGR4,10
GO:0009914,BP,GO:0009914,hormone transport,16/269,322/18888,0.049689441,3.488974578,5.414628661,1.64E-05,9.07E-05,3.80E-05,IL6/IL1B/PPARG/SOX11/MYB/HIF1A/TNF/HNF1B/EGFR/IRS1/NKX3-1/GATA3/FGFR1/UCN/CYP19A1/CLOCK,16
GO:0032637,BP,GO:0032637,interleukin-8 production,9/269,103/18888,0.087378641,6.135344859,6.281481432,1.65E-05,9.07E-05,3.81E-05,IL6/IL1B/STAT3/TLR4/TNF/RELA/IL10/SERPINE1/MYD88,9
GO:0002752,BP,GO:0002752,cell surface pattern recognition receptor signaling pathway,8/269,79/18888,0.101265823,7.110441862,6.541581596,1.66E-05,9.13E-05,3.83E-05,MAP3K7/TLR4/SQSTM1/RELA/MIR200C/DAB2IP/NFKBIA/MYD88,8
GO:0070227,BP,GO:0070227,lymphocyte apoptotic process,8/269,79/18888,0.101265823,7.110441862,6.541581596,1.66E-05,9.13E-05,3.83E-05,TP53/FASLG/HIF1A/AKT1/IL10/CHEK2/BAX/CD274,8
GO:0006352,BP,GO:0006352,DNA-templated transcription initiation,12/269,189/18888,0.063492063,4.458134183,5.743055408,1.78E-05,9.71E-05,4.07E-05,TP53/MYC/ERCC1/CDK4/NFKB1/ARID1A/SMARCA4/HNF1B/TWIST1/NFKBIA/MED1/ESR1,12
GO:0032640,BP,GO:0032640,tumor necrosis factor production,12/269,189/18888,0.063492063,4.458134183,5.743055408,1.78E-05,9.71E-05,4.07E-05,THBS1/IL6/GSTP1/STAT3/TLR4/TGFB1/IL10/IGF1/TWIST1/MC1R/MYD88/CLU,12
GO:0032680,BP,GO:0032680,regulation of tumor necrosis factor production,12/269,189/18888,0.063492063,4.458134183,5.743055408,1.78E-05,9.71E-05,4.07E-05,THBS1/IL6/GSTP1/STAT3/TLR4/TGFB1/IL10/IGF1/TWIST1/MC1R/MYD88/CLU,12
GO:0042306,BP,GO:0042306,regulation of protein import into nucleus,7/269,58/18888,0.120689655,8.474298167,6.852336941,1.78E-05,9.71E-05,4.07E-05,PTGS2/CDH1/MAPK14/PRKCD/SMAD3/TGFB1/HSP90AA1,7
GO:0009408,BP,GO:0009408,response to heat,9/269,104/18888,0.086538462,6.076351158,6.239556777,1.78E-05,9.71E-05,4.07E-05,THBS1/PTGS2/MTOR/HDAC6/AKT1/IGF1/HSP90AA1/CDKN1A/MAP2K7,9
GO:0014897,BP,GO:0014897,striated muscle hypertrophy,9/269,104/18888,0.086538462,6.076351158,6.239556777,1.78E-05,9.71E-05,4.07E-05,MIR25/PPARG/PARP1/NOTCH1/EZH2/SMAD3/IGF1/MIR145/ROCK1,9
GO:0042100,BP,GO:0042100,B cell proliferation,9/269,104/18888,0.086538462,6.076351158,6.239556777,1.78E-05,9.71E-05,4.07E-05,CASP3/TLR4/PRKCD/BMI1/IL10/BAX/PAWR/CDKN1A/IFNA1,9
GO:0046883,BP,GO:0046883,regulation of hormone secretion,14/269,254/18888,0.05511811,3.870151919,5.535389068,1.78E-05,9.71E-05,4.07E-05,IL6/IL1B/PPARG/SOX11/MYB/HIF1A/TNF/EGFR/IRS1/NKX3-1/FGFR1/UCN/CYP19A1/CLOCK,14
GO:0033145,BP,GO:0033145,positive regulation of intracellular steroid hormone receptor signaling pathway,4/269,12/18888,0.333333333,23.40520446,9.33176953,1.82E-05,9.86E-05,4.13E-05,AR/PARP1/FOXA1/MED1,4
GO:0070561,BP,GO:0070561,vitamin D receptor signaling pathway,4/269,12/18888,0.333333333,23.40520446,9.33176953,1.82E-05,9.86E-05,4.13E-05,VDR/SNAI2/PIM1/MED1,4
GO:1902337,BP,GO:1902337,regulation of apoptotic process involved in morphogenesis,4/269,12/18888,0.333333333,23.40520446,9.33176953,1.82E-05,9.86E-05,4.13E-05,VDR/NOTCH1/HNF1B/BAX,4
GO:1904672,BP,GO:1904672,regulation of somatic stem cell population maintenance,4/269,12/18888,0.333333333,23.40520446,9.33176953,1.82E-05,9.86E-05,4.13E-05,MYC/HNF1B/MIR145/TP63,4
GO:0021536,BP,GO:0021536,diencephalon development,8/269,80/18888,0.1,7.021561338,6.487274192,1.82E-05,9.86E-05,4.14E-05,SRD5A2/CTNNB1/NCOA1/FGF2/CDH1/BAX/PCSK1/SOX2,8
GO:0010595,BP,GO:0010595,positive regulation of endothelial cell migration,10/269,131/18888,0.076335878,5.359970487,6.018897706,1.85E-05,9.98E-05,4.18E-05,THBS1/PTGS2/VEGFA/FGF2/HIF1A/AKT1/TGFB1/KDR/GATA3/FGFR1,10
GO:0009651,BP,GO:0009651,response to salt stress,5/269,24/18888,0.208333333,14.62825279,8.02986718,1.92E-05,0.000103004,4.32E-05,TP53/TNF/BAX/HSP90AA1/FBP1,5
GO:0030539,BP,GO:0030539,male genitalia development,5/269,24/18888,0.208333333,14.62825279,8.02986718,1.92E-05,0.000103004,4.32E-05,SRD5A2/CTNNB1/AR/WT1/LGR4,5
GO:0035162,BP,GO:0035162,embryonic hemopoiesis,5/269,24/18888,0.208333333,14.62825279,8.02986718,1.92E-05,0.000103004,4.32E-05,VEGFA/HIF1A/KDR/GATA3/MED1,5
GO:0035357,BP,GO:0035357,peroxisome proliferator activated receptor signaling pathway,5/269,24/18888,0.208333333,14.62825279,8.02986718,1.92E-05,0.000103004,4.32E-05,PPARG/NCOA1/ALOX15B/TWIST1/MED1,5
GO:0043373,BP,GO:0043373,"CD4-positive, alpha-beta T cell lineage commitment",5/269,24/18888,0.208333333,14.62825279,8.02986718,1.92E-05,0.000103004,4.32E-05,IL6/STAT3/MTOR/BRD2/BRD4,5
GO:0060571,BP,GO:0060571,morphogenesis of an epithelial fold,5/269,24/18888,0.208333333,14.62825279,8.02986718,1.92E-05,0.000103004,4.32E-05,CTNNB1/AR/HIF1A/EGFR/TP63,5
GO:2000209,BP,GO:2000209,regulation of anoikis,5/269,24/18888,0.208333333,14.62825279,8.02986718,1.92E-05,0.000103004,4.32E-05,PIK3CA/NOTCH1/CAV1/PTK2/SNAI2,5
GO:0090100,BP,GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,9/269,105/18888,0.085714286,6.018481147,6.198176248,1.92E-05,0.000103004,4.32E-05,THBS1/PARP1/SOX11/NOTCH1/TWSG1/TGFBR1/TGFB1/ILK/KDR,9
GO:0006631,BP,GO:0006631,fatty acid metabolic process,18/269,401/18888,0.044887781,3.151823045,5.235099906,1.93E-05,0.000103004,4.32E-05,BRCA1/AMACR/ALOX12/GPX1/PTGS2/FASN/IL1B/PPARG/GSTP1/MAPK14/AKT1/ALOX15B/CAV1/CYP1A1/IRS1/SGPL1/TWIST1/AKR1C3,18
GO:0097696,BP,GO:0097696,receptor signaling pathway via STAT,12/269,191/18888,0.062827225,4.41145215,5.69573084,1.97E-05,0.000105245,4.41E-05,IL6/PPARG/NOTCH1/STAT3/TNF/CAV1/TGFB1/IL10/VHL/IGF1/STAT1/IFNA1,12
GO:0010466,BP,GO:0010466,negative regulation of peptidase activity,10/269,132/18888,0.075757576,5.31936465,5.985716966,1.97E-05,0.000105245,4.41E-05,TIMP1/THBS1/GPX1/CD44/VEGFA/TNF/AKT1/MMP9/SERPINE1/SFN,10
GO:0007566,BP,GO:0007566,embryo implantation,7/269,59/18888,0.118644068,8.330665995,6.778525975,1.99E-05,0.000106058,4.45E-05,TIMP1/PTGS2/IL1B/VEGFA/MMP9/MMP2/BSG,7
GO:0038066,BP,GO:0038066,p38MAPK cascade,7/269,59/18888,0.118644068,8.330665995,6.778525975,1.99E-05,0.000106058,4.45E-05,MAP3K7/IL1B/VEGFA/MAPK14/DAB2IP/SPHK1/PER1,7
GO:0001953,BP,GO:0001953,negative regulation of cell-matrix adhesion,6/269,40/18888,0.15,10.53234201,7.253981258,2.02E-05,0.000106997,4.49E-05,THBS1/PTEN/MMP14/DLC1/SERPINE1/CDKN2A,6
GO:0045023,BP,GO:0045023,G0 to G1 transition,6/269,40/18888,0.15,10.53234201,7.253981258,2.02E-05,0.000106997,4.49E-05,ARID1A/SMARCA4/SMARCA2/DAB2IP/SMARCE1/MED1,6
GO:0048246,BP,GO:0048246,macrophage chemotaxis,6/269,40/18888,0.15,10.53234201,7.253981258,2.02E-05,0.000106997,4.49E-05,THBS1/EDNRB/MAPK1/MMP2/PTK2/CYP19A1,6
GO:0002699,BP,GO:0002699,positive regulation of immune effector process,14/269,257/18888,0.054474708,3.824975048,5.480782264,2.03E-05,0.000107672,4.52E-05,KLK3/IL6/MAP3K7/IL1B/TLR4/TNF/TGFB1/IL10/BRD2/BRD4/GATA3/MLH1/MSH2/MYD88,14
GO:0045089,BP,GO:0045089,positive regulation of innate immune response,17/269,365/18888,0.046575342,3.27031624,5.264493318,2.06E-05,0.000109002,4.57E-05,MAP3K7/PARP1/TLR4/SQSTM1/TNF/RELA/AKT1/CAV1/MIR200C/DAB2IP/HSP90AA1/CD274/NFKBIA/MED1/LGR4/ESR1/MYD88,17
GO:0014896,BP,GO:0014896,muscle hypertrophy,9/269,106/18888,0.08490566,5.961703023,6.157327238,2.08E-05,0.00010956,4.59E-05,MIR25/PPARG/PARP1/NOTCH1/EZH2/SMAD3/IGF1/MIR145/ROCK1,9
GO:0032204,BP,GO:0032204,regulation of telomere maintenance,9/269,106/18888,0.08490566,5.961703023,6.157327238,2.08E-05,0.00010956,4.59E-05,TP53/CTNNB1/MYC/XRCC1/ERCC1/PARP1/MAPK1/NBN/MAP2K7,9
GO:0002822,BP,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,12/269,192/18888,0.0625,4.388475836,5.672312014,2.08E-05,0.00010956,4.59E-05,IL6/MAP3K7/IL1B/TNF/TGFB1/IL10/BRD2/BRD4/GATA3/CD274/MLH1/MSH2,12
GO:0045621,BP,GO:0045621,positive regulation of lymphocyte differentiation,10/269,133/18888,0.07518797,5.279369427,5.952871667,2.11E-05,0.000110965,4.65E-05,MMP14/ARID1A/SMARCA4/SMARCA2/RHOA/IL10/BRD2/BRD4/SMARCE1/GATA3,10
GO:0120254,BP,GO:0120254,olefinic compound metabolic process,11/269,162/18888,0.067901235,4.767726835,5.788870846,2.14E-05,0.000112361,4.71E-05,SRD5A2/ALOX12/GPX1/PTGS2/EDNRB/GSTP1/ALOX15B/CYP1A1/AKR1C3/CYP17A1/CYP19A1,11
GO:0050730,BP,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,13/269,225/18888,0.057777778,4.056902107,5.544488875,2.17E-05,0.000114183,4.79E-05,TP53/FBXW7/IL6/CD44/VEGFA/MTOR/PRKCD/TNF/CAV1/TGFB1/EGFR/TGFA/IGF1,13
GO:0043537,BP,GO:0043537,negative regulation of blood vessel endothelial cell migration,8/269,82/18888,0.097560976,6.850303745,6.381408985,2.19E-05,0.00011479,4.81E-05,THBS1/PPARG/FGF2/NOTCH1/TNF/RHOA/TGFB1/MIR200C,8
GO:0007596,BP,GO:0007596,blood coagulation,13/269,226/18888,0.057522124,4.038951212,5.524313407,2.28E-05,0.000119361,5.01E-05,THBS1/ALOX12/IL6/PIK3CA/MAPK14/TLR4/PRKCD/CAV1/ILK/SERPINE1/CD9/THBD/PLAU,13
GO:0002040,BP,GO:0002040,sprouting angiogenesis,12/269,194/18888,0.06185567,4.343233817,5.625951075,2.30E-05,0.000120601,5.06E-05,THBS1/FBXW7/PTGS2/VEGFA/FGF2/NOTCH1/RHOA/AKT1/TGFB1/IL10/MIR200C/KDR,12
GO:0009636,BP,GO:0009636,response to toxic substance,14/269,260/18888,0.053846154,3.780840721,5.426991331,2.31E-05,0.00012093,5.07E-05,GPX1/PTGS2/KDM1A/SOD2/GSTP1/CDH1/FOS/TNF/CYP1A1/TXN/BAX/AIFM1/PIM1/CDKN1A,14
GO:0071402,BP,GO:0071402,cellular response to lipoprotein particle stimulus,6/269,41/18888,0.146341463,10.27545562,7.146370347,2.34E-05,0.000121868,5.11E-05,PPARG/TLR4/AKT1/TGFB1/CD9/MYD88,6
GO:0071634,BP,GO:0071634,regulation of transforming growth factor beta production,6/269,41/18888,0.146341463,10.27545562,7.146370347,2.34E-05,0.000121868,5.11E-05,THBS1/PTGS2/MYB/HIF1A/SMAD3/FN1,6
GO:0002070,BP,GO:0002070,epithelial cell maturation,5/269,25/18888,0.2,14.04312268,7.843784533,2.38E-05,0.000123663,5.19E-05,HOXB13/HIF1A/FOXA1/KDR/CDKN1A,5
GO:0046697,BP,GO:0046697,decidualization,5/269,25/18888,0.2,14.04312268,7.843784533,2.38E-05,0.000123663,5.19E-05,VDR/PTGS2/PARP1/BSG/CTSB,5
GO:0070665,BP,GO:0070665,positive regulation of leukocyte proliferation,11/269,164/18888,0.067073171,4.709583824,5.734918509,2.39E-05,0.000124454,5.22E-05,IL6/IL1B/TLR4/MAPK1/BMI1/PTK2/IGF1/CD274/CDKN1A/IGF2/MYD88,11
GO:0045814,BP,GO:0045814,"negative regulation of gene expression, epigenetic",10/269,135/18888,0.074074074,5.201156547,5.888163035,2.40E-05,0.000124454,5.22E-05,BRCA1/MYC/CDKN2B-AS1/KDM1A/CDK2/HDAC6/BMI1/EZH2/MBD2/RB1,10
GO:0072175,BP,GO:0072175,epithelial tube formation,10/269,135/18888,0.074074074,5.201156547,5.888163035,2.40E-05,0.000124454,5.22E-05,CTNNB1/CASP3/FGF2/HIF1A/HNF1B/TGFB1/BRD2/DLC1/TWIST1/GATA3,10
GO:0043470,BP,GO:0043470,regulation of carbohydrate catabolic process,7/269,61/18888,0.114754098,8.057529405,6.636001976,2.49E-05,0.00012892,5.41E-05,TP53/HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,7
GO:0051147,BP,GO:0051147,regulation of muscle cell differentiation,11/269,165/18888,0.066666667,4.681040892,5.708267932,2.53E-05,0.000131166,5.50E-05,YBX1/SOD2/MMP14/NOTCH1/MAPK14/MTOR/EZH2/TGFB1/IGF1/MIR145/IGF2,11
GO:0002526,BP,GO:0002526,acute inflammatory response,9/269,109/18888,0.082568807,5.797619454,6.037849298,2.60E-05,0.000133533,5.60E-05,CXCR2/IL6/PTGS2/EDNRB/IL1B/GSTP1/TNF/A2M/FN1,9
GO:0010917,BP,GO:0010917,negative regulation of mitochondrial membrane potential,4/269,13/18888,0.307692308,21.60480412,8.93256408,2.60E-05,0.000133533,5.60E-05,BAX/BNIP3/PMAIP1/BNIP3L,4
GO:0042362,BP,GO:0042362,fat-soluble vitamin biosynthetic process,4/269,13/18888,0.307692308,21.60480412,8.93256408,2.60E-05,0.000133533,5.60E-05,NFKB1/TNF/SNAI1/SNAI2,4
GO:0045837,BP,GO:0045837,negative regulation of membrane potential,4/269,13/18888,0.307692308,21.60480412,8.93256408,2.60E-05,0.000133533,5.60E-05,BAX/BNIP3/PMAIP1/BNIP3L,4
GO:0051918,BP,GO:0051918,negative regulation of fibrinolysis,4/269,13/18888,0.307692308,21.60480412,8.93256408,2.60E-05,0.000133533,5.60E-05,THBS1/SERPINE1/THBD/PLAU,4
GO:0061029,BP,GO:0061029,eyelid development in camera-type eye,4/269,13/18888,0.307692308,21.60480412,8.93256408,2.60E-05,0.000133533,5.60E-05,SOX11/EGFR/TWIST1/TFAP2A,4
GO:1904748,BP,GO:1904748,regulation of apoptotic process involved in development,4/269,13/18888,0.307692308,21.60480412,8.93256408,2.60E-05,0.000133533,5.60E-05,VDR/NOTCH1/HNF1B/BAX,4
GO:0014855,BP,GO:0014855,striated muscle cell proliferation,8/269,84/18888,0.095238095,6.687201275,6.279030238,2.61E-05,0.000133922,5.62E-05,FGF2/MYB/NOTCH1/MAPK14/FOS/TGFBR1/PIM1/FGFR1,8
GO:0060563,BP,GO:0060563,neuroepithelial cell differentiation,6/269,42/18888,0.142857143,10.03080191,7.042402163,2.69E-05,0.000137966,5.79E-05,CTNNB1/SOX11/FGF2/NOTCH1/TGFB1/SERPINE1,6
GO:0090288,BP,GO:0090288,negative regulation of cellular response to growth factor stimulus,10/269,137/18888,0.072992701,5.125227254,5.82472464,2.72E-05,0.000139443,5.85E-05,THBS1/PPARG/FGF2/NOTCH1/TWSG1/MIR200C/HHEX/DAB2IP/MIR145/GATA3,10
GO:0033619,BP,GO:0033619,membrane protein proteolysis,7/269,62/18888,0.112903226,7.927569253,6.567153201,2.77E-05,0.000141645,5.94E-05,TIMP1/IL1B/TNF/TGFB1/IL10/MMP7/ROCK1,7
GO:0001708,BP,GO:0001708,cell fate specification,9/269,110/18888,0.081818182,5.744913822,5.999008241,2.79E-05,0.000142589,5.98E-05,CTNNB1/AR/FGF2/NOTCH1/HNF1B/FOXA1/SOX2/FGFR1/NANOG,9
GO:0051100,BP,GO:0051100,negative regulation of binding,9/269,110/18888,0.081818182,5.744913822,5.999008241,2.79E-05,0.000142589,5.98E-05,AURKA/KDM1A/SOX11/PRKCD/AKT1/IL10/BAX/CDKN1A/ROCK1,9
GO:0051149,BP,GO:0051149,positive regulation of muscle cell differentiation,8/269,85/18888,0.094117647,6.608528318,6.229085056,2.85E-05,0.000145056,6.08E-05,SOD2/MMP14/NOTCH1/MAPK14/MTOR/TGFB1/IGF1/MIR145,8
GO:0050817,BP,GO:0050817,coagulation,13/269,231/18888,0.056277056,3.951528026,5.425146243,2.86E-05,0.000145756,6.11E-05,THBS1/ALOX12/IL6/PIK3CA/MAPK14/TLR4/PRKCD/CAV1/ILK/SERPINE1/CD9/THBD/PLAU,13
GO:0002053,BP,GO:0002053,positive regulation of mesenchymal cell proliferation,5/269,26/18888,0.192307692,13.50300257,7.668078999,2.91E-05,0.000146966,6.16E-05,CTNNB1/MYC/KDR/STAT1/FGFR1,5
GO:0032967,BP,GO:0032967,positive regulation of collagen biosynthetic process,5/269,26/18888,0.192307692,13.50300257,7.668078999,2.91E-05,0.000146966,6.16E-05,MYB/TGFB1/CBX8/VIM/UCN,5
GO:0035902,BP,GO:0035902,response to immobilization stress,5/269,26/18888,0.192307692,13.50300257,7.668078999,2.91E-05,0.000146966,6.16E-05,ERCC1/SOD2/HDAC6/FOS/CYP1A1,5
GO:1900543,BP,GO:1900543,negative regulation of purine nucleotide metabolic process,5/269,26/18888,0.192307692,13.50300257,7.668078999,2.91E-05,0.000146966,6.16E-05,TP53/PARP1/STAT3/GIT1/FBP1,5
GO:1904353,BP,GO:1904353,regulation of telomere capping,5/269,26/18888,0.192307692,13.50300257,7.668078999,2.91E-05,0.000146966,6.16E-05,XRCC1/ERCC1/MAPK1/NBN/MAP2K7,5
GO:2000108,BP,GO:2000108,positive regulation of leukocyte apoptotic process,5/269,26/18888,0.192307692,13.50300257,7.668078999,2.91E-05,0.000146966,6.16E-05,TP53/IL10/BAX/CD274/CDKN2A,5
GO:0015980,BP,GO:0015980,energy derivation by oxidation of organic compounds,16/269,338/18888,0.047337278,3.323816018,5.181644196,2.97E-05,0.000149991,6.29E-05,TP53/COX2/PIK3CA/BID/SOD2/HIF1A/MTOR/TNF/RHOA/AKT1/IRS1/IGF1/BNIP3/MSH2/UCN/IGF2,16
GO:0090263,BP,GO:0090263,positive regulation of canonical Wnt signaling pathway,9/269,111/18888,0.081081081,5.693157842,5.960641487,3.00E-05,0.000151568,6.36E-05,NFKB1/FGF2/SMAD3/TGFB1/ILK/EGFR/HHEX/MIR145/LGR4,9
GO:0010453,BP,GO:0010453,regulation of cell fate commitment,6/269,43/18888,0.139534884,9.797527449,6.941866247,3.09E-05,0.000155295,6.51E-05,AR/FGF2/SPDEF/BRD2/BRD4/FGFR1,6
GO:0042554,BP,GO:0042554,superoxide anion generation,6/269,43/18888,0.139534884,9.797527449,6.941866247,3.09E-05,0.000155295,6.51E-05,ALOX12/SOD2/GSTP1/PRKCD/TGFB1/EGFR,6
GO:0043368,BP,GO:0043368,positive T cell selection,6/269,43/18888,0.139534884,9.797527449,6.941866247,3.09E-05,0.000155295,6.51E-05,IL6/STAT3/MTOR/BRD2/BRD4/BRAF,6
GO:0045740,BP,GO:0045740,positive regulation of DNA replication,6/269,43/18888,0.139534884,9.797527449,6.941866247,3.09E-05,0.000155295,6.51E-05,CDK2/PCNA/EGFR/FGFR1/CDKN1A/UCN,6
GO:0034243,BP,GO:0034243,regulation of transcription elongation by RNA polymerase II,8/269,86/18888,0.093023256,6.531684966,6.179937662,3.10E-05,0.000155379,6.52E-05,CTNNB1/PARP1/ELL2/EZH2/CDK12/BRD4/VHL/MED1,8
GO:0048678,BP,GO:0048678,response to axon injury,8/269,86/18888,0.093023256,6.531684966,6.179937662,3.10E-05,0.000155379,6.52E-05,SOD2/IGF1R/FGF2/MMP2/BAX/PCSK1/BNIP3/BRAF,8
GO:0007599,BP,GO:0007599,hemostasis,13/269,233/18888,0.055793991,3.91760933,5.38625521,3.13E-05,0.000156838,6.58E-05,THBS1/ALOX12/IL6/PIK3CA/MAPK14/TLR4/PRKCD/CAV1/ILK/SERPINE1/CD9/THBD/PLAU,13
GO:0048639,BP,GO:0048639,positive regulation of developmental growth,11/269,169/18888,0.065088757,4.570247025,5.603762883,3.16E-05,0.000158153,6.63E-05,VEGFA/FGF2/NOTCH1/MAPK14/AKT1/FN1/WT1/IGF1/PIM1/FGFR1/IGF2,11
GO:0032388,BP,GO:0032388,positive regulation of intracellular transport,10/269,140/18888,0.071428571,5.015400956,5.731851334,3.28E-05,0.000164009,6.88E-05,PTGS2/IL1B/CDH1/MAPK14/TENM1/PRKCD/SMAD3/TGFB1/HSP90AA1/SFN,10
GO:0002312,BP,GO:0002312,B cell activation involved in immune response,8/269,87/18888,0.091954023,6.456608127,6.131565491,3.37E-05,0.000168106,7.05E-05,ERCC1/IL6/TLR4/TGFB1/IL10/MLH1/MSH2/NBN,8
GO:0098586,BP,GO:0098586,cellular response to virus,8/269,87/18888,0.091954023,6.456608127,6.131565491,3.37E-05,0.000168106,7.05E-05,IL6/NFKB1/MAPK14/HIF1A/SMAD3/BAX/HSP90AA1/IFNA1,8
GO:0043124,BP,GO:0043124,negative regulation of canonical NF-kappaB signal transduction,7/269,64/18888,0.109375,7.679832714,6.433970576,3.42E-05,0.000169873,7.12E-05,CASP8/GSTP1/DAB2IP/STAT1/NFKBIA/PER1/ESR1,7
GO:2000179,BP,GO:2000179,positive regulation of neural precursor cell proliferation,7/269,64/18888,0.109375,7.679832714,6.433970576,3.42E-05,0.000169873,7.12E-05,CTNNB1/KDM1A/VEGFA/FGF2/NOTCH1/HIF1A/ID4,7
GO:0010714,BP,GO:0010714,positive regulation of collagen metabolic process,5/269,27/18888,0.185185185,13.00289137,7.501789164,3.53E-05,0.000174229,7.31E-05,MYB/TGFB1/CBX8/VIM/UCN,5
GO:0045980,BP,GO:0045980,negative regulation of nucleotide metabolic process,5/269,27/18888,0.185185185,13.00289137,7.501789164,3.53E-05,0.000174229,7.31E-05,TP53/PARP1/STAT3/GIT1/FBP1,5
GO:0051043,BP,GO:0051043,regulation of membrane protein ectodomain proteolysis,5/269,27/18888,0.185185185,13.00289137,7.501789164,3.53E-05,0.000174229,7.31E-05,TIMP1/IL1B/TNF/IL10/ROCK1,5
GO:0071480,BP,GO:0071480,cellular response to gamma radiation,5/269,27/18888,0.185185185,13.00289137,7.501789164,3.53E-05,0.000174229,7.31E-05,TP53/KDM1A/CHEK2/HRAS/CDKN1A,5
GO:0010828,BP,GO:0010828,positive regulation of glucose transmembrane transport,6/269,44/18888,0.136363636,9.57485637,6.84456889,3.54E-05,0.000174229,7.31E-05,MAPK14/RNASEL/AKT1/IRS1/IGF1/BRAF,6
GO:0071604,BP,GO:0071604,transforming growth factor beta production,6/269,44/18888,0.136363636,9.57485637,6.84456889,3.54E-05,0.000174229,7.31E-05,THBS1/PTGS2/MYB/HIF1A/SMAD3/FN1,6
GO:0120178,BP,GO:0120178,steroid hormone biosynthetic process,6/269,44/18888,0.136363636,9.57485637,6.84456889,3.54E-05,0.000174229,7.31E-05,SRD5A2/HSD3B1/HSD3B2/MED1/CYP17A1/CYP19A1,6
GO:1904037,BP,GO:1904037,positive regulation of epithelial cell apoptotic process,6/269,44/18888,0.136363636,9.57485637,6.84456889,3.54E-05,0.000174229,7.31E-05,THBS1/IL6/FASLG/TGFB1/BAX/AKR1C3,6
GO:1905521,BP,GO:1905521,regulation of macrophage migration,6/269,44/18888,0.136363636,9.57485637,6.84456889,3.54E-05,0.000174229,7.31E-05,THBS1/MMP14/MAPK1/PTK2/CD9/CYP19A1,6
GO:0000722,BP,GO:0000722,telomere maintenance via recombination,4/269,14/18888,0.285714286,20.06160382,8.575726771,3.60E-05,0.000176879,7.42E-05,BRCA2/XRCC1/ERCC1/XRCC3,4
GO:0034116,BP,GO:0034116,positive regulation of heterotypic cell-cell adhesion,4/269,14/18888,0.285714286,20.06160382,8.575726771,3.60E-05,0.000176879,7.42E-05,IL1B/CD44/TNF/IL10,4
GO:0051053,BP,GO:0051053,negative regulation of DNA metabolic process,10/269,142/18888,0.070422535,4.944761506,5.671397294,3.71E-05,0.000182045,7.63E-05,TP53/XRCC1/ERCC1/PARP1/TWIST1/GATA3/MLH1/MSH2/NBN/CDKN1A,10
GO:0042177,BP,GO:0042177,negative regulation of protein catabolic process,9/269,114/18888,0.078947368,5.543337899,5.848284758,3.71E-05,0.000182108,7.64E-05,TIMP1/RILP/RELA/SMAD3/IL10/EGFR/DAB2IP/ROCK1/FHIT,9
GO:0030595,BP,GO:0030595,leukocyte chemotaxis,13/269,237/18888,0.054852321,3.851489342,5.309752998,3.74E-05,0.000183141,7.68E-05,THBS1/CXCR2/IL6/EDNRB/IL1B/VEGFA/MAPK1/MMP2/PTK2/IL10/BSG/SERPINE1/CYP19A1,13
GO:0050435,BP,GO:0050435,amyloid-beta metabolic process,7/269,65/18888,0.107692308,7.561681441,6.369522172,3.78E-05,0.000184856,7.75E-05,CASP3/TNF/RELA/IGF1/MME/ROCK1/CLU,7
GO:0090303,BP,GO:0090303,positive regulation of wound healing,7/269,65/18888,0.107692308,7.561681441,6.369522172,3.78E-05,0.000184856,7.75E-05,THBS1/MTOR/PTK2/SERPINE1/HRAS/THBD/PLAU,7
GO:0007093,BP,GO:0007093,mitotic cell cycle checkpoint signaling,10/269,143/18888,0.06993007,4.910182754,5.641593711,3.94E-05,0.000192278,8.06E-05,TP53/BRCA1/CCND1/XRCC3/CDK2/CHEK2/MUC1/MSH2/NBN/CDKN1A,10
GO:2000243,BP,GO:2000243,positive regulation of reproductive process,8/269,89/18888,0.08988764,6.31151581,6.037060972,3.98E-05,0.00019402,8.14E-05,CTNNB1/AR/AURKA/EDNRB/DEFB1/VEGFA/WT1/BAX,8
GO:0014014,BP,GO:0014014,negative regulation of gliogenesis,6/269,45/18888,0.133333333,9.362081784,6.750331451,4.03E-05,0.000196109,8.22E-05,TP53/CTNNB1/SOX11/NOTCH1/RB1/ID4,6
GO:0030574,BP,GO:0030574,collagen catabolic process,6/269,45/18888,0.133333333,9.362081784,6.750331451,4.03E-05,0.000196109,8.22E-05,MMP14/MMP9/MMP2/MMP7/CTSB/MMP1,6
GO:0032881,BP,GO:0032881,regulation of polysaccharide metabolic process,6/269,45/18888,0.133333333,9.362081784,6.750331451,4.03E-05,0.000196109,8.22E-05,NFKB1/AKT1/TGFB1/IRS1/IGF1/IGF2,6
GO:0002440,BP,GO:0002440,production of molecular mediator of immune response,15/269,310/18888,0.048387097,3.39752968,5.115932597,4.10E-05,0.000199296,8.36E-05,KLK3/ERCC1/IL6/MAP3K7/IL1B/TLR4/TNF/TGFB1/IL10/TWIST1/GATA3/MLH1/MSH2/NBN/MYD88,15
GO:0010565,BP,GO:0010565,regulation of cellular ketone metabolic process,10/269,144/18888,0.069444444,4.876084263,5.612066029,4.18E-05,0.000202562,8.49E-05,BRCA1/PTGS2/IL1B/PPARG/AKT1/CAV1/FGFR4/IRS1/TWIST1/AKR1C3,10
GO:0050994,BP,GO:0050994,regulation of lipid catabolic process,7/269,66/18888,0.106060606,7.44711051,6.306431052,4.18E-05,0.000202562,8.49E-05,ALK/IL1B/PRKCD/TNF/AKT1/IRS1/TWIST1,7
GO:0003156,BP,GO:0003156,regulation of animal organ formation,5/269,28/18888,0.178571429,12.53850239,7.344074436,4.24E-05,0.000204536,8.58E-05,CTNNB1/AR/FGF2/WT1/FGFR1,5
GO:0032104,BP,GO:0032104,regulation of response to extracellular stimulus,5/269,28/18888,0.178571429,12.53850239,7.344074436,4.24E-05,0.000204536,8.58E-05,VDR/BAX/SNAI2/MED1/UCN,5
GO:0032107,BP,GO:0032107,regulation of response to nutrient levels,5/269,28/18888,0.178571429,12.53850239,7.344074436,4.24E-05,0.000204536,8.58E-05,VDR/BAX/SNAI2/MED1/UCN,5
GO:0032770,BP,GO:0032770,positive regulation of monooxygenase activity,5/269,28/18888,0.178571429,12.53850239,7.344074436,4.24E-05,0.000204536,8.58E-05,VDR/IL1B/HIF1A/TNF/AKT1,5
GO:0035116,BP,GO:0035116,embryonic hindlimb morphogenesis,5/269,28/18888,0.178571429,12.53850239,7.344074436,4.24E-05,0.000204536,8.58E-05,CTNNB1/NOTCH1/TWIST1/TP63/MED1,5
GO:1902749,BP,GO:1902749,regulation of cell cycle G2/M phase transition,9/269,116/18888,0.077586207,5.447763107,5.775569632,4.26E-05,0.000205208,8.61E-05,TP53/BRCA1/AURKA/CCND1/CDK4/CDK2/BRD4/NBN/CDKN1A,9
GO:0003018,BP,GO:0003018,vascular process in circulatory system,14/269,275/18888,0.050909091,3.574613045,5.169512357,4.28E-05,0.000205869,8.63E-05,CXCR2/GPX1/PTGS2/EDNRB/VEGFA/SOD2/TNF/RHOA/CAV1/TGFB1/MMP2/EGFR/UCN/ROCK1,14
GO:0002088,BP,GO:0002088,lens development in camera-type eye,8/269,90/18888,0.088888889,6.241387856,5.990887778,4.31E-05,0.000207033,8.68E-05,CTNNB1/SOX11/FGF2/TGFBR1/SMAD3/VIM/GATA3/MED1,8
GO:0007422,BP,GO:0007422,peripheral nervous system development,8/269,90/18888,0.088888889,6.241387856,5.990887778,4.31E-05,0.000207033,8.68E-05,ERBB2/ETV1/EDNRB/MAPK1/RELA/AKT1/ILK/HRAS,8
GO:0002819,BP,GO:0002819,regulation of adaptive immune response,12/269,207/18888,0.057971014,4.070470341,5.339117436,4.36E-05,0.000208723,8.75E-05,IL6/MAP3K7/IL1B/TNF/TGFB1/IL10/BRD2/BRD4/GATA3/CD274/MLH1/MSH2,12
GO:1902905,BP,GO:1902905,positive regulation of supramolecular fiber organization,11/269,175/18888,0.062857143,4.413552841,5.452973659,4.36E-05,0.000208723,8.75E-05,GPX1/TENM1/MTOR/RHOA/KATNB1/TGFBR1/SMAD3/GIT1/RB1/BRAF/CLU,11
GO:0033209,BP,GO:0033209,tumor necrosis factor-mediated signaling pathway,9/269,117/18888,0.076923077,5.401201029,5.739841317,4.56E-05,0.000217795,9.13E-05,TP53/CASP8/GSTP1/TNF/RELA/ILK/SPHK1/STAT1/NFKBIA,9
GO:1901989,BP,GO:1901989,positive regulation of cell cycle phase transition,9/269,117/18888,0.076923077,5.401201029,5.739841317,4.56E-05,0.000217795,9.13E-05,CCND1/CDK4/EZH2/AKT1/CYP1A1/EGFR/CUL3/BRD4/RB1,9
GO:0009746,BP,GO:0009746,response to hexose,12/269,208/18888,0.057692308,4.050900772,5.318029824,4.57E-05,0.000217795,9.13E-05,THBS1/GPX1/PTGS2/PIK3CA/CASP3/IGF1R/HIF1A/SMARCA4/TNF/HNF1B/SMAD3/PCSK1,12
GO:0050851,BP,GO:0050851,antigen receptor-mediated signaling pathway,12/269,208/18888,0.057692308,4.050900772,5.318029824,4.57E-05,0.000217795,9.13E-05,MAP3K7/PIK3CA/NFKB1/MAPK1/RELA/BAX/BRAF/HRAS/GATA3/CD8A/PAWR/NFKBIA,12
GO:0032635,BP,GO:0032635,interleukin-6 production,11/269,176/18888,0.0625,4.388475836,5.428502931,4.59E-05,0.000218495,9.16E-05,IL6/IL1B/STAT3/TLR4/TNF/RELA/TGFB1/IL10/TWIST1/UCN/MYD88,11
GO:0032675,BP,GO:0032675,regulation of interleukin-6 production,11/269,176/18888,0.0625,4.388475836,5.428502931,4.59E-05,0.000218495,9.16E-05,IL6/IL1B/STAT3/TLR4/TNF/RELA/TGFB1/IL10/TWIST1/UCN/MYD88,11
GO:0003002,BP,GO:0003002,regionalization,18/269,429/18888,0.041958042,2.946109652,4.900849005,4.67E-05,0.000221427,9.29E-05,TP53/CTNNB1/AR/AURKA/FGF2/NOTCH1/HIF1A/BMI1/HNF1B/TGFBR1/SMAD3/FOXA1/WT1/HHEX/SNAI1/NKX3-1/TP63/FGFR1,18
GO:0055017,BP,GO:0055017,cardiac muscle tissue growth,8/269,91/18888,0.087912088,6.172801177,5.945408034,4.67E-05,0.000221427,9.29E-05,MIR25/FGF2/NOTCH1/MAPK14/TGFBR1/IGF1/PIM1/FGFR1,8
GO:0060021,BP,GO:0060021,roof of mouth development,8/269,91/18888,0.087912088,6.172801177,5.945408034,4.67E-05,0.000221427,9.29E-05,SOX11/TGFBR1/COL11A2/SNAI1/SGPL1/TWIST1/SNAI2/TFAP2A,8
GO:1900542,BP,GO:1900542,regulation of purine nucleotide metabolic process,8/269,91/18888,0.087912088,6.172801177,5.945408034,4.67E-05,0.000221427,9.29E-05,TP53/PARP1/HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,8
GO:0030177,BP,GO:0030177,positive regulation of Wnt signaling pathway,10/269,146/18888,0.068493151,4.809288588,5.553819883,4.70E-05,0.000222612,9.34E-05,NFKB1/FGF2/SMARCA4/SMAD3/TGFB1/ILK/EGFR/HHEX/MIR145/LGR4,10
GO:0001711,BP,GO:0001711,endodermal cell fate commitment,4/269,15/18888,0.266666667,18.72416357,8.254112105,4.85E-05,0.000228165,9.57E-05,CTNNB1/HNF1B/SOX2/NANOG,4
GO:0003198,BP,GO:0003198,epithelial to mesenchymal transition involved in endocardial cushion formation,4/269,15/18888,0.266666667,18.72416357,8.254112105,4.85E-05,0.000228165,9.57E-05,NOTCH1/TGFBR1/SNAI1/SNAI2,4
GO:0006978,BP,GO:0006978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",4/269,15/18888,0.266666667,18.72416357,8.254112105,4.85E-05,0.000228165,9.57E-05,TP53/BRCA2/CHEK2/CDKN1A,4
GO:0010455,BP,GO:0010455,positive regulation of cell fate commitment,4/269,15/18888,0.266666667,18.72416357,8.254112105,4.85E-05,0.000228165,9.57E-05,FGF2/SPDEF/BRD2/BRD4,4
GO:0045725,BP,GO:0045725,positive regulation of glycogen biosynthetic process,4/269,15/18888,0.266666667,18.72416357,8.254112105,4.85E-05,0.000228165,9.57E-05,AKT1/IRS1/IGF1/IGF2,4
GO:2000671,BP,GO:2000671,regulation of motor neuron apoptotic process,4/269,15/18888,0.266666667,18.72416357,8.254112105,4.85E-05,0.000228165,9.57E-05,RHOA/BAX/MAP2K7/ROCK1,4
GO:2001028,BP,GO:2001028,positive regulation of endothelial cell chemotaxis,4/269,15/18888,0.266666667,18.72416357,8.254112105,4.85E-05,0.000228165,9.57E-05,VEGFA/FGF2/KDR/FGFR1,4
GO:0051783,BP,GO:0051783,regulation of nuclear division,10/269,147/18888,0.068027211,4.776572339,5.525092447,4.98E-05,0.000233966,9.81E-05,AURKA/IL1B/XRCC3/TNF/CUL3/RB1/TGFA/IGF1/SPHK1/IGF2,10
GO:0006140,BP,GO:0006140,regulation of nucleotide metabolic process,8/269,92/18888,0.086956522,6.105705512,5.900603214,5.05E-05,0.000237099,9.94E-05,TP53/PARP1/HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,8
GO:2000273,BP,GO:2000273,positive regulation of signaling receptor activity,5/269,29/18888,0.172413793,12.10614024,7.194196171,5.07E-05,0.000237502,9.96E-05,FBXW7/NCOA3/HIF1A/HDAC6/IL10,5
GO:0051055,BP,GO:0051055,negative regulation of lipid biosynthetic process,7/269,68/18888,0.102941176,7.228077848,6.184123206,5.08E-05,0.000237532,9.96E-05,BRCA1/FBXW7/NFKB1/SNAI1/SPHK1/SNAI2/AKR1C3,7
GO:2000144,BP,GO:2000144,positive regulation of DNA-templated transcription initiation,7/269,68/18888,0.102941176,7.228077848,6.184123206,5.08E-05,0.000237532,9.96E-05,TP53/ERCC1/NFKB1/HNF1B/TWIST1/NFKBIA/MED1,7
GO:0006509,BP,GO:0006509,membrane protein ectodomain proteolysis,6/269,47/18888,0.127659574,8.963695325,6.570388427,5.19E-05,0.000242357,0.000101631,TIMP1/IL1B/TNF/IL10/MMP7/ROCK1,6
GO:1901861,BP,GO:1901861,regulation of muscle tissue development,6/269,47/18888,0.127659574,8.963695325,6.570388427,5.19E-05,0.000242357,0.000101631,CTNNB1/SMAD3/TGFB1/TWIST1/IGF2/FGF3,6
GO:0090092,BP,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,15/269,317/18888,0.047318612,3.322505365,5.012428218,5.29E-05,0.000246709,0.000103456,TP53/THBS1/PPARG/PARP1/SOX11/NOTCH1/TWSG1/TGFBR1/SMAD3/TGFB1/ILK/HSPA5/PEG10/KDR/MIR145,15
GO:0001656,BP,GO:0001656,metanephros development,8/269,93/18888,0.086021505,6.040052764,5.856455485,5.46E-05,0.000254425,0.000106691,CTNNB1/CXCR2/MYC/HNF1B/WT1/NKX3-1/STAT1/LGR4,8
GO:1990778,BP,GO:1990778,protein localization to cell periphery,16/269,356/18888,0.04494382,3.155757905,4.935637948,5.52E-05,0.000257067,0.000107799,ERBB2/AR/MMP14/CDH1/SQSTM1/TNF/AKT1/CAV1/TGFB1/EPB41L3/BSG/EGFR/PKP3/HRAS/ROCK1/MAL,16
GO:0072655,BP,GO:0072655,establishment of protein localization to mitochondrion,9/269,120/18888,0.075,5.266171004,5.635070313,5.56E-05,0.000258611,0.000108447,FBXW7/BID/NPEPPS/BAP1/AKT1/BAX/AIFM1/HSP90AA1/BNIP3L,9
GO:0002673,BP,GO:0002673,regulation of acute inflammatory response,6/269,48/18888,0.125,8.776951673,6.484388454,5.86E-05,0.000270652,0.000113496,IL6/PTGS2/EDNRB/IL1B/GSTP1/TNF,6
GO:0031670,BP,GO:0031670,cellular response to nutrient,6/269,48/18888,0.125,8.776951673,6.484388454,5.86E-05,0.000270652,0.000113496,VDR/NCOA1/MTOR/SNAI2/PIM1/MED1,6
GO:0042311,BP,GO:0042311,vasodilation,6/269,48/18888,0.125,8.776951673,6.484388454,5.86E-05,0.000270652,0.000113496,GPX1/EDNRB/SOD2/TNF/EGFR/UCN,6
GO:0060043,BP,GO:0060043,regulation of cardiac muscle cell proliferation,6/269,48/18888,0.125,8.776951673,6.484388454,5.86E-05,0.000270652,0.000113496,FGF2/NOTCH1/MAPK14/TGFBR1/PIM1/FGFR1,6
GO:1902003,BP,GO:1902003,regulation of amyloid-beta formation,6/269,48/18888,0.125,8.776951673,6.484388454,5.86E-05,0.000270652,0.000113496,CASP3/TNF/RELA/IGF1/ROCK1/CLU,6
GO:1902041,BP,GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,6/269,48/18888,0.125,8.776951673,6.484388454,5.86E-05,0.000270652,0.000113496,BRCA1/THBS1/GPX1/SERPINE1/PMAIP1/MAL,6
GO:1902459,BP,GO:1902459,positive regulation of stem cell population maintenance,6/269,48/18888,0.125,8.776951673,6.484388454,5.86E-05,0.000270652,0.000113496,ARID1A/NCOA3/SMARCA4/SMARCA2/SMARCE1/TP63,6
GO:0001942,BP,GO:0001942,hair follicle development,8/269,94/18888,0.085106383,5.975796884,5.812947672,5.90E-05,0.000270834,0.000113572,CTNNB1/NOTCH1/TNF/RELA/EGFR/SNAI1/TP63/LGR4,8
GO:0019915,BP,GO:0019915,lipid storage,8/269,94/18888,0.085106383,5.975796884,5.812947672,5.90E-05,0.000270834,0.000113572,FBXW7/IL6/IL1B/NFKB1/PPARG/TNF/CAV1/NFKBIA,8
GO:0043367,BP,GO:0043367,"CD4-positive, alpha-beta T cell differentiation",8/269,94/18888,0.085106383,5.975796884,5.812947672,5.90E-05,0.000270834,0.000113572,IL6/MYB/STAT3/MTOR/BRD2/BRD4/BRAF/GATA3,8
GO:0043502,BP,GO:0043502,regulation of muscle adaptation,8/269,94/18888,0.085106383,5.975796884,5.812947672,5.90E-05,0.000270834,0.000113572,MIR25/PPARG/PARP1/NOTCH1/SMAD3/IGF1/MIR145/ROCK1,8
GO:0048704,BP,GO:0048704,embryonic skeletal system morphogenesis,8/269,94/18888,0.085106383,5.975796884,5.812947672,5.90E-05,0.000270834,0.000113572,CTNNB1/SOX11/MMP14/BMI1/TGFBR1/SMAD3/TWIST1/TFAP2A,8
GO:0046631,BP,GO:0046631,alpha-beta T cell activation,11/269,181/18888,0.060773481,4.267247222,5.308828134,5.92E-05,0.00027165,0.000113915,IL6/MYB/STAT3/MTOR/RHOA/TWSG1/BRD2/BRD4/BRAF/GATA3/CD274,11
GO:0120161,BP,GO:0120161,regulation of cold-induced thermogenesis,10/269,151/18888,0.066225166,4.650040621,5.412720443,6.25E-05,0.00028657,0.000120171,KDM1A/VEGFA/ID1/IGF1R/NOTCH1/SMARCA4/TLR4/CAV1/RB1/LGR4,10
GO:0045619,BP,GO:0045619,regulation of lymphocyte differentiation,12/269,215/18888,0.055813953,3.91901098,5.174011195,6.29E-05,0.000287624,0.000120613,ERBB2/MMP14/ARID1A/SMARCA4/SMARCA2/RHOA/IL10/BRD2/BRD4/SMARCE1/BRAF/GATA3,12
GO:0050866,BP,GO:0050866,negative regulation of cell activation,12/269,215/18888,0.055813953,3.91901098,5.174011195,6.29E-05,0.000287624,0.000120613,ERBB2/ALOX12/CASP3/SOX11/PRKCD/TWSG1/IL10/FN1/CD9/THBD/CD274/PAWR,12
GO:0030278,BP,GO:0030278,regulation of ossification,9/269,122/18888,0.073770492,5.179840332,5.567153624,6.33E-05,0.000288039,0.000120787,VDR/SOX11/NOTCH1/MAPK14/HIF1A/MAPK1/SMAD3/TWIST1/TFAP2A,9
GO:1904892,BP,GO:1904892,regulation of receptor signaling pathway via STAT,9/269,122/18888,0.073770492,5.179840332,5.567153624,6.33E-05,0.000288039,0.000120787,IL6/PPARG/NOTCH1/TNF/CAV1/TGFB1/IL10/VHL/IFNA1,9
GO:0033555,BP,GO:0033555,multicellular organismal response to stress,8/269,95/18888,0.084210526,5.912893759,5.770063233,6.36E-05,0.000288039,0.000120787,THBS1/PTEN/EDNRB/MTOR/AKT1/TAC1/GRPR/UCN,8
GO:0060395,BP,GO:0060395,SMAD protein signal transduction,8/269,95/18888,0.084210526,5.912893759,5.770063233,6.36E-05,0.000288039,0.000120787,PPARG/PARP1/FOS/TWSG1/TGFBR1/SMAD3/TGFB1/MIR145,8
GO:0007252,BP,GO:0007252,I-kappaB phosphorylation,4/269,16/18888,0.25,17.55390335,7.96215993,6.40E-05,0.000288039,0.000120787,MAP3K7/TLR4/TNF/AKT1,4
GO:0030214,BP,GO:0030214,hyaluronan catabolic process,4/269,16/18888,0.25,17.55390335,7.96215993,6.40E-05,0.000288039,0.000120787,CD44/FGF2/TGFB1/LYVE1,4
GO:0031649,BP,GO:0031649,heat generation,4/269,16/18888,0.25,17.55390335,7.96215993,6.40E-05,0.000288039,0.000120787,PTGS2/EDNRB/IL1B/TNF,4
GO:0034349,BP,GO:0034349,glial cell apoptotic process,4/269,16/18888,0.25,17.55390335,7.96215993,6.40E-05,0.000288039,0.000120787,TP53/CASP3/PRKCD/RB1,4
GO:0042772,BP,GO:0042772,"DNA damage response, signal transduction resulting in transcription",4/269,16/18888,0.25,17.55390335,7.96215993,6.40E-05,0.000288039,0.000120787,TP53/BRCA2/CHEK2/CDKN1A,4
GO:0045651,BP,GO:0045651,positive regulation of macrophage differentiation,4/269,16/18888,0.25,17.55390335,7.96215993,6.40E-05,0.000288039,0.000120787,CASP8/TGFB1/RB1/MIR145,4
GO:0051895,BP,GO:0051895,negative regulation of focal adhesion assembly,4/269,16/18888,0.25,17.55390335,7.96215993,6.40E-05,0.000288039,0.000120787,THBS1/PTEN/MMP14/DLC1,4
GO:0070230,BP,GO:0070230,positive regulation of lymphocyte apoptotic process,4/269,16/18888,0.25,17.55390335,7.96215993,6.40E-05,0.000288039,0.000120787,TP53/IL10/BAX/CD274,4
GO:0150118,BP,GO:0150118,negative regulation of cell-substrate junction organization,4/269,16/18888,0.25,17.55390335,7.96215993,6.40E-05,0.000288039,0.000120787,THBS1/PTEN/MMP14/DLC1,4
GO:1902065,BP,GO:1902065,response to L-glutamate,4/269,16/18888,0.25,17.55390335,7.96215993,6.40E-05,0.000288039,0.000120787,IGF1R/PCNA/TNF/AIFM1,4
GO:1903798,BP,GO:1903798,regulation of miRNA processing,4/269,16/18888,0.25,17.55390335,7.96215993,6.40E-05,0.000288039,0.000120787,TP53/IL6/STAT3/TGFB1,4
GO:2000696,BP,GO:2000696,regulation of epithelial cell differentiation involved in kidney development,4/269,16/18888,0.25,17.55390335,7.96215993,6.40E-05,0.000288039,0.000120787,CTNNB1/MMP9/GATA3/STAT1,4
GO:0007219,BP,GO:0007219,Notch signaling pathway,11/269,183/18888,0.06010929,4.220610641,5.262163844,6.54E-05,0.000294105,0.000123331,FBXW7/MMP14/NOTCH1/STAT3/HNF1B/AKT1/FOXA1/SNAI1/SNAI2/TP63/NFKBIA,11
GO:0014037,BP,GO:0014037,Schwann cell differentiation,6/269,49/18888,0.12244898,8.59783021,6.400857448,6.60E-05,0.000296112,0.000124173,ERBB2/MAPK1/RELA/AKT1/ILK/HRAS,6
GO:0035966,BP,GO:0035966,response to topologically incorrect protein,10/269,152/18888,0.065789474,4.619448249,5.385241461,6.61E-05,0.000296112,0.000124173,THBS1/CCND1/HDAC6/CAV1/CUL3/BAX/DAB2IP/HSPA5/HSP90AA1/CLU,10
GO:0044839,BP,GO:0044839,cell cycle G2/M phase transition,10/269,152/18888,0.065789474,4.619448249,5.385241461,6.61E-05,0.000296112,0.000124173,TP53/BRCA1/AURKA/CCND1/CDK4/CDK2/CHEK2/BRD4/NBN/CDKN1A,10
GO:0106106,BP,GO:0106106,cold-induced thermogenesis,10/269,152/18888,0.065789474,4.619448249,5.385241461,6.61E-05,0.000296112,0.000124173,KDM1A/VEGFA/ID1/IGF1R/NOTCH1/SMARCA4/TLR4/CAV1/RB1/LGR4,10
GO:0090559,BP,GO:0090559,regulation of membrane permeability,7/269,71/18888,0.098591549,6.922666108,6.009670845,6.72E-05,0.000300657,0.000126078,TP53/BID/MTOR/BAX/BNIP3/PMAIP1/BNIP3L,7
GO:0001838,BP,GO:0001838,embryonic epithelial tube formation,9/269,123/18888,0.073170732,5.137727809,5.533751385,6.75E-05,0.000301627,0.000126485,CTNNB1/CASP3/HIF1A/HNF1B/TGFB1/BRD2/DLC1/TWIST1/GATA3,9
GO:1903532,BP,GO:1903532,positive regulation of secretion by cell,14/269,288/18888,0.048611111,3.413258984,4.960473771,7.04E-05,0.000314527,0.000131895,IL1B/PPARG/SOX11/MYB/HIF1A/TLR4/TGFB1/EGFR/PCSK1/IGF1/NKX3-1/FGFR1/UCN/CYP19A1,14
GO:0060045,BP,GO:0060045,positive regulation of cardiac muscle cell proliferation,5/269,31/18888,0.161290323,11.32509893,6.915414596,7.08E-05,0.000316063,0.000132539,FGF2/NOTCH1/MAPK14/PIM1/FGFR1,5
GO:0050821,BP,GO:0050821,protein stabilization,12/269,218/18888,0.055045872,3.865079636,5.114135609,7.18E-05,0.000319989,0.000134185,TP53/PTEN/FBXW7/CTNND1/PRKCD/SMAD3/CHEK2/VHL/IGF1/HSP90AA1/PIM1/CLU,12
GO:0002286,BP,GO:0002286,T cell activation involved in immune response,9/269,124/18888,0.072580645,5.09629452,5.500710123,7.19E-05,0.000319989,0.000134185,TP53/IL6/MYB/STAT3/MTOR/BRD2/BRD4/GATA3/IFNA1,9
GO:1900076,BP,GO:1900076,regulation of cellular response to insulin stimulus,7/269,72/18888,0.097222222,6.826517968,5.953757482,7.35E-05,0.000326468,0.000136902,IL1B/PPARG/NCOA1/PRKCD/RELA/IRS1/IGF2,7
GO:1903578,BP,GO:1903578,regulation of ATP metabolic process,7/269,72/18888,0.097222222,6.826517968,5.953757482,7.35E-05,0.000326468,0.000136902,PARP1/HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,7
GO:1904888,BP,GO:1904888,cranial skeletal system development,7/269,72/18888,0.097222222,6.826517968,5.953757482,7.35E-05,0.000326468,0.000136902,CTNNB1/MMP14/TGFBR1/SMAD3/TWIST1/TP63/TFAP2A,7
GO:0022404,BP,GO:0022404,molting cycle process,8/269,97/18888,0.082474227,5.790978423,5.686101267,7.38E-05,0.000326768,0.000137028,CTNNB1/NOTCH1/TNF/RELA/EGFR/SNAI1/TP63/LGR4,8
GO:0022405,BP,GO:0022405,hair cycle process,8/269,97/18888,0.082474227,5.790978423,5.686101267,7.38E-05,0.000326768,0.000137028,CTNNB1/NOTCH1/TNF/RELA/EGFR/SNAI1/TP63/LGR4,8
GO:0051153,BP,GO:0051153,regulation of striated muscle cell differentiation,8/269,97/18888,0.082474227,5.790978423,5.686101267,7.38E-05,0.000326768,0.000137028,YBX1/MMP14/NOTCH1/MAPK14/MTOR/EZH2/TGFB1/IGF1,8
GO:0009299,BP,GO:0009299,mRNA transcription,6/269,50/18888,0.12,8.425873606,6.319673086,7.41E-05,0.00032731,0.000137255,TP53/VDR/PPARG/NCOA1/STAT3/MED1,6
GO:0022602,BP,GO:0022602,ovulation cycle process,6/269,50/18888,0.12,8.425873606,6.319673086,7.41E-05,0.00032731,0.000137255,CASP3/NOTCH1/MMP2/A2M/SGPL1/ESR1,6
GO:0051403,BP,GO:0051403,stress-activated MAPK cascade,6/269,50/18888,0.12,8.425873606,6.319673086,7.41E-05,0.00032731,0.000137255,MYC/MAP3K7/GSTP1/MAPK14/MAPK1/MAP2K7,6
GO:0061013,BP,GO:0061013,regulation of mRNA catabolic process,14/269,290/18888,0.048275862,3.389719267,4.929379067,7.58E-05,0.000334394,0.000140226,YBX1/MAPK14/RNASEL/PRKCD/AKT1/MIR200C/PKP1/PKP3/VIM/MIR145/MLH1/MIR130B/ROCK1/MYD88,14
GO:0046632,BP,GO:0046632,alpha-beta T cell differentiation,9/269,125/18888,0.072,5.055524164,5.468022775,7.65E-05,0.000336966,0.000141304,IL6/MYB/STAT3/MTOR/RHOA/BRD2/BRD4/BRAF/GATA3,9
GO:0030183,BP,GO:0030183,B cell differentiation,10/269,155/18888,0.064516129,4.530039573,5.304216116,7.79E-05,0.000342874,0.000143782,TP53/IL6/MMP14/EZH2/IL10/HHEX/BAX/MSH2/KLF6/IFNA1,10
GO:0070664,BP,GO:0070664,negative regulation of leukocyte proliferation,8/269,98/18888,0.081632653,5.731886807,5.644993539,7.94E-05,0.000349115,0.000146399,ERBB2/CASP3/SOX11/GSTP1/TWSG1/IL10/CD274/PAWR,8
GO:0051788,BP,GO:0051788,response to misfolded protein,4/269,17/18888,0.235294118,16.5213208,7.695469701,8.27E-05,0.000360698,0.000151256,HDAC6/CAV1/CUL3/CLU,4
GO:0060253,BP,GO:0060253,negative regulation of glial cell proliferation,4/269,17/18888,0.235294118,16.5213208,7.695469701,8.27E-05,0.000360698,0.000151256,TP53/SOX11/NOTCH1/RB1,4
GO:0070875,BP,GO:0070875,positive regulation of glycogen metabolic process,4/269,17/18888,0.235294118,16.5213208,7.695469701,8.27E-05,0.000360698,0.000151256,AKT1/IRS1/IGF1/IGF2,4
GO:0070920,BP,GO:0070920,regulation of regulatory ncRNA processing,4/269,17/18888,0.235294118,16.5213208,7.695469701,8.27E-05,0.000360698,0.000151256,TP53/IL6/STAT3/TGFB1,4
GO:0072540,BP,GO:0072540,T-helper 17 cell lineage commitment,4/269,17/18888,0.235294118,16.5213208,7.695469701,8.27E-05,0.000360698,0.000151256,IL6/STAT3/BRD2/BRD4,4
GO:0097396,BP,GO:0097396,response to interleukin-17,4/269,17/18888,0.235294118,16.5213208,7.695469701,8.27E-05,0.000360698,0.000151256,IL1B/NFKB1/NOTCH1/STAT3,4
GO:0097398,BP,GO:0097398,cellular response to interleukin-17,4/269,17/18888,0.235294118,16.5213208,7.695469701,8.27E-05,0.000360698,0.000151256,IL1B/NFKB1/NOTCH1/STAT3,4
GO:1901550,BP,GO:1901550,regulation of endothelial cell development,4/269,17/18888,0.235294118,16.5213208,7.695469701,8.27E-05,0.000360698,0.000151256,IL1B/VEGFA/TNF/ROCK1,4
GO:1903140,BP,GO:1903140,regulation of establishment of endothelial barrier,4/269,17/18888,0.235294118,16.5213208,7.695469701,8.27E-05,0.000360698,0.000151256,IL1B/VEGFA/TNF/ROCK1,4
GO:0006110,BP,GO:0006110,regulation of glycolytic process,6/269,51/18888,0.117647059,8.260660398,6.240721433,8.30E-05,0.000360969,0.00015137,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:0030811,BP,GO:0030811,regulation of nucleotide catabolic process,6/269,51/18888,0.117647059,8.260660398,6.240721433,8.30E-05,0.000360969,0.00015137,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:0033121,BP,GO:0033121,regulation of purine nucleotide catabolic process,6/269,51/18888,0.117647059,8.260660398,6.240721433,8.30E-05,0.000360969,0.00015137,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:0008361,BP,GO:0008361,regulation of cell size,11/269,188/18888,0.058510638,4.108360358,5.148360352,8.33E-05,0.000361919,0.000151768,PTEN/MAP3K7/KDM1A/VEGFA/CDH1/MTOR/HDAC6/RHOA/FN1/HSP90AA1/UCN,11
GO:0019217,BP,GO:0019217,regulation of fatty acid metabolic process,8/269,99/18888,0.080808081,5.67398896,5.60444873,8.53E-05,0.000369837,0.000155088,BRCA1/PTGS2/IL1B/PPARG/AKT1/CAV1/IRS1/TWIST1,8
GO:1901992,BP,GO:1901992,positive regulation of mitotic cell cycle phase transition,8/269,99/18888,0.080808081,5.67398896,5.60444873,8.53E-05,0.000369837,0.000155088,CCND1/CDK4/AKT1/CYP1A1/EGFR/CUL3/BRD4/RB1,8
GO:0021987,BP,GO:0021987,cerebral cortex development,9/269,127/18888,0.070866142,4.97590961,5.403682522,8.65E-05,0.000374173,0.000156907,CTNNB1/KDM1A/NCOA1/HIF1A/RHOA/EGFR/BAX/DAB2IP/BNIP3,9
GO:0070585,BP,GO:0070585,protein localization to mitochondrion,9/269,127/18888,0.070866142,4.97590961,5.403682522,8.65E-05,0.000374173,0.000156907,FBXW7/BID/NPEPPS/BAP1/AKT1/BAX/AIFM1/HSP90AA1/BNIP3L,9
GO:0042093,BP,GO:0042093,T-helper cell differentiation,7/269,74/18888,0.094594595,6.642017482,5.845062667,8.77E-05,0.000378955,0.000158912,IL6/MYB/STAT3/MTOR/BRD2/BRD4/GATA3,7
GO:0042593,BP,GO:0042593,glucose homeostasis,13/269,258/18888,0.050387597,3.537996023,4.933712256,8.90E-05,0.000384278,0.000161144,GPX1/IL6/PIK3CA/PPARG/IGF1R/HIF1A/STAT3/SMARCA4/AKT1/SMAD3/FOXA1/FGFR4/IRS1,13
GO:0048285,BP,GO:0048285,organelle fission,19/269,493/18888,0.038539554,2.706078406,4.613728176,8.94E-05,0.000385745,0.000161759,PTEN/AURKA/BRCA2/IL1B/PPARG/XRCC3/TNF/RHOA/KATNB1/CHEK2/CUL3/RB1/TGFA/KDR/IGF1/SPHK1/BNIP3/MLH1/IGF2,19
GO:0030902,BP,GO:0030902,hindbrain development,10/269,158/18888,0.063291139,4.444026163,5.225231677,9.14E-05,0.00039407,0.000165251,TP53/CTNNB1/XRCC1/IGF1R/NCOA1/FGF2/EZH2/HNF1B/DLC1/HSPA5,10
GO:0002220,BP,GO:0002220,innate immune response activating cell surface receptor signaling pathway,8/269,100/18888,0.08,5.617249071,5.564453032,9.16E-05,0.000394485,0.000165425,MAP3K7/TLR4/SQSTM1/RELA/MIR200C/DAB2IP/NFKBIA/MYD88,8
GO:0006275,BP,GO:0006275,regulation of DNA replication,9/269,128/18888,0.0703125,4.937035316,5.372016433,9.19E-05,0.000395287,0.000165761,TP53/CDK2/PCNA/EGFR/MEAF6/NBN/FGFR1/CDKN1A/UCN,9
GO:0033500,BP,GO:0033500,carbohydrate homeostasis,13/269,259/18888,0.05019305,3.524335807,4.916790373,9.25E-05,0.000397538,0.000166705,GPX1/IL6/PIK3CA/PPARG/IGF1R/HIF1A/STAT3/SMARCA4/AKT1/SMAD3/FOXA1/FGFR4/IRS1,13
GO:0010543,BP,GO:0010543,regulation of platelet activation,6/269,52/18888,0.115384615,8.101801544,6.163896208,9.28E-05,0.000397538,0.000166705,ALOX12/IL6/TLR4/PRKCD/CD9/THBD,6
GO:0101023,BP,GO:0101023,vascular endothelial cell proliferation,6/269,52/18888,0.115384615,8.101801544,6.163896208,9.28E-05,0.000397538,0.000166705,PPARG/FGF2/STAT3/SLC39A9/FGFR1/IGF2,6
GO:1905562,BP,GO:1905562,regulation of vascular endothelial cell proliferation,6/269,52/18888,0.115384615,8.101801544,6.163896208,9.28E-05,0.000397538,0.000166705,PPARG/FGF2/STAT3/SLC39A9/FGFR1/IGF2,6
GO:0010464,BP,GO:0010464,regulation of mesenchymal cell proliferation,5/269,33/18888,0.151515152,10.6387293,6.661053767,9.67E-05,0.000412357,0.000172919,CTNNB1/MYC/KDR/STAT1/FGFR1,5
GO:0010743,BP,GO:0010743,regulation of macrophage derived foam cell differentiation,5/269,33/18888,0.151515152,10.6387293,6.661053767,9.67E-05,0.000412357,0.000172919,NFKB1/PPARG/ALOX15B/MIR130B/NFKBIA,5
GO:0045648,BP,GO:0045648,positive regulation of erythrocyte differentiation,5/269,33/18888,0.151515152,10.6387293,6.661053767,9.67E-05,0.000412357,0.000172919,MAPK14/HIF1A/STAT3/STAT1/MED1,5
GO:0060055,BP,GO:0060055,angiogenesis involved in wound healing,5/269,33/18888,0.151515152,10.6387293,6.661053767,9.67E-05,0.000412357,0.000172919,GPX1/VEGFA/TNF/SERPINE1/KDR,5
GO:0060795,BP,GO:0060795,cell fate commitment involved in formation of primary germ layer,5/269,33/18888,0.151515152,10.6387293,6.661053767,9.67E-05,0.000412357,0.000172919,CTNNB1/HNF1B/SOX2/FGFR1/NANOG,5
GO:0072330,BP,GO:0072330,monocarboxylic acid biosynthetic process,12/269,225/18888,0.053333333,3.744832714,4.978469678,9.71E-05,0.000413751,0.000173504,BRCA1/AMACR/ALOX12/PTGS2/FASN/IL1B/GSTP1/ALOX15B/CYP1A1/FGFR4/AKR1C3/RBP1,12
GO:0048562,BP,GO:0048562,embryonic organ morphogenesis,14/269,297/18888,0.047138047,3.309826893,4.822649917,9.77E-05,0.000415888,0.0001744,CTNNB1/SOX11/MMP14/NOTCH1/HIF1A/MAPK1/BMI1/HNF1B/TGFBR1/SMAD3/TWIST1/GATA3/FGFR1/TFAP2A,14
GO:0032784,BP,GO:0032784,regulation of DNA-templated transcription elongation,8/269,101/18888,0.079207921,5.561632743,5.524993109,9.83E-05,0.000418078,0.000175318,CTNNB1/PARP1/ELL2/EZH2/CDK12/BRD4/VHL/MED1,8
GO:0002066,BP,GO:0002066,columnar/cuboidal epithelial cell development,6/269,53/18888,0.113207547,7.948937364,6.08909814,0.000103358,0.000438045,0.000183691,FASN/HIF1A/AKT1/SPDEF/CDKN1A/CLOCK,6
GO:0002204,BP,GO:0002204,somatic recombination of immunoglobulin genes involved in immune response,6/269,53/18888,0.113207547,7.948937364,6.08909814,0.000103358,0.000438045,0.000183691,ERCC1/TGFB1/IL10/MLH1/MSH2/NBN,6
GO:0002208,BP,GO:0002208,somatic diversification of immunoglobulins involved in immune response,6/269,53/18888,0.113207547,7.948937364,6.08909814,0.000103358,0.000438045,0.000183691,ERCC1/TGFB1/IL10/MLH1/MSH2/NBN,6
GO:0045190,BP,GO:0045190,isotype switching,6/269,53/18888,0.113207547,7.948937364,6.08909814,0.000103358,0.000438045,0.000183691,ERCC1/TGFB1/IL10/MLH1/MSH2/NBN,6
GO:0043393,BP,GO:0043393,regulation of protein binding,9/269,130/18888,0.069230769,4.861080927,5.309660693,0.000103534,0.000438384,0.000183833,AURKA/KDM1A/PRKCD/AKT1/MMP9/IL10/BAX/CDKN1A/ROCK1,9
GO:0002294,BP,GO:0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response",7/269,76/18888,0.092105263,6.467227548,5.740317513,0.000103961,0.000439781,0.000184419,IL6/MYB/STAT3/MTOR/BRD2/BRD4/GATA3,7
GO:0051235,BP,GO:0051235,maintenance of location,15/269,337/18888,0.044510386,3.125324038,4.731903684,0.000104974,0.00044208,0.000185383,FBXW7/IL6/IL1B/NFKB1/PPARG/FASLG/FGF2/TNF/AKT1/CAV1/IL10/TXN/BAX/HSPA5/NFKBIA,15
GO:0010544,BP,GO:0010544,negative regulation of platelet activation,4/269,18/18888,0.222222222,15.60346964,7.450506686,0.000105183,0.00044208,0.000185383,ALOX12/PRKCD/CD9/THBD,4
GO:0010715,BP,GO:0010715,regulation of extracellular matrix disassembly,4/269,18/18888,0.222222222,15.60346964,7.450506686,0.000105183,0.00044208,0.000185383,IL6/TGFB1/FSCN1/FGFR4,4
GO:0032930,BP,GO:0032930,positive regulation of superoxide anion generation,4/269,18/18888,0.222222222,15.60346964,7.450506686,0.000105183,0.00044208,0.000185383,GSTP1/PRKCD/TGFB1/EGFR,4
GO:0043117,BP,GO:0043117,positive regulation of vascular permeability,4/269,18/18888,0.222222222,15.60346964,7.450506686,0.000105183,0.00044208,0.000185383,CXCR2/VEGFA/TGFB1/UCN,4
GO:0043217,BP,GO:0043217,myelin maintenance,4/269,18/18888,0.222222222,15.60346964,7.450506686,0.000105183,0.00044208,0.000185383,PTEN/AKT1/EPB41L3/CLU,4
GO:0051917,BP,GO:0051917,regulation of fibrinolysis,4/269,18/18888,0.222222222,15.60346964,7.450506686,0.000105183,0.00044208,0.000185383,THBS1/SERPINE1/THBD/PLAU,4
GO:0000422,BP,GO:0000422,autophagy of mitochondrion,8/269,102/18888,0.078431373,5.507106932,5.486056083,0.000105349,0.000442367,0.000185503,TP53/FBXW7/HIF1A/HDAC6/SQSTM1/BNIP3/BNIP3L/CAMKK2,8
GO:0007264,BP,GO:0007264,small GTPase-mediated signal transduction,19/269,500/18888,0.038,2.668193309,4.544055045,0.000107466,0.000450842,0.000189057,TP53/ERBB2/FGF2/NOTCH1/CDK2/SQSTM1/RHOA/KRAS/CUL3/DLC1/GIT1/RB1/DAB2IP/IGF1/HRAS/CDKN1A/CDKN2A/FBP1/ROCK1,19
GO:0051450,BP,GO:0051450,myoblast proliferation,5/269,34/18888,0.147058824,10.3258255,6.541908209,0.00011202,0.000468224,0.000196346,CTNNB1/GPX1/MALAT1/FOS/IGF1,5
GO:0110110,BP,GO:0110110,positive regulation of animal organ morphogenesis,5/269,34/18888,0.147058824,10.3258255,6.541908209,0.00011202,0.000468224,0.000196346,CTNNB1/AR/FGF2/GATA3/FGFR1,5
GO:1902253,BP,GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,5/269,34/18888,0.147058824,10.3258255,6.541908209,0.00011202,0.000468224,0.000196346,TP53/MYC/KDM1A/CD44/MUC1,5
GO:2000677,BP,GO:2000677,regulation of transcription regulatory region DNA binding,5/269,34/18888,0.147058824,10.3258255,6.541908209,0.00011202,0.000468224,0.000196346,SOX11/RB1/IGF1/TWIST1/GATA3,5
GO:0070167,BP,GO:0070167,regulation of biomineral tissue development,8/269,103/18888,0.077669903,5.453639874,5.447629506,0.000112833,0.000470095,0.000197131,VDR/NOTCH1/HIF1A/SMAD3/TGFB1/TWIST1/TFAP2A/ROCK1,8
GO:0002287,BP,GO:0002287,alpha-beta T cell activation involved in immune response,7/269,77/18888,0.090909091,6.38323758,5.689346993,0.000112984,0.000470095,0.000197131,IL6/MYB/STAT3/MTOR/BRD2/BRD4/GATA3,7
GO:0002293,BP,GO:0002293,alpha-beta T cell differentiation involved in immune response,7/269,77/18888,0.090909091,6.38323758,5.689346993,0.000112984,0.000470095,0.000197131,IL6/MYB/STAT3/MTOR/BRD2/BRD4/GATA3,7
GO:0031016,BP,GO:0031016,pancreas development,7/269,77/18888,0.090909091,6.38323758,5.689346993,0.000112984,0.000470095,0.000197131,CTNNB1/IL6/HNF1B/AKT1/PCSK1/IGF2/CLOCK,7
GO:0045913,BP,GO:0045913,positive regulation of carbohydrate metabolic process,7/269,77/18888,0.090909091,6.38323758,5.689346993,0.000112984,0.000470095,0.000197131,NFKB1/MTOR/AKT1/IRS1/IGF1/PMAIP1/IGF2,7
GO:0010975,BP,GO:0010975,regulation of neuron projection development,18/269,460/18888,0.039130435,2.74756748,4.560928067,0.000113329,0.000471102,0.000197553,PTEN/ALK/KDM1A/VEGFA/IGF1R/CDH1/HDAC6/RHOA/EZH2/AKT1/KATNB1/MIR200C/FN1/DAB2IP/VIM/BRAF/GATA3/FGFR1,18
GO:0048705,BP,GO:0048705,skeletal system morphogenesis,12/269,229/18888,0.052401747,3.679420789,4.903361758,0.000114685,0.000476304,0.000199735,CTNNB1/SOX11/MMP14/MAPK14/BMI1/TGFBR1/SMAD3/MMP2/SGPL1/TWIST1/FGFR1/TFAP2A,12
GO:0010883,BP,GO:0010883,regulation of lipid storage,6/269,54/18888,0.111111111,7.80173482,6.01623438,0.000114904,0.000476777,0.000199933,FBXW7/IL6/NFKB1/PPARG/TNF/NFKBIA,6
GO:0007292,BP,GO:0007292,female gamete generation,10/269,163/18888,0.061349693,4.307706343,5.097876255,0.000118406,0.000490415,0.000205652,PTEN/CTNNB1/AURKA/BRCA2/ERCC1/AKT1/MMP2/IGF1/MLH1/ZFX,10
GO:0051017,BP,GO:0051017,actin filament bundle assembly,10/269,163/18888,0.061349693,4.307706343,5.097876255,0.000118406,0.000490415,0.000205652,MTOR/RHOA/TGFBR1/SMAD3/FSCN1/CUL3/DLC1/BRAF/PAWR/ROCK1,10
GO:0010389,BP,GO:0010389,regulation of G2/M transition of mitotic cell cycle,8/269,104/18888,0.076923077,5.401201029,5.40970135,0.000120752,0.000499677,0.000209536,BRCA1/AURKA/CCND1/CDK4/CDK2/BRD4/NBN/CDKN1A,8
GO:0000079,BP,GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,7/269,78/18888,0.08974359,6.301401201,5.639271836,0.000122633,0.000507003,0.000212608,PTEN/CCND1/AKT1/EGFR/HHEX/CDKN1A/CDKN2A,7
GO:0050731,BP,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,10/269,164/18888,0.06097561,4.28143984,5.07301923,0.00012454,0.000514417,0.000215717,TP53/FBXW7/IL6/CD44/VEGFA/MTOR/TNF/TGFB1/TGFA/IGF1,10
GO:0032386,BP,GO:0032386,regulation of intracellular transport,13/269,267/18888,0.048689139,3.41873773,4.784343622,0.000125412,0.000517551,0.000217032,PTGS2/IL1B/CDH1/MAPK14/TENM1/MAPK1/PRKCD/SMAD3/TGFB1/TXN/IFI27/HSP90AA1/SFN,13
GO:0042743,BP,GO:0042743,hydrogen peroxide metabolic process,6/269,55/18888,0.109090909,7.659885096,5.945217973,0.00012745,0.000524064,0.000219762,GPX1/SOD2/HDAC6/CYP1A1/EGFR/TXN,6
GO:0060425,BP,GO:0060425,lung morphogenesis,6/269,55/18888,0.109090909,7.659885096,5.945217973,0.00012745,0.000524064,0.000219762,CTNNB1/SOX11/MAPK1/TNF/KRAS/FOXA1,6
GO:0085029,BP,GO:0085029,extracellular matrix assembly,6/269,55/18888,0.109090909,7.659885096,5.945217973,0.00012745,0.000524064,0.000219762,PPARG/NOTCH1/TGFBR1/SMAD3/TGFB1/MIR145,6
GO:1902991,BP,GO:1902991,regulation of amyloid precursor protein catabolic process,6/269,55/18888,0.109090909,7.659885096,5.945217973,0.00012745,0.000524064,0.000219762,CASP3/TNF/RELA/IGF1/ROCK1/CLU,6
GO:0031507,BP,GO:0031507,heterochromatin formation,8/269,105/18888,0.076190476,5.34976102,5.372259982,0.000129124,0.000528795,0.000221746,BRCA1/MYC/CDKN2B-AS1/KDM1A/CDK2/EZH2/MBD2/RB1,8
GO:1901222,BP,GO:1901222,regulation of non-canonical NF-kappaB signal transduction,8/269,105/18888,0.076190476,5.34976102,5.372259982,0.000129124,0.000528795,0.000221746,MAP3K7/IL1B/TLR4/TNF/RELA/RHOA/EGFR/SPHK1,8
GO:0010614,BP,GO:0010614,negative regulation of cardiac muscle hypertrophy,5/269,35/18888,0.142857143,10.03080191,6.427610608,0.000129181,0.000528795,0.000221746,MIR25/PPARG/NOTCH1/SMAD3/MIR145,5
GO:0030224,BP,GO:0030224,monocyte differentiation,5/269,35/18888,0.142857143,10.03080191,6.427610608,0.000129181,0.000528795,0.000221746,MYC/FASN/PPARG/VEGFA/MED1,5
GO:0030947,BP,GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,5/269,35/18888,0.142857143,10.03080191,6.427610608,0.000129181,0.000528795,0.000221746,IL1B/HIF1A/MIR200C/HHEX/DAB2IP,5
GO:0035051,BP,GO:0035051,cardiocyte differentiation,10/269,165/18888,0.060606061,4.25549172,5.048359835,0.00013094,0.000534966,0.000224334,VEGFA/NOTCH1/MTOR/MAPK1/TGFB1/EGFR/WT1/IGF1/TWIST1/MIR145,10
GO:0002544,BP,GO:0002544,chronic inflammatory response,4/269,19/18888,0.210526316,14.7822344,7.224394348,0.000131745,0.000534966,0.000224334,THBS1/TNF/IL10/CYP19A1,4
GO:0006977,BP,GO:0006977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",4/269,19/18888,0.210526316,14.7822344,7.224394348,0.000131745,0.000534966,0.000224334,TP53/CHEK2/MUC1/CDKN1A,4
GO:0016202,BP,GO:0016202,regulation of striated muscle tissue development,4/269,19/18888,0.210526316,14.7822344,7.224394348,0.000131745,0.000534966,0.000224334,SMAD3/TGFB1/TWIST1/FGF3,4
GO:0031053,BP,GO:0031053,primary miRNA processing,4/269,19/18888,0.210526316,14.7822344,7.224394348,0.000131745,0.000534966,0.000224334,IL6/STAT3/SMAD3/TGFB1,4
GO:0060231,BP,GO:0060231,mesenchymal to epithelial transition,4/269,19/18888,0.210526316,14.7822344,7.224394348,0.000131745,0.000534966,0.000224334,CTNNB1/WT1/GATA3/STAT1,4
GO:0060977,BP,GO:0060977,coronary vasculature morphogenesis,4/269,19/18888,0.210526316,14.7822344,7.224394348,0.000131745,0.000534966,0.000224334,VEGFA/FGF2/NOTCH1/TGFBR1,4
GO:0070242,BP,GO:0070242,thymocyte apoptotic process,4/269,19/18888,0.210526316,14.7822344,7.224394348,0.000131745,0.000534966,0.000224334,TP53/HIF1A/CHEK2/BAX,4
GO:1904044,BP,GO:1904044,response to aldosterone,4/269,19/18888,0.210526316,14.7822344,7.224394348,0.000131745,0.000534966,0.000224334,PARP1/IGF1R/AIFM1/CDKN1A,4
GO:0042246,BP,GO:0042246,tissue regeneration,7/269,79/18888,0.088607595,6.221636629,5.590064164,0.000132941,0.000538862,0.000225968,GPX1/NOTCH1/EZH2/IGF1/CD9/SOX2/CDKN1A,7
GO:0045685,BP,GO:0045685,regulation of glial cell differentiation,7/269,79/18888,0.088607595,6.221636629,5.590064164,0.000132941,0.000538862,0.000225968,CTNNB1/IL6/NOTCH1/MTOR/RELA/TGFB1/ID4,7
GO:0002697,BP,GO:0002697,regulation of immune effector process,16/269,385/18888,0.041558442,2.918051465,4.570345166,0.000137512,0.000556818,0.000233498,KLK3/IL6/MAP3K7/IL1B/TLR4/TNF/TGFB1/IL10/A2M/BRD2/BRD4/TWIST1/GATA3/MLH1/MSH2/MYD88,16
GO:0062207,BP,GO:0062207,regulation of pattern recognition receptor signaling pathway,10/269,166/18888,0.060240964,4.229856228,5.023895168,0.000137616,0.000556818,0.000233498,PARP1/TLR4/SQSTM1/AKT1/CAV1/MIR200C/DAB2IP/LGR4/ESR1/MYD88,10
GO:0034205,BP,GO:0034205,amyloid-beta formation,6/269,56/18888,0.107142857,7.523101434,5.875967388,0.000141058,0.000570241,0.000239127,CASP3/TNF/RELA/IGF1/ROCK1/CLU,6
GO:1903556,BP,GO:1903556,negative regulation of tumor necrosis factor superfamily cytokine production,7/269,80/18888,0.0875,6.143866171,5.541697308,0.000143941,0.00058138,0.000243798,GSTP1/TLR4/IL10/IGF1/TWIST1/MC1R/CD274,7
GO:0061572,BP,GO:0061572,actin filament bundle organization,10/269,167/18888,0.05988024,4.204527747,4.999622393,0.000144577,0.000583429,0.000244657,MTOR/RHOA/TGFBR1/SMAD3/FSCN1/CUL3/DLC1/BRAF/PAWR/ROCK1,10
GO:0000086,BP,GO:0000086,G2/M transition of mitotic cell cycle,9/269,136/18888,0.066176471,4.646621474,5.129981469,0.000146176,0.000588841,0.000246926,BRCA1/AURKA/CCND1/CDK4/CDK2/CHEK2/BRD4/NBN/CDKN1A,9
GO:0030168,BP,GO:0030168,platelet activation,9/269,136/18888,0.066176471,4.646621474,5.129981469,0.000146176,0.000588841,0.000246926,ALOX12/IL6/PIK3CA/MAPK14/TLR4/PRKCD/ILK/CD9/THBD,9
GO:0002068,BP,GO:0002068,glandular epithelial cell development,5/269,36/18888,0.138888889,9.752168525,6.317825997,0.000148285,0.00059523,0.000249605,FASN/HIF1A/AKT1/SPDEF/CLOCK,5
GO:0032205,BP,GO:0032205,negative regulation of telomere maintenance,5/269,36/18888,0.138888889,9.752168525,6.317825997,0.000148285,0.00059523,0.000249605,TP53/XRCC1/ERCC1/PARP1/NBN,5
GO:0035137,BP,GO:0035137,hindlimb morphogenesis,5/269,36/18888,0.138888889,9.752168525,6.317825997,0.000148285,0.00059523,0.000249605,CTNNB1/NOTCH1/TWIST1/TP63/MED1,5
GO:0060317,BP,GO:0060317,cardiac epithelial to mesenchymal transition,5/269,36/18888,0.138888889,9.752168525,6.317825997,0.000148285,0.00059523,0.000249605,NOTCH1/TGFBR1/SNAI1/TWIST1/SNAI2,5
GO:0006402,BP,GO:0006402,mRNA catabolic process,15/269,348/18888,0.043103448,3.02653506,4.586362025,0.000149411,0.000599223,0.00025128,YBX1/MAPK14/RNASEL/PRKCD/AKT1/MIR200C/PKP1/PKP3/VIM/MIR145/ZHX2/MLH1/MIR130B/ROCK1/MYD88,15
GO:0003151,BP,GO:0003151,outflow tract morphogenesis,7/269,81/18888,0.086419753,6.068015971,5.494145749,0.000155668,0.000620987,0.000260407,CTNNB1/SOX11/VEGFA/NOTCH1/HIF1A/ILK/TWIST1,7
GO:0050810,BP,GO:0050810,regulation of steroid biosynthetic process,7/269,81/18888,0.086419753,6.068015971,5.494145749,0.000155668,0.000620987,0.000260407,NFKB1/IGF1R/TNF/FGFR4/SNAI1/SNAI2/AKR1C3,7
GO:1904029,BP,GO:1904029,regulation of cyclin-dependent protein kinase activity,7/269,81/18888,0.086419753,6.068015971,5.494145749,0.000155668,0.000620987,0.000260407,PTEN/CCND1/AKT1/EGFR/HHEX/CDKN1A/CDKN2A,7
GO:0031663,BP,GO:0031663,lipopolysaccharide-mediated signaling pathway,6/269,57/18888,0.105263158,7.391117198,5.808406088,0.000155792,0.000620987,0.000260407,MAPK14/TLR4/MAPK1/AKT1/NFKBIA/MYD88,6
GO:0046902,BP,GO:0046902,regulation of mitochondrial membrane permeability,6/269,57/18888,0.105263158,7.391117198,5.808406088,0.000155792,0.000620987,0.000260407,TP53/BID/BAX/BNIP3/PMAIP1/BNIP3L,6
GO:0061900,BP,GO:0061900,glial cell activation,6/269,57/18888,0.105263158,7.391117198,5.808406088,0.000155792,0.000620987,0.000260407,IL6/IL1B/TNF/EGFR/SPHK1/CLU,6
GO:0070542,BP,GO:0070542,response to fatty acid,6/269,57/18888,0.105263158,7.391117198,5.808406088,0.000155792,0.000620987,0.000260407,PTGS2/CDK4/PIK3CA/PCSK1/IRS1/AKR1C3,6
GO:0001776,BP,GO:0001776,leukocyte homeostasis,8/269,108/18888,0.074074074,5.201156547,5.262745915,0.000157162,0.000625355,0.000262238,CXCR2/IL6/CASP3/HIF1A/BAP1/AKT1/BAX/PMAIP1,8
GO:0031398,BP,GO:0031398,positive regulation of protein ubiquitination,8/269,108/18888,0.074074074,5.201156547,5.262745915,0.000157162,0.000625355,0.000262238,PTEN/FBXW7/KDM1A/BMI1/CAV1/CUL3/HSPA5/SPHK1,8
GO:1990845,BP,GO:1990845,adaptive thermogenesis,10/269,169/18888,0.059171598,4.154770023,4.95164145,0.000159393,0.000633676,0.000265728,KDM1A/VEGFA/ID1/IGF1R/NOTCH1/SMARCA4/TLR4/CAV1/RB1/LGR4,10
GO:0051767,BP,GO:0051767,nitric-oxide synthase biosynthetic process,4/269,20/18888,0.2,14.04312268,7.014764529,0.000162845,0.000642914,0.000269601,GSTP1/TLR4/KDR/STAT1,4
GO:0051769,BP,GO:0051769,regulation of nitric-oxide synthase biosynthetic process,4/269,20/18888,0.2,14.04312268,7.014764529,0.000162845,0.000642914,0.000269601,GSTP1/TLR4/KDR/STAT1,4
GO:0072567,BP,GO:0072567,chemokine (C-X-C motif) ligand 2 production,4/269,20/18888,0.2,14.04312268,7.014764529,0.000162845,0.000642914,0.000269601,TLR4/TNF/TGFB1/MYD88,4
GO:0090201,BP,GO:0090201,negative regulation of release of cytochrome c from mitochondria,4/269,20/18888,0.2,14.04312268,7.014764529,0.000162845,0.000642914,0.000269601,GPX1/AKT1/IGF1/CLU,4
GO:1902004,BP,GO:1902004,positive regulation of amyloid-beta formation,4/269,20/18888,0.2,14.04312268,7.014764529,0.000162845,0.000642914,0.000269601,CASP3/TNF/RELA/CLU,4
GO:2000269,BP,GO:2000269,regulation of fibroblast apoptotic process,4/269,20/18888,0.2,14.04312268,7.014764529,0.000162845,0.000642914,0.000269601,TP53/PIK3CA/BID/TP63,4
GO:2000341,BP,GO:2000341,regulation of chemokine (C-X-C motif) ligand 2 production,4/269,20/18888,0.2,14.04312268,7.014764529,0.000162845,0.000642914,0.000269601,TLR4/TNF/TGFB1/MYD88,4
GO:2000679,BP,GO:2000679,positive regulation of transcription regulatory region DNA binding,4/269,20/18888,0.2,14.04312268,7.014764529,0.000162845,0.000642914,0.000269601,RB1/IGF1/TWIST1/GATA3,4
GO:0051047,BP,GO:0051047,positive regulation of secretion,14/269,312/18888,0.044871795,3.150700601,4.604268125,0.000163623,0.000645424,0.000270654,IL1B/PPARG/SOX11/MYB/HIF1A/TLR4/TGFB1/EGFR/PCSK1/IGF1/NKX3-1/FGFR1/UCN/CYP19A1,14
GO:0007389,BP,GO:0007389,pattern specification process,18/269,474/18888,0.037974684,2.666415698,4.416496634,0.000164418,0.000648002,0.000271735,TP53/CTNNB1/AR/AURKA/FGF2/NOTCH1/HIF1A/BMI1/HNF1B/TGFBR1/SMAD3/FOXA1/WT1/HHEX/SNAI1/NKX3-1/TP63/FGFR1,18
GO:0032760,BP,GO:0032760,positive regulation of tumor necrosis factor production,8/269,109/18888,0.073394495,5.153439514,5.227142773,0.000167553,0.000659785,0.000276676,THBS1/IL6/STAT3/TLR4/TGFB1/TWIST1/MYD88/CLU,8
GO:1902903,BP,GO:1902903,regulation of supramolecular fiber organization,16/269,392/18888,0.040816327,2.865943403,4.487268391,0.000168876,0.000663343,0.000278168,GPX1/PIK3CA/TENM1/MTOR/HDAC6/PRKCD/RHOA/KATNB1/TGFBR1/SMAD3/DLC1/GIT1/RB1/BRAF/ROCK1/CLU,16
GO:0008207,BP,GO:0008207,C21-steroid hormone metabolic process,5/269,37/18888,0.135135135,9.488596403,6.212251144,0.000169476,0.000663343,0.000278168,HSD3B1/EDNRB/HSD3B2/AKR1C3/CYP17A1,5
GO:0014741,BP,GO:0014741,negative regulation of muscle hypertrophy,5/269,37/18888,0.135135135,9.488596403,6.212251144,0.000169476,0.000663343,0.000278168,MIR25/PPARG/NOTCH1/SMAD3/MIR145,5
GO:0033280,BP,GO:0033280,response to vitamin D,5/269,37/18888,0.135135135,9.488596403,6.212251144,0.000169476,0.000663343,0.000278168,VDR/PTGS2/SNAI2/PIM1/MED1,5
GO:0046326,BP,GO:0046326,positive regulation of glucose import,5/269,37/18888,0.135135135,9.488596403,6.212251144,0.000169476,0.000663343,0.000278168,MAPK14/RNASEL/AKT1/IRS1/IGF1,5
GO:0048730,BP,GO:0048730,epidermis morphogenesis,5/269,37/18888,0.135135135,9.488596403,6.212251144,0.000169476,0.000663343,0.000278168,CTNNB1/NOTCH1/KLK14/SNAI1/TP63,5
GO:0071276,BP,GO:0071276,cellular response to cadmium ion,5/269,37/18888,0.135135135,9.488596403,6.212251144,0.000169476,0.000663343,0.000278168,MAPK1/FOS/AKT1/MMP9/EGFR,5
GO:0120032,BP,GO:0120032,regulation of plasma membrane bounded cell projection assembly,11/269,204/18888,0.053921569,3.786136016,4.809079128,0.000171657,0.000668669,0.000280401,PIK3CA/TENM1/MTOR/PRKCD/AKT1/TGFBR1/CAV1/FSCN1/HSP90AA1/HRAS/MIEN1,11
GO:0002381,BP,GO:0002381,immunoglobulin production involved in immunoglobulin-mediated immune response,6/269,58/18888,0.103448276,7.263684143,5.742462139,0.000171717,0.000668669,0.000280401,ERCC1/TGFB1/IL10/MLH1/MSH2/NBN,6
GO:0019369,BP,GO:0019369,arachidonic acid metabolic process,6/269,58/18888,0.103448276,7.263684143,5.742462139,0.000171717,0.000668669,0.000280401,ALOX12/GPX1/PTGS2/ALOX15B/CYP1A1/AKR1C3,6
GO:0031638,BP,GO:0031638,zymogen activation,6/269,58/18888,0.103448276,7.263684143,5.742462139,0.000171717,0.000668669,0.000280401,THBS1/CASP8/MMP14/SERPINE1/THBD/PLAU,6
GO:0032786,BP,GO:0032786,"positive regulation of DNA-templated transcription, elongation",6/269,58/18888,0.103448276,7.263684143,5.742462139,0.000171717,0.000668669,0.000280401,CTNNB1/PARP1/ELL2/CDK12/BRD4/MED1,6
GO:0043331,BP,GO:0043331,response to dsRNA,6/269,58/18888,0.103448276,7.263684143,5.742462139,0.000171717,0.000668669,0.000280401,NFKB1/MAPK1/CAV1/PMAIP1/NFKBIA/IFNA1,6
GO:0042116,BP,GO:0042116,macrophage activation,8/269,110/18888,0.072727273,5.106590064,5.191973671,0.000178502,0.000693905,0.000290984,THBS1/IL6/TLR4/TNF/IL10/SPHK1/MIR145/CLU,8
GO:0048477,BP,GO:0048477,oogenesis,8/269,110/18888,0.072727273,5.106590064,5.191973671,0.000178502,0.000693905,0.000290984,CTNNB1/AURKA/BRCA2/ERCC1/AKT1/IGF1/MLH1/ZFX,8
GO:0140014,BP,GO:0140014,mitotic nuclear division,13/269,277/18888,0.046931408,3.295317596,4.625697944,0.000180338,0.000700442,0.000293725,AURKA/IL1B/XRCC3/TNF/RHOA/KATNB1/CHEK2/CUL3/RB1/TGFA/IGF1/SPHK1/IGF2,13
GO:0006289,BP,GO:0006289,nucleotide-excision repair,7/269,83/18888,0.084337349,5.921798719,5.401391795,0.000181441,0.000704128,0.000295271,TP53/BRCA2/ERCC1/ARID1A/SMARCA4/SMARCA2/SMARCE1,7
GO:0009266,BP,GO:0009266,response to temperature stimulus,10/269,172/18888,0.058139535,4.082303104,4.881041532,0.000184004,0.000712859,0.000298932,THBS1/PTGS2/MTOR/HDAC6/AKT1/IGF1/HSP90AA1/CDKN1A/NFKBIA/MAP2K7,10
GO:0009267,BP,GO:0009267,cellular response to starvation,10/269,172/18888,0.058139535,4.082303104,4.881041532,0.000184004,0.000712859,0.000298932,TP53/IGF1R/MTOR/MAPK1/FOS/HSPA5/PMAIP1/AKR1C3/CDKN1A/NPRL2,10
GO:0002274,BP,GO:0002274,myeloid leukocyte activation,12/269,241/18888,0.049792531,3.496213115,4.687757643,0.000184871,0.000715609,0.000300086,THBS1/CXCR2/IL6/TLR4/PRKCD/TNF/IL10/FN1/SPHK1/MIR145/MYD88/CLU,12
GO:0007611,BP,GO:0007611,learning or memory,13/269,278/18888,0.04676259,3.283463935,4.610232441,0.000186823,0.000722255,0.000302873,PTEN/PTGS2/CASP3/HIF1A/MAPK1/FOS/KRAS/EGFR/GIT1/BRAF/GRPR/MME/UCN,13
GO:0060491,BP,GO:0060491,regulation of cell projection assembly,11/269,206/18888,0.053398058,3.749377414,4.769092446,0.000186905,0.000722255,0.000302873,PIK3CA/TENM1/MTOR/PRKCD/AKT1/TGFBR1/CAV1/FSCN1/HSP90AA1/HRAS/MIEN1,11
GO:0031098,BP,GO:0031098,stress-activated protein kinase signaling cascade,6/269,59/18888,0.101694915,7.140570852,5.678067867,0.000188901,0.000728731,0.000305588,MYC/MAP3K7/GSTP1/MAPK14/MAPK1/MAP2K7,6
GO:0043616,BP,GO:0043616,keratinocyte proliferation,6/269,59/18888,0.101694915,7.140570852,5.678067867,0.000188901,0.000728731,0.000305588,VDR/SNAI2/TP63/CDKN1A/MED1/SFN,6
GO:0030038,BP,GO:0030038,contractile actin filament bundle assembly,8/269,111/18888,0.072072072,5.060584748,5.15722904,0.000190033,0.000731244,0.000306642,MTOR/RHOA/TGFBR1/SMAD3/CUL3/DLC1/BRAF/ROCK1,8
GO:0043149,BP,GO:0043149,stress fiber assembly,8/269,111/18888,0.072072072,5.060584748,5.15722904,0.000190033,0.000731244,0.000306642,MTOR/RHOA/TGFBR1/SMAD3/CUL3/DLC1/BRAF/ROCK1,8
GO:0120034,BP,GO:0120034,positive regulation of plasma membrane bounded cell projection assembly,8/269,111/18888,0.072072072,5.060584748,5.15722904,0.000190033,0.000731244,0.000306642,PIK3CA/TENM1/MTOR/TGFBR1/FSCN1/HSP90AA1/HRAS/MIEN1,8
GO:0070828,BP,GO:0070828,heterochromatin organization,9/269,141/18888,0.063829787,4.481847663,4.988073989,0.000192092,0.000738542,0.000309702,BRCA1/MYC/CDKN2B-AS1/KDM1A/CDK2/EZH2/MBD2/RB1/SNAI1,9
GO:0034391,BP,GO:0034391,regulation of smooth muscle cell apoptotic process,5/269,38/18888,0.131578947,9.238896498,6.110610785,0.000192902,0.000741031,0.000310746,PPARG/SOD2/IGF1/CDKN2A/ESR1,5
GO:0002437,BP,GO:0002437,inflammatory response to antigenic stimulus,7/269,84/18888,0.083333333,5.851301115,5.356143545,0.000195563,0.00075062,0.000314767,CXCR2/GPX1/NOTCH1/MAPK14/TNF/IL10/A2M,7
GO:0032928,BP,GO:0032928,regulation of superoxide anion generation,4/269,21/18888,0.19047619,13.37440255,6.819647338,0.000198919,0.000761576,0.000319362,GSTP1/PRKCD/TGFB1/EGFR,4
GO:0032986,BP,GO:0032986,protein-DNA complex disassembly,4/269,21/18888,0.19047619,13.37440255,6.819647338,0.000198919,0.000761576,0.000319362,MYC/ARID1A/SMARCA4/SMARCE1,4
GO:0097049,BP,GO:0097049,motor neuron apoptotic process,4/269,21/18888,0.19047619,13.37440255,6.819647338,0.000198919,0.000761576,0.000319362,RHOA/BAX/MAP2K7/ROCK1,4
GO:0007259,BP,GO:0007259,receptor signaling pathway via JAK-STAT,10/269,174/18888,0.057471264,4.035380079,4.834859359,0.000202127,0.000773209,0.00032424,IL6/NOTCH1/STAT3/TNF/CAV1/IL10/VHL/IGF1/STAT1/IFNA1,10
GO:0043030,BP,GO:0043030,regulation of macrophage activation,6/269,60/18888,0.1,7.021561338,5.615159528,0.000207413,0.000790774,0.000331606,THBS1/IL6/TLR4/IL10/SPHK1/MIR145,6
GO:0046324,BP,GO:0046324,regulation of glucose import,6/269,60/18888,0.1,7.021561338,5.615159528,0.000207413,0.000790774,0.000331606,MAPK14/RNASEL/TNF/AKT1/IRS1/IGF1,6
GO:0060038,BP,GO:0060038,cardiac muscle cell proliferation,6/269,60/18888,0.1,7.021561338,5.615159528,0.000207413,0.000790774,0.000331606,FGF2/NOTCH1/MAPK14/TGFBR1/PIM1/FGFR1,6
GO:0071168,BP,GO:0071168,protein localization to chromatin,6/269,60/18888,0.1,7.021561338,5.615159528,0.000207413,0.000790774,0.000331606,PARP1/EZH2/BRD3/BRD2/MSH2/ESR1,6
GO:0002292,BP,GO:0002292,T cell differentiation involved in immune response,7/269,85/18888,0.082352941,5.782462279,5.311618774,0.000210559,0.000802097,0.000336354,IL6/MYB/STAT3/MTOR/BRD2/BRD4/GATA3,7
GO:0050671,BP,GO:0050671,positive regulation of lymphocyte proliferation,9/269,143/18888,0.062937063,4.419164479,4.933154799,0.000213543,0.000812785,0.000340836,IL6/IL1B/TLR4/BMI1/IGF1/CD274/CDKN1A/IGF2/MYD88,9
GO:0006766,BP,GO:0006766,vitamin metabolic process,8/269,113/18888,0.07079646,4.971016877,5.088976389,0.000214935,0.000816716,0.000342484,NFKB1/TNF/CYP1A1/SNAI1/SNAI2/AKR1C3/FGFR1/RBP1,8
GO:1903557,BP,GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,8/269,113/18888,0.07079646,4.971016877,5.088976389,0.000214935,0.000816716,0.000342484,THBS1/IL6/STAT3/TLR4/TGFB1/TWIST1/MYD88/CLU,8
GO:0016233,BP,GO:0016233,telomere capping,5/269,39/18888,0.128205128,9.002001716,6.012654383,0.000218718,0.000827642,0.000347066,XRCC1/ERCC1/MAPK1/NBN/MAP2K7,5
GO:0032350,BP,GO:0032350,regulation of hormone metabolic process,5/269,39/18888,0.128205128,9.002001716,6.012654383,0.000218718,0.000827642,0.000347066,NFKB1/IGF1R/HIF1A/AKR1C3/GATA3,5
GO:0033028,BP,GO:0033028,myeloid cell apoptotic process,5/269,39/18888,0.128205128,9.002001716,6.012654383,0.000218718,0.000827642,0.000347066,CXCR2/IL6/BAP1/SNAI2/CDKN2A,5
GO:0034390,BP,GO:0034390,smooth muscle cell apoptotic process,5/269,39/18888,0.128205128,9.002001716,6.012654383,0.000218718,0.000827642,0.000347066,PPARG/SOD2/IGF1/CDKN2A/ESR1,5
GO:0097242,BP,GO:0097242,amyloid-beta clearance,5/269,39/18888,0.128205128,9.002001716,6.012654383,0.000218718,0.000827642,0.000347066,IGF1R/TNF/MME/ROCK1/CLU,5
GO:0046887,BP,GO:0046887,positive regulation of hormone secretion,9/269,144/18888,0.0625,4.388475836,4.906072429,0.000224994,0.000850681,0.000356727,PPARG/SOX11/MYB/HIF1A/EGFR/NKX3-1/FGFR1/UCN/CYP19A1,9
GO:0050890,BP,GO:0050890,cognition,14/269,322/18888,0.043478261,3.052852756,4.465869385,0.000226469,0.000854842,0.000358472,PTEN/PTGS2/CASP3/HIF1A/MAPK1/FOS/TNF/KRAS/EGFR/GIT1/BRAF/GRPR/MME/UCN,14
GO:0048864,BP,GO:0048864,stem cell development,7/269,86/18888,0.081395349,5.715224345,5.267796828,0.000226469,0.000854842,0.000358472,EDNRB/FGF2/HIF1A/MAPK1/FN1/TWIST1/SNAI2,7
GO:0000423,BP,GO:0000423,mitophagy,6/269,61/18888,0.098360656,6.906453775,5.553677027,0.000227327,0.000855952,0.000358937,TP53/FBXW7/HIF1A/HDAC6/SQSTM1/BNIP3L,6
GO:0016447,BP,GO:0016447,somatic recombination of immunoglobulin gene segments,6/269,61/18888,0.098360656,6.906453775,5.553677027,0.000227327,0.000855952,0.000358937,ERCC1/TGFB1/IL10/MLH1/MSH2/NBN,6
GO:0045599,BP,GO:0045599,negative regulation of fat cell differentiation,6/269,61/18888,0.098360656,6.906453775,5.553677027,0.000227327,0.000855952,0.000358937,IL6/SOD2/TNF/SMAD3/TGFB1/ID4,6
GO:0042752,BP,GO:0042752,regulation of circadian rhythm,8/269,114/18888,0.070175439,4.927411465,5.055450667,0.000228354,0.000859108,0.000360261,TP53/FBXW7/PPARG/PARP1/MTOR/EZH2/PER1/CLOCK,8
GO:0017015,BP,GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,10/269,177/18888,0.056497175,3.966983807,4.766864027,0.00023211,0.000872521,0.000365885,TP53/THBS1/PPARG/SOX11/TWSG1/SMAD3/TGFB1/HSPA5/PEG10/MIR145,10
GO:0090090,BP,GO:0090090,negative regulation of canonical Wnt signaling pathway,9/269,145/18888,0.062068966,4.358210486,4.879235903,0.000236949,0.000889975,0.000373205,CTNNB1/CTNND1/NOTCH1/MAPK14/LZTS2/CAV1/DAB2IP/SNAI2/SOX2,9
GO:0006401,BP,GO:0006401,RNA catabolic process,16/269,404/18888,0.03960396,2.780816372,4.349018914,0.000237264,0.000890423,0.000373392,YBX1/MALAT1/MAPK14/RNASEL/PRKCD/AKT1/MIR200C/PKP1/PKP3/VIM/MIR145/ZHX2/MLH1/MIR130B/ROCK1/MYD88,16
GO:0001759,BP,GO:0001759,organ induction,4/269,22/18888,0.181818182,12.76647516,6.637388857,0.000240414,0.000897074,0.000376182,CTNNB1/AR/FGF2/FGFR1,4
GO:0010888,BP,GO:0010888,negative regulation of lipid storage,4/269,22/18888,0.181818182,12.76647516,6.637388857,0.000240414,0.000897074,0.000376182,IL6/PPARG/TNF/NFKBIA,4
GO:0048485,BP,GO:0048485,sympathetic nervous system development,4/269,22/18888,0.181818182,12.76647516,6.637388857,0.000240414,0.000897074,0.000376182,CTNNB1/SOX11/GATA3/TP63,4
GO:0060444,BP,GO:0060444,branching involved in mammary gland duct morphogenesis,4/269,22/18888,0.181818182,12.76647516,6.637388857,0.000240414,0.000897074,0.000376182,AR/VDR/MED1/ESR1,4
GO:0071305,BP,GO:0071305,cellular response to vitamin D,4/269,22/18888,0.181818182,12.76647516,6.637388857,0.000240414,0.000897074,0.000376182,VDR/SNAI2/PIM1/MED1,4
GO:0072111,BP,GO:0072111,cell proliferation involved in kidney development,4/269,22/18888,0.181818182,12.76647516,6.637388857,0.000240414,0.000897074,0.000376182,MYC/WT1/GATA3/STAT1,4
GO:1903054,BP,GO:1903054,negative regulation of extracellular matrix organization,4/269,22/18888,0.181818182,12.76647516,6.637388857,0.000240414,0.000897074,0.000376182,PPARG/NOTCH1/TGFB1/MIR145,4
GO:0033559,BP,GO:0033559,unsaturated fatty acid metabolic process,8/269,115/18888,0.069565217,4.884564409,5.022313993,0.000242452,0.000903936,0.000379059,ALOX12/GPX1/PTGS2/IL1B/GSTP1/ALOX15B/CYP1A1/AKR1C3,8
GO:0008543,BP,GO:0008543,fibroblast growth factor receptor signaling pathway,7/269,87/18888,0.08045977,5.649532111,5.224657879,0.000243335,0.000905745,0.000379818,THBS1/CTNNB1/FGF2/FGFR4/GATA3/FGFR1/FGF3,7
GO:0033077,BP,GO:0033077,T cell differentiation in thymus,7/269,87/18888,0.08045977,5.649532111,5.224657879,0.000243335,0.000905745,0.000379818,TP53/CTNNB1/ERBB2/IL1B/BMI1/BRAF/GATA3,7
GO:0008210,BP,GO:0008210,estrogen metabolic process,5/269,40/18888,0.125,8.776951673,5.918153339,0.000247082,0.000916698,0.000384411,HSD3B1/UGT2B17/CYP1A1/SGPL1/CYP19A1,5
GO:0030513,BP,GO:0030513,positive regulation of BMP signaling pathway,5/269,40/18888,0.125,8.776951673,5.918153339,0.000247082,0.000916698,0.000384411,SOX11/NOTCH1/TWSG1/ILK/KDR,5
GO:0045923,BP,GO:0045923,positive regulation of fatty acid metabolic process,5/269,40/18888,0.125,8.776951673,5.918153339,0.000247082,0.000916698,0.000384411,PTGS2/IL1B/PPARG/IRS1/TWIST1,5
GO:0062098,BP,GO:0062098,regulation of programmed necrotic cell death,5/269,40/18888,0.125,8.776951673,5.918153339,0.000247082,0.000916698,0.000384411,TP53/CASP8/PARP1/CAV1/AIFM1,5
GO:0002763,BP,GO:0002763,positive regulation of myeloid leukocyte differentiation,6/269,62/18888,0.096774194,6.79505936,5.493563649,0.000248715,0.000921258,0.000386323,CASP8/FOS/TNF/TGFB1/RB1/MIR145,6
GO:0060261,BP,GO:0060261,positive regulation of transcription initiation by RNA polymerase II,6/269,62/18888,0.096774194,6.79505936,5.493563649,0.000248715,0.000921258,0.000386323,TP53/ERCC1/NFKB1/HNF1B/NFKBIA/MED1,6
GO:0032946,BP,GO:0032946,positive regulation of mononuclear cell proliferation,9/269,146/18888,0.061643836,4.328359729,4.85264112,0.000249427,0.000922395,0.0003868,IL6/IL1B/TLR4/BMI1/IGF1/CD274/CDKN1A/IGF2/MYD88,9
GO:0050852,BP,GO:0050852,T cell receptor signaling pathway,9/269,146/18888,0.061643836,4.328359729,4.85264112,0.000249427,0.000922395,0.0003868,MAP3K7/PIK3CA/MAPK1/RELA/BRAF/HRAS/GATA3/CD8A/PAWR,9
GO:0006368,BP,GO:0006368,transcription elongation by RNA polymerase II,8/269,116/18888,0.068965517,4.842456095,4.989558167,0.000257255,0.0009498,0.000398292,CTNNB1/PARP1/ELL2/EZH2/CDK12/BRD4/VHL/MED1,8
GO:0044344,BP,GO:0044344,cellular response to fibroblast growth factor stimulus,8/269,116/18888,0.068965517,4.842456095,4.989558167,0.000257255,0.0009498,0.000398292,THBS1/CTNNB1/CD44/FGF2/FGFR4/GATA3/FGFR1/FGF3,8
GO:0046889,BP,GO:0046889,positive regulation of lipid biosynthetic process,7/269,88/18888,0.079545455,5.585332883,5.182182882,0.000261197,0.000963572,0.000404067,PTGS2/IL1B/IGF1R/MTOR/PRKCD/TNF/AKT1,7
GO:0035264,BP,GO:0035264,multicellular organism growth,9/269,147/18888,0.06122449,4.298915105,4.826284073,0.000262446,0.000967396,0.000405671,TP53/AR/ERCC1/PIK3CA/STAT3/MTOR/SGPL1/ZFX/IGF2,9
GO:1903844,BP,GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,10/269,180/18888,0.055555556,3.90086741,4.700346832,0.000265739,0.000977952,0.000410097,TP53/THBS1/PPARG/SOX11/TWSG1/SMAD3/TGFB1/HSPA5/PEG10/MIR145,10
GO:1905475,BP,GO:1905475,regulation of protein localization to membrane,10/269,180/18888,0.055555556,3.90086741,4.700346832,0.000265739,0.000977952,0.000410097,ERBB2/AR/PIK3CA/MMP14/SQSTM1/TNF/AKT1/TGFB1/EGFR/HRAS,10
GO:0032615,BP,GO:0032615,interleukin-12 production,6/269,63/18888,0.095238095,6.687201275,5.434765815,0.000271655,0.000998113,0.000418552,THBS1/NFKB1/MAPK14/TLR4/RELA/IL10,6
GO:0032655,BP,GO:0032655,regulation of interleukin-12 production,6/269,63/18888,0.095238095,6.687201275,5.434765815,0.000271655,0.000998113,0.000418552,THBS1/NFKB1/MAPK14/TLR4/RELA/IL10,6
GO:0003203,BP,GO:0003203,endocardial cushion morphogenesis,5/269,41/18888,0.12195122,8.562879681,5.826898572,0.000278155,0.001020351,0.000427877,NOTCH1/TGFBR1/SNAI1/TWIST1/SNAI2,5
GO:0043506,BP,GO:0043506,regulation of JUN kinase activity,5/269,41/18888,0.12195122,8.562879681,5.826898572,0.000278155,0.001020351,0.000427877,MAP3K7/GSTP1/TNF/DAB2IP/MAP2K7,5
GO:0050672,BP,GO:0050672,negative regulation of lymphocyte proliferation,7/269,89/18888,0.078651685,5.522576333,5.140353536,0.000280098,0.001025827,0.000430173,ERBB2/CASP3/SOX11/TWSG1/IL10/CD274/PAWR,7
GO:2000106,BP,GO:2000106,regulation of leukocyte apoptotic process,7/269,89/18888,0.078651685,5.522576333,5.140353536,0.000280098,0.001025827,0.000430173,TP53/CXCR2/HIF1A/IL10/BAX/CD274/CDKN2A,7
GO:0006925,BP,GO:0006925,inflammatory cell apoptotic process,4/269,23/18888,0.173913043,12.21141102,6.466588745,0.000287787,0.001048924,0.000439859,CXCR2/IL6/FASLG/CDKN2A,4
GO:0038128,BP,GO:0038128,ERBB2 signaling pathway,4/269,23/18888,0.173913043,12.21141102,6.466588745,0.000287787,0.001048924,0.000439859,ERBB2/MAPK1/EGFR/TGFA,4
GO:0045736,BP,GO:0045736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,4/269,23/18888,0.173913043,12.21141102,6.466588745,0.000287787,0.001048924,0.000439859,PTEN/HHEX/CDKN1A/CDKN2A,4
GO:0071636,BP,GO:0071636,positive regulation of transforming growth factor beta production,4/269,23/18888,0.173913043,12.21141102,6.466588745,0.000287787,0.001048924,0.000439859,THBS1/PTGS2/MYB/SMAD3,4
GO:1903579,BP,GO:1903579,negative regulation of ATP metabolic process,4/269,23/18888,0.173913043,12.21141102,6.466588745,0.000287787,0.001048924,0.000439859,PARP1/STAT3/GIT1/FBP1,4
GO:1904030,BP,GO:1904030,negative regulation of cyclin-dependent protein kinase activity,4/269,23/18888,0.173913043,12.21141102,6.466588745,0.000287787,0.001048924,0.000439859,PTEN/HHEX/CDKN1A/CDKN2A,4
GO:1904659,BP,GO:1904659,glucose transmembrane transport,8/269,118/18888,0.06779661,4.760380568,4.925157479,0.000289083,0.001051358,0.000440879,IL1B/MAPK14/RNASEL/TNF/AKT1/IRS1/IGF1/BRAF,8
GO:0009306,BP,GO:0009306,protein secretion,15/269,370/18888,0.040540541,2.846578921,4.311725954,0.000289146,0.001051358,0.000440879,IL6/EDNRB/IL1B/PPARG/HIF1A/TLR4/TNF/HNF1B/TGFB1/SNCG/EGFR/PCSK1/IRS1/IGF1/CLOCK,15
GO:0032535,BP,GO:0032535,regulation of cellular component size,15/269,370/18888,0.040540541,2.846578921,4.311725954,0.000289146,0.001051358,0.000440879,PTEN/MAP3K7/PIK3CA/KDM1A/VEGFA/CDH1/RILP/TENM1/MTOR/HDAC6/PRKCD/RHOA/FN1/HSP90AA1/UCN,15
GO:0030888,BP,GO:0030888,regulation of B cell proliferation,6/269,64/18888,0.09375,6.582713755,5.37723287,0.000296224,0.001076234,0.000451311,CASP3/TLR4/BMI1/IL10/PAWR/CDKN1A,6
GO:0035592,BP,GO:0035592,establishment of protein localization to extracellular region,15/269,371/18888,0.040431267,2.838906201,4.299724931,0.000297551,0.001080195,0.000452972,IL6/EDNRB/IL1B/PPARG/HIF1A/TLR4/TNF/HNF1B/TGFB1/SNCG/EGFR/PCSK1/IRS1/IGF1/CLOCK,15
GO:0010507,BP,GO:0010507,negative regulation of autophagy,7/269,90/18888,0.077777778,5.461214374,5.099152248,0.000300084,0.001086792,0.000455738,TP53/PIK3CA/STAT3/MTOR/AKT1/IL10/VHL,7
GO:0030071,BP,GO:0030071,regulation of mitotic metaphase/anaphase transition,7/269,90/18888,0.077777778,5.461214374,5.099152248,0.000300084,0.001086792,0.000455738,ARID1A/XRCC3/SMARCA4/SMARCA2/CUL3/RB1/SMARCE1,7
GO:0032945,BP,GO:0032945,negative regulation of mononuclear cell proliferation,7/269,90/18888,0.077777778,5.461214374,5.099152248,0.000300084,0.001086792,0.000455738,ERBB2/CASP3/SOX11/TWSG1/IL10/CD274/PAWR,7
GO:0001764,BP,GO:0001764,neuron migration,10/269,183/18888,0.054644809,3.836918764,4.63524872,0.000303354,0.001096888,0.000459972,CTNNB1/VEGFA/STAT3/RHOA/BAX/DAB2IP/TWIST1/HSP90AA1/GATA3/FGFR1,10
GO:0045580,BP,GO:0045580,regulation of T cell differentiation,10/269,183/18888,0.054644809,3.836918764,4.63524872,0.000303354,0.001096888,0.000459972,ERBB2/ARID1A/SMARCA4/SMARCA2/RHOA/BRD2/BRD4/SMARCE1/BRAF/GATA3,10
GO:0045582,BP,GO:0045582,positive regulation of T cell differentiation,8/269,119/18888,0.067226891,4.72037737,4.893497399,0.000306164,0.001105303,0.000463501,ARID1A/SMARCA4/SMARCA2/RHOA/BRD2/BRD4/SMARCE1/GATA3,8
GO:0002449,BP,GO:0002449,lymphocyte mediated immunity,15/269,372/18888,0.040322581,2.831274733,4.287763682,0.000306166,0.001105303,0.000463501,ERCC1/IL6/MAP3K7/IL1B/PRKCD/TNF/TGFB1/IL10/GATA3/CD8A/MLH1/MSH2/NBN/MYD88/CLU,15
GO:0006869,BP,GO:0006869,lipid transport,17/269,456/18888,0.037280702,2.617687341,4.203104924,0.000308699,0.001113566,0.000466966,THBS1/PTGS2/IL1B/NFKB1/PPARG/FASLG/MYB/PRKCD/AKT1/CAV1/MIR145/NKX3-1/MIR130B/NFKBIA/RBP1/CYP19A1/CLU,17
GO:0014044,BP,GO:0014044,Schwann cell development,5/269,42/18888,0.119047619,8.359001593,5.738698428,0.000312106,0.001122301,0.000470629,ERBB2/MAPK1/AKT1/ILK/HRAS,5
GO:0032733,BP,GO:0032733,positive regulation of interleukin-10 production,5/269,42/18888,0.119047619,8.359001593,5.738698428,0.000312106,0.001122301,0.000470629,IL6/STAT3/TLR4/MIR145/CD274,5
GO:0035794,BP,GO:0035794,positive regulation of mitochondrial membrane permeability,5/269,42/18888,0.119047619,8.359001593,5.738698428,0.000312106,0.001122301,0.000470629,TP53/BID/BAX/BNIP3/BNIP3L,5
GO:1904706,BP,GO:1904706,negative regulation of vascular associated smooth muscle cell proliferation,5/269,42/18888,0.119047619,8.359001593,5.738698428,0.000312106,0.001122301,0.000470629,PTEN/PPARG/SOD2/IL10/CDKN1A,5
GO:0009952,BP,GO:0009952,anterior/posterior pattern specification,11/269,219/18888,0.050228311,3.526811631,4.520784977,0.00031678,0.001131269,0.00047439,TP53/CTNNB1/AURKA/NOTCH1/BMI1/HNF1B/TGFBR1/SMAD3/WT1/HHEX/NKX3-1,11
GO:0007440,BP,GO:0007440,foregut morphogenesis,3/269,10/18888,0.3,21.06468401,7.628405806,0.000318325,0.001131269,0.00047439,CTNNB1/NOTCH1/SMAD3,3
GO:0014745,BP,GO:0014745,negative regulation of muscle adaptation,3/269,10/18888,0.3,21.06468401,7.628405806,0.000318325,0.001131269,0.00047439,MIR25/PPARG/SMAD3,3
GO:0016102,BP,GO:0016102,diterpenoid biosynthetic process,3/269,10/18888,0.3,21.06468401,7.628405806,0.000318325,0.001131269,0.00047439,CYP1A1/AKR1C3/RBP1,3
GO:0032025,BP,GO:0032025,response to cobalt ion,3/269,10/18888,0.3,21.06468401,7.628405806,0.000318325,0.001131269,0.00047439,CASP8/CASP3/BNIP3,3
GO:0032070,BP,GO:0032070,regulation of deoxyribonuclease activity,3/269,10/18888,0.3,21.06468401,7.628405806,0.000318325,0.001131269,0.00047439,PCNA/PRKCD/AKT1,3
GO:0060947,BP,GO:0060947,cardiac vascular smooth muscle cell differentiation,3/269,10/18888,0.3,21.06468401,7.628405806,0.000318325,0.001131269,0.00047439,VEGFA/NOTCH1/MIR145,3
GO:0070391,BP,GO:0070391,response to lipoteichoic acid,3/269,10/18888,0.3,21.06468401,7.628405806,0.000318325,0.001131269,0.00047439,MAPK14/TLR4/RELA,3
GO:0070562,BP,GO:0070562,regulation of vitamin D receptor signaling pathway,3/269,10/18888,0.3,21.06468401,7.628405806,0.000318325,0.001131269,0.00047439,VDR/SNAI2/MED1,3
GO:0071223,BP,GO:0071223,cellular response to lipoteichoic acid,3/269,10/18888,0.3,21.06468401,7.628405806,0.000318325,0.001131269,0.00047439,MAPK14/TLR4/RELA,3
GO:0071803,BP,GO:0071803,positive regulation of podosome assembly,3/269,10/18888,0.3,21.06468401,7.628405806,0.000318325,0.001131269,0.00047439,TNF/RHOA/FSCN1,3
GO:0072203,BP,GO:0072203,cell proliferation involved in metanephros development,3/269,10/18888,0.3,21.06468401,7.628405806,0.000318325,0.001131269,0.00047439,MYC/WT1/STAT1,3
GO:1903799,BP,GO:1903799,negative regulation of miRNA processing,3/269,10/18888,0.3,21.06468401,7.628405806,0.000318325,0.001131269,0.00047439,TP53/IL6/STAT3,3
GO:1904627,BP,GO:1904627,response to phorbol 13-acetate 12-myristate,3/269,10/18888,0.3,21.06468401,7.628405806,0.000318325,0.001131269,0.00047439,CDK4/FOS/FBP1,3
GO:1904628,BP,GO:1904628,cellular response to phorbol 13-acetate 12-myristate,3/269,10/18888,0.3,21.06468401,7.628405806,0.000318325,0.001131269,0.00047439,CDK4/FOS/FBP1,3
GO:1903510,BP,GO:1903510,mucopolysaccharide metabolic process,7/269,91/18888,0.076923077,5.401201029,5.058562096,0.000321199,0.001140595,0.0004783,EDNRB/IL1B/NFKB1/CD44/FGF2/TGFB1/LYVE1,7
GO:0002011,BP,GO:0002011,morphogenesis of an epithelial sheet,6/269,65/18888,0.092307692,6.481441235,5.320916871,0.000322503,0.001142554,0.000479122,PTEN/SOX11/CD44/NOTCH1/MTOR/RHOA,6
GO:0002931,BP,GO:0002931,response to ischemia,6/269,65/18888,0.092307692,6.481441235,5.320916871,0.000322503,0.001142554,0.000479122,TP53/MYB/SQSTM1/RELA/CAV1/AIFM1,6
GO:1904036,BP,GO:1904036,negative regulation of epithelial cell apoptotic process,6/269,65/18888,0.092307692,6.481441235,5.320916871,0.000322503,0.001142554,0.000479122,IGF1R/RB1/SERPINE1/KDR/BRAF/GATA3,6
GO:0071346,BP,GO:0071346,cellular response to type II interferon,8/269,120/18888,0.066666667,4.681040892,4.862187717,0.000324059,0.001147174,0.000481059,TP53/PPARG/FASLG/TLR4/TNF/VIM/STAT1/MED1,8
GO:0010508,BP,GO:0010508,positive regulation of autophagy,9/269,152/18888,0.059210526,4.157503424,4.697931061,0.000336286,0.001189532,0.000498822,MAP3K7/HIF1A/SQSTM1/KDR/BNIP3/BNIP3L/NPRL2/ROCK1/CAMKK2,9
GO:0010839,BP,GO:0010839,negative regulation of keratinocyte proliferation,4/269,24/18888,0.166666667,11.70260223,6.306052267,0.000341499,0.001202373,0.000504207,VDR/SNAI2/MED1/SFN,4
GO:0034114,BP,GO:0034114,regulation of heterotypic cell-cell adhesion,4/269,24/18888,0.166666667,11.70260223,6.306052267,0.000341499,0.001202373,0.000504207,IL1B/CD44/TNF/IL10,4
GO:0048634,BP,GO:0048634,regulation of muscle organ development,4/269,24/18888,0.166666667,11.70260223,6.306052267,0.000341499,0.001202373,0.000504207,SMAD3/TGFB1/TWIST1/FGF3,4
GO:0061042,BP,GO:0061042,vascular wound healing,4/269,24/18888,0.166666667,11.70260223,6.306052267,0.000341499,0.001202373,0.000504207,VEGFA/TNF/SERPINE1/KDR,4
GO:0072273,BP,GO:0072273,metanephric nephron morphogenesis,4/269,24/18888,0.166666667,11.70260223,6.306052267,0.000341499,0.001202373,0.000504207,CTNNB1/WT1/STAT1/LGR4,4
GO:2000810,BP,GO:2000810,regulation of bicellular tight junction assembly,4/269,24/18888,0.166666667,11.70260223,6.306052267,0.000341499,0.001202373,0.000504207,TNF/SNAI1/SNAI2/ROCK1,4
GO:0008645,BP,GO:0008645,hexose transmembrane transport,8/269,121/18888,0.066115702,4.642354604,4.831221362,0.000342799,0.001206016,0.000505734,IL1B/MAPK14/RNASEL/TNF/AKT1/IRS1/IGF1/BRAF,8
GO:0019098,BP,GO:0019098,reproductive behavior,5/269,43/18888,0.11627907,8.164606207,5.653376849,0.000349105,0.00122442,0.000513452,EDNRB/NCOA1/KLK14/TAC1/ZFX,5
GO:0045663,BP,GO:0045663,positive regulation of myoblast differentiation,5/269,43/18888,0.11627907,8.164606207,5.653376849,0.000349105,0.00122442,0.000513452,ARID1A/MAPK14/SMARCA4/SMARCA2/SMARCE1,5
GO:0051353,BP,GO:0051353,positive regulation of oxidoreductase activity,5/269,43/18888,0.11627907,8.164606207,5.653376849,0.000349105,0.00122442,0.000513452,VDR/IL1B/HIF1A/TNF/AKT1,5
GO:1904646,BP,GO:1904646,cellular response to amyloid-beta,5/269,43/18888,0.11627907,8.164606207,5.653376849,0.000349105,0.00122442,0.000513452,PARP1/IGF1R/TLR4/TNF/IGF1,5
GO:0000271,BP,GO:0000271,polysaccharide biosynthetic process,6/269,66/18888,0.090909091,6.38323758,5.265772408,0.000350574,0.001227683,0.00051482,NFKB1/AKT1/TGFB1/IRS1/IGF1/IGF2,6
GO:0016445,BP,GO:0016445,somatic diversification of immunoglobulins,6/269,66/18888,0.090909091,6.38323758,5.265772408,0.000350574,0.001227683,0.00051482,ERCC1/TGFB1/IL10/MLH1/MSH2/NBN,6
GO:0050729,BP,GO:0050729,positive regulation of inflammatory response,9/269,153/18888,0.058823529,4.130330199,4.672921354,0.000352938,0.001235012,0.000517893,IL6/PTGS2/IL1B/TLR4/TNF/TGFB1/SERPINE1/NFKBIA/CLOCK,9
GO:0051051,BP,GO:0051051,negative regulation of transport,17/269,462/18888,0.036796537,2.583691402,4.142432757,0.000358739,0.001254349,0.000526002,THBS1/PTEN/PTGS2/IL1B/NFKB1/NOTCH1/TNF/AKT1/MMP9/CAV1/MIR200C/TXN/IRS1/MIR145/BRAF/MIR130B/UCN,17
GO:0030326,BP,GO:0030326,embryonic limb morphogenesis,8/269,122/18888,0.06557377,4.604302517,4.800591465,0.000362413,0.00126525,0.000530574,CTNNB1/NOTCH1/BAX/TWIST1/TP63/FGFR1/TFAP2A/MED1,8
GO:0035113,BP,GO:0035113,embryonic appendage morphogenesis,8/269,122/18888,0.06557377,4.604302517,4.800591465,0.000362413,0.00126525,0.000530574,CTNNB1/NOTCH1/BAX/TWIST1/TP63/FGFR1/TFAP2A/MED1,8
GO:0002690,BP,GO:0002690,positive regulation of leukocyte chemotaxis,7/269,93/18888,0.075268817,5.285046169,4.979150678,0.000367002,0.001279314,0.000536471,THBS1/CXCR2/IL6/VEGFA/MAPK1/PTK2/SERPINE1,7
GO:1902099,BP,GO:1902099,regulation of metaphase/anaphase transition of cell cycle,7/269,93/18888,0.075268817,5.285046169,4.979150678,0.000367002,0.001279314,0.000536471,ARID1A/XRCC3/SMARCA4/SMARCA2/CUL3/RB1/SMARCE1,7
GO:0071692,BP,GO:0071692,protein localization to extracellular region,15/269,379/18888,0.039577836,2.77898206,4.205127323,0.000372713,0.001298226,0.000544402,IL6/EDNRB/IL1B/PPARG/HIF1A/TLR4/TNF/HNF1B/TGFB1/SNCG/EGFR/PCSK1/IRS1/IGF1/CLOCK,15
GO:0034605,BP,GO:0034605,cellular response to heat,6/269,67/18888,0.089552239,6.287965378,5.211756434,0.000380522,0.001323402,0.000554959,THBS1/PTGS2/MTOR/HDAC6/HSP90AA1/CDKN1A,6
GO:0097192,BP,GO:0097192,extrinsic apoptotic signaling pathway in absence of ligand,6/269,67/18888,0.089552239,6.287965378,5.211756434,0.000380522,0.001323402,0.000554959,IL1B/TNF/AKT1/BAX/SNAI2/FGFR1,6
GO:0002688,BP,GO:0002688,regulation of leukocyte chemotaxis,8/269,123/18888,0.06504065,4.566869163,4.77029135,0.000382931,0.001329751,0.000557622,THBS1/CXCR2/IL6/VEGFA/MAPK1/PTK2/SERPINE1/CYP19A1,8
GO:0015749,BP,GO:0015749,monosaccharide transmembrane transport,8/269,123/18888,0.06504065,4.566869163,4.77029135,0.000382931,0.001329751,0.000557622,IL1B/MAPK14/RNASEL/TNF/AKT1/IRS1/IGF1/BRAF,8
GO:0010907,BP,GO:0010907,positive regulation of glucose metabolic process,5/269,44/18888,0.113636364,7.979046975,5.570771771,0.000389327,0.001349903,0.000566072,AKT1/IRS1/IGF1/PMAIP1/IGF2,5
GO:0071548,BP,GO:0071548,response to dexamethasone,5/269,44/18888,0.113636364,7.979046975,5.570771771,0.000389327,0.001349903,0.000566072,PIK3CA/IGF1R/HDAC6/PCNA/EGFR,5
GO:0007091,BP,GO:0007091,metaphase/anaphase transition of mitotic cell cycle,7/269,94/18888,0.074468085,5.228822273,4.940298643,0.000391787,0.001355338,0.000568351,ARID1A/XRCC3/SMARCA4/SMARCA2/CUL3/RB1/SMARCE1,7
GO:0045666,BP,GO:0045666,positive regulation of neuron differentiation,7/269,94/18888,0.074468085,5.228822273,4.940298643,0.000391787,0.001355338,0.000568351,ETV5/SOX11/NCOA1/FGF2/RHOA/FOXA1/FGFR1,7
GO:0051492,BP,GO:0051492,regulation of stress fiber assembly,7/269,94/18888,0.074468085,5.228822273,4.940298643,0.000391787,0.001355338,0.000568351,MTOR/RHOA/TGFBR1/SMAD3/DLC1/BRAF/ROCK1,7
GO:0007059,BP,GO:0007059,chromosome segregation,16/269,423/18888,0.037825059,2.655909726,4.1401077,0.000394644,0.001364185,0.000572061,BRCA1/PTEN/AURKA/ARID1A/XRCC3/SMARCA4/SMARCA2/SRPK1/RHOA/LZTS2/KATNB1/CHEK2/CUL3/RB1/SMARCE1/MLH1,16
GO:0009110,BP,GO:0009110,vitamin biosynthetic process,4/269,25/18888,0.16,11.23449814,6.154752985,0.000402023,0.001382352,0.00057968,NFKB1/TNF/SNAI1/SNAI2,4
GO:0010623,BP,GO:0010623,programmed cell death involved in cell development,4/269,25/18888,0.16,11.23449814,6.154752985,0.000402023,0.001382352,0.00057968,IL1B/FASLG/FGF2/BAX,4
GO:0060561,BP,GO:0060561,apoptotic process involved in morphogenesis,4/269,25/18888,0.16,11.23449814,6.154752985,0.000402023,0.001382352,0.00057968,VDR/NOTCH1/HNF1B/BAX,4
GO:0060964,BP,GO:0060964,regulation of miRNA-mediated gene silencing,4/269,25/18888,0.16,11.23449814,6.154752985,0.000402023,0.001382352,0.00057968,TP53/IL6/STAT3/TGFB1,4
GO:1902993,BP,GO:1902993,positive regulation of amyloid precursor protein catabolic process,4/269,25/18888,0.16,11.23449814,6.154752985,0.000402023,0.001382352,0.00057968,CASP3/TNF/RELA/CLU,4
GO:1905523,BP,GO:1905523,positive regulation of macrophage migration,4/269,25/18888,0.16,11.23449814,6.154752985,0.000402023,0.001382352,0.00057968,THBS1/MMP14/MAPK1/PTK2,4
GO:2000353,BP,GO:2000353,positive regulation of endothelial cell apoptotic process,4/269,25/18888,0.16,11.23449814,6.154752985,0.000402023,0.001382352,0.00057968,THBS1/FASLG/TGFB1/AKR1C3,4
GO:0010811,BP,GO:0010811,positive regulation of cell-substrate adhesion,8/269,124/18888,0.064516129,4.530039573,4.740314526,0.000404385,0.001387332,0.000581768,VEGFA/SMAD3/ILK/FN1/OLFM4/KDR/BRAF/ROCK1,8
GO:0034502,BP,GO:0034502,protein localization to chromosome,8/269,124/18888,0.064516129,4.530039573,4.740314526,0.000404385,0.001387332,0.000581768,BRCA2/PARP1/EZH2/BRD3/BRD2/RB1/MSH2/ESR1,8
GO:0071774,BP,GO:0071774,response to fibroblast growth factor,8/269,124/18888,0.064516129,4.530039573,4.740314526,0.000404385,0.001387332,0.000581768,THBS1/CTNNB1/CD44/FGF2/FGFR4/GATA3/FGFR1/FGF3,8
GO:0043433,BP,GO:0043433,negative regulation of DNA-binding transcription factor activity,9/269,156/18888,0.057692308,4.050900772,4.599151985,0.000407028,0.00139535,0.00058513,KDM1A/ID1/IL10/RB1/DAB2IP/PIM1/NFKBIA/CDKN2A/ESR1,9
GO:0042987,BP,GO:0042987,amyloid precursor protein catabolic process,6/269,68/18888,0.088235294,6.195495298,5.158828105,0.000412432,0.001411751,0.000592008,CASP3/TNF/RELA/IGF1/ROCK1/CLU,6
GO:0045668,BP,GO:0045668,negative regulation of osteoblast differentiation,6/269,68/18888,0.088235294,6.195495298,5.158828105,0.000412432,0.001411751,0.000592008,PPARG/NOTCH1/TNF/TWSG1/SMAD3/TWIST1,6
GO:0046330,BP,GO:0046330,positive regulation of JNK cascade,7/269,95/18888,0.073684211,5.173782039,4.901996149,0.000417892,0.001428293,0.000598944,IL1B/TLR4/TNF/DAB2IP/HRAS/MAP2K7/MYD88,7
GO:0071229,BP,GO:0071229,cellular response to acid chemical,7/269,95/18888,0.073684211,5.173782039,4.901996149,0.000417892,0.001428293,0.000598944,PIK3CA/VEGFA/MTOR/TNF/MMP2/EGFR/CUL3,7
GO:0006690,BP,GO:0006690,icosanoid metabolic process,8/269,125/18888,0.064,4.493799257,4.710654686,0.000426806,0.001457667,0.000611262,ALOX12/GPX1/PTGS2/IL1B/GSTP1/ALOX15B/CYP1A1/AKR1C3,8
GO:0010463,BP,GO:0010463,mesenchymal cell proliferation,5/269,45/18888,0.111111111,7.80173482,5.490733726,0.000432951,0.001462697,0.000613372,CTNNB1/MYC/KDR/STAT1/FGFR1,5
GO:0035196,BP,GO:0035196,miRNA processing,5/269,45/18888,0.111111111,7.80173482,5.490733726,0.000432951,0.001462697,0.000613372,TP53/IL6/STAT3/SMAD3/TGFB1,5
GO:0048701,BP,GO:0048701,embryonic cranial skeleton morphogenesis,5/269,45/18888,0.111111111,7.80173482,5.490733726,0.000432951,0.001462697,0.000613372,MMP14/TGFBR1/SMAD3/TWIST1/TFAP2A,5
GO:1900744,BP,GO:1900744,regulation of p38MAPK cascade,5/269,45/18888,0.111111111,7.80173482,5.490733726,0.000432951,0.001462697,0.000613372,IL1B/VEGFA/DAB2IP/SPHK1/PER1,5
GO:1902108,BP,GO:1902108,regulation of mitochondrial membrane permeability involved in apoptotic process,5/269,45/18888,0.111111111,7.80173482,5.490733726,0.000432951,0.001462697,0.000613372,TP53/BID/BAX/BNIP3/BNIP3L,5
GO:0019372,BP,GO:0019372,lipoxygenase pathway,3/269,11/18888,0.272727273,19.14971274,7.237341483,0.000433094,0.001462697,0.000613372,ALOX12/GPX1/ALOX15B,3
GO:0035666,BP,GO:0035666,TRIF-dependent toll-like receptor signaling pathway,3/269,11/18888,0.272727273,19.14971274,7.237341483,0.000433094,0.001462697,0.000613372,MAP3K7/TLR4/CD274,3
GO:0045793,BP,GO:0045793,positive regulation of cell size,3/269,11/18888,0.272727273,19.14971274,7.237341483,0.000433094,0.001462697,0.000613372,MAP3K7/KDM1A/HSP90AA1,3
GO:0060736,BP,GO:0060736,prostate gland growth,3/269,11/18888,0.272727273,19.14971274,7.237341483,0.000433094,0.001462697,0.000613372,AR/ESR1/CYP19A1,3
GO:0060900,BP,GO:0060900,embryonic camera-type eye formation,3/269,11/18888,0.272727273,19.14971274,7.237341483,0.000433094,0.001462697,0.000613372,SOX11/TWIST1/TFAP2A,3
GO:0061370,BP,GO:0061370,testosterone biosynthetic process,3/269,11/18888,0.272727273,19.14971274,7.237341483,0.000433094,0.001462697,0.000613372,SRD5A2/AKR1C3/CYP19A1,3
GO:0062100,BP,GO:0062100,positive regulation of programmed necrotic cell death,3/269,11/18888,0.272727273,19.14971274,7.237341483,0.000433094,0.001462697,0.000613372,TP53/PARP1/AIFM1,3
GO:0090331,BP,GO:0090331,negative regulation of platelet aggregation,3/269,11/18888,0.272727273,19.14971274,7.237341483,0.000433094,0.001462697,0.000613372,ALOX12/PRKCD/CD9,3
GO:1902510,BP,GO:1902510,regulation of apoptotic DNA fragmentation,3/269,11/18888,0.272727273,19.14971274,7.237341483,0.000433094,0.001462697,0.000613372,IL6/BAX/AIFM1,3
GO:2000343,BP,GO:2000343,positive regulation of chemokine (C-X-C motif) ligand 2 production,3/269,11/18888,0.272727273,19.14971274,7.237341483,0.000433094,0.001462697,0.000613372,TLR4/TNF/TGFB1,3
GO:0006006,BP,GO:0006006,glucose metabolic process,10/269,192/18888,0.052083333,3.657063197,4.447926508,0.000443869,0.001497976,0.000628166,TP53/PIK3CA/MAPK14/TNF/AKT1/IRS1/IGF1/PMAIP1/FBP1/IGF2,10
GO:0042982,BP,GO:0042982,amyloid precursor protein metabolic process,7/269,96/18888,0.072916667,5.119888476,4.864229181,0.000445368,0.001501637,0.000629701,CASP3/TNF/RELA/IGF1/PAWR/ROCK1/CLU,7
GO:1903050,BP,GO:1903050,regulation of proteolysis involved in protein catabolic process,11/269,228/18888,0.048245614,3.387595383,4.359651642,0.000445613,0.001501637,0.000629701,PTEN/AURKA/FBXW7/GPX1/CDK2/AKT1/CAV1/PTK2/DAB2IP/CLU/FHIT,11
GO:0038034,BP,GO:0038034,signal transduction in absence of ligand,6/269,69/18888,0.086956522,6.105705512,5.10694864,0.000446394,0.001503156,0.000630338,IL1B/TNF/AKT1/BAX/SNAI2/FGFR1,6
GO:0021915,BP,GO:0021915,neural tube development,9/269,158/18888,0.056962025,3.999623547,4.550989811,0.000446747,0.001503234,0.000630371,CASP3/NOTCH1/HIF1A/BMI1/TGFB1/FOXA1/BRD2/DLC1/TWIST1,9
GO:0002726,BP,GO:0002726,positive regulation of T cell cytokine production,4/269,26/18888,0.153846154,10.80240206,6.011803399,0.000469834,0.001568177,0.000657604,IL6/MAP3K7/IL1B/GATA3,4
GO:0022010,BP,GO:0022010,central nervous system myelination,4/269,26/18888,0.153846154,10.80240206,6.011803399,0.000469834,0.001568177,0.000657604,PTEN/ID4/MAL/CLU,4
GO:0032291,BP,GO:0032291,axon ensheathment in central nervous system,4/269,26/18888,0.153846154,10.80240206,6.011803399,0.000469834,0.001568177,0.000657604,PTEN/ID4/MAL/CLU,4
GO:0045649,BP,GO:0045649,regulation of macrophage differentiation,4/269,26/18888,0.153846154,10.80240206,6.011803399,0.000469834,0.001568177,0.000657604,CASP8/TGFB1/RB1/MIR145,4
GO:0048143,BP,GO:0048143,astrocyte activation,4/269,26/18888,0.153846154,10.80240206,6.011803399,0.000469834,0.001568177,0.000657604,IL6/IL1B/TNF/EGFR,4
GO:0048641,BP,GO:0048641,regulation of skeletal muscle tissue development,4/269,26/18888,0.153846154,10.80240206,6.011803399,0.000469834,0.001568177,0.000657604,CTNNB1/TGFB1/TWIST1/IGF2,4
GO:0051894,BP,GO:0051894,positive regulation of focal adhesion assembly,4/269,26/18888,0.153846154,10.80240206,6.011803399,0.000469834,0.001568177,0.000657604,VEGFA/SMAD3/KDR/ROCK1,4
GO:0060333,BP,GO:0060333,type II interferon-mediated signaling pathway,4/269,26/18888,0.153846154,10.80240206,6.011803399,0.000469834,0.001568177,0.000657604,TP53/PPARG/STAT1/MED1,4
GO:1900368,BP,GO:1900368,regulation of post-transcriptional gene silencing by regulatory ncRNA,4/269,26/18888,0.153846154,10.80240206,6.011803399,0.000469834,0.001568177,0.000657604,TP53/IL6/STAT3/TGFB1,4
GO:1904996,BP,GO:1904996,positive regulation of leukocyte adhesion to vascular endothelial cell,4/269,26/18888,0.153846154,10.80240206,6.011803399,0.000469834,0.001568177,0.000657604,IL6/TNF/RELA/RHOA,4
GO:2000737,BP,GO:2000737,negative regulation of stem cell differentiation,4/269,26/18888,0.153846154,10.80240206,6.011803399,0.000469834,0.001568177,0.000657604,NOTCH1/STAT3/EZH2/CDK12,4
GO:0044784,BP,GO:0044784,metaphase/anaphase transition of cell cycle,7/269,97/18888,0.072164948,5.06710612,4.826984224,0.000474267,0.001580879,0.000662931,ARID1A/XRCC3/SMARCA4/SMARCA2/CUL3/RB1/SMARCE1,7
GO:0003206,BP,GO:0003206,cardiac chamber morphogenesis,8/269,127/18888,0.062992126,4.423030764,4.652261577,0.00047468,0.001580879,0.000662931,TP53/SOX11/NOTCH1/HIF1A/TGFBR1/TGFB1/GATA3/MED1,8
GO:0030282,BP,GO:0030282,bone mineralization,8/269,127/18888,0.062992126,4.423030764,4.652261577,0.00047468,0.001580879,0.000662931,VDR/PTGS2/HIF1A/SMAD3/IGF1/TWIST1/TFAP2A/LGR4,8
GO:0042789,BP,GO:0042789,mRNA transcription by RNA polymerase II,5/269,46/18888,0.108695652,7.632131889,5.413124608,0.000480161,0.001593308,0.000668142,VDR/PPARG/NCOA1/STAT3/MED1,5
GO:0045646,BP,GO:0045646,regulation of erythrocyte differentiation,5/269,46/18888,0.108695652,7.632131889,5.413124608,0.000480161,0.001593308,0.000668142,MAPK14/HIF1A/STAT3/STAT1/MED1,5
GO:0061383,BP,GO:0061383,trabecula morphogenesis,5/269,46/18888,0.108695652,7.632131889,5.413124608,0.000480161,0.001593308,0.000668142,NOTCH1/RHOA/TGFBR1/MMP2/MED1,5
GO:1905710,BP,GO:1905710,positive regulation of membrane permeability,5/269,46/18888,0.108695652,7.632131889,5.413124608,0.000480161,0.001593308,0.000668142,TP53/BID/BAX/BNIP3/BNIP3L,5
GO:2001239,BP,GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,5/269,46/18888,0.108695652,7.632131889,5.413124608,0.000480161,0.001593308,0.000668142,IL1B/TNF/AKT1/SNAI2/FGFR1,5
GO:0002562,BP,GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,6/269,70/18888,0.085714286,6.018481147,5.056081189,0.000482497,0.001598732,0.000670417,ERCC1/TGFB1/IL10/MLH1/MSH2/NBN,6
GO:0016444,BP,GO:0016444,somatic cell DNA recombination,6/269,70/18888,0.085714286,6.018481147,5.056081189,0.000482497,0.001598732,0.000670417,ERCC1/TGFB1/IL10/MLH1/MSH2/NBN,6
GO:0051607,BP,GO:0051607,defense response to virus,13/269,307/18888,0.042345277,2.97329959,4.189933458,0.000484654,0.001604713,0.000672925,IL6/IL1B/RNASEL/TNF/RELA/IFI27/BNIP3/HSP90AA1/PMAIP1/STAT1/BNIP3L/IFNA1/MYD88,13
GO:0002708,BP,GO:0002708,positive regulation of lymphocyte mediated immunity,8/269,128/18888,0.0625,4.388475836,4.623516533,0.0005002,0.001653782,0.000693502,IL6/MAP3K7/IL1B/TNF/TGFB1/GATA3/MLH1/MSH2,8
GO:0048706,BP,GO:0048706,embryonic skeletal system development,8/269,128/18888,0.0625,4.388475836,4.623516533,0.0005002,0.001653782,0.000693502,CTNNB1/SOX11/MMP14/BMI1/TGFBR1/SMAD3/TWIST1/TFAP2A,8
GO:0050708,BP,GO:0050708,regulation of protein secretion,12/269,269/18888,0.044609665,3.132295021,4.233745139,0.000501639,0.001657337,0.000694993,IL6/IL1B/PPARG/HIF1A/TLR4/TNF/TGFB1/EGFR/PCSK1/IRS1/IGF1/CLOCK,12
GO:0048534,BP,GO:0048534,hematopoietic or lymphoid organ development,7/269,98/18888,0.071428571,5.015400956,4.790248241,0.000504643,0.001666053,0.000698648,TP53/CTNNB1/MAPK1/TGFBR1/TGFB1/BRAF/GATA3,7
GO:0010976,BP,GO:0010976,positive regulation of neuron projection development,9/269,161/18888,0.055900621,3.9250964,4.480211024,0.00051226,0.001689976,0.000708679,ALK/KDM1A/IGF1R/EZH2/KATNB1/MIR200C/DAB2IP/BRAF/FGFR1,9
GO:0003208,BP,GO:0003208,cardiac ventricle morphogenesis,6/269,71/18888,0.084507042,5.933713807,5.006190706,0.000520834,0.0017133,0.00071846,NOTCH1/HIF1A/TGFBR1/TGFB1/GATA3/MED1,6
GO:0045600,BP,GO:0045600,positive regulation of fat cell differentiation,6/269,71/18888,0.084507042,5.933713807,5.006190706,0.000520834,0.0017133,0.00071846,PTGS2/PPARG/MAPK14/AKT1/SNAI2/PIM1,6
GO:0045670,BP,GO:0045670,regulation of osteoclast differentiation,6/269,71/18888,0.084507042,5.933713807,5.006190706,0.000520834,0.0017133,0.00071846,CTNNB1/FBXW7/MTOR/TLR4/FOS/TNF,6
GO:0048662,BP,GO:0048662,negative regulation of smooth muscle cell proliferation,6/269,71/18888,0.084507042,5.933713807,5.006190706,0.000520834,0.0017133,0.00071846,PTEN/PPARG/SOD2/IL10/MIR145/CDKN1A,6
GO:0010837,BP,GO:0010837,regulation of keratinocyte proliferation,5/269,47/18888,0.106382979,7.469746105,5.337816578,0.000531142,0.001739671,0.000729519,VDR/SNAI2/TP63/MED1/SFN,5
GO:0014003,BP,GO:0014003,oligodendrocyte development,5/269,47/18888,0.106382979,7.469746105,5.337816578,0.000531142,0.001739671,0.000729519,PTEN/SOX11/ID4/MAL/CLU,5
GO:0045933,BP,GO:0045933,positive regulation of muscle contraction,5/269,47/18888,0.106382979,7.469746105,5.337816578,0.000531142,0.001739671,0.000729519,PTGS2/RHOA/SPHK1/HSP90AA1/UCN,5
GO:0060711,BP,GO:0060711,labyrinthine layer development,5/269,47/18888,0.106382979,7.469746105,5.337816578,0.000531142,0.001739671,0.000729519,CASP8/NCOA1/MAPK1/AKT1/IL10,5
GO:0072538,BP,GO:0072538,T-helper 17 type immune response,5/269,47/18888,0.106382979,7.469746105,5.337816578,0.000531142,0.001739671,0.000729519,IL6/NOTCH1/STAT3/BRD2/BRD4,5
GO:0140353,BP,GO:0140353,lipid export from cell,5/269,47/18888,0.106382979,7.469746105,5.337816578,0.000531142,0.001739671,0.000729519,PTGS2/IL1B/MYB/NKX3-1/CYP19A1,5
GO:0010758,BP,GO:0010758,regulation of macrophage chemotaxis,4/269,27/18888,0.148148148,10.40231309,5.87643163,0.000545412,0.001777467,0.000745368,THBS1/MAPK1/PTK2/CYP19A1,4
GO:0032740,BP,GO:0032740,positive regulation of interleukin-17 production,4/269,27/18888,0.148148148,10.40231309,5.87643163,0.000545412,0.001777467,0.000745368,IL6/TGFB1/SPHK1/MYD88,4
GO:0042730,BP,GO:0042730,fibrinolysis,4/269,27/18888,0.148148148,10.40231309,5.87643163,0.000545412,0.001777467,0.000745368,THBS1/SERPINE1/THBD/PLAU,4
GO:0042759,BP,GO:0042759,long-chain fatty acid biosynthetic process,4/269,27/18888,0.148148148,10.40231309,5.87643163,0.000545412,0.001777467,0.000745368,ALOX12/GSTP1/ALOX15B/CYP1A1,4
GO:0050996,BP,GO:0050996,positive regulation of lipid catabolic process,4/269,27/18888,0.148148148,10.40231309,5.87643163,0.000545412,0.001777467,0.000745368,IL1B/PRKCD/IRS1/TWIST1,4
GO:0060147,BP,GO:0060147,regulation of post-transcriptional gene silencing,4/269,27/18888,0.148148148,10.40231309,5.87643163,0.000545412,0.001777467,0.000745368,TP53/IL6/STAT3/TGFB1,4
GO:1905564,BP,GO:1905564,positive regulation of vascular endothelial cell proliferation,4/269,27/18888,0.148148148,10.40231309,5.87643163,0.000545412,0.001777467,0.000745368,FGF2/STAT3/FGFR1/IGF2,4
GO:1903322,BP,GO:1903322,positive regulation of protein modification by small protein conjugation or removal,8/269,130/18888,0.061538462,4.320960824,4.566901208,0.000554577,0.001806043,0.000757351,PTEN/FBXW7/KDM1A/BMI1/CAV1/CUL3/HSPA5/SPHK1,8
GO:0002753,BP,GO:0002753,cytoplasmic pattern recognition receptor signaling pathway,9/269,163/18888,0.055214724,3.876935708,4.433967443,0.000560165,0.001822938,0.000764436,MAP3K7/PARP1/TLR4/TNF/RELA/AKT1/CAV1/NFKBIA/MYD88,9
GO:0008593,BP,GO:0008593,regulation of Notch signaling pathway,7/269,100/18888,0.07,4.915092937,4.718253321,0.000570038,0.001834507,0.000769287,FBXW7/MMP14/NOTCH1/STAT3/AKT1/TP63/NFKBIA,7
GO:0001553,BP,GO:0001553,luteinization,3/269,12/18888,0.25,17.55390335,6.894702127,0.000571392,0.001834507,0.000769287,MMP2/A2M/SGPL1,3
GO:0003263,BP,GO:0003263,cardioblast proliferation,3/269,12/18888,0.25,17.55390335,6.894702127,0.000571392,0.001834507,0.000769287,CTNNB1/NOTCH1/PIM1,3
GO:0003264,BP,GO:0003264,regulation of cardioblast proliferation,3/269,12/18888,0.25,17.55390335,6.894702127,0.000571392,0.001834507,0.000769287,CTNNB1/NOTCH1/PIM1,3
GO:0009650,BP,GO:0009650,UV protection,3/269,12/18888,0.25,17.55390335,6.894702127,0.000571392,0.001834507,0.000769287,GPX1/ERCC1/MC1R,3
GO:0010749,BP,GO:0010749,regulation of nitric oxide mediated signal transduction,3/269,12/18888,0.25,17.55390335,6.894702127,0.000571392,0.001834507,0.000769287,THBS1/VEGFA/EGFR,3
GO:0010944,BP,GO:0010944,negative regulation of transcription by competitive promoter binding,3/269,12/18888,0.25,17.55390335,6.894702127,0.000571392,0.001834507,0.000769287,HHEX/MUC1/TFAP2A,3
GO:0030948,BP,GO:0030948,negative regulation of vascular endothelial growth factor receptor signaling pathway,3/269,12/18888,0.25,17.55390335,6.894702127,0.000571392,0.001834507,0.000769287,MIR200C/HHEX/DAB2IP,3
GO:0033083,BP,GO:0033083,regulation of immature T cell proliferation,3/269,12/18888,0.25,17.55390335,6.894702127,0.000571392,0.001834507,0.000769287,ERBB2/IL1B/BMI1,3
GO:0033084,BP,GO:0033084,regulation of immature T cell proliferation in thymus,3/269,12/18888,0.25,17.55390335,6.894702127,0.000571392,0.001834507,0.000769287,ERBB2/IL1B/BMI1,3
GO:0033629,BP,GO:0033629,negative regulation of cell adhesion mediated by integrin,3/269,12/18888,0.25,17.55390335,6.894702127,0.000571392,0.001834507,0.000769287,SERPINE1/SNAI2/MUC1,3
GO:0035112,BP,GO:0035112,genitalia morphogenesis,3/269,12/18888,0.25,17.55390335,6.894702127,0.000571392,0.001834507,0.000769287,CTNNB1/AR/TP63,3
GO:0048103,BP,GO:0048103,somatic stem cell division,3/269,12/18888,0.25,17.55390335,6.894702127,0.000571392,0.001834507,0.000769287,NOTCH1/BMI1/MIR145,3
GO:0060442,BP,GO:0060442,branching involved in prostate gland morphogenesis,3/269,12/18888,0.25,17.55390335,6.894702127,0.000571392,0.001834507,0.000769287,HOXB13/NKX3-1/ESR1,3
GO:0062042,BP,GO:0062042,regulation of cardiac epithelial to mesenchymal transition,3/269,12/18888,0.25,17.55390335,6.894702127,0.000571392,0.001834507,0.000769287,NOTCH1/TGFBR1/TWIST1,3
GO:0071394,BP,GO:0071394,cellular response to testosterone stimulus,3/269,12/18888,0.25,17.55390335,6.894702127,0.000571392,0.001834507,0.000769287,AR/IGF1R/SLC39A9,3
GO:0071493,BP,GO:0071493,cellular response to UV-B,3/269,12/18888,0.25,17.55390335,6.894702127,0.000571392,0.001834507,0.000769287,MAPK14/MME/CDKN1A,3
GO:0072182,BP,GO:0072182,regulation of nephron tubule epithelial cell differentiation,3/269,12/18888,0.25,17.55390335,6.894702127,0.000571392,0.001834507,0.000769287,CTNNB1/GATA3/STAT1,3
GO:1902043,BP,GO:1902043,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,3/269,12/18888,0.25,17.55390335,6.894702127,0.000571392,0.001834507,0.000769287,THBS1/PMAIP1/MAL,3
GO:0043488,BP,GO:0043488,regulation of mRNA stability,12/269,273/18888,0.043956044,3.086400588,4.173755015,0.000571773,0.001834507,0.000769287,YBX1/MAPK14/RNASEL/PRKCD/AKT1/MIR200C/VIM/MIR145/MLH1/MIR130B/ROCK1/MYD88,12
GO:1901875,BP,GO:1901875,positive regulation of post-translational protein modification,8/269,131/18888,0.061068702,4.28797639,4.539020071,0.000583505,0.001864666,0.000781934,PTEN/FBXW7/KDM1A/BMI1/CAV1/CUL3/HSPA5/SPHK1,8
GO:1903052,BP,GO:1903052,positive regulation of proteolysis involved in protein catabolic process,8/269,131/18888,0.061068702,4.28797639,4.539020071,0.000583505,0.001864666,0.000781934,PTEN/AURKA/FBXW7/AKT1/CAV1/PTK2/DAB2IP/CLU,8
GO:0006305,BP,GO:0006305,DNA alkylation,5/269,48/18888,0.104166667,7.314126394,5.264691104,0.000586085,0.001864666,0.000781934,PARP1/FOS/BMI1/EZH2/WT1,5
GO:0006306,BP,GO:0006306,DNA methylation,5/269,48/18888,0.104166667,7.314126394,5.264691104,0.000586085,0.001864666,0.000781934,PARP1/FOS/BMI1/EZH2/WT1,5
GO:0031295,BP,GO:0031295,T cell costimulation,5/269,48/18888,0.104166667,7.314126394,5.264691104,0.000586085,0.001864666,0.000781934,PIK3CA/MTOR/AKT1/CAV1/CD274,5
GO:0032620,BP,GO:0032620,interleukin-17 production,5/269,48/18888,0.104166667,7.314126394,5.264691104,0.000586085,0.001864666,0.000781934,IL6/TLR4/TGFB1/SPHK1/MYD88,5
GO:0032660,BP,GO:0032660,regulation of interleukin-17 production,5/269,48/18888,0.104166667,7.314126394,5.264691104,0.000586085,0.001864666,0.000781934,IL6/TLR4/TGFB1/SPHK1/MYD88,5
GO:0032968,BP,GO:0032968,positive regulation of transcription elongation by RNA polymerase II,5/269,48/18888,0.104166667,7.314126394,5.264691104,0.000586085,0.001864666,0.000781934,CTNNB1/ELL2/CDK12/BRD4/MED1,5
GO:0043407,BP,GO:0043407,negative regulation of MAP kinase activity,5/269,48/18888,0.104166667,7.314126394,5.264691104,0.000586085,0.001864666,0.000781934,IL1B/PPARG/GSTP1/PRKCD/DAB2IP,5
GO:0044331,BP,GO:0044331,cell-cell adhesion mediated by cadherin,5/269,48/18888,0.104166667,7.314126394,5.264691104,0.000586085,0.001864666,0.000781934,VEGFA/CTNND1/CDH1/NOTCH1/FOXA1,5
GO:0046578,BP,GO:0046578,regulation of Ras protein signal transduction,5/269,48/18888,0.104166667,7.314126394,5.264691104,0.000586085,0.001864666,0.000781934,NOTCH1/SQSTM1/DAB2IP/IGF1/FBP1,5
GO:0120163,BP,GO:0120163,negative regulation of cold-induced thermogenesis,5/269,48/18888,0.104166667,7.314126394,5.264691104,0.000586085,0.001864666,0.000781934,ID1/NOTCH1/TLR4/RB1/LGR4,5
GO:0006801,BP,GO:0006801,superoxide metabolic process,6/269,73/18888,0.082191781,5.771146305,4.909208835,0.000604588,0.001920022,0.000805148,ALOX12/SOD2/GSTP1/PRKCD/TGFB1/EGFR,6
GO:0042130,BP,GO:0042130,negative regulation of T cell proliferation,6/269,73/18888,0.082191781,5.771146305,4.909208835,0.000604588,0.001920022,0.000805148,ERBB2/CASP3/TWSG1/IL10/CD274/PAWR,6
GO:0010906,BP,GO:0010906,regulation of glucose metabolic process,7/269,101/18888,0.069306931,4.86642865,4.682970518,0.000605169,0.001920022,0.000805148,TP53/AKT1/IRS1/IGF1/PMAIP1/FBP1/IGF2,7
GO:0043255,BP,GO:0043255,regulation of carbohydrate biosynthetic process,7/269,101/18888,0.069306931,4.86642865,4.682970518,0.000605169,0.001920022,0.000805148,NFKB1/AKT1/TGFB1/IRS1/IGF1/FBP1/IGF2,7
GO:0031929,BP,GO:0031929,TOR signaling,9/269,165/18888,0.054545455,3.829942548,4.388451737,0.000611682,0.001939334,0.000813246,PIK3CA/HIF1A/MTOR/AKT1/CUL3/VHL/PIM1/GATA3/NPRL2,9
GO:2000779,BP,GO:2000779,regulation of double-strand break repair,8/269,132/18888,0.060606061,4.25549172,4.511416285,0.000613641,0.001944193,0.000815283,PARP1/KDM1A/ARID1A/SMARCA4/SMARCA2/MEAF6/SMARCE1/TWIST1,8
GO:0002675,BP,GO:0002675,positive regulation of acute inflammatory response,4/269,28/18888,0.142857143,10.03080191,5.747962709,0.000629244,0.001974403,0.000827952,IL6/PTGS2/IL1B/TNF,4
GO:0003272,BP,GO:0003272,endocardial cushion formation,4/269,28/18888,0.142857143,10.03080191,5.747962709,0.000629244,0.001974403,0.000827952,NOTCH1/TGFBR1/SNAI1/SNAI2,4
GO:0006027,BP,GO:0006027,glycosaminoglycan catabolic process,4/269,28/18888,0.142857143,10.03080191,5.747962709,0.000629244,0.001974403,0.000827952,CD44/FGF2/TGFB1/LYVE1,4
GO:0010592,BP,GO:0010592,positive regulation of lamellipodium assembly,4/269,28/18888,0.142857143,10.03080191,5.747962709,0.000629244,0.001974403,0.000827952,PIK3CA/MTOR/FSCN1/HSP90AA1,4
GO:0021854,BP,GO:0021854,hypothalamus development,4/269,28/18888,0.142857143,10.03080191,5.747962709,0.000629244,0.001974403,0.000827952,SRD5A2/CTNNB1/NCOA1/BAX,4
GO:0030194,BP,GO:0030194,positive regulation of blood coagulation,4/269,28/18888,0.142857143,10.03080191,5.747962709,0.000629244,0.001974403,0.000827952,THBS1/SERPINE1/THBD/PLAU,4
GO:0043507,BP,GO:0043507,positive regulation of JUN kinase activity,4/269,28/18888,0.142857143,10.03080191,5.747962709,0.000629244,0.001974403,0.000827952,MAP3K7/TNF/DAB2IP/MAP2K7,4
GO:0050995,BP,GO:0050995,negative regulation of lipid catabolic process,4/269,28/18888,0.142857143,10.03080191,5.747962709,0.000629244,0.001974403,0.000827952,ALK/IL1B/TNF/AKT1,4
GO:0050999,BP,GO:0050999,regulation of nitric-oxide synthase activity,4/269,28/18888,0.142857143,10.03080191,5.747962709,0.000629244,0.001974403,0.000827952,IL1B/HIF1A/AKT1/EGFR,4
GO:0060966,BP,GO:0060966,regulation of gene silencing by regulatory ncRNA,4/269,28/18888,0.142857143,10.03080191,5.747962709,0.000629244,0.001974403,0.000827952,TP53/IL6/STAT3/TGFB1,4
GO:0090330,BP,GO:0090330,regulation of platelet aggregation,4/269,28/18888,0.142857143,10.03080191,5.747962709,0.000629244,0.001974403,0.000827952,ALOX12/IL6/PRKCD/CD9,4
GO:1900048,BP,GO:1900048,positive regulation of hemostasis,4/269,28/18888,0.142857143,10.03080191,5.747962709,0.000629244,0.001974403,0.000827952,THBS1/SERPINE1/THBD/PLAU,4
GO:2000647,BP,GO:2000647,negative regulation of stem cell proliferation,4/269,28/18888,0.142857143,10.03080191,5.747962709,0.000629244,0.001974403,0.000827952,TP53/FGF2/SNAI2/SFN,4
GO:2000819,BP,GO:2000819,regulation of nucleotide-excision repair,4/269,28/18888,0.142857143,10.03080191,5.747962709,0.000629244,0.001974403,0.000827952,ARID1A/SMARCA4/SMARCA2/SMARCE1,4
GO:0006633,BP,GO:0006633,fatty acid biosynthetic process,9/269,166/18888,0.054216867,3.806870605,4.365960178,0.000638858,0.002003191,0.000840024,BRCA1/ALOX12/PTGS2/FASN/IL1B/GSTP1/ALOX15B/CYP1A1/AKR1C3,9
GO:0035967,BP,GO:0035967,cellular response to topologically incorrect protein,7/269,102/18888,0.068627451,4.818718565,4.648148919,0.000641998,0.002010568,0.000843118,CCND1/HDAC6/CAV1/CUL3/BAX/DAB2IP/HSPA5,7
GO:0002244,BP,GO:0002244,hematopoietic progenitor cell differentiation,8/269,133/18888,0.060150376,4.223495542,4.484084772,0.000645022,0.002010568,0.000843118,TP53/MYB/NOTCH1/TGFB1/KDR/BRAF/GATA3/MED1,8
GO:0042476,BP,GO:0042476,odontogenesis,8/269,133/18888,0.060150376,4.223495542,4.484084772,0.000645022,0.002010568,0.000843118,CTNNB1/RHOA/BSG/BAX/SERPINE1/TP63/FGFR1/TFAP2A,8
GO:0031294,BP,GO:0031294,lymphocyte costimulation,5/269,49/18888,0.102040816,7.164858508,5.193638106,0.000645182,0.002010568,0.000843118,PIK3CA/MTOR/AKT1/CAV1/CD274,5
GO:0031297,BP,GO:0031297,replication fork processing,5/269,49/18888,0.102040816,7.164858508,5.193638106,0.000645182,0.002010568,0.000843118,BRCA1/BRCA2/PARP1/PCNA/NBN,5
GO:0032369,BP,GO:0032369,negative regulation of lipid transport,5/269,49/18888,0.102040816,7.164858508,5.193638106,0.000645182,0.002010568,0.000843118,THBS1/NFKB1/AKT1/MIR145/MIR130B,5
GO:0033628,BP,GO:0033628,regulation of cell adhesion mediated by integrin,5/269,49/18888,0.102040816,7.164858508,5.193638106,0.000645182,0.002010568,0.000843118,PTK2/SERPINE1/SNAI2/MUC1/PLAU,5
GO:0048538,BP,GO:0048538,thymus development,5/269,49/18888,0.102040816,7.164858508,5.193638106,0.000645182,0.002010568,0.000843118,CTNNB1/MAPK1/TGFBR1/BRAF/GATA3,5
GO:0051489,BP,GO:0051489,regulation of filopodium assembly,5/269,49/18888,0.102040816,7.164858508,5.193638106,0.000645182,0.002010568,0.000843118,TENM1/PRKCD/TGFBR1/FSCN1/MIEN1,5
GO:0050795,BP,GO:0050795,regulation of behavior,6/269,74/18888,0.081081081,5.693157842,4.862055422,0.000650198,0.002023431,0.000848512,PARP1/STAT3/MTOR/MC1R/GRPR/UCN,6
GO:0070373,BP,GO:0070373,negative regulation of ERK1 and ERK2 cascade,6/269,74/18888,0.081081081,5.693157842,4.862055422,0.000650198,0.002023431,0.000848512,GSTP1/TLR4/DUSP6/PSCA/MIR200C/DAB2IP,6
GO:0098813,BP,GO:0098813,nuclear chromosome segregation,13/269,317/18888,0.041009464,2.87950465,4.05634462,0.000653942,0.002033693,0.000852815,PTEN/AURKA/ARID1A/XRCC3/SMARCA4/SMARCA2/RHOA/KATNB1/CHEK2/CUL3/RB1/SMARCE1/MLH1,13
GO:0006260,BP,GO:0006260,DNA replication,12/269,278/18888,0.043165468,3.030889786,4.10029422,0.00067087,0.002084913,0.000874293,TP53/BRCA1/BRCA2/PARP1/CDK2/PCNA/EGFR/MEAF6/NBN/FGFR1/CDKN1A/UCN,12
GO:0045727,BP,GO:0045727,positive regulation of translation,8/269,134/18888,0.059701493,4.191976918,4.457020584,0.000677685,0.002104656,0.000882573,THBS1/CNBP/ERBB2/YBX1/IL6/MTOR/TNF/UCN,8
GO:0009749,BP,GO:0009749,response to glucose,10/269,203/18888,0.049261084,3.458897211,4.233711852,0.000685231,0.002126642,0.000891792,THBS1/GPX1/PIK3CA/CASP3/IGF1R/HIF1A/SMARCA4/HNF1B/SMAD3/PCSK1,10
GO:0003205,BP,GO:0003205,cardiac chamber development,9/269,168/18888,0.053571429,3.761550717,4.321496807,0.000696174,0.002159135,0.000905418,TP53/SOX11/IGF1R/NOTCH1/HIF1A/TGFBR1/TGFB1/GATA3/MED1,9
GO:0002637,BP,GO:0002637,regulation of immunoglobulin production,6/269,75/18888,0.08,5.617249071,4.815754739,0.00069843,0.002163187,0.000907117,IL6/TNF/TGFB1/IL10/MLH1/MSH2,6
GO:0060390,BP,GO:0060390,regulation of SMAD protein signal transduction,6/269,75/18888,0.08,5.617249071,4.815754739,0.00069843,0.002163187,0.000907117,PPARG/PARP1/TWSG1/TGFBR1/TGFB1/MIR145,6
GO:0000280,BP,GO:0000280,nuclear division,16/269,446/18888,0.035874439,2.518945772,3.901980943,0.000698946,0.002163315,0.000907171,PTEN/AURKA/BRCA2/IL1B/XRCC3/TNF/RHOA/KATNB1/CHEK2/CUL3/RB1/TGFA/IGF1/SPHK1/MLH1/IGF2,16
GO:0043457,BP,GO:0043457,regulation of cellular respiration,5/269,50/18888,0.1,7.021561338,5.12455519,0.000708631,0.002190315,0.000918493,PIK3CA/HIF1A/TNF/RHOA/BNIP3,5
GO:0060976,BP,GO:0060976,coronary vasculature development,5/269,50/18888,0.1,7.021561338,5.12455519,0.000708631,0.002190315,0.000918493,VEGFA/FGF2/NOTCH1/TGFBR1/MIR145,5
GO:0006354,BP,GO:0006354,DNA-templated transcription elongation,8/269,135/18888,0.059259259,4.160925238,4.430218901,0.000711668,0.00219821,0.000921804,CTNNB1/PARP1/ELL2/EZH2/CDK12/BRD4/VHL/MED1,8
GO:0019218,BP,GO:0019218,regulation of steroid metabolic process,7/269,104/18888,0.067307692,4.726050901,4.579845922,0.000720984,0.002219022,0.000930531,NFKB1/IGF1R/TNF/FGFR4/SNAI1/SNAI2/AKR1C3,7
GO:0033045,BP,GO:0033045,regulation of sister chromatid segregation,7/269,104/18888,0.067307692,4.726050901,4.579845922,0.000720984,0.002219022,0.000930531,ARID1A/XRCC3/SMARCA4/SMARCA2/CUL3/RB1/SMARCE1,7
GO:1903311,BP,GO:1903311,regulation of mRNA metabolic process,15/269,404/18888,0.037128713,2.607015348,3.92457092,0.000721551,0.002219022,0.000930531,YBX1/MAPK14/RNASEL/SRPK1/PRKCD/AKT1/MIR200C/PKP1/PKP3/VIM/MIR145/MLH1/MIR130B/ROCK1/MYD88,15
GO:0035872,BP,GO:0035872,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway",4/269,29/18888,0.137931034,9.684912191,5.625803446,0.000721815,0.002219022,0.000930531,MAP3K7/TLR4/RELA/NFKBIA,4
GO:0060479,BP,GO:0060479,lung cell differentiation,4/269,29/18888,0.137931034,9.684912191,5.625803446,0.000721815,0.002219022,0.000930531,CTNNB1/KRAS/FOXA1/SPDEF,4
GO:0060487,BP,GO:0060487,lung epithelial cell differentiation,4/269,29/18888,0.137931034,9.684912191,5.625803446,0.000721815,0.002219022,0.000930531,CTNNB1/KRAS/FOXA1/SPDEF,4
GO:0072207,BP,GO:0072207,metanephric epithelium development,4/269,29/18888,0.137931034,9.684912191,5.625803446,0.000721815,0.002219022,0.000930531,CXCR2/WT1/STAT1/LGR4,4
GO:0014004,BP,GO:0014004,microglia differentiation,3/269,13/18888,0.230769231,16.20360309,6.591043431,0.00073501,0.002236946,0.000938047,TLR4/TGFB1/MYD88,3
GO:0032494,BP,GO:0032494,response to peptidoglycan,3/269,13/18888,0.230769231,16.20360309,6.591043431,0.00073501,0.002236946,0.000938047,IL6/RELA/MYD88,3
GO:0033079,BP,GO:0033079,immature T cell proliferation,3/269,13/18888,0.230769231,16.20360309,6.591043431,0.00073501,0.002236946,0.000938047,ERBB2/IL1B/BMI1,3
GO:0033080,BP,GO:0033080,immature T cell proliferation in thymus,3/269,13/18888,0.230769231,16.20360309,6.591043431,0.00073501,0.002236946,0.000938047,ERBB2/IL1B/BMI1,3
GO:0034111,BP,GO:0034111,negative regulation of homotypic cell-cell adhesion,3/269,13/18888,0.230769231,16.20360309,6.591043431,0.00073501,0.002236946,0.000938047,ALOX12/PRKCD/CD9,3
GO:0042921,BP,GO:0042921,glucocorticoid receptor signaling pathway,3/269,13/18888,0.230769231,16.20360309,6.591043431,0.00073501,0.002236946,0.000938047,ARID1A/PER1/CLOCK,3
GO:0045605,BP,GO:0045605,negative regulation of epidermal cell differentiation,3/269,13/18888,0.230769231,16.20360309,6.591043431,0.00073501,0.002236946,0.000938047,NOTCH1/EZH2/TP63,3
GO:0045683,BP,GO:0045683,negative regulation of epidermis development,3/269,13/18888,0.230769231,16.20360309,6.591043431,0.00073501,0.002236946,0.000938047,NOTCH1/EZH2/TP63,3
GO:0045737,BP,GO:0045737,positive regulation of cyclin-dependent protein serine/threonine kinase activity,3/269,13/18888,0.230769231,16.20360309,6.591043431,0.00073501,0.002236946,0.000938047,CCND1/AKT1/EGFR,3
GO:0060965,BP,GO:0060965,negative regulation of miRNA-mediated gene silencing,3/269,13/18888,0.230769231,16.20360309,6.591043431,0.00073501,0.002236946,0.000938047,TP53/IL6/STAT3,3
GO:0061517,BP,GO:0061517,macrophage proliferation,3/269,13/18888,0.230769231,16.20360309,6.591043431,0.00073501,0.002236946,0.000938047,MAPK1/PTK2/CLU,3
GO:0071801,BP,GO:0071801,regulation of podosome assembly,3/269,13/18888,0.230769231,16.20360309,6.591043431,0.00073501,0.002236946,0.000938047,TNF/RHOA/FSCN1,3
GO:1901862,BP,GO:1901862,negative regulation of muscle tissue development,3/269,13/18888,0.230769231,16.20360309,6.591043431,0.00073501,0.002236946,0.000938047,TGFB1/TWIST1/FGF3,3
GO:1903377,BP,GO:1903377,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,3/269,13/18888,0.230769231,16.20360309,6.591043431,0.00073501,0.002236946,0.000938047,CTNNB1/HIF1A/IL10,3
GO:1903624,BP,GO:1903624,regulation of DNA catabolic process,3/269,13/18888,0.230769231,16.20360309,6.591043431,0.00073501,0.002236946,0.000938047,IL6/BAX/AIFM1,3
GO:0045732,BP,GO:0045732,positive regulation of protein catabolic process,10/269,205/18888,0.048780488,3.425151872,4.196353044,0.000739014,0.002247629,0.000942527,AURKA/FBXW7/IL1B/RILP/TNF/AKT1/CAV1/DAB2IP/HSP90AA1/CLU,10
GO:0050804,BP,GO:0050804,modulation of chemical synaptic transmission,17/269,493/18888,0.034482759,2.421228048,3.843410634,0.000744952,0.002264176,0.000949466,PTEN/PTGS2/IL1B/CDH1/HDAC6/SQSTM1/MAPK1/TNF/KRAS/SNCG/EGFR/GIT1/BRAF/MME/HRAS/UCN/CRHR2,17
GO:0001707,BP,GO:0001707,mesoderm formation,6/269,76/18888,0.078947368,5.543337899,4.770279246,0.000749385,0.0022731,0.000953208,TWSG1/SMAD3/MIR200C/SNAI1/MIR145/FGFR1,6
GO:0002200,BP,GO:0002200,somatic diversification of immune receptors,6/269,76/18888,0.078947368,5.543337899,4.770279246,0.000749385,0.0022731,0.000953208,ERCC1/TGFB1/IL10/MLH1/MSH2/NBN,6
GO:0002224,BP,GO:0002224,toll-like receptor signaling pathway,6/269,76/18888,0.078947368,5.543337899,4.770279246,0.000749385,0.0022731,0.000953208,MAP3K7/TLR4/CD274/LGR4/ESR1/MYD88,6
GO:0060560,BP,GO:0060560,developmental growth involved in morphogenesis,11/269,243/18888,0.04526749,3.178484556,4.108240718,0.000756874,0.002294291,0.000962095,CTNNB1/AURKA/VEGFA/CDH1/NOTCH1/HDAC6/HNF1B/LZTS2/FN1/MED1/ESR1,11
GO:0007009,BP,GO:0007009,plasma membrane organization,9/269,170/18888,0.052941176,3.717297179,4.277709925,0.000757622,0.002295031,0.000962405,PTEN/AR/FASLG/PRKCD/AKT1/CAV1/EPB41L3/CD9/CLU,9
GO:0099177,BP,GO:0099177,regulation of trans-synaptic signaling,17/269,494/18888,0.034412955,2.416326776,3.834142972,0.000761805,0.002306168,0.000967075,PTEN/PTGS2/IL1B/CDH1/HDAC6/SQSTM1/MAPK1/TNF/KRAS/SNCG/EGFR/GIT1/BRAF/MME/HRAS/UCN/CRHR2,17
GO:0110020,BP,GO:0110020,regulation of actomyosin structure organization,7/269,105/18888,0.066666667,4.681040892,4.546343716,0.000763259,0.002307504,0.000967636,MTOR/RHOA/TGFBR1/SMAD3/DLC1/BRAF/ROCK1,7
GO:1905477,BP,GO:1905477,positive regulation of protein localization to membrane,7/269,105/18888,0.066666667,4.681040892,4.546343716,0.000763259,0.002307504,0.000967636,ERBB2/PIK3CA/SQSTM1/TNF/AKT1/EGFR/HRAS,7
GO:0071674,BP,GO:0071674,mononuclear cell migration,10/269,206/18888,0.048543689,3.408524921,4.177846938,0.000767183,0.002317829,0.000971965,THBS1/CXCR2/IL6/MAPK1/TNF/RHOA/AKT1/PTK2/SERPINE1/GATA3,10
GO:0002269,BP,GO:0002269,leukocyte activation involved in inflammatory response,5/269,51/18888,0.098039216,6.883883665,5.057346974,0.000776631,0.002340167,0.000981332,IL6/TNF/SPHK1/MYD88/CLU,5
GO:0006636,BP,GO:0006636,unsaturated fatty acid biosynthetic process,5/269,51/18888,0.098039216,6.883883665,5.057346974,0.000776631,0.002340167,0.000981332,ALOX12/PTGS2/IL1B/ALOX15B/AKR1C3,5
GO:0010719,BP,GO:0010719,negative regulation of epithelial to mesenchymal transition,5/269,51/18888,0.098039216,6.883883665,5.057346974,0.000776631,0.002340167,0.000981332,PTEN/FOXA1/DAB2IP/MIR145/GATA3,5
GO:0051496,BP,GO:0051496,positive regulation of stress fiber assembly,5/269,51/18888,0.098039216,6.883883665,5.057346974,0.000776631,0.002340167,0.000981332,MTOR/RHOA/TGFBR1/SMAD3/BRAF,5
GO:0034219,BP,GO:0034219,carbohydrate transmembrane transport,8/269,137/18888,0.058394161,4.100181803,4.377384378,0.000783754,0.002358509,0.000989024,IL1B/MAPK14/RNASEL/TNF/AKT1/IRS1/IGF1/BRAF,8
GO:1904375,BP,GO:1904375,regulation of protein localization to cell periphery,8/269,137/18888,0.058394161,4.100181803,4.377384378,0.000783754,0.002358509,0.000989024,AR/MMP14/SQSTM1/TNF/AKT1/TGFB1/EGFR/HRAS,8
GO:0001937,BP,GO:0001937,negative regulation of endothelial cell proliferation,6/269,77/18888,0.077922078,5.471346497,4.725602645,0.000803165,0.002415327,0.00101285,THBS1/PPARG/TNF/TGFBR1/CAV1/STAT1,6
GO:0006626,BP,GO:0006626,protein targeting to mitochondrion,7/269,106/18888,0.066037736,4.636880129,4.513261067,0.000807472,0.002425077,0.001016939,FBXW7/BID/NPEPPS/BAP1/AIFM1/HSP90AA1/BNIP3L,7
GO:0046425,BP,GO:0046425,regulation of receptor signaling pathway via JAK-STAT,7/269,106/18888,0.066037736,4.636880129,4.513261067,0.000807472,0.002425077,0.001016939,IL6/NOTCH1/TNF/CAV1/IL10/VHL/IFNA1,7
GO:0016485,BP,GO:0016485,protein processing,11/269,245/18888,0.044897959,3.152537744,4.076198942,0.000809502,0.002429574,0.001018825,THBS1/TMPRSS2/CASP8/CASP3/PARP1/MMP14/SERPINE1/PCSK1/MME/THBD/PLAU,11
GO:0005979,BP,GO:0005979,regulation of glycogen biosynthetic process,4/269,30/18888,0.133333333,9.362081784,5.509430091,0.000823618,0.002457369,0.00103048,AKT1/IRS1/IGF1/IGF2,4
GO:0010962,BP,GO:0010962,regulation of glucan biosynthetic process,4/269,30/18888,0.133333333,9.362081784,5.509430091,0.000823618,0.002457369,0.00103048,AKT1/IRS1/IGF1/IGF2,4
GO:0043032,BP,GO:0043032,positive regulation of macrophage activation,4/269,30/18888,0.133333333,9.362081784,5.509430091,0.000823618,0.002457369,0.00103048,THBS1/TLR4/IL10/MIR145,4
GO:0050820,BP,GO:0050820,positive regulation of coagulation,4/269,30/18888,0.133333333,9.362081784,5.509430091,0.000823618,0.002457369,0.00103048,THBS1/SERPINE1/THBD/PLAU,4
GO:0060441,BP,GO:0060441,epithelial tube branching involved in lung morphogenesis,4/269,30/18888,0.133333333,9.362081784,5.509430091,0.000823618,0.002457369,0.00103048,CTNNB1/TNF/KRAS/FOXA1,4
GO:0060603,BP,GO:0060603,mammary gland duct morphogenesis,4/269,30/18888,0.133333333,9.362081784,5.509430091,0.000823618,0.002457369,0.00103048,AR/VDR/MED1/ESR1,4
GO:0070168,BP,GO:0070168,negative regulation of biomineral tissue development,4/269,30/18888,0.133333333,9.362081784,5.509430091,0.000823618,0.002457369,0.00103048,NOTCH1/HIF1A/TGFB1/ROCK1,4
GO:0071295,BP,GO:0071295,cellular response to vitamin,4/269,30/18888,0.133333333,9.362081784,5.509430091,0.000823618,0.002457369,0.00103048,VDR/SNAI2/PIM1/MED1,4
GO:0090140,BP,GO:0090140,regulation of mitochondrial fission,4/269,30/18888,0.133333333,9.362081784,5.509430091,0.000823618,0.002457369,0.00103048,AURKA/PPARG/KDR/BNIP3,4
GO:0016064,BP,GO:0016064,immunoglobulin mediated immune response,10/269,208/18888,0.048076923,3.375750643,4.141174597,0.000826177,0.002463392,0.001033006,ERCC1/PRKCD/TNF/TGFB1/IL10/MLH1/MSH2/NBN/MYD88/CLU,10
GO:0043487,BP,GO:0043487,regulation of RNA stability,12/269,285/18888,0.042105263,2.956446879,4.00017003,0.000833489,0.002483568,0.001041467,YBX1/MAPK14/RNASEL/PRKCD/AKT1/MIR200C/VIM/MIR145/MLH1/MIR130B/ROCK1/MYD88,12
GO:0003197,BP,GO:0003197,endocardial cushion development,5/269,52/18888,0.096153846,6.751501287,4.991924479,0.000849384,0.002527626,0.001059942,NOTCH1/TGFBR1/SNAI1/TWIST1/SNAI2,5
GO:0051155,BP,GO:0051155,positive regulation of striated muscle cell differentiation,5/269,52/18888,0.096153846,6.751501287,4.991924479,0.000849384,0.002527626,0.001059942,MMP14/MAPK14/MTOR/TGFB1/IGF1,5
GO:0030316,BP,GO:0030316,osteoclast differentiation,7/269,107/18888,0.065420561,4.593544801,4.480588401,0.000853683,0.002537104,0.001063917,CTNNB1/FBXW7/MAPK14/MTOR/TLR4/FOS/TNF,7
GO:0032231,BP,GO:0032231,regulation of actin filament bundle assembly,7/269,107/18888,0.065420561,4.593544801,4.480588401,0.000853683,0.002537104,0.001063917,MTOR/RHOA/TGFBR1/SMAD3/DLC1/BRAF/ROCK1,7
GO:0032720,BP,GO:0032720,negative regulation of tumor necrosis factor production,6/269,78/18888,0.076923077,5.401201029,4.681699813,0.000859876,0.002548858,0.001068846,GSTP1/TLR4/IL10/IGF1/TWIST1/MC1R,6
GO:0046323,BP,GO:0046323,glucose import,6/269,78/18888,0.076923077,5.401201029,4.681699813,0.000859876,0.002548858,0.001068846,MAPK14/RNASEL/TNF/AKT1/IRS1/IGF1,6
GO:0048332,BP,GO:0048332,mesoderm morphogenesis,6/269,78/18888,0.076923077,5.401201029,4.681699813,0.000859876,0.002548858,0.001068846,TWSG1/SMAD3/MIR200C/SNAI1/MIR145/FGFR1,6
GO:0051145,BP,GO:0051145,smooth muscle cell differentiation,6/269,78/18888,0.076923077,5.401201029,4.681699813,0.000859876,0.002548858,0.001068846,CTNNB1/EDNRB/VEGFA/SOD2/NOTCH1/MIR145,6
GO:0006605,BP,GO:0006605,protein targeting,13/269,327/18888,0.039755352,2.791446404,3.927864203,0.00087064,0.002579087,0.001081522,ERBB2/FBXW7/BID/NPEPPS/BAP1/SQSTM1/KATNB1/HSPA5/AIFM1/HSP90AA1/HRAS/BNIP3L/CLU,13
GO:0006939,BP,GO:0006939,smooth muscle contraction,7/269,108/18888,0.064814815,4.551011979,4.448316452,0.000901957,0.002666655,0.001118243,PTGS2/EDNRB/RHOA/CAV1/SPHK1/MIR145/ROCK1,7
GO:0140888,BP,GO:0140888,interferon-mediated signaling pathway,7/269,108/18888,0.064814815,4.551011979,4.448316452,0.000901957,0.002666655,0.001118243,TP53/PPARG/IFI27/STAT1/MED1/IFNA1/MYD88,7
GO:1903076,BP,GO:1903076,regulation of protein localization to plasma membrane,7/269,108/18888,0.064814815,4.551011979,4.448316452,0.000901957,0.002666655,0.001118243,AR/MMP14/SQSTM1/TNF/AKT1/TGFB1/EGFR,7
GO:0007498,BP,GO:0007498,mesoderm development,8/269,140/18888,0.057142857,4.012320765,4.299987718,0.000902782,0.002667365,0.00111854,VEGFA/TWSG1/SMAD3/MIR200C/SNAI1/MIR145/TP63/FGFR1,8
GO:0035304,BP,GO:0035304,regulation of protein dephosphorylation,6/269,79/18888,0.075949367,5.332831396,4.638546731,0.000919624,0.002698944,0.001131783,MTOR/PRKCD/TNF/TGFB1/DLC1/ROCK1,6
GO:0043297,BP,GO:0043297,apical junction assembly,6/269,79/18888,0.075949367,5.332831396,4.638546731,0.000919624,0.002698944,0.001131783,TNF/RHOA/SLC39A9/SNAI1/SNAI2/ROCK1,6
GO:0097009,BP,GO:0097009,energy homeostasis,6/269,79/18888,0.075949367,5.332831396,4.638546731,0.000919624,0.002698944,0.001131783,PIK3CA/ALK/MAPK14/STAT3/SQSTM1/TWIST1,6
GO:1903533,BP,GO:1903533,regulation of protein targeting,6/269,79/18888,0.075949367,5.332831396,4.638546731,0.000919624,0.002698944,0.001131783,ERBB2/FBXW7/NPEPPS/BAP1/HRAS/BNIP3L,6
GO:0003222,BP,GO:0003222,ventricular trabecula myocardium morphogenesis,3/269,14/18888,0.214285714,15.04620287,6.319321242,0.000925653,0.002698944,0.001131783,NOTCH1/TGFBR1/MED1,3
GO:0010745,BP,GO:0010745,negative regulation of macrophage derived foam cell differentiation,3/269,14/18888,0.214285714,15.04620287,6.319321242,0.000925653,0.002698944,0.001131783,PPARG/MIR130B/NFKBIA,3
GO:0030213,BP,GO:0030213,hyaluronan biosynthetic process,3/269,14/18888,0.214285714,15.04620287,6.319321242,0.000925653,0.002698944,0.001131783,IL1B/NFKB1/TGFB1,3
GO:0031958,BP,GO:0031958,corticosteroid receptor signaling pathway,3/269,14/18888,0.214285714,15.04620287,6.319321242,0.000925653,0.002698944,0.001131783,ARID1A/PER1/CLOCK,3
GO:0043353,BP,GO:0043353,enucleate erythrocyte differentiation,3/269,14/18888,0.214285714,15.04620287,6.319321242,0.000925653,0.002698944,0.001131783,HDAC6/RB1/MED1,3
GO:0048715,BP,GO:0048715,negative regulation of oligodendrocyte differentiation,3/269,14/18888,0.214285714,15.04620287,6.319321242,0.000925653,0.002698944,0.001131783,CTNNB1/NOTCH1/ID4,3
GO:0051547,BP,GO:0051547,regulation of keratinocyte migration,3/269,14/18888,0.214285714,15.04620287,6.319321242,0.000925653,0.002698944,0.001131783,PTEN/MTOR/MMP9,3
GO:0060149,BP,GO:0060149,negative regulation of post-transcriptional gene silencing,3/269,14/18888,0.214285714,15.04620287,6.319321242,0.000925653,0.002698944,0.001131783,TP53/IL6/STAT3,3
GO:0060967,BP,GO:0060967,negative regulation of gene silencing by regulatory ncRNA,3/269,14/18888,0.214285714,15.04620287,6.319321242,0.000925653,0.002698944,0.001131783,TP53/IL6/STAT3,3
GO:0072075,BP,GO:0072075,metanephric mesenchyme development,3/269,14/18888,0.214285714,15.04620287,6.319321242,0.000925653,0.002698944,0.001131783,MYC/WT1/STAT1,3
GO:0072160,BP,GO:0072160,nephron tubule epithelial cell differentiation,3/269,14/18888,0.214285714,15.04620287,6.319321242,0.000925653,0.002698944,0.001131783,CTNNB1/GATA3/STAT1,3
GO:0140052,BP,GO:0140052,cellular response to oxidised low-density lipoprotein particle stimulus,3/269,14/18888,0.214285714,15.04620287,6.319321242,0.000925653,0.002698944,0.001131783,TLR4/AKT1/MYD88,3
GO:1900369,BP,GO:1900369,negative regulation of post-transcriptional gene silencing by regulatory ncRNA,3/269,14/18888,0.214285714,15.04620287,6.319321242,0.000925653,0.002698944,0.001131783,TP53/IL6/STAT3,3
GO:1903894,BP,GO:1903894,regulation of IRE1-mediated unfolded protein response,3/269,14/18888,0.214285714,15.04620287,6.319321242,0.000925653,0.002698944,0.001131783,BAX/DAB2IP/HSPA5,3
GO:0002639,BP,GO:0002639,positive regulation of immunoglobulin production,5/269,53/18888,0.094339623,6.62411447,4.928204582,0.000927095,0.002698944,0.001131783,IL6/TGFB1/IL10/MLH1/MSH2,5
GO:0038084,BP,GO:0038084,vascular endothelial growth factor signaling pathway,5/269,53/18888,0.094339623,6.62411447,4.928204582,0.000927095,0.002698944,0.001131783,PIK3CA/VEGFA/RELA/DAB2IP/KDR,5
GO:0060193,BP,GO:0060193,positive regulation of lipase activity,5/269,53/18888,0.094339623,6.62411447,4.928204582,0.000927095,0.002698944,0.001131783,RHOA/EGFR/HRAS/FGFR1/ESR1,5
GO:1902743,BP,GO:1902743,regulation of lamellipodium organization,5/269,53/18888,0.094339623,6.62411447,4.928204582,0.000927095,0.002698944,0.001131783,PIK3CA/CD44/MTOR/FSCN1/HSP90AA1,5
GO:1904894,BP,GO:1904894,positive regulation of receptor signaling pathway via STAT,5/269,53/18888,0.094339623,6.62411447,4.928204582,0.000927095,0.002698944,0.001131783,IL6/NOTCH1/TNF/TGFB1/IL10,5
GO:1903008,BP,GO:1903008,organelle disassembly,9/269,175/18888,0.051428571,3.611088688,4.171078785,0.00093078,0.00270794,0.001135556,TP53/AURKA/FBXW7/HIF1A/HDAC6/SQSTM1/BNIP3/BNIP3L/CAMKK2,9
GO:0003338,BP,GO:0003338,metanephros morphogenesis,4/269,31/18888,0.129032258,9.060079146,5.398378198,0.000935142,0.002713698,0.00113797,CTNNB1/WT1/STAT1/LGR4,4
GO:0051491,BP,GO:0051491,positive regulation of filopodium assembly,4/269,31/18888,0.129032258,9.060079146,5.398378198,0.000935142,0.002713698,0.00113797,TENM1/TGFBR1/FSCN1/MIEN1,4
GO:0090322,BP,GO:0090322,regulation of superoxide metabolic process,4/269,31/18888,0.129032258,9.060079146,5.398378198,0.000935142,0.002713698,0.00113797,GSTP1/PRKCD/TGFB1/EGFR,4
GO:0150117,BP,GO:0150117,positive regulation of cell-substrate junction organization,4/269,31/18888,0.129032258,9.060079146,5.398378198,0.000935142,0.002713698,0.00113797,VEGFA/SMAD3/KDR/ROCK1,4
GO:0001676,BP,GO:0001676,long-chain fatty acid metabolic process,7/269,109/18888,0.064220183,4.509259575,4.416436249,0.000952357,0.002761896,0.001158182,ALOX12/GPX1/PTGS2/GSTP1/ALOX15B/CYP1A1/AKR1C3,7
GO:0019724,BP,GO:0019724,B cell mediated immunity,10/269,212/18888,0.047169811,3.312057235,4.069153124,0.000955383,0.002767149,0.001160384,ERCC1/PRKCD/TNF/TGFB1/IL10/MLH1/MSH2/NBN/MYD88/CLU,10
GO:0042594,BP,GO:0042594,response to starvation,10/269,212/18888,0.047169811,3.312057235,4.069153124,0.000955383,0.002767149,0.001160384,TP53/IGF1R/MTOR/MAPK1/FOS/HSPA5/PMAIP1/AKR1C3/CDKN1A/NPRL2,10
GO:0014032,BP,GO:0014032,neural crest cell development,6/269,80/18888,0.075,5.266171004,4.596120424,0.000982517,0.002843932,0.001192583,EDNRB/HIF1A/MAPK1/FN1/TWIST1/SNAI2,6
GO:0034341,BP,GO:0034341,response to type II interferon,8/269,142/18888,0.056338028,3.955809205,4.249577141,0.000989886,0.002863441,0.001200764,TP53/PPARG/FASLG/TLR4/TNF/VIM/STAT1/MED1,8
GO:0030178,BP,GO:0030178,negative regulation of Wnt signaling pathway,9/269,177/18888,0.050847458,3.570285426,4.12951399,0.001008468,0.002910457,0.00122048,CTNNB1/CTNND1/NOTCH1/MAPK14/LZTS2/CAV1/DAB2IP/SNAI2/SOX2,9
GO:0050806,BP,GO:0050806,positive regulation of synaptic transmission,9/269,177/18888,0.050847458,3.570285426,4.12951399,0.001008468,0.002910457,0.00122048,PTGS2/HDAC6/SQSTM1/MAPK1/TNF/EGFR/BRAF/MME/CRHR2,9
GO:0010656,BP,GO:0010656,negative regulation of muscle cell apoptotic process,5/269,54/18888,0.092592593,6.501445684,4.866109535,0.001009972,0.002910457,0.00122048,ALOX12/IGF1R/IGF1/MIR145/ESR1,5
GO:0010874,BP,GO:0010874,regulation of cholesterol efflux,5/269,54/18888,0.092592593,6.501445684,4.866109535,0.001009972,0.002910457,0.00122048,PPARG/CAV1/MIR145/MIR130B/NFKBIA,5
GO:0035306,BP,GO:0035306,positive regulation of dephosphorylation,5/269,54/18888,0.092592593,6.501445684,4.866109535,0.001009972,0.002910457,0.00122048,MTOR/PRKCD/TGFB1/DLC1/ROCK1,5
GO:0050873,BP,GO:0050873,brown fat cell differentiation,5/269,54/18888,0.092592593,6.501445684,4.866109535,0.001009972,0.002910457,0.00122048,PTGS2/LAMB3/MAPK14/BNIP3/PIM1,5
GO:0002720,BP,GO:0002720,positive regulation of cytokine production involved in immune response,6/269,81/18888,0.074074074,5.201156547,4.554398903,0.001048665,0.00302005,0.001266436,IL6/MAP3K7/IL1B/TLR4/GATA3/MYD88,6
GO:0003299,BP,GO:0003299,muscle hypertrophy in response to stress,4/269,32/18888,0.125,8.776951673,5.292234246,0.00105688,0.003037946,0.001273941,MIR25/PPARG/EZH2/SMAD3,4
GO:0014887,BP,GO:0014887,cardiac muscle adaptation,4/269,32/18888,0.125,8.776951673,5.292234246,0.00105688,0.003037946,0.001273941,MIR25/PPARG/EZH2/SMAD3,4
GO:0014898,BP,GO:0014898,cardiac muscle hypertrophy in response to stress,4/269,32/18888,0.125,8.776951673,5.292234246,0.00105688,0.003037946,0.001273941,MIR25/PPARG/EZH2/SMAD3,4
GO:0072659,BP,GO:0072659,protein localization to plasma membrane,12/269,293/18888,0.040955631,2.87572478,3.889415037,0.001058416,0.003040445,0.001274989,AR/MMP14/CDH1/SQSTM1/TNF/AKT1/TGFB1/EPB41L3/BSG/EGFR/PKP3/ROCK1,12
GO:0030203,BP,GO:0030203,glycosaminoglycan metabolic process,7/269,111/18888,0.063063063,4.428011655,4.353816594,0.001059799,0.003042499,0.00127585,EDNRB/IL1B/NFKB1/CD44/FGF2/TGFB1/LYVE1,7
GO:0060348,BP,GO:0060348,bone development,10/269,215/18888,0.046511628,3.265842483,4.016255662,0.001062793,0.003049172,0.001278649,SRD5A2/TP53/FBXW7/MMP14/MAPK14/RHOA/KDR/IGF1/TWIST1/TFAP2A,10
GO:0010659,BP,GO:0010659,cardiac muscle cell apoptotic process,5/269,55/18888,0.090909091,6.38323758,4.805566515,0.001098224,0.003146862,0.001319614,TP53/CXCR2/BNIP3/MIR145/HSP90AA1,5
GO:2000772,BP,GO:2000772,regulation of cellular senescence,5/269,55/18888,0.090909091,6.38323758,4.805566515,0.001098224,0.003146862,0.001319614,TP53/PTEN/YBX1/TWIST1/PAWR,5
GO:0001325,BP,GO:0001325,formation of extrachromosomal circular DNA,3/269,15/18888,0.2,14.04312268,6.074159514,0.001144934,0.003260199,0.001367141,ERCC1/XRCC3/NBN,3
GO:0032352,BP,GO:0032352,positive regulation of hormone metabolic process,3/269,15/18888,0.2,14.04312268,6.074159514,0.001144934,0.003260199,0.001367141,IGF1R/HIF1A/GATA3,3
GO:0044849,BP,GO:0044849,estrous cycle,3/269,15/18888,0.2,14.04312268,6.074159514,0.001144934,0.003260199,0.001367141,IGF1R/NCOA1/PCNA,3
GO:0060572,BP,GO:0060572,morphogenesis of an epithelial bud,3/269,15/18888,0.2,14.04312268,6.074159514,0.001144934,0.003260199,0.001367141,CTNNB1/AR/TP63,3
GO:0071218,BP,GO:0071218,cellular response to misfolded protein,3/269,15/18888,0.2,14.04312268,6.074159514,0.001144934,0.003260199,0.001367141,HDAC6/CAV1/CUL3,3
GO:0090656,BP,GO:0090656,t-circle formation,3/269,15/18888,0.2,14.04312268,6.074159514,0.001144934,0.003260199,0.001367141,ERCC1/XRCC3/NBN,3
GO:0090737,BP,GO:0090737,telomere maintenance via telomere trimming,3/269,15/18888,0.2,14.04312268,6.074159514,0.001144934,0.003260199,0.001367141,ERCC1/XRCC3/NBN,3
GO:1901203,BP,GO:1901203,positive regulation of extracellular matrix assembly,3/269,15/18888,0.2,14.04312268,6.074159514,0.001144934,0.003260199,0.001367141,TGFBR1/SMAD3/TGFB1,3
GO:1901722,BP,GO:1901722,regulation of cell proliferation involved in kidney development,3/269,15/18888,0.2,14.04312268,6.074159514,0.001144934,0.003260199,0.001367141,MYC/WT1/GATA3,3
GO:1902166,BP,GO:1902166,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,3/269,15/18888,0.2,14.04312268,6.074159514,0.001144934,0.003260199,0.001367141,KDM1A/CD44/MUC1,3
GO:0034440,BP,GO:0034440,lipid oxidation,7/269,113/18888,0.061946903,4.349639767,4.292663118,0.001176543,0.003348114,0.001404008,AMACR/ALOX12/MAPK14/AKT1/ALOX15B/IRS1/TWIST1,7
GO:0002443,BP,GO:0002443,leukocyte mediated immunity,16/269,469/18888,0.034115139,2.395415382,3.678208618,0.001184795,0.003360358,0.001409142,ERCC1/IL6/MAP3K7/IL1B/TLR4/PRKCD/TNF/TGFB1/IL10/GATA3/CD8A/MLH1/MSH2/NBN/MYD88/CLU,16
GO:0016242,BP,GO:0016242,negative regulation of macroautophagy,4/269,33/18888,0.121212121,8.51098344,5.190628659,0.001189323,0.003360358,0.001409142,TP53/PIK3CA/MTOR/AKT1,4
GO:0031069,BP,GO:0031069,hair follicle morphogenesis,4/269,33/18888,0.121212121,8.51098344,5.190628659,0.001189323,0.003360358,0.001409142,CTNNB1/NOTCH1/SNAI1/TP63,4
GO:0031128,BP,GO:0031128,developmental induction,4/269,33/18888,0.121212121,8.51098344,5.190628659,0.001189323,0.003360358,0.001409142,CTNNB1/AR/FGF2/FGFR1,4
GO:0035115,BP,GO:0035115,embryonic forelimb morphogenesis,4/269,33/18888,0.121212121,8.51098344,5.190628659,0.001189323,0.003360358,0.001409142,CTNNB1/TWIST1/TP63/TFAP2A,4
GO:0045907,BP,GO:0045907,positive regulation of vasoconstriction,4/269,33/18888,0.121212121,8.51098344,5.190628659,0.001189323,0.003360358,0.001409142,PTGS2/RHOA/CAV1/EGFR,4
GO:0051973,BP,GO:0051973,positive regulation of telomerase activity,4/269,33/18888,0.121212121,8.51098344,5.190628659,0.001189323,0.003360358,0.001409142,MYC/MAPK1/HSP90AA1/MAP2K7,4
GO:0072539,BP,GO:0072539,T-helper 17 cell differentiation,4/269,33/18888,0.121212121,8.51098344,5.190628659,0.001189323,0.003360358,0.001409142,IL6/STAT3/BRD2/BRD4,4
GO:1901524,BP,GO:1901524,regulation of mitophagy,4/269,33/18888,0.121212121,8.51098344,5.190628659,0.001189323,0.003360358,0.001409142,TP53/FBXW7/HIF1A/BNIP3L,4
GO:1903715,BP,GO:1903715,regulation of aerobic respiration,4/269,33/18888,0.121212121,8.51098344,5.190628659,0.001189323,0.003360358,0.001409142,HIF1A/TNF/RHOA/BNIP3,4
GO:0010833,BP,GO:0010833,telomere maintenance via telomere lengthening,6/269,83/18888,0.072289157,5.075827473,4.472986876,0.001191172,0.003360358,0.001409142,TP53/CTNNB1/PARP1/MAPK1/HSP90AA1/MAP2K7,6
GO:0032371,BP,GO:0032371,regulation of sterol transport,6/269,83/18888,0.072289157,5.075827473,4.472986876,0.001191172,0.003360358,0.001409142,NFKB1/PPARG/CAV1/MIR145/MIR130B/NFKBIA,6
GO:0032374,BP,GO:0032374,regulation of cholesterol transport,6/269,83/18888,0.072289157,5.075827473,4.472986876,0.001191172,0.003360358,0.001409142,NFKB1/PPARG/CAV1/MIR145/MIR130B/NFKBIA,6
GO:0120193,BP,GO:0120193,tight junction organization,6/269,83/18888,0.072289157,5.075827473,4.472986876,0.001191172,0.003360358,0.001409142,TNF/TGFBR1/SLC39A9/SNAI1/SNAI2/ROCK1,6
GO:0045912,BP,GO:0045912,negative regulation of carbohydrate metabolic process,5/269,56/18888,0.089285714,6.269251195,4.74650724,0.001192064,0.003360795,0.001409325,TP53/STAT3/TGFB1/GIT1/FBP1,5
GO:0006310,BP,GO:0006310,DNA recombination,13/269,339/18888,0.038348083,2.692634142,3.779916005,0.001207357,0.003401804,0.001426522,BRCA1/BRCA2/XRCC1/ERCC1/PARP1/KDM1A/XRCC3/TGFB1/IL10/MEAF6/MLH1/MSH2/NBN,13
GO:0006959,BP,GO:0006959,humoral immune response,11/269,258/18888,0.042635659,2.993688943,3.875611893,0.001230771,0.003465632,0.001453288,KLK3/IL6/IL1B/DEFB1/NOTCH1/TNF/BMI1/A2M/GATA3/IFNA1/CLU,11
GO:0016042,BP,GO:0016042,lipid catabolic process,13/269,340/18888,0.038235294,2.684714629,3.767876992,0.001239745,0.003488746,0.001462981,SRD5A2/AMACR/ALK/IL1B/PRKCD/TNF/AKT1/IRS1/SGPL1/SPHK1/TWIST1/AKR1C3/CYP19A1,13
GO:1905897,BP,GO:1905897,regulation of response to endoplasmic reticulum stress,6/269,84/18888,0.071428571,5.015400956,4.433256852,0.001267757,0.003565371,0.001495113,CAV1/BAX/DAB2IP/HSPA5/PMAIP1/CLU,6
GO:0001894,BP,GO:0001894,tissue homeostasis,11/269,259/18888,0.042471042,2.982130298,3.860706306,0.001269515,0.003565913,0.00149534,CTNNB1/IL6/PTGS2/VEGFA/NOTCH1/BAP1/TLR4/KRAS/EGFR/RB1/BAX,11
GO:0060249,BP,GO:0060249,anatomical structure homeostasis,11/269,259/18888,0.042471042,2.982130298,3.860706306,0.001269515,0.003565913,0.00149534,CTNNB1/IL6/PTGS2/VEGFA/NOTCH1/BAP1/TLR4/KRAS/EGFR/RB1/BAX,11
GO:0010658,BP,GO:0010658,striated muscle cell apoptotic process,5/269,57/18888,0.087719298,6.159264332,4.688867599,0.001291706,0.003623775,0.001519605,TP53/CXCR2/BNIP3/MIR145/HSP90AA1,5
GO:0045005,BP,GO:0045005,DNA-templated DNA replication maintenance of fidelity,5/269,57/18888,0.087719298,6.159264332,4.688867599,0.001291706,0.003623775,0.001519605,BRCA1/BRCA2/PARP1/PCNA/NBN,5
GO:0051099,BP,GO:0051099,positive regulation of binding,7/269,115/18888,0.060869565,4.273993858,4.232913509,0.001303138,0.003653598,0.00153211,PPARG/MMP9/TXN/RB1/IGF1/TWIST1/GATA3,7
GO:0006026,BP,GO:0006026,aminoglycan catabolic process,4/269,34/18888,0.117647059,8.260660398,5.093229964,0.001332964,0.003730333,0.001564289,CD44/FGF2/TGFB1/LYVE1,4
GO:0010863,BP,GO:0010863,positive regulation of phospholipase C activity,4/269,34/18888,0.117647059,8.260660398,5.093229964,0.001332964,0.003730333,0.001564289,EGFR/HRAS/FGFR1/ESR1,4
GO:0071353,BP,GO:0071353,cellular response to interleukin-4,4/269,34/18888,0.117647059,8.260660398,5.093229964,0.001332964,0.003730333,0.001564289,CDK4/FASN/HSPA5/GATA3,4
GO:0016236,BP,GO:0016236,macroautophagy,13/269,343/18888,0.037900875,2.66123316,3.732017632,0.001341291,0.003751332,0.001573095,TP53/FBXW7/MAP3K7/PIK3CA/CASP3/HIF1A/MTOR/HDAC6/SQSTM1/AKT1/KDR/BNIP3/BNIP3L,13
GO:2000781,BP,GO:2000781,positive regulation of double-strand break repair,6/269,85/18888,0.070588235,4.956396239,4.394152492,0.00134805,0.003767925,0.001580053,PARP1/ARID1A/SMARCA4/SMARCA2/MEAF6/SMARCE1,6
GO:0002756,BP,GO:0002756,MyD88-independent toll-like receptor signaling pathway,3/269,16/18888,0.1875,13.16542751,5.851373989,0.001394385,0.00386895,0.001622417,MAP3K7/TLR4/CD274,3
GO:0003188,BP,GO:0003188,heart valve formation,3/269,16/18888,0.1875,13.16542751,5.851373989,0.001394385,0.00386895,0.001622417,NOTCH1/RHOA/TWIST1,3
GO:0016114,BP,GO:0016114,terpenoid biosynthetic process,3/269,16/18888,0.1875,13.16542751,5.851373989,0.001394385,0.00386895,0.001622417,CYP1A1/AKR1C3/RBP1,3
GO:0035729,BP,GO:0035729,cellular response to hepatocyte growth factor stimulus,3/269,16/18888,0.1875,13.16542751,5.851373989,0.001394385,0.00386895,0.001622417,RELA/IL10/MED1,3
GO:0051770,BP,GO:0051770,positive regulation of nitric-oxide synthase biosynthetic process,3/269,16/18888,0.1875,13.16542751,5.851373989,0.001394385,0.00386895,0.001622417,TLR4/KDR/STAT1,3
GO:0071895,BP,GO:0071895,odontoblast differentiation,3/269,16/18888,0.1875,13.16542751,5.851373989,0.001394385,0.00386895,0.001622417,CTNNB1/TGFB1/SERPINE1,3
GO:0090336,BP,GO:0090336,positive regulation of brown fat cell differentiation,3/269,16/18888,0.1875,13.16542751,5.851373989,0.001394385,0.00386895,0.001622417,PTGS2/MAPK14/PIM1,3
GO:1900006,BP,GO:1900006,positive regulation of dendrite development,3/269,16/18888,0.1875,13.16542751,5.851373989,0.001394385,0.00386895,0.001622417,ALK/EZH2/DAB2IP,3
GO:1903599,BP,GO:1903599,positive regulation of autophagy of mitochondrion,3/269,16/18888,0.1875,13.16542751,5.851373989,0.001394385,0.00386895,0.001622417,HIF1A/BNIP3/CAMKK2,3
GO:1904031,BP,GO:1904031,positive regulation of cyclin-dependent protein kinase activity,3/269,16/18888,0.1875,13.16542751,5.851373989,0.001394385,0.00386895,0.001622417,CCND1/AKT1/EGFR,3
GO:1904177,BP,GO:1904177,regulation of adipose tissue development,3/269,16/18888,0.1875,13.16542751,5.851373989,0.001394385,0.00386895,0.001622417,PPARG/PARP1/NCOA1,3
GO:2000345,BP,GO:2000345,regulation of hepatocyte proliferation,3/269,16/18888,0.1875,13.16542751,5.851373989,0.001394385,0.00386895,0.001622417,FBXW7/TNF/MED1,3
GO:0061756,BP,GO:0061756,leukocyte adhesion to vascular endothelial cell,5/269,58/18888,0.086206897,6.053070119,4.632587338,0.001397365,0.003872503,0.001623907,IL6/TNF/RELA/RHOA/ROCK1,5
GO:0070228,BP,GO:0070228,regulation of lymphocyte apoptotic process,5/269,58/18888,0.086206897,6.053070119,4.632587338,0.001397365,0.003872503,0.001623907,TP53/HIF1A/IL10/BAX/CD274,5
GO:0002705,BP,GO:0002705,positive regulation of leukocyte mediated immunity,8/269,150/18888,0.053333333,3.744832714,4.0567603,0.001407919,0.003894643,0.001633191,IL6/MAP3K7/IL1B/TNF/TGFB1/GATA3/MLH1/MSH2,8
GO:0035107,BP,GO:0035107,appendage morphogenesis,8/269,150/18888,0.053333333,3.744832714,4.0567603,0.001407919,0.003894643,0.001633191,CTNNB1/NOTCH1/BAX/TWIST1/TP63/FGFR1/TFAP2A/MED1,8
GO:0035108,BP,GO:0035108,limb morphogenesis,8/269,150/18888,0.053333333,3.744832714,4.0567603,0.001407919,0.003894643,0.001633191,CTNNB1/NOTCH1/BAX/TWIST1/TP63/FGFR1/TFAP2A/MED1,8
GO:0002706,BP,GO:0002706,regulation of lymphocyte mediated immunity,9/269,186/18888,0.048387097,3.39752968,3.949625263,0.001425822,0.003941776,0.001652956,IL6/MAP3K7/IL1B/TNF/TGFB1/IL10/GATA3/MLH1/MSH2,9
GO:0007006,BP,GO:0007006,mitochondrial membrane organization,7/269,117/18888,0.05982906,4.200934134,4.174509156,0.001440147,0.003978962,0.001668549,TP53/BID/BAX/BNIP3/HSP90AA1/PMAIP1/BNIP3L,7
GO:0008217,BP,GO:0008217,regulation of blood pressure,9/269,187/18888,0.048128342,3.379361072,3.930322561,0.001479695,0.004085752,0.001713331,AR/PTGS2/EDNRB/PPARG/SOD2/TNF/RHOA/SMAD3/UCN,9
GO:0002719,BP,GO:0002719,negative regulation of cytokine production involved in immune response,4/269,35/18888,0.114285714,8.024641529,4.999739874,0.001488291,0.004092125,0.001716004,TNF/TGFB1/IL10/TWIST1,4
GO:0008340,BP,GO:0008340,determination of adult lifespan,4/269,35/18888,0.114285714,8.024641529,4.999739874,0.001488291,0.004092125,0.001716004,TP53/ERCC1/TP63/MSH2,4
GO:0034110,BP,GO:0034110,regulation of homotypic cell-cell adhesion,4/269,35/18888,0.114285714,8.024641529,4.999739874,0.001488291,0.004092125,0.001716004,ALOX12/IL6/PRKCD/CD9,4
GO:0046825,BP,GO:0046825,regulation of protein export from nucleus,4/269,35/18888,0.114285714,8.024641529,4.999739874,0.001488291,0.004092125,0.001716004,IL1B/TXN/IFI27/SFN,4
GO:0060544,BP,GO:0060544,regulation of necroptotic process,4/269,35/18888,0.114285714,8.024641529,4.999739874,0.001488291,0.004092125,0.001716004,CASP8/PARP1/CAV1/AIFM1,4
GO:1901099,BP,GO:1901099,negative regulation of signal transduction in absence of ligand,4/269,35/18888,0.114285714,8.024641529,4.999739874,0.001488291,0.004092125,0.001716004,IL1B/TNF/AKT1/SNAI2,4
GO:2001240,BP,GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,4/269,35/18888,0.114285714,8.024641529,4.999739874,0.001488291,0.004092125,0.001716004,IL1B/TNF/AKT1/SNAI2,4
GO:0060612,BP,GO:0060612,adipose tissue development,5/269,59/18888,0.084745763,5.95047571,4.577609758,0.00150926,0.004147279,0.001739132,PIK3CA/PPARG/PARP1/NCOA1/HRAS,5
GO:0034103,BP,GO:0034103,regulation of tissue remodeling,6/269,87/18888,0.068965517,4.842456095,4.317750267,0.001520231,0.004174908,0.001750718,TP53/IL6/PPARG/TGFB1/EGFR/ROCK1,6
GO:0032609,BP,GO:0032609,type II interferon production,7/269,119/18888,0.058823529,4.130330199,4.117394866,0.001588147,0.004356169,0.001826729,IL1B/TLR4/TNF/IL10/HRAS/GATA3/CD274,7
GO:0032649,BP,GO:0032649,regulation of type II interferon production,7/269,119/18888,0.058823529,4.130330199,4.117394866,0.001588147,0.004356169,0.001826729,IL1B/TLR4/TNF/IL10/HRAS/GATA3/CD274,7
GO:0060759,BP,GO:0060759,regulation of response to cytokine stimulus,9/269,189/18888,0.047619048,3.343600637,3.892107015,0.001592352,0.00436245,0.001829362,IL6/CASP8/PPARG/GSTP1/HIF1A/TLR4/CAV1/SPHK1/MED1,9
GO:0061136,BP,GO:0061136,regulation of proteasomal protein catabolic process,9/269,189/18888,0.047619048,3.343600637,3.892107015,0.001592352,0.00436245,0.001829362,AURKA/FBXW7/GPX1/CDK2/AKT1/CAV1/DAB2IP/CLU/FHIT,9
GO:0045185,BP,GO:0045185,maintenance of protein location,6/269,88/18888,0.068181818,4.787428185,4.280418894,0.001612355,0.004414598,0.00185123,AKT1/CAV1/IL10/TXN/HSPA5/NFKBIA,6
GO:0006940,BP,GO:0006940,regulation of smooth muscle contraction,5/269,60/18888,0.083333333,5.851301115,4.523881457,0.00162761,0.004453687,0.001867622,PTGS2/RHOA/CAV1/SPHK1/MIR145,5
GO:0007617,BP,GO:0007617,mating behavior,4/269,36/18888,0.111111111,7.80173482,4.909889126,0.001655791,0.004517237,0.001894271,EDNRB/NCOA1/KLK14/TAC1,4
GO:0090050,BP,GO:0090050,positive regulation of cell migration involved in sprouting angiogenesis,4/269,36/18888,0.111111111,7.80173482,4.909889126,0.001655791,0.004517237,0.001894271,PTGS2/VEGFA/FGF2/KDR,4
GO:1900274,BP,GO:1900274,regulation of phospholipase C activity,4/269,36/18888,0.111111111,7.80173482,4.909889126,0.001655791,0.004517237,0.001894271,EGFR/HRAS/FGFR1/ESR1,4
GO:1902745,BP,GO:1902745,positive regulation of lamellipodium organization,4/269,36/18888,0.111111111,7.80173482,4.909889126,0.001655791,0.004517237,0.001894271,PIK3CA/MTOR/FSCN1/HSP90AA1,4
GO:2000352,BP,GO:2000352,negative regulation of endothelial cell apoptotic process,4/269,36/18888,0.111111111,7.80173482,4.909889126,0.001655791,0.004517237,0.001894271,SERPINE1/KDR/BRAF/GATA3,4
GO:0010831,BP,GO:0010831,positive regulation of myotube differentiation,3/269,17/18888,0.176470588,12.3909906,5.647652294,0.001675453,0.004554512,0.001909903,MMP14/MAPK14/MTOR,3
GO:0030889,BP,GO:0030889,negative regulation of B cell proliferation,3/269,17/18888,0.176470588,12.3909906,5.647652294,0.001675453,0.004554512,0.001909903,CASP3/IL10/PAWR,3
GO:0036005,BP,GO:0036005,response to macrophage colony-stimulating factor,3/269,17/18888,0.176470588,12.3909906,5.647652294,0.001675453,0.004554512,0.001909903,TLR4/TNF/MST1R,3
GO:0060644,BP,GO:0060644,mammary gland epithelial cell differentiation,3/269,17/18888,0.176470588,12.3909906,5.647652294,0.001675453,0.004554512,0.001909903,FGF2/HIF1A/AKT1,3
GO:0072074,BP,GO:0072074,kidney mesenchyme development,3/269,17/18888,0.176470588,12.3909906,5.647652294,0.001675453,0.004554512,0.001909903,MYC/WT1/STAT1,3
GO:1902165,BP,GO:1902165,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,3/269,17/18888,0.176470588,12.3909906,5.647652294,0.001675453,0.004554512,0.001909903,KDM1A/CD44/MUC1,3
GO:0000819,BP,GO:0000819,sister chromatid segregation,10/269,229/18888,0.043668122,3.066183991,3.781133447,0.001702829,0.00462617,0.001939952,ARID1A/XRCC3/SMARCA4/SMARCA2/RHOA/KATNB1/CHEK2/CUL3/RB1/SMARCE1,10
GO:0042310,BP,GO:0042310,vasoconstriction,6/269,89/18888,0.06741573,4.733636857,4.243646101,0.001708663,0.004639254,0.001945438,PTGS2/EDNRB/RHOA/CAV1/MMP2/EGFR,6
GO:0034976,BP,GO:0034976,response to endoplasmic reticulum stress,11/269,269/18888,0.040892193,2.871270436,3.715471843,0.001715107,0.004653978,0.001951613,TP53/THBS1/CCND1/CAV1/MIR200C/BAX/DAB2IP/HSPA5/AIFM1/PMAIP1/CLU,11
GO:0032233,BP,GO:0032233,positive regulation of actin filament bundle assembly,5/269,61/18888,0.081967213,5.755378146,4.471352079,0.001752635,0.004748217,0.001991131,MTOR/RHOA/TGFBR1/SMAD3/BRAF,5
GO:0048599,BP,GO:0048599,oocyte development,5/269,61/18888,0.081967213,5.755378146,4.471352079,0.001752635,0.004748217,0.001991131,CTNNB1/AURKA/BRCA2/IGF1/ZFX,5
GO:0044403,BP,GO:0044403,biological process involved in symbiotic interaction,12/269,311/18888,0.038585209,2.709284118,3.653306549,0.001752963,0.004748217,0.001991131,TMPRSS2/GPX1/FASN/SMARCA4/AKT1/CAV1/BSG/EGFR/FN1/IFI27/CTSB/MYD88,12
GO:0006096,BP,GO:0006096,glycolytic process,6/269,90/18888,0.066666667,4.681040892,4.207416718,0.001809276,0.004897838,0.002053873,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:0006936,BP,GO:0006936,muscle contraction,13/269,355/18888,0.036619718,2.571275983,3.59230531,0.001819369,0.004922235,0.002064104,PTGS2/EDNRB/PIK3CA/MTOR/TNF/RHOA/CAV1/MIR200C/SPHK1/MIR145/HSP90AA1/UCN/ROCK1,13
GO:0006022,BP,GO:0006022,aminoglycan metabolic process,7/269,122/18888,0.057377049,4.028764702,4.034029305,0.001832054,0.004934862,0.0020694,EDNRB/IL1B/NFKB1/CD44/FGF2/TGFB1/LYVE1,7
GO:0010092,BP,GO:0010092,specification of animal organ identity,4/269,37/18888,0.108108108,7.590877122,4.823433934,0.001835951,0.004934862,0.0020694,CTNNB1/AR/FGF2/FGFR1,4
GO:0010934,BP,GO:0010934,macrophage cytokine production,4/269,37/18888,0.108108108,7.590877122,4.823433934,0.001835951,0.004934862,0.0020694,TLR4/TGFB1/TWIST1/MYD88,4
GO:0010935,BP,GO:0010935,regulation of macrophage cytokine production,4/269,37/18888,0.108108108,7.590877122,4.823433934,0.001835951,0.004934862,0.0020694,TLR4/TGFB1/TWIST1/MYD88,4
GO:0043243,BP,GO:0043243,positive regulation of protein-containing complex disassembly,4/269,37/18888,0.108108108,7.590877122,4.823433934,0.001835951,0.004934862,0.0020694,IGF1R/TNF/KATNB1/BNIP3,4
GO:0045191,BP,GO:0045191,regulation of isotype switching,4/269,37/18888,0.108108108,7.590877122,4.823433934,0.001835951,0.004934862,0.0020694,TGFB1/IL10/MLH1/MSH2,4
GO:0046677,BP,GO:0046677,response to antibiotic,4/269,37/18888,0.108108108,7.590877122,4.823433934,0.001835951,0.004934862,0.0020694,TP53/KDM1A/EZH2/HSP90AA1,4
GO:0060391,BP,GO:0060391,positive regulation of SMAD protein signal transduction,4/269,37/18888,0.108108108,7.590877122,4.823433934,0.001835951,0.004934862,0.0020694,PARP1/TWSG1/TGFBR1/TGFB1,4
GO:0070670,BP,GO:0070670,response to interleukin-4,4/269,37/18888,0.108108108,7.590877122,4.823433934,0.001835951,0.004934862,0.0020694,CDK4/FASN/HSPA5/GATA3,4
GO:0070873,BP,GO:0070873,regulation of glycogen metabolic process,4/269,37/18888,0.108108108,7.590877122,4.823433934,0.001835951,0.004934862,0.0020694,AKT1/IRS1/IGF1/IGF2,4
GO:1905898,BP,GO:1905898,positive regulation of response to endoplasmic reticulum stress,4/269,37/18888,0.108108108,7.590877122,4.823433934,0.001835951,0.004934862,0.0020694,CAV1/BAX/DAB2IP/PMAIP1,4
GO:0019318,BP,GO:0019318,hexose metabolic process,10/269,232/18888,0.043103448,3.02653506,3.733088636,0.001874053,0.005034308,0.002111102,TP53/PIK3CA/MAPK14/TNF/AKT1/IRS1/IGF1/PMAIP1/FBP1/IGF2,10
GO:0002712,BP,GO:0002712,regulation of B cell mediated immunity,5/269,62/18888,0.080645161,5.662549466,4.419974097,0.001884558,0.005053587,0.002119186,TNF/TGFB1/IL10/MLH1/MSH2,5
GO:0002889,BP,GO:0002889,regulation of immunoglobulin mediated immune response,5/269,62/18888,0.080645161,5.662549466,4.419974097,0.001884558,0.005053587,0.002119186,TNF/TGFB1/IL10/MLH1/MSH2,5
GO:0006611,BP,GO:0006611,protein export from nucleus,5/269,62/18888,0.080645161,5.662549466,4.419974097,0.001884558,0.005053587,0.002119186,IL1B/TGFB1/TXN/IFI27/SFN,5
GO:0030258,BP,GO:0030258,lipid modification,9/269,194/18888,0.046391753,3.257425363,3.798766507,0.001904321,0.005103581,0.002140151,PTEN/AMACR/ALOX12/MAPK14/AKT1/ALOX15B/CYP1A1/IRS1/TWIST1,9
GO:0030901,BP,GO:0030901,midbrain development,6/269,91/18888,0.065934066,4.629600882,4.171716158,0.001914317,0.005127352,0.002150119,CTNNB1/CXCR2/FGF2/RHOA/HSPA5/FGFR1,6
GO:0071675,BP,GO:0071675,regulation of mononuclear cell migration,7/269,123/18888,0.056910569,3.996010518,4.006831314,0.001919501,0.005138218,0.002154675,THBS1/MAPK1/TNF/RHOA/AKT1/PTK2/SERPINE1,7
GO:1901136,BP,GO:1901136,carbohydrate derivative catabolic process,11/269,273/18888,0.04029304,2.829200539,3.659237333,0.001925828,0.005152126,0.002160508,CD44/FGF2/HIF1A/STAT3/MTOR/PRKCD/TGFB1/GIT1/IGF1/LYVE1/FBP1,11
GO:0010612,BP,GO:0010612,regulation of cardiac muscle adaptation,3/269,18/18888,0.166666667,11.70260223,5.460333157,0.001989507,0.005282163,0.002215038,MIR25/PPARG/SMAD3,3
GO:0010755,BP,GO:0010755,regulation of plasminogen activation,3/269,18/18888,0.166666667,11.70260223,5.460333157,0.001989507,0.005282163,0.002215038,THBS1/SERPINE1/PLAU,3
GO:0010759,BP,GO:0010759,positive regulation of macrophage chemotaxis,3/269,18/18888,0.166666667,11.70260223,5.460333157,0.001989507,0.005282163,0.002215038,THBS1/MAPK1/PTK2,3
GO:0030730,BP,GO:0030730,sequestering of triglyceride,3/269,18/18888,0.166666667,11.70260223,5.460333157,0.001989507,0.005282163,0.002215038,IL1B/PPARG/TNF,3
GO:0030812,BP,GO:0030812,negative regulation of nucleotide catabolic process,3/269,18/18888,0.166666667,11.70260223,5.460333157,0.001989507,0.005282163,0.002215038,STAT3/GIT1/FBP1,3
GO:0033122,BP,GO:0033122,negative regulation of purine nucleotide catabolic process,3/269,18/18888,0.166666667,11.70260223,5.460333157,0.001989507,0.005282163,0.002215038,STAT3/GIT1/FBP1,3
GO:0035728,BP,GO:0035728,response to hepatocyte growth factor,3/269,18/18888,0.166666667,11.70260223,5.460333157,0.001989507,0.005282163,0.002215038,RELA/IL10/MED1,3
GO:0045820,BP,GO:0045820,negative regulation of glycolytic process,3/269,18/18888,0.166666667,11.70260223,5.460333157,0.001989507,0.005282163,0.002215038,STAT3/GIT1/FBP1,3
GO:0060576,BP,GO:0060576,intestinal epithelial cell development,3/269,18/18888,0.166666667,11.70260223,5.460333157,0.001989507,0.005282163,0.002215038,HIF1A/SPDEF/CDKN1A,3
GO:0061323,BP,GO:0061323,cell proliferation involved in heart morphogenesis,3/269,18/18888,0.166666667,11.70260223,5.460333157,0.001989507,0.005282163,0.002215038,CTNNB1/NOTCH1/PIM1,3
GO:0150078,BP,GO:0150078,positive regulation of neuroinflammatory response,3/269,18/18888,0.166666667,11.70260223,5.460333157,0.001989507,0.005282163,0.002215038,IL6/IL1B/TNF,3
GO:1903242,BP,GO:1903242,regulation of cardiac muscle hypertrophy in response to stress,3/269,18/18888,0.166666667,11.70260223,5.460333157,0.001989507,0.005282163,0.002215038,MIR25/PPARG/SMAD3,3
GO:2000136,BP,GO:2000136,regulation of cell proliferation involved in heart morphogenesis,3/269,18/18888,0.166666667,11.70260223,5.460333157,0.001989507,0.005282163,0.002215038,CTNNB1/NOTCH1/PIM1,3
GO:1904356,BP,GO:1904356,regulation of telomere maintenance via telomere lengthening,5/269,63/18888,0.079365079,5.572667729,4.369702611,0.002023601,0.005367247,0.002250717,TP53/CTNNB1/PARP1/MAPK1/MAP2K7,5
GO:0046032,BP,GO:0046032,ADP catabolic process,6/269,92/18888,0.065217391,4.579279134,4.13653038,0.002023909,0.005367247,0.002250717,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:0002369,BP,GO:0002369,T cell cytokine production,4/269,38/18888,0.105263158,7.391117198,4.740152967,0.002029251,0.005372031,0.002252723,IL6/MAP3K7/IL1B/GATA3,4
GO:0002724,BP,GO:0002724,regulation of T cell cytokine production,4/269,38/18888,0.105263158,7.391117198,4.740152967,0.002029251,0.005372031,0.002252723,IL6/MAP3K7/IL1B/GATA3,4
GO:1902110,BP,GO:1902110,positive regulation of mitochondrial membrane permeability involved in apoptotic process,4/269,38/18888,0.105263158,7.391117198,4.740152967,0.002029251,0.005372031,0.002252723,BID/BAX/BNIP3/BNIP3L,4
GO:0008643,BP,GO:0008643,carbohydrate transport,8/269,159/18888,0.050314465,3.532861051,3.855068392,0.002034253,0.005382146,0.002256965,IL1B/MAPK14/RNASEL/TNF/AKT1/IRS1/IGF1/BRAF,8
GO:0060041,BP,GO:0060041,retina development in camera-type eye,8/269,160/18888,0.05,3.510780669,3.833562265,0.00211555,0.005593991,0.002345801,NOTCH1/HIF1A/STAT3/SMARCA4/BAX/ZHX2/TFAP2A/MED1,8
GO:0014033,BP,GO:0014033,neural crest cell differentiation,6/269,93/18888,0.064516129,4.530039573,4.101845871,0.002138179,0.005643998,0.002366771,EDNRB/HIF1A/MAPK1/FN1/TWIST1/SNAI2,6
GO:0032465,BP,GO:0032465,regulation of cytokinesis,6/269,93/18888,0.064516129,4.530039573,4.101845871,0.002138179,0.005643998,0.002366771,AURKA/BRCA2/IGF1R/RHOA/CUL3/GIT1,6
GO:2001251,BP,GO:2001251,negative regulation of chromosome organization,6/269,93/18888,0.064516129,4.530039573,4.101845871,0.002138179,0.005643998,0.002366771,TP53/XRCC1/ERCC1/PARP1/XRCC3/NBN,6
GO:0040036,BP,GO:0040036,regulation of fibroblast growth factor receptor signaling pathway,4/269,39/18888,0.102564103,7.201601373,4.659844749,0.002236169,0.005895824,0.002472372,THBS1/CTNNB1/FGF2/GATA3,4
GO:0045746,BP,GO:0045746,negative regulation of Notch signaling pathway,4/269,39/18888,0.102564103,7.201601373,4.659844749,0.002236169,0.005895824,0.002472372,FBXW7/MMP14/AKT1/NFKBIA,4
GO:0019364,BP,GO:0019364,pyridine nucleotide catabolic process,6/269,94/18888,0.063829787,4.481847663,4.067649613,0.002257251,0.005947967,0.002494238,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:0003231,BP,GO:0003231,cardiac ventricle development,7/269,127/18888,0.05511811,3.870151919,3.900840633,0.002302084,0.006062599,0.002542308,SOX11/NOTCH1/HIF1A/TGFBR1/TGFB1/GATA3/MED1,7
GO:0009994,BP,GO:0009994,oocyte differentiation,5/269,65/18888,0.076923077,5.401201029,4.27231157,0.002323946,0.006086392,0.002552285,CTNNB1/AURKA/BRCA2/IGF1/ZFX,5
GO:0032613,BP,GO:0032613,interleukin-10 production,5/269,65/18888,0.076923077,5.401201029,4.27231157,0.002323946,0.006086392,0.002552285,IL6/STAT3/TLR4/MIR145/CD274,5
GO:0032653,BP,GO:0032653,regulation of interleukin-10 production,5/269,65/18888,0.076923077,5.401201029,4.27231157,0.002323946,0.006086392,0.002552285,IL6/STAT3/TLR4/MIR145/CD274,5
GO:0042058,BP,GO:0042058,regulation of epidermal growth factor receptor signaling pathway,5/269,65/18888,0.076923077,5.401201029,4.27231157,0.002323946,0.006086392,0.002552285,FASLG/MMP9/TGFB1/EGFR/DAB2IP,5
GO:0070059,BP,GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,5/269,65/18888,0.076923077,5.401201029,4.27231157,0.002323946,0.006086392,0.002552285,TP53/BAX/DAB2IP/AIFM1/PMAIP1,5
GO:0006337,BP,GO:0006337,nucleosome disassembly,3/269,19/18888,0.157894737,11.0866758,5.287250349,0.002337837,0.006086392,0.002552285,ARID1A/SMARCA4/SMARCE1,3
GO:0007620,BP,GO:0007620,copulation,3/269,19/18888,0.157894737,11.0866758,5.287250349,0.002337837,0.006086392,0.002552285,EDNRB/KLK14/TAC1,3
GO:0010663,BP,GO:0010663,positive regulation of striated muscle cell apoptotic process,3/269,19/18888,0.157894737,11.0866758,5.287250349,0.002337837,0.006086392,0.002552285,TP53/CXCR2/BNIP3,3
GO:0010666,BP,GO:0010666,positive regulation of cardiac muscle cell apoptotic process,3/269,19/18888,0.157894737,11.0866758,5.287250349,0.002337837,0.006086392,0.002552285,TP53/CXCR2/BNIP3,3
GO:0032695,BP,GO:0032695,negative regulation of interleukin-12 production,3/269,19/18888,0.157894737,11.0866758,5.287250349,0.002337837,0.006086392,0.002552285,THBS1/NFKB1/IL10,3
GO:0033194,BP,GO:0033194,response to hydroperoxide,3/269,19/18888,0.157894737,11.0866758,5.287250349,0.002337837,0.006086392,0.002552285,GPX1/XRCC1/PRKCD,3
GO:0035743,BP,GO:0035743,"CD4-positive, alpha-beta T cell cytokine production",3/269,19/18888,0.157894737,11.0866758,5.287250349,0.002337837,0.006086392,0.002552285,IL6/IL1B/GATA3,3
GO:0045603,BP,GO:0045603,positive regulation of endothelial cell differentiation,3/269,19/18888,0.157894737,11.0866758,5.287250349,0.002337837,0.006086392,0.002552285,CTNNB1/NOTCH1/MIR200C,3
GO:0048266,BP,GO:0048266,behavioral response to pain,3/269,19/18888,0.157894737,11.0866758,5.287250349,0.002337837,0.006086392,0.002552285,THBS1/MTOR/AKT1,3
GO:0060039,BP,GO:0060039,pericardium development,3/269,19/18888,0.157894737,11.0866758,5.287250349,0.002337837,0.006086392,0.002552285,NOTCH1/SMAD3/WT1,3
GO:0060602,BP,GO:0060602,branch elongation of an epithelium,3/269,19/18888,0.157894737,11.0866758,5.287250349,0.002337837,0.006086392,0.002552285,HNF1B/MED1/ESR1,3
GO:0070431,BP,GO:0070431,nucleotide-binding oligomerization domain containing 2 signaling pathway,3/269,19/18888,0.157894737,11.0866758,5.287250349,0.002337837,0.006086392,0.002552285,TLR4/RELA/NFKBIA,3
GO:1905038,BP,GO:1905038,regulation of membrane lipid metabolic process,3/269,19/18888,0.157894737,11.0866758,5.287250349,0.002337837,0.006086392,0.002552285,PRKCD/TNF/SPHK1,3
GO:1905288,BP,GO:1905288,vascular associated smooth muscle cell apoptotic process,3/269,19/18888,0.157894737,11.0866758,5.287250349,0.002337837,0.006086392,0.002552285,PPARG/SOD2/IGF1,3
GO:1905459,BP,GO:1905459,regulation of vascular associated smooth muscle cell apoptotic process,3/269,19/18888,0.157894737,11.0866758,5.287250349,0.002337837,0.006086392,0.002552285,PPARG/SOD2/IGF1,3
GO:0009137,BP,GO:0009137,purine nucleoside diphosphate catabolic process,6/269,95/18888,0.063157895,4.434670319,4.033929065,0.002381252,0.006188811,0.002595234,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:0009181,BP,GO:0009181,purine ribonucleoside diphosphate catabolic process,6/269,95/18888,0.063157895,4.434670319,4.033929065,0.002381252,0.006188811,0.002595234,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:0014020,BP,GO:0014020,primary neural tube formation,6/269,95/18888,0.063157895,4.434670319,4.033929065,0.002381252,0.006188811,0.002595234,CASP3/HIF1A/TGFB1/BRD2/DLC1/TWIST1,6
GO:0000266,BP,GO:0000266,mitochondrial fission,4/269,40/18888,0.1,7.021561338,4.58232542,0.002457178,0.006360741,0.002667332,AURKA/PPARG/KDR/BNIP3,4
GO:0035886,BP,GO:0035886,vascular associated smooth muscle cell differentiation,4/269,40/18888,0.1,7.021561338,4.58232542,0.002457178,0.006360741,0.002667332,VEGFA/SOD2/NOTCH1/MIR145,4
GO:0043403,BP,GO:0043403,skeletal muscle tissue regeneration,4/269,40/18888,0.1,7.021561338,4.58232542,0.002457178,0.006360741,0.002667332,GPX1/EZH2/IGF1/CD9,4
GO:0044060,BP,GO:0044060,regulation of endocrine process,4/269,40/18888,0.1,7.021561338,4.58232542,0.002457178,0.006360741,0.002667332,NKX3-1/FGFR1/UCN/CYP19A1,4
GO:0071354,BP,GO:0071354,cellular response to interleukin-6,4/269,40/18888,0.1,7.021561338,4.58232542,0.002457178,0.006360741,0.002667332,IL6/NFKB1/STAT3/RELA,4
GO:1902686,BP,GO:1902686,mitochondrial outer membrane permeabilization involved in programmed cell death,4/269,40/18888,0.1,7.021561338,4.58232542,0.002457178,0.006360741,0.002667332,BID/BAX/BNIP3/BNIP3L,4
GO:1902742,BP,GO:1902742,apoptotic process involved in development,4/269,40/18888,0.1,7.021561338,4.58232542,0.002457178,0.006360741,0.002667332,VDR/NOTCH1/HNF1B/BAX,4
GO:0018107,BP,GO:0018107,peptidyl-threonine phosphorylation,6/269,96/18888,0.0625,4.388475836,4.00067214,0.002510311,0.006494593,0.002723462,MAPK1/PRKCD/LMTK2/AKT1/SPHK1/ROCK1,6
GO:0097237,BP,GO:0097237,cellular response to toxic substance,7/269,129/18888,0.054263566,3.810149563,3.849451945,0.002514166,0.006500875,0.002726096,GPX1/PTGS2/SOD2/GSTP1/TNF/TXN/PIM1,7
GO:0045638,BP,GO:0045638,negative regulation of myeloid cell differentiation,6/269,97/18888,0.06185567,4.343233817,3.96786718,0.002644556,0.006830271,0.002864226,CTNNB1/FBXW7/MYC/MYB/TLR4/NFKBIA,6
GO:0072526,BP,GO:0072526,pyridine-containing compound catabolic process,6/269,97/18888,0.06185567,4.343233817,3.96786718,0.002644556,0.006830271,0.002864226,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:2000058,BP,GO:2000058,regulation of ubiquitin-dependent protein catabolic process,8/269,166/18888,0.048192771,3.383884982,3.708025187,0.002658485,0.006862355,0.00287768,PTEN/AURKA/FBXW7/CDK2/AKT1/PTK2/CLU/FHIT,8
GO:0010591,BP,GO:0010591,regulation of lamellipodium assembly,4/269,41/18888,0.097560976,6.850303745,4.507426797,0.002692748,0.006931164,0.002906535,PIK3CA/MTOR/FSCN1/HSP90AA1,4
GO:0035136,BP,GO:0035136,forelimb morphogenesis,4/269,41/18888,0.097560976,6.850303745,4.507426797,0.002692748,0.006931164,0.002906535,CTNNB1/TWIST1/TP63/TFAP2A,4
GO:0071542,BP,GO:0071542,dopaminergic neuron differentiation,4/269,41/18888,0.097560976,6.850303745,4.507426797,0.002692748,0.006931164,0.002906535,CTNNB1/VEGFA/HIF1A/FOXA1,4
GO:0072210,BP,GO:0072210,metanephric nephron development,4/269,41/18888,0.097560976,6.850303745,4.507426797,0.002692748,0.006931164,0.002906535,CTNNB1/WT1/STAT1/LGR4,4
GO:1904994,BP,GO:1904994,regulation of leukocyte adhesion to vascular endothelial cell,4/269,41/18888,0.097560976,6.850303745,4.507426797,0.002692748,0.006931164,0.002906535,IL6/TNF/RELA/RHOA,4
GO:0002755,BP,GO:0002755,MyD88-dependent toll-like receptor signaling pathway,3/269,20/18888,0.15,10.53234201,5.126620078,0.002721659,0.006946711,0.002913054,MAP3K7/TLR4/MYD88,3
GO:0006309,BP,GO:0006309,apoptotic DNA fragmentation,3/269,20/18888,0.15,10.53234201,5.126620078,0.002721659,0.006946711,0.002913054,IL6/BAX/AIFM1,3
GO:0031998,BP,GO:0031998,regulation of fatty acid beta-oxidation,3/269,20/18888,0.15,10.53234201,5.126620078,0.002721659,0.006946711,0.002913054,AKT1/IRS1/TWIST1,3
GO:0034144,BP,GO:0034144,negative regulation of toll-like receptor 4 signaling pathway,3/269,20/18888,0.15,10.53234201,5.126620078,0.002721659,0.006946711,0.002913054,SQSTM1/MIR200C/DAB2IP,3
GO:0034244,BP,GO:0034244,negative regulation of transcription elongation by RNA polymerase II,3/269,20/18888,0.15,10.53234201,5.126620078,0.002721659,0.006946711,0.002913054,PARP1/EZH2/VHL,3
GO:0034393,BP,GO:0034393,positive regulation of smooth muscle cell apoptotic process,3/269,20/18888,0.15,10.53234201,5.126620078,0.002721659,0.006946711,0.002913054,PPARG/SOD2/CDKN2A,3
GO:0036498,BP,GO:0036498,IRE1-mediated unfolded protein response,3/269,20/18888,0.15,10.53234201,5.126620078,0.002721659,0.006946711,0.002913054,BAX/DAB2IP/HSPA5,3
GO:0038166,BP,GO:0038166,angiotensin-activated signaling pathway,3/269,20/18888,0.15,10.53234201,5.126620078,0.002721659,0.006946711,0.002913054,CAV1/MIR145/ROCK1,3
GO:0051546,BP,GO:0051546,keratinocyte migration,3/269,20/18888,0.15,10.53234201,5.126620078,0.002721659,0.006946711,0.002913054,PTEN/MTOR/MMP9,3
GO:0060353,BP,GO:0060353,regulation of cell adhesion molecule production,3/269,20/18888,0.15,10.53234201,5.126620078,0.002721659,0.006946711,0.002913054,IL1B/NOTCH1/CAV1,3
GO:0071391,BP,GO:0071391,cellular response to estrogen stimulus,3/269,20/18888,0.15,10.53234201,5.126620078,0.002721659,0.006946711,0.002913054,AR/ESR1/ESR2,3
GO:0071731,BP,GO:0071731,response to nitric oxide,3/269,20/18888,0.15,10.53234201,5.126620078,0.002721659,0.006946711,0.002913054,CDK2/TXN/AIFM1,3
GO:0072079,BP,GO:0072079,nephron tubule formation,3/269,20/18888,0.15,10.53234201,5.126620078,0.002721659,0.006946711,0.002913054,CTNNB1/HNF1B/GATA3,3
GO:0097284,BP,GO:0097284,hepatocyte apoptotic process,3/269,20/18888,0.15,10.53234201,5.126620078,0.002721659,0.006946711,0.002913054,BID/IGF1R/RB1,3
GO:1900221,BP,GO:1900221,regulation of amyloid-beta clearance,3/269,20/18888,0.15,10.53234201,5.126620078,0.002721659,0.006946711,0.002913054,TNF/ROCK1/CLU,3
GO:0051983,BP,GO:0051983,regulation of chromosome segregation,7/269,131/18888,0.053435115,3.751979341,3.799081253,0.002740972,0.006992087,0.002932082,ARID1A/XRCC3/SMARCA4/SMARCA2/CUL3/RB1/SMARCE1,7
GO:0006937,BP,GO:0006937,regulation of muscle contraction,8/269,167/18888,0.047904192,3.363622198,3.687663019,0.002758684,0.007033333,0.002949378,PTGS2/RHOA/CAV1/MIR200C/SPHK1/MIR145/HSP90AA1/UCN,8
GO:0045333,BP,GO:0045333,cellular respiration,10/269,245/18888,0.040816327,2.865943403,3.533483466,0.002784051,0.007086274,0.002971579,COX2/PIK3CA/BID/SOD2/HIF1A/TNF/RHOA/BNIP3/MSH2/UCN,10
GO:0009191,BP,GO:0009191,ribonucleoside diphosphate catabolic process,6/269,98/18888,0.06122449,4.298915105,3.935502943,0.002784116,0.007086274,0.002971579,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:0046031,BP,GO:0046031,ADP metabolic process,6/269,98/18888,0.06122449,4.298915105,3.935502943,0.002784116,0.007086274,0.002971579,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:0046847,BP,GO:0046847,filopodium assembly,5/269,68/18888,0.073529412,5.162912749,4.133533003,0.002833489,0.007199874,0.003019216,TENM1/PRKCD/TGFBR1/FSCN1/MIEN1,5
GO:0070918,BP,GO:0070918,regulatory ncRNA processing,5/269,68/18888,0.073529412,5.162912749,4.133533003,0.002833489,0.007199874,0.003019216,TP53/IL6/STAT3/SMAD3/TGFB1,5
GO:1902808,BP,GO:1902808,positive regulation of cell cycle G1/S phase transition,5/269,68/18888,0.073529412,5.162912749,4.133533003,0.002833489,0.007199874,0.003019216,CCND1/EZH2/AKT1/CYP1A1/EGFR,5
GO:0042742,BP,GO:0042742,defense response to bacterium,12/269,330/18888,0.036363636,2.553295032,3.42156498,0.002854929,0.00725031,0.003040366,KLK3/IL6/MAP3K7/IL1B/NFKB1/DEFB1/TLR4/PRKCD/TNF/IL10/SERPINE1/MYD88,12
GO:0000018,BP,GO:0000018,regulation of DNA recombination,7/269,132/18888,0.053030303,3.723555255,3.774265944,0.002860102,0.00725536,0.003042484,PARP1/KDM1A/TGFB1/IL10/MEAF6/MLH1/MSH2,7
GO:0030301,BP,GO:0030301,cholesterol transport,7/269,132/18888,0.053030303,3.723555255,3.774265944,0.002860102,0.00725536,0.003042484,NFKB1/PPARG/CAV1/MIR145/MIR130B/NFKBIA/CLU,7
GO:0002703,BP,GO:0002703,regulation of leukocyte mediated immunity,10/269,246/18888,0.040650407,2.854293227,3.518675102,0.002866556,0.007267685,0.003047652,IL6/MAP3K7/IL1B/TLR4/TNF/TGFB1/IL10/GATA3/MLH1/MSH2,10
GO:0038202,BP,GO:0038202,TORC1 signaling,6/269,99/18888,0.060606061,4.25549172,3.903568577,0.00292912,0.007421066,0.003111972,MTOR/AKT1/CUL3/VHL/PIM1/NPRL2,6
GO:0002714,BP,GO:0002714,positive regulation of B cell mediated immunity,4/269,42/18888,0.095238095,6.687201275,4.434994694,0.002943342,0.007421066,0.003111972,TNF/TGFB1/MLH1/MSH2,4
GO:0002891,BP,GO:0002891,positive regulation of immunoglobulin mediated immune response,4/269,42/18888,0.095238095,6.687201275,4.434994694,0.002943342,0.007421066,0.003111972,TNF/TGFB1/MLH1/MSH2,4
GO:0021983,BP,GO:0021983,pituitary gland development,4/269,42/18888,0.095238095,6.687201275,4.434994694,0.002943342,0.007421066,0.003111972,FGF2/CDH1/PCSK1/SOX2,4
GO:0042092,BP,GO:0042092,type 2 immune response,4/269,42/18888,0.095238095,6.687201275,4.434994694,0.002943342,0.007421066,0.003111972,IL6/MYB/IL10/GATA3,4
GO:0042119,BP,GO:0042119,neutrophil activation,4/269,42/18888,0.095238095,6.687201275,4.434994694,0.002943342,0.007421066,0.003111972,CXCR2/PRKCD/TNF/MYD88,4
GO:0044319,BP,GO:0044319,"wound healing, spreading of cells",4/269,42/18888,0.095238095,6.687201275,4.434994694,0.002943342,0.007421066,0.003111972,PTEN/CD44/MTOR/RHOA,4
GO:0046627,BP,GO:0046627,negative regulation of insulin receptor signaling pathway,4/269,42/18888,0.095238095,6.687201275,4.434994694,0.002943342,0.007421066,0.003111972,IL1B/PRKCD/RELA/IRS1,4
GO:0048512,BP,GO:0048512,circadian behavior,4/269,42/18888,0.095238095,6.687201275,4.434994694,0.002943342,0.007421066,0.003111972,TP53/PTEN/PARP1/MTOR,4
GO:0090505,BP,GO:0090505,epiboly involved in wound healing,4/269,42/18888,0.095238095,6.687201275,4.434994694,0.002943342,0.007421066,0.003111972,PTEN/CD44/MTOR/RHOA,4
GO:0014902,BP,GO:0014902,myotube differentiation,7/269,133/18888,0.052631579,3.695558599,3.749691324,0.002983163,0.007517306,0.003152329,GPX1/MMP14/NOTCH1/MAPK14/MTOR/IGF1/CD9,7
GO:0019229,BP,GO:0019229,regulation of vasoconstriction,5/269,69/18888,0.072463768,5.088087926,4.089083287,0.003019981,0.007597477,0.003185948,PTGS2/RHOA/CAV1/MMP2/EGFR,5
GO:0045911,BP,GO:0045911,positive regulation of DNA recombination,5/269,69/18888,0.072463768,5.088087926,4.089083287,0.003019981,0.007597477,0.003185948,PARP1/TGFB1/MEAF6/MLH1/MSH2,5
GO:0060191,BP,GO:0060191,regulation of lipase activity,5/269,69/18888,0.072463768,5.088087926,4.089083287,0.003019981,0.007597477,0.003185948,RHOA/EGFR/HRAS/FGFR1/ESR1,5
GO:0006304,BP,GO:0006304,DNA modification,6/269,100/18888,0.06,4.212936803,3.87205361,0.0030797,0.007743439,0.003247156,PARP1/FOS/BMI1/EZH2/WT1/GATA3,6
GO:0043651,BP,GO:0043651,linoleic acid metabolic process,3/269,21/18888,0.142857143,10.03080191,4.976958198,0.003142116,0.007865648,0.003298404,ALOX12/GSTP1/ALOX15B,3
GO:0051443,BP,GO:0051443,positive regulation of ubiquitin-protein transferase activity,3/269,21/18888,0.142857143,10.03080191,4.976958198,0.003142116,0.007865648,0.003298404,PTEN/FBXW7/BMI1,3
GO:0060973,BP,GO:0060973,cell migration involved in heart development,3/269,21/18888,0.142857143,10.03080191,4.976958198,0.003142116,0.007865648,0.003298404,NOTCH1/TWIST1/SNAI2,3
GO:0071605,BP,GO:0071605,monocyte chemotactic protein-1 production,3/269,21/18888,0.142857143,10.03080191,4.976958198,0.003142116,0.007865648,0.003298404,IL1B/GSTP1/TWIST1,3
GO:0071637,BP,GO:0071637,regulation of monocyte chemotactic protein-1 production,3/269,21/18888,0.142857143,10.03080191,4.976958198,0.003142116,0.007865648,0.003298404,IL1B/GSTP1/TWIST1,3
GO:0071800,BP,GO:0071800,podosome assembly,3/269,21/18888,0.142857143,10.03080191,4.976958198,0.003142116,0.007865648,0.003298404,TNF/RHOA/FSCN1,3
GO:0090141,BP,GO:0090141,positive regulation of mitochondrial fission,3/269,21/18888,0.142857143,10.03080191,4.976958198,0.003142116,0.007865648,0.003298404,AURKA/KDR/BNIP3,3
GO:2000047,BP,GO:2000047,regulation of cell-cell adhesion mediated by cadherin,3/269,21/18888,0.142857143,10.03080191,4.976958198,0.003142116,0.007865648,0.003298404,VEGFA/NOTCH1/FOXA1,3
GO:0046394,BP,GO:0046394,carboxylic acid biosynthetic process,12/269,334/18888,0.035928144,2.522716648,3.374838599,0.003146737,0.007872891,0.003301441,BRCA1/AMACR/ALOX12/PTGS2/FASN/IL1B/GSTP1/ALOX15B/CYP1A1/FGFR4/AKR1C3/RBP1,12
GO:0010518,BP,GO:0010518,positive regulation of phospholipase activity,4/269,43/18888,0.093023256,6.531684966,4.36488745,0.003209418,0.008016506,0.003361665,EGFR/HRAS/FGFR1/ESR1,4
GO:0090504,BP,GO:0090504,epiboly,4/269,43/18888,0.093023256,6.531684966,4.36488745,0.003209418,0.008016506,0.003361665,PTEN/CD44/MTOR/RHOA,4
GO:1900077,BP,GO:1900077,negative regulation of cellular response to insulin stimulus,4/269,43/18888,0.093023256,6.531684966,4.36488745,0.003209418,0.008016506,0.003361665,IL1B/PRKCD/RELA/IRS1,4
GO:0032922,BP,GO:0032922,circadian regulation of gene expression,5/269,70/18888,0.071428571,5.015400956,4.045485605,0.003215172,0.008022082,0.003364003,ID1/PER1/LGR4/ID4/CLOCK,5
GO:0046626,BP,GO:0046626,regulation of insulin receptor signaling pathway,5/269,70/18888,0.071428571,5.015400956,4.045485605,0.003215172,0.008022082,0.003364003,IL1B/PRKCD/RELA/IRS1/IGF2,5
GO:0005976,BP,GO:0005976,polysaccharide metabolic process,6/269,101/18888,0.059405941,4.171224557,3.840947927,0.003235986,0.008065181,0.003382077,NFKB1/AKT1/TGFB1/IRS1/IGF1/IGF2,6
GO:0034446,BP,GO:0034446,substrate adhesion-dependent cell spreading,6/269,101/18888,0.059405941,4.171224557,3.840947927,0.003235986,0.008065181,0.003382077,RHOA/PTK2/ILK/FN1/OLFM4/BRAF,6
GO:0016053,BP,GO:0016053,organic acid biosynthetic process,12/269,337/18888,0.035608309,2.50025923,3.340235207,0.003381086,0.008422212,0.003531795,BRCA1/AMACR/ALOX12/PTGS2/FASN/IL1B/GSTP1/ALOX15B/CYP1A1/FGFR4/AKR1C3/RBP1,12
GO:0001841,BP,GO:0001841,neural tube formation,6/269,102/18888,0.058823529,4.130330199,3.810241756,0.00339811,0.008450758,0.003543766,CASP3/HIF1A/TGFB1/BRD2/DLC1/TWIST1,6
GO:0009134,BP,GO:0009134,nucleoside diphosphate catabolic process,6/269,102/18888,0.058823529,4.130330199,3.810241756,0.00339811,0.008450758,0.003543766,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:2000060,BP,GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,6/269,102/18888,0.058823529,4.130330199,3.810241756,0.00339811,0.008450758,0.003543766,PTEN/AURKA/FBXW7/AKT1/PTK2/CLU,6
GO:0005996,BP,GO:0005996,monosaccharide metabolic process,10/269,252/18888,0.03968254,2.786333864,3.431357794,0.003403539,0.008455029,0.003545556,TP53/PIK3CA/MAPK14/TNF/AKT1/IRS1/IGF1/PMAIP1/FBP1/IGF2,10
GO:0032984,BP,GO:0032984,protein-containing complex disassembly,10/269,252/18888,0.03968254,2.786333864,3.431357794,0.003403539,0.008455029,0.003545556,MYC/PIK3CA/IGF1R/ARID1A/SMARCA4/HDAC6/TNF/KATNB1/SMARCE1/BNIP3,10
GO:0007004,BP,GO:0007004,telomere maintenance via telomerase,5/269,71/18888,0.070422535,4.944761506,4.002710566,0.003419288,0.008480281,0.003556146,TP53/CTNNB1/MAPK1/HSP90AA1/MAP2K7,5
GO:0032206,BP,GO:0032206,positive regulation of telomere maintenance,5/269,71/18888,0.070422535,4.944761506,4.002710566,0.003419288,0.008480281,0.003556146,CTNNB1/ERCC1/MAPK1/NBN/MAP2K7,5
GO:0070830,BP,GO:0070830,bicellular tight junction assembly,5/269,71/18888,0.070422535,4.944761506,4.002710566,0.003419288,0.008480281,0.003556146,TNF/SLC39A9/SNAI1/SNAI2/ROCK1,5
GO:0016032,BP,GO:0016032,viral process,14/269,428/18888,0.03271028,2.2967724,3.26173932,0.003454127,0.008562026,0.003590425,TP53/TMPRSS2/NOTCH1/RNASEL/SMARCA4/SRPK1/TNF/AKT1/CAV1/BSG/EGFR/IFI27/STAT1/CTSB,14
GO:0007622,BP,GO:0007622,rhythmic behavior,4/269,44/18888,0.090909091,6.38323758,4.296974652,0.003491427,0.008626324,0.003617388,TP53/PTEN/PARP1/MTOR,4
GO:0032689,BP,GO:0032689,negative regulation of type II interferon production,4/269,44/18888,0.090909091,6.38323758,4.296974652,0.003491427,0.008626324,0.003617388,TLR4/IL10/GATA3/CD274,4
GO:0035307,BP,GO:0035307,positive regulation of protein dephosphorylation,4/269,44/18888,0.090909091,6.38323758,4.296974652,0.003491427,0.008626324,0.003617388,MTOR/PRKCD/TGFB1/DLC1,4
GO:0046006,BP,GO:0046006,regulation of activated T cell proliferation,4/269,44/18888,0.090909091,6.38323758,4.296974652,0.003491427,0.008626324,0.003617388,CASP3/IGF1/CD274/IGF2,4
GO:0051972,BP,GO:0051972,regulation of telomerase activity,4/269,44/18888,0.090909091,6.38323758,4.296974652,0.003491427,0.008626324,0.003617388,MYC/MAPK1/HSP90AA1/MAP2K7,4
GO:0070741,BP,GO:0070741,response to interleukin-6,4/269,44/18888,0.090909091,6.38323758,4.296974652,0.003491427,0.008626324,0.003617388,IL6/NFKB1/STAT3/RELA,4
GO:0034764,BP,GO:0034764,positive regulation of transmembrane transport,9/269,213/18888,0.042253521,2.966856904,3.469858104,0.00356125,0.008794067,0.00368773,MAPK14/RNASEL/AKT1/CAV1/BAX/IRS1/IGF1/BRAF/LRRC26,9
GO:0035282,BP,GO:0035282,segmentation,6/269,103/18888,0.058252427,4.090229906,3.779925654,0.003566204,0.008801531,0.00369086,TP53/NOTCH1/BMI1/SMAD3/WT1/NKX3-1,6
GO:0001832,BP,GO:0001832,blastocyst growth,3/269,22/18888,0.136363636,9.57485637,4.837018338,0.003600279,0.008871212,0.00372008,BRCA2/IGF1/NBN,3
GO:0032069,BP,GO:0032069,regulation of nuclease activity,3/269,22/18888,0.136363636,9.57485637,4.837018338,0.003600279,0.008871212,0.00372008,PCNA/PRKCD/AKT1,3
GO:0060445,BP,GO:0060445,branching involved in salivary gland morphogenesis,3/269,22/18888,0.136363636,9.57485637,4.837018338,0.003600279,0.008871212,0.00372008,TNF/SNAI2/FGFR1,3
GO:1901184,BP,GO:1901184,regulation of ERBB signaling pathway,5/269,72/18888,0.069444444,4.876084263,3.960730201,0.003632556,0.008945905,0.003751402,FASLG/MMP9/TGFB1/EGFR/DAB2IP,5
GO:0032970,BP,GO:0032970,regulation of actin filament-based process,13/269,385/18888,0.033766234,2.370916816,3.266629261,0.003654965,0.00899623,0.003772505,PIK3CA/TENM1/MTOR/PRKCD/RHOA/TGFBR1/SMAD3/CAV1/FSCN1/DLC1/BRAF/HRAS/ROCK1,13
GO:0042102,BP,GO:0042102,positive regulation of T cell proliferation,6/269,104/18888,0.057692308,4.050900772,3.749990495,0.003740402,0.009201549,0.003858605,IL6/IL1B/BMI1/IGF1/CD274/IGF2,6
GO:0031032,BP,GO:0031032,actomyosin structure organization,9/269,215/18888,0.041860465,2.939258235,3.437377895,0.003786575,0.009293001,0.003896954,MTOR/RHOA/TGFBR1/SMAD3/EPB41L3/CUL3/DLC1/BRAF/ROCK1,9
GO:0002347,BP,GO:0002347,response to tumor cell,4/269,45/18888,0.088888889,6.241387856,4.231136002,0.003789815,0.009293001,0.003896954,NOTCH1/RELA/TGFB1/CD274,4
GO:0031641,BP,GO:0031641,regulation of myelination,4/269,45/18888,0.088888889,6.241387856,4.231136002,0.003789815,0.009293001,0.003896954,CTNNB1/MTOR/TNF/AKT1,4
GO:0060428,BP,GO:0060428,lung epithelium development,4/269,45/18888,0.088888889,6.241387856,4.231136002,0.003789815,0.009293001,0.003896954,CTNNB1/KRAS/FOXA1/SPDEF,4
GO:0090051,BP,GO:0090051,negative regulation of cell migration involved in sprouting angiogenesis,4/269,45/18888,0.088888889,6.241387856,4.231136002,0.003789815,0.009293001,0.003896954,THBS1/NOTCH1/RHOA/MIR200C,4
GO:1903214,BP,GO:1903214,regulation of protein targeting to mitochondrion,4/269,45/18888,0.088888889,6.241387856,4.231136002,0.003789815,0.009293001,0.003896954,FBXW7/NPEPPS/BAP1/BNIP3L,4
GO:0000724,BP,GO:0000724,double-strand break repair via homologous recombination,8/269,176/18888,0.045454545,3.19161879,3.51107979,0.003799152,0.009310887,0.003904454,BRCA1/BRCA2/XRCC1/PARP1/KDM1A/XRCC3/MEAF6/NBN,8
GO:0045665,BP,GO:0045665,negative regulation of neuron differentiation,5/269,73/18888,0.068493151,4.809288588,3.919517867,0.003855201,0.009443169,0.003959926,NOTCH1/SOX2/ZHX2/MED1/ID4,5
GO:0021549,BP,GO:0021549,cerebellum development,6/269,105/18888,0.057142857,4.012320765,3.72042745,0.003920834,0.009598776,0.004025179,TP53/XRCC1/IGF1R/NCOA1/EZH2/HSPA5,6
GO:0001959,BP,GO:0001959,regulation of cytokine-mediated signaling pathway,8/269,177/18888,0.04519774,3.173587046,3.492163952,0.003931256,0.00961912,0.00403371,IL6/CASP8/PPARG/GSTP1/HIF1A/CAV1/SPHK1/MED1,8
GO:0032956,BP,GO:0032956,regulation of actin cytoskeleton organization,12/269,344/18888,0.034883721,2.449381862,3.260917327,0.003983055,0.009740633,0.004084666,PIK3CA/TENM1/MTOR/PRKCD/RHOA/TGFBR1/SMAD3/FSCN1/DLC1/BRAF/HRAS/ROCK1,12
GO:0032886,BP,GO:0032886,regulation of microtubule-based process,10/269,258/18888,0.03875969,2.721535402,3.346561711,0.004017642,0.009819944,0.004117924,BRCA1/ERBB2/AURKA/DEFB1/XRCC3/HDAC6/RHOA/KATNB1/GIT1/ROCK1,10
GO:0033344,BP,GO:0033344,cholesterol efflux,5/269,74/18888,0.067567568,4.744298202,3.879048177,0.004087447,0.009933328,0.004165471,PPARG/CAV1/MIR145/MIR130B/NFKBIA,5
GO:0060415,BP,GO:0060415,muscle tissue morphogenesis,5/269,74/18888,0.067567568,4.744298202,3.879048177,0.004087447,0.009933328,0.004165471,NOTCH1/TGFBR1/TGFB1/MIR145/MED1,5
GO:0070527,BP,GO:0070527,platelet aggregation,5/269,74/18888,0.067567568,4.744298202,3.879048177,0.004087447,0.009933328,0.004165471,ALOX12/IL6/PRKCD/ILK/CD9,5
GO:0006590,BP,GO:0006590,thyroid hormone generation,3/269,23/18888,0.130434783,9.158558267,4.705744973,0.004097153,0.009933328,0.004165471,GATA3/MED1/CTSB,3
GO:0010560,BP,GO:0010560,positive regulation of glycoprotein biosynthetic process,3/269,23/18888,0.130434783,9.158558267,4.705744973,0.004097153,0.009933328,0.004165471,CTNNB1/IGF1/PAWR,3
GO:0032785,BP,GO:0032785,"negative regulation of DNA-templated transcription, elongation",3/269,23/18888,0.130434783,9.158558267,4.705744973,0.004097153,0.009933328,0.004165471,PARP1/EZH2/VHL,3
GO:0051354,BP,GO:0051354,negative regulation of oxidoreductase activity,3/269,23/18888,0.130434783,9.158558267,4.705744973,0.004097153,0.009933328,0.004165471,NFKB1/HDAC6/MIR130B,3
GO:0060352,BP,GO:0060352,cell adhesion molecule production,3/269,23/18888,0.130434783,9.158558267,4.705744973,0.004097153,0.009933328,0.004165471,IL1B/NOTCH1/CAV1,3
GO:0072202,BP,GO:0072202,cell differentiation involved in metanephros development,3/269,23/18888,0.130434783,9.158558267,4.705744973,0.004097153,0.009933328,0.004165471,CTNNB1/STAT1/LGR4,3
GO:1902254,BP,GO:1902254,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,3/269,23/18888,0.130434783,9.158558267,4.705744973,0.004097153,0.009933328,0.004165471,KDM1A/CD44/MUC1,3
GO:0002701,BP,GO:0002701,negative regulation of production of molecular mediator of immune response,4/269,46/18888,0.086956522,6.105705512,4.167260333,0.00410502,0.009933328,0.004165471,TNF/TGFB1/IL10/TWIST1,4
GO:0002920,BP,GO:0002920,regulation of humoral immune response,4/269,46/18888,0.086956522,6.105705512,4.167260333,0.00410502,0.009933328,0.004165471,KLK3/IL1B/TNF/A2M,4
GO:0005978,BP,GO:0005978,glycogen biosynthetic process,4/269,46/18888,0.086956522,6.105705512,4.167260333,0.00410502,0.009933328,0.004165471,AKT1/IRS1/IGF1/IGF2,4
GO:0009250,BP,GO:0009250,glucan biosynthetic process,4/269,46/18888,0.086956522,6.105705512,4.167260333,0.00410502,0.009933328,0.004165471,AKT1/IRS1/IGF1/IGF2,4
GO:0043029,BP,GO:0043029,T cell homeostasis,4/269,46/18888,0.086956522,6.105705512,4.167260333,0.00410502,0.009933328,0.004165471,CASP3/AKT1/BAX/PMAIP1,4
GO:0045687,BP,GO:0045687,positive regulation of glial cell differentiation,4/269,46/18888,0.086956522,6.105705512,4.167260333,0.00410502,0.009933328,0.004165471,NOTCH1/MTOR/RELA/TGFB1,4
GO:0048713,BP,GO:0048713,regulation of oligodendrocyte differentiation,4/269,46/18888,0.086956522,6.105705512,4.167260333,0.00410502,0.009933328,0.004165471,CTNNB1/NOTCH1/MTOR/ID4,4
GO:0018210,BP,GO:0018210,peptidyl-threonine modification,6/269,106/18888,0.056603774,3.974468682,3.691227981,0.004107636,0.009933328,0.004165471,MAPK1/PRKCD/LMTK2/AKT1/SPHK1/ROCK1,6
GO:0019395,BP,GO:0019395,fatty acid oxidation,6/269,106/18888,0.056603774,3.974468682,3.691227981,0.004107636,0.009933328,0.004165471,AMACR/ALOX12/MAPK14/AKT1/IRS1/TWIST1,6
GO:0035303,BP,GO:0035303,regulation of dephosphorylation,6/269,106/18888,0.056603774,3.974468682,3.691227981,0.004107636,0.009933328,0.004165471,MTOR/PRKCD/TNF/TGFB1/DLC1/ROCK1,6
GO:0010830,BP,GO:0010830,regulation of myotube differentiation,4/269,47/18888,0.085106383,5.975796884,4.105244729,0.004437474,0.010702557,0.004488041,MMP14/NOTCH1/MAPK14/MTOR,4
GO:0050798,BP,GO:0050798,activated T cell proliferation,4/269,47/18888,0.085106383,5.975796884,4.105244729,0.004437474,0.010702557,0.004488041,CASP3/IGF1/CD274/IGF2,4
GO:0055010,BP,GO:0055010,ventricular cardiac muscle tissue morphogenesis,4/269,47/18888,0.085106383,5.975796884,4.105244729,0.004437474,0.010702557,0.004488041,NOTCH1/TGFBR1/TGFB1/MED1,4
GO:0140894,BP,GO:0140894,endolysosomal toll-like receptor signaling pathway,4/269,47/18888,0.085106383,5.975796884,4.105244729,0.004437474,0.010702557,0.004488041,MAP3K7/TNF/CAV1/MYD88,4
GO:1903747,BP,GO:1903747,regulation of establishment of protein localization to mitochondrion,4/269,47/18888,0.085106383,5.975796884,4.105244729,0.004437474,0.010702557,0.004488041,FBXW7/NPEPPS/BAP1/BNIP3L,4
GO:1903522,BP,GO:1903522,regulation of blood circulation,10/269,262/18888,0.038167939,2.679985244,3.291362886,0.004473551,0.010783862,0.004522136,PTGS2/EDNRB/TNF/RHOA/CAV1/MMP2/MIR200C/EGFR/HSP90AA1/UCN,10
GO:0000725,BP,GO:0000725,recombinational repair,8/269,181/18888,0.044198895,3.103452525,3.417821544,0.004495496,0.010831031,0.004541916,BRCA1/BRCA2/XRCC1/PARP1/KDM1A/XRCC3/MEAF6/NBN,8
GO:0034762,BP,GO:0034762,regulation of transmembrane transport,15/269,489/18888,0.030674847,2.153853171,3.1073296,0.004551228,0.010959512,0.004595794,THBS1/IL1B/MAPK14/RNASEL/TNF/AKT1/MMP9/CAV1/MIR200C/BAX/IRS1/IGF1/BRAF/PIM1/LRRC26,15
GO:0002260,BP,GO:0002260,lymphocyte homeostasis,5/269,76/18888,0.065789474,4.619448249,3.800240979,0.004581642,0.011021099,0.00462162,CASP3/HIF1A/AKT1/BAX/PMAIP1,5
GO:1902373,BP,GO:1902373,negative regulation of mRNA catabolic process,5/269,76/18888,0.065789474,4.619448249,3.800240979,0.004581642,0.011021099,0.00462162,YBX1/MAPK14/PKP1/PKP3/MYD88,5
GO:0034763,BP,GO:0034763,negative regulation of transmembrane transport,7/269,144/18888,0.048611111,3.413258984,3.494085228,0.004620552,0.01110883,0.004658409,THBS1/IL1B/TNF/AKT1/MMP9/CAV1/MIR200C,7
GO:0002922,BP,GO:0002922,positive regulation of humoral immune response,3/269,24/18888,0.125,8.776951673,4.582237354,0.004633675,0.011111065,0.004659346,KLK3/IL1B/TNF,3
GO:0032891,BP,GO:0032891,negative regulation of organic acid transport,3/269,24/18888,0.125,8.776951673,4.582237354,0.004633675,0.011111065,0.004659346,THBS1/TNF/AKT1,3
GO:0040037,BP,GO:0040037,negative regulation of fibroblast growth factor receptor signaling pathway,3/269,24/18888,0.125,8.776951673,4.582237354,0.004633675,0.011111065,0.004659346,THBS1/FGF2/GATA3,3
GO:0046885,BP,GO:0046885,regulation of hormone biosynthetic process,3/269,24/18888,0.125,8.776951673,4.582237354,0.004633675,0.011111065,0.004659346,NFKB1/IGF1R/HIF1A,3
GO:0051152,BP,GO:0051152,positive regulation of smooth muscle cell differentiation,3/269,24/18888,0.125,8.776951673,4.582237354,0.004633675,0.011111065,0.004659346,SOD2/NOTCH1/MIR145,3
GO:0006839,BP,GO:0006839,mitochondrial transport,8/269,182/18888,0.043956044,3.086400588,3.39955741,0.004645823,0.011134333,0.004669104,TP53/BID/BAX/AIFM1/BNIP3/HSP90AA1/PMAIP1/BNIP3L,8
GO:1901800,BP,GO:1901800,positive regulation of proteasomal protein catabolic process,6/269,109/18888,0.055045872,3.865079636,3.605729724,0.004707591,0.011276437,0.004728694,AURKA/FBXW7/AKT1/CAV1/DAB2IP/CLU,6
GO:0001774,BP,GO:0001774,microglial cell activation,4/269,48/18888,0.083333333,5.851301115,4.044993754,0.0047876,0.011426038,0.004791428,IL6/TNF/SPHK1/CLU,4
GO:0002861,BP,GO:0002861,regulation of inflammatory response to antigenic stimulus,4/269,48/18888,0.083333333,5.851301115,4.044993754,0.0047876,0.011426038,0.004791428,GPX1/MAPK14/TNF/IL10,4
GO:0021795,BP,GO:0021795,cerebral cortex cell migration,4/269,48/18888,0.083333333,5.851301115,4.044993754,0.0047876,0.011426038,0.004791428,CTNNB1/RHOA/EGFR/DAB2IP,4
GO:0042088,BP,GO:0042088,T-helper 1 type immune response,4/269,48/18888,0.083333333,5.851301115,4.044993754,0.0047876,0.011426038,0.004791428,IL1B/MTOR/TLR4/HRAS,4
GO:0090329,BP,GO:0090329,regulation of DNA-templated DNA replication,4/269,48/18888,0.083333333,5.851301115,4.044993754,0.0047876,0.011426038,0.004791428,CDK2/PCNA/NBN/FGFR1,4
GO:0140718,BP,GO:0140718,facultative heterochromatin formation,4/269,48/18888,0.083333333,5.851301115,4.044993754,0.0047876,0.011426038,0.004791428,MYC/KDM1A/EZH2/MBD2,4
GO:1990090,BP,GO:1990090,cellular response to nerve growth factor stimulus,4/269,48/18888,0.083333333,5.851301115,4.044993754,0.0047876,0.011426038,0.004791428,PARP1/AKT1/TAC1/BRAF,4
GO:0015918,BP,GO:0015918,sterol transport,7/269,145/18888,0.048275862,3.389719267,3.472088511,0.004797455,0.011437575,0.004796266,NFKB1/PPARG/CAV1/MIR145/MIR130B/NFKBIA/CLU,7
GO:0032006,BP,GO:0032006,regulation of TOR signaling,7/269,145/18888,0.048275862,3.389719267,3.472088511,0.004797455,0.011437575,0.004796266,PIK3CA/HIF1A/AKT1/CUL3/VHL/PIM1/NPRL2,7
GO:0035914,BP,GO:0035914,skeletal muscle cell differentiation,5/269,77/18888,0.064935065,4.559455414,3.761858298,0.004844036,0.011536555,0.004837773,SOX11/NOTCH1/FOS/KRAS/RB1,5
GO:0120192,BP,GO:0120192,tight junction assembly,5/269,77/18888,0.064935065,4.559455414,3.761858298,0.004844036,0.011536555,0.004837773,TNF/SLC39A9/SNAI1/SNAI2/ROCK1,5
GO:0009135,BP,GO:0009135,purine nucleoside diphosphate metabolic process,6/269,110/18888,0.054545455,3.829942548,3.577904532,0.004921205,0.011701987,0.004907146,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:0009179,BP,GO:0009179,purine ribonucleoside diphosphate metabolic process,6/269,110/18888,0.054545455,3.829942548,3.577904532,0.004921205,0.011701987,0.004907146,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:2001252,BP,GO:2001252,positive regulation of chromosome organization,6/269,110/18888,0.054545455,3.829942548,3.577904532,0.004921205,0.011701987,0.004907146,CTNNB1/ERCC1/CDK2/MAPK1/NBN/MAP2K7,6
GO:0051495,BP,GO:0051495,positive regulation of cytoskeleton organization,8/269,184/18888,0.043478261,3.052852756,3.36340309,0.004958034,0.011783413,0.004941291,TENM1/MTOR/RHOA/KATNB1/TGFBR1/SMAD3/GIT1/BRAF,8
GO:0051592,BP,GO:0051592,response to calcium ion,7/269,146/18888,0.047945205,3.366502012,3.450283595,0.004979415,0.011828057,0.004960012,THBS1/FOS/CAV1/EGFR/PCSK1/BRAF/AKR1C3,7
GO:0006278,BP,GO:0006278,RNA-templated DNA biosynthetic process,5/269,78/18888,0.064102564,4.501000858,3.72412779,0.005116924,0.012135714,0.005089025,TP53/CTNNB1/MAPK1/HSP90AA1/MAP2K7,5
GO:2000242,BP,GO:2000242,negative regulation of reproductive process,5/269,78/18888,0.064102564,4.501000858,3.72412779,0.005116924,0.012135714,0.005089025,TIMP1/WT1/SNAI1/IGF1/NKX3-1,5
GO:2000514,BP,GO:2000514,"regulation of CD4-positive, alpha-beta T cell activation",5/269,78/18888,0.064102564,4.501000858,3.72412779,0.005116924,0.012135714,0.005089025,TWSG1/BRD2/BRD4/GATA3/CD274,5
GO:0050954,BP,GO:0050954,sensory perception of mechanical stimulus,8/269,185/18888,0.043243243,3.036350849,3.345509654,0.005120045,0.012136798,0.00508948,GPX1/CASP3/TNF/COL11A2/SNAI2/FGFR1/TFAP2A/UCN,8
GO:0014812,BP,GO:0014812,muscle cell migration,6/269,111/18888,0.054054054,3.795438561,3.550404147,0.005141856,0.012182162,0.005108503,MAP3K7/TLR4/SERPINE1/IGF1/ROCK1/PLAU,6
GO:0031648,BP,GO:0031648,protein destabilization,4/269,49/18888,0.081632653,5.731886807,3.986418763,0.005155815,0.012196206,0.005114393,FBXW7/MTOR/HDAC6/CUL3,4
GO:0036230,BP,GO:0036230,granulocyte activation,4/269,49/18888,0.081632653,5.731886807,3.986418763,0.005155815,0.012196206,0.005114393,CXCR2/PRKCD/TNF/MYD88,4
GO:0046427,BP,GO:0046427,positive regulation of receptor signaling pathway via JAK-STAT,4/269,49/18888,0.081632653,5.731886807,3.986418763,0.005155815,0.012196206,0.005114393,IL6/NOTCH1/TNF/IL10,4
GO:0050714,BP,GO:0050714,positive regulation of protein secretion,7/269,147/18888,0.047619048,3.343600637,3.428667325,0.00516652,0.012215187,0.005122352,PPARG/HIF1A/TLR4/TGFB1/EGFR/PCSK1/IGF1,7
GO:0014856,BP,GO:0014856,skeletal muscle cell proliferation,3/269,25/18888,0.12,8.425873606,4.465721436,0.005210718,0.012262414,0.005142156,FGF2/MYB/FOS,3
GO:0032331,BP,GO:0032331,negative regulation of chondrocyte differentiation,3/269,25/18888,0.12,8.425873606,4.465721436,0.005210718,0.012262414,0.005142156,CTNNB1/TGFBR1/SNAI2,3
GO:0042659,BP,GO:0042659,regulation of cell fate specification,3/269,25/18888,0.12,8.425873606,4.465721436,0.005210718,0.012262414,0.005142156,AR/FGF2/FGFR1,3
GO:0043567,BP,GO:0043567,regulation of insulin-like growth factor receptor signaling pathway,3/269,25/18888,0.12,8.425873606,4.465721436,0.005210718,0.012262414,0.005142156,AR/IGF1/NKX3-1,3
GO:0045662,BP,GO:0045662,negative regulation of myoblast differentiation,3/269,25/18888,0.12,8.425873606,4.465721436,0.005210718,0.012262414,0.005142156,NOTCH1/TNF/TGFB1,3
GO:0048520,BP,GO:0048520,positive regulation of behavior,3/269,25/18888,0.12,8.425873606,4.465721436,0.005210718,0.012262414,0.005142156,MC1R/GRPR/UCN,3
GO:0050927,BP,GO:0050927,positive regulation of positive chemotaxis,3/269,25/18888,0.12,8.425873606,4.465721436,0.005210718,0.012262414,0.005142156,VEGFA/SMAD3/KDR,3
GO:0072170,BP,GO:0072170,metanephric tubule development,3/269,25/18888,0.12,8.425873606,4.465721436,0.005210718,0.012262414,0.005142156,CXCR2/STAT1/LGR4,3
GO:0090335,BP,GO:0090335,regulation of brown fat cell differentiation,3/269,25/18888,0.12,8.425873606,4.465721436,0.005210718,0.012262414,0.005142156,PTGS2/MAPK14/PIM1,3
GO:0048736,BP,GO:0048736,appendage development,8/269,186/18888,0.043010753,3.020026382,3.327736586,0.005286078,0.012426919,0.00521114,CTNNB1/NOTCH1/BAX/TWIST1/TP63/FGFR1/TFAP2A/MED1,8
GO:0060173,BP,GO:0060173,limb development,8/269,186/18888,0.043010753,3.020026382,3.327736586,0.005286078,0.012426919,0.00521114,CTNNB1/NOTCH1/BAX/TWIST1/TP63/FGFR1/TFAP2A/MED1,8
GO:1903038,BP,GO:1903038,negative regulation of leukocyte cell-cell adhesion,7/269,148/18888,0.047297297,3.321008741,3.407236619,0.00535886,0.012591526,0.005280167,ERBB2/CASP3/TWSG1/AKT1/IL10/CD274/PAWR,7
GO:0016239,BP,GO:0016239,positive regulation of macroautophagy,5/269,79/18888,0.063291139,4.444026163,3.687029298,0.005400525,0.012682883,0.005318477,MAP3K7/HIF1A/KDR/BNIP3/BNIP3L,5
GO:0006693,BP,GO:0006693,prostaglandin metabolic process,4/269,50/18888,0.08,5.617249071,3.929437294,0.005542527,0.012982905,0.005444289,PTGS2/IL1B/GSTP1/AKR1C3,4
GO:0043114,BP,GO:0043114,regulation of vascular permeability,4/269,50/18888,0.08,5.617249071,3.929437294,0.005542527,0.012982905,0.005444289,CXCR2/VEGFA/TGFB1/UCN,4
GO:0043330,BP,GO:0043330,response to exogenous dsRNA,4/269,50/18888,0.08,5.617249071,3.929437294,0.005542527,0.012982905,0.005444289,MAPK1/CAV1/NFKBIA/IFNA1,4
GO:0061082,BP,GO:0061082,myeloid leukocyte cytokine production,4/269,50/18888,0.08,5.617249071,3.929437294,0.005542527,0.012982905,0.005444289,TLR4/TGFB1/TWIST1/MYD88,4
GO:1990089,BP,GO:1990089,response to nerve growth factor,4/269,50/18888,0.08,5.617249071,3.929437294,0.005542527,0.012982905,0.005444289,PARP1/AKT1/TAC1/BRAF,4
GO:0000910,BP,GO:0000910,cytokinesis,8/269,188/18888,0.042553191,2.987898442,3.292545376,0.005630462,0.013182109,0.005527824,AURKA/BRCA2/IGF1R/RHOA/LZTS2/CUL3/GIT1/ROCK1,8
GO:0051966,BP,GO:0051966,"regulation of synaptic transmission, glutamatergic",5/269,80/18888,0.0625,4.388475836,3.65054354,0.005695059,0.013326497,0.005588372,PTGS2/HDAC6/TNF/EGFR/UCN,5
GO:0034138,BP,GO:0034138,toll-like receptor 3 signaling pathway,3/269,26/18888,0.115384615,8.101801544,4.355527799,0.005829095,0.013591277,0.005699406,MAP3K7/TNF/CAV1,3
GO:0048596,BP,GO:0048596,embryonic camera-type eye morphogenesis,3/269,26/18888,0.115384615,8.101801544,4.355527799,0.005829095,0.013591277,0.005699406,SOX11/TWIST1/TFAP2A,3
GO:0050926,BP,GO:0050926,regulation of positive chemotaxis,3/269,26/18888,0.115384615,8.101801544,4.355527799,0.005829095,0.013591277,0.005699406,VEGFA/SMAD3/KDR,3
GO:0060065,BP,GO:0060065,uterus development,3/269,26/18888,0.115384615,8.101801544,4.355527799,0.005829095,0.013591277,0.005699406,GATA3/ESR1/CYP19A1,3
GO:0060259,BP,GO:0060259,regulation of feeding behavior,3/269,26/18888,0.115384615,8.101801544,4.355527799,0.005829095,0.013591277,0.005699406,STAT3/MC1R/UCN,3
GO:1903020,BP,GO:1903020,positive regulation of glycoprotein metabolic process,3/269,26/18888,0.115384615,8.101801544,4.355527799,0.005829095,0.013591277,0.005699406,CTNNB1/IGF1/PAWR,3
GO:2000773,BP,GO:2000773,negative regulation of cellular senescence,3/269,26/18888,0.115384615,8.101801544,4.355527799,0.005829095,0.013591277,0.005699406,PTEN/YBX1/TWIST1,3
GO:0110053,BP,GO:0110053,regulation of actin filament organization,10/269,273/18888,0.036630037,2.57200049,3.144719651,0.005939806,0.013819328,0.005795037,PIK3CA/TENM1/MTOR/PRKCD/RHOA/TGFBR1/SMAD3/DLC1/BRAF/ROCK1,10
GO:0006692,BP,GO:0006692,prostanoid metabolic process,4/269,51/18888,0.078431373,5.507106932,3.873972516,0.005948135,0.013819328,0.005795037,PTGS2/IL1B/GSTP1/AKR1C3,4
GO:0010665,BP,GO:0010665,regulation of cardiac muscle cell apoptotic process,4/269,51/18888,0.078431373,5.507106932,3.873972516,0.005948135,0.013819328,0.005795037,TP53/CXCR2/BNIP3/MIR145,4
GO:0032692,BP,GO:0032692,negative regulation of interleukin-1 production,4/269,51/18888,0.078431373,5.507106932,3.873972516,0.005948135,0.013819328,0.005795037,GSTP1/IL10/GIT1/IGF1,4
GO:0034198,BP,GO:0034198,cellular response to amino acid starvation,4/269,51/18888,0.078431373,5.507106932,3.873972516,0.005948135,0.013819328,0.005795037,MTOR/MAPK1/CDKN1A/NPRL2,4
GO:0048013,BP,GO:0048013,ephrin receptor signaling pathway,4/269,51/18888,0.078431373,5.507106932,3.873972516,0.005948135,0.013819328,0.005795037,MMP9/MMP2/PTK2/GIT1,4
GO:0071622,BP,GO:0071622,regulation of granulocyte chemotaxis,4/269,51/18888,0.078431373,5.507106932,3.873972516,0.005948135,0.013819328,0.005795037,THBS1/CXCR2/MAPK1/PTK2,4
GO:0048644,BP,GO:0048644,muscle organ morphogenesis,5/269,81/18888,0.061728395,4.334297122,3.614652058,0.006000743,0.013934447,0.005843312,NOTCH1/TGFBR1/TGFB1/MIR145/MED1,5
GO:0015908,BP,GO:0015908,fatty acid transport,6/269,115/18888,0.052173913,3.663423307,3.443513026,0.006097519,0.014137556,0.005928484,THBS1/PTGS2/IL1B/PPARG/AKT1/RBP1,6
GO:0022037,BP,GO:0022037,metencephalon development,6/269,115/18888,0.052173913,3.663423307,3.443513026,0.006097519,0.014137556,0.005928484,TP53/XRCC1/IGF1R/NCOA1/EZH2/HSPA5,6
GO:0046634,BP,GO:0046634,regulation of alpha-beta T cell activation,6/269,115/18888,0.052173913,3.663423307,3.443513026,0.006097519,0.014137556,0.005928484,RHOA/TWSG1/BRD2/BRD4/GATA3/CD274,6
GO:0019722,BP,GO:0019722,calcium-mediated signaling,9/269,232/18888,0.038793103,2.723881554,3.175569358,0.006184466,0.014331855,0.006009962,CXCR2/EDNRB/DEFB1/MTOR/TNF/KDR/IGF1/SPHK1/CAMKK2,9
GO:0003407,BP,GO:0003407,neural retina development,5/269,82/18888,0.06097561,4.28143984,3.579337176,0.006317793,0.014618519,0.006130172,NOTCH1/STAT3/SMARCA4/ZHX2/TFAP2A,5
GO:0030500,BP,GO:0030500,regulation of bone mineralization,5/269,82/18888,0.06097561,4.28143984,3.579337176,0.006317793,0.014618519,0.006130172,VDR/HIF1A/SMAD3/TWIST1/TFAP2A,5
GO:0032147,BP,GO:0032147,activation of protein kinase activity,5/269,82/18888,0.06097561,4.28143984,3.579337176,0.006317793,0.014618519,0.006130172,MAP3K7/VEGFA/PRKCD/TXN/IGF1,5
GO:0002695,BP,GO:0002695,negative regulation of leukocyte activation,8/269,192/18888,0.041666667,2.925650558,3.223541002,0.006370306,0.014716435,0.006171233,ERBB2/CASP3/SOX11/TWSG1/IL10/FN1/CD274/PAWR,8
GO:0010517,BP,GO:0010517,regulation of phospholipase activity,4/269,52/18888,0.076923077,5.401201029,3.81995275,0.00637303,0.014716435,0.006171233,EGFR/HRAS/FGFR1/ESR1,4
GO:0060324,BP,GO:0060324,face development,4/269,52/18888,0.076923077,5.401201029,3.81995275,0.00637303,0.014716435,0.006171233,MAPK1/MMP2/SGPL1/BRAF,4
GO:0071470,BP,GO:0071470,cellular response to osmotic stress,4/269,52/18888,0.076923077,5.401201029,3.81995275,0.00637303,0.014716435,0.006171233,PTGS2/CASP3/MTOR/FBP1,4
GO:0007612,BP,GO:0007612,learning,7/269,153/18888,0.045751634,3.212479044,3.302763578,0.006402222,0.014776355,0.00619636,PTGS2/HIF1A/FOS/KRAS/GIT1/BRAF/UCN,7
GO:0010875,BP,GO:0010875,positive regulation of cholesterol efflux,3/269,27/18888,0.111111111,7.80173482,4.251074096,0.006489555,0.014940077,0.006265015,PPARG/CAV1/NFKBIA,3
GO:0016540,BP,GO:0016540,protein autoprocessing,3/269,27/18888,0.111111111,7.80173482,4.251074096,0.006489555,0.014940077,0.006265015,TMPRSS2/PARP1/PCSK1,3
GO:0031639,BP,GO:0031639,plasminogen activation,3/269,27/18888,0.111111111,7.80173482,4.251074096,0.006489555,0.014940077,0.006265015,THBS1/SERPINE1/PLAU,3
GO:0042832,BP,GO:0042832,defense response to protozoan,3/269,27/18888,0.111111111,7.80173482,4.251074096,0.006489555,0.014940077,0.006265015,IL10/HRAS/MYD88,3
GO:0060669,BP,GO:0060669,embryonic placenta morphogenesis,3/269,27/18888,0.111111111,7.80173482,4.251074096,0.006489555,0.014940077,0.006265015,NCOA1/IL10/IGF2,3
GO:0001824,BP,GO:0001824,blastocyst development,6/269,117/18888,0.051282051,3.600800686,3.391843076,0.006621055,0.015235114,0.006388737,BRCA2/HNF1B/TGFBR1/CUL3/IGF1/NBN,6
GO:0097530,BP,GO:0097530,granulocyte migration,7/269,154/18888,0.045454545,3.19161879,3.282385398,0.006627856,0.015243064,0.006392071,THBS1/CXCR2/IL1B/MAPK1/PTK2/BSG/MYD88,7
GO:2000736,BP,GO:2000736,regulation of stem cell differentiation,5/269,83/18888,0.060240964,4.229856228,3.544581956,0.006646422,0.015278052,0.006406743,FGF2/NOTCH1/STAT3/EZH2/CDK12,5
GO:0002377,BP,GO:0002377,immunoglobulin production,8/269,194/18888,0.041237113,2.895489212,3.189704984,0.006766798,0.015546915,0.006519489,ERCC1/IL6/TNF/TGFB1/IL10/MLH1/MSH2/NBN,8
GO:0010662,BP,GO:0010662,regulation of striated muscle cell apoptotic process,4/269,53/18888,0.075471698,5.299291576,3.767311025,0.006817597,0.015639965,0.006558508,TP53/CXCR2/BNIP3/MIR145,4
GO:0032330,BP,GO:0032330,regulation of chondrocyte differentiation,4/269,53/18888,0.075471698,5.299291576,3.767311025,0.006817597,0.015639965,0.006558508,CTNNB1/TGFBR1/SMAD3/SNAI2,4
GO:0045778,BP,GO:0045778,positive regulation of ossification,4/269,53/18888,0.075471698,5.299291576,3.767311025,0.006817597,0.015639965,0.006558508,VDR/SOX11/SMAD3/TFAP2A,4
GO:0006090,BP,GO:0006090,pyruvate metabolic process,6/269,118/18888,0.050847458,3.570285426,3.366430674,0.006894715,0.015808918,0.006629358,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:0051702,BP,GO:0051702,biological process involved in interaction with symbiont,6/269,119/18888,0.050420168,3.540283028,3.341292334,0.007176479,0.016385181,0.006871009,GPX1/FASN/SMARCA4/FN1/IFI27/MYD88,6
GO:1903707,BP,GO:1903707,negative regulation of hemopoiesis,6/269,119/18888,0.050420168,3.540283028,3.341292334,0.007176479,0.016385181,0.006871009,CTNNB1/ERBB2/FBXW7/MYC/TLR4/SNAI2,6
GO:1990748,BP,GO:1990748,cellular detoxification,6/269,119/18888,0.050420168,3.540283028,3.341292334,0.007176479,0.016385181,0.006871009,GPX1/PTGS2/SOD2/GSTP1/TXN/PIM1,6
GO:0009648,BP,GO:0009648,photoperiodism,3/269,28/18888,0.107142857,7.523101434,4.151850982,0.007192792,0.016385181,0.006871009,TP53/PER1/CLOCK,3
GO:0010039,BP,GO:0010039,response to iron ion,3/269,28/18888,0.107142857,7.523101434,4.151850982,0.007192792,0.016385181,0.006871009,HIF1A/CYP1A1/TFAP2A,3
GO:0010971,BP,GO:0010971,positive regulation of G2/M transition of mitotic cell cycle,3/269,28/18888,0.107142857,7.523101434,4.151850982,0.007192792,0.016385181,0.006871009,CCND1/CDK4/BRD4,3
GO:0034698,BP,GO:0034698,response to gonadotropin,3/269,28/18888,0.107142857,7.523101434,4.151850982,0.007192792,0.016385181,0.006871009,SRD5A2/NOTCH1/WT1,3
GO:0042634,BP,GO:0042634,regulation of hair cycle,3/269,28/18888,0.107142857,7.523101434,4.151850982,0.007192792,0.016385181,0.006871009,TNF/PER1/CLOCK,3
GO:0045686,BP,GO:0045686,negative regulation of glial cell differentiation,3/269,28/18888,0.107142857,7.523101434,4.151850982,0.007192792,0.016385181,0.006871009,CTNNB1/NOTCH1/ID4,3
GO:0045830,BP,GO:0045830,positive regulation of isotype switching,3/269,28/18888,0.107142857,7.523101434,4.151850982,0.007192792,0.016385181,0.006871009,TGFB1/MLH1/MSH2,3
GO:0060575,BP,GO:0060575,intestinal epithelial cell differentiation,3/269,28/18888,0.107142857,7.523101434,4.151850982,0.007192792,0.016385181,0.006871009,HIF1A/SPDEF/CDKN1A,3
GO:0120255,BP,GO:0120255,olefinic compound biosynthetic process,3/269,28/18888,0.107142857,7.523101434,4.151850982,0.007192792,0.016385181,0.006871009,SRD5A2/AKR1C3/CYP19A1,3
GO:1903672,BP,GO:1903672,positive regulation of sprouting angiogenesis,3/269,28/18888,0.107142857,7.523101434,4.151850982,0.007192792,0.016385181,0.006871009,VEGFA/FGF2/IL10,3
GO:0002762,BP,GO:0002762,negative regulation of myeloid leukocyte differentiation,4/269,54/18888,0.074074074,5.201156547,3.715984689,0.007282207,0.016555755,0.006942539,CTNNB1/FBXW7/MYC/TLR4,4
GO:0035315,BP,GO:0035315,hair cell differentiation,4/269,54/18888,0.074074074,5.201156547,3.715984689,0.007282207,0.016555755,0.006942539,CTNNB1/FGF2/NOTCH1/FGFR1,4
GO:0038093,BP,GO:0038093,Fc receptor signaling pathway,4/269,54/18888,0.074074074,5.201156547,3.715984689,0.007282207,0.016555755,0.006942539,MAP3K7/PRKCD/PTK2/MAP2K7,4
GO:1990928,BP,GO:1990928,response to amino acid starvation,4/269,54/18888,0.074074074,5.201156547,3.715984689,0.007282207,0.016555755,0.006942539,MTOR/MAPK1/CDKN1A/NPRL2,4
GO:0007015,BP,GO:0007015,actin filament organization,14/269,467/18888,0.029978587,2.104964855,2.906228505,0.007323644,0.016641658,0.006978561,PIK3CA/TENM1/MTOR/HDAC6/PRKCD/RHOA/TGFBR1/SMAD3/FSCN1/CUL3/DLC1/BRAF/PAWR/ROCK1,14
GO:0090276,BP,GO:0090276,regulation of peptide hormone secretion,8/269,197/18888,0.040609137,2.851395467,3.139753077,0.007396212,0.016798176,0.007044196,IL6/IL1B/HIF1A/TNF/EGFR/IRS1/UCN/CLOCK,8
GO:0009185,BP,GO:0009185,ribonucleoside diphosphate metabolic process,6/269,120/18888,0.05,3.510780669,3.316422525,0.007466481,0.016949321,0.007107577,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:0016052,BP,GO:0016052,carbohydrate catabolic process,7/269,158/18888,0.044303797,3.110818314,3.202506078,0.007589929,0.017220975,0.007221494,TP53/HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,7
GO:0035050,BP,GO:0035050,embryonic heart tube development,5/269,86/18888,0.058139535,4.082303104,3.443515159,0.007703904,0.017462183,0.007322643,CTNNB1/NOTCH1/HIF1A/SMAD3/MED1,5
GO:0071230,BP,GO:0071230,cellular response to amino acid stimulus,5/269,86/18888,0.058139535,4.082303104,3.443515159,0.007703904,0.017462183,0.007322643,MTOR/TNF/MMP2/EGFR/CUL3,5
GO:0030510,BP,GO:0030510,regulation of BMP signaling pathway,6/269,121/18888,0.049586777,3.481765953,3.291815869,0.00776485,0.017579471,0.007371827,PPARG/SOX11/NOTCH1/TWSG1/ILK/KDR,6
GO:0032210,BP,GO:0032210,regulation of telomere maintenance via telomerase,4/269,55/18888,0.072727273,5.106590064,3.665915058,0.007767225,0.017579471,0.007371827,TP53/CTNNB1/MAPK1/MAP2K7,4
GO:1900087,BP,GO:1900087,positive regulation of G1/S transition of mitotic cell cycle,4/269,55/18888,0.072727273,5.106590064,3.665915058,0.007767225,0.017579471,0.007371827,CCND1/AKT1/CYP1A1/EGFR,4
GO:0009060,BP,GO:0009060,aerobic respiration,8/269,199/18888,0.040201005,2.822738226,3.106971447,0.007839699,0.017734692,0.007436917,COX2/BID/HIF1A/TNF/RHOA/BNIP3/MSH2/UCN,8
GO:0003401,BP,GO:0003401,axis elongation,3/269,29/18888,0.103448276,7.263684143,4.057410721,0.007939443,0.01788927,0.007501739,HNF1B/MED1/ESR1,3
GO:0007263,BP,GO:0007263,nitric oxide mediated signal transduction,3/269,29/18888,0.103448276,7.263684143,4.057410721,0.007939443,0.01788927,0.007501739,THBS1/VEGFA/EGFR,3
GO:0008299,BP,GO:0008299,isoprenoid biosynthetic process,3/269,29/18888,0.103448276,7.263684143,4.057410721,0.007939443,0.01788927,0.007501739,CYP1A1/AKR1C3/RBP1,3
GO:0033137,BP,GO:0033137,negative regulation of peptidyl-serine phosphorylation,3/269,29/18888,0.103448276,7.263684143,4.057410721,0.007939443,0.01788927,0.007501739,PTEN/CAV1/BAX,3
GO:0042403,BP,GO:0042403,thyroid hormone metabolic process,3/269,29/18888,0.103448276,7.263684143,4.057410721,0.007939443,0.01788927,0.007501739,GATA3/MED1/CTSB,3
GO:0045742,BP,GO:0045742,positive regulation of epidermal growth factor receptor signaling pathway,3/269,29/18888,0.103448276,7.263684143,4.057410721,0.007939443,0.01788927,0.007501739,FASLG/MMP9/TGFB1,3
GO:0060765,BP,GO:0060765,regulation of androgen receptor signaling pathway,3/269,29/18888,0.103448276,7.263684143,4.057410721,0.007939443,0.01788927,0.007501739,KDM1A/SMARCA4/HDAC6,3
GO:1902430,BP,GO:1902430,negative regulation of amyloid-beta formation,3/269,29/18888,0.103448276,7.263684143,4.057410721,0.007939443,0.01788927,0.007501739,IGF1/ROCK1/CLU,3
GO:0030072,BP,GO:0030072,peptide hormone secretion,9/269,242/18888,0.037190083,2.611324465,3.032335835,0.008060423,0.018152886,0.007612284,IL6/IL1B/HIF1A/TNF/HNF1B/EGFR/IRS1/UCN/CLOCK,9
GO:0002791,BP,GO:0002791,regulation of peptide secretion,8/269,200/18888,0.04,2.808624535,3.090732774,0.008068802,0.018160372,0.007615423,IL6/IL1B/HIF1A/TNF/EGFR/IRS1/UCN/CLOCK,8
GO:0045471,BP,GO:0045471,response to ethanol,6/269,122/18888,0.049180328,3.453226888,3.267467146,0.008071719,0.018160372,0.007615423,CASP8/SOD2/IGF1R/FOS/TNF/MYD88,6
GO:0008306,BP,GO:0008306,associative learning,5/269,87/18888,0.057471264,4.035380079,3.410842654,0.008080958,0.018172183,0.007620376,HIF1A/FOS/KRAS/BRAF/UCN,5
GO:0006261,BP,GO:0006261,DNA-templated DNA replication,7/269,160/18888,0.04375,3.071933086,3.163511887,0.00810795,0.018223888,0.007642058,BRCA1/BRCA2/PARP1/CDK2/PCNA/NBN/FGFR1,7
GO:0050807,BP,GO:0050807,regulation of synapse organization,9/269,243/18888,0.037037037,2.600578273,3.018410581,0.008269488,0.018567397,0.007786107,PTEN/CTNNB1/MAPK14/TNF/RHOA/AKT1/IL10/DAB2IP/ROCK1,9
GO:0001954,BP,GO:0001954,positive regulation of cell-matrix adhesion,4/269,56/18888,0.071428571,5.015400956,3.617047091,0.008273006,0.018567397,0.007786107,VEGFA/SMAD3/KDR/ROCK1,4
GO:0014888,BP,GO:0014888,striated muscle adaptation,4/269,56/18888,0.071428571,5.015400956,3.617047091,0.008273006,0.018567397,0.007786107,MIR25/PPARG/EZH2/SMAD3,4
GO:0007605,BP,GO:0007605,sensory perception of sound,7/269,161/18888,0.043478261,3.052852756,3.144242886,0.008376521,0.018632807,0.007813536,GPX1/CASP3/COL11A2/SNAI2/FGFR1/TFAP2A/UCN,7
GO:0071322,BP,GO:0071322,cellular response to carbohydrate stimulus,7/269,161/18888,0.043478261,3.052852756,3.144242886,0.008376521,0.018632807,0.007813536,GPX1/PIK3CA/IGF1R/HIF1A/SMARCA4/SMAD3/FBP1,7
GO:0002934,BP,GO:0002934,desmosome organization,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,PKP3/SNAI2,2
GO:0003266,BP,GO:0003266,regulation of secondary heart field cardioblast proliferation,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,CTNNB1/NOTCH1,2
GO:0008627,BP,GO:0008627,intrinsic apoptotic signaling pathway in response to osmotic stress,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,PTGS2/CASP3,2
GO:0009750,BP,GO:0009750,response to fructose,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,PTGS2/TNF,2
GO:0035768,BP,GO:0035768,endothelial cell chemotaxis to fibroblast growth factor,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,FGF2/FGFR1,2
GO:0038129,BP,GO:0038129,ERBB3 signaling pathway,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,ERBB2/MAPK1,2
GO:0038130,BP,GO:0038130,ERBB4 signaling pathway,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,ERBB2/NRG4,2
GO:0043653,BP,GO:0043653,mitochondrial fragmentation involved in apoptotic process,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,BAX/BNIP3,2
GO:0048304,BP,GO:0048304,positive regulation of isotype switching to IgG isotypes,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,MLH1/MSH2,2
GO:0060068,BP,GO:0060068,vagina development,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,BAX/ESR1,2
GO:0060536,BP,GO:0060536,cartilage morphogenesis,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,SNAI1/SNAI2,2
GO:0071374,BP,GO:0071374,cellular response to parathyroid hormone stimulus,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,HDAC6/FOS,2
GO:0072172,BP,GO:0072172,mesonephric tubule formation,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,HNF1B/GATA3,2
GO:0090269,BP,GO:0090269,fibroblast growth factor production,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,PTGS2/FGFR1,2
GO:0090270,BP,GO:0090270,regulation of fibroblast growth factor production,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,PTGS2/FGFR1,2
GO:1901329,BP,GO:1901329,regulation of odontoblast differentiation,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,CTNNB1/SERPINE1,2
GO:1901838,BP,GO:1901838,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,SMARCA4/MTOR,2
GO:1901856,BP,GO:1901856,negative regulation of cellular respiration,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,TNF/RHOA,2
GO:1902460,BP,GO:1902460,regulation of mesenchymal stem cell proliferation,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,TGFBR1/TGFB1,2
GO:1903596,BP,GO:1903596,regulation of gap junction assembly,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,IL1B/CAV1,2
GO:1904179,BP,GO:1904179,positive regulation of adipose tissue development,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,PPARG/NCOA1,2
GO:1904383,BP,GO:1904383,response to sodium phosphate,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,EDNRB/FGFR1,2
GO:1904760,BP,GO:1904760,regulation of myofibroblast differentiation,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,PARP1/RB1,2
GO:1905770,BP,GO:1905770,regulation of mesodermal cell differentiation,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,MIR200C/FGFR1,2
GO:2000048,BP,GO:2000048,negative regulation of cell-cell adhesion mediated by cadherin,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,VEGFA/NOTCH1,2
GO:2000271,BP,GO:2000271,positive regulation of fibroblast apoptotic process,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,BID/TP63,2
GO:2000321,BP,GO:2000321,positive regulation of T-helper 17 cell differentiation,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,BRD2/BRD4,2
GO:2000347,BP,GO:2000347,positive regulation of hepatocyte proliferation,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,TNF/MED1,2
GO:2000544,BP,GO:2000544,regulation of endothelial cell chemotaxis to fibroblast growth factor,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,FGF2/FGFR1,2
GO:2000822,BP,GO:2000822,regulation of behavioral fear response,2/269,10/18888,0.2,14.04312268,4.958873645,0.008433022,0.018632807,0.007813536,GRPR/UCN,2
GO:0033627,BP,GO:0033627,cell adhesion mediated by integrin,5/269,88/18888,0.056818182,3.989523488,3.378654907,0.008470633,0.018688718,0.007836981,PTK2/SERPINE1/SNAI2/MUC1/PLAU,5
GO:0061515,BP,GO:0061515,myeloid cell development,5/269,88/18888,0.056818182,3.989523488,3.378654907,0.008470633,0.018688718,0.007836981,FBXW7/MYB/BAP1/HDAC6/MED1,5
GO:1902369,BP,GO:1902369,negative regulation of RNA catabolic process,5/269,88/18888,0.056818182,3.989523488,3.378654907,0.008470633,0.018688718,0.007836981,YBX1/MAPK14/PKP1/PKP3/MYD88,5
GO:0090087,BP,GO:0090087,regulation of peptide transport,8/269,202/18888,0.03960396,2.780816372,3.058553674,0.008542055,0.018837175,0.007899236,IL6/IL1B/HIF1A/TNF/EGFR/IRS1/UCN/CLOCK,8
GO:0032479,BP,GO:0032479,regulation of type I interferon production,6/269,124/18888,0.048387097,3.39752968,3.219523332,0.008711475,0.019131454,0.00802264,TLR4/IL10/CUL3/HSP90AA1/STAT1/MYD88,6
GO:0032606,BP,GO:0032606,type I interferon production,6/269,124/18888,0.048387097,3.39752968,3.219523332,0.008711475,0.019131454,0.00802264,TLR4/IL10/CUL3/HSP90AA1/STAT1/MYD88,6
GO:0043244,BP,GO:0043244,regulation of protein-containing complex disassembly,6/269,124/18888,0.048387097,3.39752968,3.219523332,0.008711475,0.019131454,0.00802264,PIK3CA/IGF1R/HDAC6/TNF/KATNB1/BNIP3,6
GO:0001562,BP,GO:0001562,response to protozoan,3/269,30/18888,0.1,7.021561338,3.9673579,0.008730091,0.019131454,0.00802264,IL10/HRAS/MYD88,3
GO:0006359,BP,GO:0006359,regulation of transcription by RNA polymerase III,3/269,30/18888,0.1,7.021561338,3.9673579,0.008730091,0.019131454,0.00802264,AR/TENM1/MTOR,3
GO:0010894,BP,GO:0010894,negative regulation of steroid biosynthetic process,3/269,30/18888,0.1,7.021561338,3.9673579,0.008730091,0.019131454,0.00802264,NFKB1/SNAI1/SNAI2,3
GO:0010955,BP,GO:0010955,negative regulation of protein processing,3/269,30/18888,0.1,7.021561338,3.9673579,0.008730091,0.019131454,0.00802264,THBS1/SERPINE1/PLAU,3
GO:0032607,BP,GO:0032607,interferon-alpha production,3/269,30/18888,0.1,7.021561338,3.9673579,0.008730091,0.019131454,0.00802264,TLR4/IL10/STAT1,3
GO:0032647,BP,GO:0032647,regulation of interferon-alpha production,3/269,30/18888,0.1,7.021561338,3.9673579,0.008730091,0.019131454,0.00802264,TLR4/IL10/STAT1,3
GO:0045987,BP,GO:0045987,positive regulation of smooth muscle contraction,3/269,30/18888,0.1,7.021561338,3.9673579,0.008730091,0.019131454,0.00802264,PTGS2/RHOA/SPHK1,3
GO:0060037,BP,GO:0060037,pharyngeal system development,3/269,30/18888,0.1,7.021561338,3.9673579,0.008730091,0.019131454,0.00802264,TGFBR1/NKX3-1/GATA3,3
GO:1900101,BP,GO:1900101,regulation of endoplasmic reticulum unfolded protein response,3/269,30/18888,0.1,7.021561338,3.9673579,0.008730091,0.019131454,0.00802264,BAX/DAB2IP/HSPA5,3
GO:1903318,BP,GO:1903318,negative regulation of protein maturation,3/269,30/18888,0.1,7.021561338,3.9673579,0.008730091,0.019131454,0.00802264,THBS1/SERPINE1/PLAU,3
GO:0001755,BP,GO:0001755,neural crest cell migration,4/269,57/18888,0.070175439,4.927411465,3.569329111,0.008799897,0.019265896,0.008079017,EDNRB/HIF1A/FN1/TWIST1,4
GO:0051058,BP,GO:0051058,negative regulation of small GTPase mediated signal transduction,4/269,57/18888,0.070175439,4.927411465,3.569329111,0.008799897,0.019265896,0.008079017,CUL3/DLC1/DAB2IP/FBP1,4
GO:0001843,BP,GO:0001843,neural tube closure,5/269,89/18888,0.056179775,3.944697381,3.346938665,0.008873131,0.019407577,0.00813843,CASP3/TGFB1/BRD2/DLC1/TWIST1,5
GO:0006112,BP,GO:0006112,energy reserve metabolic process,5/269,89/18888,0.056179775,3.944697381,3.346938665,0.008873131,0.019407577,0.00813843,MTOR/AKT1/IRS1/IGF1/IGF2,5
GO:0002790,BP,GO:0002790,peptide secretion,9/269,247/18888,0.036437247,2.558463646,2.963398137,0.009147272,0.019997587,0.008385846,IL6/IL1B/HIF1A/TNF/HNF1B/EGFR/IRS1/UCN/CLOCK,9
GO:0019362,BP,GO:0019362,pyridine nucleotide metabolic process,7/269,164/18888,0.042682927,2.997007888,3.087321393,0.009221553,0.020140651,0.008445839,TP53/HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,7
GO:0046496,BP,GO:0046496,nicotinamide nucleotide metabolic process,7/269,164/18888,0.042682927,2.997007888,3.087321393,0.009221553,0.020140651,0.008445839,TP53/HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,7
GO:0060606,BP,GO:0060606,tube closure,5/269,90/18888,0.055555556,3.90086741,3.315681188,0.009288652,0.020267767,0.008499144,CASP3/TGFB1/BRD2/DLC1/TWIST1,5
GO:1903321,BP,GO:1903321,negative regulation of protein modification by small protein conjugation or removal,5/269,90/18888,0.055555556,3.90086741,3.315681188,0.009288652,0.020267767,0.008499144,CTNNB1/SQSTM1/RELA/AKT1/CAV1,5
GO:0042733,BP,GO:0042733,embryonic digit morphogenesis,4/269,58/18888,0.068965517,4.842456095,3.522712536,0.009348233,0.020388008,0.008549567,CTNNB1/NOTCH1/BAX/TWIST1,4
GO:0050905,BP,GO:0050905,neuromuscular process,7/269,165/18888,0.042424242,2.978844204,3.068635542,0.009516634,0.020702775,0.008681562,PTEN/XRCC1/MTOR/TNF/HSP90AA1/NBN/UCN,7
GO:0051250,BP,GO:0051250,negative regulation of lymphocyte activation,7/269,165/18888,0.042424242,2.978844204,3.068635542,0.009516634,0.020702775,0.008681562,ERBB2/CASP3/SOX11/TWSG1/IL10/CD274/PAWR,7
GO:0016051,BP,GO:0016051,carbohydrate biosynthetic process,8/269,206/18888,0.038834951,2.726819937,2.995355922,0.009550581,0.020702775,0.008681562,NFKB1/PARP1/AKT1/TGFB1/IRS1/IGF1/FBP1/IGF2,8
GO:0001516,BP,GO:0001516,prostaglandin biosynthetic process,3/269,31/18888,0.096774194,6.79505936,3.8813418,0.009565264,0.020702775,0.008681562,PTGS2/IL1B/AKR1C3,3
GO:0001945,BP,GO:0001945,lymph vessel development,3/269,31/18888,0.096774194,6.79505936,3.8813418,0.009565264,0.020702775,0.008681562,VEGFA/FGF2/KDR,3
GO:0030262,BP,GO:0030262,apoptotic nuclear changes,3/269,31/18888,0.096774194,6.79505936,3.8813418,0.009565264,0.020702775,0.008681562,IL6/BAX/AIFM1,3
GO:0030878,BP,GO:0030878,thyroid gland development,3/269,31/18888,0.096774194,6.79505936,3.8813418,0.009565264,0.020702775,0.008681562,MAPK1/SMAD3/BRAF,3
GO:0032682,BP,GO:0032682,negative regulation of chemokine production,3/269,31/18888,0.096774194,6.79505936,3.8813418,0.009565264,0.020702775,0.008681562,IL6/GSTP1/IL10,3
GO:0033688,BP,GO:0033688,regulation of osteoblast proliferation,3/269,31/18888,0.096774194,6.79505936,3.8813418,0.009565264,0.020702775,0.008681562,IGF1R/RHOA/SMAD3,3
GO:0046457,BP,GO:0046457,prostanoid biosynthetic process,3/269,31/18888,0.096774194,6.79505936,3.8813418,0.009565264,0.020702775,0.008681562,PTGS2/IL1B/AKR1C3,3
GO:0097345,BP,GO:0097345,mitochondrial outer membrane permeabilization,3/269,31/18888,0.096774194,6.79505936,3.8813418,0.009565264,0.020702775,0.008681562,BID/BNIP3/BNIP3L,3
GO:1900745,BP,GO:1900745,positive regulation of p38MAPK cascade,3/269,31/18888,0.096774194,6.79505936,3.8813418,0.009565264,0.020702775,0.008681562,IL1B/VEGFA/SPHK1,3
GO:1901186,BP,GO:1901186,positive regulation of ERBB signaling pathway,3/269,31/18888,0.096774194,6.79505936,3.8813418,0.009565264,0.020702775,0.008681562,FASLG/MMP9/TGFB1,3
GO:1902042,BP,GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,3/269,31/18888,0.096774194,6.79505936,3.8813418,0.009565264,0.020702775,0.008681562,BRCA1/GPX1/SERPINE1,3
GO:1902751,BP,GO:1902751,positive regulation of cell cycle G2/M phase transition,3/269,31/18888,0.096774194,6.79505936,3.8813418,0.009565264,0.020702775,0.008681562,CCND1/CDK4/BRD4,3
GO:2000191,BP,GO:2000191,regulation of fatty acid transport,3/269,31/18888,0.096774194,6.79505936,3.8813418,0.009565264,0.020702775,0.008681562,THBS1/IL1B/AKT1,3
GO:0050803,BP,GO:0050803,regulation of synapse structure or activity,9/269,249/18888,0.036144578,2.537913737,2.936295771,0.00961178,0.020783708,0.0087155,PTEN/CTNNB1/MAPK14/TNF/RHOA/AKT1/IL10/DAB2IP/ROCK1,9
GO:0060047,BP,GO:0060047,heart contraction,9/269,249/18888,0.036144578,2.537913737,2.936295771,0.00961178,0.020783708,0.0087155,GPX1/EDNRB/PIK3CA/MTOR/TNF/CAV1/MIR200C/HSP90AA1/UCN,9
GO:0014910,BP,GO:0014910,regulation of smooth muscle cell migration,5/269,91/18888,0.054945055,3.858000735,3.284870219,0.009717392,0.020992147,0.008802908,MAP3K7/TLR4/SERPINE1/IGF1/PLAU,5
GO:0097581,BP,GO:0097581,lamellipodium organization,5/269,91/18888,0.054945055,3.858000735,3.284870219,0.009717392,0.020992147,0.008802908,PIK3CA/CD44/MTOR/FSCN1/HSP90AA1,5
GO:0009132,BP,GO:0009132,nucleoside diphosphate metabolic process,6/269,127/18888,0.047244094,3.317273073,3.149419688,0.009738092,0.021026894,0.008817479,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:0003229,BP,GO:0003229,ventricular cardiac muscle tissue development,4/269,59/18888,0.06779661,4.760380568,3.47715165,0.00991834,0.02137557,0.008963694,NOTCH1/TGFBR1/TGFB1/MED1,4
GO:0050881,BP,GO:0050881,musculoskeletal movement,4/269,59/18888,0.06779661,4.760380568,3.47715165,0.00991834,0.02137557,0.008963694,XRCC1/MTOR/TNF/HSP90AA1,4
GO:0090497,BP,GO:0090497,mesenchymal cell migration,4/269,59/18888,0.06779661,4.760380568,3.47715165,0.00991834,0.02137557,0.008963694,EDNRB/HIF1A/FN1/TWIST1,4
GO:1903409,BP,GO:1903409,reactive oxygen species biosynthetic process,4/269,59/18888,0.06779661,4.760380568,3.47715165,0.00991834,0.02137557,0.008963694,SOD2/TLR4/RHOA/CYP1A1,4
GO:0071621,BP,GO:0071621,granulocyte chemotaxis,6/269,128/18888,0.046875,3.291356877,3.126516734,0.010098671,0.021697915,0.009098867,THBS1/CXCR2/IL1B/MAPK1/PTK2/BSG,6
GO:0009166,BP,GO:0009166,nucleotide catabolic process,7/269,167/18888,0.041916168,2.943169423,3.031683333,0.010127435,0.021697915,0.009098867,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1/FHIT,7
GO:0043161,BP,GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,12/269,389/18888,0.030848329,2.166034346,2.793132072,0.010201736,0.021697915,0.009098867,CTNNB1/AURKA/FBXW7/CDK2/SPOP/AKT1/CUL3/IFI27/VHL/CLOCK/CLU/FHIT,12
GO:0003337,BP,GO:0003337,mesenchymal to epithelial transition involved in metanephros morphogenesis,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,CTNNB1/STAT1,2
GO:0006703,BP,GO:0006703,estrogen biosynthetic process,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,HSD3B1/CYP19A1,2
GO:0006983,BP,GO:0006983,ER overload response,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,TP53/HSPA5,2
GO:0030223,BP,GO:0030223,neutrophil differentiation,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,FASN/BAP1,2
GO:0032000,BP,GO:0032000,positive regulation of fatty acid beta-oxidation,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,IRS1/TWIST1,2
GO:0032966,BP,GO:0032966,negative regulation of collagen biosynthetic process,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,IL6/NOTCH1,2
GO:0033234,BP,GO:0033234,negative regulation of protein sumoylation,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,CTNNB1/RELA,2
GO:0033327,BP,GO:0033327,Leydig cell differentiation,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,AR/SGPL1,2
GO:0035766,BP,GO:0035766,cell chemotaxis to fibroblast growth factor,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,FGF2/FGFR1,2
GO:0042447,BP,GO:0042447,hormone catabolic process,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,MME/CYP19A1,2
GO:0051095,BP,GO:0051095,regulation of helicase activity,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,TP53/MSH2,2
GO:0060020,BP,GO:0060020,Bergmann glial cell differentiation,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,MAPK1/VIM,2
GO:0060439,BP,GO:0060439,trachea morphogenesis,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,CTNNB1/MAPK1,2
GO:0060601,BP,GO:0060601,lateral sprouting from an epithelium,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,AR/TP63,2
GO:0072173,BP,GO:0072173,metanephric tubule morphogenesis,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,CXCR2/LGR4,2
GO:0072178,BP,GO:0072178,nephric duct morphogenesis,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,HNF1B/GATA3,2
GO:0072584,BP,GO:0072584,caveolin-mediated endocytosis,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,MAPK1/CAV1,2
GO:0090557,BP,GO:0090557,establishment of endothelial intestinal barrier,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,FASN/MYD88,2
GO:0097168,BP,GO:0097168,mesenchymal stem cell proliferation,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,TGFBR1/TGFB1,2
GO:1900119,BP,GO:1900119,positive regulation of execution phase of apoptosis,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,TP53/DLC1,2
GO:1903365,BP,GO:1903365,regulation of fear response,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,GRPR/UCN,2
GO:1903689,BP,GO:1903689,"regulation of wound healing, spreading of epidermal cells",2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,PTEN/MTOR,2
GO:1904181,BP,GO:1904181,positive regulation of membrane depolarization,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,PARP1/KDR,2
GO:1904847,BP,GO:1904847,regulation of cell chemotaxis to fibroblast growth factor,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,FGF2/FGFR1,2
GO:2000672,BP,GO:2000672,negative regulation of motor neuron apoptotic process,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,RHOA/ROCK1,2
GO:2000833,BP,GO:2000833,positive regulation of steroid hormone secretion,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,NKX3-1/CYP19A1,2
GO:2001054,BP,GO:2001054,negative regulation of mesenchymal cell apoptotic process,2/269,11/18888,0.181818182,12.76647516,4.691975019,0.010210784,0.021697915,0.009098867,HIF1A/HNF1B,2
GO:0006308,BP,GO:0006308,DNA catabolic process,3/269,32/18888,0.09375,6.582713755,3.799050086,0.010445441,0.022093515,0.009264759,IL6/BAX/AIFM1,3
GO:0032372,BP,GO:0032372,negative regulation of sterol transport,3/269,32/18888,0.09375,6.582713755,3.799050086,0.010445441,0.022093515,0.009264759,NFKB1/MIR145/MIR130B,3
GO:0032375,BP,GO:0032375,negative regulation of cholesterol transport,3/269,32/18888,0.09375,6.582713755,3.799050086,0.010445441,0.022093515,0.009264759,NFKB1/MIR145/MIR130B,3
GO:0033032,BP,GO:0033032,regulation of myeloid cell apoptotic process,3/269,32/18888,0.09375,6.582713755,3.799050086,0.010445441,0.022093515,0.009264759,CXCR2/SNAI2/CDKN2A,3
GO:0034694,BP,GO:0034694,response to prostaglandin,3/269,32/18888,0.09375,6.582713755,3.799050086,0.010445441,0.022093515,0.009264759,AKT1/A2M/AKR1C3,3
GO:0048384,BP,GO:0048384,retinoic acid receptor signaling pathway,3/269,32/18888,0.09375,6.582713755,3.799050086,0.010445441,0.022093515,0.009264759,PPARG/EZH2/AKR1C3,3
GO:0048710,BP,GO:0048710,regulation of astrocyte differentiation,3/269,32/18888,0.09375,6.582713755,3.799050086,0.010445441,0.022093515,0.009264759,IL6/NOTCH1/ID4,3
GO:0061037,BP,GO:0061037,negative regulation of cartilage development,3/269,32/18888,0.09375,6.582713755,3.799050086,0.010445441,0.022093515,0.009264759,CTNNB1/TGFBR1/SNAI2,3
GO:0061384,BP,GO:0061384,heart trabecula morphogenesis,3/269,32/18888,0.09375,6.582713755,3.799050086,0.010445441,0.022093515,0.009264759,NOTCH1/TGFBR1/MED1,3
GO:1902992,BP,GO:1902992,negative regulation of amyloid precursor protein catabolic process,3/269,32/18888,0.09375,6.582713755,3.799050086,0.010445441,0.022093515,0.009264759,IGF1/ROCK1/CLU,3
GO:0050868,BP,GO:0050868,negative regulation of T cell activation,6/269,129/18888,0.046511628,3.265842483,3.103838979,0.010468646,0.022122056,0.009276727,ERBB2/CASP3/TWSG1/IL10/CD274/PAWR,6
GO:0051225,BP,GO:0051225,spindle assembly,6/269,129/18888,0.046511628,3.265842483,3.103838979,0.010468646,0.022122056,0.009276727,PTEN/AURKA/RHOA/LZTS2/CHEK2/MLH1,6
GO:0022029,BP,GO:0022029,telencephalon cell migration,4/269,60/18888,0.066666667,4.681040892,3.432603386,0.010510535,0.022200276,0.009309529,CTNNB1/RHOA/EGFR/DAB2IP,4
GO:0042475,BP,GO:0042475,odontogenesis of dentin-containing tooth,5/269,93/18888,0.053763441,3.775032978,3.224541064,0.010615306,0.022400803,0.009393618,CTNNB1/BSG/BAX/SERPINE1/TP63,5
GO:1903432,BP,GO:1903432,regulation of TORC1 signaling,5/269,93/18888,0.053763441,3.775032978,3.224541064,0.010615306,0.022400803,0.009393618,AKT1/CUL3/VHL/PIM1/NPRL2,5
GO:0006470,BP,GO:0006470,protein dephosphorylation,8/269,210/18888,0.038095238,2.67488051,2.933646257,0.010645291,0.02245368,0.009415791,PTEN/MTOR/PRKCD/TNF/DUSP6/TGFB1/DLC1/ROCK1,8
GO:1901874,BP,GO:1901874,negative regulation of post-translational protein modification,5/269,94/18888,0.053191489,3.734873052,3.195000583,0.011084859,0.023370023,0.009800053,CTNNB1/SQSTM1/RELA/AKT1/CAV1,5
GO:0072524,BP,GO:0072524,pyridine-containing compound metabolic process,7/269,170/18888,0.041176471,2.891231139,2.97727399,0.011096558,0.023383866,0.009805859,TP53/HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,7
GO:0008347,BP,GO:0008347,glial cell migration,4/269,61/18888,0.06557377,4.604302517,3.38902713,0.011125124,0.023411578,0.009817479,CTNNB1/MMP14/DAB2IP/CD9,4
GO:0050879,BP,GO:0050879,multicellular organismal movement,4/269,61/18888,0.06557377,4.604302517,3.38902713,0.011125124,0.023411578,0.009817479,XRCC1/MTOR/TNF/HSP90AA1,4
GO:0055008,BP,GO:0055008,cardiac muscle tissue morphogenesis,4/269,61/18888,0.06557377,4.604302517,3.38902713,0.011125124,0.023411578,0.009817479,NOTCH1/TGFBR1/TGFB1/MED1,4
GO:0002862,BP,GO:0002862,negative regulation of inflammatory response to antigenic stimulus,3/269,33/18888,0.090909091,6.38323758,3.72020355,0.011371053,0.023819089,0.009988366,GPX1/MAPK14/IL10,3
GO:0006921,BP,GO:0006921,cellular component disassembly involved in execution phase of apoptosis,3/269,33/18888,0.090909091,6.38323758,3.72020355,0.011371053,0.023819089,0.009988366,IL6/BAX/AIFM1,3
GO:0042573,BP,GO:0042573,retinoic acid metabolic process,3/269,33/18888,0.090909091,6.38323758,3.72020355,0.011371053,0.023819089,0.009988366,CYP1A1/AKR1C3/RBP1,3
GO:0045671,BP,GO:0045671,negative regulation of osteoclast differentiation,3/269,33/18888,0.090909091,6.38323758,3.72020355,0.011371053,0.023819089,0.009988366,CTNNB1/FBXW7/TLR4,3
GO:0048566,BP,GO:0048566,embryonic digestive tract development,3/269,33/18888,0.090909091,6.38323758,3.72020355,0.011371053,0.023819089,0.009988366,SOX11/TNF/HNF1B,3
GO:0048799,BP,GO:0048799,animal organ maturation,3/269,33/18888,0.090909091,6.38323758,3.72020355,0.011371053,0.023819089,0.009988366,RHOA/IGF1/GATA3,3
GO:0050869,BP,GO:0050869,negative regulation of B cell activation,3/269,33/18888,0.090909091,6.38323758,3.72020355,0.011371053,0.023819089,0.009988366,CASP3/IL10/PAWR,3
GO:0061436,BP,GO:0061436,establishment of skin barrier,3/269,33/18888,0.090909091,6.38323758,3.72020355,0.011371053,0.023819089,0.009988366,ALOX12/TP63/SFN,3
GO:1905207,BP,GO:1905207,regulation of cardiocyte differentiation,3/269,33/18888,0.090909091,6.38323758,3.72020355,0.011371053,0.023819089,0.009988366,TGFB1/EGFR/MIR145,3
GO:2000765,BP,GO:2000765,regulation of cytoplasmic translation,3/269,33/18888,0.090909091,6.38323758,3.72020355,0.011371053,0.023819089,0.009988366,CNBP/YBX1/MTOR,3
GO:0050808,BP,GO:0050808,synapse organization,14/269,493/18888,0.028397566,1.99395251,2.68793432,0.011426406,0.023924038,0.010032376,PTEN/CTNNB1/ERBB2/IGF1R/CDH1/MAPK14/HDAC6/TNF/RHOA/AKT1/SNCG/IL10/DAB2IP/ROCK1,14
GO:0051168,BP,GO:0051168,nuclear export,7/269,171/18888,0.040935673,2.874323355,2.959401611,0.011434062,0.023929071,0.010034486,IL1B/LZTS2/TGFB1/TXN/HHEX/IFI27/SFN,7
GO:0034113,BP,GO:0034113,heterotypic cell-cell adhesion,4/269,62/18888,0.064516129,4.530039573,3.346384545,0.011762405,0.024571076,0.010303706,IL1B/CD44/TNF/IL10,4
GO:1900024,BP,GO:1900024,regulation of substrate adhesion-dependent cell spreading,4/269,62/18888,0.064516129,4.530039573,3.346384545,0.011762405,0.024571076,0.010303706,PTK2/ILK/OLFM4/BRAF,4
GO:1903078,BP,GO:1903078,positive regulation of protein localization to plasma membrane,4/269,62/18888,0.064516129,4.530039573,3.346384545,0.011762405,0.024571076,0.010303706,SQSTM1/TNF/AKT1/EGFR,4
GO:1903670,BP,GO:1903670,regulation of sprouting angiogenesis,4/269,62/18888,0.064516129,4.530039573,3.346384545,0.011762405,0.024571076,0.010303706,THBS1/VEGFA/FGF2/IL10,4
GO:0042391,BP,GO:0042391,regulation of membrane potential,13/269,446/18888,0.029147982,2.046643439,2.688695561,0.011912861,0.024873967,0.010430722,PTEN/BID/PARP1/SOD2/MTOR/TNF/AKT1/CAV1/BAX/KDR/BNIP3/PMAIP1/BNIP3L,13
GO:0003073,BP,GO:0003073,regulation of systemic arterial blood pressure,5/269,96/18888,0.052083333,3.657063197,3.137115098,0.01206609,0.025001693,0.010484283,AR/EDNRB/SOD2/TNF/RHOA,5
GO:0051056,BP,GO:0051056,regulation of small GTPase mediated signal transduction,10/269,304/18888,0.032894737,2.309724124,2.767110324,0.012127069,0.025001693,0.010484283,ERBB2/NOTCH1/SQSTM1/KRAS/CUL3/DLC1/GIT1/DAB2IP/IGF1/FBP1,10
GO:0000012,BP,GO:0000012,single strand break repair,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,XRCC1/PARP1,2
GO:0003157,BP,GO:0003157,endocardium development,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,NOTCH1/KDR,2
GO:0003183,BP,GO:0003183,mitral valve morphogenesis,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,NOTCH1/TWIST1,2
GO:0005984,BP,GO:0005984,disaccharide metabolic process,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,BRAF/FBP1,2
GO:0007320,BP,GO:0007320,insemination,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,KLK14/TAC1,2
GO:0007494,BP,GO:0007494,midgut development,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,EDNRB/EGFR,2
GO:0010713,BP,GO:0010713,negative regulation of collagen metabolic process,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,IL6/NOTCH1,2
GO:0010936,BP,GO:0010936,negative regulation of macrophage cytokine production,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,TGFB1/TWIST1,2
GO:0014854,BP,GO:0014854,response to inactivity,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,PIK3CA/IL10,2
GO:0031293,BP,GO:0031293,membrane protein intracellular domain proteolysis,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,TGFB1/MMP7,2
GO:0031392,BP,GO:0031392,regulation of prostaglandin biosynthetic process,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,PTGS2/IL1B,2
GO:0032351,BP,GO:0032351,negative regulation of hormone metabolic process,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,NFKB1/AKR1C3,2
GO:0043696,BP,GO:0043696,dedifferentiation,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,NCOA3/MIR145,2
GO:0043697,BP,GO:0043697,cell dedifferentiation,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,NCOA3/MIR145,2
GO:0051549,BP,GO:0051549,positive regulation of keratinocyte migration,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,MTOR/MMP9,2
GO:0071236,BP,GO:0071236,cellular response to antibiotic,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,TP53/EZH2,2
GO:0090153,BP,GO:0090153,regulation of sphingolipid biosynthetic process,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,PRKCD/SPHK1,2
GO:0090306,BP,GO:0090306,meiotic spindle assembly,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,PTEN/AURKA,2
GO:0090677,BP,GO:0090677,reversible differentiation,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,SOD2/MIR145,2
GO:0097067,BP,GO:0097067,cellular response to thyroid hormone stimulus,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,MED1/CTSB,2
GO:0097084,BP,GO:0097084,vascular associated smooth muscle cell development,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,VEGFA/NOTCH1,2
GO:0106014,BP,GO:0106014,regulation of inflammatory response to wounding,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,STAT3/GIT1,2
GO:0160049,BP,GO:0160049,negative regulation of cGAS/STING signaling pathway,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,PARP1/AKT1,2
GO:1901202,BP,GO:1901202,negative regulation of extracellular matrix assembly,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,PPARG/MIR145,2
GO:1905461,BP,GO:1905461,positive regulation of vascular associated smooth muscle cell apoptotic process,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,PPARG/SOD2,2
GO:2000035,BP,GO:2000035,regulation of stem cell division,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,NCOA3/MIR145,2
GO:2000303,BP,GO:2000303,regulation of ceramide biosynthetic process,2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,PRKCD/SPHK1,2
GO:2000562,BP,GO:2000562,"negative regulation of CD4-positive, alpha-beta T cell proliferation",2/269,12/18888,0.166666667,11.70260223,4.457634723,0.012138662,0.025001693,0.010484283,TWSG1/CD274,2
GO:0001782,BP,GO:0001782,B cell homeostasis,3/269,34/18888,0.088235294,6.195495298,3.644551718,0.012342481,0.02531848,0.010617125,CASP3/HIF1A/BAX,3
GO:0009112,BP,GO:0009112,nucleobase metabolic process,3/269,34/18888,0.088235294,6.195495298,3.644551718,0.012342481,0.02531848,0.010617125,KDM1A/MTOR/MAPK1,3
GO:0034405,BP,GO:0034405,response to fluid shear stress,3/269,34/18888,0.088235294,6.195495298,3.644551718,0.012342481,0.02531848,0.010617125,PTGS2/AKT1/MMP2,3
GO:0045939,BP,GO:0045939,negative regulation of steroid metabolic process,3/269,34/18888,0.088235294,6.195495298,3.644551718,0.012342481,0.02531848,0.010617125,NFKB1/SNAI1/SNAI2,3
GO:0046320,BP,GO:0046320,regulation of fatty acid oxidation,3/269,34/18888,0.088235294,6.195495298,3.644551718,0.012342481,0.02531848,0.010617125,AKT1/IRS1/TWIST1,3
GO:0060074,BP,GO:0060074,synapse maturation,3/269,34/18888,0.088235294,6.195495298,3.644551718,0.012342481,0.02531848,0.010617125,PTEN/DAB2IP/ROCK1,3
GO:0060914,BP,GO:0060914,heart formation,3/269,34/18888,0.088235294,6.195495298,3.644551718,0.012342481,0.02531848,0.010617125,CTNNB1/NOTCH1/PIM1,3
GO:1903749,BP,GO:1903749,positive regulation of establishment of protein localization to mitochondrion,3/269,34/18888,0.088235294,6.195495298,3.644551718,0.012342481,0.02531848,0.010617125,FBXW7/NPEPPS/BAP1,3
GO:1903955,BP,GO:1903955,positive regulation of protein targeting to mitochondrion,3/269,34/18888,0.088235294,6.195495298,3.644551718,0.012342481,0.02531848,0.010617125,FBXW7/NPEPPS/BAP1,3
GO:0021885,BP,GO:0021885,forebrain cell migration,4/269,63/18888,0.063492063,4.458134183,3.304639406,0.012422663,0.02547149,0.010681289,CTNNB1/RHOA/EGFR/DAB2IP,4
GO:0048167,BP,GO:0048167,regulation of synaptic plasticity,8/269,216/18888,0.037037037,2.600578273,2.843726518,0.01245807,0.025532599,0.010706914,PTGS2/SQSTM1/MAPK1/KRAS/BRAF/MME/HRAS/CRHR2,8
GO:0003015,BP,GO:0003015,heart process,9/269,260/18888,0.034615385,2.430540463,2.791792653,0.012492176,0.025590987,0.010731399,GPX1/EDNRB/PIK3CA/MTOR/TNF/CAV1/MIR200C/HSP90AA1/UCN,9
GO:0009154,BP,GO:0009154,purine ribonucleotide catabolic process,6/269,135/18888,0.044444444,3.120693928,2.972274767,0.012892774,0.026399766,0.011070555,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:0014909,BP,GO:0014909,smooth muscle cell migration,5/269,98/18888,0.051020408,3.582429254,3.080757645,0.01310469,0.026788573,0.011233598,MAP3K7/TLR4/SERPINE1/IGF1/PLAU,5
GO:0034109,BP,GO:0034109,homotypic cell-cell adhesion,5/269,98/18888,0.051020408,3.582429254,3.080757645,0.01310469,0.026788573,0.011233598,ALOX12/IL6/PRKCD/ILK/CD9,5
GO:0040014,BP,GO:0040014,regulation of multicellular organism growth,4/269,64/18888,0.0625,4.388475836,3.263757457,0.013106174,0.026788573,0.011233598,PIK3CA/STAT3/SGPL1/IGF2,4
GO:0071384,BP,GO:0071384,cellular response to corticosteroid stimulus,4/269,64/18888,0.0625,4.388475836,3.263757457,0.013106174,0.026788573,0.011233598,IGF1R/EGFR/AIFM1/AKR1C3,4
GO:1901292,BP,GO:1901292,nucleoside phosphate catabolic process,7/269,176/18888,0.039772727,2.792666441,2.871938742,0.013233956,0.027037625,0.011338036,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1/FHIT,7
GO:0006298,BP,GO:0006298,mismatch repair,3/269,35/18888,0.085714286,6.018481147,3.57186914,0.013360062,0.027161286,0.011389893,PCNA/MLH1/MSH2,3
GO:0006301,BP,GO:0006301,postreplication repair,3/269,35/18888,0.085714286,6.018481147,3.57186914,0.013360062,0.027161286,0.011389893,BRCA1/PCNA/MSH2,3
GO:0006346,BP,GO:0006346,DNA methylation-dependent heterochromatin formation,3/269,35/18888,0.085714286,6.018481147,3.57186914,0.013360062,0.027161286,0.011389893,MYC/KDM1A/MBD2,3
GO:0010613,BP,GO:0010613,positive regulation of cardiac muscle hypertrophy,3/269,35/18888,0.085714286,6.018481147,3.57186914,0.013360062,0.027161286,0.011389893,PARP1/IGF1/ROCK1,3
GO:0032212,BP,GO:0032212,positive regulation of telomere maintenance via telomerase,3/269,35/18888,0.085714286,6.018481147,3.57186914,0.013360062,0.027161286,0.011389893,CTNNB1/MAPK1/MAP2K7,3
GO:0032872,BP,GO:0032872,regulation of stress-activated MAPK cascade,3/269,35/18888,0.085714286,6.018481147,3.57186914,0.013360062,0.027161286,0.011389893,MYC/GSTP1/MAPK1,3
GO:0045943,BP,GO:0045943,positive regulation of transcription by RNA polymerase I,3/269,35/18888,0.085714286,6.018481147,3.57186914,0.013360062,0.027161286,0.011389893,ERBB2/SMARCA4/MTOR,3
GO:0048048,BP,GO:0048048,embryonic eye morphogenesis,3/269,35/18888,0.085714286,6.018481147,3.57186914,0.013360062,0.027161286,0.011389893,SOX11/TWIST1/TFAP2A,3
GO:0048333,BP,GO:0048333,mesodermal cell differentiation,3/269,35/18888,0.085714286,6.018481147,3.57186914,0.013360062,0.027161286,0.011389893,MIR200C/MIR145/FGFR1,3
GO:0048873,BP,GO:0048873,homeostasis of number of cells within a tissue,3/269,35/18888,0.085714286,6.018481147,3.57186914,0.013360062,0.027161286,0.011389893,NOTCH1/KRAS/BAX,3
GO:0071398,BP,GO:0071398,cellular response to fatty acid,3/269,35/18888,0.085714286,6.018481147,3.57186914,0.013360062,0.027161286,0.011389893,CDK4/IRS1/AKR1C3,3
GO:0098869,BP,GO:0098869,cellular oxidant detoxification,5/269,99/18888,0.050505051,3.5462431,3.053128501,0.013645943,0.027730115,0.011628427,GPX1/PTGS2/SOD2/GSTP1/TXN,5
GO:0046034,BP,GO:0046034,ATP metabolic process,8/269,220/18888,0.036363636,2.553295032,2.785453108,0.013786421,0.028003091,0.011742898,PARP1/HIF1A/STAT3/MTOR/TGFB1/GIT1/IGF1/FBP1,8
GO:0007409,BP,GO:0007409,axonogenesis,13/269,455/18888,0.028571429,2.006160382,2.61128548,0.013863751,0.028147616,0.011803503,PTEN/ERBB2/ETV1/VEGFA/IGF1R/CDH1/NOTCH1/S100A6/HDAC6/PTK2/FN1/BRAF/GATA3,13
GO:0015850,BP,GO:0015850,organic hydroxy compound transport,10/269,311/18888,0.032154341,2.257736765,2.688200231,0.01402936,0.028471164,0.011939181,NFKB1/PPARG/MYB/CAV1/SNCG/MIR145/MIR130B/NFKBIA/CYP19A1/CLU,10
GO:1903312,BP,GO:1903312,negative regulation of mRNA metabolic process,5/269,100/18888,0.05,3.510780669,3.0258539,0.014202061,0.028536851,0.011966726,YBX1/MAPK14/PKP1/PKP3/MYD88,5
GO:0003174,BP,GO:0003174,mitral valve development,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,NOTCH1/TWIST1,2
GO:0010225,BP,GO:0010225,response to UV-C,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,TP53/BRCA2,2
GO:0010524,BP,GO:0010524,positive regulation of calcium ion transport into cytosol,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,CAV1/BAX,2
GO:0010764,BP,GO:0010764,negative regulation of fibroblast migration,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,FGF2/BRAF,2
GO:0016446,BP,GO:0016446,somatic hypermutation of immunoglobulin genes,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,MLH1/MSH2,2
GO:0021781,BP,GO:0021781,glial cell fate commitment,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,CTNNB1/SOX2,2
GO:0032769,BP,GO:0032769,negative regulation of monooxygenase activity,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,NFKB1/MIR130B,2
GO:0035745,BP,GO:0035745,T-helper 2 cell cytokine production,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,IL6/GATA3,2
GO:0036006,BP,GO:0036006,cellular response to macrophage colony-stimulating factor stimulus,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,TLR4/MST1R,2
GO:0043568,BP,GO:0043568,positive regulation of insulin-like growth factor receptor signaling pathway,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,AR/IGF1,2
GO:0048680,BP,GO:0048680,positive regulation of axon regeneration,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,IGF1R/BRAF,2
GO:0061430,BP,GO:0061430,bone trabecula morphogenesis,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,RHOA/MMP2,2
GO:0070234,BP,GO:0070234,positive regulation of T cell apoptotic process,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,TP53/CD274,2
GO:0070243,BP,GO:0070243,regulation of thymocyte apoptotic process,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,TP53/HIF1A,2
GO:0070486,BP,GO:0070486,leukocyte aggregation,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,IL1B/CD44,2
GO:0070572,BP,GO:0070572,positive regulation of neuron projection regeneration,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,IGF1R/BRAF,2
GO:0070914,BP,GO:0070914,UV-damage excision repair,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,ERCC1/MC1R,2
GO:0071107,BP,GO:0071107,response to parathyroid hormone,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,HDAC6/FOS,2
GO:0071389,BP,GO:0071389,cellular response to mineralocorticoid stimulus,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,IGF1R/AIFM1,2
GO:0140896,BP,GO:0140896,cGAS/STING signaling pathway,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,PARP1/AKT1,2
GO:1900103,BP,GO:1900103,positive regulation of endoplasmic reticulum unfolded protein response,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,BAX/DAB2IP,2
GO:1905065,BP,GO:1905065,positive regulation of vascular associated smooth muscle cell differentiation,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,SOD2/MIR145,2
GO:2000551,BP,GO:2000551,regulation of T-helper 2 cell cytokine production,2/269,13/18888,0.153846154,10.80240206,4.249522783,0.014212053,0.028536851,0.011966726,IL6/GATA3,2
GO:0006986,BP,GO:0006986,response to unfolded protein,6/269,138/18888,0.043478261,3.052852756,2.909217299,0.014241597,0.028583576,0.01198632,THBS1/CCND1/BAX/DAB2IP/HSPA5/HSP90AA1,6
GO:0015718,BP,GO:0015718,monocarboxylic acid transport,7/269,179/18888,0.039106145,2.745861976,2.820918822,0.014406862,0.028822867,0.012086665,THBS1/PTGS2/IL1B/PPARG/TNF/AKT1/RBP1,7
GO:0001569,BP,GO:0001569,branching involved in blood vessel morphogenesis,3/269,36/18888,0.083333333,5.851301115,3.501952255,0.014424086,0.028822867,0.012086665,CTNNB1/VEGFA/KDR,3
GO:0014742,BP,GO:0014742,positive regulation of muscle hypertrophy,3/269,36/18888,0.083333333,5.851301115,3.501952255,0.014424086,0.028822867,0.012086665,PARP1/IGF1/ROCK1,3
GO:0032094,BP,GO:0032094,response to food,3/269,36/18888,0.083333333,5.851301115,3.501952255,0.014424086,0.028822867,0.012086665,AKT1/CYP1A1/UCN,3
GO:0033687,BP,GO:0033687,osteoblast proliferation,3/269,36/18888,0.083333333,5.851301115,3.501952255,0.014424086,0.028822867,0.012086665,IGF1R/RHOA/SMAD3,3
GO:0034143,BP,GO:0034143,regulation of toll-like receptor 4 signaling pathway,3/269,36/18888,0.083333333,5.851301115,3.501952255,0.014424086,0.028822867,0.012086665,SQSTM1/MIR200C/DAB2IP,3
GO:0045815,BP,GO:0045815,transcription initiation-coupled chromatin remodeling,3/269,36/18888,0.083333333,5.851301115,3.501952255,0.014424086,0.028822867,0.012086665,TP53/ARID1A/SMARCA4,3
GO:0051968,BP,GO:0051968,"positive regulation of synaptic transmission, glutamatergic",3/269,36/18888,0.083333333,5.851301115,3.501952255,0.014424086,0.028822867,0.012086665,PTGS2/HDAC6/EGFR,3
GO:0071425,BP,GO:0071425,hematopoietic stem cell proliferation,3/269,36/18888,0.083333333,5.851301115,3.501952255,0.014424086,0.028822867,0.012086665,BRCA2/SNAI2/PIM1,3
GO:1904893,BP,GO:1904893,negative regulation of receptor signaling pathway via STAT,3/269,36/18888,0.083333333,5.851301115,3.501952255,0.014424086,0.028822867,0.012086665,PPARG/CAV1/VHL,3
GO:0001756,BP,GO:0001756,somitogenesis,4/269,66/18888,0.060606061,4.25549172,3.18445512,0.014544012,0.02898623,0.01215517,TP53/NOTCH1/SMAD3/NKX3-1,4
GO:0006949,BP,GO:0006949,syncytium formation,4/269,66/18888,0.060606061,4.25549172,3.18445512,0.014544012,0.02898623,0.01215517,ERCC1/MAPK14/CD9/CYP19A1,4
GO:0032507,BP,GO:0032507,maintenance of protein location in cell,4/269,66/18888,0.060606061,4.25549172,3.18445512,0.014544012,0.02898623,0.01215517,AKT1/CAV1/TXN/HSPA5,4
GO:0051898,BP,GO:0051898,negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,4/269,66/18888,0.060606061,4.25549172,3.18445512,0.014544012,0.02898623,0.01215517,PTEN/DAB2IP/TWIST1/MIR145,4
GO:0060042,BP,GO:0060042,retina morphogenesis in camera-type eye,4/269,66/18888,0.060606061,4.25549172,3.18445512,0.014544012,0.02898623,0.01215517,NOTCH1/STAT3/ZHX2/TFAP2A,4
GO:0070613,BP,GO:0070613,regulation of protein processing,4/269,66/18888,0.060606061,4.25549172,3.18445512,0.014544012,0.02898623,0.01215517,THBS1/MMP14/SERPINE1/PLAU,4
GO:0007098,BP,GO:0007098,centrosome cycle,6/269,139/18888,0.043165468,3.030889786,2.888578372,0.014712251,0.029308707,0.012290399,BRCA1/CTNNB1/AURKA/BRCA2/XRCC3/CDK2,6
GO:0120162,BP,GO:0120162,positive regulation of cold-induced thermogenesis,5/269,101/18888,0.04950495,3.476020464,2.998925336,0.014773211,0.029417286,0.01233593,KDM1A/VEGFA/IGF1R/SMARCA4/CAV1,5
GO:0071772,BP,GO:0071772,response to BMP,7/269,180/18888,0.038888889,2.730607187,2.804145402,0.01481383,0.029472406,0.012359045,PPARG/SOX11/NOTCH1/TWSG1/ILK/KDR/GATA3,7
GO:0071773,BP,GO:0071773,cellular response to BMP stimulus,7/269,180/18888,0.038888889,2.730607187,2.804145402,0.01481383,0.029472406,0.012359045,PPARG/SOX11/NOTCH1/TWSG1/ILK/KDR/GATA3,7
GO:0043583,BP,GO:0043583,ear development,8/269,223/18888,0.035874439,2.518945772,2.742585388,0.014848495,0.029528479,0.012382558,FGF2/NOTCH1/MAPK1/TWIST1/SOX2/GATA3/FGFR1/TFAP2A,8
GO:0008360,BP,GO:0008360,regulation of cell shape,6/269,140/18888,0.042857143,3.009240574,2.868124102,0.015193617,0.030201623,0.012664837,VEGFA/PTK2/EPB41L3/FN1/DLC1/KDR,6
GO:0007095,BP,GO:0007095,mitotic G2 DNA damage checkpoint signaling,3/269,37/18888,0.081081081,5.693157842,3.434616724,0.015534804,0.030812611,0.01292105,BRCA1/NBN/CDKN1A,3
GO:0031076,BP,GO:0031076,embryonic camera-type eye development,3/269,37/18888,0.081081081,5.693157842,3.434616724,0.015534804,0.030812611,0.01292105,SOX11/TWIST1/TFAP2A,3
GO:0060323,BP,GO:0060323,head morphogenesis,3/269,37/18888,0.081081081,5.693157842,3.434616724,0.015534804,0.030812611,0.01292105,MMP2/SGPL1/BRAF,3
GO:0070269,BP,GO:0070269,pyroptosis,3/269,37/18888,0.081081081,5.693157842,3.434616724,0.015534804,0.030812611,0.01292105,CASP8/CASP3/IFI27,3
GO:0070306,BP,GO:0070306,lens fiber cell differentiation,3/269,37/18888,0.081081081,5.693157842,3.434616724,0.015534804,0.030812611,0.01292105,FGF2/SMAD3/VIM,3
GO:0009261,BP,GO:0009261,ribonucleotide catabolic process,6/269,141/18888,0.042553191,2.987898442,2.847851334,0.015685809,0.031098584,0.013040971,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:0015833,BP,GO:0015833,peptide transport,9/269,271/18888,0.033210332,2.331883839,2.65445642,0.015971939,0.03165209,0.01327308,IL6/IL1B/HIF1A/TNF/HNF1B/EGFR/IRS1/UCN/CLOCK,9
GO:0002069,BP,GO:0002069,columnar/cuboidal epithelial cell maturation,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,HIF1A/CDKN1A,2
GO:0002566,BP,GO:0002566,somatic diversification of immune receptors via somatic mutation,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,MLH1/MSH2,2
GO:0021819,BP,GO:0021819,layer formation in cerebral cortex,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,CTNNB1/DAB2IP,2
GO:0032621,BP,GO:0032621,interleukin-18 production,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,TNF/IL10,2
GO:0032661,BP,GO:0032661,regulation of interleukin-18 production,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,TNF/IL10,2
GO:0045348,BP,GO:0045348,positive regulation of MHC class II biosynthetic process,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,TLR4/IL10,2
GO:0045842,BP,GO:0045842,positive regulation of mitotic metaphase/anaphase transition,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,CUL3/RB1,2
GO:0045989,BP,GO:0045989,positive regulation of striated muscle contraction,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,HSP90AA1/UCN,2
GO:0048302,BP,GO:0048302,regulation of isotype switching to IgG isotypes,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,MLH1/MSH2,2
GO:0051255,BP,GO:0051255,spindle midzone assembly,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,LZTS2/MLH1,2
GO:0060019,BP,GO:0060019,radial glial cell differentiation,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,STAT3/RHOA,2
GO:0060330,BP,GO:0060330,regulation of response to type II interferon,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,PPARG/MED1,2
GO:0060334,BP,GO:0060334,regulation of type II interferon-mediated signaling pathway,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,PPARG/MED1,2
GO:0060837,BP,GO:0060837,blood vessel endothelial cell differentiation,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,NOTCH1/KDR,2
GO:0072283,BP,GO:0072283,metanephric renal vesicle morphogenesis,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,CTNNB1/STAT1,2
GO:1901533,BP,GO:1901533,negative regulation of hematopoietic progenitor cell differentiation,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,MYB/NOTCH1,2
GO:1903845,BP,GO:1903845,negative regulation of cellular response to transforming growth factor beta stimulus,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,PPARG/MIR145,2
GO:1905203,BP,GO:1905203,regulation of connective tissue replacement,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,PPARG/ROCK1,2
GO:2000105,BP,GO:2000105,positive regulation of DNA-templated DNA replication,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,CDK2/FGFR1,2
GO:2000288,BP,GO:2000288,positive regulation of myoblast proliferation,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,CTNNB1/MALAT1,2
GO:2001053,BP,GO:2001053,regulation of mesenchymal cell apoptotic process,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,HIF1A/HNF1B,2
GO:2001279,BP,GO:2001279,regulation of unsaturated fatty acid biosynthetic process,2/269,14/18888,0.142857143,10.03080191,4.062915714,0.016426453,0.032244258,0.013521401,PTGS2/IL1B,2
GO:0019058,BP,GO:0019058,viral life cycle,10/269,319/18888,0.031347962,2.201116407,2.600552567,0.016467924,0.032311741,0.0135497,TMPRSS2/NOTCH1/RNASEL/SRPK1/TNF/CAV1/BSG/EGFR/IFI27/CTSB,10
GO:0031952,BP,GO:0031952,regulation of protein autophosphorylation,3/269,38/18888,0.078947368,5.543337899,3.369695149,0.016692423,0.032667817,0.013699018,VEGFA/CAV1/NBN,3
GO:0035633,BP,GO:0035633,maintenance of blood-brain barrier,3/269,38/18888,0.078947368,5.543337899,3.369695149,0.016692423,0.032667817,0.013699018,IL6/PTGS2/VEGFA,3
GO:0051438,BP,GO:0051438,regulation of ubiquitin-protein transferase activity,3/269,38/18888,0.078947368,5.543337899,3.369695149,0.016692423,0.032667817,0.013699018,PTEN/FBXW7/BMI1,3
GO:0070302,BP,GO:0070302,regulation of stress-activated protein kinase signaling cascade,3/269,38/18888,0.078947368,5.543337899,3.369695149,0.016692423,0.032667817,0.013699018,MYC/GSTP1/MAPK1,3
GO:0141137,BP,GO:0141137,"positive regulation of gene expression, epigenetic",3/269,38/18888,0.078947368,5.543337899,3.369695149,0.016692423,0.032667817,0.013699018,TP53/ARID1A/SMARCA4,3
GO:1904358,BP,GO:1904358,positive regulation of telomere maintenance via telomere lengthening,3/269,38/18888,0.078947368,5.543337899,3.369695149,0.016692423,0.032667817,0.013699018,CTNNB1/MAPK1/MAP2K7,3
GO:0002711,BP,GO:0002711,positive regulation of T cell mediated immunity,4/269,69/18888,0.057971014,4.070470341,3.071217934,0.016881491,0.033023646,0.013848232,IL6/MAP3K7/IL1B/GATA3,4
GO:0006195,BP,GO:0006195,purine nucleotide catabolic process,6/269,144/18888,0.041666667,2.925650558,2.788091627,0.017228441,0.033687888,0.014126777,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:0044242,BP,GO:0044242,cellular lipid catabolic process,8/269,230/18888,0.034782609,2.442282205,2.645215586,0.017556236,0.034314119,0.014389383,AMACR/PRKCD/AKT1/IRS1/SGPL1/SPHK1/TWIST1/AKR1C3,8
GO:0050918,BP,GO:0050918,positive chemotaxis,4/269,70/18888,0.057142857,4.012320765,3.034890021,0.017709753,0.03456968,0.01449655,VEGFA/FGF2/SMAD3/KDR,4
GO:0050922,BP,GO:0050922,negative regulation of chemotaxis,4/269,70/18888,0.057142857,4.012320765,3.034890021,0.017709753,0.03456968,0.01449655,THBS1/NOTCH1/HDAC6/CYP19A1,4
GO:1903317,BP,GO:1903317,regulation of protein maturation,4/269,70/18888,0.057142857,4.012320765,3.034890021,0.017709753,0.03456968,0.01449655,THBS1/MMP14/SERPINE1/PLAU,4
GO:0060048,BP,GO:0060048,cardiac muscle contraction,6/269,145/18888,0.04137931,2.905473657,2.768514815,0.017765031,0.034647894,0.014529349,PIK3CA/MTOR/CAV1/MIR200C/HSP90AA1/UCN,6
GO:0071333,BP,GO:0071333,cellular response to glucose stimulus,6/269,145/18888,0.04137931,2.905473657,2.768514815,0.017765031,0.034647894,0.014529349,GPX1/PIK3CA/IGF1R/HIF1A/SMARCA4/SMAD3,6
GO:0007143,BP,GO:0007143,female meiotic nuclear division,3/269,39/18888,0.076923077,5.401201029,3.307035115,0.017897111,0.03481607,0.014599872,PTEN/AURKA/MLH1,3
GO:0030149,BP,GO:0030149,sphingolipid catabolic process,3/269,39/18888,0.076923077,5.401201029,3.307035115,0.017897111,0.03481607,0.014599872,PRKCD/SGPL1/SPHK1,3
GO:0032373,BP,GO:0032373,positive regulation of sterol transport,3/269,39/18888,0.076923077,5.401201029,3.307035115,0.017897111,0.03481607,0.014599872,PPARG/CAV1/NFKBIA,3
GO:0032376,BP,GO:0032376,positive regulation of cholesterol transport,3/269,39/18888,0.076923077,5.401201029,3.307035115,0.017897111,0.03481607,0.014599872,PPARG/CAV1/NFKBIA,3
GO:0060416,BP,GO:0060416,response to growth hormone,3/269,39/18888,0.076923077,5.401201029,3.307035115,0.017897111,0.03481607,0.014599872,STAT3/AKT1/PTK2,3
GO:0070232,BP,GO:0070232,regulation of T cell apoptotic process,3/269,39/18888,0.076923077,5.401201029,3.307035115,0.017897111,0.03481607,0.014599872,TP53/HIF1A/CD274,3
GO:0090150,BP,GO:0090150,establishment of protein localization to membrane,9/269,277/18888,0.032490975,2.28137372,2.582321415,0.018146064,0.035285303,0.014796642,ERBB2/BID/EGFR/BAX/HSPA5/HSP90AA1/BRAF/HRAS/MAL,9
GO:0032835,BP,GO:0032835,glomerulus development,4/269,71/18888,0.056338028,3.955809205,2.999230427,0.018562915,0.036080478,0.015130093,EDNRB/NOTCH1/WT1/LGR4,4
GO:0003376,BP,GO:0003376,sphingosine-1-phosphate receptor signaling pathway,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,AKT1/SPHK1,2
GO:0007567,BP,GO:0007567,parturition,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,MMP2/CYP1A1,2
GO:0030174,BP,GO:0030174,regulation of DNA-templated DNA replication initiation,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,CDK2/NBN,2
GO:0033147,BP,GO:0033147,negative regulation of intracellular estrogen receptor signaling pathway,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,BRCA1/TP63,2
GO:0035358,BP,GO:0035358,regulation of peroxisome proliferator activated receptor signaling pathway,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,ALOX15B/TWIST1,2
GO:0043201,BP,GO:0043201,response to leucine,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,PIK3CA/MTOR,2
GO:0045475,BP,GO:0045475,locomotor rhythm,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,PTEN/MTOR,2
GO:0046007,BP,GO:0046007,negative regulation of activated T cell proliferation,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,CASP3/CD274,2
GO:0046321,BP,GO:0046321,positive regulation of fatty acid oxidation,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,IRS1/TWIST1,2
GO:0048291,BP,GO:0048291,isotype switching to IgG isotypes,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,MLH1/MSH2,2
GO:0051220,BP,GO:0051220,cytoplasmic sequestering of protein,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,IL10/NFKBIA,2
GO:0061043,BP,GO:0061043,regulation of vascular wound healing,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,TNF/SERPINE1,2
GO:0061307,BP,GO:0061307,cardiac neural crest cell differentiation involved in heart development,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,MAPK1/TWIST1,2
GO:0061308,BP,GO:0061308,cardiac neural crest cell development involved in heart development,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,MAPK1/TWIST1,2
GO:0061684,BP,GO:0061684,chaperone-mediated autophagy,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,HSP90AA1/CLU,2
GO:0071639,BP,GO:0071639,positive regulation of monocyte chemotactic protein-1 production,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,IL1B/TWIST1,2
GO:0071732,BP,GO:0071732,cellular response to nitric oxide,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,CDK2/AIFM1,2
GO:0072148,BP,GO:0072148,epithelial cell fate commitment,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,NOTCH1/SPDEF,2
GO:0072176,BP,GO:0072176,nephric duct development,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,HNF1B/GATA3,2
GO:1901836,BP,GO:1901836,regulation of transcription of nucleolar large rRNA by RNA polymerase I,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,SMARCA4/MTOR,2
GO:1902101,BP,GO:1902101,positive regulation of metaphase/anaphase transition of cell cycle,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,CUL3/RB1,2
GO:2000767,BP,GO:2000767,positive regulation of cytoplasmic translation,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,CNBP/YBX1,2
GO:2001138,BP,GO:2001138,regulation of phospholipid transport,2/269,15/18888,0.133333333,9.362081784,3.894206924,0.018777456,0.036142836,0.015156242,FASLG/PRKCD,2
GO:0009303,BP,GO:0009303,rRNA transcription,3/269,40/18888,0.075,5.266171004,3.246497501,0.019148997,0.036811321,0.015436567,TP53/SMARCA4/MTOR,3
GO:0070884,BP,GO:0070884,regulation of calcineurin-NFAT signaling cascade,3/269,40/18888,0.075,5.266171004,3.246497501,0.019148997,0.036811321,0.015436567,MTOR/TNF/IGF1,3
GO:1901532,BP,GO:1901532,regulation of hematopoietic progenitor cell differentiation,3/269,40/18888,0.075,5.266171004,3.246497501,0.019148997,0.036811321,0.015436567,MYB/NOTCH1/KDR,3
GO:0003279,BP,GO:0003279,cardiac septum development,5/269,108/18888,0.046296296,3.250722842,2.819457526,0.019205485,0.036857705,0.015456017,TP53/SOX11/NOTCH1/TGFBR1/GATA3,5
GO:0039531,BP,GO:0039531,regulation of cytoplasmic pattern recognition receptor signaling pathway,5/269,108/18888,0.046296296,3.250722842,2.819457526,0.019205485,0.036857705,0.015456017,PARP1/TLR4/AKT1/CAV1/MYD88,5
GO:0060291,BP,GO:0060291,long-term synaptic potentiation,5/269,108/18888,0.046296296,3.250722842,2.819457526,0.019205485,0.036857705,0.015456017,SQSTM1/MAPK1/BRAF/MME/CRHR2,5
GO:1901890,BP,GO:1901890,positive regulation of cell junction assembly,5/269,108/18888,0.046296296,3.250722842,2.819457526,0.019205485,0.036857705,0.015456017,VEGFA/SMAD3/CAV1/KDR/ROCK1,5
GO:0046434,BP,GO:0046434,organophosphate catabolic process,8/269,234/18888,0.034188034,2.400533791,2.591164519,0.019254075,0.036935397,0.015488597,HIF1A/STAT3/MTOR/PRKCD/GIT1/IGF1/FBP1/FHIT,8
GO:0030032,BP,GO:0030032,lamellipodium assembly,4/269,72/18888,0.055555556,3.90086741,2.96421656,0.019441171,0.0372046,0.015601485,PIK3CA/MTOR/FSCN1/HSP90AA1,4
GO:0032008,BP,GO:0032008,positive regulation of TOR signaling,4/269,72/18888,0.055555556,3.90086741,2.96421656,0.019441171,0.0372046,0.015601485,PIK3CA/AKT1/CUL3/PIM1,4
GO:0051148,BP,GO:0051148,negative regulation of muscle cell differentiation,4/269,72/18888,0.055555556,3.90086741,2.96421656,0.019441171,0.0372046,0.015601485,YBX1/NOTCH1/EZH2/IGF2,4
GO:0060411,BP,GO:0060411,cardiac septum morphogenesis,4/269,72/18888,0.055555556,3.90086741,2.96421656,0.019441171,0.0372046,0.015601485,TP53/SOX11/NOTCH1/TGFBR1,4
GO:0061035,BP,GO:0061035,regulation of cartilage development,4/269,72/18888,0.055555556,3.90086741,2.96421656,0.019441171,0.0372046,0.015601485,CTNNB1/TGFBR1/SMAD3/SNAI2,4
GO:0071331,BP,GO:0071331,cellular response to hexose stimulus,6/269,148/18888,0.040540541,2.846578921,2.710774504,0.019443405,0.0372046,0.015601485,GPX1/PIK3CA/IGF1R/HIF1A/SMARCA4/SMAD3,6
GO:0006941,BP,GO:0006941,striated muscle contraction,7/269,191/18888,0.036649215,2.573347087,2.626846614,0.019845196,0.037957477,0.015917199,PIK3CA/MTOR/TNF/CAV1/MIR200C/HSP90AA1/UCN,7
GO:0072523,BP,GO:0072523,purine-containing compound catabolic process,6/269,149/18888,0.040268456,2.827474364,2.691848888,0.020026071,0.03828736,0.016055533,HIF1A/STAT3/MTOR/GIT1/IGF1/FBP1,6
GO:0032481,BP,GO:0032481,positive regulation of type I interferon production,4/269,73/18888,0.054794521,3.84743087,2.929826899,0.020344706,0.038880234,0.016304151,TLR4/HSP90AA1/STAT1/MYD88,4
GO:0033260,BP,GO:0033260,nuclear DNA replication,3/269,41/18888,0.073170732,5.137727809,3.187955022,0.020448175,0.039028858,0.016366475,BRCA2/PCNA/FGFR1,3
GO:0045454,BP,GO:0045454,cell redox homeostasis,3/269,41/18888,0.073170732,5.137727809,3.187955022,0.020448175,0.039028858,0.016366475,GPX1/GIT1/TXN,3
GO:0106056,BP,GO:0106056,regulation of calcineurin-mediated signaling,3/269,41/18888,0.073170732,5.137727809,3.187955022,0.020448175,0.039028858,0.016366475,MTOR/TNF/IGF1,3
GO:0006909,BP,GO:0006909,phagocytosis,8/269,237/18888,0.033755274,2.370147287,2.551348714,0.020602222,0.039306416,0.016482867,THBS1/PIK3CA/TLR4/PRKCD/PTK2/SPHK1/MST1R/MYD88,8
GO:0071326,BP,GO:0071326,cellular response to monosaccharide stimulus,6/269,150/18888,0.04,2.808624535,2.673079557,0.020620507,0.039324835,0.016490591,GPX1/PIK3CA/IGF1R/HIF1A/SMARCA4/SMAD3,6
GO:0006206,BP,GO:0006206,pyrimidine nucleobase metabolic process,2/269,16/18888,0.125,8.776951673,3.740588047,0.021260752,0.040283849,0.016892747,MTOR/MAPK1,2
GO:0021984,BP,GO:0021984,adenohypophysis development,2/269,16/18888,0.125,8.776951673,3.740588047,0.021260752,0.040283849,0.016892747,FGF2/SOX2,2
GO:0032354,BP,GO:0032354,response to follicle-stimulating hormone,2/269,16/18888,0.125,8.776951673,3.740588047,0.021260752,0.040283849,0.016892747,SRD5A2/NOTCH1,2
GO:0042448,BP,GO:0042448,progesterone metabolic process,2/269,16/18888,0.125,8.776951673,3.740588047,0.021260752,0.040283849,0.016892747,AKR1C3/CYP17A1,2
GO:0045579,BP,GO:0045579,positive regulation of B cell differentiation,2/269,16/18888,0.125,8.776951673,3.740588047,0.021260752,0.040283849,0.016892747,MMP14/IL10,2
GO:0046642,BP,GO:0046642,negative regulation of alpha-beta T cell proliferation,2/269,16/18888,0.125,8.776951673,3.740588047,0.021260752,0.040283849,0.016892747,TWSG1/CD274,2
GO:0048385,BP,GO:0048385,regulation of retinoic acid receptor signaling pathway,2/269,16/18888,0.125,8.776951673,3.740588047,0.021260752,0.040283849,0.016892747,EZH2/AKR1C3,2
GO:0050665,BP,GO:0050665,hydrogen peroxide biosynthetic process,2/269,16/18888,0.125,8.776951673,3.740588047,0.021260752,0.040283849,0.016892747,SOD2/CYP1A1,2
GO:0051044,BP,GO:0051044,positive regulation of membrane protein ectodomain proteolysis,2/269,16/18888,0.125,8.776951673,3.740588047,0.021260752,0.040283849,0.016892747,IL1B/TNF,2
GO:0060841,BP,GO:0060841,venous blood vessel development,2/269,16/18888,0.125,8.776951673,3.740588047,0.021260752,0.040283849,0.016892747,VEGFA/NOTCH1,2
GO:0061101,BP,GO:0061101,neuroendocrine cell differentiation,2/269,16/18888,0.125,8.776951673,3.740588047,0.021260752,0.040283849,0.016892747,FGF2/NOTCH1,2
GO:0097091,BP,GO:0097091,synaptic vesicle clustering,2/269,16/18888,0.125,8.776951673,3.740588047,0.021260752,0.040283849,0.016892747,PTEN/CTNNB1,2
GO:0097152,BP,GO:0097152,mesenchymal cell apoptotic process,2/269,16/18888,0.125,8.776951673,3.740588047,0.021260752,0.040283849,0.016892747,HIF1A/HNF1B,2
GO:0003281,BP,GO:0003281,ventricular septum development,4/269,74/18888,0.054054054,3.795438561,2.896040933,0.021273692,0.040283849,0.016892747,SOX11/NOTCH1/TGFBR1/GATA3,4
GO:0046637,BP,GO:0046637,regulation of alpha-beta T cell differentiation,4/269,74/18888,0.054054054,3.795438561,2.896040933,0.021273692,0.040283849,0.016892747,RHOA/BRD2/BRD4/GATA3,4
GO:0048663,BP,GO:0048663,neuron fate commitment,4/269,74/18888,0.054054054,3.795438561,2.896040933,0.021273692,0.040283849,0.016892747,CTNNB1/NOTCH1/TGFBR1/FOXA1,4
GO:1904377,BP,GO:1904377,positive regulation of protein localization to cell periphery,4/269,74/18888,0.054054054,3.795438561,2.896040933,0.021273692,0.040283849,0.016892747,SQSTM1/TNF/AKT1/EGFR,4
GO:0007218,BP,GO:0007218,neuropeptide signaling pathway,5/269,111/18888,0.045045045,3.162865468,2.7469917,0.021345802,0.040386825,0.016935929,TENM1/RELA/TAC1/GRPR/UCN,5
GO:0007229,BP,GO:0007229,integrin-mediated signaling pathway,5/269,111/18888,0.045045045,3.162865468,2.7469917,0.021345802,0.040386825,0.016935929,TIMP1/PTK2/ILK/CUL3/FN1,5
GO:0050777,BP,GO:0050777,negative regulation of immune response,7/269,194/18888,0.036082474,2.53355306,2.580643461,0.021402065,0.040476467,0.01697352,GPX1/PPARG/PARP1/MAPK14/TGFB1/IL10/A2M,7
GO:0030866,BP,GO:0030866,cortical actin cytoskeleton organization,3/269,42/18888,0.071428571,5.015400956,3.131290959,0.0217947,0.041116627,0.017241966,TNF/EPB41L3/ROCK1,3
GO:0032735,BP,GO:0032735,positive regulation of interleukin-12 production,3/269,42/18888,0.071428571,5.015400956,3.131290959,0.0217947,0.041116627,0.017241966,MAPK14/TLR4/RELA,3
GO:0050691,BP,GO:0050691,regulation of defense response to virus by host,3/269,42/18888,0.071428571,5.015400956,3.131290959,0.0217947,0.041116627,0.017241966,IL1B/HSP90AA1/STAT1,3
GO:0051154,BP,GO:0051154,negative regulation of striated muscle cell differentiation,3/269,42/18888,0.071428571,5.015400956,3.131290959,0.0217947,0.041116627,0.017241966,YBX1/NOTCH1/EZH2,3
GO:0072595,BP,GO:0072595,maintenance of protein localization in organelle,3/269,42/18888,0.071428571,5.015400956,3.131290959,0.0217947,0.041116627,0.017241966,AKT1/TXN/HSPA5,3
GO:2000008,BP,GO:2000008,regulation of protein localization to cell surface,3/269,42/18888,0.071428571,5.015400956,3.131290959,0.0217947,0.041116627,0.017241966,CTNNB1/TNF/AKT1,3
GO:0031023,BP,GO:0031023,microtubule organizing center organization,6/269,152/18888,0.039473684,2.771668949,2.635999861,0.021845075,0.041194604,0.017274665,BRCA1/CTNNB1/AURKA/BRCA2/XRCC3/CDK2,6
GO:1902106,BP,GO:1902106,negative regulation of leukocyte differentiation,5/269,112/18888,0.044642857,3.134625597,2.723382486,0.02209235,0.041643668,0.017462977,CTNNB1/ERBB2/FBXW7/MYC/TLR4,5
GO:0005977,BP,GO:0005977,glycogen metabolic process,4/269,75/18888,0.053333333,3.744832714,2.862839095,0.022228293,0.041847977,0.017548652,AKT1/IRS1/IGF1/IGF2,4
GO:0006635,BP,GO:0006635,fatty acid beta-oxidation,4/269,75/18888,0.053333333,3.744832714,2.862839095,0.022228293,0.041847977,0.017548652,AMACR/AKT1/IRS1/TWIST1,4
GO:0051298,BP,GO:0051298,centrosome duplication,4/269,75/18888,0.053333333,3.744832714,2.862839095,0.022228293,0.041847977,0.017548652,BRCA1/BRCA2/XRCC3/CDK2,4
GO:0035249,BP,GO:0035249,"synaptic transmission, glutamatergic",5/269,113/18888,0.044247788,3.106885548,2.700036575,0.022855662,0.042993557,0.018029044,PTGS2/HDAC6/TNF/EGFR/UCN,5
GO:0060840,BP,GO:0060840,artery development,5/269,113/18888,0.044247788,3.106885548,2.700036575,0.022855662,0.042993557,0.018029044,VEGFA/NOTCH1/TGFBR1/MIR145/NKX3-1,5
GO:0030010,BP,GO:0030010,establishment of cell polarity,6/269,154/18888,0.038961039,2.735673249,2.59951619,0.023117863,0.043468834,0.018228348,IGF1R/RHOA/PTK2/FSCN1/GATA3/ROCK1,6
GO:0032691,BP,GO:0032691,negative regulation of interleukin-1 beta production,3/269,43/18888,0.069767442,4.898763724,3.076398052,0.023188597,0.043512045,0.018246468,GSTP1/GIT1/IGF1,3
GO:0045622,BP,GO:0045622,regulation of T-helper cell differentiation,3/269,43/18888,0.069767442,4.898763724,3.076398052,0.023188597,0.043512045,0.018246468,BRD2/BRD4/GATA3,3
GO:0048821,BP,GO:0048821,erythrocyte development,3/269,43/18888,0.069767442,4.898763724,3.076398052,0.023188597,0.043512045,0.018246468,BAP1/HDAC6/MED1,3
GO:0060412,BP,GO:0060412,ventricular septum morphogenesis,3/269,43/18888,0.069767442,4.898763724,3.076398052,0.023188597,0.043512045,0.018246468,SOX11/NOTCH1/TGFBR1,3
GO:1900026,BP,GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,3/269,43/18888,0.069767442,4.898763724,3.076398052,0.023188597,0.043512045,0.018246468,ILK/OLFM4/BRAF,3
GO:0030968,BP,GO:0030968,endoplasmic reticulum unfolded protein response,4/269,76/18888,0.052631579,3.695558599,2.830202712,0.023208663,0.043513855,0.018247227,CCND1/BAX/DAB2IP/HSPA5,4
GO:0051057,BP,GO:0051057,positive regulation of small GTPase mediated signal transduction,4/269,76/18888,0.052631579,3.695558599,2.830202712,0.023208663,0.043513855,0.018247227,ERBB2/NOTCH1/KRAS/IGF1,4
GO:0090101,BP,GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,7/269,198/18888,0.035353535,2.48237017,2.520368631,0.023607239,0.044242938,0.018552962,TP53/PPARG/NOTCH1/TWSG1/HSPA5/PEG10/MIR145,7
GO:0043473,BP,GO:0043473,pigmentation,5/269,114/18888,0.043859649,3.079632166,2.676948395,0.023635858,0.044247927,0.018555055,EDNRB/SOD2/BAX/MC1R/SNAI2,5
GO:0048640,BP,GO:0048640,negative regulation of developmental growth,5/269,114/18888,0.043859649,3.079632166,2.676948395,0.023635858,0.044247927,0.018555055,PTEN/MIR25/CDH1/HDAC6/CDKN1A,5
GO:0003159,BP,GO:0003159,morphogenesis of an endothelium,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,CTNNB1/RHOA,2
GO:0031573,BP,GO:0031573,mitotic intra-S DNA damage checkpoint signaling,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,CHEK2/MSH2,2
GO:0032310,BP,GO:0032310,prostaglandin secretion,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,PTGS2/IL1B,2
GO:0034392,BP,GO:0034392,negative regulation of smooth muscle cell apoptotic process,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,IGF1/ESR1,2
GO:0036166,BP,GO:0036166,phenotypic switching,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,SOD2/MIR145,2
GO:0043129,BP,GO:0043129,surfactant homeostasis,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,VEGFA/KDR,2
GO:0045019,BP,GO:0045019,negative regulation of nitric oxide biosynthetic process,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,CAV1/IL10,2
GO:0048532,BP,GO:0048532,anatomical structure arrangement,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,HSPA5/TFAP2A,2
GO:0048557,BP,GO:0048557,embryonic digestive tract morphogenesis,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,SOX11/HNF1B,2
GO:0050872,BP,GO:0050872,white fat cell differentiation,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,PPARG/SNAI2,2
GO:0051000,BP,GO:0051000,positive regulation of nitric-oxide synthase activity,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,HIF1A/AKT1,2
GO:0051782,BP,GO:0051782,negative regulation of cell division,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,MYC/MIR145,2
GO:0061154,BP,GO:0061154,endothelial tube morphogenesis,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,CTNNB1/RHOA,2
GO:0072077,BP,GO:0072077,renal vesicle morphogenesis,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,CTNNB1/STAT1,2
GO:0072109,BP,GO:0072109,glomerular mesangium development,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,NOTCH1/WT1,2
GO:0072224,BP,GO:0072224,metanephric glomerulus development,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,WT1/LGR4,2
GO:0110096,BP,GO:0110096,cellular response to aldehyde,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,IGF1R/AIFM1,2
GO:1900120,BP,GO:1900120,regulation of receptor binding,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,MMP9/IL10,2
GO:1901163,BP,GO:1901163,regulation of trophoblast cell migration,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,TIMP1/VEGFA,2
GO:1902033,BP,GO:1902033,regulation of hematopoietic stem cell proliferation,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,SNAI2/PIM1,2
GO:1902170,BP,GO:1902170,cellular response to reactive nitrogen species,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,CDK2/AIFM1,2
GO:1902969,BP,GO:1902969,mitotic DNA replication,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,BRCA2/FGFR1,2
GO:1903729,BP,GO:1903729,regulation of plasma membrane organization,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,FASLG/PRKCD,2
GO:1904355,BP,GO:1904355,positive regulation of telomere capping,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,MAPK1/MAP2K7,2
GO:1904406,BP,GO:1904406,negative regulation of nitric oxide metabolic process,2/269,17/18888,0.117647059,8.260660398,3.599834888,0.023872126,0.044247927,0.018555055,CAV1/IL10,2
GO:0009205,BP,GO:0009205,purine ribonucleoside triphosphate metabolic process,8/269,244/18888,0.032786885,2.302151258,2.460742982,0.024006438,0.044478784,0.018651863,PARP1/HIF1A/STAT3/MTOR/TGFB1/GIT1/IGF1/FBP1,8
GO:0032729,BP,GO:0032729,positive regulation of type II interferon production,4/269,77/18888,0.051948052,3.647564332,2.79811395,0.024214943,0.044792238,0.018783308,IL1B/TLR4/TNF/HRAS,4
GO:0032890,BP,GO:0032890,regulation of organic acid transport,4/269,77/18888,0.051948052,3.647564332,2.79811395,0.024214943,0.044792238,0.018783308,THBS1/IL1B/TNF/AKT1,4
GO:0044042,BP,GO:0044042,glucan metabolic process,4/269,77/18888,0.051948052,3.647564332,2.79811395,0.024214943,0.044792238,0.018783308,AKT1/IRS1/IGF1/IGF2,4
GO:0055117,BP,GO:0055117,regulation of cardiac muscle contraction,4/269,77/18888,0.051948052,3.647564332,2.79811395,0.024214943,0.044792238,0.018783308,CAV1/MIR200C/HSP90AA1/UCN,4
GO:0050770,BP,GO:0050770,regulation of axonogenesis,6/269,156/18888,0.038461538,2.700600515,2.563610165,0.024439599,0.045189454,0.018949877,PTEN/VEGFA/CDH1/HDAC6/FN1/BRAF,6
GO:0006284,BP,GO:0006284,base-excision repair,3/269,44/18888,0.068181818,4.787428185,3.023177533,0.024629853,0.045375499,0.019027894,XRCC1/PARP1/PCNA,3
GO:0021762,BP,GO:0021762,substantia nigra development,3/269,44/18888,0.068181818,4.787428185,3.023177533,0.024629853,0.045375499,0.019027894,FGF2/RHOA/HSPA5,3
GO:0030501,BP,GO:0030501,positive regulation of bone mineralization,3/269,44/18888,0.068181818,4.787428185,3.023177533,0.024629853,0.045375499,0.019027894,VDR/SMAD3/TFAP2A,3
GO:0030890,BP,GO:0030890,positive regulation of B cell proliferation,3/269,44/18888,0.068181818,4.787428185,3.023177533,0.024629853,0.045375499,0.019027894,TLR4/BMI1/CDKN1A,3
GO:0031018,BP,GO:0031018,endocrine pancreas development,3/269,44/18888,0.068181818,4.787428185,3.023177533,0.024629853,0.045375499,0.019027894,IL6/AKT1/CLOCK,3
GO:0045022,BP,GO:0045022,early endosome to late endosome transport,3/269,44/18888,0.068181818,4.787428185,3.023177533,0.024629853,0.045375499,0.019027894,RILP/MAPK1/LMTK2,3
GO:0051602,BP,GO:0051602,response to electrical stimulus,3/269,44/18888,0.068181818,4.787428185,3.023177533,0.024629853,0.045375499,0.019027894,PTEN/SOD2/MMP2,3
GO:0071526,BP,GO:0071526,semaphorin-plexin signaling pathway,3/269,44/18888,0.068181818,4.787428185,3.023177533,0.024629853,0.045375499,0.019027894,ERBB2/RHOA/KDR,3
GO:1901976,BP,GO:1901976,regulation of cell cycle checkpoint,3/269,44/18888,0.068181818,4.787428185,3.023177533,0.024629853,0.045375499,0.019027894,BRCA1/BRCA2/XRCC3,3
GO:0030073,BP,GO:0030073,insulin secretion,7/269,200/18888,0.035,2.457546468,2.490780453,0.024766517,0.045608833,0.019125741,IL6/IL1B/HIF1A/TNF/HNF1B/IRS1/CLOCK,7
GO:0022604,BP,GO:0022604,regulation of cell morphogenesis,8/269,246/18888,0.032520325,2.283434582,2.435423503,0.025047536,0.046107706,0.01933494,CD44/VEGFA/HDAC6/PTK2/EPB41L3/FN1/DLC1/KDR,8
GO:0042509,BP,GO:0042509,regulation of tyrosine phosphorylation of STAT protein,4/269,78/18888,0.051282051,3.600800686,2.766555766,0.025247269,0.046437851,0.019473384,IL6/TNF/CAV1/IGF1,4
GO:0050853,BP,GO:0050853,B cell receptor signaling pathway,4/269,78/18888,0.051282051,3.600800686,2.766555766,0.025247269,0.046437851,0.019473384,NFKB1/MAPK1/BAX/NFKBIA,4
GO:0098754,BP,GO:0098754,detoxification,6/269,158/18888,0.037974684,2.666415698,2.528264212,0.02581098,0.047455539,0.019900144,GPX1/PTGS2/SOD2/GSTP1/TXN/PIM1,6
GO:0033173,BP,GO:0033173,calcineurin-NFAT signaling cascade,3/269,45/18888,0.066666667,4.681040892,2.971538278,0.026118427,0.047924105,0.020096634,MTOR/TNF/IGF1,3
GO:0042149,BP,GO:0042149,cellular response to glucose starvation,3/269,45/18888,0.066666667,4.681040892,2.971538278,0.026118427,0.047924105,0.020096634,TP53/HSPA5/PMAIP1,3
GO:0044786,BP,GO:0044786,cell cycle DNA replication,3/269,45/18888,0.066666667,4.681040892,2.971538278,0.026118427,0.047924105,0.020096634,BRCA2/PCNA/FGFR1,3
GO:0046466,BP,GO:0046466,membrane lipid catabolic process,3/269,45/18888,0.066666667,4.681040892,2.971538278,0.026118427,0.047924105,0.020096634,PRKCD/SGPL1/SPHK1,3
GO:1903426,BP,GO:1903426,regulation of reactive oxygen species biosynthetic process,3/269,45/18888,0.066666667,4.681040892,2.971538278,0.026118427,0.047924105,0.020096634,SOD2/TLR4/RHOA,3
GO:0002830,BP,GO:0002830,positive regulation of type 2 immune response,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,IL6/GATA3,2
GO:0006089,BP,GO:0006089,lactate metabolic process,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,TP53/HIF1A,2
GO:0010042,BP,GO:0010042,response to manganese ion,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,PTGS2/SOD2,2
GO:0010310,BP,GO:0010310,regulation of hydrogen peroxide metabolic process,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,SOD2/HDAC6,2
GO:0010522,BP,GO:0010522,regulation of calcium ion transport into cytosol,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,CAV1/BAX,2
GO:0016264,BP,GO:0016264,gap junction assembly,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,IL1B/CAV1,2
GO:0019896,BP,GO:0019896,axonal transport of mitochondrion,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,HIF1A/HDAC6,2
GO:0030949,BP,GO:0030949,positive regulation of vascular endothelial growth factor receptor signaling pathway,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,IL1B/HIF1A,2
GO:0035234,BP,GO:0035234,ectopic germ cell programmed cell death,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,IL1B/BAX,2
GO:0044030,BP,GO:0044030,regulation of DNA methylation,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,PARP1/WT1,2
GO:0044539,BP,GO:0044539,long-chain fatty acid import into cell,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,THBS1/AKT1,2
GO:0045064,BP,GO:0045064,T-helper 2 cell differentiation,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,MYB/GATA3,2
GO:0045346,BP,GO:0045346,regulation of MHC class II biosynthetic process,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,TLR4/IL10,2
GO:0045945,BP,GO:0045945,positive regulation of transcription by RNA polymerase III,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,AR/MTOR,2
GO:0046579,BP,GO:0046579,positive regulation of Ras protein signal transduction,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,NOTCH1/IGF1,2
GO:0061450,BP,GO:0061450,trophoblast cell migration,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,TIMP1/VEGFA,2
GO:0071371,BP,GO:0071371,cellular response to gonadotropin stimulus,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,NOTCH1/WT1,2
GO:0072087,BP,GO:0072087,renal vesicle development,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,CTNNB1/STAT1,2
GO:0072189,BP,GO:0072189,ureter development,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,LZTS2/GATA3,2
GO:0090036,BP,GO:0090036,regulation of protein kinase C signaling,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,VEGFA/MC1R,2
GO:0090190,BP,GO:0090190,positive regulation of branching involved in ureteric bud morphogenesis,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,VEGFA/LGR4,2
GO:0090520,BP,GO:0090520,sphingolipid mediated signaling pathway,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,AKT1/SPHK1,2
GO:0097094,BP,GO:0097094,craniofacial suture morphogenesis,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,MMP14/TWIST1,2
GO:1901970,BP,GO:1901970,positive regulation of mitotic sister chromatid separation,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,CUL3/RB1,2
GO:1905209,BP,GO:1905209,positive regulation of cardiocyte differentiation,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,TGFB1/MIR145,2
GO:2000318,BP,GO:2000318,positive regulation of T-helper 17 type immune response,2/269,18/18888,0.111111111,7.80173482,3.470159627,0.026607453,0.048315487,0.020260757,BRD2/BRD4,2
GO:0050830,BP,GO:0050830,defense response to Gram-positive bacterium,5/269,118/18888,0.042372881,2.975237855,2.587067271,0.026927755,0.048877631,0.020496488,IL6/IL1B/DEFB1/TNF/MYD88,5
GO:0009144,BP,GO:0009144,purine nucleoside triphosphate metabolic process,8/269,250/18888,0.032,2.246899628,2.385510323,0.027223769,0.049395257,0.020713551,PARP1/HIF1A/STAT3/MTOR/TGFB1/GIT1/IGF1/FBP1,8
GO:0042491,BP,GO:0042491,inner ear auditory receptor cell differentiation,3/269,46/18888,0.065217391,4.579279134,2.921396058,0.027654246,0.050136389,0.021024339,FGF2/NOTCH1/FGFR1,3
GO:0051205,BP,GO:0051205,protein insertion into membrane,3/269,46/18888,0.065217391,4.579279134,2.921396058,0.027654246,0.050136389,0.021024339,EGFR/BAX/MAL,3
GO:0009199,BP,GO:0009199,ribonucleoside triphosphate metabolic process,8/269,251/18888,0.03187251,2.237947837,2.37317988,0.027787715,0.050358326,0.021117407,PARP1/HIF1A/STAT3/MTOR/TGFB1/GIT1/IGF1/FBP1,8
GO:0019233,BP,GO:0019233,sensory perception of pain,4/269,81/18888,0.049382716,3.467437698,2.674905212,0.028501694,0.051570181,0.02162559,TNF/TAC1/MC1R/MME,4
GO:0032088,BP,GO:0032088,negative regulation of NF-kappaB transcription factor activity,4/269,81/18888,0.049382716,3.467437698,2.674905212,0.028501694,0.051570181,0.02162559,IL10/DAB2IP/NFKBIA/CDKN2A,4
GO:0043242,BP,GO:0043242,negative regulation of protein-containing complex disassembly,4/269,81/18888,0.049382716,3.467437698,2.674905212,0.028501694,0.051570181,0.02162559,PIK3CA/HDAC6/TNF/KATNB1,4
GO:0048844,BP,GO:0048844,artery morphogenesis,4/269,81/18888,0.049382716,3.467437698,2.674905212,0.028501694,0.051570181,0.02162559,VEGFA/NOTCH1/TGFBR1/MIR145,4
GO:0006417,BP,GO:0006417,regulation of translation,12/269,451/18888,0.026607539,1.868264658,2.243234734,0.028716636,0.051938466,0.021780028,THBS1/CNBP/ERBB2/YBX1/IL6/MTOR/TNF/AKT1/MIR200C/MIR145/UCN/PER1,12
GO:0003044,BP,GO:0003044,regulation of systemic arterial blood pressure mediated by a chemical signal,3/269,47/18888,0.063829787,4.481847663,2.87267288,0.029237208,0.052796163,0.022139697,EDNRB/SOD2/RHOA,3
GO:0006984,BP,GO:0006984,ER-nucleus signaling pathway,3/269,47/18888,0.063829787,4.481847663,2.87267288,0.029237208,0.052796163,0.022139697,TP53/FBXW7/HSPA5,3
GO:0032467,BP,GO:0032467,positive regulation of cytokinesis,3/269,47/18888,0.063829787,4.481847663,2.87267288,0.029237208,0.052796163,0.022139697,IGF1R/RHOA/CUL3,3
GO:0043666,BP,GO:0043666,regulation of phosphoprotein phosphatase activity,3/269,47/18888,0.063829787,4.481847663,2.87267288,0.029237208,0.052796163,0.022139697,MTOR/TNF/ROCK1,3
GO:0000212,BP,GO:0000212,meiotic spindle organization,2/269,19/18888,0.105263158,7.391117198,3.35010635,0.029462702,0.052909764,0.022187335,PTEN/AURKA,2
GO:0010744,BP,GO:0010744,positive regulation of macrophage derived foam cell differentiation,2/269,19/18888,0.105263158,7.391117198,3.35010635,0.029462702,0.052909764,0.022187335,NFKB1/ALOX15B,2
GO:0032026,BP,GO:0032026,response to magnesium ion,2/269,19/18888,0.105263158,7.391117198,3.35010635,0.029462702,0.052909764,0.022187335,THBS1/FBP1,2
GO:0045342,BP,GO:0045342,MHC class II biosynthetic process,2/269,19/18888,0.105263158,7.391117198,3.35010635,0.029462702,0.052909764,0.022187335,TLR4/IL10,2
GO:0046827,BP,GO:0046827,positive regulation of protein export from nucleus,2/269,19/18888,0.105263158,7.391117198,3.35010635,0.029462702,0.052909764,0.022187335,IL1B/SFN,2
GO:0048339,BP,GO:0048339,paraxial mesoderm development,2/269,19/18888,0.105263158,7.391117198,3.35010635,0.029462702,0.052909764,0.022187335,SMAD3/FGFR1,2
GO:0060438,BP,GO:0060438,trachea development,2/269,19/18888,0.105263158,7.391117198,3.35010635,0.029462702,0.052909764,0.022187335,CTNNB1/MAPK1,2
GO:0070314,BP,GO:0070314,G1 to G0 transition,2/269,19/18888,0.105263158,7.391117198,3.35010635,0.029462702,0.052909764,0.022187335,TP53/EZH2,2
GO:1902001,BP,GO:1902001,fatty acid transmembrane transport,2/269,19/18888,0.105263158,7.391117198,3.35010635,0.029462702,0.052909764,0.022187335,THBS1/AKT1,2
GO:1902074,BP,GO:1902074,response to salt,2/269,19/18888,0.105263158,7.391117198,3.35010635,0.029462702,0.052909764,0.022187335,EDNRB/FGFR1,2
GO:1903428,BP,GO:1903428,positive regulation of reactive oxygen species biosynthetic process,2/269,19/18888,0.105263158,7.391117198,3.35010635,0.029462702,0.052909764,0.022187335,SOD2/TLR4,2
GO:1903978,BP,GO:1903978,regulation of microglial cell activation,2/269,19/18888,0.105263158,7.391117198,3.35010635,0.029462702,0.052909764,0.022187335,IL6/SPHK1,2
GO:1904505,BP,GO:1904505,regulation of telomere maintenance in response to DNA damage,2/269,19/18888,0.105263158,7.391117198,3.35010635,0.029462702,0.052909764,0.022187335,XRCC1/ERCC1,2
GO:2000774,BP,GO:2000774,positive regulation of cellular senescence,2/269,19/18888,0.105263158,7.391117198,3.35010635,0.029462702,0.052909764,0.022187335,TP53/PAWR,2
GO:0002698,BP,GO:0002698,negative regulation of immune effector process,5/269,121/18888,0.041322314,2.901471627,2.522113123,0.029579269,0.053098167,0.02226634,TNF/TGFB1/IL10/A2M/TWIST1,5
GO:0007260,BP,GO:0007260,tyrosine phosphorylation of STAT protein,4/269,82/18888,0.048780488,3.425151872,2.645313239,0.02963933,0.053164089,0.022293984,IL6/TNF/CAV1/IGF1,4
GO:0070897,BP,GO:0070897,transcription preinitiation complex assembly,4/269,82/18888,0.048780488,3.425151872,2.645313239,0.02963933,0.053164089,0.022293984,TP53/SMARCA4/MED1/ESR1,4
GO:0060337,BP,GO:0060337,type I interferon-mediated signaling pathway,4/269,83/18888,0.048192771,3.383884982,2.616177036,0.030803527,0.055192653,0.023144648,IFI27/STAT1/IFNA1/MYD88,4
GO:0006356,BP,GO:0006356,regulation of transcription by RNA polymerase I,3/269,48/18888,0.0625,4.388475836,2.825296404,0.030867182,0.055192653,0.023144648,ERBB2/SMARCA4/MTOR,3
GO:0021575,BP,GO:0021575,hindbrain morphogenesis,3/269,48/18888,0.0625,4.388475836,2.825296404,0.030867182,0.055192653,0.023144648,XRCC1/DLC1/HSPA5,3
GO:0045776,BP,GO:0045776,negative regulation of blood pressure,3/269,48/18888,0.0625,4.388475836,2.825296404,0.030867182,0.055192653,0.023144648,SOD2/TNF/UCN,3
GO:0090279,BP,GO:0090279,regulation of calcium ion import,3/269,48/18888,0.0625,4.388475836,2.825296404,0.030867182,0.055192653,0.023144648,CTNNB1/MIR200C/UCN,3
GO:0097720,BP,GO:0097720,calcineurin-mediated signaling,3/269,48/18888,0.0625,4.388475836,2.825296404,0.030867182,0.055192653,0.023144648,MTOR/TNF/IGF1,3
GO:1903587,BP,GO:1903587,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,3/269,48/18888,0.0625,4.388475836,2.825296404,0.030867182,0.055192653,0.023144648,THBS1/VEGFA/FGF2,3
GO:2001258,BP,GO:2001258,negative regulation of cation channel activity,3/269,48/18888,0.0625,4.388475836,2.825296404,0.030867182,0.055192653,0.023144648,MMP9/CAV1/MIR200C,3
GO:0051494,BP,GO:0051494,negative regulation of cytoskeleton organization,6/269,165/18888,0.036363636,2.553295032,2.408727444,0.031011146,0.055428317,0.023243472,BRCA1/PIK3CA/HDAC6/PRKCD/KATNB1/DLC1,6
GO:0001678,BP,GO:0001678,intracellular glucose homeostasis,6/269,166/18888,0.036144578,2.537913737,2.392155206,0.031805867,0.056826483,0.023829783,GPX1/PIK3CA/IGF1R/HIF1A/SMARCA4/SMAD3,6
GO:0071357,BP,GO:0071357,cellular response to type I interferon,4/269,84/18888,0.047619048,3.343600637,2.587483466,0.031994362,0.057140851,0.023961611,IFI27/STAT1/IFNA1/MYD88,4
GO:0002902,BP,GO:0002902,regulation of B cell apoptotic process,2/269,20/18888,0.1,7.021561338,3.238475627,0.032433929,0.057609739,0.024158236,IL10/BAX,2
GO:0003215,BP,GO:0003215,cardiac right ventricle morphogenesis,2/269,20/18888,0.1,7.021561338,3.238475627,0.032433929,0.057609739,0.024158236,NOTCH1/GATA3,2
GO:0006515,BP,GO:0006515,protein quality control for misfolded or incompletely synthesized proteins,2/269,20/18888,0.1,7.021561338,3.238475627,0.032433929,0.057609739,0.024158236,HDAC6/CUL3,2
GO:0030813,BP,GO:0030813,positive regulation of nucleotide catabolic process,2/269,20/18888,0.1,7.021561338,3.238475627,0.032433929,0.057609739,0.024158236,MTOR/IGF1,2
GO:0032515,BP,GO:0032515,negative regulation of phosphoprotein phosphatase activity,2/269,20/18888,0.1,7.021561338,3.238475627,0.032433929,0.057609739,0.024158236,TNF/ROCK1,2
GO:0033123,BP,GO:0033123,positive regulation of purine nucleotide catabolic process,2/269,20/18888,0.1,7.021561338,3.238475627,0.032433929,0.057609739,0.024158236,MTOR/IGF1,2
GO:0045821,BP,GO:0045821,positive regulation of glycolytic process,2/269,20/18888,0.1,7.021561338,3.238475627,0.032433929,0.057609739,0.024158236,MTOR/IGF1,2
GO:0048643,BP,GO:0048643,positive regulation of skeletal muscle tissue development,2/269,20/18888,0.1,7.021561338,3.238475627,0.032433929,0.057609739,0.024158236,CTNNB1/IGF2,2
GO:0051900,BP,GO:0051900,regulation of mitochondrial depolarization,2/269,20/18888,0.1,7.021561338,3.238475627,0.032433929,0.057609739,0.024158236,PARP1/KDR,2
GO:0060716,BP,GO:0060716,labyrinthine layer blood vessel development,2/269,20/18888,0.1,7.021561338,3.238475627,0.032433929,0.057609739,0.024158236,MAPK1/AKT1,2
GO:0071514,BP,GO:0071514,genomic imprinting,2/269,20/18888,0.1,7.021561338,3.238475627,0.032433929,0.057609739,0.024158236,PIK3CA/IGF2,2
GO:0090128,BP,GO:0090128,regulation of synapse maturation,2/269,20/18888,0.1,7.021561338,3.238475627,0.032433929,0.057609739,0.024158236,DAB2IP/ROCK1,2
GO:1900037,BP,GO:1900037,regulation of cellular response to hypoxia,2/269,20/18888,0.1,7.021561338,3.238475627,0.032433929,0.057609739,0.024158236,VHL/MIR145,2
GO:1900227,BP,GO:1900227,positive regulation of NLRP3 inflammasome complex assembly,2/269,20/18888,0.1,7.021561338,3.238475627,0.032433929,0.057609739,0.024158236,TLR4/MYD88,2
GO:0008542,BP,GO:0008542,visual learning,3/269,49/18888,0.06122449,4.298915105,2.779199421,0.03254401,0.057647943,0.024174257,HIF1A/KRAS/BRAF,3
GO:0010171,BP,GO:0010171,body morphogenesis,3/269,49/18888,0.06122449,4.298915105,2.779199421,0.03254401,0.057647943,0.024174257,MMP2/SGPL1/BRAF,3
GO:0042181,BP,GO:0042181,ketone biosynthetic process,3/269,49/18888,0.06122449,4.298915105,2.779199421,0.03254401,0.057647943,0.024174257,SRD5A2/AKR1C3/CYP19A1,3
GO:0042551,BP,GO:0042551,neuron maturation,3/269,49/18888,0.06122449,4.298915105,2.779199421,0.03254401,0.057647943,0.024174257,EDNRB/KDM1A/RB1,3
GO:0048066,BP,GO:0048066,developmental pigmentation,3/269,49/18888,0.06122449,4.298915105,2.779199421,0.03254401,0.057647943,0.024174257,EDNRB/SOD2/BAX,3
GO:0051150,BP,GO:0051150,regulation of smooth muscle cell differentiation,3/269,49/18888,0.06122449,4.298915105,2.779199421,0.03254401,0.057647943,0.024174257,SOD2/NOTCH1/MIR145,3
GO:0098927,BP,GO:0098927,vesicle-mediated transport between endosomal compartments,3/269,49/18888,0.06122449,4.298915105,2.779199421,0.03254401,0.057647943,0.024174257,RILP/MAPK1/LMTK2,3
GO:0050796,BP,GO:0050796,regulation of insulin secretion,6/269,167/18888,0.035928144,2.522716648,2.375703646,0.032613759,0.057749043,0.024216652,IL6/IL1B/HIF1A/TNF/IRS1/CLOCK,6
GO:0045069,BP,GO:0045069,regulation of viral genome replication,4/269,85/18888,0.047058824,3.304264159,2.559219928,0.033211897,0.058762487,0.024641632,NOTCH1/RNASEL/SRPK1/TNF,4
GO:0061053,BP,GO:0061053,somite development,4/269,85/18888,0.047058824,3.304264159,2.559219928,0.033211897,0.058762487,0.024641632,TP53/NOTCH1/SMAD3/NKX3-1,4
GO:0032434,BP,GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,5/269,125/18888,0.04,2.808624535,2.438550419,0.03336282,0.059006602,0.024744,AURKA/CDK2/AKT1/CLU/FHIT,5
GO:0030509,BP,GO:0030509,BMP signaling pathway,6/269,168/18888,0.035714286,2.507700478,2.359371045,0.033434886,0.059088185,0.024778212,PPARG/SOX11/NOTCH1/TWSG1/ILK/KDR,6
GO:0050792,BP,GO:0050792,regulation of viral process,6/269,168/18888,0.035714286,2.507700478,2.359371045,0.033434886,0.059088185,0.024778212,TMPRSS2/NOTCH1/RNASEL/SRPK1/TNF/STAT1,6
GO:0016311,BP,GO:0016311,dephosphorylation,9/269,309/18888,0.029126214,2.045114953,2.226443035,0.033491833,0.059165874,0.02481079,PTEN/MTOR/PRKCD/TNF/DUSP6/TGFB1/DLC1/FBP1/ROCK1,9
GO:0001754,BP,GO:0001754,eye photoreceptor cell differentiation,3/269,50/18888,0.06,4.212936803,2.734319397,0.034267509,0.060398832,0.025327822,VEGFA/NOTCH1/STAT3,3
GO:0014911,BP,GO:0014911,positive regulation of smooth muscle cell migration,3/269,50/18888,0.06,4.212936803,2.734319397,0.034267509,0.060398832,0.025327822,MAP3K7/TLR4/IGF1,3
GO:0045747,BP,GO:0045747,positive regulation of Notch signaling pathway,3/269,50/18888,0.06,4.212936803,2.734319397,0.034267509,0.060398832,0.025327822,NOTCH1/STAT3/TP63,3
GO:0071320,BP,GO:0071320,cellular response to cAMP,3/269,50/18888,0.06,4.212936803,2.734319397,0.034267509,0.060398832,0.025327822,KDM1A/WT1/FBP1,3
GO:0007204,BP,GO:0007204,positive regulation of cytosolic calcium ion concentration,6/269,169/18888,0.035502959,2.492862014,2.343155721,0.034269311,0.060398832,0.025327822,CXCR2/EDNRB/CAV1/BAX/TAC1/ESR1,6
GO:1902904,BP,GO:1902904,negative regulation of supramolecular fiber organization,6/269,169/18888,0.035502959,2.492862014,2.343155721,0.034269311,0.060398832,0.025327822,PIK3CA/HDAC6/PRKCD/KATNB1/DLC1/CLU,6
GO:0140694,BP,GO:0140694,non-membrane-bounded organelle assembly,11/269,413/18888,0.026634383,1.870149509,2.149097584,0.035118664,0.061871862,0.025945527,BRCA1/PTEN/AURKA/CDK2/SQSTM1/TNF/RHOA/LZTS2/FSCN1/CHEK2/MLH1,11
GO:0042886,BP,GO:0042886,amide transport,9/269,312/18888,0.028846154,2.025450386,2.195307206,0.035284678,0.062046288,0.026018671,IL6/IL1B/HIF1A/TNF/HNF1B/EGFR/IRS1/UCN/CLOCK,9
GO:0030512,BP,GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,5/269,127/18888,0.039370079,2.764394228,2.397998744,0.035362396,0.062046288,0.026018671,TP53/PPARG/HSPA5/PEG10/MIR145,5
GO:0042471,BP,GO:0042471,ear morphogenesis,5/269,127/18888,0.039370079,2.764394228,2.397998744,0.035362396,0.062046288,0.026018671,MAPK1/TWIST1/GATA3/FGFR1/TFAP2A,5
GO:1903828,BP,GO:1903828,negative regulation of protein localization,7/269,216/18888,0.032407407,2.275505989,2.266174835,0.035468542,0.062046288,0.026018671,IL1B/MTOR/AKT1/LZTS2/TGFB1/TXN/IRS1,7
GO:0001780,BP,GO:0001780,neutrophil homeostasis,2/269,21/18888,0.095238095,6.687201275,3.134269059,0.035517278,0.062046288,0.026018671,CXCR2/IL6,2
GO:0006098,BP,GO:0006098,pentose-phosphate shunt,2/269,21/18888,0.095238095,6.687201275,3.134269059,0.035517278,0.062046288,0.026018671,TP53/MTOR,2
GO:0010829,BP,GO:0010829,negative regulation of glucose transmembrane transport,2/269,21/18888,0.095238095,6.687201275,3.134269059,0.035517278,0.062046288,0.026018671,IL1B/TNF,2
GO:0033033,BP,GO:0033033,negative regulation of myeloid cell apoptotic process,2/269,21/18888,0.095238095,6.687201275,3.134269059,0.035517278,0.062046288,0.026018671,CXCR2/SNAI2,2
GO:0034104,BP,GO:0034104,negative regulation of tissue remodeling,2/269,21/18888,0.095238095,6.687201275,3.134269059,0.035517278,0.062046288,0.026018671,IL6/PPARG,2
GO:0043586,BP,GO:0043586,tongue development,2/269,21/18888,0.095238095,6.687201275,3.134269059,0.035517278,0.062046288,0.026018671,CTNNB1/EGFR,2
GO:0044321,BP,GO:0044321,response to leptin,2/269,21/18888,0.095238095,6.687201275,3.134269059,0.035517278,0.062046288,0.026018671,CCND1/STAT3,2
GO:0070886,BP,GO:0070886,positive regulation of calcineurin-NFAT signaling cascade,2/269,21/18888,0.095238095,6.687201275,3.134269059,0.035517278,0.062046288,0.026018671,TNF/IGF1,2
GO:0071379,BP,GO:0071379,cellular response to prostaglandin stimulus,2/269,21/18888,0.095238095,6.687201275,3.134269059,0.035517278,0.062046288,0.026018671,AKT1/AKR1C3,2
GO:0071498,BP,GO:0071498,cellular response to fluid shear stress,2/269,21/18888,0.095238095,6.687201275,3.134269059,0.035517278,0.062046288,0.026018671,PTGS2/MMP2,2
GO:0090189,BP,GO:0090189,regulation of branching involved in ureteric bud morphogenesis,2/269,21/18888,0.095238095,6.687201275,3.134269059,0.035517278,0.062046288,0.026018671,VEGFA/LGR4,2
GO:0098780,BP,GO:0098780,response to mitochondrial depolarisation,2/269,21/18888,0.095238095,6.687201275,3.134269059,0.035517278,0.062046288,0.026018671,HDAC6/SQSTM1,2
GO:0106058,BP,GO:0106058,positive regulation of calcineurin-mediated signaling,2/269,21/18888,0.095238095,6.687201275,3.134269059,0.035517278,0.062046288,0.026018671,TNF/IGF1,2
GO:0140354,BP,GO:0140354,lipid import into cell,2/269,21/18888,0.095238095,6.687201275,3.134269059,0.035517278,0.062046288,0.026018671,THBS1/AKT1,2
GO:0141087,BP,GO:0141087,positive regulation of inflammasome-mediated signaling pathway,2/269,21/18888,0.095238095,6.687201275,3.134269059,0.035517278,0.062046288,0.026018671,TLR4/MYD88,2
GO:1905048,BP,GO:1905048,regulation of metallopeptidase activity,2/269,21/18888,0.095238095,6.687201275,3.134269059,0.035517278,0.062046288,0.026018671,TIMP1/STAT3,2
GO:2000001,BP,GO:2000001,regulation of DNA damage checkpoint,2/269,21/18888,0.095238095,6.687201275,3.134269059,0.035517278,0.062046288,0.026018671,BRCA1/BRCA2,2
GO:2000010,BP,GO:2000010,positive regulation of protein localization to cell surface,2/269,21/18888,0.095238095,6.687201275,3.134269059,0.035517278,0.062046288,0.026018671,TNF/AKT1,2
GO:0030865,BP,GO:0030865,cortical cytoskeleton organization,3/269,51/18888,0.058823529,4.130330199,2.690598058,0.03603747,0.062906787,0.026379515,TNF/EPB41L3/ROCK1,3
GO:1901570,BP,GO:1901570,fatty acid derivative biosynthetic process,3/269,51/18888,0.058823529,4.130330199,2.690598058,0.03603747,0.062906787,0.026379515,ALOX12/ALOX15B/ACSS3,3
GO:0045824,BP,GO:0045824,negative regulation of innate immune response,4/269,88/18888,0.045454545,3.19161879,2.476890919,0.037025221,0.064581511,0.027081799,PPARG/PARP1/TGFB1/A2M,4
GO:0099072,BP,GO:0099072,regulation of postsynaptic membrane neurotransmitter receptor levels,4/269,88/18888,0.045454545,3.19161879,2.476890919,0.037025221,0.064581511,0.027081799,ERBB2/CTNND1/HSP90AA1/HRAS,4
GO:0009141,BP,GO:0009141,nucleoside triphosphate metabolic process,8/269,266/18888,0.030075188,2.111747771,2.194893128,0.037239421,0.064930272,0.02722805,PARP1/HIF1A/STAT3/MTOR/TGFB1/GIT1/IGF1/FBP1,8
GO:0002456,BP,GO:0002456,T cell mediated immunity,5/269,129/18888,0.03875969,2.721535402,2.358226014,0.037434567,0.065220608,0.0273498,IL6/MAP3K7/IL1B/GATA3/CD8A,5
GO:0019079,BP,GO:0019079,viral genome replication,5/269,129/18888,0.03875969,2.721535402,2.358226014,0.037434567,0.065220608,0.0273498,NOTCH1/RNASEL/SRPK1/TNF/IFI27,5
GO:0051048,BP,GO:0051048,negative regulation of secretion,6/269,173/18888,0.034682081,2.435223586,2.279434686,0.037741176,0.065729662,0.027563268,IL1B/NOTCH1/TNF/IRS1/BRAF/UCN,6
GO:0035176,BP,GO:0035176,social behavior,3/269,52/18888,0.057692308,4.050900772,2.64798102,0.03785366,0.065875201,0.027624299,PTEN/GRPR/UCN,3
GO:1904263,BP,GO:1904263,positive regulation of TORC1 signaling,3/269,52/18888,0.057692308,4.050900772,2.64798102,0.03785366,0.065875201,0.027624299,AKT1/CUL3/PIM1,3
GO:0016101,BP,GO:0016101,diterpenoid metabolic process,4/269,89/18888,0.04494382,3.155757905,2.450231229,0.038350025,0.066600492,0.027928444,CYP1A1/EGFR/AKR1C3/RBP1,4
GO:0050829,BP,GO:0050829,defense response to Gram-negative bacterium,4/269,89/18888,0.04494382,3.155757905,2.450231229,0.038350025,0.066600492,0.027928444,IL6/DEFB1/TLR4/SERPINE1,4
GO:0055007,BP,GO:0055007,cardiac muscle cell differentiation,5/269,130/18888,0.038461538,2.700600515,2.338622753,0.038498024,0.066600492,0.027928444,VEGFA/MTOR/TGFB1/WT1/IGF1,5
GO:0002089,BP,GO:0002089,lens morphogenesis in camera-type eye,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,CTNNB1/SOX11,2
GO:0002433,BP,GO:0002433,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,PRKCD/PTK2,2
GO:0002837,BP,GO:0002837,regulation of immune response to tumor cell,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,TGFB1/CD274,2
GO:0007398,BP,GO:0007398,ectoderm development,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,CTNNB1/MIR145,2
GO:0007530,BP,GO:0007530,sex determination,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,AR/WT1,2
GO:0010923,BP,GO:0010923,negative regulation of phosphatase activity,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,TNF/ROCK1,2
GO:0023019,BP,GO:0023019,signal transduction involved in regulation of gene expression,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,PARP1/SMAD3,2
GO:0030449,BP,GO:0030449,regulation of complement activation,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,IL1B/A2M,2
GO:0032148,BP,GO:0032148,activation of protein kinase B activity,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,TXN/IGF1,2
GO:0034260,BP,GO:0034260,negative regulation of GTPase activity,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,DAB2IP/HRAS,2
GO:0035024,BP,GO:0035024,negative regulation of Rho protein signal transduction,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,CUL3/DLC1,2
GO:0035089,BP,GO:0035089,establishment of apical/basal cell polarity,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,RHOA/FSCN1,2
GO:0035584,BP,GO:0035584,calcium-mediated signaling using intracellular calcium source,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,DEFB1/KDR,2
GO:0035739,BP,GO:0035739,"CD4-positive, alpha-beta T cell proliferation",2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,TWSG1/CD274,2
GO:0038096,BP,GO:0038096,Fc-gamma receptor signaling pathway involved in phagocytosis,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,PRKCD/PTK2,2
GO:0042953,BP,GO:0042953,lipoprotein transport,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,PPARG/MIR130B,2
GO:0043249,BP,GO:0043249,erythrocyte maturation,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,BAP1/HDAC6,2
GO:0060546,BP,GO:0060546,negative regulation of necroptotic process,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,CASP8/CAV1,2
GO:0060713,BP,GO:0060713,labyrinthine layer morphogenesis,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,NCOA1/IL10,2
GO:0061318,BP,GO:0061318,renal filtration cell differentiation,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,EDNRB/WT1,2
GO:0072112,BP,GO:0072112,podocyte differentiation,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,EDNRB/WT1,2
GO:0072234,BP,GO:0072234,metanephric nephron tubule development,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,STAT1/LGR4,2
GO:0090370,BP,GO:0090370,negative regulation of cholesterol efflux,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,MIR145/MIR130B,2
GO:1900273,BP,GO:1900273,positive regulation of long-term synaptic potentiation,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,SQSTM1/MME,2
GO:2000319,BP,GO:2000319,regulation of T-helper 17 cell differentiation,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,BRD2/BRD4,2
GO:2000561,BP,GO:2000561,"regulation of CD4-positive, alpha-beta T cell proliferation",2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,TWSG1/CD274,2
GO:2000831,BP,GO:2000831,regulation of steroid hormone secretion,2/269,22/18888,0.090909091,6.38323758,3.036647819,0.038708978,0.066600492,0.027928444,NKX3-1/CYP19A1,2
GO:0034340,BP,GO:0034340,response to type I interferon,4/269,90/18888,0.044444444,3.120693928,2.423945658,0.039701717,0.068178332,0.028590101,IFI27/STAT1/IFNA1/MYD88,4
GO:0034620,BP,GO:0034620,cellular response to unfolded protein,4/269,90/18888,0.044444444,3.120693928,2.423945658,0.039701717,0.068178332,0.028590101,CCND1/BAX/DAB2IP/HSPA5,4
GO:0046849,BP,GO:0046849,bone remodeling,4/269,90/18888,0.044444444,3.120693928,2.423945658,0.039701717,0.068178332,0.028590101,CTNNB1/IL6/EGFR/LGR4,4
GO:0044818,BP,GO:0044818,mitotic G2/M transition checkpoint,3/269,53/18888,0.056603774,3.974468682,2.606417467,0.039715824,0.068178332,0.028590101,BRCA1/NBN/CDKN1A,3
GO:0048260,BP,GO:0048260,positive regulation of receptor-mediated endocytosis,3/269,53/18888,0.056603774,3.974468682,2.606417467,0.039715824,0.068178332,0.028590101,VEGFA/SERPINE1/CLU,3
GO:0050982,BP,GO:0050982,detection of mechanical stimulus,3/269,53/18888,0.056603774,3.974468682,2.606417467,0.039715824,0.068178332,0.028590101,CTNNB1/TNF/PTK2,3
GO:0055088,BP,GO:0055088,lipid homeostasis,6/269,176/18888,0.034090909,2.393714093,2.232797695,0.040487476,0.069476813,0.029134609,CNBP/FBXW7/PPARG/CAV1/FGFR4/RBP1,6
GO:0032273,BP,GO:0032273,positive regulation of protein polymerization,4/269,91/18888,0.043956044,3.086400588,2.398024281,0.041080306,0.070467574,0.029550078,TENM1/MTOR/GIT1/HSP90AA1,4
GO:1990138,BP,GO:1990138,neuron projection extension,6/269,177/18888,0.033898305,2.380190284,2.217463877,0.041430299,0.07104119,0.02979062,CTNNB1/AURKA/VEGFA/CDH1/HDAC6/FN1,6
GO:0031103,BP,GO:0031103,axon regeneration,3/269,54/18888,0.055555556,3.90086741,2.565859844,0.041623684,0.071185249,0.02985103,IGF1R/MMP2/BRAF,3
GO:0031279,BP,GO:0031279,regulation of cyclase activity,3/269,54/18888,0.055555556,3.90086741,2.565859844,0.041623684,0.071185249,0.02985103,EDNRB/MAPK14/LGR4,3
GO:0042304,BP,GO:0042304,regulation of fatty acid biosynthetic process,3/269,54/18888,0.055555556,3.90086741,2.565859844,0.041623684,0.071185249,0.02985103,BRCA1/PTGS2/IL1B,3
GO:0046605,BP,GO:0046605,regulation of centrosome cycle,3/269,54/18888,0.055555556,3.90086741,2.565859844,0.041623684,0.071185249,0.02985103,BRCA1/AURKA/XRCC3,3
GO:0046638,BP,GO:0046638,positive regulation of alpha-beta T cell differentiation,3/269,54/18888,0.055555556,3.90086741,2.565859844,0.041623684,0.071185249,0.02985103,RHOA/BRD2/BRD4,3
GO:0051703,BP,GO:0051703,biological process involved in intraspecies interaction between organisms,3/269,54/18888,0.055555556,3.90086741,2.565859844,0.041623684,0.071185249,0.02985103,PTEN/GRPR/UCN,3
GO:0070169,BP,GO:0070169,positive regulation of biomineral tissue development,3/269,54/18888,0.055555556,3.90086741,2.565859844,0.041623684,0.071185249,0.02985103,VDR/SMAD3/TFAP2A,3
GO:0002834,BP,GO:0002834,regulation of response to tumor cell,2/269,23/18888,0.086956522,6.105705512,2.944901202,0.042005342,0.071462412,0.029967256,TGFB1/CD274,2
GO:0003085,BP,GO:0003085,negative regulation of systemic arterial blood pressure,2/269,23/18888,0.086956522,6.105705512,2.944901202,0.042005342,0.071462412,0.029967256,SOD2/TNF,2
GO:0010893,BP,GO:0010893,positive regulation of steroid biosynthetic process,2/269,23/18888,0.086956522,6.105705512,2.944901202,0.042005342,0.071462412,0.029967256,IGF1R/TNF,2
GO:0032042,BP,GO:0032042,mitochondrial DNA metabolic process,2/269,23/18888,0.086956522,6.105705512,2.944901202,0.042005342,0.071462412,0.029967256,TP53/PARP1,2
GO:0036303,BP,GO:0036303,lymph vessel morphogenesis,2/269,23/18888,0.086956522,6.105705512,2.944901202,0.042005342,0.071462412,0.029967256,VEGFA/FGF2,2
GO:0044872,BP,GO:0044872,lipoprotein localization,2/269,23/18888,0.086956522,6.105705512,2.944901202,0.042005342,0.071462412,0.029967256,PPARG/MIR130B,2
GO:0045723,BP,GO:0045723,positive regulation of fatty acid biosynthetic process,2/269,23/18888,0.086956522,6.105705512,2.944901202,0.042005342,0.071462412,0.029967256,PTGS2/IL1B,2
GO:0046580,BP,GO:0046580,negative regulation of Ras protein signal transduction,2/269,23/18888,0.086956522,6.105705512,2.944901202,0.042005342,0.071462412,0.029967256,DAB2IP/FBP1,2
GO:0048015,BP,GO:0048015,phosphatidylinositol-mediated signaling,2/269,23/18888,0.086956522,6.105705512,2.944901202,0.042005342,0.071462412,0.029967256,PIK3CA/FGFR1,2
GO:0051131,BP,GO:0051131,chaperone-mediated protein complex assembly,2/269,23/18888,0.086956522,6.105705512,2.944901202,0.042005342,0.071462412,0.029967256,HSP90AA1/CLU,2
GO:0062099,BP,GO:0062099,negative regulation of programmed necrotic cell death,2/269,23/18888,0.086956522,6.105705512,2.944901202,0.042005342,0.071462412,0.029967256,CASP8/CAV1,2
GO:0071359,BP,GO:0071359,cellular response to dsRNA,2/269,23/18888,0.086956522,6.105705512,2.944901202,0.042005342,0.071462412,0.029967256,NFKB1/CAV1,2
GO:0072311,BP,GO:0072311,glomerular epithelial cell differentiation,2/269,23/18888,0.086956522,6.105705512,2.944901202,0.042005342,0.071462412,0.029967256,EDNRB/WT1,2
GO:2000114,BP,GO:2000114,regulation of establishment of cell polarity,2/269,23/18888,0.086956522,6.105705512,2.944901202,0.042005342,0.071462412,0.029967256,GATA3/ROCK1,2
GO:0030516,BP,GO:0030516,regulation of axon extension,4/269,92/18888,0.043478261,3.052852756,2.372457546,0.042485796,0.072252812,0.030298705,VEGFA/CDH1/HDAC6/FN1,4
GO:0007163,BP,GO:0007163,establishment or maintenance of cell polarity,7/269,226/18888,0.030973451,2.174819884,2.135629295,0.043512969,0.073970396,0.031018961,IGF1R/RHOA/PTK2/FSCN1/ILK/GATA3/ROCK1,7
GO:0006816,BP,GO:0006816,calcium ion transport,11/269,428/18888,0.025700935,1.804606886,2.02380766,0.043534175,0.073970396,0.031018961,CTNNB1/VDR/PTGS2/EDNRB/FASLG/FGF2/CAV1/MIR200C/BAX/TMEM37/UCN,11
GO:0002043,BP,GO:0002043,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,3/269,55/18888,0.054545455,3.829942548,2.5262636,0.043576941,0.073970396,0.031018961,THBS1/VEGFA/FGF2,3
GO:0010559,BP,GO:0010559,regulation of glycoprotein biosynthetic process,3/269,55/18888,0.054545455,3.829942548,2.5262636,0.043576941,0.073970396,0.031018961,CTNNB1/IGF1/PAWR,3
GO:0045071,BP,GO:0045071,negative regulation of viral genome replication,3/269,55/18888,0.054545455,3.829942548,2.5262636,0.043576941,0.073970396,0.031018961,RNASEL/SRPK1/TNF,3
GO:0048525,BP,GO:0048525,negative regulation of viral process,4/269,93/18888,0.043010753,3.020026382,2.347236257,0.043918177,0.074521868,0.031250217,RNASEL/SRPK1/TNF/STAT1,4
GO:0051651,BP,GO:0051651,maintenance of location in cell,7/269,228/18888,0.030701754,2.155742516,2.110338625,0.045252166,0.076358436,0.032020369,FASLG/FGF2/AKT1/CAV1/TXN/BAX/HSPA5,7
GO:0043414,BP,GO:0043414,macromolecule methylation,6/269,181/18888,0.033149171,2.327589394,2.157150484,0.045339703,0.076358436,0.032020369,PARP1/FOS/BMI1/EZH2/AKT1/WT1,6
GO:0055006,BP,GO:0055006,cardiac cell development,4/269,94/18888,0.042553191,2.987898442,2.322351553,0.045377436,0.076358436,0.032020369,VEGFA/NOTCH1/MTOR/IGF1,4
GO:0002082,BP,GO:0002082,regulation of oxidative phosphorylation,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,TNF/RHOA,2
GO:0002320,BP,GO:0002320,lymphoid progenitor cell differentiation,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,NOTCH1/GATA3,2
GO:0003323,BP,GO:0003323,type B pancreatic cell development,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,AKT1/CLOCK,2
GO:0006706,BP,GO:0006706,steroid catabolic process,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,SRD5A2/CYP19A1,2
GO:0006740,BP,GO:0006740,NADPH regeneration,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,TP53/MTOR,2
GO:0031145,BP,GO:0031145,anaphase-promoting complex-dependent catabolic process,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,CDK2/CUL3,2
GO:0032288,BP,GO:0032288,myelin assembly,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,EPB41L3/CD9,2
GO:0032727,BP,GO:0032727,positive regulation of interferon-alpha production,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,TLR4/STAT1,2
GO:0033233,BP,GO:0033233,regulation of protein sumoylation,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,CTNNB1/RELA,2
GO:0034695,BP,GO:0034695,response to prostaglandin E,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,AKT1/A2M,2
GO:0042790,BP,GO:0042790,nucleolar large rRNA transcription by RNA polymerase I,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,SMARCA4/MTOR,2
GO:0045624,BP,GO:0045624,positive regulation of T-helper cell differentiation,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,BRD2/BRD4,2
GO:0046426,BP,GO:0046426,negative regulation of receptor signaling pathway via JAK-STAT,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,CAV1/VHL,2
GO:0046628,BP,GO:0046628,positive regulation of insulin receptor signaling pathway,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,IRS1/IGF2,2
GO:0060706,BP,GO:0060706,cell differentiation involved in embryonic placenta development,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,CASP8/SNAI1,2
GO:0060907,BP,GO:0060907,positive regulation of macrophage cytokine production,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,TLR4/MYD88,2
GO:0061162,BP,GO:0061162,establishment of monopolar cell polarity,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,RHOA/FSCN1,2
GO:0070841,BP,GO:0070841,inclusion body assembly,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,HDAC6/CLU,2
GO:0097066,BP,GO:0097066,response to thyroid hormone,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,MED1/CTSB,2
GO:0097150,BP,GO:0097150,neuronal stem cell population maintenance,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,NOTCH1/SOX2,2
GO:1903429,BP,GO:1903429,regulation of cell maturation,2/269,24/18888,0.083333333,5.851301115,2.858422441,0.045402766,0.076358436,0.032020369,AURKA/EDNRB,2
GO:0031529,BP,GO:0031529,ruffle organization,3/269,56/18888,0.053571429,3.761550717,2.487586943,0.045575277,0.076592018,0.03211832,MTOR/CAV1/HRAS,3
GO:0043370,BP,GO:0043370,"regulation of CD4-positive, alpha-beta T cell differentiation",3/269,56/18888,0.053571429,3.761550717,2.487586943,0.045575277,0.076592018,0.03211832,BRD2/BRD4/GATA3,3
GO:0006749,BP,GO:0006749,glutathione metabolic process,3/269,57/18888,0.052631579,3.695558599,2.449790622,0.047618354,0.079848811,0.033484033,GPX1/SOD2/GSTP1,3
GO:0007632,BP,GO:0007632,visual behavior,3/269,57/18888,0.052631579,3.695558599,2.449790622,0.047618354,0.079848811,0.033484033,HIF1A/KRAS/BRAF,3
GO:0019748,BP,GO:0019748,secondary metabolic process,3/269,57/18888,0.052631579,3.695558599,2.449790622,0.047618354,0.079848811,0.033484033,CYP1A1/MC1R/AKR1C3,3
GO:0034332,BP,GO:0034332,adherens junction organization,3/269,57/18888,0.052631579,3.695558599,2.449790622,0.047618354,0.079848811,0.033484033,CTNNB1/VEGFA/CDH1,3
GO:0035088,BP,GO:0035088,establishment or maintenance of apical/basal cell polarity,3/269,57/18888,0.052631579,3.695558599,2.449790622,0.047618354,0.079848811,0.033484033,RHOA/FSCN1/ILK,3
GO:0061245,BP,GO:0061245,establishment or maintenance of bipolar cell polarity,3/269,57/18888,0.052631579,3.695558599,2.449790622,0.047618354,0.079848811,0.033484033,RHOA/FSCN1/ILK,3
GO:0001960,BP,GO:0001960,negative regulation of cytokine-mediated signaling pathway,4/269,96/18888,0.041666667,2.925650558,2.273558056,0.04837648,0.08109023,0.034004613,IL6/PPARG/GSTP1/CAV1,4
GO:0003071,BP,GO:0003071,renal system process involved in regulation of systemic arterial blood pressure,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,EDNRB/RHOA,2
GO:0003081,BP,GO:0003081,regulation of systemic arterial blood pressure by renin-angiotensin,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,EDNRB/RHOA,2
GO:0030859,BP,GO:0030859,polarized epithelial cell differentiation,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,RHOA/TP63,2
GO:0031445,BP,GO:0031445,regulation of heterochromatin formation,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,KDM1A/CDK2,2
GO:0031954,BP,GO:0031954,positive regulation of protein autophosphorylation,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,VEGFA/NBN,2
GO:0036344,BP,GO:0036344,platelet morphogenesis,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,CASP3/BAP1,2
GO:0038095,BP,GO:0038095,Fc-epsilon receptor signaling pathway,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,MAP3K7/MAP2K7,2
GO:0043153,BP,GO:0043153,entrainment of circadian clock by photoperiod,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,TP53/PER1,2
GO:0046716,BP,GO:0046716,muscle cell cellular homeostasis,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,HIF1A/CAV1,2
GO:0048169,BP,GO:0048169,regulation of long-term neuronal synaptic plasticity,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,KRAS/HRAS,2
GO:0051882,BP,GO:0051882,mitochondrial depolarization,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,PARP1/KDR,2
GO:0060396,BP,GO:0060396,growth hormone receptor signaling pathway,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,STAT3/PTK2,2
GO:0061339,BP,GO:0061339,establishment or maintenance of monopolar cell polarity,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,RHOA/FSCN1,2
GO:0072243,BP,GO:0072243,metanephric nephron epithelium development,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,STAT1/LGR4,2
GO:0099633,BP,GO:0099633,protein localization to postsynaptic specialization membrane,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,ERBB2/HRAS,2
GO:0099645,BP,GO:0099645,neurotransmitter receptor localization to postsynaptic specialization membrane,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,ERBB2/HRAS,2
GO:0120261,BP,GO:0120261,regulation of heterochromatin organization,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,KDM1A/CDK2,2
GO:1901863,BP,GO:1901863,positive regulation of muscle tissue development,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,CTNNB1/IGF2,2
GO:1903306,BP,GO:1903306,negative regulation of regulated secretory pathway,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,NOTCH1/BRAF,2
GO:1905063,BP,GO:1905063,regulation of vascular associated smooth muscle cell differentiation,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,SOD2/MIR145,2
GO:2000178,BP,GO:2000178,negative regulation of neural precursor cell proliferation,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,TP53/ILK,2
GO:2000291,BP,GO:2000291,regulation of myoblast proliferation,2/269,25/18888,0.08,5.617249071,2.776689888,0.048897727,0.081305856,0.034095034,CTNNB1/MALAT1,2
GO:0048008,BP,GO:0048008,platelet-derived growth factor receptor signaling pathway,3/269,58/18888,0.051724138,3.631842072,2.412837734,0.049705815,0.08261937,0.034645847,PDGFRL/VEGFA/SGPL1,3
GO:0007411,BP,GO:0007411,axon guidance,7/269,234/18888,0.02991453,2.100467067,2.036003156,0.050735521,0.084238715,0.035324908,ERBB2/ETV1/VEGFA/NOTCH1/HDAC6/PTK2/GATA3,7
GO:0034249,BP,GO:0034249,negative regulation of amide metabolic process,7/269,234/18888,0.02991453,2.100467067,2.036003156,0.050735521,0.084238715,0.035324908,YBX1/MIR200C/IGF1/SPHK1/MIR145/ROCK1/CLU,7
GO:0097485,BP,GO:0097485,neuron projection guidance,7/269,234/18888,0.02991453,2.100467067,2.036003156,0.050735521,0.084238715,0.035324908,ERBB2/ETV1/VEGFA/NOTCH1/HDAC6/PTK2/GATA3,7
GO:0006942,BP,GO:0006942,regulation of striated muscle contraction,4/269,98/18888,0.040816327,2.865943403,2.226012347,0.051482641,0.085448056,0.035832037,CAV1/MIR200C/HSP90AA1/UCN,4
GO:0007062,BP,GO:0007062,sister chromatid cohesion,3/269,59/18888,0.050847458,3.570285426,2.376693542,0.051837287,0.085911487,0.036026373,CTNNB1/FBXW7/RB1,3
GO:0009948,BP,GO:0009948,anterior/posterior axis specification,3/269,59/18888,0.050847458,3.570285426,2.376693542,0.051837287,0.085911487,0.036026373,CTNNB1/AURKA/WT1,3
GO:0010921,BP,GO:0010921,regulation of phosphatase activity,3/269,59/18888,0.050847458,3.570285426,2.376693542,0.051837287,0.085911487,0.036026373,MTOR/TNF/ROCK1,3
GO:0010965,BP,GO:0010965,regulation of mitotic sister chromatid separation,3/269,59/18888,0.050847458,3.570285426,2.376693542,0.051837287,0.085911487,0.036026373,XRCC3/CUL3/RB1,3
GO:0001783,BP,GO:0001783,B cell apoptotic process,2/269,26/18888,0.076923077,5.401201029,2.699252199,0.05248678,0.086390812,0.036227375,IL10/BAX,2
GO:0003181,BP,GO:0003181,atrioventricular valve morphogenesis,2/269,26/18888,0.076923077,5.401201029,2.699252199,0.05248678,0.086390812,0.036227375,NOTCH1/TWIST1,2
GO:0006929,BP,GO:0006929,substrate-dependent cell migration,2/269,26/18888,0.076923077,5.401201029,2.699252199,0.05248678,0.086390812,0.036227375,FN1/SNAI2,2
GO:0014829,BP,GO:0014829,vascular associated smooth muscle contraction,2/269,26/18888,0.076923077,5.401201029,2.699252199,0.05248678,0.086390812,0.036227375,EDNRB/RHOA,2
GO:0018904,BP,GO:0018904,ether metabolic process,2/269,26/18888,0.076923077,5.401201029,2.699252199,0.05248678,0.086390812,0.036227375,ALOX12/FASN,2
GO:0032878,BP,GO:0032878,regulation of establishment or maintenance of cell polarity,2/269,26/18888,0.076923077,5.401201029,2.699252199,0.05248678,0.086390812,0.036227375,GATA3/ROCK1,2
GO:0034643,BP,GO:0034643,"establishment of mitochondrion localization, microtubule-mediated",2/269,26/18888,0.076923077,5.401201029,2.699252199,0.05248678,0.086390812,0.036227375,HIF1A/HDAC6,2
GO:0035330,BP,GO:0035330,regulation of hippo signaling,2/269,26/18888,0.076923077,5.401201029,2.699252199,0.05248678,0.086390812,0.036227375,SOX11/MAPK14,2
GO:0042059,BP,GO:0042059,negative regulation of epidermal growth factor receptor signaling pathway,2/269,26/18888,0.076923077,5.401201029,2.699252199,0.05248678,0.086390812,0.036227375,EGFR/DAB2IP,2
GO:0043931,BP,GO:0043931,ossification involved in bone maturation,2/269,26/18888,0.076923077,5.401201029,2.699252199,0.05248678,0.086390812,0.036227375,RHOA/IGF1,2
GO:0047497,BP,GO:0047497,mitochondrion transport along microtubule,2/269,26/18888,0.076923077,5.401201029,2.699252199,0.05248678,0.086390812,0.036227375,HIF1A/HDAC6,2
GO:0062009,BP,GO:0062009,secondary palate development,2/269,26/18888,0.076923077,5.401201029,2.699252199,0.05248678,0.086390812,0.036227375,SOX11/COL11A2,2
GO:0070102,BP,GO:0070102,interleukin-6-mediated signaling pathway,2/269,26/18888,0.076923077,5.401201029,2.699252199,0.05248678,0.086390812,0.036227375,IL6/STAT3,2
GO:0070935,BP,GO:0070935,3'-UTR-mediated mRNA stabilization,2/269,26/18888,0.076923077,5.401201029,2.699252199,0.05248678,0.086390812,0.036227375,MAPK14/MYD88,2
GO:0071378,BP,GO:0071378,cellular response to growth hormone stimulus,2/269,26/18888,0.076923077,5.401201029,2.699252199,0.05248678,0.086390812,0.036227375,STAT3/PTK2,2
GO:0072010,BP,GO:0072010,glomerular epithelium development,2/269,26/18888,0.076923077,5.401201029,2.699252199,0.05248678,0.086390812,0.036227375,EDNRB/WT1,2
GO:1900078,BP,GO:1900078,positive regulation of cellular response to insulin stimulus,2/269,26/18888,0.076923077,5.401201029,2.699252199,0.05248678,0.086390812,0.036227375,IRS1/IGF2,2
GO:1902455,BP,GO:1902455,negative regulation of stem cell population maintenance,2/269,26/18888,0.076923077,5.401201029,2.699252199,0.05248678,0.086390812,0.036227375,HNF1B/MIR145,2
GO:2000272,BP,GO:2000272,negative regulation of signaling receptor activity,2/269,26/18888,0.076923077,5.401201029,2.699252199,0.05248678,0.086390812,0.036227375,PPARG/TNF,2
GO:0000070,BP,GO:0000070,mitotic sister chromatid segregation,6/269,188/18888,0.031914894,2.240923831,2.055335392,0.052718345,0.086740622,0.036374065,XRCC3/RHOA/KATNB1/CHEK2/CUL3/RB1,6
GO:0002709,BP,GO:0002709,regulation of T cell mediated immunity,4/269,99/18888,0.04040404,2.83699448,2.202688425,0.053075766,0.087234195,0.036581041,IL6/MAP3K7/IL1B/GATA3,4
GO:0009798,BP,GO:0009798,axis specification,4/269,99/18888,0.04040404,2.83699448,2.202688425,0.053075766,0.087234195,0.036581041,CTNNB1/AURKA/NOTCH1/WT1,4
GO:0050773,BP,GO:0050773,regulation of dendrite development,4/269,99/18888,0.04040404,2.83699448,2.202688425,0.053075766,0.087234195,0.036581041,ALK/HDAC6/EZH2/DAB2IP,4
GO:1903900,BP,GO:1903900,regulation of viral life cycle,5/269,143/18888,0.034965035,2.455091377,2.099399153,0.054003443,0.088677621,0.037186332,TMPRSS2/NOTCH1/RNASEL/SRPK1/TNF,5
GO:0006473,BP,GO:0006473,protein acetylation,3/269,60/18888,0.05,3.510780669,2.341325315,0.054012379,0.088677621,0.037186332,HDAC6/SPHK1/CLOCK,3
GO:0046456,BP,GO:0046456,icosanoid biosynthetic process,3/269,60/18888,0.05,3.510780669,2.341325315,0.054012379,0.088677621,0.037186332,PTGS2/IL1B/AKR1C3,3
GO:0048588,BP,GO:0048588,developmental cell growth,7/269,238/18888,0.029411765,2.065165099,1.987675309,0.054614849,0.089634457,0.037587574,CTNNB1/AURKA/VEGFA/CDH1/HDAC6/FN1/IGF1,7
GO:0006721,BP,GO:0006721,terpenoid metabolic process,4/269,100/18888,0.04,2.808624535,2.179654189,0.054695503,0.0897022,0.037615982,CYP1A1/EGFR/AKR1C3/RBP1,4
GO:0019935,BP,GO:0019935,cyclic-nucleotide-mediated signaling,4/269,100/18888,0.04,2.808624535,2.179654189,0.054695503,0.0897022,0.037615982,THBS1/EDNRB/DEFB1/UCN,4
GO:0006575,BP,GO:0006575,cellular modified amino acid metabolic process,6/269,191/18888,0.031413613,2.205726075,2.013069768,0.056091833,0.091685717,0.038447756,GPX1/SOD2/GSTP1/GATA3/MED1/CTSB,6
GO:0007026,BP,GO:0007026,negative regulation of microtubule depolymerization,2/269,27/18888,0.074074074,5.201156547,2.625716562,0.056166558,0.091685717,0.038447756,HDAC6/KATNB1,2
GO:0018149,BP,GO:0018149,peptide cross-linking,2/269,27/18888,0.074074074,5.201156547,2.625716562,0.056166558,0.091685717,0.038447756,THBS1/FN1,2
GO:0021801,BP,GO:0021801,cerebral cortex radial glia-guided migration,2/269,27/18888,0.074074074,5.201156547,2.625716562,0.056166558,0.091685717,0.038447756,CTNNB1/DAB2IP,2
GO:0022030,BP,GO:0022030,telencephalon glial cell migration,2/269,27/18888,0.074074074,5.201156547,2.625716562,0.056166558,0.091685717,0.038447756,CTNNB1/DAB2IP,2
GO:0031579,BP,GO:0031579,membrane raft organization,2/269,27/18888,0.074074074,5.201156547,2.625716562,0.056166558,0.091685717,0.038447756,CAV1/MAL,2
GO:0035313,BP,GO:0035313,"wound healing, spreading of epidermal cells",2/269,27/18888,0.074074074,5.201156547,2.625716562,0.056166558,0.091685717,0.038447756,PTEN/MTOR,2
GO:0035929,BP,GO:0035929,steroid hormone secretion,2/269,27/18888,0.074074074,5.201156547,2.625716562,0.056166558,0.091685717,0.038447756,NKX3-1/CYP19A1,2
GO:0042026,BP,GO:0042026,protein refolding,2/269,27/18888,0.074074074,5.201156547,2.625716562,0.056166558,0.091685717,0.038447756,HSPA5/HSP90AA1,2
GO:0042104,BP,GO:0042104,positive regulation of activated T cell proliferation,2/269,27/18888,0.074074074,5.201156547,2.625716562,0.056166558,0.091685717,0.038447756,IGF1/IGF2,2
GO:0045940,BP,GO:0045940,positive regulation of steroid metabolic process,2/269,27/18888,0.074074074,5.201156547,2.625716562,0.056166558,0.091685717,0.038447756,IGF1R/TNF,2
GO:0071549,BP,GO:0071549,cellular response to dexamethasone stimulus,2/269,27/18888,0.074074074,5.201156547,2.625716562,0.056166558,0.091685717,0.038447756,IGF1R/EGFR,2
GO:0150146,BP,GO:0150146,cell junction disassembly,2/269,27/18888,0.074074074,5.201156547,2.625716562,0.056166558,0.091685717,0.038447756,TGFBR1/SNAI2,2
GO:0006383,BP,GO:0006383,transcription by RNA polymerase III,3/269,61/18888,0.049180328,3.453226888,2.306702182,0.056230685,0.09169184,0.038450323,AR/TENM1/MTOR,3
GO:0031102,BP,GO:0031102,neuron projection regeneration,3/269,61/18888,0.049180328,3.453226888,2.306702182,0.056230685,0.09169184,0.038450323,IGF1R/MMP2/BRAF,3
GO:1903018,BP,GO:1903018,regulation of glycoprotein metabolic process,3/269,61/18888,0.049180328,3.453226888,2.306702182,0.056230685,0.09169184,0.038450323,CTNNB1/IGF1/PAWR,3
GO:0060761,BP,GO:0060761,negative regulation of response to cytokine stimulus,4/269,101/18888,0.03960396,2.780816372,2.156902744,0.056341783,0.09184013,0.038512508,IL6/PPARG/GSTP1/CAV1,4
GO:0007266,BP,GO:0007266,Rho protein signal transduction,5/269,145/18888,0.034482759,2.421228048,2.064941119,0.056667758,0.092338449,0.038721474,ERBB2/RHOA/CUL3/DLC1/ROCK1,5
GO:0007200,BP,GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,4/269,102/18888,0.039215686,2.753553466,2.134427428,0.058014527,0.094499173,0.039627558,CXCR2/EDNRB/GRPR/ESR1,4
GO:0051306,BP,GO:0051306,mitotic sister chromatid separation,3/269,62/18888,0.048387097,3.39752968,2.272794993,0.058491784,0.095242519,0.039939276,XRCC3/CUL3/RB1,3
GO:0001964,BP,GO:0001964,startle response,2/269,28/18888,0.071428571,5.015400956,2.555739256,0.05993377,0.097139188,0.04073463,PTEN/UCN,2
GO:0006817,BP,GO:0006817,phosphate ion transport,2/269,28/18888,0.071428571,5.015400956,2.555739256,0.05993377,0.097139188,0.04073463,VDR/FGFR1,2
GO:0010800,BP,GO:0010800,positive regulation of peptidyl-threonine phosphorylation,2/269,28/18888,0.071428571,5.015400956,2.555739256,0.05993377,0.097139188,0.04073463,MAPK1/SPHK1,2
GO:0010922,BP,GO:0010922,positive regulation of phosphatase activity,2/269,28/18888,0.071428571,5.015400956,2.555739256,0.05993377,0.097139188,0.04073463,MTOR/ROCK1,2
GO:0015732,BP,GO:0015732,prostaglandin transport,2/269,28/18888,0.071428571,5.015400956,2.555739256,0.05993377,0.097139188,0.04073463,PTGS2/IL1B,2
GO:0030325,BP,GO:0030325,adrenal gland development,2/269,28/18888,0.071428571,5.015400956,2.555739256,0.05993377,0.097139188,0.04073463,SMAD3/WT1,2
GO:0035308,BP,GO:0035308,negative regulation of protein dephosphorylation,2/269,28/18888,0.071428571,5.015400956,2.555739256,0.05993377,0.097139188,0.04073463,TNF/ROCK1,2
GO:0045116,BP,GO:0045116,protein neddylation,2/269,28/18888,0.071428571,5.015400956,2.555739256,0.05993377,0.097139188,0.04073463,HIF1A/UBE2M,2
GO:0045948,BP,GO:0045948,positive regulation of translational initiation,2/269,28/18888,0.071428571,5.015400956,2.555739256,0.05993377,0.097139188,0.04073463,MTOR/TNF,2
GO:0060402,BP,GO:0060402,calcium ion transport into cytosol,2/269,28/18888,0.071428571,5.015400956,2.555739256,0.05993377,0.097139188,0.04073463,CAV1/BAX,2
GO:0071577,BP,GO:0071577,zinc ion transmembrane transport,2/269,28/18888,0.071428571,5.015400956,2.555739256,0.05993377,0.097139188,0.04073463,SLC39A9/SLC39A11,2
GO:0090314,BP,GO:0090314,positive regulation of protein targeting to membrane,2/269,28/18888,0.071428571,5.015400956,2.555739256,0.05993377,0.097139188,0.04073463,ERBB2/HRAS,2
GO:1904357,BP,GO:1904357,negative regulation of telomere maintenance via telomere lengthening,2/269,28/18888,0.071428571,5.015400956,2.555739256,0.05993377,0.097139188,0.04073463,TP53/PARP1,2
GO:0032623,BP,GO:0032623,interleukin-2 production,3/269,63/18888,0.047619048,3.343600637,2.239576202,0.06079524,0.09840941,0.041267289,MAP3K7/IL1B/GATA3,3
GO:0032663,BP,GO:0032663,regulation of interleukin-2 production,3/269,63/18888,0.047619048,3.343600637,2.239576202,0.06079524,0.09840941,0.041267289,MAP3K7/IL1B/GATA3,3
GO:0050688,BP,GO:0050688,regulation of defense response to virus,3/269,63/18888,0.047619048,3.343600637,2.239576202,0.06079524,0.09840941,0.041267289,IL1B/HSP90AA1/STAT1,3
GO:0006119,BP,GO:0006119,oxidative phosphorylation,5/269,148/18888,0.033783784,2.372149101,2.014312389,0.060803882,0.09840941,0.041267289,COX2/BID/TNF/RHOA/MSH2,5
GO:0048839,BP,GO:0048839,inner ear development,6/269,196/18888,0.030612245,2.149457553,1.944341482,0.061997648,0.100305854,0.042062549,FGF2/NOTCH1/SOX2/GATA3/FGFR1/TFAP2A,6
GO:0010803,BP,GO:0010803,regulation of tumor necrosis factor-mediated signaling pathway,3/269,64/18888,0.046875,3.291356877,2.20701975,0.063140604,0.102046326,0.042792404,CASP8/GSTP1/SPHK1,3
GO:0048524,BP,GO:0048524,positive regulation of viral process,3/269,64/18888,0.046875,3.291356877,2.20701975,0.063140604,0.102046326,0.042792404,TMPRSS2/NOTCH1/SRPK1,3
GO:0062208,BP,GO:0062208,positive regulation of pattern recognition receptor signaling pathway,3/269,64/18888,0.046875,3.291356877,2.20701975,0.063140604,0.102046326,0.042792404,TLR4/CAV1/MYD88,3
GO:0007051,BP,GO:0007051,spindle organization,6/269,197/18888,0.030456853,2.1385466,1.930843655,0.06322139,0.102140656,0.04283196,PTEN/AURKA/RHOA/LZTS2/CHEK2/MLH1,6
GO:0002418,BP,GO:0002418,immune response to tumor cell,2/269,29/18888,0.068965517,4.842456095,2.489017997,0.063785202,0.102723712,0.043076461,TGFB1/CD274,2
GO:0003171,BP,GO:0003171,atrioventricular valve development,2/269,29/18888,0.068965517,4.842456095,2.489017997,0.063785202,0.102723712,0.043076461,NOTCH1/TWIST1,2
GO:0003309,BP,GO:0003309,type B pancreatic cell differentiation,2/269,29/18888,0.068965517,4.842456095,2.489017997,0.063785202,0.102723712,0.043076461,AKT1/CLOCK,2
GO:0006829,BP,GO:0006829,zinc ion transport,2/269,29/18888,0.068965517,4.842456095,2.489017997,0.063785202,0.102723712,0.043076461,SLC39A9/SLC39A11,2
GO:0022011,BP,GO:0022011,myelination in peripheral nervous system,2/269,29/18888,0.068965517,4.842456095,2.489017997,0.063785202,0.102723712,0.043076461,AKT1/ILK,2
GO:0032292,BP,GO:0032292,peripheral nervous system axon ensheathment,2/269,29/18888,0.068965517,4.842456095,2.489017997,0.063785202,0.102723712,0.043076461,AKT1/ILK,2
GO:0045672,BP,GO:0045672,positive regulation of osteoclast differentiation,2/269,29/18888,0.068965517,4.842456095,2.489017997,0.063785202,0.102723712,0.043076461,FOS/TNF,2
GO:0070977,BP,GO:0070977,bone maturation,2/269,29/18888,0.068965517,4.842456095,2.489017997,0.063785202,0.102723712,0.043076461,RHOA/IGF1,2
GO:1905820,BP,GO:1905820,positive regulation of chromosome separation,2/269,29/18888,0.068965517,4.842456095,2.489017997,0.063785202,0.102723712,0.043076461,CUL3/RB1,2
GO:0061157,BP,GO:0061157,mRNA destabilization,6/269,198/18888,0.03030303,2.12774586,1.917426124,0.064459332,0.103772691,0.043516343,YBX1/MIR200C/MIR145/MLH1/MIR130B/ROCK1,6
GO:0009062,BP,GO:0009062,fatty acid catabolic process,4/269,106/18888,0.037735849,2.649645788,2.04716181,0.064968319,0.104481348,0.043813513,AMACR/AKT1/IRS1/TWIST1,4
GO:0032526,BP,GO:0032526,response to retinoic acid,4/269,106/18888,0.037735849,2.649645788,2.04716181,0.064968319,0.104481348,0.043813513,NCOA1/MYB/TNF/MMP2,4
GO:0034308,BP,GO:0034308,primary alcohol metabolic process,4/269,106/18888,0.037735849,2.649645788,2.04716181,0.064968319,0.104481348,0.043813513,EDNRB/CYP1A1/IGF1/AKR1C3,4
GO:0035904,BP,GO:0035904,aorta development,3/269,65/18888,0.046153846,3.240720618,2.175100968,0.065527414,0.105306137,0.044159382,NOTCH1/MIR145/NKX3-1,3
GO:0060113,BP,GO:0060113,inner ear receptor cell differentiation,3/269,65/18888,0.046153846,3.240720618,2.175100968,0.065527414,0.105306137,0.044159382,FGF2/NOTCH1/FGFR1,3
GO:0099504,BP,GO:0099504,synaptic vesicle cycle,6/269,199/18888,0.030150754,2.11705367,1.90408793,0.065711474,0.105564695,0.044267807,PTEN/CTNNB1/SNCG/GIT1/BRAF/ROCK1,6
GO:1903531,BP,GO:1903531,negative regulation of secretion by cell,5/269,152/18888,0.032894737,2.309724124,1.948689461,0.066578732,0.106920234,0.044836242,IL1B/NOTCH1/IRS1/BRAF/UCN,5
GO:0007631,BP,GO:0007631,feeding behavior,4/269,107/18888,0.037383178,2.624882743,2.025974679,0.066771954,0.107192749,0.04495052,STAT3/FOS/MC1R/UCN,4
GO:0002230,BP,GO:0002230,positive regulation of defense response to virus by host,2/269,30/18888,0.066666667,4.681040892,2.42528571,0.06771771,0.108291291,0.045411185,HSP90AA1/STAT1,2
GO:0002438,BP,GO:0002438,acute inflammatory response to antigenic stimulus,2/269,30/18888,0.066666667,4.681040892,2.42528571,0.06771771,0.108291291,0.045411185,CXCR2/A2M,2
GO:0009649,BP,GO:0009649,entrainment of circadian clock,2/269,30/18888,0.066666667,4.681040892,2.42528571,0.06771771,0.108291291,0.045411185,TP53/PER1,2
GO:0038094,BP,GO:0038094,Fc-gamma receptor signaling pathway,2/269,30/18888,0.066666667,4.681040892,2.42528571,0.06771771,0.108291291,0.045411185,PRKCD/PTK2,2
GO:0043247,BP,GO:0043247,telomere maintenance in response to DNA damage,2/269,30/18888,0.066666667,4.681040892,2.42528571,0.06771771,0.108291291,0.045411185,XRCC1/ERCC1,2
GO:0043392,BP,GO:0043392,negative regulation of DNA binding,2/269,30/18888,0.066666667,4.681040892,2.42528571,0.06771771,0.108291291,0.045411185,KDM1A/SOX11,2
GO:0051156,BP,GO:0051156,glucose 6-phosphate metabolic process,2/269,30/18888,0.066666667,4.681040892,2.42528571,0.06771771,0.108291291,0.045411185,TP53/MTOR,2
GO:0070723,BP,GO:0070723,response to cholesterol,2/269,30/18888,0.066666667,4.681040892,2.42528571,0.06771771,0.108291291,0.045411185,TGFBR1/TGFB1,2
GO:0072012,BP,GO:0072012,glomerulus vasculature development,2/269,30/18888,0.066666667,4.681040892,2.42528571,0.06771771,0.108291291,0.045411185,NOTCH1/WT1,2
GO:1900746,BP,GO:1900746,regulation of vascular endothelial growth factor signaling pathway,2/269,30/18888,0.066666667,4.681040892,2.42528571,0.06771771,0.108291291,0.045411185,VEGFA/DAB2IP,2
GO:1901798,BP,GO:1901798,positive regulation of signal transduction by p53 class mediator,2/269,30/18888,0.066666667,4.681040892,2.42528571,0.06771771,0.108291291,0.045411185,MYC/PMAIP1,2
GO:0001947,BP,GO:0001947,heart looping,3/269,66/18888,0.045454545,3.19161879,2.143796476,0.067955195,0.108328855,0.045426938,NOTCH1/HIF1A/SMAD3,3
GO:0015909,BP,GO:0015909,long-chain fatty acid transport,3/269,66/18888,0.045454545,3.19161879,2.143796476,0.067955195,0.108328855,0.045426938,THBS1/PPARG/AKT1,3
GO:0030199,BP,GO:0030199,collagen fibril organization,3/269,66/18888,0.045454545,3.19161879,2.143796476,0.067955195,0.108328855,0.045426938,TGFBR1/RB1/COL11A2,3
GO:0042531,BP,GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein,3/269,66/18888,0.045454545,3.19161879,2.143796476,0.067955195,0.108328855,0.045426938,IL6/TNF/IGF1,3
GO:0045453,BP,GO:0045453,bone resorption,3/269,66/18888,0.045454545,3.19161879,2.143796476,0.067955195,0.108328855,0.045426938,CTNNB1/IL6/EGFR,3
GO:0046530,BP,GO:0046530,photoreceptor cell differentiation,3/269,66/18888,0.045454545,3.19161879,2.143796476,0.067955195,0.108328855,0.045426938,VEGFA/NOTCH1/STAT3,3
GO:0048255,BP,GO:0048255,mRNA stabilization,3/269,66/18888,0.045454545,3.19161879,2.143796476,0.067955195,0.108328855,0.045426938,YBX1/MAPK14/MYD88,3
GO:0050771,BP,GO:0050771,negative regulation of axonogenesis,3/269,66/18888,0.045454545,3.19161879,2.143796476,0.067955195,0.108328855,0.045426938,PTEN/CDH1/HDAC6,3
GO:0071806,BP,GO:0071806,protein transmembrane transport,3/269,66/18888,0.045454545,3.19161879,2.143796476,0.067955195,0.108328855,0.045426938,EDNRB/HSPA5/AIFM1,3
GO:0031345,BP,GO:0031345,negative regulation of cell projection organization,6/269,201/18888,0.029850746,2.095988459,1.877645804,0.068258343,0.108774051,0.045613628,PTEN/CDH1/HDAC6/PRKCD/AKT1/VIM,6
GO:0007626,BP,GO:0007626,locomotory behavior,6/269,202/18888,0.02970297,2.085612279,1.864540037,0.069553059,0.110721082,0.046430101,PTEN/ALK/SOD2/MTOR/SNCG/GIT1,6
GO:0050779,BP,GO:0050779,RNA destabilization,6/269,202/18888,0.02970297,2.085612279,1.864540037,0.069553059,0.110721082,0.046430101,YBX1/MIR200C/MIR145/MLH1/MIR130B/ROCK1,6
GO:0051701,BP,GO:0051701,biological process involved in interaction with host,6/269,202/18888,0.02970297,2.085612279,1.864540037,0.069553059,0.110721082,0.046430101,TMPRSS2/AKT1/CAV1/BSG/EGFR/CTSB,6
GO:0006956,BP,GO:0006956,complement activation,3/269,67/18888,0.044776119,3.143982689,2.113084102,0.070423461,0.111950206,0.046945526,IL1B/A2M/CLU,3
GO:0046888,BP,GO:0046888,negative regulation of hormone secretion,3/269,67/18888,0.044776119,3.143982689,2.113084102,0.070423461,0.111950206,0.046945526,IL1B/IRS1/UCN,3
GO:0048857,BP,GO:0048857,neural nucleus development,3/269,67/18888,0.044776119,3.143982689,2.113084102,0.070423461,0.111950206,0.046945526,FGF2/RHOA/HSPA5,3
GO:0060760,BP,GO:0060760,positive regulation of response to cytokine stimulus,3/269,67/18888,0.044776119,3.143982689,2.113084102,0.070423461,0.111950206,0.046945526,HIF1A/TLR4/MED1,3
GO:0061387,BP,GO:0061387,regulation of extent of cell growth,4/269,109/18888,0.036697248,2.576719757,1.984316674,0.070456631,0.111963868,0.046951255,VEGFA/CDH1/HDAC6/FN1,4
GO:0061014,BP,GO:0061014,positive regulation of mRNA catabolic process,6/269,203/18888,0.02955665,2.075338327,1.851509936,0.07086195,0.112568704,0.047204888,YBX1/MIR200C/MIR145/MLH1/MIR130B/ROCK1,6
GO:0000002,BP,GO:0000002,mitochondrial genome maintenance,2/269,31/18888,0.064516129,4.530039573,2.364305402,0.071728224,0.113588386,0.047632485,TP53/PARP1,2
GO:0002313,BP,GO:0002313,mature B cell differentiation involved in immune response,2/269,31/18888,0.064516129,4.530039573,2.364305402,0.071728224,0.113588386,0.047632485,IL6/IL10,2
GO:0002431,BP,GO:0002431,Fc receptor mediated stimulatory signaling pathway,2/269,31/18888,0.064516129,4.530039573,2.364305402,0.071728224,0.113588386,0.047632485,PRKCD/PTK2,2
GO:0031114,BP,GO:0031114,regulation of microtubule depolymerization,2/269,31/18888,0.064516129,4.530039573,2.364305402,0.071728224,0.113588386,0.047632485,HDAC6/KATNB1,2
GO:0045070,BP,GO:0045070,positive regulation of viral genome replication,2/269,31/18888,0.064516129,4.530039573,2.364305402,0.071728224,0.113588386,0.047632485,NOTCH1/SRPK1,2
GO:0045745,BP,GO:0045745,positive regulation of G protein-coupled receptor signaling pathway,2/269,31/18888,0.064516129,4.530039573,2.364305402,0.071728224,0.113588386,0.047632485,HIF1A/KLK14,2
GO:0060325,BP,GO:0060325,face morphogenesis,2/269,31/18888,0.064516129,4.530039573,2.364305402,0.071728224,0.113588386,0.047632485,MMP2/SGPL1,2
GO:1900027,BP,GO:1900027,regulation of ruffle assembly,2/269,31/18888,0.064516129,4.530039573,2.364305402,0.071728224,0.113588386,0.047632485,CAV1/HRAS,2
GO:1901185,BP,GO:1901185,negative regulation of ERBB signaling pathway,2/269,31/18888,0.064516129,4.530039573,2.364305402,0.071728224,0.113588386,0.047632485,EGFR/DAB2IP,2
GO:0055001,BP,GO:0055001,muscle cell development,6/269,204/18888,0.029411765,2.065165099,1.838554621,0.072185005,0.114272023,0.047919163,GPX1/KDM1A/VEGFA/NOTCH1/MTOR/IGF1,6
GO:0046718,BP,GO:0046718,symbiont entry into host cell,5/269,156/18888,0.032051282,2.250500429,1.885096226,0.072649123,0.114966796,0.048210511,TMPRSS2/CAV1/BSG/EGFR/CTSB,5
GO:0006303,BP,GO:0006303,double-strand break repair via nonhomologous end joining,3/269,68/18888,0.044117647,3.097747649,2.082942801,0.072931717,0.11517397,0.048297388,XRCC1/ERCC1/MLH1,3
GO:0010972,BP,GO:0010972,negative regulation of G2/M transition of mitotic cell cycle,3/269,68/18888,0.044117647,3.097747649,2.082942801,0.072931717,0.11517397,0.048297388,BRCA1/NBN/CDKN1A,3
GO:0032715,BP,GO:0032715,negative regulation of interleukin-6 production,3/269,68/18888,0.044117647,3.097747649,2.082942801,0.072931717,0.11517397,0.048297388,TLR4/TNF/IL10,3
GO:0034394,BP,GO:0034394,protein localization to cell surface,3/269,68/18888,0.044117647,3.097747649,2.082942801,0.072931717,0.11517397,0.048297388,CTNNB1/TNF/AKT1,3
GO:0035825,BP,GO:0035825,homologous recombination,3/269,68/18888,0.044117647,3.097747649,2.082942801,0.072931717,0.11517397,0.048297388,BRCA1/MLH1/NBN,3
GO:0051123,BP,GO:0051123,RNA polymerase II preinitiation complex assembly,3/269,68/18888,0.044117647,3.097747649,2.082942801,0.072931717,0.11517397,0.048297388,TP53/MED1/ESR1,3
GO:0032007,BP,GO:0032007,negative regulation of TOR signaling,3/269,69/18888,0.043478261,3.052852756,2.053352581,0.075479454,0.119156062,0.04996725,HIF1A/VHL/NPRL2,3
GO:0008053,BP,GO:0008053,mitochondrial fusion,2/269,32/18888,0.0625,4.388475836,2.305865925,0.075813742,0.119188202,0.049980728,BAX/BNIP3,2
GO:0021532,BP,GO:0021532,neural tube patterning,2/269,32/18888,0.0625,4.388475836,2.305865925,0.075813742,0.119188202,0.049980728,BMI1/FOXA1,2
GO:0034505,BP,GO:0034505,tooth mineralization,2/269,32/18888,0.0625,4.388475836,2.305865925,0.075813742,0.119188202,0.049980728,FGFR1/TFAP2A,2
GO:0046685,BP,GO:0046685,response to arsenic-containing substance,2/269,32/18888,0.0625,4.388475836,2.305865925,0.075813742,0.119188202,0.049980728,CYP1A1/CDKN1A,2
GO:0048679,BP,GO:0048679,regulation of axon regeneration,2/269,32/18888,0.0625,4.388475836,2.305865925,0.075813742,0.119188202,0.049980728,IGF1R/BRAF,2
GO:0060219,BP,GO:0060219,camera-type eye photoreceptor cell differentiation,2/269,32/18888,0.0625,4.388475836,2.305865925,0.075813742,0.119188202,0.049980728,NOTCH1/STAT3,2
GO:0060674,BP,GO:0060674,placenta blood vessel development,2/269,32/18888,0.0625,4.388475836,2.305865925,0.075813742,0.119188202,0.049980728,MAPK1/AKT1,2
GO:0061437,BP,GO:0061437,renal system vasculature development,2/269,32/18888,0.0625,4.388475836,2.305865925,0.075813742,0.119188202,0.049980728,NOTCH1/WT1,2
GO:0061440,BP,GO:0061440,kidney vasculature development,2/269,32/18888,0.0625,4.388475836,2.305865925,0.075813742,0.119188202,0.049980728,NOTCH1/WT1,2
GO:1902547,BP,GO:1902547,regulation of cellular response to vascular endothelial growth factor stimulus,2/269,32/18888,0.0625,4.388475836,2.305865925,0.075813742,0.119188202,0.049980728,VEGFA/DAB2IP,2
GO:1903580,BP,GO:1903580,positive regulation of ATP metabolic process,2/269,32/18888,0.0625,4.388475836,2.305865925,0.075813742,0.119188202,0.049980728,MTOR/IGF1,2
GO:2000316,BP,GO:2000316,regulation of T-helper 17 type immune response,2/269,32/18888,0.0625,4.388475836,2.305865925,0.075813742,0.119188202,0.049980728,BRD2/BRD4,2
GO:0009566,BP,GO:0009566,fertilization,6/269,207/18888,0.028985507,2.035235171,1.800128819,0.076239014,0.119815435,0.050243754,AR/KLK14/BAX/CD9/MST1R/ZFX,6
GO:0008016,BP,GO:0008016,regulation of heart contraction,6/269,208/18888,0.028846154,2.025450386,1.787464144,0.077618574,0.121941455,0.051135285,EDNRB/TNF/CAV1/MIR200C/HSP90AA1/UCN,6
GO:0006898,BP,GO:0006898,receptor-mediated endocytosis,7/269,259/18888,0.027027027,1.897719281,1.748538172,0.077966169,0.122445318,0.051346576,CXCR2/VEGFA/CAV1/SERPINE1/CD9/LYVE1/CLU,7
GO:0042490,BP,GO:0042490,mechanoreceptor differentiation,3/269,70/18888,0.042857143,3.009240574,2.024294437,0.078066158,0.122517883,0.051377006,FGF2/NOTCH1/FGFR1,3
GO:1902750,BP,GO:1902750,negative regulation of cell cycle G2/M phase transition,3/269,70/18888,0.042857143,3.009240574,2.024294437,0.078066158,0.122517883,0.051377006,BRCA1/NBN/CDKN1A,3
GO:0018958,BP,GO:0018958,phenol-containing compound metabolic process,4/269,113/18888,0.03539823,2.485508438,1.903723304,0.07813185,0.122578757,0.051402533,MC1R/GATA3/MED1/CTSB,4
GO:0070507,BP,GO:0070507,regulation of microtubule cytoskeleton organization,5/269,160/18888,0.03125,2.194237918,1.823411131,0.079012446,0.123917627,0.051963979,HDAC6/RHOA/KATNB1/GIT1/ROCK1,5
GO:0032409,BP,GO:0032409,regulation of transporter activity,7/269,260/18888,0.026923077,1.89042036,1.737713182,0.079203891,0.12417513,0.052071961,PPARG/PRKCD/MMP9/CAV1/MIR200C/PIM1/LRRC26,7
GO:0001556,BP,GO:0001556,oocyte maturation,2/269,33/18888,0.060606061,4.25549172,2.249778442,0.079971335,0.124905521,0.052378245,AURKA/BRCA2,2
GO:0019934,BP,GO:0019934,cGMP-mediated signaling,2/269,33/18888,0.060606061,4.25549172,2.249778442,0.079971335,0.124905521,0.052378245,THBS1/EDNRB,2
GO:0030511,BP,GO:0030511,positive regulation of transforming growth factor beta receptor signaling pathway,2/269,33/18888,0.060606061,4.25549172,2.249778442,0.079971335,0.124905521,0.052378245,THBS1/TWSG1,2
GO:0033198,BP,GO:0033198,response to ATP,2/269,33/18888,0.060606061,4.25549172,2.249778442,0.079971335,0.124905521,0.052378245,PTGS2/IL1B,2
GO:0034121,BP,GO:0034121,regulation of toll-like receptor signaling pathway,2/269,33/18888,0.060606061,4.25549172,2.249778442,0.079971335,0.124905521,0.052378245,LGR4/ESR1,2
GO:0035305,BP,GO:0035305,negative regulation of dephosphorylation,2/269,33/18888,0.060606061,4.25549172,2.249778442,0.079971335,0.124905521,0.052378245,TNF/ROCK1,2
GO:0043171,BP,GO:0043171,peptide catabolic process,2/269,33/18888,0.060606061,4.25549172,2.249778442,0.079971335,0.124905521,0.052378245,NPEPPS/MME,2
GO:0051654,BP,GO:0051654,establishment of mitochondrion localization,2/269,33/18888,0.060606061,4.25549172,2.249778442,0.079971335,0.124905521,0.052378245,HIF1A/HDAC6,2
GO:1900117,BP,GO:1900117,regulation of execution phase of apoptosis,2/269,33/18888,0.060606061,4.25549172,2.249778442,0.079971335,0.124905521,0.052378245,TP53/DLC1,2
GO:1903846,BP,GO:1903846,positive regulation of cellular response to transforming growth factor beta stimulus,2/269,33/18888,0.060606061,4.25549172,2.249778442,0.079971335,0.124905521,0.052378245,THBS1/TWSG1,2
GO:2000515,BP,GO:2000515,"negative regulation of CD4-positive, alpha-beta T cell activation",2/269,33/18888,0.060606061,4.25549172,2.249778442,0.079971335,0.124905521,0.052378245,TWSG1/CD274,2
GO:0061371,BP,GO:0061371,determination of heart left/right asymmetry,3/269,71/18888,0.042253521,2.966856904,1.995750288,0.080691301,0.125900536,0.052795498,NOTCH1/HIF1A/SMAD3,3
GO:0071677,BP,GO:0071677,positive regulation of mononuclear cell migration,3/269,71/18888,0.042253521,2.966856904,1.995750288,0.080691301,0.125900536,0.052795498,TNF/RHOA/SERPINE1,3
GO:1901880,BP,GO:1901880,negative regulation of protein depolymerization,3/269,71/18888,0.042253521,2.966856904,1.995750288,0.080691301,0.125900536,0.052795498,PIK3CA/HDAC6/KATNB1,3
GO:0003143,BP,GO:0003143,embryonic heart tube morphogenesis,3/269,72/18888,0.041666667,2.925650558,1.967702919,0.08335435,0.129833305,0.054444676,NOTCH1/HIF1A/SMAD3,3
GO:0006024,BP,GO:0006024,glycosaminoglycan biosynthetic process,3/269,72/18888,0.041666667,2.925650558,1.967702919,0.08335435,0.129833305,0.054444676,IL1B/NFKB1/TGFB1,3
GO:0010569,BP,GO:0010569,regulation of double-strand break repair via homologous recombination,3/269,72/18888,0.041666667,2.925650558,1.967702919,0.08335435,0.129833305,0.054444676,PARP1/KDM1A/MEAF6,3
GO:0030514,BP,GO:0030514,negative regulation of BMP signaling pathway,3/269,72/18888,0.041666667,2.925650558,1.967702919,0.08335435,0.129833305,0.054444676,PPARG/NOTCH1/TWSG1,3
GO:0032413,BP,GO:0032413,negative regulation of ion transmembrane transporter activity,3/269,72/18888,0.041666667,2.925650558,1.967702919,0.08335435,0.129833305,0.054444676,MMP9/CAV1/MIR200C,3
GO:0044409,BP,GO:0044409,symbiont entry into host,5/269,163/18888,0.030674847,2.153853171,1.778332196,0.08397512,0.130522872,0.054733841,TMPRSS2/CAV1/BSG/EGFR/CTSB,5
GO:2001257,BP,GO:2001257,regulation of cation channel activity,4/269,116/18888,0.034482759,2.421228048,1.845512307,0.084151192,0.130522872,0.054733841,MMP9/CAV1/MIR200C/LRRC26,4
GO:0002828,BP,GO:0002828,regulation of type 2 immune response,2/269,34/18888,0.058823529,4.130330199,2.195873473,0.084198139,0.130522872,0.054733841,IL6/GATA3,2
GO:0003382,BP,GO:0003382,epithelial cell morphogenesis,2/269,34/18888,0.058823529,4.130330199,2.195873473,0.084198139,0.130522872,0.054733841,AR/ROCK1,2
GO:0009954,BP,GO:0009954,proximal/distal pattern formation,2/269,34/18888,0.058823529,4.130330199,2.195873473,0.084198139,0.130522872,0.054733841,CTNNB1/TP63,2
GO:0032743,BP,GO:0032743,positive regulation of interleukin-2 production,2/269,34/18888,0.058823529,4.130330199,2.195873473,0.084198139,0.130522872,0.054733841,MAP3K7/IL1B,2
GO:0048841,BP,GO:0048841,regulation of axon extension involved in axon guidance,2/269,34/18888,0.058823529,4.130330199,2.195873473,0.084198139,0.130522872,0.054733841,VEGFA/HDAC6,2
GO:0050901,BP,GO:0050901,leukocyte tethering or rolling,2/269,34/18888,0.058823529,4.130330199,2.195873473,0.084198139,0.130522872,0.054733841,TNF/ROCK1,2
GO:0070528,BP,GO:0070528,protein kinase C signaling,2/269,34/18888,0.058823529,4.130330199,2.195873473,0.084198139,0.130522872,0.054733841,VEGFA/MC1R,2
GO:0070570,BP,GO:0070570,regulation of neuron projection regeneration,2/269,34/18888,0.058823529,4.130330199,2.195873473,0.084198139,0.130522872,0.054733841,IGF1R/BRAF,2
GO:0090151,BP,GO:0090151,establishment of protein localization to mitochondrial membrane,2/269,34/18888,0.058823529,4.130330199,2.195873473,0.084198139,0.130522872,0.054733841,BAX/HSP90AA1,2
GO:0090313,BP,GO:0090313,regulation of protein targeting to membrane,2/269,34/18888,0.058823529,4.130330199,2.195873473,0.084198139,0.130522872,0.054733841,ERBB2/HRAS,2
GO:1900225,BP,GO:1900225,regulation of NLRP3 inflammasome complex assembly,2/269,34/18888,0.058823529,4.130330199,2.195873473,0.084198139,0.130522872,0.054733841,TLR4/MYD88,2
GO:2000279,BP,GO:2000279,negative regulation of DNA biosynthetic process,2/269,34/18888,0.058823529,4.130330199,2.195873473,0.084198139,0.130522872,0.054733841,TP53/CDKN1A,2
GO:0006360,BP,GO:0006360,transcription by RNA polymerase I,3/269,73/18888,0.04109589,2.885573153,1.940135931,0.086054763,0.133264956,0.055883715,ERBB2/SMARCA4/MTOR,3
GO:0046635,BP,GO:0046635,positive regulation of alpha-beta T cell activation,3/269,73/18888,0.04109589,2.885573153,1.940135931,0.086054763,0.133264956,0.055883715,RHOA/BRD2/BRD4,3
GO:0140962,BP,GO:0140962,multicellular organismal-level chemical homeostasis,3/269,73/18888,0.04109589,2.885573153,1.940135931,0.086054763,0.133264956,0.055883715,VEGFA/SOD2/KDR,3
GO:0000209,BP,GO:0000209,protein polyubiquitination,7/269,267/18888,0.026217228,1.840858778,1.66324661,0.08818701,0.136520564,0.057248931,BRCA1/CTNNB1/NPEPPS/SPOP/HDAC6/CUL3/IFI27,7
GO:0002446,BP,GO:0002446,neutrophil mediated immunity,2/269,35/18888,0.057142857,4.012320765,2.143998406,0.088491355,0.136759367,0.057349072,IL6/MYD88,2
GO:0036314,BP,GO:0036314,response to sterol,2/269,35/18888,0.057142857,4.012320765,2.143998406,0.088491355,0.136759367,0.057349072,TGFBR1/TGFB1,2
GO:0045577,BP,GO:0045577,regulation of B cell differentiation,2/269,35/18888,0.057142857,4.012320765,2.143998406,0.088491355,0.136759367,0.057349072,MMP14/IL10,2
GO:0061081,BP,GO:0061081,positive regulation of myeloid leukocyte cytokine production involved in immune response,2/269,35/18888,0.057142857,4.012320765,2.143998406,0.088491355,0.136759367,0.057349072,TLR4/MYD88,2
GO:0070293,BP,GO:0070293,renal absorption,2/269,35/18888,0.057142857,4.012320765,2.143998406,0.088491355,0.136759367,0.057349072,EDNRB/AKR1C3,2
GO:0009880,BP,GO:0009880,embryonic pattern specification,3/269,74/18888,0.040540541,2.846578921,1.913033688,0.088791991,0.137130953,0.057504894,CTNNB1/SMAD3/WT1,3
GO:1905818,BP,GO:1905818,regulation of chromosome separation,3/269,74/18888,0.040540541,2.846578921,1.913033688,0.088791991,0.137130953,0.057504894,XRCC3/CUL3/RB1,3
GO:0002832,BP,GO:0002832,negative regulation of response to biotic stimulus,4/269,119/18888,0.033613445,2.360188685,1.78908727,0.090390914,0.13950576,0.058500752,PPARG/PARP1/TGFB1/A2M,4
GO:0048675,BP,GO:0048675,axon extension,4/269,119/18888,0.033613445,2.360188685,1.78908727,0.090390914,0.13950576,0.058500752,VEGFA/CDH1/HDAC6/FN1,4
GO:0043489,BP,GO:0043489,RNA stabilization,3/269,75/18888,0.04,2.808624535,1.886381273,0.091565479,0.141222858,0.059220805,YBX1/MAPK14/MYD88,3
GO:0045123,BP,GO:0045123,cellular extravasation,3/269,75/18888,0.04,2.808624535,1.886381273,0.091565479,0.141222858,0.059220805,TNF/LYVE1/ROCK1,3
GO:0050000,BP,GO:0050000,chromosome localization,4/269,120/18888,0.033333333,2.340520446,1.770657332,0.092518951,0.142645123,0.059817222,KATNB1/CUL3/RB1/MLH1,4
GO:0021799,BP,GO:0021799,cerebral cortex radially oriented cell migration,2/269,36/18888,0.055555556,3.90086741,2.094015384,0.092848254,0.142718166,0.059847852,CTNNB1/DAB2IP,2
GO:0031112,BP,GO:0031112,positive regulation of microtubule polymerization or depolymerization,2/269,36/18888,0.055555556,3.90086741,2.094015384,0.092848254,0.142718166,0.059847852,KATNB1/GIT1,2
GO:0035883,BP,GO:0035883,enteroendocrine cell differentiation,2/269,36/18888,0.055555556,3.90086741,2.094015384,0.092848254,0.142718166,0.059847852,AKT1/CLOCK,2
GO:0043372,BP,GO:0043372,"positive regulation of CD4-positive, alpha-beta T cell differentiation",2/269,36/18888,0.055555556,3.90086741,2.094015384,0.092848254,0.142718166,0.059847852,BRD2/BRD4,2
GO:0045920,BP,GO:0045920,negative regulation of exocytosis,2/269,36/18888,0.055555556,3.90086741,2.094015384,0.092848254,0.142718166,0.059847852,NOTCH1/BRAF,2
GO:0046329,BP,GO:0046329,negative regulation of JNK cascade,2/269,36/18888,0.055555556,3.90086741,2.094015384,0.092848254,0.142718166,0.059847852,GSTP1/PER1,2
GO:0050931,BP,GO:0050931,pigment cell differentiation,2/269,36/18888,0.055555556,3.90086741,2.094015384,0.092848254,0.142718166,0.059847852,EDNRB/SOD2,2
GO:0060218,BP,GO:0060218,hematopoietic stem cell differentiation,2/269,36/18888,0.055555556,3.90086741,2.094015384,0.092848254,0.142718166,0.059847852,TP53/MED1,2
GO:1905168,BP,GO:1905168,positive regulation of double-strand break repair via homologous recombination,2/269,36/18888,0.055555556,3.90086741,2.094015384,0.092848254,0.142718166,0.059847852,PARP1/MEAF6,2
GO:0006023,BP,GO:0006023,aminoglycan biosynthetic process,3/269,76/18888,0.039473684,2.771668949,1.860164445,0.094374663,0.14496661,0.060790721,IL1B/NFKB1/TGFB1,3
GO:0006081,BP,GO:0006081,cellular aldehyde metabolic process,3/269,76/18888,0.039473684,2.771668949,1.860164445,0.094374663,0.14496661,0.060790721,EDNRB/RELA/AKR1C3,3
GO:0055074,BP,GO:0055074,calcium ion homeostasis,8/269,326/18888,0.024539877,1.723082537,1.582937411,0.095484488,0.146621951,0.061484876,VDR/FASLG/FGF2/CAV1/BAX/KDR/BNIP3/FGFR1,8
GO:0099003,BP,GO:0099003,vesicle-mediated transport in synapse,6/269,221/18888,0.027149321,1.906306246,1.628970803,0.096823494,0.148627978,0.06232609,PTEN/CTNNB1/SNCG/GIT1/BRAF/ROCK1,6
GO:0032436,BP,GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,3/269,77/18888,0.038961039,2.735673249,1.834369602,0.097218976,0.148706258,0.062358915,AURKA/AKT1/CLU,3
GO:1901568,BP,GO:1901568,fatty acid derivative metabolic process,3/269,77/18888,0.038961039,2.735673249,1.834369602,0.097218976,0.148706258,0.062358915,ALOX12/ALOX15B/ACSS3,3
GO:0002335,BP,GO:0002335,mature B cell differentiation,2/269,37/18888,0.054054054,3.795438561,2.045799514,0.097266165,0.148706258,0.062358915,IL6/IL10,2
GO:0003230,BP,GO:0003230,cardiac atrium development,2/269,37/18888,0.054054054,3.795438561,2.045799514,0.097266165,0.148706258,0.062358915,IGF1R/NOTCH1,2
GO:0006270,BP,GO:0006270,DNA replication initiation,2/269,37/18888,0.054054054,3.795438561,2.045799514,0.097266165,0.148706258,0.062358915,CDK2/NBN,2
GO:0022616,BP,GO:0022616,DNA strand elongation,2/269,37/18888,0.054054054,3.795438561,2.045799514,0.097266165,0.148706258,0.062358915,PCNA/NBN,2
GO:0044546,BP,GO:0044546,NLRP3 inflammasome complex assembly,2/269,37/18888,0.054054054,3.795438561,2.045799514,0.097266165,0.148706258,0.062358915,TLR4/MYD88,2
GO:0045773,BP,GO:0045773,positive regulation of axon extension,2/269,37/18888,0.054054054,3.795438561,2.045799514,0.097266165,0.148706258,0.062358915,VEGFA/FN1,2
GO:0046621,BP,GO:0046621,negative regulation of organ growth,2/269,37/18888,0.054054054,3.795438561,2.045799514,0.097266165,0.148706258,0.062358915,PTEN/MIR25,2
GO:0060392,BP,GO:0060392,negative regulation of SMAD protein signal transduction,2/269,37/18888,0.054054054,3.795438561,2.045799514,0.097266165,0.148706258,0.062358915,PPARG/MIR145,2
GO:0141085,BP,GO:0141085,regulation of inflammasome-mediated signaling pathway,2/269,37/18888,0.054054054,3.795438561,2.045799514,0.097266165,0.148706258,0.062358915,TLR4/MYD88,2
GO:1902275,BP,GO:1902275,regulation of chromatin organization,2/269,37/18888,0.054054054,3.795438561,2.045799514,0.097266165,0.148706258,0.062358915,KDM1A/CDK2,2
GO:1902115,BP,GO:1902115,regulation of organelle assembly,6/269,223/18888,0.02690583,1.889209329,1.605542842,0.099984719,0.152811265,0.064080321,BRCA1/MTOR/TNF/RHOA/AKT1/FSCN1,6
GO:0031397,BP,GO:0031397,negative regulation of protein ubiquitination,3/269,78/18888,0.038461538,2.700600515,1.808983743,0.100097844,0.152881588,0.064109811,SQSTM1/AKT1/CAV1,3
GO:0050772,BP,GO:0050772,positive regulation of axonogenesis,3/269,78/18888,0.038461538,2.700600515,1.808983743,0.100097844,0.152881588,0.064109811,VEGFA/FN1/BRAF,3
GO:0006699,BP,GO:0006699,bile acid biosynthetic process,2/269,38/18888,0.052631579,3.695558599,1.999237331,0.101742484,0.154926055,0.064967143,AMACR/FGFR4,2
GO:0031281,BP,GO:0031281,positive regulation of cyclase activity,2/269,38/18888,0.052631579,3.695558599,1.999237331,0.101742484,0.154926055,0.064967143,MAPK14/LGR4,2
GO:0035909,BP,GO:0035909,aorta morphogenesis,2/269,38/18888,0.052631579,3.695558599,1.999237331,0.101742484,0.154926055,0.064967143,NOTCH1/MIR145,2
GO:0045823,BP,GO:0045823,positive regulation of heart contraction,2/269,38/18888,0.052631579,3.695558599,1.999237331,0.101742484,0.154926055,0.064967143,HSP90AA1/UCN,2
GO:0045981,BP,GO:0045981,positive regulation of nucleotide metabolic process,2/269,38/18888,0.052631579,3.695558599,1.999237331,0.101742484,0.154926055,0.064967143,MTOR/IGF1,2
GO:0048846,BP,GO:0048846,axon extension involved in axon guidance,2/269,38/18888,0.052631579,3.695558599,1.999237331,0.101742484,0.154926055,0.064967143,VEGFA/HDAC6,2
GO:1900181,BP,GO:1900181,negative regulation of protein localization to nucleus,2/269,38/18888,0.052631579,3.695558599,1.999237331,0.101742484,0.154926055,0.064967143,MTOR/LZTS2,2
GO:1900544,BP,GO:1900544,positive regulation of purine nucleotide metabolic process,2/269,38/18888,0.052631579,3.695558599,1.999237331,0.101742484,0.154926055,0.064967143,MTOR/IGF1,2
GO:1902284,BP,GO:1902284,neuron projection extension involved in neuron projection guidance,2/269,38/18888,0.052631579,3.695558599,1.999237331,0.101742484,0.154926055,0.064967143,VEGFA/HDAC6,2
GO:0006805,BP,GO:0006805,xenobiotic metabolic process,4/269,126/18888,0.031746032,2.229067092,1.663798588,0.105778791,0.161018433,0.067521939,UGT2B17/GSTP1/CYP1A1/NAT1,4
GO:0001990,BP,GO:0001990,regulation of systemic arterial blood pressure by hormone,2/269,39/18888,0.051282051,3.600800686,1.95422548,0.106274666,0.161503462,0.067725332,EDNRB/RHOA,2
GO:0010737,BP,GO:0010737,protein kinase A signaling,2/269,39/18888,0.051282051,3.600800686,1.95422548,0.106274666,0.161503462,0.067725332,MC1R/SFN,2
GO:0031111,BP,GO:0031111,negative regulation of microtubule polymerization or depolymerization,2/269,39/18888,0.051282051,3.600800686,1.95422548,0.106274666,0.161503462,0.067725332,HDAC6/KATNB1,2
GO:0140632,BP,GO:0140632,canonical inflammasome complex assembly,2/269,39/18888,0.051282051,3.600800686,1.95422548,0.106274666,0.161503462,0.067725332,TLR4/MYD88,2
GO:1903524,BP,GO:1903524,positive regulation of blood circulation,2/269,39/18888,0.051282051,3.600800686,1.95422548,0.106274666,0.161503462,0.067725332,HSP90AA1/UCN,2
GO:0031623,BP,GO:0031623,receptor internalization,4/269,127/18888,0.031496063,2.211515382,1.646577799,0.108068755,0.16417514,0.068845682,CXCR2/VEGFA/CAV1/CD9,4
GO:0051304,BP,GO:0051304,chromosome separation,3/269,81/18888,0.037037037,2.600578273,1.735158367,0.108935977,0.165382309,0.0693519,XRCC3/CUL3/RB1,3
GO:0097061,BP,GO:0097061,dendritic spine organization,3/269,81/18888,0.037037037,2.600578273,1.735158367,0.108935977,0.165382309,0.0693519,PTEN/IGF1R/HDAC6,3
GO:0030279,BP,GO:0030279,negative regulation of ossification,2/269,40/18888,0.05,3.510780669,1.910669582,0.110860228,0.168135552,0.070506452,NOTCH1/HIF1A,2
GO:0032728,BP,GO:0032728,positive regulation of interferon-beta production,2/269,40/18888,0.05,3.510780669,1.910669582,0.110860228,0.168135552,0.070506452,TLR4/HSP90AA1,2
GO:0140448,BP,GO:0140448,signaling receptor ligand precursor processing,2/269,40/18888,0.05,3.510780669,1.910669582,0.110860228,0.168135552,0.070506452,PCSK1/MME,2
GO:0010959,BP,GO:0010959,regulation of metal ion transport,9/269,394/18888,0.02284264,1.60390995,1.456076939,0.11154066,0.169111231,0.070915596,CTNNB1/PTGS2/AKT1/CAV1/MIR200C/BAX/UCN/PER1/LRRC26,9
GO:0036465,BP,GO:0036465,synaptic vesicle recycling,3/269,82/18888,0.036585366,2.568863904,1.711289303,0.111947242,0.169614777,0.071126755,SNCG/GIT1/ROCK1,3
GO:0046928,BP,GO:0046928,regulation of neurotransmitter secretion,3/269,82/18888,0.036585366,2.568863904,1.711289303,0.111947242,0.169614777,0.071126755,SNCG/GIT1/BRAF,3
GO:1990266,BP,GO:1990266,neutrophil migration,4/269,129/18888,0.031007752,2.177228322,1.612613048,0.112715278,0.170721678,0.071590926,CXCR2/IL1B/BSG/MYD88,4
GO:0070509,BP,GO:0070509,calcium ion import,3/269,83/18888,0.036144578,2.537913737,1.687772116,0.114990131,0.174109351,0.073011523,CTNNB1/MIR200C/UCN,3
GO:0030851,BP,GO:0030851,granulocyte differentiation,2/269,41/18888,0.048780488,3.425151872,1.868483247,0.115496743,0.174702245,0.073260149,FASN/BAP1,2
GO:0036297,BP,GO:0036297,interstrand cross-link repair,2/269,41/18888,0.048780488,3.425151872,1.868483247,0.115496743,0.174702245,0.073260149,ERCC1/XRCC3,2
GO:0120033,BP,GO:0120033,negative regulation of plasma membrane bounded cell projection assembly,2/269,41/18888,0.048780488,3.425151872,1.868483247,0.115496743,0.174702245,0.073260149,PRKCD/AKT1,2
GO:0072329,BP,GO:0072329,monocarboxylic acid catabolic process,4/269,131/18888,0.030534351,2.143988195,1.579264801,0.117449069,0.177596402,0.074473793,AMACR/AKT1/IRS1/TWIST1,4
GO:0001523,BP,GO:0001523,retinoid metabolic process,3/269,84/18888,0.035714286,2.507700478,1.664596773,0.118064049,0.178407896,0.074814087,CYP1A1/AKR1C3/RBP1,3
GO:1902117,BP,GO:1902117,positive regulation of organelle assembly,3/269,84/18888,0.035714286,2.507700478,1.664596773,0.118064049,0.178407896,0.074814087,TNF/RHOA/FSCN1,3
GO:0000578,BP,GO:0000578,embryonic axis specification,2/269,42/18888,0.047619048,3.343600637,1.827587224,0.120181846,0.181127519,0.075954541,CTNNB1/WT1,2
GO:0001662,BP,GO:0001662,behavioral fear response,2/269,42/18888,0.047619048,3.343600637,1.827587224,0.120181846,0.181127519,0.075954541,GRPR/UCN,2
GO:0001709,BP,GO:0001709,cell fate determination,2/269,42/18888,0.047619048,3.343600637,1.827587224,0.120181846,0.181127519,0.075954541,CTNNB1/GATA3,2
GO:0002251,BP,GO:0002251,organ or tissue specific immune response,2/269,42/18888,0.047619048,3.343600637,1.827587224,0.120181846,0.181127519,0.075954541,IL6/DEFB1,2
GO:0009409,BP,GO:0009409,response to cold,2/269,42/18888,0.047619048,3.343600637,1.827587224,0.120181846,0.181127519,0.075954541,HSP90AA1/NFKBIA,2
GO:0045922,BP,GO:0045922,negative regulation of fatty acid metabolic process,2/269,42/18888,0.047619048,3.343600637,1.827587224,0.120181846,0.181127519,0.075954541,BRCA1/AKT1,2
GO:0141084,BP,GO:0141084,inflammasome-mediated signaling pathway,2/269,42/18888,0.047619048,3.343600637,1.827587224,0.120181846,0.181127519,0.075954541,TLR4/MYD88,2
GO:1990000,BP,GO:1990000,amyloid fibril formation,2/269,42/18888,0.047619048,3.343600637,1.827587224,0.120181846,0.181127519,0.075954541,VHL/CLU,2
GO:0043271,BP,GO:0043271,negative regulation of monoatomic ion transport,4/269,133/18888,0.030075188,2.111747771,1.54651098,0.122268247,0.184211023,0.077247587,PTGS2/MMP9/CAV1/MIR200C,4
GO:0051851,BP,GO:0051851,modulation by host of symbiont process,3/269,86/18888,0.034883721,2.449381862,1.619233491,0.124302572,0.187214055,0.078506887,FASN/SMARCA4/IFI27,3
GO:0002209,BP,GO:0002209,behavioral defense response,2/269,43/18888,0.046511628,3.265842483,1.787908653,0.124913224,0.187823316,0.078762377,GRPR/UCN,2
GO:0007099,BP,GO:0007099,centriole replication,2/269,43/18888,0.046511628,3.265842483,1.787908653,0.124913224,0.187823316,0.078762377,BRCA1/CDK2,2
GO:0014904,BP,GO:0014904,myotube cell development,2/269,43/18888,0.046511628,3.265842483,1.787908653,0.124913224,0.187823316,0.078762377,GPX1/IGF1,2
GO:0045124,BP,GO:0045124,regulation of bone resorption,2/269,43/18888,0.046511628,3.265842483,1.787908653,0.124913224,0.187823316,0.078762377,IL6/EGFR,2
GO:0046640,BP,GO:0046640,regulation of alpha-beta T cell proliferation,2/269,43/18888,0.046511628,3.265842483,1.787908653,0.124913224,0.187823316,0.078762377,TWSG1/CD274,2
GO:0006720,BP,GO:0006720,isoprenoid metabolic process,4/269,135/18888,0.02962963,2.080462619,1.514330633,0.127170882,0.191154911,0.080159458,CYP1A1/EGFR/AKR1C3/RBP1,4
GO:0055013,BP,GO:0055013,cardiac muscle cell development,3/269,87/18888,0.034482759,2.421228048,1.59702743,0.127465975,0.191409025,0.080266018,VEGFA/MTOR/IGF1,3
GO:0071277,BP,GO:0071277,cellular response to calcium ion,3/269,87/18888,0.034482759,2.421228048,1.59702743,0.127465975,0.191409025,0.080266018,FOS/BRAF/AKR1C3,3
GO:1901879,BP,GO:1901879,regulation of protein depolymerization,3/269,87/18888,0.034482759,2.421228048,1.59702743,0.127465975,0.191409025,0.080266018,PIK3CA/HDAC6/KATNB1,3
GO:0065004,BP,GO:0065004,protein-DNA complex assembly,6/269,240/18888,0.025,1.755390335,1.415599395,0.12899338,0.193575046,0.081174324,TP53/SMARCA4/BRD2/RB1/MED1/ESR1,6
GO:1903313,BP,GO:1903313,positive regulation of mRNA metabolic process,6/269,240/18888,0.025,1.755390335,1.415599395,0.12899338,0.193575046,0.081174324,YBX1/MIR200C/MIR145/MLH1/MIR130B/ROCK1,6
GO:0097553,BP,GO:0097553,calcium ion transmembrane import into cytosol,5/269,187/18888,0.026737968,1.877422818,1.449361653,0.129277012,0.193936802,0.081326024,FASLG/FGF2/CAV1/MIR200C/BAX,5
GO:0010799,BP,GO:0010799,regulation of peptidyl-threonine phosphorylation,2/269,44/18888,0.045454545,3.19161879,1.749380414,0.129688622,0.194170675,0.081424096,MAPK1/SPHK1,2
GO:0035329,BP,GO:0035329,hippo signaling,2/269,44/18888,0.045454545,3.19161879,1.749380414,0.129688622,0.194170675,0.081424096,SOX11/MAPK14,2
GO:0045761,BP,GO:0045761,regulation of adenylate cyclase activity,2/269,44/18888,0.045454545,3.19161879,1.749380414,0.129688622,0.194170675,0.081424096,EDNRB/LGR4,2
GO:0097178,BP,GO:0097178,ruffle assembly,2/269,44/18888,0.045454545,3.19161879,1.749380414,0.129688622,0.194170675,0.081424096,CAV1/HRAS,2
GO:1903539,BP,GO:1903539,protein localization to postsynaptic membrane,2/269,44/18888,0.045454545,3.19161879,1.749380414,0.129688622,0.194170675,0.081424096,ERBB2/HRAS,2
GO:2000300,BP,GO:2000300,regulation of synaptic vesicle exocytosis,2/269,44/18888,0.045454545,3.19161879,1.749380414,0.129688622,0.194170675,0.081424096,GIT1/BRAF,2
GO:0000281,BP,GO:0000281,mitotic cytokinesis,3/269,88/18888,0.034090909,2.393714093,1.575126931,0.130658002,0.195493548,0.081978834,RHOA/LZTS2/ROCK1,3
GO:0072665,BP,GO:0072665,protein localization to vacuole,3/269,88/18888,0.034090909,2.393714093,1.575126931,0.130658002,0.195493548,0.081978834,SQSTM1/AKT1/CLU,3
GO:0001188,BP,GO:0001188,RNA polymerase I preinitiation complex assembly,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,SMARCA4,1
GO:0002420,BP,GO:0002420,natural killer cell mediated cytotoxicity directed against tumor cell target,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,TGFB1,1
GO:0002775,BP,GO:0002775,antimicrobial peptide production,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,KLK3,1
GO:0002855,BP,GO:0002855,regulation of natural killer cell mediated immune response to tumor cell,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,TGFB1,1
GO:0003056,BP,GO:0003056,regulation of vascular associated smooth muscle contraction,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,RHOA,1
GO:0003253,BP,GO:0003253,cardiac neural crest cell migration involved in outflow tract morphogenesis,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,TWIST1,1
GO:0008300,BP,GO:0008300,isoprenoid catabolic process,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,AKR1C3,1
GO:0009756,BP,GO:0009756,carbohydrate mediated signaling,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,SMARCA4,1
GO:0010454,BP,GO:0010454,negative regulation of cell fate commitment,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,SPDEF,1
GO:0010496,BP,GO:0010496,intercellular transport,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,PEG10,1
GO:0014012,BP,GO:0014012,peripheral nervous system axon regeneration,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,MMP2,1
GO:0017038,BP,GO:0017038,protein import,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,CLU,1
GO:0030002,BP,GO:0030002,intracellular monoatomic anion homeostasis,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,FASLG,1
GO:0030638,BP,GO:0030638,polyketide metabolic process,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,AKR1C3,1
GO:0030644,BP,GO:0030644,intracellular chloride ion homeostasis,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,FASLG,1
GO:0030647,BP,GO:0030647,aminoglycoside antibiotic metabolic process,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,AKR1C3,1
GO:0032096,BP,GO:0032096,negative regulation of response to food,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,UCN,1
GO:0032099,BP,GO:0032099,negative regulation of appetite,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,UCN,1
GO:0032105,BP,GO:0032105,negative regulation of response to extracellular stimulus,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,UCN,1
GO:0032108,BP,GO:0032108,negative regulation of response to nutrient levels,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,UCN,1
GO:0032353,BP,GO:0032353,negative regulation of hormone biosynthetic process,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,NFKB1,1
GO:0033085,BP,GO:0033085,negative regulation of T cell differentiation in thymus,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,ERBB2,1
GO:0033210,BP,GO:0033210,leptin-mediated signaling pathway,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,STAT3,1
GO:0033572,BP,GO:0033572,transferrin transport,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,LMTK2,1
GO:0034351,BP,GO:0034351,negative regulation of glial cell apoptotic process,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,PRKCD,1
GO:0035022,BP,GO:0035022,positive regulation of Rac protein signal transduction,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,KRAS,1
GO:0035655,BP,GO:0035655,interleukin-18-mediated signaling pathway,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,AKT1,1
GO:0035907,BP,GO:0035907,dorsal aorta development,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,NKX3-1,1
GO:0042538,BP,GO:0042538,hyperosmotic salinity response,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,FBP1,1
GO:0042756,BP,GO:0042756,drinking behavior,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,UCN,1
GO:0043587,BP,GO:0043587,tongue morphogenesis,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,CTNNB1,1
GO:0044598,BP,GO:0044598,doxorubicin metabolic process,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,AKR1C3,1
GO:0048263,BP,GO:0048263,determination of dorsal identity,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,CTNNB1,1
GO:0048340,BP,GO:0048340,paraxial mesoderm morphogenesis,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,SMAD3,1
GO:0048664,BP,GO:0048664,neuron fate determination,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,CTNNB1,1
GO:0051409,BP,GO:0051409,response to nitrosative stress,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,DUSP6,1
GO:0060346,BP,GO:0060346,bone trabecula formation,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,MMP2,1
GO:0060397,BP,GO:0060397,growth hormone receptor signaling pathway via JAK-STAT,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,STAT3,1
GO:0060430,BP,GO:0060430,lung saccule development,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,FOXA1,1
GO:0070432,BP,GO:0070432,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,TLR4,1
GO:0071351,BP,GO:0071351,cellular response to interleukin-18,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,AKT1,1
GO:0071372,BP,GO:0071372,cellular response to follicle-stimulating hormone stimulus,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,NOTCH1,1
GO:0071578,BP,GO:0071578,zinc ion import across plasma membrane,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,SLC39A11,1
GO:0090184,BP,GO:0090184,positive regulation of kidney development,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,MYC,1
GO:0097050,BP,GO:0097050,type B pancreatic cell apoptotic process,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,IL6,1
GO:0097090,BP,GO:0097090,presynaptic membrane organization,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,PTEN,1
GO:0097267,BP,GO:0097267,omega-hydroxylase P450 pathway,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,CYP1A1,1
GO:0098779,BP,GO:0098779,positive regulation of mitophagy in response to mitochondrial depolarization,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,HDAC6,1
GO:0098903,BP,GO:0098903,regulation of membrane repolarization during action potential,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,CAV1,1
GO:0099159,BP,GO:0099159,regulation of modification of postsynaptic structure,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,RHOA,1
GO:0140719,BP,GO:0140719,constitutive heterochromatin formation,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,EZH2,1
GO:1900748,BP,GO:1900748,positive regulation of vascular endothelial growth factor signaling pathway,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,VEGFA,1
GO:1903010,BP,GO:1903010,regulation of bone development,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,KDR,1
GO:1903044,BP,GO:1903044,protein localization to membrane raft,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,CAV1,1
GO:1904338,BP,GO:1904338,regulation of dopaminergic neuron differentiation,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,FOXA1,1
GO:1990253,BP,GO:1990253,cellular response to leucine starvation,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,MTOR,1
GO:2000253,BP,GO:2000253,positive regulation of feeding behavior,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,MC1R,1
GO:2000625,BP,GO:2000625,regulation of miRNA catabolic process,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,MALAT1,1
GO:2000659,BP,GO:2000659,regulation of interleukin-1-mediated signaling pathway,1/269,10/18888,0.1,7.021561338,2.289341484,0.133659086,0.196182602,0.082267784,IL6,1
GO:0035023,BP,GO:0035023,regulation of Rho protein signal transduction,3/269,89/18888,0.033707865,2.366818429,1.553523794,0.133878047,0.196440703,0.082376017,ERBB2/CUL3/DLC1,3
GO:0001825,BP,GO:0001825,blastocyst formation,2/269,45/18888,0.044444444,3.120693928,1.711940554,0.134505841,0.196854677,0.082549614,HNF1B/CUL3,2
GO:0006739,BP,GO:0006739,NADP metabolic process,2/269,45/18888,0.044444444,3.120693928,1.711940554,0.134505841,0.196854677,0.082549614,TP53/MTOR,2
GO:0021587,BP,GO:0021587,cerebellum morphogenesis,2/269,45/18888,0.044444444,3.120693928,1.711940554,0.134505841,0.196854677,0.082549614,XRCC1/HSPA5,2
GO:0032309,BP,GO:0032309,icosanoid secretion,2/269,45/18888,0.044444444,3.120693928,1.711940554,0.134505841,0.196854677,0.082549614,PTGS2/IL1B,2
GO:0032480,BP,GO:0032480,negative regulation of type I interferon production,2/269,45/18888,0.044444444,3.120693928,1.711940554,0.134505841,0.196854677,0.082549614,IL10/CUL3,2
GO:0046636,BP,GO:0046636,negative regulation of alpha-beta T cell activation,2/269,45/18888,0.044444444,3.120693928,1.711940554,0.134505841,0.196854677,0.082549614,TWSG1/CD274,2
GO:0062237,BP,GO:0062237,protein localization to postsynapse,2/269,45/18888,0.044444444,3.120693928,1.711940554,0.134505841,0.196854677,0.082549614,ERBB2/HRAS,2
GO:1903573,BP,GO:1903573,negative regulation of response to endoplasmic reticulum stress,2/269,45/18888,0.044444444,3.120693928,1.711940554,0.134505841,0.196854677,0.082549614,HSPA5/CLU,2
GO:0034728,BP,GO:0034728,nucleosome organization,4/269,138/18888,0.028985507,2.035235171,1.467092103,0.134676973,0.19704184,0.082628099,ARID1A/SMARCA4/BRD2/SMARCE1,4
GO:0043269,BP,GO:0043269,regulation of monoatomic ion transport,10/269,470/18888,0.021276596,1.493949221,1.303435225,0.135618663,0.198355899,0.083179141,CTNNB1/PTGS2/AKT1/MMP9/CAV1/MIR200C/BAX/UCN/PER1/LRRC26,10
GO:0003009,BP,GO:0003009,skeletal muscle contraction,2/269,46/18888,0.043478261,3.052852756,1.675531783,0.139362731,0.203309831,0.085256537,TNF/HSP90AA1,2
GO:0007019,BP,GO:0007019,microtubule depolymerization,2/269,46/18888,0.043478261,3.052852756,1.675531783,0.139362731,0.203309831,0.085256537,HDAC6/KATNB1,2
GO:0030517,BP,GO:0030517,negative regulation of axon extension,2/269,46/18888,0.043478261,3.052852756,1.675531783,0.139362731,0.203309831,0.085256537,CDH1/HDAC6,2
GO:0046633,BP,GO:0046633,alpha-beta T cell proliferation,2/269,46/18888,0.043478261,3.052852756,1.675531783,0.139362731,0.203309831,0.085256537,TWSG1/CD274,2
GO:0050856,BP,GO:0050856,regulation of T cell receptor signaling pathway,2/269,46/18888,0.043478261,3.052852756,1.675531783,0.139362731,0.203309831,0.085256537,RELA/PAWR,2
GO:0140467,BP,GO:0140467,integrated stress response signaling,2/269,46/18888,0.043478261,3.052852756,1.675531783,0.139362731,0.203309831,0.085256537,FOS/HSPA5,2
GO:1902622,BP,GO:1902622,regulation of neutrophil migration,2/269,46/18888,0.043478261,3.052852756,1.675531783,0.139362731,0.203309831,0.085256537,CXCR2/MYD88,2
GO:2000516,BP,GO:2000516,"positive regulation of CD4-positive, alpha-beta T cell activation",2/269,46/18888,0.043478261,3.052852756,1.675531783,0.139362731,0.203309831,0.085256537,BRD2/BRD4,2
GO:0051924,BP,GO:0051924,regulation of calcium ion transport,6/269,247/18888,0.024291498,1.70564243,1.341769806,0.14200207,0.207093929,0.086843371,CTNNB1/PTGS2/CAV1/MIR200C/BAX/UCN,6
GO:0051262,BP,GO:0051262,protein tetramerization,3/269,92/18888,0.032608696,2.289639567,1.490421129,0.143700246,0.207290073,0.086925623,TP53/SOD2/TP63,3
GO:0106027,BP,GO:0106027,neuron projection organization,3/269,92/18888,0.032608696,2.289639567,1.490421129,0.143700246,0.207290073,0.086925623,PTEN/IGF1R/HDAC6,3
GO:1904063,BP,GO:1904063,negative regulation of cation transmembrane transport,3/269,92/18888,0.032608696,2.289639567,1.490421129,0.143700246,0.207290073,0.086925623,MMP9/CAV1/MIR200C,3
GO:0010824,BP,GO:0010824,regulation of centrosome duplication,2/269,47/18888,0.042553191,2.987898442,1.640101031,0.144257199,0.207290073,0.086925623,BRCA1/XRCC3,2
GO:0050732,BP,GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation,2/269,47/18888,0.042553191,2.987898442,1.640101031,0.144257199,0.207290073,0.086925623,PRKCD/CAV1,2
GO:1900271,BP,GO:1900271,regulation of long-term synaptic potentiation,2/269,47/18888,0.042553191,2.987898442,1.640101031,0.144257199,0.207290073,0.086925623,SQSTM1/MME,2
GO:1904262,BP,GO:1904262,negative regulation of TORC1 signaling,2/269,47/18888,0.042553191,2.987898442,1.640101031,0.144257199,0.207290073,0.086925623,VHL/NPRL2,2
GO:0001867,BP,GO:0001867,"complement activation, lectin pathway",1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,A2M,1
GO:0002423,BP,GO:0002423,natural killer cell mediated immune response to tumor cell,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,TGFB1,1
GO:0002604,BP,GO:0002604,regulation of dendritic cell antigen processing and presentation,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,THBS1,1
GO:0002759,BP,GO:0002759,regulation of antimicrobial humoral response,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,KLK3,1
GO:0003357,BP,GO:0003357,noradrenergic neuron differentiation,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,SOX11,1
GO:0006678,BP,GO:0006678,glucosylceramide metabolic process,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,PRKCD,1
GO:0007406,BP,GO:0007406,negative regulation of neuroblast proliferation,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,TP53,1
GO:0008063,BP,GO:0008063,Toll signaling pathway,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,MYD88,1
GO:0008611,BP,GO:0008611,ether lipid biosynthetic process,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,FASN,1
GO:0010248,BP,GO:0010248,establishment or maintenance of transmembrane electrochemical gradient,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,BAX,1
GO:0010887,BP,GO:0010887,negative regulation of cholesterol storage,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,PPARG,1
GO:0019065,BP,GO:0019065,receptor-mediated endocytosis of virus by host cell,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,CAV1,1
GO:0021603,BP,GO:0021603,cranial nerve formation,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,TFAP2A,1
GO:0021903,BP,GO:0021903,rostrocaudal neural tube patterning,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,BMI1,1
GO:0022605,BP,GO:0022605,mammalian oogenesis stage,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,AKT1,1
GO:0031915,BP,GO:0031915,positive regulation of synaptic plasticity,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,PTGS2,1
GO:0032060,BP,GO:0032060,bleb assembly,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,ROCK1,1
GO:0032754,BP,GO:0032754,positive regulation of interleukin-5 production,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,GATA3,1
GO:0032836,BP,GO:0032836,glomerular basement membrane development,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,WT1,1
GO:0034115,BP,GO:0034115,negative regulation of heterotypic cell-cell adhesion,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,IL10,1
GO:0034350,BP,GO:0034350,regulation of glial cell apoptotic process,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,PRKCD,1
GO:0034975,BP,GO:0034975,protein folding in endoplasmic reticulum,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,HSPA5,1
GO:0035723,BP,GO:0035723,interleukin-15-mediated signaling pathway,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,STAT3,1
GO:0036462,BP,GO:0036462,TRAIL-activated apoptotic signaling pathway,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,CASP8,1
GO:0038183,BP,GO:0038183,bile acid signaling pathway,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,VDR,1
GO:0042118,BP,GO:0042118,endothelial cell activation,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,TGFBR1,1
GO:0044848,BP,GO:0044848,biological phase,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,CTNNB1,1
GO:0045141,BP,GO:0045141,meiotic telomere clustering,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,MLH1,1
GO:0045602,BP,GO:0045602,negative regulation of endothelial cell differentiation,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,VEGFA,1
GO:0046477,BP,GO:0046477,glycosylceramide catabolic process,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,PRKCD,1
GO:0046504,BP,GO:0046504,glycerol ether biosynthetic process,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,FASN,1
GO:0046689,BP,GO:0046689,response to mercury ion,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,BSG,1
GO:0048262,BP,GO:0048262,determination of dorsal/ventral asymmetry,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,CTNNB1,1
GO:0048630,BP,GO:0048630,skeletal muscle tissue growth,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,IGF2,1
GO:0051561,BP,GO:0051561,positive regulation of mitochondrial calcium ion concentration,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,BNIP3,1
GO:0051593,BP,GO:0051593,response to folic acid,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,GPX1,1
GO:0060081,BP,GO:0060081,membrane hyperpolarization,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,SOD2,1
GO:0060159,BP,GO:0060159,regulation of dopamine receptor signaling pathway,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,ALK,1
GO:0060272,BP,GO:0060272,embryonic skeletal joint morphogenesis,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,CTNNB1,1
GO:0060433,BP,GO:0060433,bronchus development,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,SPDEF,1
GO:0060746,BP,GO:0060746,parental behavior,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,ZFX,1
GO:0061140,BP,GO:0061140,lung secretory cell differentiation,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,SPDEF,1
GO:0070213,BP,GO:0070213,protein auto-ADP-ribosylation,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,PARP1,1
GO:0070587,BP,GO:0070587,regulation of cell-cell adhesion involved in gastrulation,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,IL10,1
GO:0070601,BP,GO:0070601,centromeric sister chromatid cohesion,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,CTNNB1,1
GO:0070669,BP,GO:0070669,response to interleukin-2,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,STAT3,1
GO:0070934,BP,GO:0070934,CRD-mediated mRNA stabilization,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,YBX1,1
GO:0070944,BP,GO:0070944,neutrophil-mediated killing of bacterium,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,MYD88,1
GO:0071350,BP,GO:0071350,cellular response to interleukin-15,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,STAT3,1
GO:0071476,BP,GO:0071476,cellular hypotonic response,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,FBP1,1
GO:0071481,BP,GO:0071481,cellular response to X-ray,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,GATA3,1
GO:0071609,BP,GO:0071609,chemokine (C-C motif) ligand 5 production,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,IL10,1
GO:0071635,BP,GO:0071635,negative regulation of transforming growth factor beta production,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,FN1,1
GO:0071649,BP,GO:0071649,regulation of chemokine (C-C motif) ligand 5 production,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,IL10,1
GO:0072124,BP,GO:0072124,regulation of glomerular mesangial cell proliferation,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,WT1,1
GO:0086100,BP,GO:0086100,endothelin receptor signaling pathway,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,EDNRB,1
GO:0090220,BP,GO:0090220,chromosome localization to nuclear envelope involved in homologous chromosome segregation,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,MLH1,1
GO:0090394,BP,GO:0090394,negative regulation of excitatory postsynaptic potential,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,PTEN,1
GO:0090657,BP,GO:0090657,telomeric loop disassembly,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,XRCC3,1
GO:0097400,BP,GO:0097400,interleukin-17-mediated signaling pathway,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,NOTCH1,1
GO:0098696,BP,GO:0098696,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,HRAS,1
GO:0098885,BP,GO:0098885,modification of postsynaptic actin cytoskeleton,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,RHOA,1
GO:1900222,BP,GO:1900222,negative regulation of amyloid-beta clearance,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,TNF,1
GO:1901535,BP,GO:1901535,regulation of DNA demethylation,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,GATA3,1
GO:1901731,BP,GO:1901731,positive regulation of platelet aggregation,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,IL6,1
GO:1901844,BP,GO:1901844,regulation of cell communication by electrical coupling involved in cardiac conduction,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,CAV1,1
GO:1903897,BP,GO:1903897,regulation of PERK-mediated unfolded protein response,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,HSPA5,1
GO:1904238,BP,GO:1904238,pericyte cell differentiation,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,NOTCH1,1
GO:1904464,BP,GO:1904464,regulation of matrix metallopeptidase secretion,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,TLR4,1
GO:1905049,BP,GO:1905049,negative regulation of metallopeptidase activity,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,TIMP1,1
GO:1990773,BP,GO:1990773,matrix metallopeptidase secretion,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,TLR4,1
GO:2000049,BP,GO:2000049,positive regulation of cell-cell adhesion mediated by cadherin,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,FOXA1,1
GO:2000109,BP,GO:2000109,regulation of macrophage apoptotic process,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,CDKN2A,1
GO:2000169,BP,GO:2000169,regulation of peptidyl-cysteine S-nitrosylation,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,TXN,1
GO:2000392,BP,GO:2000392,regulation of lamellipodium morphogenesis,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,CD44,1
GO:2000727,BP,GO:2000727,positive regulation of cardiac muscle cell differentiation,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,TGFB1,1
GO:2001204,BP,GO:2001204,regulation of osteoclast development,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,FBXW7,1
GO:2001223,BP,GO:2001223,negative regulation of neuron migration,1/269,11/18888,0.090909091,6.38323758,2.146608556,0.146003917,0.207290073,0.086925623,STAT3,1
GO:0045132,BP,GO:0045132,meiotic chromosome segregation,3/269,93/18888,0.032258065,2.265019787,1.46993145,0.147026315,0.208611614,0.087479802,PTEN/AURKA/MLH1,3
GO:0051899,BP,GO:0051899,membrane depolarization,3/269,93/18888,0.032258065,2.265019787,1.46993145,0.147026315,0.208611614,0.087479802,PARP1/CAV1/KDR,3
GO:0009582,BP,GO:0009582,detection of abiotic stimulus,4/269,143/18888,0.027972028,1.964073102,1.390960241,0.147575779,0.209260892,0.087752072,CTNNB1/TNF/PTK2/TAC1,4
GO:0060972,BP,GO:0060972,left/right pattern formation,4/269,143/18888,0.027972028,1.964073102,1.390960241,0.147575779,0.209260892,0.087752072,NOTCH1/HIF1A/SMAD3/SNAI1,4
GO:0003254,BP,GO:0003254,regulation of membrane depolarization,2/269,48/18888,0.041666667,2.925650558,1.605599053,0.1491872,0.211020454,0.088489932,PARP1/KDR,2
GO:0006623,BP,GO:0006623,protein targeting to vacuole,2/269,48/18888,0.041666667,2.925650558,1.605599053,0.1491872,0.211020454,0.088489932,SQSTM1/CLU,2
GO:0007520,BP,GO:0007520,myoblast fusion,2/269,48/18888,0.041666667,2.925650558,1.605599053,0.1491872,0.211020454,0.088489932,MAPK14/CD9,2
GO:0042596,BP,GO:0042596,fear response,2/269,48/18888,0.041666667,2.925650558,1.605599053,0.1491872,0.211020454,0.088489932,GRPR/UCN,2
GO:0046189,BP,GO:0046189,phenol-containing compound biosynthetic process,2/269,48/18888,0.041666667,2.925650558,1.605599053,0.1491872,0.211020454,0.088489932,MC1R/GATA3,2
GO:0098534,BP,GO:0098534,centriole assembly,2/269,48/18888,0.041666667,2.925650558,1.605599053,0.1491872,0.211020454,0.088489932,BRCA1/CDK2,2
GO:1902116,BP,GO:1902116,negative regulation of organelle assembly,2/269,48/18888,0.041666667,2.925650558,1.605599053,0.1491872,0.211020454,0.088489932,BRCA1/AKT1,2
GO:2001222,BP,GO:2001222,regulation of neuron migration,2/269,48/18888,0.041666667,2.925650558,1.605599053,0.1491872,0.211020454,0.088489932,STAT3/DAB2IP,2
GO:0050848,BP,GO:0050848,regulation of calcium-mediated signaling,3/269,94/18888,0.031914894,2.240923831,1.449702523,0.150377377,0.212637905,0.089168199,MTOR/TNF/IGF1,3
GO:0043279,BP,GO:0043279,response to alkaloid,3/269,95/18888,0.031578947,2.217335159,1.429727812,0.153752828,0.217343433,0.091141429,CASP3/IGF1R/HSP90AA1,3
GO:0014075,BP,GO:0014075,response to amine,2/269,49/18888,0.040816327,2.865943403,1.571980079,0.15415074,0.217703276,0.091292326,HDAC6/MYD88,2
GO:0044788,BP,GO:0044788,modulation by host of viral process,2/269,49/18888,0.040816327,2.865943403,1.571980079,0.15415074,0.217703276,0.091292326,FASN/IFI27,2
GO:0045910,BP,GO:0045910,negative regulation of DNA recombination,2/269,49/18888,0.040816327,2.865943403,1.571980079,0.15415074,0.217703276,0.091292326,MLH1/MSH2,2
GO:0010977,BP,GO:0010977,negative regulation of neuron projection development,4/269,146/18888,0.02739726,1.923715435,1.346747308,0.155536676,0.217853118,0.091355161,PTEN/CDH1/HDAC6/VIM,4
GO:0031110,BP,GO:0031110,regulation of microtubule polymerization or depolymerization,3/269,96/18888,0.03125,2.194237918,1.410001015,0.157152065,0.217853118,0.091355161,HDAC6/KATNB1/GIT1,3
GO:0032410,BP,GO:0032410,negative regulation of transporter activity,3/269,96/18888,0.03125,2.194237918,1.410001015,0.157152065,0.217853118,0.091355161,MMP9/CAV1/MIR200C,3
GO:0001547,BP,GO:0001547,antral ovarian follicle growth,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,ESR1,1
GO:0001765,BP,GO:0001765,membrane raft assembly,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,CAV1,1
GO:0002328,BP,GO:0002328,pro-B cell differentiation,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,NOTCH1,1
GO:0002551,BP,GO:0002551,mast cell chemotaxis,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,VEGFA,1
GO:0002645,BP,GO:0002645,positive regulation of tolerance induction,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,CD274,1
GO:0002674,BP,GO:0002674,negative regulation of acute inflammatory response,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,GSTP1,1
GO:0003084,BP,GO:0003084,positive regulation of systemic arterial blood pressure,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,RHOA,1
GO:0003207,BP,GO:0003207,cardiac chamber formation,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,NOTCH1,1
GO:0006002,BP,GO:0006002,fructose 6-phosphate metabolic process,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,FBP1,1
GO:0010459,BP,GO:0010459,negative regulation of heart rate,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,TNF,1
GO:0010572,BP,GO:0010572,positive regulation of platelet activation,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,TLR4,1
GO:0010635,BP,GO:0010635,regulation of mitochondrial fusion,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,BNIP3,1
GO:0010739,BP,GO:0010739,positive regulation of protein kinase A signaling,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,MC1R,1
GO:0010752,BP,GO:0010752,regulation of cGMP-mediated signaling,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,THBS1,1
GO:0010826,BP,GO:0010826,negative regulation of centrosome duplication,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,BRCA1,1
GO:0014842,BP,GO:0014842,regulation of skeletal muscle satellite cell proliferation,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,FGF2,1
GO:0032782,BP,GO:0032782,bile acid secretion,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,TNF,1
GO:0033540,BP,GO:0033540,fatty acid beta-oxidation using acyl-CoA oxidase,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,AMACR,1
GO:0034058,BP,GO:0034058,endosomal vesicle fusion,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,SPHK1,1
GO:0034397,BP,GO:0034397,telomere localization,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,MLH1,1
GO:0035812,BP,GO:0035812,renal sodium excretion,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,EDNRB,1
GO:0036295,BP,GO:0036295,cellular response to increased oxygen levels,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,CAV1,1
GO:0040034,BP,GO:0040034,"regulation of development, heterochronic",1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,NOTCH1,1
GO:0042045,BP,GO:0042045,epithelial fluid transport,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,EDNRB,1
GO:0042117,BP,GO:0042117,monocyte activation,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,FN1,1
GO:0042532,BP,GO:0042532,negative regulation of tyrosine phosphorylation of STAT protein,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,CAV1,1
GO:0043589,BP,GO:0043589,skin morphogenesis,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,TP63,1
GO:0044857,BP,GO:0044857,plasma membrane raft organization,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,CAV1,1
GO:0045838,BP,GO:0045838,positive regulation of membrane potential,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,BID,1
GO:0045906,BP,GO:0045906,negative regulation of vasoconstriction,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,MMP2,1
GO:0046606,BP,GO:0046606,negative regulation of centrosome cycle,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,BRCA1,1
GO:0048484,BP,GO:0048484,enteric nervous system development,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,EDNRB,1
GO:0048505,BP,GO:0048505,regulation of timing of cell differentiation,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,NOTCH1,1
GO:0048548,BP,GO:0048548,regulation of pinocytosis,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,CAV1,1
GO:0050847,BP,GO:0050847,progesterone receptor signaling pathway,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,MAPK1,1
GO:0051451,BP,GO:0051451,myoblast migration,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,ROCK1,1
GO:0051798,BP,GO:0051798,positive regulation of hair follicle development,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,TNF,1
GO:0060148,BP,GO:0060148,positive regulation of post-transcriptional gene silencing,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,TGFB1,1
GO:0060312,BP,GO:0060312,regulation of blood vessel remodeling,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,TGFB1,1
GO:0060379,BP,GO:0060379,cardiac muscle cell myoblast differentiation,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,NOTCH1,1
GO:0060707,BP,GO:0060707,trophoblast giant cell differentiation,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,SNAI1,1
GO:0060788,BP,GO:0060788,ectodermal placode formation,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,CTNNB1,1
GO:0061303,BP,GO:0061303,cornea development in camera-type eye,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,SOX11,1
GO:0061309,BP,GO:0061309,cardiac neural crest cell development involved in outflow tract morphogenesis,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,TWIST1,1
GO:0070099,BP,GO:0070099,regulation of chemokine-mediated signaling pathway,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,HIF1A,1
GO:0070170,BP,GO:0070170,regulation of tooth mineralization,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,TFAP2A,1
GO:0070586,BP,GO:0070586,cell-cell adhesion involved in gastrulation,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,IL10,1
GO:0070672,BP,GO:0070672,response to interleukin-15,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,STAT3,1
GO:0070673,BP,GO:0070673,response to interleukin-18,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,AKT1,1
GO:0070857,BP,GO:0070857,regulation of bile acid biosynthetic process,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,FGFR4,1
GO:0070943,BP,GO:0070943,neutrophil-mediated killing of symbiont cell,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,MYD88,1
GO:0071233,BP,GO:0071233,cellular response to leucine,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,MTOR,1
GO:0071257,BP,GO:0071257,cellular response to electrical stimulus,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,PTEN,1
GO:0071697,BP,GO:0071697,ectodermal placode morphogenesis,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,CTNNB1,1
GO:0072017,BP,GO:0072017,distal tubule development,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,NOTCH1,1
GO:0072110,BP,GO:0072110,glomerular mesangial cell proliferation,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,WT1,1
GO:0072497,BP,GO:0072497,mesenchymal stem cell differentiation,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,CTNNB1,1
GO:0090267,BP,GO:0090267,positive regulation of mitotic cell cycle spindle assembly checkpoint,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,XRCC3,1
GO:0097264,BP,GO:0097264,self proteolysis,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,CASP8,1
GO:0097384,BP,GO:0097384,cellular lipid biosynthetic process,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,FASN,1
GO:0097475,BP,GO:0097475,motor neuron migration,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,VEGFA,1
GO:0098911,BP,GO:0098911,regulation of ventricular cardiac muscle cell action potential,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,CAV1,1
GO:0099004,BP,GO:0099004,calmodulin dependent kinase signaling pathway,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,CAMKK2,1
GO:1900121,BP,GO:1900121,negative regulation of receptor binding,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,IL10,1
GO:1900152,BP,GO:1900152,"negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,YBX1,1
GO:1900370,BP,GO:1900370,positive regulation of post-transcriptional gene silencing by RNA,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,TGFB1,1
GO:1901503,BP,GO:1901503,ether biosynthetic process,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,FASN,1
GO:1902093,BP,GO:1902093,positive regulation of flagellated sperm motility,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,DEFB1,1
GO:1903818,BP,GO:1903818,positive regulation of voltage-gated potassium channel activity,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,LRRC26,1
GO:1905205,BP,GO:1905205,positive regulation of connective tissue replacement,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,ROCK1,1
GO:1905456,BP,GO:1905456,regulation of lymphoid progenitor cell differentiation,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,NOTCH1,1
GO:1905651,BP,GO:1905651,regulation of artery morphogenesis,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,NOTCH1,1
GO:1905671,BP,GO:1905671,regulation of lysosome organization,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,MTOR,1
GO:2000155,BP,GO:2000155,positive regulation of cilium-dependent cell motility,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,DEFB1,1
GO:2000637,BP,GO:2000637,positive regulation of miRNA-mediated gene silencing,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,TGFB1,1
GO:2001214,BP,GO:2001214,positive regulation of vasculogenesis,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,KDR,1
GO:2001267,BP,GO:2001267,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,1/269,12/18888,0.083333333,5.851301115,2.02056732,0.158173485,0.217853118,0.091355161,MMP9,1
GO:0009799,BP,GO:0009799,specification of symmetry,4/269,147/18888,0.027210884,1.910628936,1.332242203,0.15822563,0.217853118,0.091355161,CTNNB1/NOTCH1/HIF1A/SMAD3,4
GO:0009855,BP,GO:0009855,determination of bilateral symmetry,4/269,147/18888,0.027210884,1.910628936,1.332242203,0.15822563,0.217853118,0.091355161,CTNNB1/NOTCH1/HIF1A/SMAD3,4
GO:0031333,BP,GO:0031333,negative regulation of protein-containing complex assembly,4/269,147/18888,0.027210884,1.910628936,1.332242203,0.15822563,0.217853118,0.091355161,HDAC6/PRKCD/HSPA5/CLU,4
GO:0032924,BP,GO:0032924,activin receptor signaling pathway,2/269,50/18888,0.04,2.808624535,1.539201501,0.159145874,0.219053959,0.091858725,TGFBR1/SMAD3,2
GO:0007032,BP,GO:0007032,endosome organization,3/269,97/18888,0.030927835,2.171616909,1.390516049,0.160574487,0.220886884,0.09262735,FASLG/RILP/SQSTM1,3
GO:0021675,BP,GO:0021675,nerve development,3/269,97/18888,0.030927835,2.171616909,1.390516049,0.160574487,0.220886884,0.09262735,CTNNB1/ILK/TFAP2A,3
GO:0008277,BP,GO:0008277,regulation of G protein-coupled receptor signaling pathway,4/269,149/18888,0.026845638,1.88498291,1.303569728,0.163654879,0.225056332,0.094375778,HIF1A/KLK14/GIT1/ROCK1,4
GO:0001974,BP,GO:0001974,blood vessel remodeling,2/269,51/18888,0.039215686,2.753553466,1.507223599,0.164170707,0.225289681,0.094473631,TGFB1/BAX,2
GO:0008206,BP,GO:0008206,bile acid metabolic process,2/269,51/18888,0.039215686,2.753553466,1.507223599,0.164170707,0.225289681,0.094473631,AMACR/FGFR4,2
GO:0010043,BP,GO:0010043,response to zinc ion,2/269,51/18888,0.039215686,2.753553466,1.507223599,0.164170707,0.225289681,0.094473631,PARP1/SOD2,2
GO:0039532,BP,GO:0039532,negative regulation of cytoplasmic pattern recognition receptor signaling pathway,2/269,51/18888,0.039215686,2.753553466,1.507223599,0.164170707,0.225289681,0.094473631,PARP1/AKT1,2
GO:0046850,BP,GO:0046850,regulation of bone remodeling,2/269,51/18888,0.039215686,2.753553466,1.507223599,0.164170707,0.225289681,0.094473631,IL6/EGFR,2
GO:0048286,BP,GO:0048286,lung alveolus development,2/269,51/18888,0.039215686,2.753553466,1.507223599,0.164170707,0.225289681,0.094473631,FOXA1/KDR,2
GO:0061097,BP,GO:0061097,regulation of protein tyrosine kinase activity,2/269,51/18888,0.039215686,2.753553466,1.507223599,0.164170707,0.225289681,0.094473631,FBXW7/CAV1,2
GO:0098739,BP,GO:0098739,import across plasma membrane,5/269,203/18888,0.024630542,1.729448605,1.255959457,0.164503191,0.225677971,0.094636458,THBS1/TNF/AKT1/MIR200C/SLC39A11,5
GO:0032271,BP,GO:0032271,regulation of protein polymerization,5/269,204/18888,0.024509804,1.720970916,1.24444972,0.166822744,0.228791216,0.095941975,TENM1/MTOR/PRKCD/GIT1/HSP90AA1,5
GO:0051588,BP,GO:0051588,regulation of neurotransmitter transport,3/269,99/18888,0.03030303,2.12774586,1.352248349,0.167486484,0.2293096,0.096159356,SNCG/GIT1/BRAF,3
GO:0060349,BP,GO:0060349,bone morphogenesis,3/269,99/18888,0.03030303,2.12774586,1.352248349,0.167486484,0.2293096,0.096159356,MMP14/TWIST1/TFAP2A,3
GO:0006968,BP,GO:0006968,cellular defense response,2/269,52/18888,0.038461538,2.700600515,1.476009291,0.169223389,0.2293096,0.096159356,CXCR2/RELA,2
GO:0021695,BP,GO:0021695,cerebellar cortex development,2/269,52/18888,0.038461538,2.700600515,1.476009291,0.169223389,0.2293096,0.096159356,EZH2/HSPA5,2
GO:0030838,BP,GO:0030838,positive regulation of actin filament polymerization,2/269,52/18888,0.038461538,2.700600515,1.476009291,0.169223389,0.2293096,0.096159356,TENM1/MTOR,2
GO:0042572,BP,GO:0042572,retinol metabolic process,2/269,52/18888,0.038461538,2.700600515,1.476009291,0.169223389,0.2293096,0.096159356,CYP1A1/AKR1C3,2
GO:0045332,BP,GO:0045332,phospholipid translocation,2/269,52/18888,0.038461538,2.700600515,1.476009291,0.169223389,0.2293096,0.096159356,FASLG/PRKCD,2
GO:0051646,BP,GO:0051646,mitochondrion localization,2/269,52/18888,0.038461538,2.700600515,1.476009291,0.169223389,0.2293096,0.096159356,HIF1A/HDAC6,2
GO:0070988,BP,GO:0070988,demethylation,2/269,52/18888,0.038461538,2.700600515,1.476009291,0.169223389,0.2293096,0.096159356,KDM1A/GATA3,2
GO:0002357,BP,GO:0002357,defense response to tumor cell,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,RELA,1
GO:0002863,BP,GO:0002863,positive regulation of inflammatory response to antigenic stimulus,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,TNF,1
GO:0003334,BP,GO:0003334,keratinocyte development,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,SFN,1
GO:0003353,BP,GO:0003353,positive regulation of cilium movement,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,DEFB1,1
GO:0006971,BP,GO:0006971,hypotonic response,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,FBP1,1
GO:0007144,BP,GO:0007144,female meiosis I,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,AURKA,1
GO:0007501,BP,GO:0007501,mesodermal cell fate specification,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,FGFR1,1
GO:0009415,BP,GO:0009415,response to water,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,PIK3CA,1
GO:0009812,BP,GO:0009812,flavonoid metabolic process,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,CYP1A1,1
GO:0010992,BP,GO:0010992,ubiquitin recycling,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,FBXW7,1
GO:0021559,BP,GO:0021559,trigeminal nerve development,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,TFAP2A,1
GO:0031453,BP,GO:0031453,positive regulation of heterochromatin formation,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,CDK2,1
GO:0032306,BP,GO:0032306,regulation of prostaglandin secretion,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,IL1B,1
GO:0032308,BP,GO:0032308,positive regulation of prostaglandin secretion,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,IL1B,1
GO:0032341,BP,GO:0032341,aldosterone metabolic process,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,EDNRB,1
GO:0032490,BP,GO:0032490,detection of molecule of bacterial origin,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,TLR4,1
GO:0032530,BP,GO:0032530,regulation of microvillus organization,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,FSCN1,1
GO:0033690,BP,GO:0033690,positive regulation of osteoblast proliferation,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,IGF1R,1
GO:0034086,BP,GO:0034086,maintenance of sister chromatid cohesion,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,RB1,1
GO:0034088,BP,GO:0034088,maintenance of mitotic sister chromatid cohesion,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,RB1,1
GO:0034139,BP,GO:0034139,regulation of toll-like receptor 3 signaling pathway,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,CAV1,1
GO:0034333,BP,GO:0034333,adherens junction assembly,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,CTNNB1,1
GO:0035437,BP,GO:0035437,maintenance of protein localization in endoplasmic reticulum,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,HSPA5,1
GO:0035810,BP,GO:0035810,positive regulation of urine volume,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,EDNRB,1
GO:0042670,BP,GO:0042670,retinal cone cell differentiation,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,NOTCH1,1
GO:0043508,BP,GO:0043508,negative regulation of JUN kinase activity,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,GSTP1,1
GO:0045916,BP,GO:0045916,negative regulation of complement activation,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,A2M,1
GO:0045986,BP,GO:0045986,negative regulation of smooth muscle contraction,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,PTGS2,1
GO:0048521,BP,GO:0048521,negative regulation of behavior,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,UCN,1
GO:0048711,BP,GO:0048711,positive regulation of astrocyte differentiation,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,NOTCH1,1
GO:0048853,BP,GO:0048853,forebrain morphogenesis,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,PTEN,1
GO:0051036,BP,GO:0051036,regulation of endosome size,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,RILP,1
GO:0051481,BP,GO:0051481,negative regulation of cytosolic calcium ion concentration,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,SMAD3,1
GO:0060134,BP,GO:0060134,prepulse inhibition,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,PTEN,1
GO:0060670,BP,GO:0060670,branching involved in labyrinthine layer morphogenesis,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,IL10,1
GO:0060911,BP,GO:0060911,cardiac cell fate commitment,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,WT1,1
GO:0070278,BP,GO:0070278,extracellular matrix constituent secretion,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,NOTCH1,1
GO:0070294,BP,GO:0070294,renal sodium ion absorption,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,EDNRB,1
GO:0070417,BP,GO:0070417,cellular response to cold,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,NFKBIA,1
GO:0071679,BP,GO:0071679,commissural neuron axon guidance,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,VEGFA,1
GO:0075509,BP,GO:0075509,endocytosis involved in viral entry into host cell,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,CAV1,1
GO:0090232,BP,GO:0090232,positive regulation of spindle checkpoint,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,XRCC3,1
GO:0097202,BP,GO:0097202,activation of cysteine-type endopeptidase activity,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,CASP8,1
GO:0106049,BP,GO:0106049,regulation of cellular response to osmotic stress,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,PTGS2,1
GO:0120263,BP,GO:0120263,positive regulation of heterochromatin organization,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,CDK2,1
GO:0140588,BP,GO:0140588,chromatin looping,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,BRD2,1
GO:1901526,BP,GO:1901526,positive regulation of mitophagy,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,HIF1A,1
GO:1904683,BP,GO:1904683,regulation of metalloendopeptidase activity,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,STAT3,1
GO:1905907,BP,GO:1905907,negative regulation of amyloid fibril formation,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,CLU,1
GO:1905939,BP,GO:1905939,regulation of gonad development,1/269,13/18888,0.076923077,5.401201029,1.908002134,0.170170271,0.2293096,0.096159356,WT1,1
GO:0000041,BP,GO:0000041,transition metal ion transport,3/269,100/18888,0.03,2.106468401,1.333454478,0.170974865,0.230121561,0.096499846,LMTK2/SLC39A9/SLC39A11,3
GO:0034766,BP,GO:0034766,negative regulation of monoatomic ion transmembrane transport,3/269,100/18888,0.03,2.106468401,1.333454478,0.170974865,0.230121561,0.096499846,MMP9/CAV1/MIR200C,3
GO:0035279,BP,GO:0035279,miRNA-mediated gene silencing by mRNA destabilization,3/269,100/18888,0.03,2.106468401,1.333454478,0.170974865,0.230121561,0.096499846,MIR200C/MIR145/MIR130B,3
GO:0051310,BP,GO:0051310,metaphase chromosome alignment,3/269,100/18888,0.03,2.106468401,1.333454478,0.170974865,0.230121561,0.096499846,CUL3/RB1/MLH1,3
GO:0032259,BP,GO:0032259,methylation,6/269,262/18888,0.022900763,1.607991146,1.191153018,0.171794369,0.231156274,0.096933745,PARP1/FOS/BMI1/EZH2/AKT1/WT1,6
GO:0045197,BP,GO:0045197,establishment or maintenance of epithelial cell apical/basal polarity,2/269,53/18888,0.037735849,2.649645788,1.445523909,0.174302117,0.23436005,0.098277226,RHOA/ILK,2
GO:0050850,BP,GO:0050850,positive regulation of calcium-mediated signaling,2/269,53/18888,0.037735849,2.649645788,1.445523909,0.174302117,0.23436005,0.098277226,TNF/IGF1,2
GO:0042632,BP,GO:0042632,cholesterol homeostasis,3/269,101/18888,0.02970297,2.085612279,1.314880153,0.174484041,0.23436005,0.098277226,CNBP/CAV1/FGFR4,3
GO:0043543,BP,GO:0043543,protein acylation,3/269,101/18888,0.02970297,2.085612279,1.314880153,0.174484041,0.23436005,0.098277226,HDAC6/SPHK1/CLOCK,3
GO:1990868,BP,GO:1990868,response to chemokine,3/269,101/18888,0.02970297,2.085612279,1.314880153,0.174484041,0.23436005,0.098277226,CXCR2/HIF1A/RHOA,3
GO:1990869,BP,GO:1990869,cellular response to chemokine,3/269,101/18888,0.02970297,2.085612279,1.314880153,0.174484041,0.23436005,0.098277226,CXCR2/HIF1A/RHOA,3
GO:0008064,BP,GO:0008064,regulation of actin polymerization or depolymerization,4/269,154/18888,0.025974026,1.823782166,1.233777774,0.177514562,0.238360255,0.099954684,PIK3CA/TENM1/MTOR/PRKCD,4
GO:0055092,BP,GO:0055092,sterol homeostasis,3/269,102/18888,0.029411765,2.065165099,1.296520265,0.17801342,0.238959676,0.100206047,CNBP/CAV1/FGFR4,3
GO:0021872,BP,GO:0021872,forebrain generation of neurons,2/269,54/18888,0.037037037,2.600578273,1.415734999,0.179405134,0.24006284,0.100668651,RHOA/FGFR1,2
GO:0050805,BP,GO:0050805,negative regulation of synaptic transmission,2/269,54/18888,0.037037037,2.600578273,1.415734999,0.179405134,0.24006284,0.100668651,PTGS2/IL1B,2
GO:0071385,BP,GO:0071385,cellular response to glucocorticoid stimulus,2/269,54/18888,0.037037037,2.600578273,1.415734999,0.179405134,0.24006284,0.100668651,IGF1R/EGFR,2
GO:0001833,BP,GO:0001833,inner cell mass cell proliferation,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,BRCA2,1
GO:0001976,BP,GO:0001976,nervous system process involved in regulation of systemic arterial blood pressure,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,SOD2,1
GO:0006000,BP,GO:0006000,fructose metabolic process,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,FBP1,1
GO:0006287,BP,GO:0006287,"base-excision repair, gap-filling",1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,PCNA,1
GO:0006361,BP,GO:0006361,transcription initiation at RNA polymerase I promoter,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,SMARCA4,1
GO:0007100,BP,GO:0007100,mitotic centrosome separation,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,AURKA,1
GO:0007194,BP,GO:0007194,negative regulation of adenylate cyclase activity,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,EDNRB,1
GO:0007250,BP,GO:0007250,activation of NF-kappaB-inducing kinase activity,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,MAP3K7,1
GO:0007638,BP,GO:0007638,mechanosensory behavior,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,ETV1,1
GO:0008212,BP,GO:0008212,mineralocorticoid metabolic process,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,EDNRB,1
GO:0009950,BP,GO:0009950,dorsal/ventral axis specification,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,CTNNB1,1
GO:0021534,BP,GO:0021534,cell proliferation in hindbrain,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,FGF2,1
GO:0021924,BP,GO:0021924,cell proliferation in external granule layer,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,FGF2,1
GO:0021930,BP,GO:0021930,cerebellar granule cell precursor proliferation,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,FGF2,1
GO:0030238,BP,GO:0030238,male sex determination,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,AR,1
GO:0032095,BP,GO:0032095,regulation of response to food,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,UCN,1
GO:0032736,BP,GO:0032736,positive regulation of interleukin-13 production,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,GATA3,1
GO:0032908,BP,GO:0032908,regulation of transforming growth factor beta1 production,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,THBS1,1
GO:0033262,BP,GO:0033262,regulation of nuclear cell cycle DNA replication,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,FGFR1,1
GO:0035331,BP,GO:0035331,negative regulation of hippo signaling,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,MAPK14,1
GO:0035630,BP,GO:0035630,bone mineralization involved in bone maturation,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,IGF1,1
GO:0035791,BP,GO:0035791,platelet-derived growth factor receptor-beta signaling pathway,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,PDGFRL,1
GO:0035973,BP,GO:0035973,aggrephagy,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,SQSTM1,1
GO:0042541,BP,GO:0042541,hemoglobin biosynthetic process,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,HIF1A,1
GO:0042762,BP,GO:0042762,regulation of sulfur metabolic process,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,CTNNB1,1
GO:0046322,BP,GO:0046322,negative regulation of fatty acid oxidation,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,AKT1,1
GO:0046512,BP,GO:0046512,sphingosine biosynthetic process,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,SPHK1,1
GO:0046520,BP,GO:0046520,sphingoid biosynthetic process,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,SPHK1,1
GO:0046598,BP,GO:0046598,positive regulation of viral entry into host cell,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,TMPRSS2,1
GO:0048388,BP,GO:0048388,endosomal lumen acidification,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,FASLG,1
GO:0050930,BP,GO:0050930,induction of positive chemotaxis,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,VEGFA,1
GO:0051775,BP,GO:0051775,response to redox state,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,CLOCK,1
GO:0060354,BP,GO:0060354,negative regulation of cell adhesion molecule production,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,NOTCH1,1
GO:0061000,BP,GO:0061000,negative regulation of dendritic spine development,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,PTEN,1
GO:0061469,BP,GO:0061469,regulation of type B pancreatic cell proliferation,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,CDK4,1
GO:0061635,BP,GO:0061635,regulation of protein complex stability,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,SQSTM1,1
GO:0070307,BP,GO:0070307,lens fiber cell development,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,VIM,1
GO:0070365,BP,GO:0070365,hepatocyte differentiation,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,CYP1A1,1
GO:0070942,BP,GO:0070942,neutrophil mediated cytotoxicity,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,MYD88,1
GO:0070986,BP,GO:0070986,left/right axis specification,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,NOTCH1,1
GO:0071285,BP,GO:0071285,cellular response to lithium ion,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,CDH1,1
GO:0071361,BP,GO:0071361,cellular response to ethanol,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,SOD2,1
GO:0071472,BP,GO:0071472,cellular response to salt stress,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,FBP1,1
GO:0071696,BP,GO:0071696,ectodermal placode development,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,CTNNB1,1
GO:0071888,BP,GO:0071888,macrophage apoptotic process,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,CDKN2A,1
GO:0075294,BP,GO:0075294,positive regulation by symbiont of entry into host,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,TMPRSS2,1
GO:0085020,BP,GO:0085020,protein K6-linked ubiquitination,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,BRCA1,1
GO:0098761,BP,GO:0098761,cellular response to interleukin-7,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,YBX1,1
GO:1900426,BP,GO:1900426,positive regulation of defense response to bacterium,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,KLK3,1
GO:1903727,BP,GO:1903727,positive regulation of phospholipid metabolic process,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,PRKCD,1
GO:1904925,BP,GO:1904925,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,HDAC6,1
GO:1905208,BP,GO:1905208,negative regulation of cardiocyte differentiation,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,EGFR,1
GO:1905244,BP,GO:1905244,regulation of modification of synaptic structure,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,RHOA,1
GO:1905269,BP,GO:1905269,positive regulation of chromatin organization,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,CDK2,1
GO:1905522,BP,GO:1905522,negative regulation of macrophage migration,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,CYP19A1,1
GO:1905664,BP,GO:1905664,regulation of calcium ion import across plasma membrane,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,MIR200C,1
GO:2001140,BP,GO:2001140,positive regulation of phospholipid transport,1/269,14/18888,0.071428571,5.015400956,1.806510186,0.181996719,0.24006284,0.100668651,FASLG,1
GO:0043270,BP,GO:0043270,positive regulation of monoatomic ion transport,5/269,211/18888,0.023696682,1.663877094,1.165614139,0.18341358,0.241861728,0.101423002,AKT1/CAV1/BAX/UCN/LRRC26,5
GO:0002686,BP,GO:0002686,negative regulation of leukocyte migration,2/269,55/18888,0.036363636,2.553295032,1.386612143,0.184530726,0.243123767,0.101952229,AKT1/CYP19A1,2
GO:0007140,BP,GO:0007140,male meiotic nuclear division,2/269,55/18888,0.036363636,2.553295032,1.386612143,0.184530726,0.243123767,0.101952229,BRCA2/MLH1,2
GO:0097479,BP,GO:0097479,synaptic vesicle localization,2/269,55/18888,0.036363636,2.553295032,1.386612143,0.184530726,0.243123767,0.101952229,PTEN/CTNNB1,2
GO:0002027,BP,GO:0002027,regulation of heart rate,3/269,104/18888,0.028846154,2.025450386,1.260424212,0.185130433,0.243843381,0.102253994,EDNRB/TNF/CAV1,3
GO:0030832,BP,GO:0030832,regulation of actin filament length,4/269,157/18888,0.025477707,1.788932825,1.193132909,0.186015668,0.24493855,0.102713245,PIK3CA/TENM1/MTOR/PRKCD,4
GO:0006885,BP,GO:0006885,regulation of pH,3/269,105/18888,0.028571429,2.006160382,1.242678651,0.188716898,0.248423631,0.104174689,EDNRB/FASLG/MAPK1,3
GO:0002455,BP,GO:0002455,humoral immune response mediated by circulating immunoglobulin,2/269,56/18888,0.035714286,2.507700478,1.358126794,0.189677224,0.249399548,0.104583933,TNF/CLU,2
GO:0034204,BP,GO:0034204,lipid translocation,2/269,56/18888,0.035714286,2.507700478,1.358126794,0.189677224,0.249399548,0.104583933,FASLG/PRKCD,2
GO:0052372,BP,GO:0052372,modulation by symbiont of entry into host,2/269,56/18888,0.035714286,2.507700478,1.358126794,0.189677224,0.249399548,0.104583933,TMPRSS2/CAV1,2
GO:1901016,BP,GO:1901016,regulation of potassium ion transmembrane transporter activity,2/269,56/18888,0.035714286,2.507700478,1.358126794,0.189677224,0.249399548,0.104583933,CAV1/LRRC26,2
GO:0042472,BP,GO:0042472,inner ear morphogenesis,3/269,106/18888,0.028301887,1.987234341,1.225128725,0.192321225,0.25093665,0.105228506,GATA3/FGFR1/TFAP2A,3
GO:0006271,BP,GO:0006271,DNA strand elongation involved in DNA replication,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,PCNA,1
GO:0006620,BP,GO:0006620,post-translational protein targeting to endoplasmic reticulum membrane,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,HSPA5,1
GO:0007008,BP,GO:0007008,outer mitochondrial membrane organization,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,HSP90AA1,1
GO:0009048,BP,GO:0009048,dosage compensation by inactivation of X chromosome,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,BRCA1,1
GO:0009404,BP,GO:0009404,toxin metabolic process,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,CYP1A1,1
GO:0010457,BP,GO:0010457,centriole-centriole cohesion,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,CTNNB1,1
GO:0010649,BP,GO:0010649,regulation of cell communication by electrical coupling,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,CAV1,1
GO:0010838,BP,GO:0010838,positive regulation of keratinocyte proliferation,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,TP63,1
GO:0010889,BP,GO:0010889,regulation of sequestering of triglyceride,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,PPARG,1
GO:0031280,BP,GO:0031280,negative regulation of cyclase activity,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,EDNRB,1
GO:0032725,BP,GO:0032725,positive regulation of granulocyte macrophage colony-stimulating factor production,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,IL1B,1
GO:0032933,BP,GO:0032933,SREBP signaling pathway,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,FBXW7,1
GO:0033189,BP,GO:0033189,response to vitamin A,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,CYP1A1,1
GO:0033689,BP,GO:0033689,negative regulation of osteoblast proliferation,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,SMAD3,1
GO:0034310,BP,GO:0034310,primary alcohol catabolic process,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,AKR1C3,1
GO:0042415,BP,GO:0042415,norepinephrine metabolic process,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,GATA3,1
GO:0043652,BP,GO:0043652,engulfment of apoptotic cell,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,THBS1,1
GO:0045040,BP,GO:0045040,protein insertion into mitochondrial outer membrane,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,HSP90AA1,1
GO:0045176,BP,GO:0045176,apical protein localization,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,MAL,1
GO:0045187,BP,GO:0045187,"regulation of circadian sleep/wake cycle, sleep",1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,PARP1,1
GO:0045472,BP,GO:0045472,response to ether,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,CDK4,1
GO:0048070,BP,GO:0048070,regulation of developmental pigmentation,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,BAX,1
GO:0048308,BP,GO:0048308,organelle inheritance,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,MAPK1,1
GO:0048313,BP,GO:0048313,Golgi inheritance,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,MAPK1,1
GO:0048820,BP,GO:0048820,hair follicle maturation,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,CTNNB1,1
GO:0048934,BP,GO:0048934,peripheral nervous system neuron differentiation,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,ETV1,1
GO:0048935,BP,GO:0048935,peripheral nervous system neuron development,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,ETV1,1
GO:0050966,BP,GO:0050966,detection of mechanical stimulus involved in sensory perception of pain,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,TNF,1
GO:0051299,BP,GO:0051299,centrosome separation,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,AURKA,1
GO:0055057,BP,GO:0055057,neuroblast division,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,FGFR1,1
GO:0060766,BP,GO:0060766,negative regulation of androgen receptor signaling pathway,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,SMARCA4,1
GO:0070341,BP,GO:0070341,fat cell proliferation,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,SQSTM1,1
GO:0070424,BP,GO:0070424,"regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway",1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,TLR4,1
GO:0070885,BP,GO:0070885,negative regulation of calcineurin-NFAT signaling cascade,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,MTOR,1
GO:0071599,BP,GO:0071599,otic vesicle development,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,GATA3,1
GO:0072044,BP,GO:0072044,collecting duct development,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,NOTCH1,1
GO:0072498,BP,GO:0072498,embryonic skeletal joint development,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,CTNNB1,1
GO:0072537,BP,GO:0072537,fibroblast activation,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,MYB,1
GO:0090030,BP,GO:0090030,regulation of steroid hormone biosynthetic process,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,IGF1R,1
GO:0097531,BP,GO:0097531,mast cell migration,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,VEGFA,1
GO:0098760,BP,GO:0098760,response to interleukin-7,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,YBX1,1
GO:0106057,BP,GO:0106057,negative regulation of calcineurin-mediated signaling,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,MTOR,1
GO:1900029,BP,GO:1900029,positive regulation of ruffle assembly,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,HRAS,1
GO:1900102,BP,GO:1900102,negative regulation of endoplasmic reticulum unfolded protein response,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,HSPA5,1
GO:1901298,BP,GO:1901298,regulation of hydrogen peroxide-mediated programmed cell death,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,PAWR,1
GO:1901386,BP,GO:1901386,negative regulation of voltage-gated calcium channel activity,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,MIR200C,1
GO:1901741,BP,GO:1901741,positive regulation of myoblast fusion,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,MAPK14,1
GO:1904251,BP,GO:1904251,regulation of bile acid metabolic process,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,FGFR4,1
GO:1904923,BP,GO:1904923,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,HDAC6,1
GO:2000402,BP,GO:2000402,negative regulation of lymphocyte migration,1/269,15/18888,0.066666667,4.681040892,1.714254333,0.193655238,0.25093665,0.105228506,AKT1,1
GO:0060632,BP,GO:0060632,regulation of microtubule-based movement,2/269,57/18888,0.035087719,2.463705733,1.330252134,0.194843001,0.252260504,0.105783655,DEFB1/HDAC6,2
GO:0060997,BP,GO:0060997,dendritic spine morphogenesis,2/269,57/18888,0.035087719,2.463705733,1.330252134,0.194843001,0.252260504,0.105783655,PTEN/HDAC6,2
GO:2000107,BP,GO:2000107,negative regulation of leukocyte apoptotic process,2/269,57/18888,0.035087719,2.463705733,1.330252134,0.194843001,0.252260504,0.105783655,CXCR2/HIF1A,2
GO:0030593,BP,GO:0030593,neutrophil chemotaxis,3/269,107/18888,0.028037383,1.968662057,1.207770104,0.195942839,0.253612379,0.106350554,CXCR2/IL1B/BSG,3
GO:0006643,BP,GO:0006643,membrane lipid metabolic process,5/269,217/18888,0.023041475,1.617871276,1.100331479,0.198097734,0.256328678,0.107489615,PRKCD/TNF/BAX/SGPL1/SPHK1,5
GO:0006641,BP,GO:0006641,triglyceride metabolic process,3/269,108/18888,0.027777778,1.950433705,1.190598599,0.199581165,0.25817484,0.10826379,FBXW7/GPX1/CAV1,3
GO:0048168,BP,GO:0048168,regulation of neuronal synaptic plasticity,2/269,58/18888,0.034482759,2.421228048,1.302962932,0.200026472,0.258530668,0.108413004,KRAS/HRAS,2
GO:0051339,BP,GO:0051339,regulation of lyase activity,2/269,58/18888,0.034482759,2.421228048,1.302962932,0.200026472,0.258530668,0.108413004,EDNRB/LGR4,2
GO:0099024,BP,GO:0099024,plasma membrane invagination,2/269,58/18888,0.034482759,2.421228048,1.302962932,0.200026472,0.258530668,0.108413004,THBS1/RHOA,2
GO:0070588,BP,GO:0070588,calcium ion transmembrane transport,7/269,334/18888,0.020958084,1.471584712,1.045186108,0.200381565,0.258916168,0.10857466,EDNRB/FASLG/FGF2/CAV1/MIR200C/BAX/TMEM37,7
GO:0002468,BP,GO:0002468,dendritic cell antigen processing and presentation,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,THBS1,1
GO:0002836,BP,GO:0002836,positive regulation of response to tumor cell,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,CD274,1
GO:0002839,BP,GO:0002839,positive regulation of immune response to tumor cell,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,CD274,1
GO:0003096,BP,GO:0003096,renal sodium ion transport,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,EDNRB,1
GO:0003214,BP,GO:0003214,cardiac left ventricle morphogenesis,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,NOTCH1,1
GO:0006266,BP,GO:0006266,DNA ligation,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,XRCC1,1
GO:0006704,BP,GO:0006704,glucocorticoid biosynthetic process,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,CYP17A1,1
GO:0010226,BP,GO:0010226,response to lithium ion,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,CDH1,1
GO:0010832,BP,GO:0010832,negative regulation of myotube differentiation,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,NOTCH1,1
GO:0010958,BP,GO:0010958,regulation of amino acid import across plasma membrane,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,TNF,1
GO:0014857,BP,GO:0014857,regulation of skeletal muscle cell proliferation,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,FGF2,1
GO:0017014,BP,GO:0017014,protein nitrosylation,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,TXN,1
GO:0018119,BP,GO:0018119,peptidyl-cysteine S-nitrosylation,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,TXN,1
GO:0021904,BP,GO:0021904,dorsal/ventral neural tube patterning,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,FOXA1,1
GO:0030033,BP,GO:0030033,microvillus assembly,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,FSCN1,1
GO:0030242,BP,GO:0030242,autophagy of peroxisome,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,SQSTM1,1
GO:0030728,BP,GO:0030728,ovulation,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,MMP2,1
GO:0031645,BP,GO:0031645,negative regulation of nervous system process,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,TNF,1
GO:0034112,BP,GO:0034112,positive regulation of homotypic cell-cell adhesion,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,IL6,1
GO:0035435,BP,GO:0035435,phosphate ion transmembrane transport,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,VDR,1
GO:0042795,BP,GO:0042795,snRNA transcription by RNA polymerase II,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,ELL2,1
GO:0043517,BP,GO:0043517,"positive regulation of DNA damage response, signal transduction by p53 class mediator",1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,PMAIP1,1
GO:0045779,BP,GO:0045779,negative regulation of bone resorption,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,IL6,1
GO:0046325,BP,GO:0046325,negative regulation of glucose import,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,TNF,1
GO:0047484,BP,GO:0047484,regulation of response to osmotic stress,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,PTGS2,1
GO:0048712,BP,GO:0048712,negative regulation of astrocyte differentiation,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,ID4,1
GO:0050802,BP,GO:0050802,"circadian sleep/wake cycle, sleep",1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,PARP1,1
GO:0051956,BP,GO:0051956,negative regulation of amino acid transport,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,TNF,1
GO:0060856,BP,GO:0060856,establishment of blood-brain barrier,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,CTNNB1,1
GO:0071380,BP,GO:0071380,cellular response to prostaglandin E stimulus,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,AKT1,1
GO:0071501,BP,GO:0071501,cellular response to sterol depletion,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,FBXW7,1
GO:0072378,BP,GO:0072378,"blood coagulation, fibrin clot formation",1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,THBD,1
GO:0072520,BP,GO:0072520,seminiferous tubule development,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,AR,1
GO:1900034,BP,GO:1900034,regulation of cellular response to heat,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,MTOR,1
GO:1901142,BP,GO:1901142,insulin metabolic process,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,PCSK1,1
GO:1903358,BP,GO:1903358,regulation of Golgi organization,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,MAPK1,1
GO:1903789,BP,GO:1903789,regulation of amino acid transmembrane transport,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,TNF,1
GO:1904948,BP,GO:1904948,midbrain dopaminergic neuron differentiation,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,CTNNB1,1
GO:2001212,BP,GO:2001212,regulation of vasculogenesis,1/269,16/18888,0.0625,4.388475836,1.629802106,0.205148203,0.261907585,0.10982909,KDR,1
GO:0031122,BP,GO:0031122,cytoplasmic microtubule organization,2/269,59/18888,0.033898305,2.380190284,1.276235433,0.205226092,0.261907585,0.10982909,RHOA/KATNB1,2
GO:0032608,BP,GO:0032608,interferon-beta production,2/269,59/18888,0.033898305,2.380190284,1.276235433,0.205226092,0.261907585,0.10982909,TLR4/HSP90AA1,2
GO:0032648,BP,GO:0032648,regulation of interferon-beta production,2/269,59/18888,0.033898305,2.380190284,1.276235433,0.205226092,0.261907585,0.10982909,TLR4/HSP90AA1,2
GO:0051932,BP,GO:0051932,"synaptic transmission, GABAergic",2/269,59/18888,0.033898305,2.380190284,1.276235433,0.205226092,0.261907585,0.10982909,KRAS/EZH2,2
GO:0098900,BP,GO:0098900,regulation of action potential,2/269,59/18888,0.033898305,2.380190284,1.276235433,0.205226092,0.261907585,0.10982909,TNF/CAV1,2
GO:0001961,BP,GO:0001961,positive regulation of cytokine-mediated signaling pathway,2/269,60/18888,0.033333333,2.340520446,1.250047244,0.210440358,0.268411611,0.112556507,HIF1A/MED1,2
GO:0061462,BP,GO:0061462,protein localization to lysosome,2/269,60/18888,0.033333333,2.340520446,1.250047244,0.210440358,0.268411611,0.112556507,AKT1/CLU,2
GO:0006672,BP,GO:0006672,ceramide metabolic process,3/269,111/18888,0.027027027,1.897719281,1.140166806,0.210590733,0.2684531,0.112573905,PRKCD/SGPL1/SPHK1,3
GO:0090277,BP,GO:0090277,positive regulation of peptide hormone secretion,3/269,111/18888,0.027027027,1.897719281,1.140166806,0.210590733,0.2684531,0.112573905,HIF1A/EGFR/UCN,3
GO:0051303,BP,GO:0051303,establishment of chromosome localization,3/269,112/18888,0.026785714,1.880775358,1.123704404,0.214290244,0.2730547,0.114503554,CUL3/RB1/MLH1,3
GO:0006665,BP,GO:0006665,sphingolipid metabolic process,4/269,167/18888,0.023952096,1.681811099,1.063744273,0.215245863,0.2730547,0.114503554,PRKCD/BAX/SGPL1/SPHK1,4
GO:0001738,BP,GO:0001738,morphogenesis of a polarized epithelium,2/269,61/18888,0.032786885,2.302151258,1.224377233,0.215667805,0.2730547,0.114503554,RHOA/TP63,2
GO:0071709,BP,GO:0071709,membrane assembly,2/269,61/18888,0.032786885,2.302151258,1.224377233,0.215667805,0.2730547,0.114503554,PTEN/CAV1,2
GO:0097035,BP,GO:0097035,regulation of membrane lipid distribution,2/269,61/18888,0.032786885,2.302151258,1.224377233,0.215667805,0.2730547,0.114503554,FASLG/PRKCD,2
GO:0000712,BP,GO:0000712,resolution of meiotic recombination intermediates,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,MLH1,1
GO:0002076,BP,GO:0002076,osteoblast development,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,SMAD3,1
GO:0002730,BP,GO:0002730,regulation of dendritic cell cytokine production,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,TLR4,1
GO:0002921,BP,GO:0002921,negative regulation of humoral immune response,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,A2M,1
GO:0007063,BP,GO:0007063,regulation of sister chromatid cohesion,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,CTNNB1,1
GO:0007379,BP,GO:0007379,segment specification,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,BMI1,1
GO:0007549,BP,GO:0007549,sex-chromosome dosage compensation,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,BRCA1,1
GO:0014841,BP,GO:0014841,skeletal muscle satellite cell proliferation,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,FGF2,1
GO:0021783,BP,GO:0021783,preganglionic parasympathetic fiber development,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,TFAP2A,1
GO:0030202,BP,GO:0030202,heparin metabolic process,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,EDNRB,1
GO:0032905,BP,GO:0032905,transforming growth factor beta1 production,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,THBS1,1
GO:0035092,BP,GO:0035092,sperm DNA condensation,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,SRPK1,1
GO:0035821,BP,GO:0035821,modulation of process of another organism,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,AKT1,1
GO:0042693,BP,GO:0042693,muscle cell fate commitment,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,WT1,1
GO:0043923,BP,GO:0043923,positive regulation by host of viral transcription,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,SMARCA4,1
GO:0044320,BP,GO:0044320,cellular response to leptin stimulus,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,STAT3,1
GO:0045198,BP,GO:0045198,establishment of epithelial cell apical/basal polarity,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,RHOA,1
GO:0046112,BP,GO:0046112,nucleobase biosynthetic process,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,MTOR,1
GO:0055119,BP,GO:0055119,relaxation of cardiac muscle,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,PIK3CA,1
GO:0060221,BP,GO:0060221,retinal rod cell differentiation,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,STAT3,1
GO:0061548,BP,GO:0061548,ganglion development,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,CTNNB1,1
GO:0070254,BP,GO:0070254,mucus secretion,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,EGFR,1
GO:0071360,BP,GO:0071360,cellular response to exogenous dsRNA,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,CAV1,1
GO:0090083,BP,GO:0090083,regulation of inclusion body assembly,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,CLU,1
GO:0090209,BP,GO:0090209,negative regulation of triglyceride metabolic process,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,FBXW7,1
GO:0098712,BP,GO:0098712,L-glutamate import across plasma membrane,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,TNF,1
GO:0120305,BP,GO:0120305,regulation of pigmentation,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,BAX,1
GO:0150079,BP,GO:0150079,negative regulation of neuroinflammatory response,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,IGF1,1
GO:1900747,BP,GO:1900747,negative regulation of vascular endothelial growth factor signaling pathway,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,DAB2IP,1
GO:1904294,BP,GO:1904294,positive regulation of ERAD pathway,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,CAV1,1
GO:1905906,BP,GO:1905906,regulation of amyloid fibril formation,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,CLU,1
GO:1905962,BP,GO:1905962,glutamatergic neuron differentiation,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,ZHX2,1
GO:1990403,BP,GO:1990403,embryonic brain development,1/269,17/18888,0.058823529,4.130330199,1.552017481,0.216477958,0.2730547,0.114503554,CTNNB1,1
GO:0002793,BP,GO:0002793,positive regulation of peptide secretion,3/269,113/18888,0.026548673,1.864131329,1.107410033,0.218003654,0.274826964,0.11524674,HIF1A/EGFR/UCN,3
GO:0070252,BP,GO:0070252,actin-mediated cell contraction,3/269,113/18888,0.026548673,1.864131329,1.107410033,0.218003654,0.274826964,0.11524674,PIK3CA/CAV1/ROCK1,3
GO:0000768,BP,GO:0000768,syncytium formation by plasma membrane fusion,2/269,62/18888,0.032258065,2.265019787,1.199205441,0.220907006,0.278179192,0.116652473,MAPK14/CD9,2
GO:0071715,BP,GO:0071715,icosanoid transport,2/269,62/18888,0.032258065,2.265019787,1.199205441,0.220907006,0.278179192,0.116652473,PTGS2/IL1B,2
GO:0097120,BP,GO:0097120,receptor localization to synapse,2/269,62/18888,0.032258065,2.265019787,1.199205441,0.220907006,0.278179192,0.116652473,ERBB2/HRAS,2
GO:0140253,BP,GO:0140253,cell-cell fusion,2/269,62/18888,0.032258065,2.265019787,1.199205441,0.220907006,0.278179192,0.116652473,MAPK14/CD9,2
GO:0048259,BP,GO:0048259,regulation of receptor-mediated endocytosis,3/269,115/18888,0.026086957,1.831711653,1.075311575,0.225469979,0.283846704,0.119029104,VEGFA/SERPINE1/CLU,3
GO:0001710,BP,GO:0001710,mesodermal cell fate commitment,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,FGFR1,1
GO:0001991,BP,GO:0001991,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,EDNRB,1
GO:0002371,BP,GO:0002371,dendritic cell cytokine production,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,TLR4,1
GO:0002827,BP,GO:0002827,positive regulation of T-helper 1 type immune response,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,IL1B,1
GO:0002923,BP,GO:0002923,regulation of humoral immune response mediated by circulating immunoglobulin,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,TNF,1
GO:0006825,BP,GO:0006825,copper ion transport,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,SLC39A11,1
GO:0006991,BP,GO:0006991,response to sterol depletion,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,FBXW7,1
GO:0007176,BP,GO:0007176,regulation of epidermal growth factor-activated receptor activity,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,FBXW7,1
GO:0010002,BP,GO:0010002,cardioblast differentiation,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,NOTCH1,1
GO:0010421,BP,GO:0010421,hydrogen peroxide-mediated programmed cell death,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,PAWR,1
GO:0019373,BP,GO:0019373,epoxygenase P450 pathway,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,CYP1A1,1
GO:0020027,BP,GO:0020027,hemoglobin metabolic process,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,HIF1A,1
GO:0032604,BP,GO:0032604,granulocyte macrophage colony-stimulating factor production,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,IL1B,1
GO:0032645,BP,GO:0032645,regulation of granulocyte macrophage colony-stimulating factor production,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,IL1B,1
GO:0032780,BP,GO:0032780,negative regulation of ATP-dependent activity,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,TP53,1
GO:0035455,BP,GO:0035455,response to interferon-alpha,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,GATA3,1
GO:0036035,BP,GO:0036035,osteoclast development,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,FBXW7,1
GO:0042574,BP,GO:0042574,retinal metabolic process,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,AKR1C3,1
GO:0042753,BP,GO:0042753,positive regulation of circadian rhythm,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,CLOCK,1
GO:0043116,BP,GO:0043116,negative regulation of vascular permeability,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,VEGFA,1
GO:0046851,BP,GO:0046851,negative regulation of bone remodeling,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,IL6,1
GO:0048368,BP,GO:0048368,lateral mesoderm development,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,FGFR1,1
GO:0048535,BP,GO:0048535,lymph node development,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,TGFB1,1
GO:0050862,BP,GO:0050862,positive regulation of T cell receptor signaling pathway,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,RELA,1
GO:0051350,BP,GO:0051350,negative regulation of lyase activity,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,EDNRB,1
GO:0070200,BP,GO:0070200,establishment of protein localization to telomere,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,BRCA2,1
GO:0071318,BP,GO:0071318,cellular response to ATP,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,PTGS2,1
GO:0072673,BP,GO:0072673,lamellipodium morphogenesis,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,CD44,1
GO:0090281,BP,GO:0090281,negative regulation of calcium ion import,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,MIR200C,1
GO:0098751,BP,GO:0098751,bone cell development,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,FBXW7,1
GO:1903817,BP,GO:1903817,negative regulation of voltage-gated potassium channel activity,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,CAV1,1
GO:1904666,BP,GO:1904666,regulation of ubiquitin protein ligase activity,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,PTEN,1
GO:2001169,BP,GO:2001169,regulation of ATP biosynthetic process,1/269,18/18888,0.055555556,3.90086741,1.479986097,0.227646811,0.283997501,0.119092339,PARP1,1
GO:0022898,BP,GO:0022898,regulation of transmembrane transporter activity,5/269,229/18888,0.021834061,1.533091995,0.975562672,0.228598358,0.28510652,0.119557399,MMP9/CAV1/MIR200C/PIM1/LRRC26,5
GO:0021545,BP,GO:0021545,cranial nerve development,2/269,64/18888,0.03125,2.194237918,1.150282044,0.231415151,0.288461677,0.12096436,CTNNB1/TFAP2A,2
GO:0070050,BP,GO:0070050,neuron cellular homeostasis,2/269,64/18888,0.03125,2.194237918,1.150282044,0.231415151,0.288461677,0.12096436,IL6/BAP1,2
GO:0051261,BP,GO:0051261,protein depolymerization,3/269,117/18888,0.025641026,1.800400343,1.043844834,0.232985356,0.290180777,0.121685253,PIK3CA/HDAC6/KATNB1,3
GO:0051928,BP,GO:0051928,positive regulation of calcium ion transport,3/269,117/18888,0.025641026,1.800400343,1.043844834,0.232985356,0.290180777,0.121685253,CAV1/BAX/UCN,3
GO:0061640,BP,GO:0061640,cytoskeleton-dependent cytokinesis,3/269,117/18888,0.025641026,1.800400343,1.043844834,0.232985356,0.290180777,0.121685253,RHOA/LZTS2/ROCK1,3
GO:0030100,BP,GO:0030100,regulation of endocytosis,6/269,291/18888,0.020618557,1.447744606,0.925198384,0.235721475,0.293428153,0.123047017,VEGFA/CAV1/SERPINE1/SPHK1/ROCK1/CLU,6
GO:0051321,BP,GO:0051321,meiotic cell cycle,6/269,291/18888,0.020618557,1.447744606,0.925198384,0.235721475,0.293428153,0.123047017,PTEN/AURKA/BRCA2/CDK2/MLH1/NBN,6
GO:0010324,BP,GO:0010324,membrane invagination,2/269,65/18888,0.030769231,2.160480412,1.126495667,0.236681429,0.293553313,0.123099502,THBS1/RHOA,2
GO:0030166,BP,GO:0030166,proteoglycan biosynthetic process,2/269,65/18888,0.030769231,2.160480412,1.126495667,0.236681429,0.293553313,0.123099502,CTNNB1/IGF1,2
GO:0043462,BP,GO:0043462,regulation of ATP-dependent activity,2/269,65/18888,0.030769231,2.160480412,1.126495667,0.236681429,0.293553313,0.123099502,TP53/MSH2,2
GO:0043903,BP,GO:0043903,regulation of biological process involved in symbiotic interaction,2/269,65/18888,0.030769231,2.160480412,1.126495667,0.236681429,0.293553313,0.123099502,TMPRSS2/CAV1,2
GO:0044091,BP,GO:0044091,membrane biogenesis,2/269,65/18888,0.030769231,2.160480412,1.126495667,0.236681429,0.293553313,0.123099502,PTEN/CAV1,2
GO:0072666,BP,GO:0072666,establishment of protein localization to vacuole,2/269,65/18888,0.030769231,2.160480412,1.126495667,0.236681429,0.293553313,0.123099502,SQSTM1/CLU,2
GO:0098930,BP,GO:0098930,axonal transport,2/269,65/18888,0.030769231,2.160480412,1.126495667,0.236681429,0.293553313,0.123099502,HIF1A/HDAC6,2
GO:0051224,BP,GO:0051224,negative regulation of protein transport,3/269,118/18888,0.025423729,1.785142713,1.028340466,0.236760101,0.293553313,0.123099502,IL1B/TXN/IRS1,3
GO:0001502,BP,GO:0001502,cartilage condensation,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,MAPK14,1
GO:0001829,BP,GO:0001829,trophectodermal cell differentiation,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,CUL3,1
GO:0002281,BP,GO:0002281,macrophage activation involved in immune response,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,TNF,1
GO:0002283,BP,GO:0002283,neutrophil activation involved in immune response,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,MYD88,1
GO:0002523,BP,GO:0002523,leukocyte migration involved in inflammatory response,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,TNF,1
GO:0002693,BP,GO:0002693,positive regulation of cellular extravasation,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,LYVE1,1
GO:0003184,BP,GO:0003184,pulmonary valve morphogenesis,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,NOTCH1,1
GO:0006144,BP,GO:0006144,purine nucleobase metabolic process,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,KDM1A,1
GO:0006684,BP,GO:0006684,sphingomyelin metabolic process,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,PRKCD,1
GO:0008356,BP,GO:0008356,asymmetric cell division,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,ETV5,1
GO:0010587,BP,GO:0010587,miRNA catabolic process,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,MALAT1,1
GO:0010885,BP,GO:0010885,regulation of cholesterol storage,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,PPARG,1
GO:0010968,BP,GO:0010968,regulation of microtubule nucleation,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,GIT1,1
GO:0022410,BP,GO:0022410,circadian sleep/wake cycle process,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,PARP1,1
GO:0032305,BP,GO:0032305,positive regulation of icosanoid secretion,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,IL1B,1
GO:0032516,BP,GO:0032516,positive regulation of phosphoprotein phosphatase activity,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,MTOR,1
GO:0036342,BP,GO:0036342,post-anal tail morphogenesis,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,TP63,1
GO:0036499,BP,GO:0036499,PERK-mediated unfolded protein response,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,HSPA5,1
GO:0042749,BP,GO:0042749,regulation of circadian sleep/wake cycle,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,PARP1,1
GO:0043950,BP,GO:0043950,positive regulation of cAMP-mediated signaling,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,UCN,1
GO:0045780,BP,GO:0045780,positive regulation of bone resorption,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,EGFR,1
GO:0048486,BP,GO:0048486,parasympathetic nervous system development,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,TFAP2A,1
GO:0051797,BP,GO:0051797,regulation of hair follicle development,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,TNF,1
GO:0055064,BP,GO:0055064,chloride ion homeostasis,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,FASLG,1
GO:0061298,BP,GO:0061298,retina vasculature development in camera-type eye,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,HIF1A,1
GO:0072376,BP,GO:0072376,protein activation cascade,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,THBD,1
GO:0098543,BP,GO:0098543,detection of other organism,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,TLR4,1
GO:1900242,BP,GO:1900242,regulation of synaptic vesicle endocytosis,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,ROCK1,1
GO:1901881,BP,GO:1901881,positive regulation of protein depolymerization,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,KATNB1,1
GO:1901978,BP,GO:1901978,positive regulation of cell cycle checkpoint,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,XRCC3,1
GO:1902548,BP,GO:1902548,negative regulation of cellular response to vascular endothelial growth factor stimulus,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,DAB2IP,1
GO:1902931,BP,GO:1902931,negative regulation of alcohol biosynthetic process,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,NFKB1,1
GO:1903427,BP,GO:1903427,negative regulation of reactive oxygen species biosynthetic process,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,RHOA,1
GO:2000434,BP,GO:2000434,regulation of protein neddylation,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,HIF1A,1
GO:2000641,BP,GO:2000641,regulation of early endosome to late endosome transport,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,MAPK1,1
GO:2001224,BP,GO:2001224,positive regulation of neuron migration,1/269,19/18888,0.052631579,3.695558599,1.412962351,0.23865704,0.293553313,0.123099502,DAB2IP,1
GO:0022900,BP,GO:0022900,electron transport chain,4/269,175/18888,0.022857143,1.604928306,0.966341601,0.239475898,0.294481023,0.12348853,COX2/BID/SOD2/CYP19A1,4
GO:0030219,BP,GO:0030219,megakaryocyte differentiation,2/269,66/18888,0.03030303,2.12774586,1.103137832,0.241954124,0.297448189,0.12473279,MYB/MED1,2
GO:0016358,BP,GO:0016358,dendrite development,5/269,235/18888,0.021276596,1.493949221,0.915843664,0.244340483,0.300300847,0.125929032,PTEN/ALK/HDAC6/EZH2/DAB2IP,5
GO:0000288,BP,GO:0000288,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",2/269,67/18888,0.029850746,2.095988459,1.080193325,0.24723199,0.303690738,0.127350559,YBX1/MLH1,2
GO:0009620,BP,GO:0009620,response to fungus,2/269,67/18888,0.029850746,2.095988459,1.080193325,0.24723199,0.303690738,0.127350559,TLR4/MYD88,2
GO:0002577,BP,GO:0002577,regulation of antigen processing and presentation,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,THBS1,1
GO:0002643,BP,GO:0002643,regulation of tolerance induction,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,CD274,1
GO:0006670,BP,GO:0006670,sphingosine metabolic process,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,SPHK1,1
GO:0007351,BP,GO:0007351,tripartite regional subdivision,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,WT1,1
GO:0007413,BP,GO:0007413,axonal fasciculation,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,CASP3,1
GO:0008595,BP,GO:0008595,"anterior/posterior axis specification, embryo",1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,WT1,1
GO:0009301,BP,GO:0009301,snRNA transcription,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,ELL2,1
GO:0010738,BP,GO:0010738,regulation of protein kinase A signaling,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,MC1R,1
GO:0032098,BP,GO:0032098,regulation of appetite,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,UCN,1
GO:0032303,BP,GO:0032303,regulation of icosanoid secretion,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,IL1B,1
GO:0032332,BP,GO:0032332,positive regulation of chondrocyte differentiation,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,SMAD3,1
GO:0032634,BP,GO:0032634,interleukin-5 production,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,GATA3,1
GO:0032674,BP,GO:0032674,regulation of interleukin-5 production,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,GATA3,1
GO:0033141,BP,GO:0033141,positive regulation of peptidyl-serine phosphorylation of STAT protein,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,IFNA1,1
GO:0034122,BP,GO:0034122,negative regulation of toll-like receptor signaling pathway,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,LGR4,1
GO:0035795,BP,GO:0035795,negative regulation of mitochondrial membrane permeability,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,BNIP3,1
GO:0038092,BP,GO:0038092,nodal signaling pathway,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,SMAD3,1
GO:0043691,BP,GO:0043691,reverse cholesterol transport,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,CLU,1
GO:0045653,BP,GO:0045653,negative regulation of megakaryocyte differentiation,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,MYB,1
GO:0045655,BP,GO:0045655,regulation of monocyte differentiation,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,MYC,1
GO:0045953,BP,GO:0045953,negative regulation of natural killer cell mediated cytotoxicity,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,TGFB1,1
GO:0055062,BP,GO:0055062,phosphate ion homeostasis,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,FGFR4,1
GO:0071474,BP,GO:0071474,cellular hyperosmotic response,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,FBP1,1
GO:0090026,BP,GO:0090026,positive regulation of monocyte chemotaxis,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,SERPINE1,1
GO:0090308,BP,GO:0090308,regulation of DNA methylation-dependent heterochromatin formation,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,KDM1A,1
GO:0097254,BP,GO:0097254,renal tubular secretion,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,EDNRB,1
GO:0097468,BP,GO:0097468,programmed cell death in response to reactive oxygen species,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,PAWR,1
GO:0097494,BP,GO:0097494,regulation of vesicle size,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,RILP,1
GO:0106030,BP,GO:0106030,neuron projection fasciculation,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,CASP3,1
GO:1900424,BP,GO:1900424,regulation of defense response to bacterium,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,KLK3,1
GO:1901739,BP,GO:1901739,regulation of myoblast fusion,1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,MAPK14,1
GO:2001185,BP,GO:2001185,"regulation of CD8-positive, alpha-beta T cell activation",1/269,20/18888,0.05,3.510780669,1.350331176,0.249510887,0.303868378,0.127425051,CD274,1
GO:0046942,BP,GO:0046942,carboxylic acid transport,7/269,358/18888,0.019553073,1.372930988,0.856271974,0.250077527,0.304477074,0.127680304,THBS1/PTGS2/IL1B/PPARG/TNF/AKT1/RBP1,7
GO:0015849,BP,GO:0015849,organic acid transport,7/269,359/18888,0.019498607,1.369106668,0.848696827,0.252227989,0.306787453,0.128649144,THBS1/PTGS2/IL1B/PPARG/TNF/AKT1/RBP1,7
GO:0006687,BP,GO:0006687,glycosphingolipid metabolic process,2/269,68/18888,0.029411765,2.065165099,1.0576477,0.252513817,0.306787453,0.128649144,PRKCD/BAX,2
GO:0009311,BP,GO:0009311,oligosaccharide metabolic process,2/269,68/18888,0.029411765,2.065165099,1.0576477,0.252513817,0.306787453,0.128649144,BRAF/FBP1,2
GO:0016925,BP,GO:0016925,protein sumoylation,2/269,68/18888,0.029411765,2.065165099,1.0576477,0.252513817,0.306787453,0.128649144,CTNNB1/RELA,2
GO:0046513,BP,GO:0046513,ceramide biosynthetic process,2/269,68/18888,0.029411765,2.065165099,1.0576477,0.252513817,0.306787453,0.128649144,PRKCD/SPHK1,2
GO:0050854,BP,GO:0050854,regulation of antigen receptor-mediated signaling pathway,2/269,68/18888,0.029411765,2.065165099,1.0576477,0.252513817,0.306787453,0.128649144,RELA/PAWR,2
GO:0051926,BP,GO:0051926,negative regulation of calcium ion transport,2/269,68/18888,0.029411765,2.065165099,1.0576477,0.252513817,0.306787453,0.128649144,PTGS2/MIR200C,2
GO:0071300,BP,GO:0071300,cellular response to retinoic acid,2/269,68/18888,0.029411765,2.065165099,1.0576477,0.252513817,0.306787453,0.128649144,MYB/TNF,2
GO:0022904,BP,GO:0022904,respiratory electron transport chain,3/269,123/18888,0.024390244,1.712575936,0.952991172,0.255783426,0.310676963,0.130280183,COX2/BID/SOD2,3
GO:0019731,BP,GO:0019731,antibacterial humoral response,2/269,69/18888,0.028985507,2.035235171,1.035487228,0.257798424,0.313040944,0.131271502,KLK3/DEFB1,2
GO:0000729,BP,GO:0000729,DNA double-strand break processing,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,NBN,1
GO:0002716,BP,GO:0002716,negative regulation of natural killer cell mediated immunity,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,TGFB1,1
GO:0006662,BP,GO:0006662,glycerol ether metabolic process,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,FASN,1
GO:0006677,BP,GO:0006677,glycosylceramide metabolic process,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,PRKCD,1
GO:0006907,BP,GO:0006907,pinocytosis,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,CAV1,1
GO:0010288,BP,GO:0010288,response to lead ion,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,PTGS2,1
GO:0016137,BP,GO:0016137,glycoside metabolic process,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,AKR1C3,1
GO:0019081,BP,GO:0019081,viral translation,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,TMPRSS2,1
GO:0030502,BP,GO:0030502,negative regulation of bone mineralization,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,HIF1A,1
GO:0032011,BP,GO:0032011,ARF protein signal transduction,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,GIT1,1
GO:0032012,BP,GO:0032012,regulation of ARF protein signal transduction,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,GIT1,1
GO:0032211,BP,GO:0032211,negative regulation of telomere maintenance via telomerase,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,TP53,1
GO:0032616,BP,GO:0032616,interleukin-13 production,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,GATA3,1
GO:0032656,BP,GO:0032656,regulation of interleukin-13 production,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,GATA3,1
GO:0035809,BP,GO:0035809,regulation of urine volume,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,EDNRB,1
GO:0042474,BP,GO:0042474,middle ear morphogenesis,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,FGFR1,1
GO:0042745,BP,GO:0042745,circadian sleep/wake cycle,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,PARP1,1
GO:0045056,BP,GO:0045056,transcytosis,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,IGF1R,1
GO:0046485,BP,GO:0046485,ether lipid metabolic process,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,FASN,1
GO:0050849,BP,GO:0050849,negative regulation of calcium-mediated signaling,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,MTOR,1
GO:0052695,BP,GO:0052695,cellular glucuronidation,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,UGT2B17,1
GO:0055081,BP,GO:0055081,monoatomic anion homeostasis,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,FASLG,1
GO:0061050,BP,GO:0061050,regulation of cell growth involved in cardiac muscle cell development,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,IGF1,1
GO:0090043,BP,GO:0090043,regulation of tubulin deacetylation,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,HDAC6,1
GO:0090266,BP,GO:0090266,regulation of mitotic cell cycle spindle assembly checkpoint,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,XRCC3,1
GO:1901018,BP,GO:1901018,positive regulation of potassium ion transmembrane transporter activity,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,LRRC26,1
GO:1901317,BP,GO:1901317,regulation of flagellated sperm motility,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,DEFB1,1
GO:1902683,BP,GO:1902683,regulation of receptor localization to synapse,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,HRAS,1
GO:1903504,BP,GO:1903504,regulation of mitotic spindle checkpoint,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,XRCC3,1
GO:2000738,BP,GO:2000738,positive regulation of stem cell differentiation,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,FGF2,1
GO:2001044,BP,GO:2001044,regulation of integrin-mediated signaling pathway,1/269,21/18888,0.047619048,3.343600637,1.291579919,0.260210568,0.313380742,0.131413994,TIMP1,1
GO:0006874,BP,GO:0006874,intracellular calcium ion homeostasis,6/269,302/18888,0.01986755,1.395012186,0.831764639,0.261702212,0.315093889,0.13213239,VDR/FASLG/FGF2/CAV1/BAX/BNIP3,6
GO:0002548,BP,GO:0002548,monocyte chemotaxis,2/269,70/18888,0.028571429,2.006160382,1.013698853,0.263084668,0.316591058,0.132760217,IL6/SERPINE1,2
GO:2000401,BP,GO:2000401,regulation of lymphocyte migration,2/269,70/18888,0.028571429,2.006160382,1.013698853,0.263084668,0.316591058,0.132760217,RHOA/AKT1,2
GO:0072676,BP,GO:0072676,lymphocyte migration,3/269,125/18888,0.024,1.685174721,0.923814242,0.263453023,0.316866941,0.132875906,RHOA/AKT1/GATA3,3
GO:1903305,BP,GO:1903305,regulation of regulated secretory pathway,3/269,125/18888,0.024,1.685174721,0.923814242,0.263453023,0.316866941,0.132875906,NOTCH1/GIT1/BRAF,3
GO:0019933,BP,GO:0019933,cAMP-mediated signaling,2/269,71/18888,0.028169014,1.977904602,0.992270148,0.268371432,0.322612201,0.135285141,DEFB1/UCN,2
GO:0048488,BP,GO:0048488,synaptic vesicle endocytosis,2/269,71/18888,0.028169014,1.977904602,0.992270148,0.268371432,0.322612201,0.135285141,SNCG/ROCK1,2
GO:0009713,BP,GO:0009713,catechol-containing compound biosynthetic process,1/269,22/18888,0.045454545,3.19161879,1.2362773,0.270758263,0.323772873,0.13577186,GATA3,1
GO:0010566,BP,GO:0010566,regulation of ketone biosynthetic process,1/269,22/18888,0.045454545,3.19161879,1.2362773,0.270758263,0.323772873,0.13577186,AKR1C3,1
GO:0019430,BP,GO:0019430,removal of superoxide radicals,1/269,22/18888,0.045454545,3.19161879,1.2362773,0.270758263,0.323772873,0.13577186,SOD2,1
GO:0030431,BP,GO:0030431,sleep,1/269,22/18888,0.045454545,3.19161879,1.2362773,0.270758263,0.323772873,0.13577186,PARP1,1
GO:0032700,BP,GO:0032700,negative regulation of interleukin-17 production,1/269,22/18888,0.045454545,3.19161879,1.2362773,0.270758263,0.323772873,0.13577186,TLR4,1
GO:0034312,BP,GO:0034312,diol biosynthetic process,1/269,22/18888,0.045454545,3.19161879,1.2362773,0.270758263,0.323772873,0.13577186,SPHK1,1
GO:0036092,BP,GO:0036092,phosphatidylinositol-3-phosphate biosynthetic process,1/269,22/18888,0.045454545,3.19161879,1.2362773,0.270758263,0.323772873,0.13577186,PIK3CA,1
GO:0042423,BP,GO:0042423,catecholamine biosynthetic process,1/269,22/18888,0.045454545,3.19161879,1.2362773,0.270758263,0.323772873,0.13577186,GATA3,1
GO:0046519,BP,GO:0046519,sphingoid metabolic process,1/269,22/18888,0.045454545,3.19161879,1.2362773,0.270758263,0.323772873,0.13577186,SPHK1,1
GO:0061099,BP,GO:0061099,negative regulation of protein tyrosine kinase activity,1/269,22/18888,0.045454545,3.19161879,1.2362773,0.270758263,0.323772873,0.13577186,CAV1,1
GO:0061687,BP,GO:0061687,detoxification of inorganic compound,1/269,22/18888,0.045454545,3.19161879,1.2362773,0.270758263,0.323772873,0.13577186,TXN,1
GO:0090231,BP,GO:0090231,regulation of spindle checkpoint,1/269,22/18888,0.045454545,3.19161879,1.2362773,0.270758263,0.323772873,0.13577186,XRCC3,1
GO:0097062,BP,GO:0097062,dendritic spine maintenance,1/269,22/18888,0.045454545,3.19161879,1.2362773,0.270758263,0.323772873,0.13577186,IGF1R,1
GO:0099010,BP,GO:0099010,modification of postsynaptic structure,1/269,22/18888,0.045454545,3.19161879,1.2362773,0.270758263,0.323772873,0.13577186,RHOA,1
GO:0140861,BP,GO:0140861,DNA repair-dependent chromatin remodeling,1/269,22/18888,0.045454545,3.19161879,1.2362773,0.270758263,0.323772873,0.13577186,KDM1A,1
GO:1902018,BP,GO:1902018,negative regulation of cilium assembly,1/269,22/18888,0.045454545,3.19161879,1.2362773,0.270758263,0.323772873,0.13577186,AKT1,1
GO:1902473,BP,GO:1902473,regulation of protein localization to synapse,1/269,22/18888,0.045454545,3.19161879,1.2362773,0.270758263,0.323772873,0.13577186,HRAS,1
GO:1902644,BP,GO:1902644,tertiary alcohol metabolic process,1/269,22/18888,0.045454545,3.19161879,1.2362773,0.270758263,0.323772873,0.13577186,AKR1C3,1
GO:1903589,BP,GO:1903589,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,1/269,22/18888,0.045454545,3.19161879,1.2362773,0.270758263,0.323772873,0.13577186,VEGFA,1
GO:2000725,BP,GO:2000725,regulation of cardiac muscle cell differentiation,1/269,22/18888,0.045454545,3.19161879,1.2362773,0.270758263,0.323772873,0.13577186,TGFB1,1
GO:0003014,BP,GO:0003014,renal system process,3/269,127/18888,0.023622047,1.658636537,0.895156855,0.271151074,0.324157516,0.135933158,EDNRB/RHOA/AKR1C3,3
GO:0043112,BP,GO:0043112,receptor metabolic process,2/269,72/18888,0.027777778,1.950433705,0.971189279,0.273657634,0.326982476,0.137117784,LMTK2/TGFB1,2
GO:0140238,BP,GO:0140238,presynaptic endocytosis,2/269,72/18888,0.027777778,1.950433705,0.971189279,0.273657634,0.326982476,0.137117784,SNCG/ROCK1,2
GO:0006612,BP,GO:0006612,protein targeting to membrane,3/269,128/18888,0.0234375,1.645678439,0.881017036,0.275009556,0.328511678,0.137759044,ERBB2/HSPA5/HRAS,3
GO:0034470,BP,GO:0034470,ncRNA processing,8/269,433/18888,0.018475751,1.297286159,0.752213404,0.277015964,0.330821685,0.13872773,TP53/IL6/STAT3/RNASEL/AKT1/SMAD3/TGFB1/FRG1,8
GO:0051209,BP,GO:0051209,release of sequestered calcium ion into cytosol,3/269,129/18888,0.023255814,1.632921241,0.867000083,0.278873706,0.332686064,0.139509543,FASLG/FGF2/BAX,3
GO:0006879,BP,GO:0006879,intracellular iron ion homeostasis,2/269,73/18888,0.02739726,1.923715435,0.950444963,0.278942222,0.332686064,0.139509543,MYC/HIF1A,2
GO:0045109,BP,GO:0045109,intermediate filament organization,2/269,73/18888,0.02739726,1.923715435,0.950444963,0.278942222,0.332686064,0.139509543,PKP1/VIM,2
GO:0051865,BP,GO:0051865,protein autoubiquitination,2/269,73/18888,0.02739726,1.923715435,0.950444963,0.278942222,0.332686064,0.139509543,BRCA1/CUL3,2
GO:0090307,BP,GO:0090307,mitotic spindle assembly,2/269,73/18888,0.02739726,1.923715435,0.950444963,0.278942222,0.332686064,0.139509543,RHOA/CHEK2,2
GO:0002223,BP,GO:0002223,stimulatory C-type lectin receptor signaling pathway,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,MAP3K7,1
GO:0002689,BP,GO:0002689,negative regulation of leukocyte chemotaxis,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,CYP19A1,1
GO:0003177,BP,GO:0003177,pulmonary valve development,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,NOTCH1,1
GO:0010866,BP,GO:0010866,regulation of triglyceride biosynthetic process,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,FBXW7,1
GO:0021542,BP,GO:0021542,dentate gyrus development,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,PTEN,1
GO:0030220,BP,GO:0030220,platelet formation,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,CASP3,1
GO:0031290,BP,GO:0031290,retinal ganglion cell axon guidance,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,VEGFA,1
GO:0031338,BP,GO:0031338,regulation of vesicle fusion,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,SPHK1,1
GO:0033139,BP,GO:0033139,regulation of peptidyl-serine phosphorylation of STAT protein,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,IFNA1,1
GO:0034105,BP,GO:0034105,positive regulation of tissue remodeling,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,ROCK1,1
GO:0035855,BP,GO:0035855,megakaryocyte development,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,MED1,1
GO:0036120,BP,GO:0036120,cellular response to platelet-derived growth factor stimulus,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,TLR4,1
GO:0045063,BP,GO:0045063,T-helper 1 cell differentiation,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,MTOR,1
GO:0045932,BP,GO:0045932,negative regulation of muscle contraction,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,PTGS2,1
GO:0046479,BP,GO:0046479,glycosphingolipid catabolic process,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,PRKCD,1
GO:0046599,BP,GO:0046599,regulation of centriole replication,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,BRCA1,1
GO:0046794,BP,GO:0046794,transport of virus,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,CAV1,1
GO:0046823,BP,GO:0046823,negative regulation of nucleocytoplasmic transport,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,TXN,1
GO:0051457,BP,GO:0051457,maintenance of protein location in nucleus,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,TXN,1
GO:0060143,BP,GO:0060143,positive regulation of syncytium formation by plasma membrane fusion,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,MAPK14,1
GO:0061744,BP,GO:0061744,motor behavior,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,GRPR,1
GO:0090042,BP,GO:0090042,tubulin deacetylation,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,HDAC6,1
GO:0097107,BP,GO:0097107,postsynaptic density assembly,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,PTEN,1
GO:0098743,BP,GO:0098743,cell aggregation,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,MAPK14,1
GO:1905709,BP,GO:1905709,negative regulation of membrane permeability,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,BNIP3,1
GO:1990840,BP,GO:1990840,response to lectin,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,MAP3K7,1
GO:1990858,BP,GO:1990858,cellular response to lectin,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,MAP3K7,1
GO:2000193,BP,GO:2000193,positive regulation of fatty acid transport,1/269,23/18888,0.043478261,3.052852756,1.18405743,0.281156123,0.332886511,0.1395936,IL1B,1
GO:0051283,BP,GO:0051283,negative regulation of sequestering of calcium ion,3/269,130/18888,0.023076923,1.620360309,0.853103784,0.282743052,0.334672102,0.140342374,FASLG/FGF2/BAX,3
GO:0006066,BP,GO:0006066,alcohol metabolic process,7/269,373/18888,0.018766756,1.317719286,0.744930215,0.282884606,0.334672102,0.140342374,EDNRB/NFKB1/CYP1A1/IGF1/SPHK1/AKR1C3/FGFR1,7
GO:0044282,BP,GO:0044282,small molecule catabolic process,7/269,373/18888,0.018766756,1.317719286,0.744930215,0.282884606,0.334672102,0.140342374,TP53/AMACR/AKT1/CYP1A1/IRS1/TWIST1/AKR1C3,7
GO:0050709,BP,GO:0050709,negative regulation of protein secretion,2/269,74/18888,0.027027027,1.897719281,0.930026443,0.284224173,0.336169609,0.140970343,IL1B/IRS1,2
GO:0007052,BP,GO:0007052,mitotic spindle organization,3/269,131/18888,0.022900763,1.607991146,0.839325983,0.28661713,0.338823986,0.142083438,AURKA/RHOA/CHEK2,3
GO:0007127,BP,GO:0007127,meiosis I,3/269,131/18888,0.022900763,1.607991146,0.839325983,0.28661713,0.338823986,0.142083438,AURKA/BRCA2/MLH1,3
GO:0061077,BP,GO:0061077,chaperone-mediated protein folding,2/269,75/18888,0.026666667,1.872416357,0.90992345,0.289502493,0.342146137,0.143476558,HSPA5/CLU,2
GO:0051282,BP,GO:0051282,regulation of sequestering of calcium ion,3/269,132/18888,0.022727273,1.595809395,0.825664581,0.290495479,0.342530175,0.143637602,FASLG/FGF2/BAX,3
GO:0002407,BP,GO:0002407,dendritic cell chemotaxis,1/269,24/18888,0.041666667,2.925650558,1.134607528,0.291406269,0.342530175,0.143637602,CXCR2,1
GO:0010954,BP,GO:0010954,positive regulation of protein processing,1/269,24/18888,0.041666667,2.925650558,1.134607528,0.291406269,0.342530175,0.143637602,MMP14,1
GO:0014821,BP,GO:0014821,phasic smooth muscle contraction,1/269,24/18888,0.041666667,2.925650558,1.134607528,0.291406269,0.342530175,0.143637602,EDNRB,1
GO:0016093,BP,GO:0016093,polyprenol metabolic process,1/269,24/18888,0.041666667,2.925650558,1.134607528,0.291406269,0.342530175,0.143637602,AKR1C3,1
GO:0030277,BP,GO:0030277,maintenance of gastrointestinal epithelium,1/269,24/18888,0.041666667,2.925650558,1.134607528,0.291406269,0.342530175,0.143637602,TLR4,1
GO:0032528,BP,GO:0032528,microvillus organization,1/269,24/18888,0.041666667,2.925650558,1.134607528,0.291406269,0.342530175,0.143637602,FSCN1,1
GO:0032693,BP,GO:0032693,negative regulation of interleukin-10 production,1/269,24/18888,0.041666667,2.925650558,1.134607528,0.291406269,0.342530175,0.143637602,CD274,1
GO:0042438,BP,GO:0042438,melanin biosynthetic process,1/269,24/18888,0.041666667,2.925650558,1.134607528,0.291406269,0.342530175,0.143637602,MC1R,1
GO:0042501,BP,GO:0042501,serine phosphorylation of STAT protein,1/269,24/18888,0.041666667,2.925650558,1.134607528,0.291406269,0.342530175,0.143637602,IFNA1,1
GO:0045061,BP,GO:0045061,thymic T cell selection,1/269,24/18888,0.041666667,2.925650558,1.134607528,0.291406269,0.342530175,0.143637602,GATA3,1
GO:0045822,BP,GO:0045822,negative regulation of heart contraction,1/269,24/18888,0.041666667,2.925650558,1.134607528,0.291406269,0.342530175,0.143637602,TNF,1
GO:0061484,BP,GO:0061484,hematopoietic stem cell homeostasis,1/269,24/18888,0.041666667,2.925650558,1.134607528,0.291406269,0.342530175,0.143637602,BAP1,1
GO:0070233,BP,GO:0070233,negative regulation of T cell apoptotic process,1/269,24/18888,0.041666667,2.925650558,1.134607528,0.291406269,0.342530175,0.143637602,HIF1A,1
GO:0071294,BP,GO:0071294,cellular response to zinc ion,1/269,24/18888,0.041666667,2.925650558,1.134607528,0.291406269,0.342530175,0.143637602,PARP1,1
GO:0071450,BP,GO:0071450,cellular response to oxygen radical,1/269,24/18888,0.041666667,2.925650558,1.134607528,0.291406269,0.342530175,0.143637602,SOD2,1
GO:0071451,BP,GO:0071451,cellular response to superoxide,1/269,24/18888,0.041666667,2.925650558,1.134607528,0.291406269,0.342530175,0.143637602,SOD2,1
GO:1900407,BP,GO:1900407,regulation of cellular response to oxidative stress,1/269,24/18888,0.041666667,2.925650558,1.134607528,0.291406269,0.342530175,0.143637602,HDAC6,1
GO:1901983,BP,GO:1901983,regulation of protein acetylation,1/269,24/18888,0.041666667,2.925650558,1.134607528,0.291406269,0.342530175,0.143637602,HDAC6,1
GO:1903902,BP,GO:1903902,positive regulation of viral life cycle,1/269,24/18888,0.041666667,2.925650558,1.134607528,0.291406269,0.342530175,0.143637602,TMPRSS2,1
GO:1904292,BP,GO:1904292,regulation of ERAD pathway,1/269,24/18888,0.041666667,2.925650558,1.134607528,0.291406269,0.342530175,0.143637602,CAV1,1
GO:1904950,BP,GO:1904950,negative regulation of establishment of protein localization,3/269,133/18888,0.022556391,1.583810828,0.812117532,0.294377646,0.345933597,0.145064803,IL1B/TXN/IRS1,3
GO:0008088,BP,GO:0008088,axo-dendritic transport,2/269,76/18888,0.026315789,1.8477793,0.890126178,0.294776218,0.346312649,0.145223755,HIF1A/HDAC6,2
GO:0006123,BP,GO:0006123,"mitochondrial electron transport, cytochrome c to oxygen",1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,COX2,1
GO:0006582,BP,GO:0006582,melanin metabolic process,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,MC1R,1
GO:0007190,BP,GO:0007190,activation of adenylate cyclase activity,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,LGR4,1
GO:0007350,BP,GO:0007350,blastoderm segmentation,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,WT1,1
GO:0008156,BP,GO:0008156,negative regulation of DNA replication,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,TP53,1
GO:0008211,BP,GO:0008211,glucocorticoid metabolic process,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,CYP17A1,1
GO:0010842,BP,GO:0010842,retina layer formation,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,TFAP2A,1
GO:0010878,BP,GO:0010878,cholesterol storage,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,PPARG,1
GO:0016973,BP,GO:0016973,poly(A)+ mRNA export from nucleus,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,HHEX,1
GO:0017121,BP,GO:0017121,plasma membrane phospholipid scrambling,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,FASLG,1
GO:0030318,BP,GO:0030318,melanocyte differentiation,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,EDNRB,1
GO:0035020,BP,GO:0035020,regulation of Rac protein signal transduction,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,KRAS,1
GO:0036119,BP,GO:0036119,response to platelet-derived growth factor,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,TLR4,1
GO:0042178,BP,GO:0042178,xenobiotic catabolic process,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,CYP1A1,1
GO:0043576,BP,GO:0043576,regulation of respiratory gaseous exchange,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,GRPR,1
GO:0046514,BP,GO:0046514,ceramide catabolic process,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,PRKCD,1
GO:0048011,BP,GO:0048011,neurotrophin TRK receptor signaling pathway,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,CASP3,1
GO:0050860,BP,GO:0050860,negative regulation of T cell receptor signaling pathway,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,PAWR,1
GO:0060117,BP,GO:0060117,auditory receptor cell development,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,FGFR1,1
GO:0060586,BP,GO:0060586,multicellular organismal-level iron ion homeostasis,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,SOD2,1
GO:0071676,BP,GO:0071676,negative regulation of mononuclear cell migration,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,AKT1,1
GO:0086064,BP,GO:0086064,cell communication by electrical coupling involved in cardiac conduction,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,CAV1,1
GO:0090023,BP,GO:0090023,positive regulation of neutrophil chemotaxis,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,CXCR2,1
GO:0090280,BP,GO:0090280,positive regulation of calcium ion import,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,UCN,1
GO:1901017,BP,GO:1901017,negative regulation of potassium ion transmembrane transporter activity,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,CAV1,1
GO:1903523,BP,GO:1903523,negative regulation of blood circulation,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,TNF,1
GO:1905563,BP,GO:1905563,negative regulation of vascular endothelial cell proliferation,1/269,25/18888,0.04,2.808624535,1.08765834,0.301510791,0.351775458,0.147514546,PPARG,1
GO:0031109,BP,GO:0031109,microtubule polymerization or depolymerization,3/269,135/18888,0.022222222,1.560346964,0.785358566,0.302151643,0.352432895,0.147790237,HDAC6/KATNB1/GIT1,3
GO:0009150,BP,GO:0009150,purine ribonucleotide metabolic process,8/269,446/18888,0.01793722,1.259472886,0.66655326,0.303876914,0.354354548,0.148596069,PARP1/HIF1A/STAT3/MTOR/TGFB1/GIT1/IGF1/FBP1,8
GO:0035418,BP,GO:0035418,protein localization to synapse,2/269,78/18888,0.025641026,1.800400343,0.85141172,0.305306163,0.355930113,0.149256771,ERBB2/HRAS,2
GO:0008154,BP,GO:0008154,actin polymerization or depolymerization,4/269,196/18888,0.020408163,1.432971702,0.732384452,0.30554938,0.356031451,0.149299266,PIK3CA/TENM1/MTOR/PRKCD,4
GO:0099173,BP,GO:0099173,postsynapse organization,4/269,196/18888,0.020408163,1.432971702,0.732384452,0.30554938,0.356031451,0.149299266,PTEN/IGF1R/HDAC6/AKT1,4
GO:0006639,BP,GO:0006639,acylglycerol metabolic process,3/269,136/18888,0.022058824,1.548873825,0.772142809,0.306042593,0.356332751,0.149425614,FBXW7/GPX1/CAV1,3
GO:0030833,BP,GO:0030833,regulation of actin filament polymerization,3/269,136/18888,0.022058824,1.548873825,0.772142809,0.306042593,0.356332751,0.149425614,TENM1/MTOR/PRKCD,3
GO:0051208,BP,GO:0051208,sequestering of calcium ion,3/269,136/18888,0.022058824,1.548873825,0.772142809,0.306042593,0.356332751,0.149425614,FASLG/FGF2/BAX,3
GO:0140013,BP,GO:0140013,meiotic nuclear division,4/269,197/18888,0.020304569,1.425697734,0.721934234,0.308755237,0.3593993,0.15071155,PTEN/AURKA/BRCA2/MLH1,4
GO:0006638,BP,GO:0006638,neutral lipid metabolic process,3/269,137/18888,0.02189781,1.537568176,0.759033723,0.309935599,0.359894826,0.150919345,FBXW7/GPX1/CAV1,3
GO:0007368,BP,GO:0007368,determination of left/right symmetry,3/269,137/18888,0.02189781,1.537568176,0.759033723,0.309935599,0.359894826,0.150919345,NOTCH1/HIF1A/SMAD3,3
GO:0070972,BP,GO:0070972,protein localization to endoplasmic reticulum,2/269,79/18888,0.025316456,1.777610465,0.832477,0.310560591,0.359894826,0.150919345,AKT1/HSPA5,2
GO:0001911,BP,GO:0001911,negative regulation of leukocyte mediated cytotoxicity,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,TGFB1,1
GO:0002026,BP,GO:0002026,regulation of the force of heart contraction,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,CAV1,1
GO:0002092,BP,GO:0002092,positive regulation of receptor internalization,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,VEGFA,1
GO:0006063,BP,GO:0006063,uronic acid metabolic process,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,UGT2B17,1
GO:0007202,BP,GO:0007202,activation of phospholipase C activity,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,EGFR,1
GO:0008045,BP,GO:0008045,motor neuron axon guidance,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,ERBB2,1
GO:0019377,BP,GO:0019377,glycolipid catabolic process,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,PRKCD,1
GO:0019585,BP,GO:0019585,glucuronate metabolic process,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,UGT2B17,1
GO:0019985,BP,GO:0019985,translesion synthesis,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,PCNA,1
GO:0021895,BP,GO:0021895,cerebral cortex neuron differentiation,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,ID4,1
GO:0032469,BP,GO:0032469,endoplasmic reticulum calcium ion homeostasis,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,BAX,1
GO:0033622,BP,GO:0033622,integrin activation,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,FN1,1
GO:0035988,BP,GO:0035988,chondrocyte proliferation,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,MMP14,1
GO:0042537,BP,GO:0042537,benzene-containing compound metabolic process,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,SRD5A2,1
GO:0044550,BP,GO:0044550,secondary metabolite biosynthetic process,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,MC1R,1
GO:0044827,BP,GO:0044827,modulation by host of viral genome replication,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,IFI27,1
GO:0045717,BP,GO:0045717,negative regulation of fatty acid biosynthetic process,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,BRCA1,1
GO:0051560,BP,GO:0051560,mitochondrial calcium ion homeostasis,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,BNIP3,1
GO:0060343,BP,GO:0060343,trabecula formation,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,MMP2,1
GO:0071280,BP,GO:0071280,cellular response to copper ion,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,CYP1A1,1
GO:0098581,BP,GO:0098581,detection of external biotic stimulus,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,TLR4,1
GO:1900151,BP,GO:1900151,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,YBX1,1
GO:1903319,BP,GO:1903319,positive regulation of protein maturation,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,MMP14,1
GO:1903421,BP,GO:1903421,regulation of synaptic vesicle recycling,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,ROCK1,1
GO:1903588,BP,GO:1903588,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,THBS1,1
GO:1904754,BP,GO:1904754,positive regulation of vascular associated smooth muscle cell migration,1/269,26/18888,0.038461538,2.700600515,1.042976598,0.311471752,0.359894826,0.150919345,MAP3K7,1
GO:0030048,BP,GO:0030048,actin filament-based movement,3/269,138/18888,0.02173913,1.526426378,0.746029505,0.313830235,0.362436134,0.151985025,PIK3CA/CAV1/ROCK1,3
GO:1904064,BP,GO:1904064,positive regulation of cation transmembrane transport,3/269,138/18888,0.02173913,1.526426378,0.746029505,0.313830235,0.362436134,0.151985025,CAV1/BAX/LRRC26,3
GO:0061982,BP,GO:0061982,meiosis I cell cycle process,3/269,139/18888,0.021582734,1.515444893,0.733128396,0.317726081,0.366842378,0.153832752,AURKA/BRCA2/MLH1,3
GO:0000303,BP,GO:0000303,response to superoxide,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,SOD2,1
GO:0002227,BP,GO:0002227,innate immune response in mucosa,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,DEFB1,1
GO:0006007,BP,GO:0006007,glucose catabolic process,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,TP53,1
GO:0006972,BP,GO:0006972,hyperosmotic response,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,FBP1,1
GO:0007141,BP,GO:0007141,male meiosis I,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,BRCA2,1
GO:0007289,BP,GO:0007289,spermatid nucleus differentiation,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,SRPK1,1
GO:0010884,BP,GO:0010884,positive regulation of lipid storage,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,NFKB1,1
GO:0021846,BP,GO:0021846,cell proliferation in forebrain,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,FGFR1,1
GO:0032753,BP,GO:0032753,positive regulation of interleukin-4 production,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,GATA3,1
GO:0033081,BP,GO:0033081,regulation of T cell differentiation in thymus,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,ERBB2,1
GO:0035458,BP,GO:0035458,cellular response to interferon-beta,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,STAT1,1
GO:0042983,BP,GO:0042983,amyloid precursor protein biosynthetic process,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,PAWR,1
GO:0042984,BP,GO:0042984,regulation of amyloid precursor protein biosynthetic process,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,PAWR,1
GO:0048207,BP,GO:0048207,"vesicle targeting, rough ER to cis-Golgi",1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,CUL3,1
GO:0048208,BP,GO:0048208,COPII vesicle coating,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,CUL3,1
GO:0048745,BP,GO:0048745,smooth muscle tissue development,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,MIR145,1
GO:0061098,BP,GO:0061098,positive regulation of protein tyrosine kinase activity,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,FBXW7,1
GO:0071108,BP,GO:0071108,protein K48-linked deubiquitination,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,BAP1,1
GO:0071624,BP,GO:0071624,positive regulation of granulocyte chemotaxis,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,CXCR2,1
GO:0099170,BP,GO:0099170,postsynaptic modulation of chemical synaptic transmission,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,CDH1,1
GO:0099560,BP,GO:0099560,synaptic membrane adhesion,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,MAPK14,1
GO:1902410,BP,GO:1902410,mitotic cytokinetic process,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,RHOA,1
GO:1903077,BP,GO:1903077,negative regulation of protein localization to plasma membrane,1/269,27/18888,0.037037037,2.600578273,1.000359029,0.321291182,0.368808926,0.15465741,TGFB1,1
GO:0009581,BP,GO:0009581,detection of external stimulus,3/269,140/18888,0.021428571,1.504620287,0.720328678,0.321622721,0.369096503,0.154778003,CTNNB1/TNF/PTK2,3
GO:0061844,BP,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,2/269,82/18888,0.024390244,1.712575936,0.777265366,0.326271497,0.374148739,0.156896622,KLK3/DEFB1,2
GO:0070936,BP,GO:0070936,protein K48-linked ubiquitination,2/269,82/18888,0.024390244,1.712575936,0.777265366,0.326271497,0.374148739,0.156896622,CUL3/IFI27,2
GO:1904427,BP,GO:1904427,positive regulation of calcium ion transmembrane transport,2/269,82/18888,0.024390244,1.712575936,0.777265366,0.326271497,0.374148739,0.156896622,CAV1/BAX,2
GO:0016072,BP,GO:0016072,rRNA metabolic process,5/269,266/18888,0.018796992,1.319842357,0.631455991,0.329271984,0.377353421,0.158240483,TP53/RNASEL/SMARCA4/MTOR/FRG1,5
GO:0000305,BP,GO:0000305,response to oxygen radical,1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,SOD2,1
GO:0001702,BP,GO:0001702,gastrulation with mouth forming second,1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,CTNNB1,1
GO:0001773,BP,GO:0001773,myeloid dendritic cell activation,1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,IL10,1
GO:0001963,BP,GO:0001963,"synaptic transmission, dopaminergic",1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,PTGS2,1
GO:0014850,BP,GO:0014850,response to muscle activity,1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,HIF1A,1
GO:0021680,BP,GO:0021680,cerebellar Purkinje cell layer development,1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,HSPA5,1
GO:0032703,BP,GO:0032703,negative regulation of interleukin-2 production,1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,GATA3,1
GO:0032801,BP,GO:0032801,receptor catabolic process,1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,TGFB1,1
GO:0034508,BP,GO:0034508,centromere complex assembly,1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,RB1,1
GO:0036037,BP,GO:0036037,"CD8-positive, alpha-beta T cell activation",1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,CD274,1
GO:0044342,BP,GO:0044342,type B pancreatic cell proliferation,1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,CDK4,1
GO:0048668,BP,GO:0048668,collateral sprouting,1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,HDAC6,1
GO:0048714,BP,GO:0048714,positive regulation of oligodendrocyte differentiation,1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,MTOR,1
GO:0048843,BP,GO:0048843,negative regulation of axon extension involved in axon guidance,1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,HDAC6,1
GO:0050857,BP,GO:0050857,positive regulation of antigen receptor-mediated signaling pathway,1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,RELA,1
GO:0051873,BP,GO:0051873,killing by host of symbiont cells,1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,MYD88,1
GO:0051953,BP,GO:0051953,negative regulation of amine transport,1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,TNF,1
GO:0055022,BP,GO:0055022,negative regulation of cardiac muscle tissue growth,1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,MIR25,1
GO:0061117,BP,GO:0061117,negative regulation of heart growth,1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,MIR25,1
GO:0062149,BP,GO:0062149,detection of stimulus involved in sensory perception of pain,1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,TNF,1
GO:0070199,BP,GO:0070199,establishment of protein localization to chromosome,1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,BRCA2,1
GO:0090025,BP,GO:0090025,regulation of monocyte chemotaxis,1/269,28/18888,0.035714286,2.507700478,0.959627529,0.330971086,0.377353421,0.158240483,SERPINE1,1
GO:0086003,BP,GO:0086003,cardiac muscle cell contraction,2/269,83/18888,0.024096386,1.691942491,0.759367196,0.331488321,0.377848584,0.158448126,PIK3CA/CAV1,2
GO:0002028,BP,GO:0002028,regulation of sodium ion transport,2/269,84/18888,0.023809524,1.671800319,0.74171008,0.336693791,0.383494228,0.160815587,AKT1/PER1,2
GO:0006446,BP,GO:0006446,regulation of translational initiation,2/269,84/18888,0.023809524,1.671800319,0.74171008,0.336693791,0.383494228,0.160815587,MTOR/TNF,2
GO:0072527,BP,GO:0072527,pyrimidine-containing compound metabolic process,2/269,84/18888,0.023809524,1.671800319,0.74171008,0.336693791,0.383494228,0.160815587,MTOR/MAPK1,2
GO:0007269,BP,GO:0007269,neurotransmitter secretion,3/269,144/18888,0.020833333,1.462825279,0.670110825,0.337209132,0.383889257,0.16098124,SNCG/GIT1/BRAF,3
GO:0099643,BP,GO:0099643,signal release from synapse,3/269,144/18888,0.020833333,1.462825279,0.670110825,0.337209132,0.383889257,0.16098124,SNCG/GIT1/BRAF,3
GO:0003209,BP,GO:0003209,cardiac atrium morphogenesis,1/269,29/18888,0.034482759,2.421228048,0.920625272,0.340513439,0.386492085,0.162072717,NOTCH1,1
GO:0007342,BP,GO:0007342,fusion of sperm to egg plasma membrane involved in single fertilization,1/269,29/18888,0.034482759,2.421228048,0.920625272,0.340513439,0.386492085,0.162072717,CD9,1
GO:0009312,BP,GO:0009312,oligosaccharide biosynthetic process,1/269,29/18888,0.034482759,2.421228048,0.920625272,0.340513439,0.386492085,0.162072717,FBP1,1
GO:0015813,BP,GO:0015813,L-glutamate transmembrane transport,1/269,29/18888,0.034482759,2.421228048,0.920625272,0.340513439,0.386492085,0.162072717,TNF,1
GO:0031342,BP,GO:0031342,negative regulation of cell killing,1/269,29/18888,0.034482759,2.421228048,0.920625272,0.340513439,0.386492085,0.162072717,TGFB1,1
GO:0060142,BP,GO:0060142,regulation of syncytium formation by plasma membrane fusion,1/269,29/18888,0.034482759,2.421228048,0.920625272,0.340513439,0.386492085,0.162072717,MAPK14,1
GO:0090311,BP,GO:0090311,regulation of protein deacetylation,1/269,29/18888,0.034482759,2.421228048,0.920625272,0.340513439,0.386492085,0.162072717,HDAC6,1
GO:0098698,BP,GO:0098698,postsynaptic specialization assembly,1/269,29/18888,0.034482759,2.421228048,0.920625272,0.340513439,0.386492085,0.162072717,PTEN,1
GO:0098901,BP,GO:0098901,regulation of cardiac muscle cell action potential,1/269,29/18888,0.034482759,2.421228048,0.920625272,0.340513439,0.386492085,0.162072717,CAV1,1
GO:0099563,BP,GO:0099563,modification of synaptic structure,1/269,29/18888,0.034482759,2.421228048,0.920625272,0.340513439,0.386492085,0.162072717,RHOA,1
GO:1903671,BP,GO:1903671,negative regulation of sprouting angiogenesis,1/269,29/18888,0.034482759,2.421228048,0.920625272,0.340513439,0.386492085,0.162072717,THBS1,1
GO:1904376,BP,GO:1904376,negative regulation of protein localization to cell periphery,1/269,29/18888,0.034482759,2.421228048,0.920625272,0.340513439,0.386492085,0.162072717,TGFB1,1
GO:0008589,BP,GO:0008589,regulation of smoothened signaling pathway,2/269,85/18888,0.023529412,1.65213208,0.724287364,0.341887174,0.387954661,0.162686038,FOXA1/RB1,2
GO:0009259,BP,GO:0009259,ribonucleotide metabolic process,8/269,466/18888,0.017167382,1.205418256,0.539688371,0.34622644,0.392780792,0.164709842,PARP1/HIF1A/STAT3/MTOR/TGFB1/GIT1/IGF1/FBP1,8
GO:0006900,BP,GO:0006900,vesicle budding from membrane,2/269,86/18888,0.023255814,1.632921241,0.707092657,0.34706776,0.393539252,0.165027896,RILP/CUL3,2
GO:1901379,BP,GO:1901379,regulation of potassium ion transmembrane transport,2/269,86/18888,0.023255814,1.632921241,0.707092657,0.34706776,0.393539252,0.165027896,CAV1/LRRC26,2
GO:0002507,BP,GO:0002507,tolerance induction,1/269,30/18888,0.033333333,2.340520446,0.883213519,0.349920189,0.395886859,0.166012349,CD274,1
GO:0007588,BP,GO:0007588,excretion,1/269,30/18888,0.033333333,2.340520446,0.883213519,0.349920189,0.395886859,0.166012349,EDNRB,1
GO:0045762,BP,GO:0045762,positive regulation of adenylate cyclase activity,1/269,30/18888,0.033333333,2.340520446,0.883213519,0.349920189,0.395886859,0.166012349,LGR4,1
GO:0046856,BP,GO:0046856,phosphatidylinositol dephosphorylation,1/269,30/18888,0.033333333,2.340520446,0.883213519,0.349920189,0.395886859,0.166012349,PTEN,1
GO:0060295,BP,GO:0060295,regulation of cilium movement involved in cell motility,1/269,30/18888,0.033333333,2.340520446,0.883213519,0.349920189,0.395886859,0.166012349,DEFB1,1
GO:0086011,BP,GO:0086011,membrane repolarization during action potential,1/269,30/18888,0.033333333,2.340520446,0.883213519,0.349920189,0.395886859,0.166012349,CAV1,1
GO:1901380,BP,GO:1901380,negative regulation of potassium ion transmembrane transport,1/269,30/18888,0.033333333,2.340520446,0.883213519,0.349920189,0.395886859,0.166012349,CAV1,1
GO:1901385,BP,GO:1901385,regulation of voltage-gated calcium channel activity,1/269,30/18888,0.033333333,2.340520446,0.883213519,0.349920189,0.395886859,0.166012349,MIR200C,1
GO:1902019,BP,GO:1902019,regulation of cilium-dependent cell motility,1/269,30/18888,0.033333333,2.340520446,0.883213519,0.349920189,0.395886859,0.166012349,DEFB1,1
GO:0001508,BP,GO:0001508,action potential,3/269,149/18888,0.020134228,1.413737182,0.609430149,0.356662609,0.403414808,0.169169141,MTOR/TNF/CAV1,3
GO:0002825,BP,GO:0002825,regulation of T-helper 1 type immune response,1/269,31/18888,0.032258065,2.265019787,0.847269005,0.359193254,0.404569707,0.16965344,IL1B,1
GO:0003298,BP,GO:0003298,physiological muscle hypertrophy,1/269,31/18888,0.032258065,2.265019787,0.847269005,0.359193254,0.404569707,0.16965344,IGF1,1
GO:0003301,BP,GO:0003301,physiological cardiac muscle hypertrophy,1/269,31/18888,0.032258065,2.265019787,0.847269005,0.359193254,0.404569707,0.16965344,IGF1,1
GO:0007064,BP,GO:0007064,mitotic sister chromatid cohesion,1/269,31/18888,0.032258065,2.265019787,0.847269005,0.359193254,0.404569707,0.16965344,RB1,1
GO:0010765,BP,GO:0010765,positive regulation of sodium ion transport,1/269,31/18888,0.032258065,2.265019787,0.847269005,0.359193254,0.404569707,0.16965344,AKT1,1
GO:0010804,BP,GO:0010804,negative regulation of tumor necrosis factor-mediated signaling pathway,1/269,31/18888,0.032258065,2.265019787,0.847269005,0.359193254,0.404569707,0.16965344,GSTP1,1
GO:0010996,BP,GO:0010996,response to auditory stimulus,1/269,31/18888,0.032258065,2.265019787,0.847269005,0.359193254,0.404569707,0.16965344,UCN,1
GO:0021602,BP,GO:0021602,cranial nerve morphogenesis,1/269,31/18888,0.032258065,2.265019787,0.847269005,0.359193254,0.404569707,0.16965344,TFAP2A,1
GO:0030808,BP,GO:0030808,regulation of nucleotide biosynthetic process,1/269,31/18888,0.032258065,2.265019787,0.847269005,0.359193254,0.404569707,0.16965344,PARP1,1
GO:0034311,BP,GO:0034311,diol metabolic process,1/269,31/18888,0.032258065,2.265019787,0.847269005,0.359193254,0.404569707,0.16965344,SPHK1,1
GO:0036336,BP,GO:0036336,dendritic cell migration,1/269,31/18888,0.032258065,2.265019787,0.847269005,0.359193254,0.404569707,0.16965344,CXCR2,1
GO:0040018,BP,GO:0040018,positive regulation of multicellular organism growth,1/269,31/18888,0.032258065,2.265019787,0.847269005,0.359193254,0.404569707,0.16965344,IGF2,1
GO:0042744,BP,GO:0042744,hydrogen peroxide catabolic process,1/269,31/18888,0.032258065,2.265019787,0.847269005,0.359193254,0.404569707,0.16965344,GPX1,1
GO:0061049,BP,GO:0061049,cell growth involved in cardiac muscle cell development,1/269,31/18888,0.032258065,2.265019787,0.847269005,0.359193254,0.404569707,0.16965344,IGF1,1
GO:0065002,BP,GO:0065002,intracellular protein transmembrane transport,1/269,31/18888,0.032258065,2.265019787,0.847269005,0.359193254,0.404569707,0.16965344,HSPA5,1
GO:0070198,BP,GO:0070198,"protein localization to chromosome, telomeric region",1/269,31/18888,0.032258065,2.265019787,0.847269005,0.359193254,0.404569707,0.16965344,BRCA2,1
GO:1900371,BP,GO:1900371,regulation of purine nucleotide biosynthetic process,1/269,31/18888,0.032258065,2.265019787,0.847269005,0.359193254,0.404569707,0.16965344,PARP1,1
GO:0018205,BP,GO:0018205,peptidyl-lysine modification,3/269,150/18888,0.02,1.404312268,0.597558441,0.360545629,0.405992557,0.170250102,CTNNB1/HDAC6/RELA,3
GO:0006029,BP,GO:0006029,proteoglycan metabolic process,2/269,89/18888,0.02247191,1.577878952,0.656816358,0.362525966,0.408020825,0.171100642,CTNNB1/IGF1,2
GO:0072384,BP,GO:0072384,organelle transport along microtubule,2/269,89/18888,0.02247191,1.577878952,0.656816358,0.362525966,0.408020825,0.171100642,HIF1A/HDAC6,2
GO:0009953,BP,GO:0009953,dorsal/ventral pattern formation,2/269,90/18888,0.022222222,1.560346964,0.640474598,0.367648704,0.412418804,0.172944903,CTNNB1/FOXA1,2
GO:0000289,BP,GO:0000289,nuclear-transcribed mRNA poly(A) tail shortening,1/269,32/18888,0.03125,2.194237918,0.812681765,0.368334529,0.412418804,0.172944903,MLH1,1
GO:0001958,BP,GO:0001958,endochondral ossification,1/269,32/18888,0.03125,2.194237918,0.812681765,0.368334529,0.412418804,0.172944903,MMP14,1
GO:0010644,BP,GO:0010644,cell communication by electrical coupling,1/269,32/18888,0.03125,2.194237918,0.812681765,0.368334529,0.412418804,0.172944903,CAV1,1
GO:0010667,BP,GO:0010667,negative regulation of cardiac muscle cell apoptotic process,1/269,32/18888,0.03125,2.194237918,0.812681765,0.368334529,0.412418804,0.172944903,MIR145,1
GO:0031116,BP,GO:0031116,positive regulation of microtubule polymerization,1/269,32/18888,0.03125,2.194237918,0.812681765,0.368334529,0.412418804,0.172944903,GIT1,1
GO:0035335,BP,GO:0035335,peptidyl-tyrosine dephosphorylation,1/269,32/18888,0.03125,2.194237918,0.812681765,0.368334529,0.412418804,0.172944903,DUSP6,1
GO:0035774,BP,GO:0035774,positive regulation of insulin secretion involved in cellular response to glucose stimulus,1/269,32/18888,0.03125,2.194237918,0.812681765,0.368334529,0.412418804,0.172944903,HIF1A,1
GO:0036075,BP,GO:0036075,replacement ossification,1/269,32/18888,0.03125,2.194237918,0.812681765,0.368334529,0.412418804,0.172944903,MMP14,1
GO:0045777,BP,GO:0045777,positive regulation of blood pressure,1/269,32/18888,0.03125,2.194237918,0.812681765,0.368334529,0.412418804,0.172944903,RHOA,1
GO:0045879,BP,GO:0045879,negative regulation of smoothened signaling pathway,1/269,32/18888,0.03125,2.194237918,0.812681765,0.368334529,0.412418804,0.172944903,RB1,1
GO:0051085,BP,GO:0051085,chaperone cofactor-dependent protein refolding,1/269,32/18888,0.03125,2.194237918,0.812681765,0.368334529,0.412418804,0.172944903,HSPA5,1
GO:0051642,BP,GO:0051642,centrosome localization,1/269,32/18888,0.03125,2.194237918,0.812681765,0.368334529,0.412418804,0.172944903,AURKA,1
GO:0061036,BP,GO:0061036,positive regulation of cartilage development,1/269,32/18888,0.03125,2.194237918,0.812681765,0.368334529,0.412418804,0.172944903,SMAD3,1
GO:0061842,BP,GO:0061842,microtubule organizing center localization,1/269,32/18888,0.03125,2.194237918,0.812681765,0.368334529,0.412418804,0.172944903,AURKA,1
GO:0080111,BP,GO:0080111,DNA demethylation,1/269,32/18888,0.03125,2.194237918,0.812681765,0.368334529,0.412418804,0.172944903,GATA3,1
GO:0090317,BP,GO:0090317,negative regulation of intracellular protein transport,1/269,32/18888,0.03125,2.194237918,0.812681765,0.368334529,0.412418804,0.172944903,TXN,1
GO:0140058,BP,GO:0140058,neuron projection arborization,1/269,32/18888,0.03125,2.194237918,0.812681765,0.368334529,0.412418804,0.172944903,ROCK1,1
GO:1901020,BP,GO:1901020,negative regulation of calcium ion transmembrane transporter activity,1/269,32/18888,0.03125,2.194237918,0.812681765,0.368334529,0.412418804,0.172944903,MIR200C,1
GO:1902235,BP,GO:1902235,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,1/269,32/18888,0.03125,2.194237918,0.812681765,0.368334529,0.412418804,0.172944903,PMAIP1,1
GO:2000463,BP,GO:2000463,positive regulation of excitatory postsynaptic potential,1/269,32/18888,0.03125,2.194237918,0.812681765,0.368334529,0.412418804,0.172944903,PTEN,1
GO:0034767,BP,GO:0034767,positive regulation of monoatomic ion transmembrane transport,3/269,154/18888,0.019480519,1.367836624,0.550908566,0.376040328,0.420943424,0.176519642,CAV1/BAX/LRRC26,3
GO:0019693,BP,GO:0019693,ribose phosphate metabolic process,8/269,480/18888,0.016666667,1.170260223,0.454161137,0.376346484,0.421182653,0.176619961,PARP1/HIF1A/STAT3/MTOR/TGFB1/GIT1/IGF1/FBP1,8
GO:1903046,BP,GO:1903046,meiotic cell cycle process,4/269,218/18888,0.018348624,1.288359879,0.514719209,0.376497455,0.421248134,0.17664742,PTEN/AURKA/BRCA2/MLH1,4
GO:0001975,BP,GO:0001975,response to amphetamine,1/269,33/18888,0.03030303,2.12774586,0.779353333,0.377345879,0.421266313,0.176655043,HDAC6,1
GO:0006622,BP,GO:0006622,protein targeting to lysosome,1/269,33/18888,0.03030303,2.12774586,0.779353333,0.377345879,0.421266313,0.176655043,CLU,1
GO:0015012,BP,GO:0015012,heparan sulfate proteoglycan biosynthetic process,1/269,33/18888,0.03030303,2.12774586,0.779353333,0.377345879,0.421266313,0.176655043,CTNNB1,1
GO:0043949,BP,GO:0043949,regulation of cAMP-mediated signaling,1/269,33/18888,0.03030303,2.12774586,0.779353333,0.377345879,0.421266313,0.176655043,UCN,1
GO:0045026,BP,GO:0045026,plasma membrane fusion,1/269,33/18888,0.03030303,2.12774586,0.779353333,0.377345879,0.421266313,0.176655043,CD9,1
GO:0050858,BP,GO:0050858,negative regulation of antigen receptor-mediated signaling pathway,1/269,33/18888,0.03030303,2.12774586,0.779353333,0.377345879,0.421266313,0.176655043,PAWR,1
GO:0051497,BP,GO:0051497,negative regulation of stress fiber assembly,1/269,33/18888,0.03030303,2.12774586,0.779353333,0.377345879,0.421266313,0.176655043,DLC1,1
GO:0051647,BP,GO:0051647,nucleus localization,1/269,33/18888,0.03030303,2.12774586,0.779353333,0.377345879,0.421266313,0.176655043,MTOR,1
GO:1902882,BP,GO:1902882,regulation of response to oxidative stress,1/269,33/18888,0.03030303,2.12774586,0.779353333,0.377345879,0.421266313,0.176655043,HDAC6,1
GO:0032411,BP,GO:0032411,positive regulation of transporter activity,2/269,92/18888,0.02173913,1.526426378,0.608384712,0.377845536,0.421514266,0.176759021,PRKCD/LRRC26,2
GO:0045995,BP,GO:0045995,regulation of embryonic development,2/269,92/18888,0.02173913,1.526426378,0.608384712,0.377845536,0.421514266,0.176759021,CTNNB1/NOTCH1,2
GO:0071103,BP,GO:0071103,DNA conformation change,2/269,92/18888,0.02173913,1.526426378,0.608384712,0.377845536,0.421514266,0.176759021,HHEX/NBN,2
GO:0045807,BP,GO:0045807,positive regulation of endocytosis,3/269,155/18888,0.019354839,1.359011872,0.539449068,0.379902965,0.423705731,0.177677996,VEGFA/SERPINE1/CLU,3
GO:0070098,BP,GO:0070098,chemokine-mediated signaling pathway,2/269,93/18888,0.021505376,1.510013191,0.592626643,0.382918486,0.426964421,0.179044504,CXCR2/HIF1A,2
GO:0032412,BP,GO:0032412,regulation of monoatomic ion transmembrane transporter activity,4/269,221/18888,0.018099548,1.27087083,0.486856045,0.386171447,0.429080707,0.179931954,MMP9/CAV1/MIR200C/LRRC26,4
GO:0002323,BP,GO:0002323,natural killer cell activation involved in immune response,1/269,34/18888,0.029411765,2.065165099,0.747195228,0.386229143,0.429080707,0.179931954,IFNA1,1
GO:0006691,BP,GO:0006691,leukotriene metabolic process,1/269,34/18888,0.029411765,2.065165099,0.747195228,0.386229143,0.429080707,0.179931954,ALOX12,1
GO:0010664,BP,GO:0010664,negative regulation of striated muscle cell apoptotic process,1/269,34/18888,0.029411765,2.065165099,0.747195228,0.386229143,0.429080707,0.179931954,MIR145,1
GO:0035456,BP,GO:0035456,response to interferon-beta,1/269,34/18888,0.029411765,2.065165099,0.747195228,0.386229143,0.429080707,0.179931954,STAT1,1
GO:0048199,BP,GO:0048199,"vesicle targeting, to, from or within Golgi",1/269,34/18888,0.029411765,2.065165099,0.747195228,0.386229143,0.429080707,0.179931954,CUL3,1
GO:0048240,BP,GO:0048240,sperm capacitation,1/269,34/18888,0.029411765,2.065165099,0.747195228,0.386229143,0.429080707,0.179931954,DEFB1,1
GO:0050775,BP,GO:0050775,positive regulation of dendrite morphogenesis,1/269,34/18888,0.029411765,2.065165099,0.747195228,0.386229143,0.429080707,0.179931954,HDAC6,1
GO:0086004,BP,GO:0086004,regulation of cardiac muscle cell contraction,1/269,34/18888,0.029411765,2.065165099,0.747195228,0.386229143,0.429080707,0.179931954,CAV1,1
GO:0090022,BP,GO:0090022,regulation of neutrophil chemotaxis,1/269,34/18888,0.029411765,2.065165099,0.747195228,0.386229143,0.429080707,0.179931954,CXCR2,1
GO:0090075,BP,GO:0090075,relaxation of muscle,1/269,34/18888,0.029411765,2.065165099,0.747195228,0.386229143,0.429080707,0.179931954,PIK3CA,1
GO:0090162,BP,GO:0090162,establishment of epithelial cell polarity,1/269,34/18888,0.029411765,2.065165099,0.747195228,0.386229143,0.429080707,0.179931954,RHOA,1
GO:1902624,BP,GO:1902624,positive regulation of neutrophil migration,1/269,34/18888,0.029411765,2.065165099,0.747195228,0.386229143,0.429080707,0.179931954,CXCR2,1
GO:1903725,BP,GO:1903725,regulation of phospholipid metabolic process,1/269,34/18888,0.029411765,2.065165099,0.747195228,0.386229143,0.429080707,0.179931954,PRKCD,1
GO:1904861,BP,GO:1904861,excitatory synapse assembly,1/269,34/18888,0.029411765,2.065165099,0.747195228,0.386229143,0.429080707,0.179931954,PTEN,1
GO:0045104,BP,GO:0045104,intermediate filament cytoskeleton organization,2/269,94/18888,0.021276596,1.493949221,0.577053493,0.387973728,0.430808751,0.180656597,PKP1/VIM,2
GO:0051952,BP,GO:0051952,regulation of amine transport,2/269,94/18888,0.021276596,1.493949221,0.577053493,0.387973728,0.430808751,0.180656597,TNF/SNCG,2
GO:0051258,BP,GO:0051258,protein polymerization,5/269,287/18888,0.017421603,1.223268526,0.458120537,0.388461126,0.431244856,0.180839475,TENM1/MTOR/PRKCD/GIT1/HSP90AA1,5
GO:0048515,BP,GO:0048515,spermatid differentiation,4/269,222/18888,0.018018018,1.265146187,0.477656505,0.389392321,0.432173305,0.181228813,DEFB1/SMARCA2/SRPK1/BAX,4
GO:1905039,BP,GO:1905039,carboxylic acid transmembrane transport,3/269,158/18888,0.018987342,1.333207849,0.505538612,0.391459169,0.434361416,0.182146382,THBS1/TNF/AKT1,3
GO:0030641,BP,GO:0030641,regulation of cellular pH,2/269,95/18888,0.021052632,1.47822344,0.561660728,0.393010736,0.435870719,0.182779297,FASLG/MAPK1,2
GO:0045103,BP,GO:0045103,intermediate filament-based process,2/269,95/18888,0.021052632,1.47822344,0.561660728,0.393010736,0.435870719,0.182779297,PKP1/VIM,2
GO:0010669,BP,GO:0010669,epithelial structure maintenance,1/269,35/18888,0.028571429,2.006160382,0.716127672,0.394986137,0.437103921,0.183296432,TLR4,1
GO:0019228,BP,GO:0019228,neuronal action potential,1/269,35/18888,0.028571429,2.006160382,0.716127672,0.394986137,0.437103921,0.183296432,MTOR,1
GO:0032228,BP,GO:0032228,"regulation of synaptic transmission, GABAergic",1/269,35/18888,0.028571429,2.006160382,0.716127672,0.394986137,0.437103921,0.183296432,KRAS,1
GO:0032633,BP,GO:0032633,interleukin-4 production,1/269,35/18888,0.028571429,2.006160382,0.716127672,0.394986137,0.437103921,0.183296432,GATA3,1
GO:0032673,BP,GO:0032673,regulation of interleukin-4 production,1/269,35/18888,0.028571429,2.006160382,0.716127672,0.394986137,0.437103921,0.183296432,GATA3,1
GO:0046164,BP,GO:0046164,alcohol catabolic process,1/269,35/18888,0.028571429,2.006160382,0.716127672,0.394986137,0.437103921,0.183296432,AKR1C3,1
GO:0050974,BP,GO:0050974,detection of mechanical stimulus involved in sensory perception,1/269,35/18888,0.028571429,2.006160382,0.716127672,0.394986137,0.437103921,0.183296432,TNF,1
GO:0086005,BP,GO:0086005,ventricular cardiac muscle cell action potential,1/269,35/18888,0.028571429,2.006160382,0.716127672,0.394986137,0.437103921,0.183296432,CAV1,1
GO:0099171,BP,GO:0099171,presynaptic modulation of chemical synaptic transmission,1/269,35/18888,0.028571429,2.006160382,0.716127672,0.394986137,0.437103921,0.183296432,GIT1,1
GO:0048284,BP,GO:0048284,organelle fusion,3/269,159/18888,0.018867925,1.324822894,0.494387354,0.395299623,0.437238428,0.183352836,BAX/SPHK1/BNIP3,3
GO:1903825,BP,GO:1903825,organic acid transmembrane transport,3/269,159/18888,0.018867925,1.324822894,0.494387354,0.395299623,0.437238428,0.183352836,THBS1/TNF/AKT1,3
GO:0016079,BP,GO:0016079,synaptic vesicle exocytosis,2/269,96/18888,0.020833333,1.462825279,0.546443973,0.398029006,0.440043715,0.184529214,GIT1/BRAF,2
GO:0060996,BP,GO:0060996,dendritic spine development,2/269,96/18888,0.020833333,1.462825279,0.546443973,0.398029006,0.440043715,0.184529214,PTEN/HDAC6,2
GO:0002181,BP,GO:0002181,cytoplasmic translation,3/269,160/18888,0.01875,1.316542751,0.483310374,0.399133761,0.441158034,0.184996495,CNBP/YBX1/MTOR,3
GO:0050657,BP,GO:0050657,nucleic acid transport,3/269,161/18888,0.01863354,1.308365467,0.47230661,0.402961285,0.444282812,0.186306849,YBX1/HHEX/PEG10,3
GO:0050658,BP,GO:0050658,RNA transport,3/269,161/18888,0.01863354,1.308365467,0.47230661,0.402961285,0.444282812,0.186306849,YBX1/HHEX/PEG10,3
GO:0002275,BP,GO:0002275,myeloid cell activation involved in immune response,2/269,97/18888,0.020618557,1.447744606,0.531399006,0.403028048,0.444282812,0.186306849,TNF/MYD88,2
GO:0002021,BP,GO:0002021,response to dietary excess,1/269,36/18888,0.027777778,1.950433705,0.686078513,0.403618648,0.444282812,0.186306849,MAPK14,1
GO:0006882,BP,GO:0006882,intracellular zinc ion homeostasis,1/269,36/18888,0.027777778,1.950433705,0.686078513,0.403618648,0.444282812,0.186306849,SLC39A9,1
GO:0010770,BP,GO:0010770,positive regulation of cell morphogenesis,1/269,36/18888,0.027777778,1.950433705,0.686078513,0.403618648,0.444282812,0.186306849,HDAC6,1
GO:0016486,BP,GO:0016486,peptide hormone processing,1/269,36/18888,0.027777778,1.950433705,0.686078513,0.403618648,0.444282812,0.186306849,PCSK1,1
GO:0032232,BP,GO:0032232,negative regulation of actin filament bundle assembly,1/269,36/18888,0.027777778,1.950433705,0.686078513,0.403618648,0.444282812,0.186306849,DLC1,1
GO:0032435,BP,GO:0032435,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,1/269,36/18888,0.027777778,1.950433705,0.686078513,0.403618648,0.444282812,0.186306849,FHIT,1
GO:0032717,BP,GO:0032717,negative regulation of interleukin-8 production,1/269,36/18888,0.027777778,1.950433705,0.686078513,0.403618648,0.444282812,0.186306849,IL10,1
GO:0042462,BP,GO:0042462,eye photoreceptor cell development,1/269,36/18888,0.027777778,1.950433705,0.686078513,0.403618648,0.444282812,0.186306849,VEGFA,1
GO:0048665,BP,GO:0048665,neuron fate specification,1/269,36/18888,0.027777778,1.950433705,0.686078513,0.403618648,0.444282812,0.186306849,FOXA1,1
GO:0070633,BP,GO:0070633,transepithelial transport,1/269,36/18888,0.027777778,1.950433705,0.686078513,0.403618648,0.444282812,0.186306849,EDNRB,1
GO:0071539,BP,GO:0071539,protein localization to centrosome,1/269,36/18888,0.027777778,1.950433705,0.686078513,0.403618648,0.444282812,0.186306849,AURKA,1
GO:1905476,BP,GO:1905476,negative regulation of protein localization to membrane,1/269,36/18888,0.027777778,1.950433705,0.686078513,0.403618648,0.444282812,0.186306849,TGFB1,1
GO:2000406,BP,GO:2000406,positive regulation of T cell migration,1/269,36/18888,0.027777778,1.950433705,0.686078513,0.403618648,0.444282812,0.186306849,RHOA,1
GO:2000780,BP,GO:2000780,negative regulation of double-strand break repair,1/269,36/18888,0.027777778,1.950433705,0.686078513,0.403618648,0.444282812,0.186306849,TWIST1,1
GO:0021510,BP,GO:0021510,spinal cord development,2/269,98/18888,0.020408163,1.432971702,0.516521751,0.408007393,0.448896808,0.188241696,SOX11/NOTCH1,2
GO:0030101,BP,GO:0030101,natural killer cell activation,2/269,98/18888,0.020408163,1.432971702,0.516521751,0.408007393,0.448896808,0.188241696,CASP8/IFNA1,2
GO:0001736,BP,GO:0001736,establishment of planar polarity,1/269,37/18888,0.027027027,1.897719281,0.656982305,0.412128439,0.451794314,0.189456744,TP63,1
GO:0002504,BP,GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,1/269,37/18888,0.027027027,1.897719281,0.656982305,0.412128439,0.451794314,0.189456744,THBS1,1
GO:0003161,BP,GO:0003161,cardiac conduction system development,1/269,37/18888,0.027027027,1.897719281,0.656982305,0.412128439,0.451794314,0.189456744,NOTCH1,1
GO:0007164,BP,GO:0007164,establishment of tissue polarity,1/269,37/18888,0.027027027,1.897719281,0.656982305,0.412128439,0.451794314,0.189456744,TP63,1
GO:0014059,BP,GO:0014059,regulation of dopamine secretion,1/269,37/18888,0.027027027,1.897719281,0.656982305,0.412128439,0.451794314,0.189456744,SNCG,1
GO:0021955,BP,GO:0021955,central nervous system neuron axonogenesis,1/269,37/18888,0.027027027,1.897719281,0.656982305,0.412128439,0.451794314,0.189456744,PTEN,1
GO:0035510,BP,GO:0035510,DNA dealkylation,1/269,37/18888,0.027027027,1.897719281,0.656982305,0.412128439,0.451794314,0.189456744,GATA3,1
GO:0043162,BP,GO:0043162,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,1/269,37/18888,0.027027027,1.897719281,0.656982305,0.412128439,0.451794314,0.189456744,HDAC6,1
GO:0043267,BP,GO:0043267,negative regulation of potassium ion transport,1/269,37/18888,0.027027027,1.897719281,0.656982305,0.412128439,0.451794314,0.189456744,CAV1,1
GO:0045880,BP,GO:0045880,positive regulation of smoothened signaling pathway,1/269,37/18888,0.027027027,1.897719281,0.656982305,0.412128439,0.451794314,0.189456744,FOXA1,1
GO:0051084,BP,GO:0051084,'de novo' post-translational protein folding,1/269,37/18888,0.027027027,1.897719281,0.656982305,0.412128439,0.451794314,0.189456744,HSPA5,1
GO:0070229,BP,GO:0070229,negative regulation of lymphocyte apoptotic process,1/269,37/18888,0.027027027,1.897719281,0.656982305,0.412128439,0.451794314,0.189456744,HIF1A,1
GO:1901381,BP,GO:1901381,positive regulation of potassium ion transmembrane transport,1/269,37/18888,0.027027027,1.897719281,0.656982305,0.412128439,0.451794314,0.189456744,LRRC26,1
GO:1903514,BP,GO:1903514,release of sequestered calcium ion into cytosol by endoplasmic reticulum,1/269,37/18888,0.027027027,1.897719281,0.656982305,0.412128439,0.451794314,0.189456744,FASLG,1
GO:1905508,BP,GO:1905508,protein localization to microtubule organizing center,1/269,37/18888,0.027027027,1.897719281,0.656982305,0.412128439,0.451794314,0.189456744,AURKA,1
GO:0035278,BP,GO:0035278,miRNA-mediated gene silencing by inhibition of translation,2/269,99/18888,0.02020202,1.41849724,0.501808272,0.412966587,0.452604227,0.189796375,MIR200C/MIR145,2
GO:0051236,BP,GO:0051236,establishment of RNA localization,3/269,164/18888,0.018292683,1.284431952,0.439724277,0.414401284,0.453958223,0.190364164,YBX1/HHEX/PEG10,3
GO:1902850,BP,GO:1902850,microtubule cytoskeleton organization involved in mitosis,3/269,164/18888,0.018292683,1.284431952,0.439724277,0.414401284,0.453958223,0.190364164,AURKA/RHOA/CHEK2,3
GO:0002385,BP,GO:0002385,mucosal immune response,1/269,38/18888,0.026315789,1.8477793,0.628779513,0.420517249,0.459663288,0.192756543,DEFB1,1
GO:0042401,BP,GO:0042401,biogenic amine biosynthetic process,1/269,38/18888,0.026315789,1.8477793,0.628779513,0.420517249,0.459663288,0.192756543,GATA3,1
GO:0042755,BP,GO:0042755,eating behavior,1/269,38/18888,0.026315789,1.8477793,0.628779513,0.420517249,0.459663288,0.192756543,STAT3,1
GO:0044743,BP,GO:0044743,protein transmembrane import into intracellular organelle,1/269,38/18888,0.026315789,1.8477793,0.628779513,0.420517249,0.459663288,0.192756543,AIFM1,1
GO:0045652,BP,GO:0045652,regulation of megakaryocyte differentiation,1/269,38/18888,0.026315789,1.8477793,0.628779513,0.420517249,0.459663288,0.192756543,MYB,1
GO:0045738,BP,GO:0045738,negative regulation of DNA repair,1/269,38/18888,0.026315789,1.8477793,0.628779513,0.420517249,0.459663288,0.192756543,TWIST1,1
GO:0046688,BP,GO:0046688,response to copper ion,1/269,38/18888,0.026315789,1.8477793,0.628779513,0.420517249,0.459663288,0.192756543,CYP1A1,1
GO:0048854,BP,GO:0048854,brain morphogenesis,1/269,38/18888,0.026315789,1.8477793,0.628779513,0.420517249,0.459663288,0.192756543,PTEN,1
GO:0071711,BP,GO:0071711,basement membrane organization,1/269,38/18888,0.026315789,1.8477793,0.628779513,0.420517249,0.459663288,0.192756543,CAV1,1
GO:0007338,BP,GO:0007338,single fertilization,3/269,166/18888,0.018072289,1.268956868,0.418350235,0.421989673,0.461162137,0.193385074,AR/CD9/MST1R,3
GO:0006754,BP,GO:0006754,ATP biosynthetic process,2/269,101/18888,0.01980198,1.390408186,0.472857562,0.422822793,0.461961785,0.193720401,PARP1/TGFB1,2
GO:0030041,BP,GO:0030041,actin filament polymerization,3/269,167/18888,0.017964072,1.261358324,0.407764586,0.425771572,0.465071993,0.195024645,TENM1/MTOR/PRKCD,3
GO:0019080,BP,GO:0019080,viral gene expression,2/269,102/18888,0.019607843,1.376776733,0.458613101,0.42771898,0.466352976,0.195561816,TMPRSS2/SMARCA4,2
GO:0042773,BP,GO:0042773,ATP synthesis coupled electron transport,2/269,102/18888,0.019607843,1.376776733,0.458613101,0.42771898,0.466352976,0.195561816,COX2/BID,2
GO:0042775,BP,GO:0042775,mitochondrial ATP synthesis coupled electron transport,2/269,102/18888,0.019607843,1.376776733,0.458613101,0.42771898,0.466352976,0.195561816,COX2/BID,2
GO:0043266,BP,GO:0043266,regulation of potassium ion transport,2/269,102/18888,0.019607843,1.376776733,0.458613101,0.42771898,0.466352976,0.195561816,CAV1/LRRC26,2
GO:0009309,BP,GO:0009309,amine biosynthetic process,1/269,39/18888,0.025641026,1.800400343,0.601415846,0.428786791,0.466352976,0.195561816,GATA3,1
GO:0014912,BP,GO:0014912,negative regulation of smooth muscle cell migration,1/269,39/18888,0.025641026,1.800400343,0.601415846,0.428786791,0.466352976,0.195561816,SERPINE1,1
GO:0017158,BP,GO:0017158,regulation of calcium ion-dependent exocytosis,1/269,39/18888,0.025641026,1.800400343,0.601415846,0.428786791,0.466352976,0.195561816,NOTCH1,1
GO:0035025,BP,GO:0035025,positive regulation of Rho protein signal transduction,1/269,39/18888,0.025641026,1.800400343,0.601415846,0.428786791,0.466352976,0.195561816,ERBB2,1
GO:0038179,BP,GO:0038179,neurotrophin signaling pathway,1/269,39/18888,0.025641026,1.800400343,0.601415846,0.428786791,0.466352976,0.195561816,CASP3,1
GO:0042044,BP,GO:0042044,fluid transport,1/269,39/18888,0.025641026,1.800400343,0.601415846,0.428786791,0.466352976,0.195561816,EDNRB,1
GO:0048741,BP,GO:0048741,skeletal muscle fiber development,1/269,39/18888,0.025641026,1.800400343,0.601415846,0.428786791,0.466352976,0.195561816,GPX1,1
GO:0050892,BP,GO:0050892,intestinal absorption,1/269,39/18888,0.025641026,1.800400343,0.601415846,0.428786791,0.466352976,0.195561816,VDR,1
GO:0051349,BP,GO:0051349,positive regulation of lyase activity,1/269,39/18888,0.025641026,1.800400343,0.601415846,0.428786791,0.466352976,0.195561816,LGR4,1
GO:0051938,BP,GO:0051938,L-glutamate import,1/269,39/18888,0.025641026,1.800400343,0.601415846,0.428786791,0.466352976,0.195561816,TNF,1
GO:0060306,BP,GO:0060306,regulation of membrane repolarization,1/269,39/18888,0.025641026,1.800400343,0.601415846,0.428786791,0.466352976,0.195561816,CAV1,1
GO:0071312,BP,GO:0071312,cellular response to alkaloid,1/269,39/18888,0.025641026,1.800400343,0.601415846,0.428786791,0.466352976,0.195561816,CASP3,1
GO:0097106,BP,GO:0097106,postsynaptic density organization,1/269,39/18888,0.025641026,1.800400343,0.601415846,0.428786791,0.466352976,0.195561816,PTEN,1
GO:1901223,BP,GO:1901223,negative regulation of non-canonical NF-kappaB signal transduction,1/269,39/18888,0.025641026,1.800400343,0.601415846,0.428786791,0.466352976,0.195561816,RELA,1
GO:1903169,BP,GO:1903169,regulation of calcium ion transmembrane transport,3/269,168/18888,0.017857143,1.253850239,0.397245283,0.429544925,0.467066033,0.195860831,CAV1/MIR200C/BAX,3
GO:0015914,BP,GO:0015914,phospholipid transport,2/269,103/18888,0.019417476,1.363409969,0.44451795,0.432593368,0.470156342,0.19715673,FASLG/PRKCD,2
GO:0099175,BP,GO:0099175,regulation of postsynapse organization,2/269,103/18888,0.019417476,1.363409969,0.44451795,0.432593368,0.470156342,0.19715673,PTEN/AKT1,2
GO:0016050,BP,GO:0016050,vesicle organization,6/269,371/18888,0.016172507,1.135562481,0.316971783,0.434512768,0.472129781,0.197984278,FASLG/RILP/SQSTM1/CAV1/CUL3/SPHK1,6
GO:0006901,BP,GO:0006901,vesicle coating,1/269,40/18888,0.025,1.755390335,0.574841663,0.436938754,0.473861691,0.198710542,CUL3,1
GO:0007212,BP,GO:0007212,dopamine receptor signaling pathway,1/269,40/18888,0.025,1.755390335,0.574841663,0.436938754,0.473861691,0.198710542,ALK,1
GO:0009595,BP,GO:0009595,detection of biotic stimulus,1/269,40/18888,0.025,1.755390335,0.574841663,0.436938754,0.473861691,0.198710542,TLR4,1
GO:0030488,BP,GO:0030488,tRNA methylation,1/269,40/18888,0.025,1.755390335,0.574841663,0.436938754,0.473861691,0.198710542,AKT1,1
GO:0046676,BP,GO:0046676,negative regulation of insulin secretion,1/269,40/18888,0.025,1.755390335,0.574841663,0.436938754,0.473861691,0.198710542,IRS1,1
GO:0071459,BP,GO:0071459,"protein localization to chromosome, centromeric region",1/269,40/18888,0.025,1.755390335,0.574841663,0.436938754,0.473861691,0.198710542,RB1,1
GO:0086091,BP,GO:0086091,regulation of heart rate by cardiac conduction,1/269,40/18888,0.025,1.755390335,0.574841663,0.436938754,0.473861691,0.198710542,CAV1,1
GO:1903115,BP,GO:1903115,regulation of actin filament-based movement,1/269,40/18888,0.025,1.755390335,0.574841663,0.436938754,0.473861691,0.198710542,CAV1,1
GO:0022600,BP,GO:0022600,digestive system process,2/269,104/18888,0.019230769,1.350300257,0.430568784,0.437445582,0.474298447,0.198893693,VDR/TLR4,2
GO:0007034,BP,GO:0007034,vacuolar transport,3/269,171/18888,0.01754386,1.231852866,0.366076507,0.440811183,0.477833869,0.200376247,RILP/SQSTM1/CLU,3
GO:0015837,BP,GO:0015837,amine transport,2/269,105/18888,0.019047619,1.337440255,0.416762385,0.442275265,0.479306877,0.200993942,TNF/SNCG,2
GO:0000731,BP,GO:0000731,DNA synthesis involved in DNA repair,1/269,41/18888,0.024390244,1.712575936,0.549011472,0.444974804,0.480973952,0.201693018,PCNA,1
GO:0003352,BP,GO:0003352,regulation of cilium movement,1/269,41/18888,0.024390244,1.712575936,0.549011472,0.444974804,0.480973952,0.201693018,DEFB1,1
GO:0006458,BP,GO:0006458,'de novo' protein folding,1/269,41/18888,0.024390244,1.712575936,0.549011472,0.444974804,0.480973952,0.201693018,HSPA5,1
GO:0032509,BP,GO:0032509,endosome transport via multivesicular body sorting pathway,1/269,41/18888,0.024390244,1.712575936,0.549011472,0.444974804,0.480973952,0.201693018,RILP,1
GO:0032781,BP,GO:0032781,positive regulation of ATP-dependent activity,1/269,41/18888,0.024390244,1.712575936,0.549011472,0.444974804,0.480973952,0.201693018,MSH2,1
GO:0045066,BP,GO:0045066,regulatory T cell differentiation,1/269,41/18888,0.024390244,1.712575936,0.549011472,0.444974804,0.480973952,0.201693018,TGFB1,1
GO:0048489,BP,GO:0048489,synaptic vesicle transport,1/269,41/18888,0.024390244,1.712575936,0.549011472,0.444974804,0.480973952,0.201693018,CTNNB1,1
GO:0051281,BP,GO:0051281,positive regulation of release of sequestered calcium ion into cytosol,1/269,41/18888,0.024390244,1.712575936,0.549011472,0.444974804,0.480973952,0.201693018,BAX,1
GO:0099068,BP,GO:0099068,postsynapse assembly,1/269,41/18888,0.024390244,1.712575936,0.549011472,0.444974804,0.480973952,0.201693018,PTEN,1
GO:1900016,BP,GO:1900016,negative regulation of cytokine production involved in inflammatory response,1/269,41/18888,0.024390244,1.712575936,0.549011472,0.444974804,0.480973952,0.201693018,EZH2,1
GO:1901661,BP,GO:1901661,quinone metabolic process,1/269,41/18888,0.024390244,1.712575936,0.549011472,0.444974804,0.480973952,0.201693018,AKR1C3,1
GO:0030148,BP,GO:0030148,sphingolipid biosynthetic process,2/269,106/18888,0.018867925,1.324822894,0.403095639,0.447082074,0.48313708,0.202600111,PRKCD/SPHK1,2
GO:1904062,BP,GO:1904062,regulation of monoatomic cation transmembrane transport,5/269,309/18888,0.01618123,1.136174974,0.290098062,0.450120437,0.486305124,0.203928608,MMP9/CAV1/MIR200C/BAX/LRRC26,5
GO:0060079,BP,GO:0060079,excitatory postsynaptic potential,2/269,107/18888,0.018691589,1.312441372,0.38956553,0.451865678,0.488074924,0.204670761,PTEN/AKT1,2
GO:0002691,BP,GO:0002691,regulation of cellular extravasation,1/269,42/18888,0.023809524,1.671800319,0.523883489,0.452896583,0.488493569,0.204846317,LYVE1,1
GO:0006958,BP,GO:0006958,"complement activation, classical pathway",1/269,42/18888,0.023809524,1.671800319,0.523883489,0.452896583,0.488493569,0.204846317,CLU,1
GO:0014046,BP,GO:0014046,dopamine secretion,1/269,42/18888,0.023809524,1.671800319,0.523883489,0.452896583,0.488493569,0.204846317,SNCG,1
GO:0072528,BP,GO:0072528,pyrimidine-containing compound biosynthetic process,1/269,42/18888,0.023809524,1.671800319,0.523883489,0.452896583,0.488493569,0.204846317,MTOR,1
GO:0098703,BP,GO:0098703,calcium ion import across plasma membrane,1/269,42/18888,0.023809524,1.671800319,0.523883489,0.452896583,0.488493569,0.204846317,MIR200C,1
GO:1902656,BP,GO:1902656,calcium ion import into cytosol,1/269,42/18888,0.023809524,1.671800319,0.523883489,0.452896583,0.488493569,0.204846317,MIR200C,1
GO:1902414,BP,GO:1902414,protein localization to cell junction,2/269,108/18888,0.018518519,1.300289137,0.376169136,0.456625764,0.492399285,0.206484151,ERBB2/HRAS,2
GO:0006476,BP,GO:0006476,protein deacetylation,1/269,43/18888,0.023255814,1.632921241,0.499419255,0.460705711,0.496094356,0.208033653,HDAC6,1
GO:0032506,BP,GO:0032506,cytokinetic process,1/269,43/18888,0.023255814,1.632921241,0.499419255,0.460705711,0.496094356,0.208033653,RHOA,1
GO:0046839,BP,GO:0046839,phospholipid dephosphorylation,1/269,43/18888,0.023255814,1.632921241,0.499419255,0.460705711,0.496094356,0.208033653,PTEN,1
GO:0051955,BP,GO:0051955,regulation of amino acid transport,1/269,43/18888,0.023255814,1.632921241,0.499419255,0.460705711,0.496094356,0.208033653,TNF,1
GO:0061001,BP,GO:0061001,regulation of dendritic spine morphogenesis,1/269,43/18888,0.023255814,1.632921241,0.499419255,0.460705711,0.496094356,0.208033653,PTEN,1
GO:2000403,BP,GO:2000403,positive regulation of lymphocyte migration,1/269,43/18888,0.023255814,1.632921241,0.499419255,0.460705711,0.496094356,0.208033653,RHOA,1
GO:0015711,BP,GO:0015711,organic anion transport,7/269,451/18888,0.015521064,1.08982105,0.232060234,0.462592675,0.49800856,0.208836361,THBS1/PTGS2/IL1B/PPARG/TNF/AKT1/RBP1,7
GO:0002183,BP,GO:0002183,cytoplasmic translational initiation,1/269,44/18888,0.022727273,1.595809395,0.475583295,0.468403783,0.503550645,0.211160395,MTOR,1
GO:0019320,BP,GO:0019320,hexose catabolic process,1/269,44/18888,0.022727273,1.595809395,0.475583295,0.468403783,0.503550645,0.211160395,TP53,1
GO:0030835,BP,GO:0030835,negative regulation of actin filament depolymerization,1/269,44/18888,0.022727273,1.595809395,0.475583295,0.468403783,0.503550645,0.211160395,PIK3CA,1
GO:0043268,BP,GO:0043268,positive regulation of potassium ion transport,1/269,44/18888,0.022727273,1.595809395,0.475583295,0.468403783,0.503550645,0.211160395,LRRC26,1
GO:0046717,BP,GO:0046717,acid secretion,1/269,44/18888,0.022727273,1.595809395,0.475583295,0.468403783,0.503550645,0.211160395,TNF,1
GO:0090114,BP,GO:0090114,COPII-coated vesicle budding,1/269,44/18888,0.022727273,1.595809395,0.475583295,0.468403783,0.503550645,0.211160395,CUL3,1
GO:0002444,BP,GO:0002444,myeloid leukocyte mediated immunity,2/269,112/18888,0.017857143,1.253850239,0.323865363,0.475425074,0.510504061,0.21407626,IL6/MYD88,2
GO:0009206,BP,GO:0009206,purine ribonucleoside triphosphate biosynthetic process,2/269,112/18888,0.017857143,1.253850239,0.323865363,0.475425074,0.510504061,0.21407626,PARP1/TGFB1,2
GO:0007020,BP,GO:0007020,microtubule nucleation,1/269,45/18888,0.022222222,1.560346964,0.452342829,0.475992373,0.510504061,0.21407626,GIT1,1
GO:0008038,BP,GO:0008038,neuron recognition,1/269,45/18888,0.022222222,1.560346964,0.452342829,0.475992373,0.510504061,0.21407626,CASP3,1
GO:0018198,BP,GO:0018198,peptidyl-cysteine modification,1/269,45/18888,0.022222222,1.560346964,0.452342829,0.475992373,0.510504061,0.21407626,TXN,1
GO:0019432,BP,GO:0019432,triglyceride biosynthetic process,1/269,45/18888,0.022222222,1.560346964,0.452342829,0.475992373,0.510504061,0.21407626,FBXW7,1
GO:0030261,BP,GO:0030261,chromosome condensation,1/269,45/18888,0.022222222,1.560346964,0.452342829,0.475992373,0.510504061,0.21407626,AIFM1,1
GO:0032941,BP,GO:0032941,secretion by tissue,1/269,45/18888,0.022222222,1.560346964,0.452342829,0.475992373,0.510504061,0.21407626,EGFR,1
GO:0090278,BP,GO:0090278,negative regulation of peptide hormone secretion,1/269,45/18888,0.022222222,1.560346964,0.452342829,0.475992373,0.510504061,0.21407626,IRS1,1
GO:0099084,BP,GO:0099084,postsynaptic specialization organization,1/269,45/18888,0.022222222,1.560346964,0.452342829,0.475992373,0.510504061,0.21407626,PTEN,1
GO:0016054,BP,GO:0016054,organic acid catabolic process,4/269,250/18888,0.016,1.123449814,0.236178438,0.477998873,0.512414792,0.214877512,AMACR/AKT1/IRS1/TWIST1,4
GO:0046395,BP,GO:0046395,carboxylic acid catabolic process,4/269,250/18888,0.016,1.123449814,0.236178438,0.477998873,0.512414792,0.214877512,AMACR/AKT1/IRS1/TWIST1,4
GO:0006664,BP,GO:0006664,glycolipid metabolic process,2/269,113/18888,0.017699115,1.242754219,0.311096761,0.480063298,0.514264845,0.215653319,PRKCD/BAX,2
GO:0009145,BP,GO:0009145,purine nucleoside triphosphate biosynthetic process,2/269,113/18888,0.017699115,1.242754219,0.311096761,0.480063298,0.514264845,0.215653319,PARP1/TGFB1,2
GO:0036503,BP,GO:0036503,ERAD pathway,2/269,113/18888,0.017699115,1.242754219,0.311096761,0.480063298,0.514264845,0.215653319,CAV1/HSPA5,2
GO:0002792,BP,GO:0002792,negative regulation of peptide secretion,1/269,46/18888,0.02173913,1.526426378,0.429667508,0.483473031,0.516702587,0.216675569,IRS1,1
GO:0007094,BP,GO:0007094,mitotic spindle assembly checkpoint signaling,1/269,46/18888,0.02173913,1.526426378,0.429667508,0.483473031,0.516702587,0.216675569,XRCC3,1
GO:0031146,BP,GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,1/269,46/18888,0.02173913,1.526426378,0.429667508,0.483473031,0.516702587,0.216675569,FBXW7,1
GO:0032892,BP,GO:0032892,positive regulation of organic acid transport,1/269,46/18888,0.02173913,1.526426378,0.429667508,0.483473031,0.516702587,0.216675569,IL1B,1
GO:0045047,BP,GO:0045047,protein targeting to ER,1/269,46/18888,0.02173913,1.526426378,0.429667508,0.483473031,0.516702587,0.216675569,HSPA5,1
GO:0071173,BP,GO:0071173,spindle assembly checkpoint signaling,1/269,46/18888,0.02173913,1.526426378,0.429667508,0.483473031,0.516702587,0.216675569,XRCC3,1
GO:0071174,BP,GO:0071174,mitotic spindle checkpoint signaling,1/269,46/18888,0.02173913,1.526426378,0.429667508,0.483473031,0.516702587,0.216675569,XRCC3,1
GO:0090207,BP,GO:0090207,regulation of triglyceride metabolic process,1/269,46/18888,0.02173913,1.526426378,0.429667508,0.483473031,0.516702587,0.216675569,FBXW7,1
GO:0099601,BP,GO:0099601,regulation of neurotransmitter receptor activity,1/269,46/18888,0.02173913,1.526426378,0.429667508,0.483473031,0.516702587,0.216675569,PSCA,1
GO:2000785,BP,GO:2000785,regulation of autophagosome assembly,1/269,46/18888,0.02173913,1.526426378,0.429667508,0.483473031,0.516702587,0.216675569,MTOR,1
GO:1903509,BP,GO:1903509,liposaccharide metabolic process,2/269,114/18888,0.01754386,1.231852866,0.298446124,0.484676385,0.517867169,0.217163928,PRKCD/BAX,2
GO:0099565,BP,GO:0099565,"chemical synaptic transmission, postsynaptic",2/269,115/18888,0.017391304,1.221141102,0.285911092,0.489264109,0.52264649,0.219168102,PTEN/AKT1,2
GO:0001881,BP,GO:0001881,receptor recycling,1/269,47/18888,0.021276596,1.493949221,0.407529182,0.490847288,0.523478522,0.219517009,LMTK2,1
GO:0006513,BP,GO:0006513,protein monoubiquitination,1/269,47/18888,0.021276596,1.493949221,0.407529182,0.490847288,0.523478522,0.219517009,CUL3,1
GO:0016339,BP,GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,1/269,47/18888,0.021276596,1.493949221,0.407529182,0.490847288,0.523478522,0.219517009,CDH1,1
GO:0031577,BP,GO:0031577,spindle checkpoint signaling,1/269,47/18888,0.021276596,1.493949221,0.407529182,0.490847288,0.523478522,0.219517009,XRCC3,1
GO:0050919,BP,GO:0050919,negative chemotaxis,1/269,47/18888,0.021276596,1.493949221,0.407529182,0.490847288,0.523478522,0.219517009,RHOA,1
GO:0055078,BP,GO:0055078,sodium ion homeostasis,1/269,47/18888,0.021276596,1.493949221,0.407529182,0.490847288,0.523478522,0.219517009,EDNRB,1
GO:0060119,BP,GO:0060119,inner ear receptor cell development,1/269,47/18888,0.021276596,1.493949221,0.407529182,0.490847288,0.523478522,0.219517009,FGFR1,1
GO:0006790,BP,GO:0006790,sulfur compound metabolic process,5/269,326/18888,0.015337423,1.076926586,0.168403971,0.49666464,0.529558647,0.222066666,CTNNB1/GPX1/EDNRB/SOD2/GSTP1,5
GO:0016601,BP,GO:0016601,Rac protein signal transduction,1/269,48/18888,0.020833333,1.462825279,0.385901703,0.498116652,0.530114335,0.22229969,KRAS,1
GO:0033046,BP,GO:0033046,negative regulation of sister chromatid segregation,1/269,48/18888,0.020833333,1.462825279,0.385901703,0.498116652,0.530114335,0.22229969,XRCC3,1
GO:0033048,BP,GO:0033048,negative regulation of mitotic sister chromatid segregation,1/269,48/18888,0.020833333,1.462825279,0.385901703,0.498116652,0.530114335,0.22229969,XRCC3,1
GO:0043277,BP,GO:0043277,apoptotic cell clearance,1/269,48/18888,0.020833333,1.462825279,0.385901703,0.498116652,0.530114335,0.22229969,THBS1,1
GO:0045841,BP,GO:0045841,negative regulation of mitotic metaphase/anaphase transition,1/269,48/18888,0.020833333,1.462825279,0.385901703,0.498116652,0.530114335,0.22229969,XRCC3,1
GO:0046365,BP,GO:0046365,monosaccharide catabolic process,1/269,48/18888,0.020833333,1.462825279,0.385901703,0.498116652,0.530114335,0.22229969,TP53,1
GO:0071985,BP,GO:0071985,multivesicular body sorting pathway,1/269,48/18888,0.020833333,1.462825279,0.385901703,0.498116652,0.530114335,0.22229969,RILP,1
GO:2000816,BP,GO:2000816,negative regulation of mitotic sister chromatid separation,1/269,48/18888,0.020833333,1.462825279,0.385901703,0.498116652,0.530114335,0.22229969,XRCC3,1
GO:0019882,BP,GO:0019882,antigen processing and presentation,2/269,117/18888,0.017094017,1.200266895,0.261178754,0.498362618,0.530252239,0.222357519,THBS1/CD8A,2
GO:0051259,BP,GO:0051259,protein complex oligomerization,4/269,258/18888,0.015503876,1.088614161,0.172260621,0.502463741,0.534490966,0.224134999,TP53/SOD2/PEG10/TP63,4
GO:0017157,BP,GO:0017157,regulation of exocytosis,3/269,188/18888,0.015957447,1.120461916,0.199520416,0.502860635,0.534551894,0.224160549,NOTCH1/GIT1/BRAF,3
GO:0009201,BP,GO:0009201,ribonucleoside triphosphate biosynthetic process,2/269,118/18888,0.016949153,1.190095142,0.248977063,0.502873006,0.534551894,0.224160549,PARP1/TGFB1,2
GO:0009308,BP,GO:0009308,amine metabolic process,2/269,118/18888,0.016949153,1.190095142,0.248977063,0.502873006,0.534551894,0.224160549,CYP1A1/GATA3,2
GO:0006911,BP,GO:0006911,"phagocytosis, engulfment",1/269,49/18888,0.020408163,1.432971702,0.364760736,0.505282609,0.535987791,0.224762682,THBS1,1
GO:0042269,BP,GO:0042269,regulation of natural killer cell mediated cytotoxicity,1/269,49/18888,0.020408163,1.432971702,0.364760736,0.505282609,0.535987791,0.224762682,TGFB1,1
GO:0045581,BP,GO:0045581,negative regulation of T cell differentiation,1/269,49/18888,0.020408163,1.432971702,0.364760736,0.505282609,0.535987791,0.224762682,ERBB2,1
GO:0046596,BP,GO:0046596,regulation of viral entry into host cell,1/269,49/18888,0.020408163,1.432971702,0.364760736,0.505282609,0.535987791,0.224762682,TMPRSS2,1
GO:0098815,BP,GO:0098815,modulation of excitatory postsynaptic potential,1/269,49/18888,0.020408163,1.432971702,0.364760736,0.505282609,0.535987791,0.224762682,PTEN,1
GO:0098926,BP,GO:0098926,postsynaptic signal transduction,1/269,49/18888,0.020408163,1.432971702,0.364760736,0.505282609,0.535987791,0.224762682,RELA,1
GO:0099054,BP,GO:0099054,presynapse assembly,1/269,49/18888,0.020408163,1.432971702,0.364760736,0.505282609,0.535987791,0.224762682,PTEN,1
GO:1903170,BP,GO:1903170,negative regulation of calcium ion transmembrane transport,1/269,49/18888,0.020408163,1.432971702,0.364760736,0.505282609,0.535987791,0.224762682,MIR200C,1
GO:2001259,BP,GO:2001259,positive regulation of cation channel activity,1/269,49/18888,0.020408163,1.432971702,0.364760736,0.505282609,0.535987791,0.224762682,LRRC26,1
GO:0031644,BP,GO:0031644,regulation of nervous system process,2/269,119/18888,0.016806723,1.180094343,0.236882206,0.507357237,0.538063215,0.225632997,PTEN/TNF,2
GO:0021515,BP,GO:0021515,cell differentiation in spinal cord,1/269,50/18888,0.02,1.404312268,0.344083604,0.512346624,0.542344614,0.227428371,NOTCH1,1
GO:0051985,BP,GO:0051985,negative regulation of chromosome segregation,1/269,50/18888,0.02,1.404312268,0.344083604,0.512346624,0.542344614,0.227428371,XRCC3,1
GO:0060071,BP,GO:0060071,"Wnt signaling pathway, planar cell polarity pathway",1/269,50/18888,0.02,1.404312268,0.344083604,0.512346624,0.542344614,0.227428371,RHOA,1
GO:0072599,BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,1/269,50/18888,0.02,1.404312268,0.344083604,0.512346624,0.542344614,0.227428371,HSPA5,1
GO:0140374,BP,GO:0140374,antiviral innate immune response,1/269,50/18888,0.02,1.404312268,0.344083604,0.512346624,0.542344614,0.227428371,TNF,1
GO:1902100,BP,GO:1902100,negative regulation of metaphase/anaphase transition of cell cycle,1/269,50/18888,0.02,1.404312268,0.344083604,0.512346624,0.542344614,0.227428371,XRCC3,1
GO:1905819,BP,GO:1905819,negative regulation of chromosome separation,1/269,50/18888,0.02,1.404312268,0.344083604,0.512346624,0.542344614,0.227428371,XRCC3,1
GO:2000404,BP,GO:2000404,regulation of T cell migration,1/269,50/18888,0.02,1.404312268,0.344083604,0.512346624,0.542344614,0.227428371,RHOA,1
GO:0019083,BP,GO:0019083,viral transcription,1/269,51/18888,0.019607843,1.376776733,0.323849141,0.519310142,0.548823244,0.230145138,SMARCA4,1
GO:0032387,BP,GO:0032387,negative regulation of intracellular transport,1/269,51/18888,0.019607843,1.376776733,0.323849141,0.519310142,0.548823244,0.230145138,TXN,1
GO:0035036,BP,GO:0035036,sperm-egg recognition,1/269,51/18888,0.019607843,1.376776733,0.323849141,0.519310142,0.548823244,0.230145138,CD9,1
GO:0042220,BP,GO:0042220,response to cocaine,1/269,51/18888,0.019607843,1.376776733,0.323849141,0.519310142,0.548823244,0.230145138,HSP90AA1,1
GO:0042461,BP,GO:0042461,photoreceptor cell development,1/269,51/18888,0.019607843,1.376776733,0.323849141,0.519310142,0.548823244,0.230145138,VEGFA,1
GO:0050885,BP,GO:0050885,neuromuscular process controlling balance,1/269,51/18888,0.019607843,1.376776733,0.323849141,0.519310142,0.548823244,0.230145138,NBN,1
GO:0089718,BP,GO:0089718,amino acid import across plasma membrane,1/269,51/18888,0.019607843,1.376776733,0.323849141,0.519310142,0.548823244,0.230145138,TNF,1
GO:0006111,BP,GO:0006111,regulation of gluconeogenesis,1/269,52/18888,0.019230769,1.350300257,0.304037562,0.526174588,0.555562323,0.232971123,FBP1,1
GO:0008608,BP,GO:0008608,attachment of spindle microtubules to kinetochore,1/269,52/18888,0.019230769,1.350300257,0.304037562,0.526174588,0.555562323,0.232971123,RB1,1
GO:0035601,BP,GO:0035601,protein deacylation,1/269,52/18888,0.019230769,1.350300257,0.304037562,0.526174588,0.555562323,0.232971123,HDAC6,1
GO:1904752,BP,GO:1904752,regulation of vascular associated smooth muscle cell migration,1/269,52/18888,0.019230769,1.350300257,0.304037562,0.526174588,0.555562323,0.232971123,MAP3K7,1
GO:0006413,BP,GO:0006413,translational initiation,2/269,124/18888,0.016129032,1.132509893,0.177940943,0.529380361,0.558817637,0.234336216,MTOR/TNF,2
GO:0002715,BP,GO:0002715,regulation of natural killer cell mediated immunity,1/269,53/18888,0.018867925,1.324822894,0.284630351,0.532941366,0.56140598,0.23542162,TGFB1,1
GO:0006778,BP,GO:0006778,porphyrin-containing compound metabolic process,1/269,53/18888,0.018867925,1.324822894,0.284630351,0.532941366,0.56140598,0.23542162,CYP1A1,1
GO:0007129,BP,GO:0007129,homologous chromosome pairing at meiosis,1/269,53/18888,0.018867925,1.324822894,0.284630351,0.532941366,0.56140598,0.23542162,MLH1,1
GO:0007157,BP,GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,1/269,53/18888,0.018867925,1.324822894,0.284630351,0.532941366,0.56140598,0.23542162,TENM1,1
GO:0030834,BP,GO:0030834,regulation of actin filament depolymerization,1/269,53/18888,0.018867925,1.324822894,0.284630351,0.532941366,0.56140598,0.23542162,PIK3CA,1
GO:0050433,BP,GO:0050433,regulation of catecholamine secretion,1/269,53/18888,0.018867925,1.324822894,0.284630351,0.532941366,0.56140598,0.23542162,SNCG,1
GO:1901799,BP,GO:1901799,negative regulation of proteasomal protein catabolic process,1/269,53/18888,0.018867925,1.324822894,0.284630351,0.532941366,0.56140598,0.23542162,FHIT,1
GO:1902930,BP,GO:1902930,regulation of alcohol biosynthetic process,1/269,53/18888,0.018867925,1.324822894,0.284630351,0.532941366,0.56140598,0.23542162,NFKB1,1
GO:2000059,BP,GO:2000059,negative regulation of ubiquitin-dependent protein catabolic process,1/269,53/18888,0.018867925,1.324822894,0.284630351,0.532941366,0.56140598,0.23542162,FHIT,1
GO:0000956,BP,GO:0000956,nuclear-transcribed mRNA catabolic process,2/269,126/18888,0.015873016,1.114533546,0.155045036,0.538001248,0.566212447,0.237437177,YBX1/MLH1,2
GO:0009142,BP,GO:0009142,nucleoside triphosphate biosynthetic process,2/269,126/18888,0.015873016,1.114533546,0.155045036,0.538001248,0.566212447,0.237437177,PARP1/TGFB1,2
GO:0098659,BP,GO:0098659,inorganic cation import across plasma membrane,2/269,126/18888,0.015873016,1.114533546,0.155045036,0.538001248,0.566212447,0.237437177,MIR200C/SLC39A11,2
GO:0099587,BP,GO:0099587,inorganic ion import across plasma membrane,2/269,126/18888,0.015873016,1.114533546,0.155045036,0.538001248,0.566212447,0.237437177,MIR200C/SLC39A11,2
GO:0009395,BP,GO:0009395,phospholipid catabolic process,1/269,54/18888,0.018518519,1.300289137,0.265610153,0.539611861,0.567121486,0.237818376,PRKCD,1
GO:0032092,BP,GO:0032092,positive regulation of protein binding,1/269,54/18888,0.018518519,1.300289137,0.265610153,0.539611861,0.567121486,0.237818376,MMP9,1
GO:0033047,BP,GO:0033047,regulation of mitotic sister chromatid segregation,1/269,54/18888,0.018518519,1.300289137,0.265610153,0.539611861,0.567121486,0.237818376,XRCC3,1
GO:0086009,BP,GO:0086009,membrane repolarization,1/269,54/18888,0.018518519,1.300289137,0.265610153,0.539611861,0.567121486,0.237818376,CAV1,1
GO:0099172,BP,GO:0099172,presynapse organization,1/269,54/18888,0.018518519,1.300289137,0.265610153,0.539611861,0.567121486,0.237818376,PTEN,1
GO:1904738,BP,GO:1904738,vascular associated smooth muscle cell migration,1/269,54/18888,0.018518519,1.300289137,0.265610153,0.539611861,0.567121486,0.237818376,MAP3K7,1
GO:0006403,BP,GO:0006403,RNA localization,3/269,200/18888,0.015,1.053234201,0.090971169,0.544478165,0.572103902,0.239907717,YBX1/HHEX/PEG10,3
GO:0034661,BP,GO:0034661,ncRNA catabolic process,1/269,55/18888,0.018181818,1.276647516,0.246960685,0.546187438,0.57337096,0.240439049,MALAT1,1
GO:0046460,BP,GO:0046460,neutral lipid biosynthetic process,1/269,55/18888,0.018181818,1.276647516,0.246960685,0.546187438,0.57337096,0.240439049,FBXW7,1
GO:0046463,BP,GO:0046463,acylglycerol biosynthetic process,1/269,55/18888,0.018181818,1.276647516,0.246960685,0.546187438,0.57337096,0.240439049,FBXW7,1
GO:1903351,BP,GO:1903351,cellular response to dopamine,1/269,55/18888,0.018181818,1.276647516,0.246960685,0.546187438,0.57337096,0.240439049,ALK,1
GO:0006584,BP,GO:0006584,catecholamine metabolic process,1/269,56/18888,0.017857143,1.253850239,0.228666646,0.552669442,0.57910809,0.242844874,GATA3,1
GO:0007187,BP,GO:0007187,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",1/269,56/18888,0.017857143,1.253850239,0.228666646,0.552669442,0.57910809,0.242844874,MC1R,1
GO:0007528,BP,GO:0007528,neuromuscular junction development,1/269,56/18888,0.017857143,1.253850239,0.228666646,0.552669442,0.57910809,0.242844874,ERBB2,1
GO:0009712,BP,GO:0009712,catechol-containing compound metabolic process,1/269,56/18888,0.017857143,1.253850239,0.228666646,0.552669442,0.57910809,0.242844874,GATA3,1
GO:0015872,BP,GO:0015872,dopamine transport,1/269,56/18888,0.017857143,1.253850239,0.228666646,0.552669442,0.57910809,0.242844874,SNCG,1
GO:0045839,BP,GO:0045839,negative regulation of mitotic nuclear division,1/269,56/18888,0.017857143,1.253850239,0.228666646,0.552669442,0.57910809,0.242844874,XRCC3,1
GO:0061178,BP,GO:0061178,regulation of insulin secretion involved in cellular response to glucose stimulus,1/269,56/18888,0.017857143,1.253850239,0.228666646,0.552669442,0.57910809,0.242844874,HIF1A,1
GO:0098732,BP,GO:0098732,macromolecule deacylation,1/269,56/18888,0.017857143,1.253850239,0.228666646,0.552669442,0.57910809,0.242844874,HDAC6,1
GO:0034765,BP,GO:0034765,regulation of monoatomic ion transmembrane transport,5/269,349/18888,0.014326648,1.005954346,0.013495318,0.557114218,0.583631266,0.244741636,MMP9/CAV1/MIR200C/BAX/LRRC26,5
GO:0002707,BP,GO:0002707,negative regulation of lymphocyte mediated immunity,1/269,57/18888,0.01754386,1.231852866,0.210713645,0.5590592,0.584475638,0.245095717,TGFB1,1
GO:0044088,BP,GO:0044088,regulation of vacuole organization,1/269,57/18888,0.01754386,1.231852866,0.210713645,0.5590592,0.584475638,0.245095717,MTOR,1
GO:0046148,BP,GO:0046148,pigment biosynthetic process,1/269,57/18888,0.01754386,1.231852866,0.210713645,0.5590592,0.584475638,0.245095717,MC1R,1
GO:0051452,BP,GO:0051452,intracellular pH reduction,1/269,57/18888,0.01754386,1.231852866,0.210713645,0.5590592,0.584475638,0.245095717,FASLG,1
GO:0072698,BP,GO:0072698,protein localization to microtubule cytoskeleton,1/269,57/18888,0.01754386,1.231852866,0.210713645,0.5590592,0.584475638,0.245095717,AURKA,1
GO:1901616,BP,GO:1901616,organic hydroxy compound catabolic process,1/269,57/18888,0.01754386,1.231852866,0.210713645,0.5590592,0.584475638,0.245095717,AKR1C3,1
GO:1903350,BP,GO:1903350,response to dopamine,1/269,57/18888,0.01754386,1.231852866,0.210713645,0.5590592,0.584475638,0.245095717,ALK,1
GO:0006661,BP,GO:0006661,phosphatidylinositol biosynthetic process,2/269,131/18888,0.015267176,1.071994097,0.099387165,0.559074809,0.584475638,0.245095717,PTEN/PIK3CA,2
GO:0051028,BP,GO:0051028,mRNA transport,2/269,131/18888,0.015267176,1.071994097,0.099387165,0.559074809,0.584475638,0.245095717,HHEX/PEG10,2
GO:0019730,BP,GO:0019730,antimicrobial humoral response,2/269,132/18888,0.015151515,1.06387293,0.08851424,0.563206799,0.588660283,0.246850518,KLK3/DEFB1,2
GO:0098742,BP,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,4/269,279/18888,0.014336918,1.006675461,0.013502099,0.564119193,0.58947868,0.247193707,CDH1/MAPK14/TENM1/IL10,4
GO:0006836,BP,GO:0006836,neurotransmitter transport,3/269,206/18888,0.014563107,1.022557476,0.039128382,0.564517623,0.589556222,0.247226224,SNCG/GIT1/BRAF,3
GO:0017148,BP,GO:0017148,negative regulation of translation,3/269,206/18888,0.014563107,1.022557476,0.039128382,0.564517623,0.589556222,0.247226224,YBX1/MIR200C/MIR145,3
GO:0006826,BP,GO:0006826,iron ion transport,1/269,58/18888,0.017241379,1.210614024,0.19308813,0.565358019,0.589556222,0.247226224,LMTK2,1
GO:0016073,BP,GO:0016073,snRNA metabolic process,1/269,58/18888,0.017241379,1.210614024,0.19308813,0.565358019,0.589556222,0.247226224,ELL2,1
GO:0030042,BP,GO:0030042,actin filament depolymerization,1/269,58/18888,0.017241379,1.210614024,0.19308813,0.565358019,0.589556222,0.247226224,PIK3CA,1
GO:0060998,BP,GO:0060998,regulation of dendritic spine development,1/269,58/18888,0.017241379,1.210614024,0.19308813,0.565358019,0.589556222,0.247226224,PTEN,1
GO:0071868,BP,GO:0071868,cellular response to monoamine stimulus,1/269,58/18888,0.017241379,1.210614024,0.19308813,0.565358019,0.589556222,0.247226224,ALK,1
GO:0071870,BP,GO:0071870,cellular response to catecholamine stimulus,1/269,58/18888,0.017241379,1.210614024,0.19308813,0.565358019,0.589556222,0.247226224,ALK,1
GO:0086065,BP,GO:0086065,cell communication involved in cardiac conduction,1/269,58/18888,0.017241379,1.210614024,0.19308813,0.565358019,0.589556222,0.247226224,CAV1,1
GO:0007416,BP,GO:0007416,synapse assembly,3/269,208/18888,0.014423077,1.012725193,0.022181304,0.571077614,0.59538435,0.249670208,PTEN/CTNNB1/CDH1,3
GO:0045620,BP,GO:0045620,negative regulation of lymphocyte differentiation,1/269,59/18888,0.016949153,1.190095142,0.175777325,0.57156719,0.595485964,0.249712819,ERBB2,1
GO:0050432,BP,GO:0050432,catecholamine secretion,1/269,59/18888,0.016949153,1.190095142,0.175777325,0.57156719,0.595485964,0.249712819,SNCG,1
GO:0051480,BP,GO:0051480,regulation of cytosolic calcium ion concentration,1/269,59/18888,0.016949153,1.190095142,0.175777325,0.57156719,0.595485964,0.249712819,CAV1,1
GO:0010927,BP,GO:0010927,cellular component assembly involved in morphogenesis,2/269,135/18888,0.014814815,1.040231309,0.056386499,0.575436204,0.599379822,0.251345681,EPB41L3/CD9,2
GO:0007080,BP,GO:0007080,mitotic metaphase chromosome alignment,1/269,60/18888,0.016666667,1.170260223,0.158769173,0.577687984,0.600626759,0.251868575,CUL3,1
GO:0007131,BP,GO:0007131,reciprocal meiotic recombination,1/269,60/18888,0.016666667,1.170260223,0.158769173,0.577687984,0.600626759,0.251868575,MLH1,1
GO:0046173,BP,GO:0046173,polyol biosynthetic process,1/269,60/18888,0.016666667,1.170260223,0.158769173,0.577687984,0.600626759,0.251868575,SPHK1,1
GO:0051289,BP,GO:0051289,protein homotetramerization,1/269,60/18888,0.016666667,1.170260223,0.158769173,0.577687984,0.600626759,0.251868575,SOD2,1
GO:0060350,BP,GO:0060350,endochondral bone morphogenesis,1/269,60/18888,0.016666667,1.170260223,0.158769173,0.577687984,0.600626759,0.251868575,MMP14,1
GO:0071867,BP,GO:0071867,response to monoamine,1/269,60/18888,0.016666667,1.170260223,0.158769173,0.577687984,0.600626759,0.251868575,ALK,1
GO:0071869,BP,GO:0071869,response to catecholamine,1/269,60/18888,0.016666667,1.170260223,0.158769173,0.577687984,0.600626759,0.251868575,ALK,1
GO:0140527,BP,GO:0140527,reciprocal homologous recombination,1/269,60/18888,0.016666667,1.170260223,0.158769173,0.577687984,0.600626759,0.251868575,MLH1,1
GO:0007041,BP,GO:0007041,lysosomal transport,2/269,136/18888,0.014705882,1.03258255,0.045836366,0.579457004,0.602191174,0.252524602,RILP/CLU,2
GO:0007586,BP,GO:0007586,digestion,2/269,136/18888,0.014705882,1.03258255,0.045836366,0.579457004,0.602191174,0.252524602,VDR/TLR4,2
GO:0031113,BP,GO:0031113,regulation of microtubule polymerization,1/269,61/18888,0.016393443,1.151075629,0.142052284,0.583721654,0.606070158,0.254151226,GIT1,1
GO:0044380,BP,GO:0044380,protein localization to cytoskeleton,1/269,61/18888,0.016393443,1.151075629,0.142052284,0.583721654,0.606070158,0.254151226,AURKA,1
GO:0045744,BP,GO:0045744,negative regulation of G protein-coupled receptor signaling pathway,1/269,61/18888,0.016393443,1.151075629,0.142052284,0.583721654,0.606070158,0.254151226,KLK14,1
GO:0086002,BP,GO:0086002,cardiac muscle cell action potential involved in contraction,1/269,61/18888,0.016393443,1.151075629,0.142052284,0.583721654,0.606070158,0.254151226,CAV1,1
GO:0002090,BP,GO:0002090,regulation of receptor internalization,1/269,62/18888,0.016129032,1.132509893,0.125615889,0.589669435,0.61196673,0.256623912,VEGFA,1
GO:0033013,BP,GO:0033013,tetrapyrrole metabolic process,1/269,62/18888,0.016129032,1.132509893,0.125615889,0.589669435,0.61196673,0.256623912,CYP1A1,1
GO:0007286,BP,GO:0007286,spermatid development,3/269,214/18888,0.014018692,0.984331029,-0.027708189,0.590388376,0.612573319,0.25687828,DEFB1/SMARCA2/SRPK1,3
GO:0016197,BP,GO:0016197,endosomal transport,4/269,289/18888,0.01384083,0.9718424,-0.057980134,0.591977875,0.614082695,0.257511227,RILP/SQSTM1/MAPK1/LMTK2,4
GO:0051648,BP,GO:0051648,vesicle localization,3/269,215/18888,0.013953488,0.979752745,-0.035888705,0.593552211,0.61557566,0.258137291,PTEN/CTNNB1/CUL3,3
GO:0048813,BP,GO:0048813,dendrite morphogenesis,2/269,140/18888,0.014285714,1.003080191,0.00439687,0.595261091,0.617207449,0.25882157,PTEN/HDAC6,2
GO:0051784,BP,GO:0051784,negative regulation of nuclear division,1/269,63/18888,0.015873016,1.114533546,0.109449792,0.595532546,0.617348414,0.258880683,XRCC3,1
GO:0048814,BP,GO:0048814,regulation of dendrite morphogenesis,1/269,64/18888,0.015625,1.097118959,0.093544337,0.601312187,0.623197981,0.261333657,HDAC6,1
GO:0046165,BP,GO:0046165,alcohol biosynthetic process,2/269,142/18888,0.014084507,0.988952301,-0.015883315,0.602995483,0.624800414,0.262005626,NFKB1/SPHK1,2
GO:0070192,BP,GO:0070192,chromosome organization involved in meiotic cell cycle,1/269,65/18888,0.015384615,1.080240206,0.077890366,0.607009542,0.628816616,0.263689792,MLH1,1
GO:0001909,BP,GO:0001909,leukocyte mediated cytotoxicity,2/269,144/18888,0.013888889,0.975216853,-0.035882775,0.610618109,0.632267296,0.26513681,TGFB1/MYD88,2
GO:0030534,BP,GO:0030534,adult behavior,2/269,144/18888,0.013888889,0.975216853,-0.035882775,0.610618109,0.632267296,0.26513681,ALK/SNCG,2
GO:0015800,BP,GO:0015800,acidic amino acid transport,1/269,66/18888,0.015151515,1.06387293,0.062479188,0.61262578,0.633626119,0.265706623,TNF,1
GO:0017156,BP,GO:0017156,calcium-ion regulated exocytosis,1/269,66/18888,0.015151515,1.06387293,0.062479188,0.61262578,0.633626119,0.265706623,NOTCH1,1
GO:0030837,BP,GO:0030837,negative regulation of actin filament polymerization,1/269,66/18888,0.015151515,1.06387293,0.062479188,0.61262578,0.633626119,0.265706623,PRKCD,1
GO:0035773,BP,GO:0035773,insulin secretion involved in cellular response to glucose stimulus,1/269,66/18888,0.015151515,1.06387293,0.062479188,0.61262578,0.633626119,0.265706623,HIF1A,1
GO:0046854,BP,GO:0046854,phosphatidylinositol phosphate biosynthetic process,1/269,66/18888,0.015151515,1.06387293,0.062479188,0.61262578,0.633626119,0.265706623,PIK3CA,1
GO:0043087,BP,GO:0043087,regulation of GTPase activity,4/269,298/18888,0.013422819,0.942491455,-0.120276359,0.61613837,0.637114483,0.267169444,EZH2/PTK2/DAB2IP/HRAS,4
GO:0007224,BP,GO:0007224,smoothened signaling pathway,2/269,146/18888,0.01369863,0.961857718,-0.055610217,0.61812908,0.638627278,0.267803824,FOXA1/RB1,2
GO:0046467,BP,GO:0046467,membrane lipid biosynthetic process,2/269,146/18888,0.01369863,0.961857718,-0.055610217,0.61812908,0.638627278,0.267803824,PRKCD/SPHK1,2
GO:0006903,BP,GO:0006903,vesicle targeting,1/269,67/18888,0.014925373,1.04799423,0.047302548,0.618162049,0.638627278,0.267803824,CUL3,1
GO:0045143,BP,GO:0045143,homologous chromosome segregation,1/269,67/18888,0.014925373,1.04799423,0.047302548,0.618162049,0.638627278,0.267803824,MLH1,1
GO:0002704,BP,GO:0002704,negative regulation of leukocyte mediated immunity,1/269,68/18888,0.014705882,1.03258255,0.032352598,0.623619486,0.644119333,0.270106878,TGFB1,1
GO:0006457,BP,GO:0006457,protein folding,3/269,225/18888,0.013333333,0.936208178,-0.115703098,0.624313455,0.64454387,0.270284905,HSPA5/HSP90AA1/CLU,3
GO:0045055,BP,GO:0045055,regulated exocytosis,3/269,225/18888,0.013333333,0.936208178,-0.115703098,0.624313455,0.64454387,0.270284905,NOTCH1/GIT1/BRAF,3
GO:0060078,BP,GO:0060078,regulation of postsynaptic membrane potential,2/269,148/18888,0.013513514,0.94885964,-0.075073955,0.625528591,0.645652075,0.270749623,PTEN/AKT1,2
GO:1903051,BP,GO:1903051,negative regulation of proteolysis involved in protein catabolic process,1/269,70/18888,0.014285714,1.003080191,0.003103269,0.634302316,0.654559763,0.274484998,FHIT,1
GO:0035567,BP,GO:0035567,non-canonical Wnt signaling pathway,1/269,71/18888,0.014084507,0.988952301,-0.011209991,0.6395299,0.659804852,0.276684489,RHOA,1
GO:0015931,BP,GO:0015931,nucleobase-containing compound transport,3/269,231/18888,0.012987013,0.911891083,-0.161951286,0.641992859,0.66219594,0.277687175,YBX1/HHEX/PEG10,3
GO:0006406,BP,GO:0006406,mRNA export from nucleus,1/269,72/18888,0.013888889,0.975216853,-0.025324362,0.644683031,0.66466981,0.278724575,HHEX,1
GO:0043954,BP,GO:0043954,cellular component maintenance,1/269,72/18888,0.013888889,0.975216853,-0.025324362,0.644683031,0.66466981,0.278724575,IGF1R,1
GO:0015748,BP,GO:0015748,organophosphate ester transport,2/269,154/18888,0.012987013,0.911891083,-0.131960642,0.647061458,0.666971042,0.27968958,FASLG/PRKCD,2
GO:0008333,BP,GO:0008333,endosome to lysosome transport,1/269,73/18888,0.01369863,0.961857718,-0.039246005,0.649762764,0.669301188,0.28066671,RILP,1
GO:0009988,BP,GO:0009988,cell-cell recognition,1/269,73/18888,0.01369863,0.961857718,-0.039246005,0.649762764,0.669301188,0.28066671,CD9,1
GO:0019226,BP,GO:0019226,transmission of nerve impulse,1/269,73/18888,0.01369863,0.961857718,-0.039246005,0.649762764,0.669301188,0.28066671,MTOR,1
GO:0008037,BP,GO:0008037,cell recognition,2/269,155/18888,0.012903226,0.906007915,-0.141231939,0.650553726,0.669964461,0.280944849,CASP3/CD9,2
GO:0051937,BP,GO:0051937,catecholamine transport,1/269,74/18888,0.013513514,0.94885964,-0.052980801,0.654770142,0.673697554,0.282510295,SNCG,1
GO:0072678,BP,GO:0072678,T cell migration,1/269,74/18888,0.013513514,0.94885964,-0.052980801,0.654770142,0.673697554,0.282510295,RHOA,1
GO:1902017,BP,GO:1902017,regulation of cilium assembly,1/269,74/18888,0.013513514,0.94885964,-0.052980801,0.654770142,0.673697554,0.282510295,AKT1,1
GO:1902475,BP,GO:1902475,L-alpha-amino acid transmembrane transport,1/269,74/18888,0.013513514,0.94885964,-0.052980801,0.654770142,0.673697554,0.282510295,TNF,1
GO:0045806,BP,GO:0045806,negative regulation of endocytosis,1/269,75/18888,0.013333333,0.936208178,-0.066534372,0.659706192,0.678469844,0.284511521,CAV1,1
GO:1901019,BP,GO:1901019,regulation of calcium ion transmembrane transporter activity,1/269,75/18888,0.013333333,0.936208178,-0.066534372,0.659706192,0.678469844,0.284511521,MIR200C,1
GO:0007189,BP,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,2/269,158/18888,0.012658228,0.888805233,-0.168703254,0.660866285,0.679509545,0.284947513,MC1R/LGR4,2
GO:0042267,BP,GO:0042267,natural killer cell mediated cytotoxicity,1/269,76/18888,0.013157895,0.92388965,-0.079912089,0.664571925,0.683165543,0.28648063,TGFB1,1
GO:0051656,BP,GO:0051656,establishment of organelle localization,6/269,472/18888,0.012711864,0.892571357,-0.284101085,0.667108833,0.685618733,0.287509357,CTNNB1/HIF1A/HDAC6/CUL3/RB1/MLH1,6
GO:0007585,BP,GO:0007585,respiratory gaseous exchange by respiratory system,1/269,77/18888,0.012987013,0.911891083,-0.093119093,0.669368339,0.687785781,0.288418094,GRPR,1
GO:0006813,BP,GO:0006813,potassium ion transport,3/269,241/18888,0.012448133,0.874053279,-0.236521354,0.670144698,0.68842824,0.288687504,CDK2/CAV1/LRRC26,3
GO:0046486,BP,GO:0046486,glycerolipid metabolic process,5/269,400/18888,0.0125,0.877695167,-0.297172147,0.676767848,0.695075364,0.291474929,PTEN/FBXW7/GPX1/PIK3CA/CAV1,5
GO:0006814,BP,GO:0006814,sodium ion transport,3/269,244/18888,0.012295082,0.863306722,-0.2583164,0.678268826,0.696459944,0.292055542,EDNRB/AKT1/PER1,3
GO:0002228,BP,GO:0002228,natural killer cell mediated immunity,1/269,79/18888,0.012658228,0.888805233,-0.119040433,0.678757135,0.696647332,0.292134122,TGFB1,1
GO:0032508,BP,GO:0032508,DNA duplex unwinding,1/269,79/18888,0.012658228,0.888805233,-0.119040433,0.678757135,0.696647332,0.292134122,NBN,1
GO:0046488,BP,GO:0046488,phosphatidylinositol metabolic process,2/269,164/18888,0.012195122,0.856287968,-0.222175002,0.680759255,0.698544857,0.292929836,PTEN/PIK3CA,2
GO:0032272,BP,GO:0032272,negative regulation of protein polymerization,1/269,80/18888,0.0125,0.877695167,-0.131763996,0.683351443,0.700889053,0.293912858,PRKCD,1
GO:0042440,BP,GO:0042440,pigment metabolic process,1/269,80/18888,0.0125,0.877695167,-0.131763996,0.683351443,0.700889053,0.293912858,MC1R,1
GO:0008344,BP,GO:0008344,adult locomotory behavior,1/269,81/18888,0.012345679,0.866859424,-0.144335324,0.687880285,0.705375327,0.295794145,SNCG,1
GO:0007188,BP,GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,3/269,249/18888,0.012048193,0.845971246,-0.294082802,0.691479715,0.708906747,0.297275021,MC1R/CRHR2/LGR4,3
GO:0015698,BP,GO:0015698,inorganic anion transport,2/269,169/18888,0.01183432,0.830954005,-0.265330009,0.696602454,0.713502244,0.29920211,VDR/FGFR1,2
GO:0031424,BP,GO:0031424,keratinization,1/269,83/18888,0.012048193,0.845971246,-0.169037723,0.696745277,0.713502244,0.29920211,SFN,1
GO:0032414,BP,GO:0032414,positive regulation of ion transmembrane transporter activity,1/269,83/18888,0.012048193,0.845971246,-0.169037723,0.696745277,0.713502244,0.29920211,LRRC26,1
GO:0051279,BP,GO:0051279,regulation of release of sequestered calcium ion into cytosol,1/269,83/18888,0.012048193,0.845971246,-0.169037723,0.696745277,0.713502244,0.29920211,BAX,1
GO:1901657,BP,GO:1901657,glycosyl compound metabolic process,1/269,83/18888,0.012048193,0.845971246,-0.169037723,0.696745277,0.713502244,0.29920211,AKR1C3,1
GO:0032418,BP,GO:0032418,lysosome localization,1/269,84/18888,0.011904762,0.835900159,-0.181176613,0.701083247,0.717460753,0.300862083,HDAC6,1
GO:0086001,BP,GO:0086001,cardiac muscle cell action potential,1/269,84/18888,0.011904762,0.835900159,-0.181176613,0.701083247,0.717460753,0.300862083,CAV1,1
GO:1990849,BP,GO:1990849,vacuolar localization,1/269,84/18888,0.011904762,0.835900159,-0.181176613,0.701083247,0.717460753,0.300862083,HDAC6,1
GO:0044782,BP,GO:0044782,cilium organization,5/269,412/18888,0.012135922,0.85213123,-0.364754404,0.701580535,0.717808426,0.301007877,AURKA/NOTCH1/RILP/HDAC6/AKT1,5
GO:0045017,BP,GO:0045017,glycerolipid biosynthetic process,3/269,254/18888,0.011811024,0.829318268,-0.329177625,0.704280406,0.720408965,0.302098394,PTEN/FBXW7/PIK3CA,3
GO:0032392,BP,GO:0032392,DNA geometric change,1/269,85/18888,0.011764706,0.82606604,-0.193178918,0.70535939,0.721350703,0.302493306,NBN,1
GO:0010970,BP,GO:0010970,transport along microtubule,2/269,172/18888,0.011627907,0.816460621,-0.290647384,0.705793608,0.721470872,0.302543698,HIF1A/HDAC6,2
GO:0044272,BP,GO:0044272,sulfur compound biosynthetic process,2/269,172/18888,0.011627907,0.816460621,-0.290647384,0.705793608,0.721470872,0.302543698,CTNNB1/GSTP1,2
GO:0021954,BP,GO:0021954,central nervous system neuron development,1/269,86/18888,0.011627907,0.816460621,-0.205048178,0.709574586,0.725010499,0.304028015,PTEN,1
GO:0032024,BP,GO:0032024,positive regulation of insulin secretion,1/269,86/18888,0.011627907,0.816460621,-0.205048178,0.709574586,0.725010499,0.304028015,HIF1A,1
GO:0015844,BP,GO:0015844,monoamine transport,1/269,87/18888,0.011494253,0.807076016,-0.216787795,0.713729699,0.729092491,0.30573977,SNCG,1
GO:0006094,BP,GO:0006094,gluconeogenesis,1/269,89/18888,0.011235955,0.788939476,-0.239891078,0.721863079,0.737235639,0.309154541,FBP1,1
GO:0021953,BP,GO:0021953,central nervous system neuron differentiation,2/269,178/18888,0.011235955,0.788939476,-0.34006315,0.723481869,0.738723307,0.309778384,PTEN/ID4,2
GO:0031640,BP,GO:0031640,killing of cells of another organism,1/269,90/18888,0.011111111,0.780173482,-0.251260932,0.725843015,0.740636233,0.310580556,MYD88,1
GO:0032456,BP,GO:0032456,endocytic recycling,1/269,90/18888,0.011111111,0.780173482,-0.251260932,0.725843015,0.740636233,0.310580556,LMTK2,1
GO:0141061,BP,GO:0141061,disruption of cell in another organism,1/269,90/18888,0.011111111,0.780173482,-0.251260932,0.725843015,0.740636233,0.310580556,MYD88,1
GO:0001510,BP,GO:0001510,RNA methylation,1/269,91/18888,0.010989011,0.771600147,-0.262513535,0.729766211,0.744139404,0.312049586,AKT1,1
GO:0006400,BP,GO:0006400,tRNA modification,1/269,91/18888,0.010989011,0.771600147,-0.262513535,0.729766211,0.744139404,0.312049586,AKT1,1
GO:0051453,BP,GO:0051453,regulation of intracellular pH,1/269,91/18888,0.010989011,0.771600147,-0.262513535,0.729766211,0.744139404,0.312049586,FASLG,1
GO:0019319,BP,GO:0019319,hexose biosynthetic process,1/269,92/18888,0.010869565,0.763213189,-0.273651705,0.733633471,0.74774812,0.313562875,FBP1,1
GO:0022406,BP,GO:0022406,membrane docking,1/269,92/18888,0.010869565,0.763213189,-0.273651705,0.733633471,0.74774812,0.313562875,ROCK1,1
GO:0006405,BP,GO:0006405,RNA export from nucleus,1/269,93/18888,0.010752688,0.755006596,-0.284678164,0.737445591,0.751048352,0.314946804,HHEX,1
GO:0015807,BP,GO:0015807,L-amino acid transport,1/269,93/18888,0.010752688,0.755006596,-0.284678164,0.737445591,0.751048352,0.314946804,TNF,1
GO:0141060,BP,GO:0141060,disruption of anatomical structure in another organism,1/269,93/18888,0.010752688,0.755006596,-0.284678164,0.737445591,0.751048352,0.314946804,MYD88,1
GO:0061025,BP,GO:0061025,membrane fusion,2/269,183/18888,0.010928962,0.767383753,-0.380072273,0.737530801,0.751048352,0.314946804,CD9/SPHK1,2
GO:0019646,BP,GO:0019646,aerobic electron transport chain,1/269,94/18888,0.010638298,0.74697461,-0.295595536,0.741203352,0.754619547,0.31644436,COX2,1
GO:0046785,BP,GO:0046785,microtubule polymerization,1/269,95/18888,0.010526316,0.73911172,-0.306406356,0.744907529,0.758221337,0.317954745,GIT1,1
GO:0000245,BP,GO:0000245,spliceosomal complex assembly,1/269,96/18888,0.010416667,0.731412639,-0.317113069,0.748558882,0.761257649,0.319228001,SRPK1,1
GO:0001910,BP,GO:0001910,regulation of leukocyte mediated cytotoxicity,1/269,96/18888,0.010416667,0.731412639,-0.317113069,0.748558882,0.761257649,0.319228001,TGFB1,1
GO:0046364,BP,GO:0046364,monosaccharide biosynthetic process,1/269,96/18888,0.010416667,0.731412639,-0.317113069,0.748558882,0.761257649,0.319228001,FBP1,1
GO:1990542,BP,GO:1990542,mitochondrial transmembrane transport,1/269,96/18888,0.010416667,0.731412639,-0.317113069,0.748558882,0.761257649,0.319228001,AIFM1,1
GO:0006576,BP,GO:0006576,biogenic amine metabolic process,1/269,98/18888,0.010204082,0.716485851,-0.338223547,0.755706108,0.768354614,0.322204063,GATA3,1
GO:0031503,BP,GO:0031503,protein-containing complex localization,2/269,191/18888,0.010471204,0.735242025,-0.442037613,0.758744753,0.771271998,0.323427447,ERBB2/HRAS,2
GO:0006835,BP,GO:0006835,dicarboxylic acid transport,1/269,99/18888,0.01010101,0.70924862,-0.348631804,0.75920345,0.771394049,0.323478628,TNF,1
GO:0061337,BP,GO:0061337,cardiac conduction,1/269,99/18888,0.01010101,0.70924862,-0.348631804,0.75920345,0.771394049,0.323478628,CAV1,1
GO:0050764,BP,GO:0050764,regulation of phagocytosis,1/269,100/18888,0.01,0.702156134,-0.358944943,0.762650907,0.774724087,0.324875056,SPHK1,1
GO:0033108,BP,GO:0033108,mitochondrial respiratory chain complex assembly,1/269,101/18888,0.00990099,0.695204093,-0.36916503,0.766049188,0.778002697,0.326249918,AIFM1,1
GO:0051260,BP,GO:0051260,protein homooligomerization,2/269,195/18888,0.01025641,0.720160137,-0.472135695,0.768786802,0.780609019,0.327342861,SOD2/PEG10,2
GO:0051650,BP,GO:0051650,establishment of vesicle localization,2/269,196/18888,0.010204082,0.716485851,-0.479572577,0.771239994,0.782925448,0.328314239,CTNNB1/CUL3,2
GO:0003333,BP,GO:0003333,amino acid transmembrane transport,1/269,104/18888,0.009615385,0.675150129,-0.399286644,0.775955915,0.787537347,0.330248206,TNF,1
GO:0030705,BP,GO:0030705,cytoskeleton-dependent intracellular transport,2/269,200/18888,0.01,0.702156134,-0.508981152,0.780827799,0.792305446,0.332247674,HIF1A/HDAC6,2
GO:0019751,BP,GO:0019751,polyol metabolic process,1/269,107/18888,0.009345794,0.656220686,-0.428639044,0.785444632,0.796812679,0.334137751,SPHK1,1
GO:0031341,BP,GO:0031341,regulation of cell killing,1/269,110/18888,0.009090909,0.638323758,-0.457268317,0.794532913,0.805853061,0.337928771,TGFB1,1
GO:0007040,BP,GO:0007040,lysosome organization,1/269,111/18888,0.009009009,0.632573094,-0.466658087,0.797476285,0.808478406,0.339029691,MTOR,1
GO:0080171,BP,GO:0080171,lytic vacuole organization,1/269,111/18888,0.009009009,0.632573094,-0.466658087,0.797476285,0.808478406,0.339029691,MTOR,1
GO:0006644,BP,GO:0006644,phospholipid metabolic process,4/269,383/18888,0.010443864,0.733322333,-0.633754336,0.798031693,0.808861489,0.339190334,PTEN/PIK3CA/PRKCD/ALOX15B,4
GO:0016579,BP,GO:0016579,protein deubiquitination,1/269,112/18888,0.008928571,0.626925119,-0.475973677,0.800377648,0.810878488,0.340036148,BAP1,1
GO:0048024,BP,GO:0048024,"regulation of mRNA splicing, via spliceosome",1/269,112/18888,0.008928571,0.626925119,-0.475973677,0.800377648,0.810878488,0.340036148,SRPK1,1
GO:0060271,BP,GO:0060271,cilium assembly,4/269,385/18888,0.01038961,0.729512866,-0.644518453,0.801313525,0.811646158,0.340358065,NOTCH1/RILP/HDAC6/AKT1,4
GO:0009100,BP,GO:0009100,glycoprotein metabolic process,4/269,386/18888,0.010362694,0.727622937,-0.64988169,0.802938277,0.813111089,0.340972374,CTNNB1/HIF1A/IGF1/PAWR,4
GO:0046474,BP,GO:0046474,glycerophospholipid biosynthetic process,2/269,210/18888,0.00952381,0.668720127,-0.5802551,0.803273626,0.81326992,0.341038978,PTEN/PIK3CA,2
GO:0009152,BP,GO:0009152,purine ribonucleotide biosynthetic process,2/269,211/18888,0.009478673,0.665550838,-0.587215127,0.805402534,0.815244155,0.34186686,PARP1/TGFB1,2
GO:0000045,BP,GO:0000045,autophagosome assembly,1/269,114/18888,0.00877193,0.615926433,-0.494387967,0.806056723,0.815725107,0.342068543,MTOR,1
GO:0051963,BP,GO:0051963,regulation of synapse assembly,1/269,115/18888,0.008695652,0.610570551,-0.503489391,0.808835606,0.818355545,0.343171599,CTNNB1,1
GO:0099111,BP,GO:0099111,microtubule-based transport,2/269,213/18888,0.009389671,0.659301534,-0.601047962,0.809599172,0.818946232,0.343419299,HIF1A/HDAC6,2
GO:0006334,BP,GO:0006334,nucleosome assembly,1/269,118/18888,0.008474576,0.595047571,-0.530386339,0.816936477,0.826184815,0.346454748,BRD2,1
GO:0071805,BP,GO:0071805,potassium ion transmembrane transport,2/269,217/18888,0.00921659,0.64714851,-0.628372958,0.817751877,0.826825911,0.346723587,CAV1/LRRC26,2
GO:0006906,BP,GO:0006906,vesicle fusion,1/269,119/18888,0.008403361,0.590047171,-0.539220327,0.81956003,0.828470268,0.347413136,SPHK1,1
GO:0008380,BP,GO:0008380,RNA splicing,5/269,484/18888,0.010330579,0.725367907,-0.735694162,0.822564369,0.831322818,0.348609333,YBX1/SRPK1/CDK12/WT1/FRG1,5
GO:0090174,BP,GO:0090174,organelle membrane fusion,1/269,121/18888,0.008264463,0.580294325,-0.556697862,0.824695285,0.833106811,0.349357438,SPHK1,1
GO:1905037,BP,GO:1905037,autophagosome organization,1/269,121/18888,0.008264463,0.580294325,-0.556697862,0.824695285,0.833106811,0.349357438,MTOR,1
GO:0006364,BP,GO:0006364,rRNA processing,2/269,224/18888,0.008928571,0.626925119,-0.675145083,0.831271841,0.839564289,0.352065335,RNASEL/FRG1,2
GO:0001906,BP,GO:0001906,cell killing,2/269,226/18888,0.008849558,0.62137711,-0.688274133,0.834965713,0.842921291,0.35347307,TGFB1/MYD88,2
GO:0009260,BP,GO:0009260,ribonucleotide biosynthetic process,2/269,226/18888,0.008849558,0.62137711,-0.688274133,0.834965713,0.842921291,0.35347307,PARP1/TGFB1,2
GO:0007613,BP,GO:0007613,memory,1/269,126/18888,0.007936508,0.557266773,-0.59933174,0.836905304,0.844692194,0.354215686,PTGS2,1
GO:0043547,BP,GO:0043547,positive regulation of GTPase activity,2/269,230/18888,0.008695652,0.610570551,-0.714232516,0.842135704,0.849783005,0.356350482,EZH2/HRAS,2
GO:0009101,BP,GO:0009101,glycoprotein biosynthetic process,3/269,324/18888,0.009259259,0.650144568,-0.763492544,0.843220644,0.850689383,0.356730565,CTNNB1/IGF1/PAWR,3
GO:0098661,BP,GO:0098661,inorganic anion transmembrane transport,1/269,130/18888,0.007692308,0.540120103,-0.632415186,0.846060253,0.853365179,0.357852641,VDR,1
GO:0046390,BP,GO:0046390,ribose phosphate biosynthetic process,2/269,233/18888,0.008583691,0.602709128,-0.73344639,0.847327191,0.854453892,0.358309185,PARP1/TGFB1,2
GO:0070646,BP,GO:0070646,protein modification by small protein removal,1/269,131/18888,0.007633588,0.535997049,-0.640551652,0.848267833,0.855213155,0.358627576,BAP1,1
GO:0022618,BP,GO:0022618,protein-RNA complex assembly,2/269,234/18888,0.008547009,0.600133448,-0.739803659,0.849023018,0.855785148,0.358867438,SRPK1/HSP90AA1,2
GO:0006888,BP,GO:0006888,endoplasmic reticulum to Golgi vesicle-mediated transport,1/269,132/18888,0.007575758,0.531936465,-0.6486361,0.850443872,0.85702771,0.359388497,CUL3,1
GO:0008033,BP,GO:0008033,tRNA processing,1/269,134/18888,0.007462687,0.523997115,-0.664652255,0.854703112,0.860939063,0.361028695,AKT1,1
GO:0050684,BP,GO:0050684,regulation of mRNA processing,1/269,134/18888,0.007462687,0.523997115,-0.664652255,0.854703112,0.860939063,0.361028695,SRPK1,1
GO:0007018,BP,GO:0007018,microtubule-based movement,4/269,426/18888,0.009389671,0.659301534,-0.854899491,0.859558794,0.865638785,0.362999491,DEFB1/HIF1A/HDAC6/KATNB1,4
GO:0071826,BP,GO:0071826,protein-RNA complex organization,2/269,244/18888,0.008196721,0.575537815,-0.802128276,0.865063895,0.8709903,0.36524361,SRPK1/HSP90AA1,2
GO:0030317,BP,GO:0030317,flagellated sperm motility,1/269,141/18888,0.007092199,0.497983074,-0.719186425,0.868680858,0.874245635,0.366608712,DEFB1,1
GO:0097722,BP,GO:0097722,sperm motility,1/269,141/18888,0.007092199,0.497983074,-0.719186425,0.868680858,0.874245635,0.366608712,DEFB1,1
GO:0006997,BP,GO:0006997,nucleus organization,1/269,143/18888,0.006993007,0.491018275,-0.734356494,0.872422507,0.877817345,0.368106484,SRPK1,1
GO:0006887,BP,GO:0006887,exocytosis,3/269,348/18888,0.00862069,0.605307012,-0.893251229,0.875783663,0.881004718,0.369443086,NOTCH1/GIT1/BRAF,3
GO:0008654,BP,GO:0008654,phospholipid biosynthetic process,2/269,253/18888,0.007905138,0.555064137,-0.856391658,0.878152684,0.883192854,0.370360665,PTEN/PIK3CA,2
GO:0006164,BP,GO:0006164,purine nucleotide biosynthetic process,2/269,256/18888,0.0078125,0.54855948,-0.874118349,0.882249439,0.887117291,0.37200635,PARP1/TGFB1,2
GO:0098876,BP,GO:0098876,vesicle-mediated transport to the plasma membrane,1/269,151/18888,0.006622517,0.465004062,-0.793356499,0.886356477,0.891050333,0.373655643,LMTK2,1
GO:1902652,BP,GO:1902652,secondary alcohol metabolic process,1/269,152/18888,0.006578947,0.461944825,-0.800552139,0.887988014,0.892493579,0.374260858,FGFR1,1
GO:0072522,BP,GO:0072522,purine-containing compound biosynthetic process,2/269,264/18888,0.007575758,0.531936465,-0.920555007,0.892561116,0.896877911,0.376099396,PARP1/TGFB1,2
GO:0016125,BP,GO:0016125,sterol metabolic process,1/269,155/18888,0.006451613,0.453003957,-0.821912946,0.892743925,0.896877911,0.376099396,CYP19A1,1
GO:0007030,BP,GO:0007030,Golgi organization,1/269,156/18888,0.006410256,0.450100086,-0.828959534,0.894284089,0.898227141,0.376665186,MAPK1,1
GO:0006865,BP,GO:0006865,amino acid transport,1/269,158/18888,0.006329114,0.444402616,-0.84294512,0.897298625,0.901056322,0.377851584,TNF,1
GO:1902600,BP,GO:1902600,proton transmembrane transport,1/269,161/18888,0.00621118,0.436121822,-0.863661529,0.901660594,0.905237035,0.379604736,COX2,1
GO:0060294,BP,GO:0060294,cilium movement involved in cell motility,1/269,165/18888,0.006060606,0.425549172,-0.890813043,0.907190747,0.910588465,0.38184882,DEFB1,1
GO:0007156,BP,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,1/269,168/18888,0.005952381,0.41795008,-0.910838558,0.911134027,0.914345072,0.383424127,CDH1,1
GO:0001539,BP,GO:0001539,cilium or flagellum-dependent cell motility,1/269,170/18888,0.005882353,0.41303302,-0.924033814,0.913669692,0.916485935,0.384321883,DEFB1,1
GO:0060285,BP,GO:0060285,cilium-dependent cell motility,1/269,170/18888,0.005882353,0.41303302,-0.924033814,0.913669692,0.916485935,0.384321883,DEFB1,1
GO:0009165,BP,GO:0009165,nucleotide biosynthetic process,2/269,293/18888,0.006825939,0.479287463,-1.079725124,0.923319468,0.925961588,0.388295431,PARP1/TGFB1,2
GO:1901293,BP,GO:1901293,nucleoside phosphate biosynthetic process,2/269,295/18888,0.006779661,0.476038057,-1.090223331,0.925102928,0.927545982,0.388959835,PARP1/TGFB1,2
GO:0009451,BP,GO:0009451,RNA modification,1/269,180/18888,0.005555556,0.390086741,-0.988257459,0.925306649,0.927546115,0.388959891,AKT1,1
GO:0022613,BP,GO:0022613,ribonucleoprotein complex biogenesis,4/269,499/18888,0.008016032,0.562850608,-1.189544105,0.927705856,0.929746564,0.389882634,RNASEL/SRPK1/HSP90AA1/FRG1,4
GO:0043484,BP,GO:0043484,regulation of RNA splicing,1/269,186/18888,0.005376344,0.377503298,-1.025484157,0.931524237,0.933368028,0.391401269,SRPK1,1
GO:0006650,BP,GO:0006650,glycerophospholipid metabolic process,2/269,307/18888,0.006514658,0.457430706,-1.152044651,0.935010267,0.936654964,0.392779622,PTEN/PIK3CA,2
GO:0042254,BP,GO:0042254,ribosome biogenesis,2/269,319/18888,0.006269592,0.440223281,-1.211979767,0.943670752,0.945122873,0.396330579,RNASEL/FRG1,2
GO:0006399,BP,GO:0006399,tRNA metabolic process,1/269,202/18888,0.004950495,0.347602046,-1.120494055,0.945697013,0.946944086,0.397094292,AKT1,1
GO:0003341,BP,GO:0003341,cilium movement,1/269,209/18888,0.004784689,0.335959873,-1.160299514,0.950939226,0.951983985,0.399207738,DEFB1,1
GO:0000377,BP,GO:0000377,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",2/269,337/18888,0.005934718,0.416709872,-1.298659714,0.954636596,0.955265612,0.400583865,SRPK1/FRG1,2
GO:0000398,BP,GO:0000398,"mRNA splicing, via spliceosome",2/269,337/18888,0.005934718,0.416709872,-1.298659714,0.954636596,0.955265612,0.400583865,SRPK1/FRG1,2
GO:0000375,BP,GO:0000375,"RNA splicing, via transesterification reactions",2/269,341/18888,0.005865103,0.411821779,-1.317433634,0.956780777,0.95720097,0.401395444,SRPK1/FRG1,2
GO:0007033,BP,GO:0007033,vacuole organization,1/269,234/18888,0.004273504,0.300066724,-1.294965022,0.96586998,0.966082026,0.405119652,MTOR,1
GO:0048193,BP,GO:0048193,Golgi vesicle transport,1/269,294/18888,0.003401361,0.238828617,-1.581062938,0.985742873,0.985742873,0.413364289,CUL3,1
GO:0031983,CC,GO:0031983,vesicle lumen,21/271,326/19894,0.064417178,4.728838883,7.977398436,4.54E-09,1.65E-06,1.20E-06,TIMP1/THBS1/NFKB1/FASLG/VEGFA/GSTP1/MAPK14/MAPK1/PRKCD/TGFB1/EGFR/A2M/FN1/OLFM4/SERPINE1/PCSK1/IGF1/HSP90AA1/ROCK1/IGF2/CLU,21
GO:0060205,CC,GO:0060205,cytoplasmic vesicle lumen,20/271,325/19894,0.061538462,4.517513483,7.513550669,2.30E-08,2.83E-06,2.06E-06,TIMP1/THBS1/NFKB1/FASLG/VEGFA/GSTP1/MAPK14/MAPK1/PRKCD/TGFB1/A2M/FN1/OLFM4/SERPINE1/PCSK1/IGF1/HSP90AA1/ROCK1/IGF2/CLU,20
GO:0031093,CC,GO:0031093,platelet alpha granule lumen,10/271,67/19894,0.149253731,10.95665584,9.593442532,2.33E-08,2.83E-06,2.06E-06,TIMP1/THBS1/VEGFA/TGFB1/A2M/FN1/SERPINE1/IGF1/IGF2/CLU,10
GO:0031091,CC,GO:0031091,platelet alpha granule,11/271,91/19894,0.120879121,8.873687198,8.846784424,4.42E-08,3.39E-06,2.47E-06,TIMP1/THBS1/VEGFA/TGFB1/A2M/FN1/SERPINE1/IGF1/CD9/IGF2/CLU,11
GO:0044853,CC,GO:0044853,plasma membrane raft,12/271,113/19894,0.10619469,7.795709108,8.513378956,4.67E-08,3.39E-06,2.47E-06,CTNNB1/PTGS2/FASLG/IGF1R/CDH1/HDAC6/MAPK1/CAV1/DLC1/IRS1/CD8A/MAL,12
GO:0034774,CC,GO:0034774,secretory granule lumen,19/271,322/19894,0.059006211,4.331622012,7.083014648,1.01E-07,6.12E-06,4.45E-06,TIMP1/THBS1/NFKB1/VEGFA/GSTP1/MAPK14/MAPK1/PRKCD/TGFB1/A2M/FN1/OLFM4/SERPINE1/PCSK1/IGF1/HSP90AA1/ROCK1/IGF2/CLU,19
GO:0005901,CC,GO:0005901,caveola,10/271,82/19894,0.12195122,8.952389524,8.479934464,1.68E-07,8.73E-06,6.35E-06,CTNNB1/PTGS2/FASLG/IGF1R/CDH1/HDAC6/MAPK1/CAV1/DLC1/IRS1,10
GO:0045121,CC,GO:0045121,membrane raft,17/271,286/19894,0.059440559,4.363507341,6.733034382,4.36E-07,1.85E-05,1.35E-05,CTNNB1/PTGS2/FASLG/IGF1R/CDH1/HDAC6/MAPK1/TNF/TGFBR1/CAV1/EGFR/DLC1/KDR/IRS1/MME/CD8A/MAL,17
GO:0098857,CC,GO:0098857,membrane microdomain,17/271,287/19894,0.059233449,4.348303483,6.714478281,4.58E-07,1.85E-05,1.35E-05,CTNNB1/PTGS2/FASLG/IGF1R/CDH1/HDAC6/MAPK1/TNF/TGFBR1/CAV1/EGFR/DLC1/KDR/IRS1/MME/CD8A/MAL,17
GO:0005925,CC,GO:0005925,focal adhesion,20/271,421/19894,0.047505938,3.487391644,6.062068951,1.46E-06,5.29E-05,3.85E-05,CTNNB1/CD44/MMP14/MAPK1/RHOA/KRAS/ALOX15B/CAV1/PTK2/ILK/BSG/EGFR/DLC1/GIT1/HSPA5/REXO2/VIM/CD9/MME/PLAU,20
GO:0031252,CC,GO:0031252,cell leading edge,20/271,426/19894,0.046948357,3.446459817,5.998384522,1.75E-06,5.76E-05,4.19E-05,CTNNB1/ERBB2/PIK3CA/CASP8/CD44/CTNND1/CDH1/S100A6/TLR4/HDAC6/RHOA/AKT1/FSCN1/ILK/EPB41L3/EGFR/DLC1/GIT1/VIM/ROCK1,20
GO:0030055,CC,GO:0030055,cell-substrate junction,20/271,431/19894,0.046403712,3.406477684,5.935641564,2.09E-06,6.31E-05,4.59E-05,CTNNB1/CD44/MMP14/MAPK1/RHOA/KRAS/ALOX15B/CAV1/PTK2/ILK/BSG/EGFR/DLC1/GIT1/HSPA5/REXO2/VIM/CD9/MME/PLAU,20
GO:0090575,CC,GO:0090575,RNA polymerase II transcription regulator complex,15/271,255/19894,0.058823529,4.318211417,6.267098828,2.39E-06,6.68E-05,4.86E-05,CTNNB1/MYC/VDR/PPARG/NCOA1/MYB/HIF1A/STAT3/FOS/SMAD3/RB1/STAT1/MXI1/MED1/CLOCK,15
GO:0000781,CC,GO:0000781,"chromosome, telomeric region",12/271,173/19894,0.069364162,5.091994966,6.352515898,4.66E-06,0.000120774,8.79E-05,BRCA2/XRCC1/ERCC1/PARP1/KDM1A/XRCC3/CDK2/PCNA/EZH2/CHEK2/MSH2/NBN,12
GO:0140092,CC,GO:0140092,bBAF complex,4/271,10/19894,0.4,29.36383764,10.54302408,6.63E-06,0.000160469,0.000116798,ARID1A/SMARCA4/SMARCA2/SMARCE1,4
GO:0000307,CC,GO:0000307,cyclin-dependent protein kinase holoenzyme complex,7/271,56/19894,0.125,9.176199262,7.200267352,1.06E-05,0.000239686,0.000174456,CCND1/CDK4/CDK2/PCNA/CDK12/RB1/CDKN1A,7
GO:0030027,CC,GO:0030027,lamellipodium,12/271,203/19894,0.0591133,4.339483395,5.620118931,2.35E-05,0.000501218,0.000364813,CTNNB1/PIK3CA/CASP8/CD44/CTNND1/CDH1/RHOA/AKT1/FSCN1/ILK/GIT1/ROCK1,12
GO:0071564,CC,GO:0071564,npBAF complex,4/271,14/19894,0.285714286,20.97416974,8.785705649,3.03E-05,0.000610558,0.000444397,ARID1A/SMARCA4/SMARCA2/SMARCE1,4
GO:0098687,CC,GO:0098687,chromosomal region,17/271,402/19894,0.042288557,3.10438582,5.009129698,4.01E-05,0.000707231,0.00051476,AURKA/BRCA2/XRCC1/ERCC1/PARP1/KDM1A/XRCC3/SMARCA4/CDK2/PCNA/EZH2/CHEK2/SNAI1/MEAF6/SMARCE1/MSH2/NBN,17
GO:0034399,CC,GO:0034399,nuclear periphery,10/271,150/19894,0.066666667,4.89397294,5.625654706,4.09E-05,0.000707231,0.00051476,TP53/MYB/RNASEL/SMARCA4/TENM1/PCNA/SRPK1/PRKCD/VIM/SMARCE1,10
GO:1902911,CC,GO:1902911,protein kinase complex,10/271,150/19894,0.066666667,4.89397294,5.625654706,4.09E-05,0.000707231,0.00051476,CCND1/CDK4/IGF1R/CDK2/PCNA/TGFBR1/CDK12/RB1/IRS1/CDKN1A,10
GO:0016514,CC,GO:0016514,SWI/SNF complex,5/271,30/19894,0.166666667,12.23493235,7.236854159,4.87E-05,0.000804245,0.000585372,ARID1A/SMARCA4/SMARCA2/RB1/SMARCE1,5
GO:0071565,CC,GO:0071565,nBAF complex,4/271,16/19894,0.25,18.35239852,8.159907701,5.39E-05,0.0008503,0.000618893,ARID1A/SMARCA4/SMARCA2/SMARCE1,4
GO:0016363,CC,GO:0016363,nuclear matrix,9/271,128/19894,0.0703125,5.161612085,5.550847169,6.57E-05,0.000993603,0.000723197,TP53/MYB/RNASEL/SMARCA4/TENM1/SRPK1/PRKCD/VIM/SMARCE1,9
GO:0043073,CC,GO:0043073,germ cell nucleus,6/271,66/19894,0.090909091,6.673599463,5.425543756,0.000277015,0.004022253,0.002927608,TP53/BRCA1/AURKA/CDK2/PCNA/MLH1,6
GO:1904090,CC,GO:1904090,peptidase inhibitor complex,3/271,11/19894,0.272727273,20.02079839,7.415427846,0.000380418,0.005311222,0.003865787,SERPINE1/CTSB/PLAU,3
GO:1990124,CC,GO:1990124,messenger ribonucleoprotein complex,3/271,12/19894,0.25,18.35239852,7.065976463,0.000502125,0.006750792,0.004913582,YBX1/PKP1/PKP3,3
GO:1902554,CC,GO:1902554,serine/threonine protein kinase complex,8/271,136/19894,0.058823529,4.318211417,4.563038171,0.000560463,0.007266007,0.005288583,CCND1/CDK4/CDK2/PCNA/TGFBR1/CDK12/RB1/CDKN1A,8
GO:0016605,CC,GO:0016605,PML body,7/271,108/19894,0.064814815,4.758029247,4.601984122,0.000696869,0.008722874,0.006348967,TP53/PTEN/MTOR/SQSTM1/CHEK2/RB1/NBN,7
GO:0035060,CC,GO:0035060,brahma complex,3/271,14/19894,0.214285714,15.73062731,6.479315897,0.000814185,0.009851644,0.007170546,ARID1A/SMARCA2/SMARCE1,3
GO:0043025,CC,GO:0043025,neuronal cell body,16/271,488/19894,0.032786885,2.406871938,3.69784369,0.001133717,0.013275464,0.009662582,SRD5A2/AURKA/CASP3/IGF1R/HDAC6/TNF/LMTK2/KATNB1/SNCG/DAB2IP/PCSK1/TAC1/HSP90AA1/MME/UCN/CYP17A1,16
GO:0070603,CC,GO:0070603,SWI/SNF superfamily-type complex,6/271,93/19894,0.064516129,4.736102845,4.243935941,0.001712766,0.019429195,0.014141592,ARID1A/SMARCA4/SMARCA2/MBD2/RB1/SMARCE1,6
GO:0031968,CC,GO:0031968,organelle outer membrane,10/271,248/19894,0.040322581,2.960064278,3.650153844,0.002214042,0.02434062,0.017716386,PTGS2/CASP8/BID/MTOR/KRAS/BAX/IFI27/BNIP3/PMAIP1/BNIP3L,10
GO:0062023,CC,GO:0062023,collagen-containing extracellular matrix,14/271,428/19894,0.03271028,2.401248405,3.443901655,0.002327052,0.02434062,0.017716386,TIMP1/THBS1/LAMB3/S100A6/MMP9/TGFB1/MMP2/A2M/FN1/COL11A2/SERPINE1/HSP90AA1/CTSB/CLU,14
GO:0019867,CC,GO:0019867,outer membrane,10/271,250/19894,0.04,2.936383764,3.620750163,0.002346892,0.02434062,0.017716386,PTGS2/CASP8/BID/MTOR/KRAS/BAX/IFI27/BNIP3/PMAIP1/BNIP3L,10
GO:0016234,CC,GO:0016234,inclusion body,5/271,71/19894,0.070422535,5.169689725,4.136188361,0.002830134,0.028537183,0.020770865,GPX1/HDAC6/SQSTM1/NBN/CLU,5
GO:1990391,CC,GO:1990391,DNA repair complex,3/271,22/19894,0.136363636,10.01039919,4.969202194,0.00317827,0.030590176,0.022265142,BRCA1/BRCA2/KDM1A,3
GO:0005741,CC,GO:0005741,mitochondrial outer membrane,9/271,219/19894,0.04109589,3.016832634,3.526847097,0.003202277,0.030590176,0.022265142,CASP8/BID/MTOR/KRAS/BAX/IFI27/BNIP3/PMAIP1/BNIP3L,9
GO:0005657,CC,GO:0005657,replication fork,5/271,74/19894,0.067567568,4.960107709,4.01072715,0.003388131,0.030847786,0.022452644,TP53/PARP1/XRCC3/PCNA/NBN,5
GO:0061695,CC,GO:0061695,"transferase complex, transferring phosphorus-containing groups",11/271,308/19894,0.035714286,2.621771218,3.370886708,0.003472054,0.030847786,0.022452644,CCND1/CDK4/PIK3CA/IGF1R/CDK2/PCNA/TGFBR1/CDK12/RB1/IRS1/CDKN1A,11
GO:0043209,CC,GO:0043209,myelin sheath,4/271,46/19894,0.086956522,6.383442965,4.295688106,0.003506938,0.030847786,0.022452644,PTEN/ERBB2/HSP90AA1/MAL,4
GO:0001726,CC,GO:0001726,ruffle,8/271,182/19894,0.043956044,3.226795345,3.546522654,0.003569165,0.030847786,0.022452644,ERBB2/S100A6/TLR4/RHOA/FSCN1/EGFR/DLC1/ROCK1,8
GO:0000152,CC,GO:0000152,nuclear ubiquitin ligase complex,4/271,47/19894,0.085106383,6.247625029,4.232689139,0.003792752,0.03201788,0.0233043,BRCA1/BRCA2/BMI1/CBX8,4
GO:0101002,CC,GO:0101002,ficolin-1-rich granule,8/271,185/19894,0.043243243,3.174468934,3.491876391,0.003939503,0.032500902,0.023655869,GSTP1/MAPK14/MAPK1/RHOA/MMP9/PKP1/HSP90AA1/CTSB,8
GO:0150034,CC,GO:0150034,distal axon,10/271,272/19894,0.036764706,2.698882136,3.31534059,0.00427535,0.032676635,0.023783777,CTNND1/LMTK2/KATNB1/SNCG/FSCN1/GIT1/PCSK1/HSP90AA1/UCN/CRHR2,10
GO:0005912,CC,GO:0005912,adherens junction,8/271,188/19894,0.042553191,3.123812515,3.438333082,0.004338848,0.032676635,0.023783777,CTNNB1/VEGFA/CTNND1/CDH1/NOTCH1/ALOX15B/PKP1/PKP3,8
GO:0042470,CC,GO:0042470,melanosome,6/271,112/19894,0.053571429,3.932656827,3.657524493,0.004342299,0.032676635,0.023783777,FASN/MMP14/BSG/HSPA5/HSP90AA1/CTSB,6
GO:0048770,CC,GO:0048770,pigment granule,6/271,112/19894,0.053571429,3.932656827,3.657524493,0.004342299,0.032676635,0.023783777,FASN/MMP14/BSG/HSPA5/HSP90AA1/CTSB,6
GO:0031519,CC,GO:0031519,PcG protein complex,4/271,49/19894,0.081632653,5.992619926,4.111999744,0.004410896,0.032676635,0.023783777,BAP1/BMI1/EZH2/CBX8,4
GO:0043296,CC,GO:0043296,apical junction complex,7/271,150/19894,0.046666667,3.425781058,3.504545829,0.004545955,0.033003633,0.024021783,CTNNB1/CCND1/CDK4/CTNND1/CDH1/RHOA/TGFBR1,7
GO:0000792,CC,GO:0000792,heterochromatin,5/271,81/19894,0.061728395,4.531456426,3.742599251,0.004991063,0.035524627,0.025856695,BMI1/EZH2/CBX8/SNAI1/CDKN2A,5
GO:0001673,CC,GO:0001673,male germ cell nucleus,4/271,52/19894,0.076923077,5.646891854,3.942971149,0.005459969,0.03811478,0.027741945,BRCA1/CDK2/PCNA/MLH1,4
GO:0009898,CC,GO:0009898,cytoplasmic side of plasma membrane,7/271,161/19894,0.043478261,3.191721482,3.281359619,0.006647979,0.045532385,0.033140869,PTEN/CDH1/S100A6/RHOA/KRAS/MIEN1/MYD88,7
GO:1904813,CC,GO:1904813,ficolin-1-rich granule lumen,6/271,124/19894,0.048387097,3.552077134,3.350066199,0.00708659,0.047637634,0.03467318,GSTP1/MAPK14/MAPK1/MMP9/HSP90AA1/CTSB,6
GO:0097136,CC,GO:0097136,Bcl-2 family protein complex,2/271,10/19894,0.2,14.68191882,5.085658766,0.007740709,0.051088679,0.037185032,BAX/PMAIP1,2
GO:0044306,CC,GO:0044306,neuron projection terminus,6/271,128/19894,0.046875,3.441074723,3.255957653,0.008231201,0.053355823,0.038835179,SNCG/GIT1/PCSK1/MME/UCN/CRHR2,6
GO:0016342,CC,GO:0016342,catenin complex,3/271,31/19894,0.096774194,7.104154267,3.997017146,0.008478255,0.053993098,0.039299022,CTNNB1/CTNND1/CDH1,3
GO:0005635,CC,GO:0005635,nuclear envelope,14/271,498/19894,0.02811245,2.063723529,2.825136487,0.008659909,0.054199083,0.039448948,PTGS2/CCND1/CDK4/EDNRB/PARP1/S100A6/CDK2/MTOR/SMAD3/EGFR/BAX/IFI27/BNIP3/BNIP3L,14
GO:0032300,CC,GO:0032300,mismatch repair complex,2/271,11/19894,0.181818182,13.34719893,4.813665592,0.009376329,0.055796844,0.040611883,MLH1/MSH2,2
GO:0043220,CC,GO:0043220,Schmidt-Lanterman incisure,2/271,11/19894,0.181818182,13.34719893,4.813665592,0.009376329,0.055796844,0.040611883,PTEN/MAL,2
GO:1905370,CC,GO:1905370,serine-type endopeptidase complex,2/271,11/19894,0.181818182,13.34719893,4.813665592,0.009376329,0.055796844,0.040611883,THBD/PLAU,2
GO:0009897,CC,GO:0009897,external side of plasma membrane,12/271,405/19894,0.02962963,2.175099084,2.807755628,0.009920981,0.058085746,0.042277867,THBS1/CXCR2/FASLG/TLR4/TNF/KDR/CD9/THBD/CD8A/CD274/CTSB/PLAU,12
GO:0005902,CC,GO:0005902,microvillus,5/271,97/19894,0.051546392,3.783999696,3.230036604,0.010542768,0.060746427,0.044214451,CTNNB1/CD44/TGFB1/FSCN1/FOXA1,5
GO:0005788,CC,GO:0005788,endoplasmic reticulum lumen,10/271,313/19894,0.031948882,2.345354444,2.819314582,0.011013205,0.062274995,0.045327023,TIMP1/THBS1/IL6/PTGS2/MAPK1/MSLN/FN1/COL11A2/HSPA5/CLU,10
GO:0000109,CC,GO:0000109,nucleotide-excision repair complex,2/271,12/19894,0.166666667,12.23493235,4.57491611,0.01115117,0.062274995,0.045327023,XRCC1/ERCC1,2
GO:0005677,CC,GO:0005677,chromatin silencing complex,2/271,13/19894,0.153846154,11.29378371,4.362944485,0.013061164,0.070764214,0.051505924,EZH2/RB1,2
GO:1905286,CC,GO:1905286,serine-type peptidase complex,2/271,13/19894,0.153846154,11.29378371,4.362944485,0.013061164,0.070764214,0.051505924,THBD/PLAU,2
GO:0000800,CC,GO:0000800,lateral element,2/271,14/19894,0.142857143,10.48708487,4.172926145,0.015102327,0.075844166,0.05520338,BRCA1/BRCA2,2
GO:0043218,CC,GO:0043218,compact myelin,2/271,14/19894,0.142857143,10.48708487,4.172926145,0.015102327,0.075844166,0.05520338,PTEN/MAL,2
GO:0045120,CC,GO:0045120,pronucleus,2/271,14/19894,0.142857143,10.48708487,4.172926145,0.015102327,0.075844166,0.05520338,AURKA/EZH2,2
GO:0099092,CC,GO:0099092,"postsynaptic density, intracellular component",2/271,14/19894,0.142857143,10.48708487,4.172926145,0.015102327,0.075844166,0.05520338,CTNNB1/CTNND1,2
GO:0140288,CC,GO:0140288,GBAF complex,2/271,14/19894,0.142857143,10.48708487,4.172926145,0.015102327,0.075844166,0.05520338,SMARCA4/SMARCA2,2
GO:0000793,CC,GO:0000793,condensed chromosome,9/271,281/19894,0.03202847,2.351196964,2.680722696,0.015252408,0.075844166,0.05520338,BRCA1/AURKA/BRCA2/SMARCA4/CDK2/BRD4/MEAF6/SMARCE1/MLH1,9
GO:1904949,CC,GO:1904949,ATPase complex,6/271,149/19894,0.040268456,2.956091037,2.816473784,0.01649054,0.080375451,0.058501489,ARID1A/SMARCA4/SMARCA2/MBD2/RB1/SMARCE1,6
GO:0000795,CC,GO:0000795,synaptonemal complex,3/271,40/19894,0.075,5.505719557,3.352140621,0.017040669,0.080375451,0.058501489,BRCA1/BRCA2/MLH1,3
GO:0099086,CC,GO:0099086,synaptonemal structure,3/271,40/19894,0.075,5.505719557,3.352140621,0.017040669,0.080375451,0.058501489,BRCA1/BRCA2/MLH1,3
GO:0016586,CC,GO:0016586,RSC-type complex,2/271,15/19894,0.133333333,9.787945879,4.001177529,0.017270758,0.080375451,0.058501489,SMARCA4/SMARCE1,2
GO:0090571,CC,GO:0090571,RNA polymerase II transcription repressor complex,2/271,15/19894,0.133333333,9.787945879,4.001177529,0.017270758,0.080375451,0.058501489,CTNNB1/MYC,2
GO:0043679,CC,GO:0043679,axon terminus,5/271,112/19894,0.044642857,3.277214022,2.840075247,0.018650004,0.085695589,0.062373765,SNCG/GIT1/PCSK1/UCN/CRHR2,5
GO:0098562,CC,GO:0098562,cytoplasmic side of membrane,7/271,199/19894,0.035175879,2.582247029,2.63617914,0.019555422,0.088732727,0.064584354,PTEN/CDH1/S100A6/RHOA/KRAS/MIEN1/MYD88,7
GO:0017053,CC,GO:0017053,transcription repressor complex,4/271,77/19894,0.051948052,3.813485408,2.906853601,0.02098801,0.094057377,0.068459915,TP53/CTNNB1/MYC/CCND1,4
GO:0019908,CC,GO:0019908,nuclear cyclin-dependent protein kinase holoenzyme complex,2/271,17/19894,0.117647059,8.636422835,3.701613704,0.021974229,0.09603539,0.069899617,CDK12/RB1,2
GO:0099091,CC,GO:0099091,"postsynaptic specialization, intracellular component",2/271,17/19894,0.117647059,8.636422835,3.701613704,0.021974229,0.09603539,0.069899617,CTNNB1/CTNND1,2
GO:0030139,CC,GO:0030139,endocytic vesicle,10/271,350/19894,0.028571429,2.097416974,2.434170828,0.022223066,0.09603539,0.069899617,RILP/MTOR/CAV1/EGFR/TGFA/DAB2IP/VIM/CD9/SPHK1/HSP90AA1,10
GO:0005758,CC,GO:0005758,mitochondrial intermembrane space,4/271,80/19894,0.05,3.670479705,2.812550187,0.023772987,0.10094121,0.073470331,HSD3B1/HSD3B2/REXO2/AIFM1,4
GO:0016323,CC,GO:0016323,basolateral plasma membrane,8/271,255/19894,0.031372549,2.303046089,2.46106037,0.024004232,0.10094121,0.073470331,CTNNB1/ERBB2/AURKA/CD44/BSG/EGFR/TGFA/HSP90AA1,8
GO:0035102,CC,GO:0035102,PRC1 complex,2/271,18/19894,0.111111111,8.156621566,3.569701454,0.024501867,0.10094121,0.073470331,BMI1/CBX8,2
GO:0098831,CC,GO:0098831,presynaptic active zone cytoplasmic component,2/271,18/19894,0.111111111,8.156621566,3.569701454,0.024501867,0.10094121,0.073470331,CTNNB1/CTNND1,2
GO:0000794,CC,GO:0000794,condensed nuclear chromosome,4/271,81/19894,0.049382716,3.625165141,2.782121568,0.024748671,0.10094121,0.073470331,BRCA1/BRCA2/BRD4/MLH1,4
GO:0005938,CC,GO:0005938,cell cortex,9/271,309/19894,0.029126214,2.138143517,2.369553756,0.026279975,0.105995898,0.077149399,CTNNB1/CTNND1/CDH1/RHOA/AKT1/CAV1/PTK2/FSCN1/DLC1,9
GO:0090734,CC,GO:0090734,site of DNA damage,5/271,123/19894,0.040650407,2.984129841,2.593942898,0.026674683,0.106405603,0.077447604,TP53/XRCC1/PARP1/NKX3-1/NBN,5
GO:0016607,CC,GO:0016607,nuclear speck,11/271,416/19894,0.026442308,1.941119075,2.279665597,0.027932458,0.110211762,0.080217928,AR/MAPK14/HIF1A/TENM1/SPOP/SRPK1/CDK12/BRD2/WT1/SOX2/BNIP3L,11
GO:0001725,CC,GO:0001725,stress fiber,4/271,85/19894,0.047058824,3.454569134,2.665051098,0.028891124,0.111568914,0.081205734,PTK2/FSCN1/ILK/MST1R,4
GO:0097517,CC,GO:0097517,contractile actin filament bundle,4/271,85/19894,0.047058824,3.454569134,2.665051098,0.028891124,0.111568914,0.081205734,PTK2/FSCN1/ILK/MST1R,4
GO:0030667,CC,GO:0030667,secretory granule membrane,9/271,317/19894,0.028391167,2.08418406,2.286713013,0.030264112,0.115640764,0.084169441,CXCR2/CD44/RHOA/CAV1/BSG/PKP1/CD9/MME/PLAU,9
GO:0008023,CC,GO:0008023,transcription elongation factor complex,3/271,51/19894,0.058823529,4.318211417,2.788287553,0.032223831,0.12184636,0.088686201,ELL2/CDK12/RB1,3
GO:0032806,CC,GO:0032806,carboxy-terminal domain protein kinase complex,2/271,21/19894,0.095238095,6.991389914,3.22817894,0.032745601,0.122542814,0.089193117,CDK12/RB1,2
GO:0000922,CC,GO:0000922,spindle pole,6/271,177/19894,0.033898305,2.488460817,2.337521996,0.034575224,0.126284687,0.091916649,CTNNB1/AURKA/MAPK14/KATNB1/CUL3/GIT1,6
GO:0031970,CC,GO:0031970,organelle envelope lumen,4/271,90/19894,0.044444444,3.262648626,2.528214961,0.034614765,0.126284687,0.091916649,HSD3B1/HSD3B2/REXO2/AIFM1,4
GO:0097225,CC,GO:0097225,sperm midpiece,3/271,53/19894,0.056603774,4.155260043,2.702983526,0.035543565,0.126284687,0.091916649,DEFB1/SQSTM1/HSP90AA1,3
GO:0000228,CC,GO:0000228,nuclear chromosome,7/271,226/19894,0.030973451,2.27374849,2.263132006,0.035649697,0.126284687,0.091916649,BRCA1/BRCA2/PARP1/PCNA/BRD4/SMARCE1/MLH1,7
GO:0005819,CC,GO:0005819,spindle,11/271,433/19894,0.025404157,1.864908857,2.138374669,0.035785857,0.126284687,0.091916649,CTNNB1/CXCR2/AURKA/MAPK14/MAPK1/AKT1/KATNB1/SNCG/CUL3/GIT1/RB1,11
GO:0042641,CC,GO:0042641,actomyosin,4/271,91/19894,0.043956044,3.226795345,2.502001651,0.035832845,0.126284687,0.091916649,PTK2/FSCN1/ILK/MST1R,4
GO:0031256,CC,GO:0031256,leading edge membrane,6/271,179/19894,0.033519553,2.460656785,2.306897987,0.036217525,0.126413094,0.09201011,ERBB2/CD44/RHOA/EPB41L3/EGFR/DLC1,6
GO:0016327,CC,GO:0016327,apicolateral plasma membrane,2/271,23/19894,0.086956522,6.383442965,3.035751774,0.038757933,0.133991712,0.097526228,CTNNB1/THBD,2
GO:0032432,CC,GO:0032432,actin filament bundle,4/271,95/19894,0.042105263,3.090930278,2.400666384,0.040950794,0.140237153,0.102071989,PTK2/FSCN1/ILK/MST1R,4
GO:0005637,CC,GO:0005637,nuclear inner membrane,3/271,57/19894,0.052631579,3.863662847,2.54432978,0.042689104,0.143841647,0.10469553,PTGS2/SMAD3/IFI27,3
GO:0009925,CC,GO:0009925,basal plasma membrane,8/271,286/19894,0.027972028,2.053415219,2.108715746,0.042795862,0.143841647,0.10469553,CTNNB1/ERBB2/AURKA/CD44/BSG/EGFR/TGFA/HSP90AA1,8
GO:0072562,CC,GO:0072562,blood microparticle,5/271,144/19894,0.034722222,2.548944239,2.192227214,0.047405553,0.157873539,0.11490868,TGFB1/A2M/FN1/HPR/CLU,5
GO:0032587,CC,GO:0032587,ruffle membrane,4/271,100/19894,0.04,2.936383764,2.281270237,0.047901319,0.158074351,0.115054842,ERBB2/RHOA/EGFR/DLC1,4
GO:0034364,CC,GO:0034364,high-density lipoprotein particle,2/271,26/19894,0.076923077,5.646891854,2.786276734,0.048486069,0.158562551,0.115410179,HPR/CLU,2
GO:0016324,CC,GO:0016324,apical plasma membrane,10/271,402/19894,0.024875622,1.826109306,1.966411586,0.049505005,0.160449258,0.116783424,PTEN/ERBB2/CD44/NOTCH1/EGFR/FN1/HSP90AA1/MUC1/CTSB/MAL,10
GO:0000791,CC,GO:0000791,euchromatin,3/271,61/19894,0.049180328,3.610307906,2.39946564,0.050495903,0.161927285,0.11785921,CTNNB1/HIF1A/ESR1,3
GO:0019897,CC,GO:0019897,extrinsic component of plasma membrane,4/271,102/19894,0.039215686,2.878807612,2.235577039,0.050853197,0.161927285,0.11785921,CTNNB1/CTNND1/CDH1/MYD88,4
GO:0030057,CC,GO:0030057,desmosome,2/271,27/19894,0.074074074,5.437747711,2.711629997,0.051905612,0.163841192,0.119252252,PKP1/PKP3,2
GO:0031253,CC,GO:0031253,cell projection membrane,9/271,354/19894,0.025423729,1.866345613,1.932780861,0.054189356,0.168242973,0.122456101,CTNNB1/ERBB2/CD44/RHOA/FSCN1/EPB41L3/EGFR/DLC1/HSP90AA1,9
GO:0098978,CC,GO:0098978,glutamatergic synapse,10/271,409/19894,0.024449878,1.794855601,1.908761967,0.054387478,0.168242973,0.122456101,CTNNB1/AURKA/CTNND1/CDH1/MAPK14/RELA/RHOA/AKT1/CUL3/HRAS,10
GO:0001650,CC,GO:0001650,fibrillar center,5/271,150/19894,0.033333333,2.44698647,2.090473244,0.054690553,0.168242973,0.122456101,SMARCA4/FOXA1/SNAI1/KLF6/FHIT,5
GO:0001891,CC,GO:0001891,phagocytic cup,2/271,28/19894,0.071428571,5.243542435,2.640611038,0.055408593,0.16901949,0.123021291,TLR4/TNF,2
GO:0045177,CC,GO:0045177,apical part of cell,11/271,468/19894,0.023504274,1.725439177,1.86631233,0.056598548,0.171148287,0.124570741,PTEN/CTNNB1/ERBB2/CD44/NOTCH1/EGFR/FN1/HSP90AA1/MUC1/CTSB/MAL,11
GO:0005796,CC,GO:0005796,Golgi lumen,4/271,106/19894,0.037735849,2.770173362,2.147434212,0.057049429,0.171148287,0.124570741,DEFB1/MMP14/TGFB1/MUC1,4
GO:0045178,CC,GO:0045178,basal part of cell,8/271,305/19894,0.026229508,1.92549755,1.914128743,0.058140693,0.172992391,0.125912977,CTNNB1/ERBB2/AURKA/CD44/BSG/EGFR/TGFA/HSP90AA1,8
GO:0036019,CC,GO:0036019,endolysosome,2/271,29/19894,0.068965517,5.062730627,2.572911376,0.058992125,0.174098711,0.126718215,PRKCD/CTSB,2
GO:0030496,CC,GO:0030496,midbody,6/271,205/19894,0.029268293,2.148573486,1.942566847,0.06216311,0.180501408,0.131378435,AURKA/CTNND1/RHOA/LZTS2/KATNB1/HSPA5,6
GO:0005721,CC,GO:0005721,pericentric heterochromatin,2/271,30/19894,0.066666667,4.89397294,2.508258474,0.062653381,0.180501408,0.131378435,EZH2/SNAI1,2
GO:0005790,CC,GO:0005790,smooth endoplasmic reticulum,2/271,30/19894,0.066666667,4.89397294,2.508258474,0.062653381,0.180501408,0.131378435,HSD3B1/HSD3B2,2
GO:0000803,CC,GO:0000803,sex chromosome,2/271,31/19894,0.064516129,4.736102845,2.446410506,0.066389597,0.189759242,0.138116774,BRCA1/CDK2,2
GO:0005769,CC,GO:0005769,early endosome,10/271,428/19894,0.023364486,1.715177432,1.757718855,0.06921033,0.196276171,0.142860139,ERBB2/TLR4/MAPK1/LMTK2/CAV1/EGFR/KDR/SPHK1/MME/CD274,10
GO:0002080,CC,GO:0002080,acrosomal membrane,2/271,32/19894,0.0625,4.588099631,2.387152031,0.070198068,0.196642239,0.143126583,CAV1/BSG,2
GO:0000151,CC,GO:0000151,ubiquitin ligase complex,8/271,318/19894,0.025157233,1.846782241,1.788856108,0.07042284,0.196642239,0.143126583,BRCA1/FBXW7/BRCA2/SPOP/BMI1/CBX8/CUL3/MED1,8
GO:0030426,CC,GO:0030426,growth cone,5/271,164/19894,0.030487805,2.238097381,1.870963311,0.074067655,0.203686051,0.14825344,CTNND1/LMTK2/KATNB1/FSCN1/HSP90AA1,5
GO:0070820,CC,GO:0070820,tertiary granule,5/271,164/19894,0.030487805,2.238097381,1.870963311,0.074067655,0.203686051,0.14825344,RHOA/MMP9/OLFM4/PKP1/PLAU,5
GO:0036126,CC,GO:0036126,sperm flagellum,5/271,168/19894,0.029761905,2.184809348,1.812323339,0.080209213,0.218916875,0.159339236,FLACC1/DEFB1/SQSTM1/CUL3/HSP90AA1,5
GO:0030427,CC,GO:0030427,site of polarized growth,5/271,169/19894,0.029585799,2.171881482,1.797921074,0.08178599,0.220571844,0.16054381,CTNND1/LMTK2/KATNB1/FSCN1/HSP90AA1,5
GO:0016235,CC,GO:0016235,aggresome,2/271,35/19894,0.057142857,4.194833948,2.223083164,0.082030851,0.220571844,0.16054381,HDAC6/SQSTM1,2
GO:0030669,CC,GO:0030669,clathrin-coated endocytic vesicle membrane,3/271,75/19894,0.04,2.936383764,1.974391534,0.082711024,0.220765453,0.160684729,EGFR/TGFA/CD9,3
GO:0034358,CC,GO:0034358,plasma lipoprotein particle,2/271,36/19894,0.055555556,4.078310783,2.172441276,0.086102469,0.224857527,0.163663156,HPR/CLU,2
GO:0099738,CC,GO:0099738,cell cortex region,2/271,36/19894,0.055555556,4.078310783,2.172441276,0.086102469,0.224857527,0.163663156,CTNNB1/CTNND1,2
GO:1990777,CC,GO:1990777,lipoprotein particle,2/271,36/19894,0.055555556,4.078310783,2.172441276,0.086102469,0.224857527,0.163663156,HPR/CLU,2
GO:0036064,CC,GO:0036064,ciliary basal body,5/271,173/19894,0.028901734,2.121664569,1.741300287,0.088256952,0.228837669,0.166560113,AURKA/RILP/HDAC6/AKT1/PTK2,5
GO:0005775,CC,GO:0005775,vacuolar lumen,5/271,176/19894,0.028409091,2.085499832,1.699834926,0.093280423,0.23944632,0.174281648,FASLG/MAPK1/PRKCD/HSP90AA1/CTSB,5
GO:0005923,CC,GO:0005923,bicellular tight junction,4/271,126/19894,0.031746032,2.330463305,1.760592681,0.093696713,0.23944632,0.174281648,CTNNB1/CCND1/CDK4/TGFBR1,4
GO:0097431,CC,GO:0097431,mitotic spindle pole,2/271,38/19894,0.052631579,3.863662847,2.076442389,0.094422144,0.23944632,0.174281648,AURKA/GIT1,2
GO:0019898,CC,GO:0019898,extrinsic component of membrane,5/271,177/19894,0.028248588,2.073717347,1.686196834,0.09498697,0.23944632,0.174281648,CTNNB1/PIK3CA/CTNND1/CDH1/MYD88,5
GO:0031463,CC,GO:0031463,Cul3-RING ubiquitin ligase complex,2/271,39/19894,0.051282051,3.764594569,2.030864243,0.098665524,0.245312228,0.178551165,SPOP/CUL3,2
GO:0032994,CC,GO:0032994,protein-lipid complex,2/271,39/19894,0.051282051,3.764594569,2.030864243,0.098665524,0.245312228,0.178551165,HPR/CLU,2
GO:0070160,CC,GO:0070160,tight junction,4/271,131/19894,0.030534351,2.241514324,1.675378862,0.104256219,0.25744903,0.187384969,CTNNB1/CCND1/CDK4/TGFBR1,4
GO:0043596,CC,GO:0043596,nuclear replication fork,2/271,41/19894,0.048780488,3.58095581,1.944068264,0.10730807,0.261587776,0.190397366,PARP1/PCNA,2
GO:0072686,CC,GO:0072686,mitotic spindle,5/271,184/19894,0.027173913,1.994825927,1.593179756,0.107373495,0.261587776,0.190397366,CXCR2/AURKA/MAPK1/CUL3/GIT1,5
GO:0097729,CC,GO:0097729,9+2 motile cilium,5/271,189/19894,0.026455026,1.942052754,1.529220076,0.11668179,0.282369932,0.205523714,FLACC1/DEFB1/SQSTM1/CUL3/HSP90AA1,5
GO:0042383,CC,GO:0042383,sarcolemma,4/271,141/19894,0.028368794,2.082541676,1.515966954,0.126902608,0.304149037,0.221375694,ALOX12/IGF1R/CAV1/BSG,4
GO:0035861,CC,GO:0035861,site of double-strand break,3/271,91/19894,0.032967033,2.420096509,1.595604112,0.127652465,0.304149037,0.221375694,TP53/PARP1/NBN,3
GO:0000805,CC,GO:0000805,X chromosome,1/271,10/19894,0.1,7.34095941,2.356976111,0.128195049,0.304149037,0.221375694,CDK2,1
GO:0005604,CC,GO:0005604,basement membrane,3/271,92/19894,0.032608696,2.393791112,1.574668577,0.130705622,0.306104135,0.222798718,TIMP1/LAMB3/FN1,3
GO:0045171,CC,GO:0045171,intercellular bridge,3/271,92/19894,0.032608696,2.393791112,1.574668577,0.130705622,0.306104135,0.222798718,HSD3B1/OLFM4/HSD3B2,3
GO:0045334,CC,GO:0045334,clathrin-coated endocytic vesicle,3/271,93/19894,0.032258065,2.368051422,1.554005026,0.133784388,0.309323139,0.225141678,EGFR/TGFA/CD9,3
GO:0098685,CC,GO:0098685,Schaffer collateral - CA1 synapse,3/271,93/19894,0.032258065,2.368051422,1.554005026,0.133784388,0.309323139,0.225141678,CTNNB1/CTNND1/ROCK1,3
GO:0031965,CC,GO:0031965,nuclear membrane,7/271,313/19894,0.022364217,1.641748111,1.34484248,0.136886315,0.314491976,0.22890383,PTGS2/CCND1/CDK4/EDNRB/SMAD3/EGFR/IFI27,7
GO:0000775,CC,GO:0000775,"chromosome, centromeric region",6/271,257/19894,0.023346304,1.713842664,1.353578904,0.139837276,0.317799513,0.231311231,AURKA/SMARCA4/EZH2/SNAI1/MEAF6/SMARCE1,6
GO:0034663,CC,GO:0034663,endoplasmic reticulum chaperone complex,1/271,11/19894,0.090909091,6.673599463,2.211903338,0.140076921,0.317799513,0.231311231,HSPA5,1
GO:0030666,CC,GO:0030666,endocytic vesicle membrane,5/271,204/19894,0.024509804,1.799254757,1.348433522,0.146773255,0.324132188,0.235920485,RILP/CAV1/EGFR/TGFA/CD9,5
GO:0043202,CC,GO:0043202,lysosomal lumen,3/271,98/19894,0.030612245,2.247232472,1.454533773,0.149543819,0.324132188,0.235920485,FASLG/HSP90AA1/CTSB,3
GO:0005583,CC,GO:0005583,fibrillar collagen trimer,1/271,12/19894,0.083333333,6.117466175,2.083855756,0.151797443,0.324132188,0.235920485,COL11A2,1
GO:0005652,CC,GO:0005652,nuclear lamina,1/271,12/19894,0.083333333,6.117466175,2.083855756,0.151797443,0.324132188,0.235920485,PCNA,1
GO:0030877,CC,GO:0030877,beta-catenin destruction complex,1/271,12/19894,0.083333333,6.117466175,2.083855756,0.151797443,0.324132188,0.235920485,CTNNB1,1
GO:0033270,CC,GO:0033270,paranode region of axon,1/271,12/19894,0.083333333,6.117466175,2.083855756,0.151797443,0.324132188,0.235920485,EPB41L3,1
GO:0038201,CC,GO:0038201,TOR complex,1/271,12/19894,0.083333333,6.117466175,2.083855756,0.151797443,0.324132188,0.235920485,MTOR,1
GO:0042405,CC,GO:0042405,nuclear inclusion body,1/271,12/19894,0.083333333,6.117466175,2.083855756,0.151797443,0.324132188,0.235920485,NBN,1
GO:0044224,CC,GO:0044224,juxtaparanode region of axon,1/271,12/19894,0.083333333,6.117466175,2.083855756,0.151797443,0.324132188,0.235920485,EPB41L3,1
GO:0098643,CC,GO:0098643,banded collagen fibril,1/271,12/19894,0.083333333,6.117466175,2.083855756,0.151797443,0.324132188,0.235920485,COL11A2,1
GO:0014704,CC,GO:0014704,intercalated disc,2/271,51/19894,0.039215686,2.878807612,1.578758921,0.15309675,0.324994856,0.23654838,CTNNB1/PIK3CA,2
GO:0002116,CC,GO:0002116,semaphorin receptor complex,1/271,13/19894,0.076923077,5.646891854,1.969550921,0.1633588,0.336927525,0.245233605,ERBB2,1
GO:0033391,CC,GO:0033391,chromatoid body,1/271,13/19894,0.076923077,5.646891854,1.969550921,0.1633588,0.336927525,0.245233605,CLOCK,1
GO:0044292,CC,GO:0044292,dendrite terminus,1/271,13/19894,0.076923077,5.646891854,1.969550921,0.1633588,0.336927525,0.245233605,HSP90AA1,1
GO:1990907,CC,GO:1990907,beta-catenin-TCF complex,1/271,13/19894,0.076923077,5.646891854,1.969550921,0.1633588,0.336927525,0.245233605,CTNNB1,1
GO:1990909,CC,GO:1990909,Wnt signalosome,1/271,13/19894,0.076923077,5.646891854,1.969550921,0.1633588,0.336927525,0.245233605,CTNNB1,1
GO:1904724,CC,GO:1904724,tertiary granule lumen,2/271,55/19894,0.036363636,2.669439785,1.456948833,0.17233331,0.34477729,0.250947078,MMP9/OLFM4,2
GO:0001741,CC,GO:0001741,XY body,1/271,14/19894,0.071428571,5.243542435,1.866536393,0.174763144,0.34477729,0.250947078,BRCA1,1
GO:0031616,CC,GO:0031616,spindle pole centrosome,1/271,14/19894,0.071428571,5.243542435,1.866536393,0.174763144,0.34477729,0.250947078,AURKA,1
GO:0035859,CC,GO:0035859,Seh1-associated complex,1/271,14/19894,0.071428571,5.243542435,1.866536393,0.174763144,0.34477729,0.250947078,NPRL2,1
GO:0042583,CC,GO:0042583,chromaffin granule,1/271,14/19894,0.071428571,5.243542435,1.866536393,0.174763144,0.34477729,0.250947078,CLU,1
GO:0044753,CC,GO:0044753,amphisome,1/271,14/19894,0.071428571,5.243542435,1.866536393,0.174763144,0.34477729,0.250947078,SQSTM1,1
GO:0097524,CC,GO:0097524,sperm plasma membrane,1/271,14/19894,0.071428571,5.243542435,1.866536393,0.174763144,0.34477729,0.250947078,HSP90AA1,1
GO:0140672,CC,GO:0140672,ATAC complex,1/271,14/19894,0.071428571,5.243542435,1.866536393,0.174763144,0.34477729,0.250947078,MAP3K7,1
GO:0031514,CC,GO:0031514,motile cilium,6/271,276/19894,0.02173913,1.595860741,1.171450746,0.176001464,0.345343412,0.251359132,FLACC1/DEFB1/HIF1A/SQSTM1/CUL3/HSP90AA1,6
GO:0030017,CC,GO:0030017,sarcomere,5/271,219/19894,0.02283105,1.67601813,1.182156883,0.179801351,0.350902637,0.255405428,CTNNB1/SQSTM1/MMP2/ILK/FRG1,5
GO:0001674,CC,GO:0001674,female germ cell nucleus,1/271,15/19894,0.066666667,4.89397294,1.772937299,0.1860126,0.355381968,0.258665721,AURKA,1
GO:0030673,CC,GO:0030673,axolemma,1/271,15/19894,0.066666667,4.89397294,1.772937299,0.1860126,0.355381968,0.258665721,EPB41L3,1
GO:0044754,CC,GO:0044754,autolysosome,1/271,15/19894,0.066666667,4.89397294,1.772937299,0.1860126,0.355381968,0.258665721,SQSTM1,1
GO:0072687,CC,GO:0072687,meiotic spindle,1/271,15/19894,0.066666667,4.89397294,1.772937299,0.1860126,0.355381968,0.258665721,AURKA,1
GO:0098858,CC,GO:0098858,actin-based cell projection,5/271,226/19894,0.022123894,1.624106064,1.108880144,0.19609304,0.365054403,0.265705829,CTNNB1/CD44/TGFB1/FSCN1/FOXA1,5
GO:0001533,CC,GO:0001533,cornified envelope,2/271,60/19894,0.033333333,2.44698647,1.319128264,0.196882417,0.365054403,0.265705829,PKP1/PKP3,2
GO:0016581,CC,GO:0016581,NuRD complex,1/271,16/19894,0.0625,4.588099631,1.687291919,0.197109264,0.365054403,0.265705829,MBD2,1
GO:0035098,CC,GO:0035098,ESC/E(Z) complex,1/271,16/19894,0.0625,4.588099631,1.687291919,0.197109264,0.365054403,0.265705829,EZH2,1
GO:0090545,CC,GO:0090545,CHD-type complex,1/271,16/19894,0.0625,4.588099631,1.687291919,0.197109264,0.365054403,0.265705829,MBD2,1
GO:0150005,CC,GO:0150005,enzyme activator complex,1/271,16/19894,0.0625,4.588099631,1.687291919,0.197109264,0.365054403,0.265705829,PCNA,1
GO:0101003,CC,GO:0101003,ficolin-1-rich granule membrane,2/271,61/19894,0.032786885,2.406871938,1.293234743,0.201844672,0.370856469,0.269928878,RHOA/PKP1,2
GO:0000776,CC,GO:0000776,kinetochore,4/271,170/19894,0.023529412,1.727284567,1.119137428,0.202285347,0.370856469,0.269928878,AURKA/SMARCA4/MEAF6/SMARCE1,4
GO:0043197,CC,GO:0043197,dendritic spine,4/271,171/19894,0.023391813,1.717183488,1.106863164,0.205094844,0.372039601,0.270790024,PTEN/CTNND1/RHOA/PTK2,4
GO:0035580,CC,GO:0035580,specific granule lumen,2/271,62/19894,0.032258065,2.368051422,1.267847722,0.206821205,0.372039601,0.270790024,NFKB1/OLFM4,2
GO:0031092,CC,GO:0031092,platelet alpha granule membrane,1/271,17/19894,0.058823529,4.318211417,1.608441167,0.208055204,0.372039601,0.270790024,CD9,1
GO:0097440,CC,GO:0097440,apical dendrite,1/271,17/19894,0.058823529,4.318211417,1.608441167,0.208055204,0.372039601,0.270790024,CLU,1
GO:0098637,CC,GO:0098637,protein complex involved in cell-matrix adhesion,1/271,17/19894,0.058823529,4.318211417,1.608441167,0.208055204,0.372039601,0.270790024,PLAU,1
GO:0044309,CC,GO:0044309,neuron spine,4/271,173/19894,0.023121387,1.697331655,1.0825552,0.210747961,0.375007401,0.272950145,PTEN/CTNND1/RHOA/PTK2,4
GO:1904115,CC,GO:1904115,axon cytoplasm,2/271,64/19894,0.03125,2.294049815,1.218517329,0.216811923,0.383915747,0.279434109,HIF1A/HDAC6,2
GO:0031143,CC,GO:0031143,pseudopodium,1/271,18/19894,0.055555556,4.078310783,1.535452221,0.218852459,0.38564778,0.280694774,MAPK1,1
GO:0000930,CC,GO:0000930,gamma-tubulin complex,1/271,19/19894,0.052631579,3.863662847,1.467564513,0.229503042,0.399644636,0.290882423,BRCA1,1
GO:0044305,CC,GO:0044305,calyx of Held,1/271,19/19894,0.052631579,3.863662847,1.467564513,0.229503042,0.399644636,0.290882423,GIT1,1
GO:0030016,CC,GO:0030016,myofibril,5/271,240/19894,0.020833333,1.529366544,0.969591322,0.230098427,0.399644636,0.290882423,CTNNB1/SQSTM1/MMP2/ILK/FRG1,5
GO:0000779,CC,GO:0000779,"condensed chromosome, centromeric region",4/271,181/19894,0.022099448,1.622311472,0.988377427,0.233778876,0.403747156,0.293868453,AURKA/SMARCA4/MEAF6/SMARCE1,4
GO:0005771,CC,GO:0005771,multivesicular body,2/271,68/19894,0.029411765,2.159105709,1.125154172,0.236909488,0.403747156,0.293868453,HDAC6/EGFR,2
GO:0016328,CC,GO:0016328,lateral plasma membrane,2/271,68/19894,0.029411765,2.159105709,1.125154172,0.236909488,0.403747156,0.293868453,CTNNB1/CDH1,2
GO:0044304,CC,GO:0044304,main axon,2/271,68/19894,0.029411765,2.159105709,1.125154172,0.236909488,0.403747156,0.293868453,EPB41L3/UCN,2
GO:0097038,CC,GO:0097038,perinuclear endoplasmic reticulum,1/271,21/19894,0.047619048,3.495694957,1.344687963,0.250372104,0.422721274,0.307678816,CLU,1
GO:0098644,CC,GO:0098644,complex of collagen trimers,1/271,21/19894,0.047619048,3.495694957,1.344687963,0.250372104,0.422721274,0.307678816,COL11A2,1
GO:0043292,CC,GO:0043292,contractile fiber,5/271,250/19894,0.02,1.468191882,0.875449312,0.25536217,0.427394949,0.311080563,CTNNB1/SQSTM1/MMP2/ILK/FRG1,5
GO:0014069,CC,GO:0014069,postsynaptic density,6/271,313/19894,0.019169329,1.407212666,0.853351779,0.255495052,0.427394949,0.311080563,PTEN/CTNNB1/AURKA/CTNND1/GIT1/BNIP3,6
GO:0030864,CC,GO:0030864,cortical actin cytoskeleton,2/271,72/19894,0.027777778,2.039155392,1.0380663,0.257100682,0.428108016,0.311599571,CDH1/DLC1,2
GO:0005767,CC,GO:0005767,secondary lysosome,1/271,22/19894,0.045454545,3.336799732,1.288736503,0.260594474,0.429980883,0.312962742,SQSTM1,1
GO:0031258,CC,GO:0031258,lamellipodium membrane,1/271,22/19894,0.045454545,3.336799732,1.288736503,0.260594474,0.429980883,0.312962742,CD44,1
GO:0044291,CC,GO:0044291,cell-cell contact zone,2/271,73/19894,0.02739726,2.011221756,1.017178422,0.262155102,0.430598651,0.313412386,CTNNB1/PIK3CA,2
GO:0071682,CC,GO:0071682,endocytic vesicle lumen,1/271,23/19894,0.043478261,3.191721482,1.23592326,0.270677954,0.442595032,0.322143985,HSP90AA1,1
GO:0005793,CC,GO:0005793,endoplasmic reticulum-Golgi intermediate compartment,3/271,133/19894,0.022556391,1.655855506,0.891829051,0.271991988,0.44274929,0.322256262,FN1/TGFA/HSPA5,3
GO:0031901,CC,GO:0031901,early endosome membrane,4/271,195/19894,0.020512821,1.505837828,0.834177754,0.27539069,0.446280448,0.324826425,CAV1/EGFR/SPHK1/CD274,4
GO:0030894,CC,GO:0030894,replisome,1/271,24/19894,0.041666667,3.058733087,1.185929348,0.280624422,0.450865873,0.328163938,PCNA,1
GO:0000118,CC,GO:0000118,histone deacetylase complex,2/271,77/19894,0.025974026,1.906742704,0.936833824,0.282369905,0.450865873,0.328163938,HDAC6/MBD2,2
GO:0048786,CC,GO:0048786,presynaptic active zone,2/271,77/19894,0.025974026,1.906742704,0.936833824,0.282369905,0.450865873,0.328163938,CTNNB1/CTNND1,2
GO:0098802,CC,GO:0098802,plasma membrane signaling receptor complex,6/271,325/19894,0.018461538,1.355254045,0.758836968,0.283188482,0.450865873,0.328163938,ERBB2/IL6/IGF1R/TGFBR1/IRS1/CD8A,6
GO:0005751,CC,GO:0005751,mitochondrial respiratory chain complex IV,1/271,25/19894,0.04,2.936383764,1.138480291,0.290435735,0.458470992,0.333699345,COX2,1
GO:0030665,CC,GO:0030665,clathrin-coated vesicle membrane,3/271,138/19894,0.02173913,1.595860741,0.825442625,0.290491262,0.458470992,0.333699345,EGFR/TGFA/CD9,3
GO:0032279,CC,GO:0032279,asymmetric synapse,6/271,329/19894,0.018237082,1.338776792,0.728154871,0.292568472,0.459750456,0.334630606,PTEN/CTNNB1/AURKA/CTNND1/GIT1/BNIP3,6
GO:0046930,CC,GO:0046930,pore complex,1/271,26/19894,0.038461538,2.823445927,1.093338326,0.300113721,0.467559145,0.340314181,BAX,1
GO:0070847,CC,GO:0070847,core mediator complex,1/271,26/19894,0.038461538,2.823445927,1.093338326,0.300113721,0.467559145,0.340314181,MED1,1
GO:0045335,CC,GO:0045335,phagocytic vesicle,3/271,142/19894,0.021126761,1.550906918,0.774228126,0.305355995,0.473076987,0.344330358,RILP/MTOR/VIM,3
GO:0005876,CC,GO:0005876,spindle microtubule,2/271,82/19894,0.024390244,1.790477905,0.842916561,0.307565204,0.473076987,0.344330358,AURKA/CUL3,2
GO:0015030,CC,GO:0015030,Cajal body,2/271,82/19894,0.024390244,1.790477905,0.842916561,0.307565204,0.473076987,0.344330358,CDK2/FRG1,2
GO:0044295,CC,GO:0044295,axonal growth cone,1/271,27/19894,0.037037037,2.718873855,1.050296279,0.309660187,0.474289653,0.345213,HSP90AA1,1
GO:0045277,CC,GO:0045277,respiratory chain complex IV,1/271,28/19894,0.035714286,2.621771218,1.009172653,0.319076913,0.486659325,0.354216298,COX2,1
GO:0099572,CC,GO:0099572,postsynaptic specialization,6/271,341/19894,0.017595308,1.291664412,0.638419312,0.321060445,0.487635739,0.354926984,PTEN/CTNNB1/AURKA/CTNND1/GIT1/BNIP3,6
GO:0001669,CC,GO:0001669,acrosomal vesicle,3/271,147/19894,0.020408163,1.498154982,0.71240124,0.323978097,0.490016872,0.356660098,NOTCH1/CAV1/BSG,3
GO:1905369,CC,GO:1905369,endopeptidase complex,2/271,86/19894,0.023255814,1.707199863,0.77236603,0.327599932,0.490521534,0.357027418,THBD/PLAU,2
GO:0005689,CC,GO:0005689,U12-type spliceosomal complex,1/271,29/19894,0.034482759,2.531365314,0.969807649,0.328365655,0.490521534,0.357027418,YBX1,1
GO:0032809,CC,GO:0032809,neuronal cell body membrane,1/271,29/19894,0.034482759,2.531365314,0.969807649,0.328365655,0.490521534,0.357027418,DAB2IP,1
GO:0005942,CC,GO:0005942,phosphatidylinositol 3-kinase complex,1/271,30/19894,0.033333333,2.44698647,0.932059912,0.337528147,0.502096163,0.365452043,PIK3CA,1
GO:0043204,CC,GO:0043204,perikaryon,3/271,151/19894,0.01986755,1.458468757,0.664574588,0.338880331,0.502096163,0.365452043,HDAC6/PCSK1/UCN,3
GO:0120111,CC,GO:0120111,neuron projection cytoplasm,2/271,89/19894,0.02247191,1.6496538,0.721841169,0.342524905,0.505433091,0.367880835,HIF1A/HDAC6,2
GO:0005640,CC,GO:0005640,nuclear outer membrane,1/271,31/19894,0.032258065,2.368051422,0.895803866,0.346566099,0.509325886,0.370714216,PTGS2,1
GO:0035578,CC,GO:0035578,azurophil granule lumen,2/271,91/19894,0.021978022,1.613397672,0.689206573,0.352417046,0.514102288,0.374190733,MAPK1/PRKCD,2
GO:0035267,CC,GO:0035267,NuA4 histone acetyltransferase complex,1/271,32/19894,0.03125,2.294049815,0.8609275,0.355481197,0.514102288,0.374190733,MEAF6,1
GO:0043189,CC,GO:0043189,H4/H2A histone acetyltransferase complex,1/271,32/19894,0.03125,2.294049815,0.8609275,0.355481197,0.514102288,0.374190733,MEAF6,1
GO:0044298,CC,GO:0044298,cell body membrane,1/271,32/19894,0.03125,2.294049815,0.8609275,0.355481197,0.514102288,0.374190733,DAB2IP,1
GO:0010494,CC,GO:0010494,cytoplasmic stress granule,2/271,92/19894,0.02173913,1.595860741,0.67318781,0.357343967,0.514745476,0.374658879,YBX1/ROCK1,2
GO:0005875,CC,GO:0005875,microtubule associated complex,3/271,157/19894,0.01910828,1.402731097,0.595355686,0.361190037,0.518229183,0.377194505,AURKA/HDAC6/KATNB1,3
GO:0002102,CC,GO:0002102,podosome,1/271,33/19894,0.03030303,2.224533154,0.827330523,0.364275104,0.518556325,0.377432616,FSCN1,1
GO:0031528,CC,GO:0031528,microvillus membrane,1/271,33/19894,0.03030303,2.224533154,0.827330523,0.364275104,0.518556325,0.377432616,CTNNB1,1
GO:0098984,CC,GO:0098984,neuron to neuron synapse,6/271,360/19894,0.016666667,1.223493235,0.502888987,0.366897188,0.518590971,0.377457833,PTEN/CTNNB1/AURKA/CTNND1/GIT1/BNIP3,6
GO:0000123,CC,GO:0000123,histone acetyltransferase complex,2/271,94/19894,0.021276596,1.561906257,0.641722527,0.367156693,0.518590971,0.377457833,MAP3K7/MEAF6,2
GO:0042581,CC,GO:0042581,specific granule,3/271,160/19894,0.01875,1.376429889,0.561808899,0.372306519,0.523826613,0.381268609,NFKB1/OLFM4/PLAU,3
GO:0008180,CC,GO:0008180,COP9 signalosome,1/271,36/19894,0.027777778,2.039155392,0.733358073,0.389945991,0.544424595,0.396260906,HSPA5,1
GO:0016592,CC,GO:0016592,mediator complex,1/271,36/19894,0.027777778,2.039155392,0.733358073,0.389945991,0.544424595,0.396260906,MED1,1
GO:0000932,CC,GO:0000932,P-body,2/271,100/19894,0.02,1.468191882,0.551580852,0.396228826,0.551076873,0.401102785,YBX1/SQSTM1,2
GO:0051233,CC,GO:0051233,spindle midzone,1/271,37/19894,0.027027027,1.984043084,0.704060926,0.398271333,0.551803412,0.401631597,AURKA,1
GO:0000407,CC,GO:0000407,phagophore assembly site,1/271,38/19894,0.026315789,1.931831424,0.675671114,0.406483473,0.558914776,0.406807623,SQSTM1,1
GO:0031904,CC,GO:0031904,endosome lumen,1/271,38/19894,0.026315789,1.931831424,0.675671114,0.406483473,0.558914776,0.406807623,CTSB,1
GO:0070461,CC,GO:0070461,SAGA-type complex,1/271,39/19894,0.025641026,1.882297285,0.648133374,0.414583946,0.562471409,0.409396328,MAP3K7,1
GO:0005811,CC,GO:0005811,lipid droplet,2/271,104/19894,0.019230769,1.411722963,0.494710294,0.415268148,0.562471409,0.409396328,CAV1/RBP1,2
GO:0030863,CC,GO:0030863,cortical cytoskeleton,2/271,104/19894,0.019230769,1.411722963,0.494710294,0.415268148,0.562471409,0.409396328,CDH1/DLC1,2
GO:0031248,CC,GO:0031248,protein acetyltransferase complex,2/271,104/19894,0.019230769,1.411722963,0.494710294,0.415268148,0.562471409,0.409396328,MAP3K7/MEAF6,2
GO:1902493,CC,GO:1902493,acetyltransferase complex,2/271,105/19894,0.019047619,1.398277983,0.48086272,0.41998142,0.566740727,0.412503762,MAP3K7/MEAF6,2
GO:0005770,CC,GO:0005770,late endosome,5/271,314/19894,0.015923567,1.168942581,0.354608948,0.425957998,0.572676864,0.416824396,RILP/HDAC6/SQSTM1/MAPK1/EGFR,5
GO:0005903,CC,GO:0005903,brush border,2/271,107/19894,0.018691589,1.372141946,0.453589112,0.429349521,0.574468743,0.41812862,HSP90AA1/MME,2
GO:1905360,CC,GO:1905360,GTPase complex,1/271,41/19894,0.024390244,1.790477905,0.595416242,0.430455918,0.574468743,0.41812862,HRAS,1
GO:0098686,CC,GO:0098686,hippocampal mossy fiber to CA3 synapse,1/271,42/19894,0.023809524,1.747847478,0.570148033,0.438230382,0.582701937,0.424121172,CTNND1,1
GO:0070069,CC,GO:0070069,cytochrome complex,1/271,43/19894,0.023255814,1.707199863,0.545553424,0.445899109,0.590734951,0.429968023,COX2,1
GO:0045111,CC,GO:0045111,intermediate filament cytoskeleton,4/271,252/19894,0.015873016,1.165231652,0.310207824,0.450028625,0.594037785,0.432371999,MMP14/SMARCA2/PKP1/VIM,4
GO:0036464,CC,GO:0036464,cytoplasmic ribonucleoprotein granule,4/271,255/19894,0.015686275,1.151523045,0.286181251,0.459022575,0.603714474,0.439415203,YBX1/SQSTM1/ROCK1/CLOCK,4
GO:1902562,CC,GO:1902562,H4 histone acetyltransferase complex,1/271,45/19894,0.022222222,1.631324313,0.498243384,0.460925062,0.60402815,0.439643513,MEAF6,1
GO:0031461,CC,GO:0031461,cullin-RING ubiquitin ligase complex,3/271,185/19894,0.016216216,1.19042585,0.305795829,0.462853428,0.604373361,0.439894776,FBXW7/SPOP/CUL3,3
GO:0009295,CC,GO:0009295,nucleoid,1/271,46/19894,0.02173913,1.595860741,0.475463735,0.468285096,0.607098177,0.441878041,SOD2,1
GO:0042645,CC,GO:0042645,mitochondrial nucleoid,1/271,46/19894,0.02173913,1.595860741,0.475463735,0.468285096,0.607098177,0.441878041,SOD2,1
GO:0005802,CC,GO:0005802,trans-Golgi network,4/271,260/19894,0.015384615,1.129378371,0.246772092,0.47389992,0.612191,0.445584866,CDH1/SLC39A9/PCSK1/MME,4
GO:0031234,CC,GO:0031234,extrinsic component of cytoplasmic side of plasma membrane,1/271,49/19894,0.020408163,1.498154982,0.410288223,0.489769878,0.63044846,0.458873607,MYD88,1
GO:1905368,CC,GO:1905368,peptidase complex,2/271,122/19894,0.016393443,1.203435969,0.264871018,0.496897777,0.637363579,0.463906795,THBD/PLAU,2
GO:0005782,CC,GO:0005782,peroxisomal matrix,1/271,51/19894,0.019607843,1.439403806,0.36923029,0.50361031,0.639197701,0.465241766,AMACR,1
GO:0030315,CC,GO:0030315,T-tubule,1/271,51/19894,0.019607843,1.439403806,0.36923029,0.50361031,0.639197701,0.465241766,IGF1R,1
GO:0031907,CC,GO:0031907,microbody lumen,1/271,51/19894,0.019607843,1.439403806,0.36923029,0.50361031,0.639197701,0.465241766,AMACR,1
GO:0035770,CC,GO:0035770,ribonucleoprotein granule,4/271,272/19894,0.014705882,1.079552854,0.155246089,0.508948065,0.643721769,0.468534621,YBX1/SQSTM1/ROCK1/CLOCK,4
GO:0032154,CC,GO:0032154,cleavage furrow,1/271,54/19894,0.018518519,1.359436928,0.31081418,0.523672706,0.660045807,0.480416116,RHOA,1
GO:0030662,CC,GO:0030662,coated vesicle membrane,3/271,205/19894,0.014634146,1.074286743,0.125640166,0.531038297,0.667013501,0.485487571,EGFR/TGFA/CD9,3
GO:0055037,CC,GO:0055037,recycling endosome,3/271,206/19894,0.014563107,1.069071759,0.117107688,0.534321262,0.667269366,0.485673803,TNF/LMTK2/CD274,3
GO:0030018,CC,GO:0030018,Z disc,2/271,131/19894,0.015267176,1.120757162,0.16295744,0.534918418,0.667269366,0.485673803,CTNNB1/FRG1,2
GO:0098636,CC,GO:0098636,protein complex involved in cell adhesion,1/271,57/19894,0.01754386,1.287887616,0.255784662,0.542927119,0.67494022,0.491257055,PLAU,1
GO:0031526,CC,GO:0031526,brush border membrane,1/271,60/19894,0.016666667,1.223493235,0.203744989,0.561405974,0.693164519,0.504521659,HSP90AA1,1
GO:0032589,CC,GO:0032589,neuron projection membrane,1/271,60/19894,0.016666667,1.223493235,0.203744989,0.561405974,0.693164519,0.504521659,EPB41L3,1
GO:0030136,CC,GO:0030136,clathrin-coated vesicle,3/271,218/19894,0.013761468,1.010223772,0.017837052,0.572679464,0.704686933,0.51290828,EGFR/TGFA/CD9,3
GO:0099568,CC,GO:0099568,cytoplasmic region,4/271,298/19894,0.013422819,0.985363679,-0.029916337,0.580979298,0.709527705,0.516431649,CTNNB1/CTNND1/HIF1A/HDAC6,4
GO:0005777,CC,GO:0005777,peroxisome,2/271,143/19894,0.013986014,1.02670761,0.037666961,0.58247729,0.709527705,0.516431649,AMACR/VIM,2
GO:0042579,CC,GO:0042579,microbody,2/271,143/19894,0.013986014,1.02670761,0.037666961,0.58247729,0.709527705,0.516431649,AMACR/VIM,2
GO:0012507,CC,GO:0012507,ER to Golgi transport vesicle membrane,1/271,64/19894,0.015625,1.147024908,0.1384432,0.584891644,0.710085842,0.51683789,TGFA,1
GO:0031674,CC,GO:0031674,I band,2/271,145/19894,0.013793103,1.012546125,0.017818583,0.590048255,0.712209114,0.518383319,CTNNB1/FRG1,2
GO:0019005,CC,GO:0019005,SCF ubiquitin ligase complex,1/271,65/19894,0.015384615,1.129378371,0.122777853,0.590564582,0.712209114,0.518383319,FBXW7,1
GO:0005874,CC,GO:0005874,microtubule,6/271,468/19894,0.012820513,0.941148642,-0.151404857,0.616410036,0.740126264,0.538702892,AURKA/HDAC6/LZTS2/KATNB1/CUL3/TUBA4B,6
GO:0035097,CC,GO:0035097,histone methyltransferase complex,1/271,70/19894,0.014285714,1.048708487,0.047974461,0.617791344,0.740126264,0.538702892,EZH2,1
GO:0001917,CC,GO:0001917,photoreceptor inner segment,1/271,71/19894,0.014084507,1.033937945,0.033665271,0.623016251,0.743047805,0.540829344,BSG,1
GO:0005766,CC,GO:0005766,primary lysosome,2/271,155/19894,0.012903226,0.947220569,-0.077521125,0.626370877,0.743047805,0.540829344,MAPK1/PRKCD,2
GO:0042582,CC,GO:0042582,azurophil granule,2/271,155/19894,0.012903226,0.947220569,-0.077521125,0.626370877,0.743047805,0.540829344,MAPK1/PRKCD,2
GO:0032153,CC,GO:0032153,cell division site,1/271,73/19894,0.01369863,1.005610878,0.005643929,0.633253531,0.746334519,0.543221587,RHOA,1
GO:0070821,CC,GO:0070821,tertiary granule membrane,1/271,73/19894,0.01369863,1.005610878,0.005643929,0.633253531,0.746334519,0.543221587,PLAU,1
GO:0031594,CC,GO:0031594,neuromuscular junction,1/271,74/19894,0.013513514,0.992021542,-0.008080442,0.638267824,0.749809773,0.54575106,ERBB2,1
GO:0005814,CC,GO:0005814,centriole,2/271,160/19894,0.0125,0.917619926,-0.122949478,0.643578191,0.753609301,0.548516556,AURKA/ROCK1,2
GO:0016529,CC,GO:0016529,sarcoplasmic reticulum,1/271,76/19894,0.013157895,0.965915712,-0.034985106,0.648092413,0.756455131,0.550587902,THBS1,1
GO:0005905,CC,GO:0005905,clathrin-coated pit,1/271,77/19894,0.012987013,0.953371352,-0.048176064,0.652904551,0.759629333,0.552898253,SPHK1,1
GO:0098862,CC,GO:0098862,cluster of actin-based cell projections,2/271,165/19894,0.012121212,0.889813262,-0.167020911,0.660156003,0.765612233,0.557252923,HSP90AA1/MME,2
GO:0005759,CC,GO:0005759,mitochondrial matrix,6/271,491/19894,0.012219959,0.89706225,-0.27141451,0.662291761,0.765643023,0.557275334,TP53/GPX1/SOD2/RNASEL/REXO2/ACSS3,6
GO:0042734,CC,GO:0042734,presynaptic membrane,2/271,167/19894,0.011976048,0.879156816,-0.18429008,0.666612492,0.768191538,0.559130277,CTNNB1/ERBB2,2
GO:0030670,CC,GO:0030670,phagocytic vesicle membrane,1/271,81/19894,0.012345679,0.906291285,-0.099311481,0.671506307,0.768948862,0.559681497,RILP,1
GO:0033116,CC,GO:0033116,endoplasmic reticulum-Golgi intermediate compartment membrane,1/271,81/19894,0.012345679,0.906291285,-0.099311481,0.671506307,0.768948862,0.559681497,TGFA,1
GO:0005743,CC,GO:0005743,mitochondrial inner membrane,6/271,499/19894,0.012024048,0.88268049,-0.311908856,0.677427177,0.773289513,0.562840852,COX2/HSD3B1/CYP1A1/HSD3B2/AIFM1/CLU,6
GO:0005581,CC,GO:0005581,collagen trimer,1/271,86/19894,0.011627907,0.853599931,-0.159890359,0.693367741,0.78900467,0.574279171,COL11A2,1
GO:0008076,CC,GO:0008076,voltage-gated potassium channel complex,1/271,89/19894,0.011235955,0.8248269,-0.194637752,0.70578238,0.800298934,0.582499732,LRRC26,1
GO:0030133,CC,GO:0030133,transport vesicle,5/271,434/19894,0.011520737,0.845732651,-0.381855938,0.707702363,0.800298934,0.582499732,FGFR4/TGFA/PCSK1/IGF1/MME,5
GO:0035579,CC,GO:0035579,specific granule membrane,1/271,91/19894,0.010989011,0.806698836,-0.217190966,0.713779295,0.802173016,0.583863787,PLAU,1
GO:0071013,CC,GO:0071013,catalytic step 2 spliceosome,1/271,91/19894,0.010989011,0.806698836,-0.217190966,0.713779295,0.802173016,0.583863787,FRG1,1
GO:0030134,CC,GO:0030134,COPII-coated ER to Golgi transport vesicle,1/271,94/19894,0.010638298,0.780953129,-0.250161499,0.725370416,0.809400344,0.589124217,TGFA,1
GO:0098803,CC,GO:0098803,respiratory chain complex,1/271,94/19894,0.010638298,0.780953129,-0.250161499,0.725370416,0.809400344,0.589124217,COX2,1
GO:0001750,CC,GO:0001750,photoreceptor outer segment,1/271,95/19894,0.010526316,0.772732569,-0.260933273,0.729129235,0.809400344,0.589124217,BSG,1
GO:0016528,CC,GO:0016528,sarcoplasm,1/271,95/19894,0.010526316,0.772732569,-0.260933273,0.729129235,0.809400344,0.589124217,THBS1,1
GO:0005746,CC,GO:0005746,mitochondrial respirasome,1/271,97/19894,0.010309278,0.756799939,-0.282164219,0.736493792,0.815083069,0.593260404,COX2,1
GO:0034705,CC,GO:0034705,potassium channel complex,1/271,100/19894,0.01,0.734095941,-0.313263841,0.747168231,0.821885054,0.598211247,LRRC26,1
GO:0034708,CC,GO:0034708,methyltransferase complex,1/271,100/19894,0.01,0.734095941,-0.313263841,0.747168231,0.821885054,0.598211247,EZH2,1
GO:0070469,CC,GO:0070469,respirasome,1/271,105/19894,0.00952381,0.699138991,-0.363245897,0.764010033,0.836362675,0.608748822,COX2,1
GO:0098791,CC,GO:0098791,Golgi apparatus subcompartment,4/271,382/19894,0.010471204,0.768686849,-0.536454876,0.767105105,0.836362675,0.608748822,CDH1/SLC39A9/PCSK1/MME,4
GO:0030175,CC,GO:0030175,filopodium,1/271,106/19894,0.009433962,0.692543341,-0.372982084,0.767241792,0.836362675,0.608748822,FSCN1,1
GO:0055038,CC,GO:0055038,recycling endosome membrane,1/271,108/19894,0.009259259,0.679718464,-0.392208375,0.773573622,0.840740194,0.611935011,CD274,1
GO:0005681,CC,GO:0005681,spliceosomal complex,2/271,208/19894,0.009615385,0.705861482,-0.501137512,0.7782386,0.843285409,0.613787553,YBX1/FRG1,2
GO:0005882,CC,GO:0005882,intermediate filament,2/271,216/19894,0.009259259,0.679718464,-0.556186426,0.795778817,0.859725329,0.625753393,PKP1/VIM,2
GO:0005776,CC,GO:0005776,autophagosome,1/271,119/19894,0.008403361,0.616887345,-0.49259933,0.805452207,0.863930954,0.628814468,SQSTM1,1
GO:0005884,CC,GO:0005884,actin filament,1/271,119/19894,0.008403361,0.616887345,-0.49259933,0.805452207,0.863930954,0.628814468,PAWR,1
GO:0097733,CC,GO:0097733,photoreceptor cell cilium,1/271,120/19894,0.008333333,0.611746617,-0.50131499,0.808118323,0.863930954,0.628814468,BSG,1
GO:0030135,CC,GO:0030135,coated vesicle,3/271,317/19894,0.009463722,0.69472802,-0.643866144,0.809191527,0.863930954,0.628814468,EGFR/TGFA/CD9,3
GO:0140534,CC,GO:0140534,endoplasmic reticulum protein-containing complex,1/271,126/19894,0.007936508,0.582615826,-0.552321525,0.82336764,0.876488133,0.637954245,HSPA5,1
GO:0070382,CC,GO:0070382,exocytic vesicle,2/271,235/19894,0.008510638,0.624762503,-0.680004106,0.832610812,0.883736037,0.643229652,IGF1/MME,2
GO:0097731,CC,GO:0097731,9+0 non-motile cilium,1/271,132/19894,0.007575758,0.556133289,-0.601279197,0.83740917,0.886237694,0.645050489,BSG,1
GO:0000786,CC,GO:0000786,nucleosome,1/271,135/19894,0.007407407,0.543774771,-0.625051478,0.844007108,0.89062378,0.648242913,MEAF6,1
GO:0042101,CC,GO:0042101,T cell receptor complex,1/271,150/19894,0.006666667,0.489397294,-0.737671925,0.873203476,0.917665615,0.667925386,CD8A,1
GO:0032838,CC,GO:0032838,plasma membrane bounded cell projection cytoplasm,2/271,262/19894,0.007633588,0.560378581,-0.841781354,0.87468954,0.917665615,0.667925386,HIF1A/HDAC6,2
GO:0098800,CC,GO:0098800,inner mitochondrial membrane protein complex,1/271,162/19894,0.00617284,0.453145643,-0.821288451,0.892586271,0.933742987,0.679627344,COX2,1
GO:0097730,CC,GO:0097730,non-motile cilium,1/271,167/19894,0.005988024,0.439578408,-0.854662518,0.899763255,0.9376345,0.682459792,BSG,1
GO:0005774,CC,GO:0005774,vacuolar membrane,4/271,487/19894,0.008213552,0.602953545,-1.042506293,0.901472287,0.9376345,0.682459792,RILP/MTOR/THBD/NPRL2,4
GO:0031902,CC,GO:0031902,late endosome membrane,1/271,174/19894,0.005747126,0.421894219,-0.900078869,0.909015355,0.942778782,0.686204072,RILP,1
GO:0098798,CC,GO:0098798,mitochondrial protein-containing complex,2/271,305/19894,0.006557377,0.481374388,-1.072629735,0.922091258,0.948783967,0.690574962,COX2/BAX,2
GO:0016442,CC,GO:0016442,RISC complex,3/271,413/19894,0.007263923,0.533241604,-1.126454428,0.922646668,0.948783967,0.690574962,MIR25/MIR200C/MIR145,3
GO:0031332,CC,GO:0031332,RNAi effector complex,3/271,413/19894,0.007263923,0.533241604,-1.126454428,0.922646668,0.948783967,0.690574962,MIR25/MIR200C/MIR145,3
GO:0034703,CC,GO:0034703,cation channel complex,1/271,204/19894,0.004901961,0.359850951,-1.080004126,0.939945514,0.961231004,0.699634572,LRRC26,1
GO:0005765,CC,GO:0005765,lysosomal membrane,3/271,443/19894,0.006772009,0.497130434,-1.257877456,0.942694869,0.961231004,0.699634572,RILP/MTOR/NPRL2,3
GO:0098852,CC,GO:0098852,lytic vacuole membrane,3/271,443/19894,0.006772009,0.497130434,-1.257877456,0.942694869,0.961231004,0.699634572,RILP/MTOR/NPRL2,3
GO:0008021,CC,GO:0008021,synaptic vesicle,1/271,216/19894,0.00462963,0.339859232,-1.146370592,0.949149072,0.963269619,0.701118383,MME,1
GO:0034702,CC,GO:0034702,monoatomic ion channel complex,2/271,344/19894,0.005813953,0.426799966,-1.260271552,0.950001442,0.963269619,0.701118383,TMEM37/LRRC26,2
GO:0030658,CC,GO:0030658,transport vesicle membrane,1/271,238/19894,0.004201681,0.308443673,-1.261306259,0.962525873,0.973250395,0.708382917,TGFA,1
GO:0097060,CC,GO:0097060,synaptic membrane,2/271,397/19894,0.005037783,0.369821633,-1.490482678,0.97305852,0.981167341,0.714145288,CTNNB1/ERBB2,2
GO:0045211,CC,GO:0045211,postsynaptic membrane,1/271,276/19894,0.003623188,0.26597679,-1.443075499,0.977899645,0.983317371,0.715710193,CTNNB1,1
GO:1902495,CC,GO:1902495,transmembrane transporter complex,2/271,444/19894,0.004504505,0.330673847,-1.676183502,0.984623491,0.987343445,0.718640582,TMEM37/LRRC26,2
GO:1990351,CC,GO:1990351,transporter complex,2/271,471/19894,0.004246285,0.311718022,-1.776522784,0.988909481,0.988909481,0.719780425,TMEM37/LRRC26,2
GO:0140297,MF,GO:0140297,DNA-binding transcription factor binding,38/271,478/18522,0.079497908,5.433432661,11.96633575,1.49E-17,9.03E-15,6.23E-15,TP53/CTNNB1/AR/MYC/VDR/MAP3K7/LMO2/PPARG/PARP1/KDM1A/ARID1A/NCOA1/NCOA3/MAPK14/HIF1A/STAT3/SMARCA4/PCNA/FOS/RELA/SMAD3/HHEX/RB1/IFI27/VHL/SMARCE1/TWIST1/NKX3-1/GATA3/STAT1/NBN/NFKBIA/MED1/PER1/CDKN2A/FBP1/ESR1/ID4,38
GO:0061629,MF,GO:0061629,RNA polymerase II-specific DNA-binding transcription factor binding,31/271,343/18522,0.090379009,6.177121771,11.79299119,5.09E-16,1.54E-13,1.06E-13,TP53/CTNNB1/AR/VDR/LMO2/PPARG/PARP1/KDM1A/ARID1A/NCOA1/NCOA3/MAPK14/HIF1A/STAT3/SMARCA4/PCNA/FOS/RELA/SMAD3/RB1/IFI27/SMARCE1/NKX3-1/GATA3/STAT1/NFKBIA/MED1/CDKN2A/FBP1/ESR1/ID4,31
GO:0001221,MF,GO:0001221,transcription coregulator binding,19/271,114/18522,0.166666667,11.39114391,13.56082187,4.29E-15,8.65E-13,5.97E-13,CTNNB1/AR/MYC/MAP3K7/LMO2/PPARG/HIF1A/SMARCA4/HDAC6/FOS/RELA/EZH2/SMAD3/TWIST1/GATA3/STAT1/MED1/PER1/ESR1,19
GO:0044389,MF,GO:0044389,ubiquitin-like protein ligase binding,29/271,324/18522,0.089506173,6.117466175,11.32372162,6.12E-15,9.25E-13,6.39E-13,TP53/BRCA1/CTNNB1/AURKA/FBXW7/MAP3K7/CASP8/BID/PARP1/HIF1A/SPOP/HDAC6/SQSTM1/RELA/TGFBR1/SMAD3/CHEK2/EGFR/CUL3/RB1/HSPA5/MC1R/HSP90AA1/STAT1/CDKN1A/NFKBIA/PER1/CLU/FHIT,29
GO:0031625,MF,GO:0031625,ubiquitin protein ligase binding,28/271,305/18522,0.091803279,6.274466154,11.31783946,9.70E-15,1.17E-12,8.11E-13,TP53/BRCA1/CTNNB1/AURKA/FBXW7/MAP3K7/CASP8/BID/PARP1/HIF1A/SPOP/HDAC6/SQSTM1/RELA/TGFBR1/SMAD3/CHEK2/EGFR/CUL3/RB1/HSPA5/MC1R/HSP90AA1/CDKN1A/NFKBIA/PER1/CLU/FHIT,28
GO:0016922,MF,GO:0016922,nuclear receptor binding,17/271,136/18522,0.125,8.543357934,10.75880585,1.52E-11,1.53E-09,1.06E-09,CTNNB1/VDR/PPARG/PARP1/KDM1A/ARID1A/NCOA1/NCOA3/HIF1A/SMARCA4/PCNA/SMAD3/SMARCE1/NKX3-1/STAT1/MED1/ESR1,17
GO:0001216,MF,GO:0001216,DNA-binding transcription activator activity,30/271,482/18522,0.062240664,4.253954158,8.820439217,2.51E-11,2.17E-09,1.50E-09,TP53/BRCA1/AR/MYC/ETV1/ETV5/ETV4/ERG/NFKB1/PPARG/SOX11/MYB/NOTCH1/HIF1A/STAT3/FOS/RELA/SMAD3/FOXA1/WT1/MYCN/HHEX/SOX2/GATA3/TP63/TFAP2A/KLF6/ZFX/ESR1/CLOCK,30
GO:0001228,MF,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",29/271,476/18522,0.06092437,4.163989581,8.521608409,9.17E-11,6.94E-09,4.79E-09,TP53/AR/MYC/ETV1/ETV5/ETV4/ERG/NFKB1/PPARG/SOX11/MYB/NOTCH1/HIF1A/STAT3/FOS/RELA/SMAD3/FOXA1/WT1/MYCN/HHEX/SOX2/GATA3/TP63/TFAP2A/KLF6/ZFX/ESR1/CLOCK,29
GO:0001223,MF,GO:0001223,transcription coactivator binding,9/271,44/18522,0.204545455,13.98004025,10.50384791,1.22E-08,8.20E-07,5.66E-07,AR/MAP3K7/HIF1A/RELA/SMAD3/GATA3/STAT1/MED1/ESR1,9
GO:0004674,MF,GO:0004674,protein serine/threonine kinase activity,24/271,427/18522,0.056206089,3.841509891,7.238646104,1.99E-08,1.20E-06,8.31E-07,AURKA/CDK4/MAP3K7/PIK3CA/MAPK14/CDK2/MTOR/SRPK1/MAPK1/PRKCD/LMTK2/AKT1/TGFBR1/ILK/CDK12/CHEK2/EGFR/BRD2/BRD4/BRAF/PIM1/MAP2K7/ROCK1/CAMKK2,24
GO:0005126,MF,GO:0005126,cytokine receptor binding,19/271,273/18522,0.06959707,4.756741414,7.619853456,2.23E-08,1.23E-06,8.47E-07,IL6/MAP3K7/CASP8/IL1B/CASP3/BID/FASLG/DEFB1/VEGFA/TNF/TGFBR1/SMAD3/TGFB1/IL10/DAB2IP/GATA3/STAT1/IFNA1/MYD88,19
GO:0004713,MF,GO:0004713,protein tyrosine kinase activity,13/271,138/18522,0.094202899,6.438472646,7.813938967,1.23E-07,6.18E-06,4.27E-06,PDGFRL/ERBB2/ALK/IGF1R/PRKCD/PTK2/FGFR4/EGFR/KDR/FGFR1/MST1R/MAP2K7/CAMKK2,13
GO:0070888,MF,GO:0070888,E-box binding,9/271,59/18522,0.152542373,10.42579273,8.836215223,1.78E-07,8.30E-06,5.74E-06,MYC/PPARG/HIF1A/SNAI1/TWIST1/SNAI2/GATA3/PER1/CLOCK,9
GO:0004714,MF,GO:0004714,transmembrane receptor protein tyrosine kinase activity,9/271,60/18522,0.15,10.25202952,8.746751546,2.07E-07,8.96E-06,6.19E-06,PDGFRL/ERBB2/ALK/IGF1R/FGFR4/EGFR/KDR/FGFR1/MST1R,9
GO:0019199,MF,GO:0019199,transmembrane receptor protein kinase activity,10/271,79/18522,0.126582278,8.651501705,8.304585689,2.26E-07,8.98E-06,6.20E-06,PDGFRL/ERBB2/ALK/IGF1R/TGFBR1/FGFR4/EGFR/KDR/FGFR1/MST1R,10
GO:0031490,MF,GO:0031490,chromatin DNA binding,13/271,146/18522,0.089041096,6.085679624,7.517500464,2.37E-07,8.98E-06,6.20E-06,NOTCH1/STAT3/BAP1/SMARCA4/RELA/EZH2/MBD2/SMAD3/SMARCE1/MED1/PER1/ZFX/CLOCK,13
GO:0005123,MF,GO:0005123,death receptor binding,6/271,21/18522,0.285714286,19.52767528,10.35157672,4.19E-07,1.45E-05,1.00E-05,CASP8/CASP3/BID/FASLG/DAB2IP/MYD88,6
GO:0106310,MF,GO:0106310,protein serine kinase activity,20/271,363/18522,0.055096419,3.765667409,6.484564716,4.32E-07,1.45E-05,1.00E-05,AURKA/CDK4/MAP3K7/PIK3CA/MAPK14/CDK2/MTOR/SRPK1/MAPK1/PRKCD/LMTK2/AKT1/ILK/CDK12/CHEK2/BRAF/PIM1/MAP2K7/ROCK1/CAMKK2,20
GO:1990841,MF,GO:1990841,promoter-specific chromatin binding,9/271,66/18522,0.136363636,9.320026837,8.250902078,4.81E-07,1.53E-05,1.06E-05,TP53/RBL2/ERCC1/KDM1A/BMI1/EZH2/SMAD3/STAT1/MED1,9
GO:0032813,MF,GO:0032813,tumor necrosis factor receptor superfamily binding,8/271,49/18522,0.163265306,11.15867159,8.676404165,5.08E-07,1.54E-05,1.06E-05,CASP8/CASP3/BID/FASLG/TNF/DAB2IP/STAT1/MYD88,8
GO:0140296,MF,GO:0140296,general transcription initiation factor binding,8/271,53/18522,0.150943396,10.31650769,8.276427591,9.50E-07,2.74E-05,1.89E-05,TP53/AR/ERCC1/MTOR/RELA/HHEX/MED1/ESR1,8
GO:0030331,MF,GO:0030331,nuclear estrogen receptor binding,7/271,39/18522,0.179487179,12.26738575,8.583072157,1.37E-06,3.77E-05,2.60E-05,CTNNB1/PARP1/NCOA1/PCNA/NKX3-1/MED1/ESR1,7
GO:0019887,MF,GO:0019887,protein kinase regulator activity,15/271,232/18522,0.064655172,4.418978242,6.385677854,1.76E-06,4.64E-05,3.20E-05,CCND1/CDK4/PIK3CA/ALK/CASP3/VEGFA/AKT1/CAV1/EGFR/TGFA/DAB2IP/CDKN1A/SFN/CDKN2A/IGF2,15
GO:0001046,MF,GO:0001046,core promoter sequence-specific DNA binding,7/271,42/18522,0.166666667,11.39114391,8.215056413,2.31E-06,5.83E-05,4.03E-05,TP53/MYC/SMARCA4/FOS/RELA/EZH2/STAT1,7
GO:0019207,MF,GO:0019207,kinase regulator activity,16/271,270/18522,0.059259259,4.050184502,6.152141148,2.49E-06,6.02E-05,4.16E-05,CCND1/CDK4/PIK3CA/ALK/CASP3/VEGFA/GSTP1/AKT1/CAV1/EGFR/TGFA/DAB2IP/CDKN1A/SFN/CDKN2A/IGF2,16
GO:0001217,MF,GO:0001217,DNA-binding transcription repressor activity,16/271,271/18522,0.05904059,4.035239172,6.133491391,2.61E-06,6.07E-05,4.19E-05,TP53/MYC/HOXB13/NFKB1/PPARG/HIF1A/RELA/SMAD3/HHEX/SNAI1/TWIST1/SNAI2/GATA3/MXI1/TFAP2A/NANOG,16
GO:0019902,MF,GO:0019902,phosphatase binding,13/271,189/18522,0.068783069,4.701107011,6.231883182,4.43E-06,9.92E-05,6.85E-05,TP53/CTNNB1/MAPK14/STAT3/MAPK1/SMAD3/PTK2/EGFR/DAB2IP/SPHK1/HSP90AA1/STAT1/MAP2K7,13
GO:0001222,MF,GO:0001222,transcription corepressor binding,7/271,47/18522,0.14893617,10.17932009,7.677869895,5.07E-06,0.000109473,7.56E-05,CTNNB1/HDAC6/EZH2/SMAD3/STAT1/PER1/ESR1,7
GO:0002039,MF,GO:0002039,p53 binding,8/271,67/18522,0.119402985,8.160819519,7.155115246,5.86E-06,0.000122151,8.44E-05,TP53/BRCA1/KDM1A/HIF1A/SMARCA4/BRD4/TP63/MUC1,8
GO:0019903,MF,GO:0019903,protein phosphatase binding,11/271,142/18522,0.077464789,5.294475339,6.259722207,7.88E-06,0.00015898,0.000109813,TP53/CTNNB1/MAPK14/STAT3/PTK2/EGFR/DAB2IP/SPHK1/HSP90AA1/STAT1/MAP2K7,11
GO:0030332,MF,GO:0030332,cyclin binding,6/271,34/18522,0.176470588,12.0612112,7.866303632,8.85E-06,0.000172691,0.000119283,FBXW7/CDK4/CDK2/CDK12/CUL3/CDKN1A,6
GO:0004252,MF,GO:0004252,serine-type endopeptidase activity,12/271,174/18522,0.068965517,4.713576791,5.997167738,1.01E-05,0.000185647,0.000128233,KLK2/KLK3/TMPRSS2/MMP14/KLK14/MMP9/MMP2/PCSK1/HPR/MMP7/PLAU/MMP1,12
GO:0004879,MF,GO:0004879,nuclear receptor activity,7/271,52/18522,0.134615385,9.200539313,7.21579469,1.01E-05,0.000185647,0.000128233,AR/VDR/PPARG/STAT3/NKX3-1/ESR1/ESR2,7
GO:0003684,MF,GO:0003684,damaged DNA binding,8/271,73/18522,0.109589041,7.490067229,6.770141394,1.12E-05,0.000189152,0.000130654,BRCA1/XRCC1/ERCC1/PARP1/PCNA/TP63/MSH2/NBN,8
GO:0016407,MF,GO:0016407,acetyltransferase activity,9/271,96/18522,0.09375,6.40751845,6.472791558,1.15E-05,0.000189152,0.000130654,BRCA2/FASN/NCOA1/NCOA3/MEAF6/SMARCE1/SPHK1/NAT1/CLOCK,9
GO:0098531,MF,GO:0098531,ligand-activated transcription factor activity,7/271,53/18522,0.132075472,9.026944232,7.130828943,1.15E-05,0.000189152,0.000130654,AR/VDR/PPARG/STAT3/NKX3-1/ESR1/ESR2,7
GO:0003713,MF,GO:0003713,transcription coactivator activity,15/271,271/18522,0.055350554,3.783036723,5.623850649,1.17E-05,0.000189152,0.000130654,BRCA1/CTNNB1/LMO2/KDM1A/ARID1A/NCOA1/NCOA3/FGF2/NOTCH1/SMARCA4/SMARCA2/BRD4/SMARCE1/CD274/MED1,15
GO:0140993,MF,GO:0140993,histone modifying activity,13/271,207/18522,0.062801932,4.292315097,5.804390645,1.19E-05,0.000189152,0.000130654,AURKA/BRCA2/MAP3K7/KDM1A/NCOA1/NCOA3/BAP1/CDK2/HDAC6/EZH2/MEAF6/KDM4B/CLOCK,13
GO:0005178,MF,GO:0005178,integrin binding,11/271,157/18522,0.070063694,4.788633746,5.809122194,2.04E-05,0.000316383,0.000218537,THBS1/IL1B/MMP14/FGF2/PTK2/EGFR/FN1/KDR/IGF1/CD9/IGF2,11
GO:0008236,MF,GO:0008236,serine-type peptidase activity,12/271,191/18522,0.062827225,4.294043778,5.576047958,2.57E-05,0.000388097,0.000268072,KLK2/KLK3/TMPRSS2/MMP14/KLK14/MMP9/MMP2/PCSK1/HPR/MMP7/PLAU/MMP1,12
GO:0008083,MF,GO:0008083,growth factor activity,11/271,162/18522,0.067901235,4.640836408,5.671472924,2.73E-05,0.000402968,0.000278344,TIMP1/IL6/VEGFA/FGF2/TGFB1/IL10/TGFA/IGF1/IGF2/FGF3/NRG4,11
GO:0019838,MF,GO:0019838,growth factor binding,10/271,135/18522,0.074074074,5.062730627,5.773019216,3.01E-05,0.000433888,0.000299702,THBS1/ERBB2/IGF1R/TWSG1/TGFBR1/FGFR4/EGFR/A2M/KDR/FGFR1,10
GO:0017171,MF,GO:0017171,serine hydrolase activity,12/271,195/18522,0.061538462,4.205960829,5.48407463,3.15E-05,0.000442938,0.000305953,KLK2/KLK3/TMPRSS2/MMP14/KLK14/MMP9/MMP2/PCSK1/HPR/MMP7/PLAU/MMP1,12
GO:0070851,MF,GO:0070851,growth factor receptor binding,10/271,138/18522,0.072463768,4.952671266,5.679155535,3.64E-05,0.000500356,0.000345613,IL6/IL1B/VEGFA/FGF2/IL10/TGFA/DAB2IP/GATA3/MYD88/FGF3,10
GO:0002020,MF,GO:0002020,protease binding,10/271,140/18522,0.071428571,4.881918819,5.618076061,4.12E-05,0.00055339,0.000382246,TP53/TIMP1/THBS1/PTEN/BRCA2/CASP3/TNF/A2M/FN1/SERPINE1,10
GO:0140311,MF,GO:0140311,protein sequestering activity,5/271,29/18522,0.172413793,11.78394198,7.081844482,5.76E-05,0.000756997,0.000522885,CTNND1/SQSTM1/CAV1/CDKN1A/NFKBIA,5
GO:0008080,MF,GO:0008080,N-acetyltransferase activity,7/271,69/18522,0.101449275,6.933739772,6.017181054,6.61E-05,0.000850757,0.000587648,BRCA2/NCOA1/NCOA3/MEAF6/SMARCE1/NAT1/CLOCK,7
GO:0004707,MF,GO:0004707,MAP kinase activity,4/271,16/18522,0.25,17.08671587,7.844127286,7.10E-05,0.000895119,0.00061829,MAP3K7/MAPK14/MAPK1/MAP2K7,4
GO:0140313,MF,GO:0140313,molecular sequestering activity,6/271,49/18522,0.12244898,8.36900369,6.293781009,7.66E-05,0.000945348,0.000652985,CTNND1/STAT3/SQSTM1/CAV1/CDKN1A/NFKBIA,6
GO:1990782,MF,GO:1990782,protein tyrosine kinase binding,9/271,124/18522,0.072580645,4.960659445,5.39220712,8.81E-05,0.001066593,0.000736733,TP53/ERBB2/MAP3K7/CTNND1/CDH1/SQSTM1/PCNA/IRS1/HSP90AA1,9
GO:0030296,MF,GO:0030296,protein tyrosine kinase activator activity,5/271,32/18522,0.15625,10.67919742,6.677584773,9.42E-05,0.001095561,0.000756742,ALK/VEGFA/EGFR/TGFA/IGF2,5
GO:0097718,MF,GO:0097718,disordered domain specific binding,5/271,32/18522,0.15625,10.67919742,6.677584773,9.42E-05,0.001095561,0.000756742,TP53/CTNNB1/NCOA3/RB1/HSP90AA1,5
GO:0042826,MF,GO:0042826,histone deacetylase binding,9/271,128/18522,0.0703125,4.805638838,5.264631683,0.000112571,0.001285004,0.000887597,TP53/CCND1/PARP1/HIF1A/HDAC6/RELA/TWIST1/HSP90AA1/NKX3-1,9
GO:0030297,MF,GO:0030297,transmembrane receptor protein tyrosine kinase activator activity,4/271,18/18522,0.222222222,15.18819188,7.33844468,0.00011668,0.001307249,0.000902962,VEGFA/EGFR/TGFA/IGF2,4
GO:0030295,MF,GO:0030295,protein kinase activator activity,9/271,129/18522,0.069767442,4.768385823,5.233563041,0.00011949,0.001314393,0.000907897,CCND1/PIK3CA/ALK/VEGFA/EGFR/TGFA/DAB2IP/CDKN1A/IGF2,9
GO:0045296,MF,GO:0045296,cadherin binding,15/271,333/18522,0.045045045,3.078687544,4.664235259,0.000123575,0.001335053,0.000922168,CTNNB1/FASN/CTNND1/CDH1/FSCN1/BSG/EGFR/OLFM4/PKP1/PKP3/DAB2IP/HSPA5/KDR/STAT1/SFN,15
GO:0001227,MF,GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",13/271,262/18522,0.049618321,3.391256584,4.750069529,0.000135461,0.001437786,0.000993129,TP53/MYC/HOXB13/NFKB1/PPARG/RELA/HHEX/SNAI1/SNAI2/GATA3/MXI1/TFAP2A/NANOG,13
GO:0000979,MF,GO:0000979,RNA polymerase II core promoter sequence-specific DNA binding,4/271,20/18522,0.2,13.66937269,6.907713237,0.000180534,0.001883152,0.001300759,FOS/RELA/EZH2/STAT1,4
GO:0019209,MF,GO:0019209,kinase activator activity,9/271,137/18522,0.065693431,4.489939936,4.995971449,0.000188765,0.001935644,0.001337017,CCND1/PIK3CA/ALK/VEGFA/EGFR/TGFA/DAB2IP/CDKN1A/IGF2,9
GO:0030291,MF,GO:0030291,protein serine/threonine kinase inhibitor activity,5/271,37/18522,0.135135135,9.236062631,6.110606306,0.000192021,0.001936208,0.001337407,CASP3/AKT1/CDKN1A/SFN/CDKN2A,5
GO:0004175,MF,GO:0004175,endopeptidase activity,16/271,388/18522,0.041237113,2.81842736,4.411015084,0.000203586,0.002019171,0.001394712,KLK2/KLK3/TMPRSS2/CASP8/CASP3/MMP14/KLK14/MMP9/MMP2/PCSK1/MME/HPR/MMP7/CTSB/PLAU/MMP1,16
GO:0005539,MF,GO:0005539,glycosaminoglycan binding,12/271,239/18522,0.050209205,3.43164168,4.610503208,0.000218952,0.002136552,0.001475791,THBS1/ALK/CD44/VEGFA/FGF2/TENM1/TWSG1/FGFR4/FN1/COL11A2/FGFR1/LYVE1,12
GO:0008201,MF,GO:0008201,heparin binding,10/271,174/18522,0.057471264,3.927980659,4.728484729,0.000250506,0.002405656,0.001661671,THBS1/ALK/VEGFA/FGF2/TENM1/TWSG1/FGFR4/FN1/COL11A2/FGFR1,10
GO:0001098,MF,GO:0001098,basal transcription machinery binding,6/271,61/18522,0.098360656,6.722642308,5.45515929,0.000262595,0.002441677,0.001686552,TP53/AR/ERCC1/NCOA3/BRD4/ESR1,6
GO:0001099,MF,GO:0001099,basal RNA polymerase II transcription machinery binding,6/271,61/18522,0.098360656,6.722642308,5.45515929,0.000262595,0.002441677,0.001686552,TP53/AR/ERCC1/NCOA3/BRD4/ESR1,6
GO:0005158,MF,GO:0005158,insulin receptor binding,4/271,22/18522,0.181818182,12.42670245,6.534613768,0.000266365,0.002441677,0.001686552,IGF1R/IRS1/IGF1/IGF2,4
GO:0008353,MF,GO:0008353,RNA polymerase II CTD heptapeptide repeat kinase activity,3/271,10/18522,0.3,20.50405904,7.517472722,0.000344482,0.003110618,0.002148613,MAPK1/CDK12/BRD4,3
GO:0042169,MF,GO:0042169,SH2 domain binding,5/271,42/18522,0.119047619,8.136531365,5.642016727,0.000353065,0.003141242,0.002169766,SQSTM1/PTK2/DLC1/IRS1/FGFR1,5
GO:0004402,MF,GO:0004402,histone acetyltransferase activity,5/271,43/18522,0.11627907,7.947309706,5.557573098,0.000394795,0.003412153,0.002356894,BRCA2/NCOA1/NCOA3/MEAF6/CLOCK,5
GO:0004712,MF,GO:0004712,protein serine/threonine/tyrosine kinase activity,5/271,43/18522,0.11627907,7.947309706,5.557573098,0.000394795,0.003412153,0.002356894,AURKA/MAPK14/AKT1/BRAF/MAP2K7,5
GO:0042562,MF,GO:0042562,hormone binding,7/271,92/18522,0.076086957,5.200304829,4.921365093,0.000403523,0.003438474,0.002375075,AR/EDNRB/IGF1R/SLC39A9/EGFR/MC1R/CRHR2,7
GO:0001091,MF,GO:0001091,RNA polymerase II general transcription initiation factor binding,4/271,25/18522,0.16,10.93549815,6.057348096,0.000445008,0.003638245,0.002513063,TP53/AR/ERCC1/ESR1,4
GO:0070412,MF,GO:0070412,R-SMAD binding,4/271,25/18522,0.16,10.93549815,6.057348096,0.000445008,0.003638245,0.002513063,PPARG/PARP1/FOS/SMAD3,4
GO:0070577,MF,GO:0070577,lysine-acetylated histone binding,4/271,25/18522,0.16,10.93549815,6.057348096,0.000445008,0.003638245,0.002513063,SMARCA4/BRD3/BRD2/BRD4,4
GO:0005114,MF,GO:0005114,type II transforming growth factor beta receptor binding,3/271,11/18522,0.272727273,18.64005367,7.131072193,0.000468546,0.003681436,0.002542897,MAP3K7/TGFBR1/TGFB1,3
GO:0032404,MF,GO:0032404,mismatch repair complex binding,3/271,11/18522,0.272727273,18.64005367,7.131072193,0.000468546,0.003681436,0.002542897,PCNA/MLH1/MSH2,3
GO:0034056,MF,GO:0034056,estrogen response element binding,3/271,11/18522,0.272727273,18.64005367,7.131072193,0.000468546,0.003681436,0.002542897,AR/ESR1/ESR2,3
GO:0005518,MF,GO:0005518,collagen binding,6/271,68/18522,0.088235294,6.0306056,5.064108441,0.000475341,0.003686941,0.0025467,THBS1/CD44/MMP9/SMAD3/FN1/CTSB,6
GO:0016410,MF,GO:0016410,N-acyltransferase activity,7/271,95/18522,0.073684211,5.036084677,4.805828655,0.000490447,0.003755957,0.002594371,BRCA2/NCOA1/NCOA3/MEAF6/SMARCE1/NAT1/CLOCK,7
GO:0005160,MF,GO:0005160,transforming growth factor beta receptor binding,4/271,26/18522,0.153846154,10.51490207,5.91596529,0.000519911,0.003835926,0.002649609,MAP3K7/TGFBR1/SMAD3/TGFB1,4
GO:0042974,MF,GO:0042974,nuclear retinoic acid receptor binding,4/271,26/18522,0.153846154,10.51490207,5.91596529,0.000519911,0.003835926,0.002649609,VDR/PPARG/NCOA1/MED1,4
GO:0140033,MF,GO:0140033,acetylation-dependent protein binding,4/271,26/18522,0.153846154,10.51490207,5.91596529,0.000519911,0.003835926,0.002649609,SMARCA4/BRD3/BRD2/BRD4,4
GO:0061733,MF,GO:0061733,peptide-lysine-N-acetyltransferase activity,5/271,47/18522,0.106382979,7.270942922,5.245212434,0.000599898,0.004372752,0.003020413,BRCA2/NCOA1/NCOA3/MEAF6/CLOCK,5
GO:0004861,MF,GO:0004861,cyclin-dependent protein serine/threonine kinase inhibitor activity,3/271,12/18522,0.25,17.08671587,6.792479456,0.000617986,0.004450967,0.003074439,CASP3/CDKN1A/CDKN2A,3
GO:0004860,MF,GO:0004860,protein kinase inhibitor activity,6/271,73/18522,0.082191781,5.617550422,4.816817476,0.000695686,0.004951647,0.003420277,CASP3/AKT1/CAV1/CDKN1A/SFN/CDKN2A,6
GO:0043560,MF,GO:0043560,insulin receptor substrate binding,3/271,13/18522,0.230769231,15.77235311,6.492372169,0.000794716,0.005435541,0.003754519,PIK3CA/IGF1R/PRKCD,3
GO:0051721,MF,GO:0051721,protein phosphatase 2A binding,4/271,29/18522,0.137931034,9.427153582,5.534135033,0.000798019,0.005435541,0.003754519,TP53/DAB2IP/SPHK1/STAT1,4
GO:0140416,MF,GO:0140416,transcription regulator inhibitor activity,4/271,29/18522,0.137931034,9.427153582,5.534135033,0.000798019,0.005435541,0.003754519,ID1/NKX3-1/NFKBIA/ID4,4
GO:0016538,MF,GO:0016538,cyclin-dependent protein serine/threonine kinase regulator activity,5/271,50/18522,0.1,6.834686347,5.034068094,0.000799609,0.005435541,0.003754519,CCND1/CDK4/CASP3/CDKN1A/CDKN2A,5
GO:0034212,MF,GO:0034212,peptide N-acetyltransferase activity,5/271,52/18522,0.096153846,6.571813795,4.902734181,0.00095783,0.006438745,0.004447468,BRCA2/NCOA1/NCOA3/MEAF6/CLOCK,5
GO:0019210,MF,GO:0019210,kinase inhibitor activity,6/271,78/18522,0.076923077,5.257451036,4.591376798,0.000987854,0.006496212,0.004487162,CASP3/AKT1/CAV1/CDKN1A/SFN/CDKN2A,6
GO:0046332,MF,GO:0046332,SMAD binding,6/271,78/18522,0.076923077,5.257451036,4.591376798,0.000987854,0.006496212,0.004487162,CTNNB1/PPARG/PARP1/FOS/TGFBR1/SMAD3,6
GO:0030983,MF,GO:0030983,mismatched DNA binding,3/271,14/18522,0.214285714,14.64575646,6.223796974,0.001000555,0.006508989,0.004495987,PCNA/MLH1/MSH2,3
GO:0005164,MF,GO:0005164,tumor necrosis factor receptor binding,4/271,31/18522,0.129032258,8.818950125,5.309120949,0.001033237,0.006650092,0.004593452,CASP8/FASLG/TNF/STAT1,4
GO:0033764,MF,GO:0033764,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",4/271,32/18522,0.125,8.543357934,5.204089751,0.001167391,0.007281149,0.005029345,SRD5A2/HSD3B1/HSD3B2/AKR1C3,4
GO:0043425,MF,GO:0043425,bHLH transcription factor binding,4/271,32/18522,0.125,8.543357934,5.204089751,0.001167391,0.007281149,0.005029345,LMO2/KDM1A/SMAD3/TWIST1,4
GO:0071889,MF,GO:0071889,14-3-3 protein binding,4/271,32/18522,0.125,8.543357934,5.204089751,0.001167391,0.007281149,0.005029345,TP53/AKT1/DAB2IP/ESR1,4
GO:0030971,MF,GO:0030971,receptor tyrosine kinase binding,6/271,81/18522,0.074074074,5.062730627,4.465209421,0.001203584,0.007338746,0.00506913,TP53/ERBB2/MAP3K7/SQSTM1/PCNA/IRS1,6
GO:0005521,MF,GO:0005521,lamin binding,3/271,15/18522,0.2,13.66937269,5.981446984,0.001237224,0.007338746,0.00506913,PKP1/IFI27/BNIP3L,3
GO:0097027,MF,GO:0097027,ubiquitin-protein transferase activator activity,3/271,15/18522,0.2,13.66937269,5.981446984,0.001237224,0.007338746,0.00506913,FBXW7/BMI1/CBX8,3
GO:0016504,MF,GO:0016504,peptidase activator activity,5/271,55/18522,0.090909091,6.213351224,4.71817107,0.001237276,0.007338746,0.00506913,CAV1/TGFB1/FN1/NKX3-1/MAL,5
GO:0030374,MF,GO:0030374,nuclear receptor coactivator activity,5/271,55/18522,0.090909091,6.213351224,4.71817107,0.001237276,0.007338746,0.00506913,KDM1A/NCOA1/NCOA3/FGF2/MED1,5
GO:0019825,MF,GO:0019825,oxygen binding,4/271,34/18522,0.117647059,8.040807467,5.007148706,0.00147145,0.008597554,0.005938632,SOD2/CYP1A1/CYP17A1/CYP19A1,4
GO:0004708,MF,GO:0004708,MAP kinase kinase activity,3/271,16/18522,0.1875,12.8150369,5.761191663,0.001506348,0.008597554,0.005938632,MAPK14/BRAF/MAP2K7,3
GO:0005159,MF,GO:0005159,insulin-like growth factor receptor binding,3/271,16/18522,0.1875,12.8150369,5.761191663,0.001506348,0.008597554,0.005938632,IRS1/IGF1/IGF2,3
GO:0070411,MF,GO:0070411,I-SMAD binding,3/271,16/18522,0.1875,12.8150369,5.761191663,0.001506348,0.008597554,0.005938632,CTNNB1/TGFBR1/SMAD3,3
GO:0008013,MF,GO:0008013,beta-catenin binding,6/271,86/18522,0.069767442,4.768385823,4.268200044,0.00164112,0.009200575,0.00635516,AR/CTNND1/CDH1/HDAC6/SMAD3/ESR1,6
GO:0016229,MF,GO:0016229,steroid dehydrogenase activity,4/271,35/18522,0.114285714,7.811070111,4.914617029,0.001642417,0.009200575,0.00635516,SRD5A2/HSD3B1/HSD3B2/AKR1C3,4
GO:0046965,MF,GO:0046965,nuclear retinoid X receptor binding,3/271,17/18522,0.176470588,12.0612112,5.559761086,0.001809465,0.01004336,0.006937302,VDR/PPARG/NCOA1,3
GO:0004857,MF,GO:0004857,enzyme inhibitor activity,14/271,389/18522,0.035989717,2.459784289,3.545701605,0.001855457,0.010205014,0.007048961,TIMP1/THBS1/CASP3/NOTCH1/LMTK2/AKT1/CAV1/A2M/SERPINE1/CDKN1A/UCN/SFN/CDKN2A/ROCK1,14
GO:1901681,MF,GO:1901681,sulfur compound binding,11/271,267/18522,0.041198502,2.815788383,3.641694196,0.001995194,0.010874706,0.007511541,THBS1/ALK/VEGFA/GSTP1/FGF2/TENM1/TWSG1/FGFR4/FN1/COL11A2/FGFR1,11
GO:0061134,MF,GO:0061134,peptidase regulator activity,10/271,232/18522,0.043103448,2.945985494,3.634546814,0.002277881,0.012304623,0.008499235,TIMP1/THBS1/CAV1/TGFB1/A2M/FN1/SERPINE1/NKX3-1/ROCK1/MAL,10
GO:0051219,MF,GO:0051219,phosphoprotein binding,6/271,93/18522,0.064516129,4.409475062,4.016535745,0.002444683,0.013088792,0.009040888,FBXW7/MTOR/MAPK1/RB1/IRS1/SFN,6
GO:0005125,MF,GO:0005125,cytokine activity,10/271,238/18522,0.042016807,2.871716952,3.541331438,0.002739419,0.014538145,0.010042007,TIMP1/IL6/IL1B/FASLG/VEGFA/FGF2/TNF/TGFB1/IL10/IFNA1,10
GO:0051787,MF,GO:0051787,misfolded protein binding,3/271,20/18522,0.15,10.25202952,5.044477602,0.002936826,0.015317067,0.010580036,HDAC6/HSPA5/CLU,3
GO:0140664,MF,GO:0140664,ATP-dependent DNA damage sensor activity,3/271,20/18522,0.15,10.25202952,5.044477602,0.002936826,0.015317067,0.010580036,XRCC3/MLH1/MSH2,3
GO:0051879,MF,GO:0051879,Hsp90 protein binding,4/271,42/18522,0.095238095,6.509225092,4.355496884,0.0032413,0.016760569,0.011577114,HIF1A/HDAC6/CYP1A1/KDR,4
GO:0070182,MF,GO:0070182,DNA polymerase binding,3/271,21/18522,0.142857143,9.763837638,4.896433918,0.003389554,0.017378645,0.01200404,SMARCA4/PCNA/HSP90AA1,3
GO:0048156,MF,GO:0048156,tau protein binding,4/271,43/18522,0.093023256,6.357847765,4.286066386,0.003533249,0.017963159,0.012407785,HDAC6/HSP90AA1/ROCK1/CLU,4
GO:0097110,MF,GO:0097110,scaffold protein binding,5/271,70/18522,0.071428571,4.881918819,3.965037278,0.003605384,0.018177144,0.012555592,MAP3K7/CASP8/VIM/HSP90AA1/BRAF,5
GO:0140097,MF,GO:0140097,"catalytic activity, acting on DNA",10/271,248/18522,0.040322581,2.755921914,3.392249271,0.003672433,0.018362165,0.012683392,XRCC1/ERCC1/XRCC3/SMARCA4/SMARCA2/PCNA/REXO2/MLH1/MSH2/MYD88,10
GO:0017134,MF,GO:0017134,fibroblast growth factor binding,3/271,23/18522,0.130434783,8.914808279,4.628110504,0.00441728,0.02155205,0.014886757,THBS1/FGFR4/FGFR1,3
GO:0035173,MF,GO:0035173,histone kinase activity,3/271,23/18522,0.130434783,8.914808279,4.628110504,0.00441728,0.02155205,0.014886757,AURKA/MAP3K7/CDK2,3
GO:0140994,MF,GO:0140994,RNA polymerase II CTD heptapeptide repeat modifying activity,3/271,23/18522,0.130434783,8.914808279,4.628110504,0.00441728,0.02155205,0.014886757,MAPK1/CDK12/BRD4,3
GO:0016702,MF,GO:0016702,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen",3/271,24/18522,0.125,8.543357934,4.505899258,0.004994301,0.023605876,0.016305407,ALOX12/PTGS2/ALOX15B,3
GO:0035035,MF,GO:0035035,histone acetyltransferase binding,3/271,24/18522,0.125,8.543357934,4.505899258,0.004994301,0.023605876,0.016305407,PCNA/STAT1/MED1,3
GO:0050431,MF,GO:0050431,transforming growth factor beta binding,3/271,24/18522,0.125,8.543357934,4.505899258,0.004994301,0.023605876,0.016305407,THBS1/TWSG1/TGFBR1,3
GO:0140612,MF,GO:0140612,DNA damage sensor activity,3/271,24/18522,0.125,8.543357934,4.505899258,0.004994301,0.023605876,0.016305407,XRCC3/MLH1/MSH2,3
GO:0004222,MF,GO:0004222,metalloendopeptidase activity,6/271,110/18522,0.054545455,3.728010735,3.496757082,0.005596537,0.025930296,0.017910966,MMP14/MMP9/MMP2/MME/MMP7/MMP1,6
GO:0016701,MF,GO:0016701,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen",3/271,25/18522,0.12,8.201623616,4.390594253,0.005614659,0.025930296,0.017910966,ALOX12/PTGS2/ALOX15B,3
GO:0043548,MF,GO:0043548,phosphatidylinositol 3-kinase binding,3/271,25/18522,0.12,8.201623616,4.390594253,0.005614659,0.025930296,0.017910966,IGF1R/DAB2IP/IRS1,3
GO:0016747,MF,GO:0016747,"acyltransferase activity, transferring groups other than amino-acyl groups",9/271,226/18522,0.039823009,2.721777749,3.17341422,0.006206277,0.028350081,0.019582396,BRCA2/FASN/NCOA1/NCOA3/MEAF6/SMARCE1/SPHK1/NAT1/CLOCK,9
GO:0004709,MF,GO:0004709,MAP kinase kinase kinase activity,3/271,26/18522,0.115384615,7.886176554,4.281534499,0.006279192,0.028350081,0.019582396,MAP3K7/EGFR/BRAF,3
GO:0008395,MF,GO:0008395,steroid hydroxylase activity,3/271,26/18522,0.115384615,7.886176554,4.281534499,0.006279192,0.028350081,0.019582396,CYP1A1/CYP17A1/CYP19A1,3
GO:0140030,MF,GO:0140030,modification-dependent protein binding,8/271,187/18522,0.042780749,2.923929988,3.222130596,0.006382849,0.028604619,0.019758214,XRCC1/SMARCA4/HDAC6/SQSTM1/CBX8/BRD3/BRD2/BRD4,8
GO:0033293,MF,GO:0033293,monocarboxylic acid binding,5/271,81/18522,0.061728395,4.218942189,3.537830171,0.00670627,0.029833039,0.020606727,VDR/PPARG/GSTP1/AKR1C3/RBP1,5
GO:0033218,MF,GO:0033218,amide binding,13/271,409/18522,0.031784841,2.172394193,2.921552184,0.007472233,0.032997817,0.02279275,SRD5A2/EDNRB/FASN/PPARG/NPEPPS/IGF1R/TLR4/RELA/GRPR/MME/NFKBIA/CRHR2/CLU,13
GO:0003697,MF,GO:0003697,single-stranded DNA binding,6/271,119/18522,0.050420168,3.446060343,3.261894144,0.008138355,0.035656426,0.024629145,TP53/YBX1/BRCA2/ERCC1/MLH1/MSH2,6
GO:0016209,MF,GO:0016209,antioxidant activity,5/271,85/18522,0.058823529,4.020403733,3.400970479,0.008192138,0.035656426,0.024629145,GPX1/PTGS2/SOD2/GSTP1/TXN,5
GO:0004693,MF,GO:0004693,cyclin-dependent protein serine/threonine kinase activity,3/271,29/18522,0.103448276,7.070365186,3.986425584,0.008545241,0.036065885,0.024911973,CDK4/CDK2/CDK12,3
GO:0051059,MF,GO:0051059,NF-kappaB binding,3/271,29/18522,0.103448276,7.070365186,3.986425584,0.008545241,0.036065885,0.024911973,RELA/NFKBIA/CDKN2A,3
GO:0055106,MF,GO:0055106,ubiquitin-protein transferase regulator activity,3/271,29/18522,0.103448276,7.070365186,3.986425584,0.008545241,0.036065885,0.024911973,FBXW7/BMI1/CBX8,3
GO:0097472,MF,GO:0097472,cyclin-dependent protein kinase activity,3/271,29/18522,0.103448276,7.070365186,3.986425584,0.008545241,0.036065885,0.024911973,CDK4/CDK2/CDK12,3
GO:0001094,MF,GO:0001094,TFIID-class transcription factor complex binding,2/271,10/18522,0.2,13.66937269,4.883171417,0.008882342,0.036065885,0.024911973,TP53/ERCC1,2
GO:0016832,MF,GO:0016832,aldehyde-lyase activity,2/271,10/18522,0.2,13.66937269,4.883171417,0.008882342,0.036065885,0.024911973,SGPL1/CYP17A1,2
GO:0031434,MF,GO:0031434,mitogen-activated protein kinase kinase binding,2/271,10/18522,0.2,13.66937269,4.883171417,0.008882342,0.036065885,0.024911973,DAB2IP/BRAF,2
GO:0032052,MF,GO:0032052,bile acid binding,2/271,10/18522,0.2,13.66937269,4.883171417,0.008882342,0.036065885,0.024911973,VDR/AKR1C3,2
GO:0032356,MF,GO:0032356,oxidized DNA binding,2/271,10/18522,0.2,13.66937269,4.883171417,0.008882342,0.036065885,0.024911973,XRCC1/MSH2,2
GO:0045294,MF,GO:0045294,alpha-catenin binding,2/271,10/18522,0.2,13.66937269,4.883171417,0.008882342,0.036065885,0.024911973,CTNNB1/PKP3,2
GO:0001968,MF,GO:0001968,fibronectin binding,3/271,30/18522,0.1,6.834686347,3.897263127,0.009393569,0.037887396,0.026170154,THBS1/VEGFA/MMP2,3
GO:0008094,MF,GO:0008094,"ATP-dependent activity, acting on DNA",6/271,123/18522,0.048780488,3.33399334,3.164671145,0.009499532,0.038061041,0.026290097,XRCC3/SMARCA4/SMARCA2/MLH1/MSH2/MYD88,6
GO:0070063,MF,GO:0070063,RNA polymerase binding,4/271,58/18522,0.068965517,4.713576791,3.451572806,0.010245615,0.040780246,0.028168347,BRCA1/ERBB2/NCOA3/BRD4,4
GO:0000014,MF,GO:0000014,single-stranded DNA endodeoxyribonuclease activity,2/271,11/18522,0.181818182,12.42670245,4.619296608,0.010752074,0.041698749,0.02880279,XRCC1/ERCC1,2
GO:0008432,MF,GO:0008432,JUN kinase binding,2/271,11/18522,0.181818182,12.42670245,4.619296608,0.010752074,0.041698749,0.02880279,GSTP1/PTK2,2
GO:0030283,MF,GO:0030283,testosterone dehydrogenase [NAD(P)] activity,2/271,11/18522,0.181818182,12.42670245,4.619296608,0.010752074,0.041698749,0.02880279,SRD5A2/AKR1C3,2
GO:0097371,MF,GO:0097371,MDM2/MDM4 family protein binding,2/271,11/18522,0.181818182,12.42670245,4.619296608,0.010752074,0.041698749,0.02880279,TP53/TP63,2
GO:0042277,MF,GO:0042277,peptide binding,11/271,336/18522,0.032738095,2.237546125,2.789561682,0.010887316,0.041954308,0.028979313,EDNRB/PPARG/NPEPPS/IGF1R/TLR4/RELA/GRPR/MME/NFKBIA/CRHR2/CLU,11
GO:0016628,MF,GO:0016628,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor",3/271,32/18522,0.09375,6.40751845,3.730594729,0.011232967,0.04301231,0.029710112,SRD5A2/FASN/AKR1C3,3
GO:0019956,MF,GO:0019956,chemokine binding,3/271,33/18522,0.090909091,6.213351224,3.652504603,0.012224935,0.046358838,0.032021677,CXCR2/FGF2/A2M,3
GO:0031072,MF,GO:0031072,heat shock protein binding,6/271,130/18522,0.046153846,3.154470622,3.003802001,0.012260189,0.046358838,0.032021677,HIF1A/HDAC6/CYP1A1/BAX/HSPA5/KDR,6
GO:0019215,MF,GO:0019215,intermediate filament binding,2/271,12/18522,0.166666667,11.39114391,4.387572462,0.012778892,0.04802006,0.033169141,PKP1/VIM,2
GO:0031491,MF,GO:0031491,nucleosome binding,5/271,96/18522,0.052083333,3.559732472,3.06399597,0.013423296,0.05013021,0.034626696,PARP1/ARID1A/SMARCA4/MBD2/SMARCE1,5
GO:0004536,MF,GO:0004536,DNA nuclease activity,4/271,63/18522,0.063492063,4.339483395,3.235333144,0.013595154,0.050460541,0.034854867,XRCC1/ERCC1/XRCC3/REXO2,4
GO:0005172,MF,GO:0005172,vascular endothelial growth factor receptor binding,2/271,13/18522,0.153846154,10.51490207,4.181749851,0.014957833,0.055179811,0.038114632,VEGFA/DAB2IP,2
GO:0043130,MF,GO:0043130,ubiquitin binding,5/271,99/18522,0.050505051,3.451861791,2.980622228,0.015167109,0.055612732,0.038413666,FBXW7/MAP3K7/HDAC6/SQSTM1/SMAD3,5
GO:0042805,MF,GO:0042805,actinin binding,3/271,36/18522,0.083333333,5.695571956,3.436305798,0.015494228,0.055797665,0.038541406,NFKB1/PPARG/RELA,3
GO:0043394,MF,GO:0043394,proteoglycan binding,3/271,36/18522,0.083333333,5.695571956,3.436305798,0.015494228,0.055797665,0.038541406,THBS1/FN1/CTSB,3
GO:0140658,MF,GO:0140658,ATP-dependent chromatin remodeler activity,3/271,36/18522,0.083333333,5.695571956,3.436305798,0.015494228,0.055797665,0.038541406,SMARCA4/SMARCA2/MYD88,3
GO:0016705,MF,GO:0016705,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen",7/271,179/18522,0.039106145,2.67278237,2.740339078,0.016459817,0.058924198,0.040701012,PTGS2/KDM1A/CYP1A1/AKR1C3/CYP17A1/CYP19A1/KDM4B,7
GO:0032454,MF,GO:0032454,histone H3K9 demethylase activity,2/271,14/18522,0.142857143,9.763837638,3.997165444,0.017284046,0.061151157,0.042239251,KDM1A/KDM4B,2
GO:0070742,MF,GO:0070742,C2H2 zinc finger domain binding,2/271,14/18522,0.142857143,9.763837638,3.997165444,0.017284046,0.061151157,0.042239251,MBD2/WT1,2
GO:0008237,MF,GO:0008237,metallopeptidase activity,7/271,183/18522,0.038251366,2.614360898,2.674310799,0.018352937,0.064555388,0.044590672,NPEPPS/MMP14/MMP9/MMP2/MME/MMP7/MMP1,7
GO:0043495,MF,GO:0043495,protein-membrane adaptor activity,3/271,39/18522,0.076923077,5.257451036,3.243166628,0.019208882,0.067175571,0.046400525,KRAS/EPB41L3/HRAS,3
GO:0010484,MF,GO:0010484,histone H3 acetyltransferase activity,2/271,15/18522,0.133333333,9.112915129,3.830258443,0.019752788,0.06828821,0.047169063,BRCA2/MEAF6,2
GO:0016863,MF,GO:0016863,"intramolecular oxidoreductase activity, transposing C=C bonds",2/271,15/18522,0.133333333,9.112915129,3.830258443,0.019752788,0.06828821,0.047169063,HSD3B1/HSD3B2,2
GO:0019955,MF,GO:0019955,cytokine binding,6/271,145/18522,0.04137931,2.828146075,2.692967527,0.01998504,0.068698577,0.047452518,THBS1/CXCR2/FGF2/TWSG1/TGFBR1/A2M,6
GO:0005496,MF,GO:0005496,steroid binding,5/271,107/18522,0.046728972,3.193778667,2.773143638,0.020540329,0.069445983,0.047968778,AR/VDR/CAV1/ESR1/ESR2,5
GO:0032451,MF,GO:0032451,demethylase activity,3/271,40/18522,0.075,5.12601476,3.183169894,0.020546828,0.069445983,0.047968778,KDM1A/CYP1A1/KDM4B,3
GO:0035198,MF,GO:0035198,miRNA binding,3/271,40/18522,0.075,5.12601476,3.183169894,0.020546828,0.069445983,0.047968778,YBX1/MALAT1/SOX2,3
GO:0043621,MF,GO:0043621,protein self-association,4/271,72/18522,0.055555556,3.79704797,2.897620506,0.021220284,0.071323731,0.049265805,TP53/PPARG/NKX3-1/MYD88,4
GO:0004520,MF,GO:0004520,DNA endonuclease activity,3/271,41/18522,0.073170732,5.00099001,3.12514513,0.02193477,0.073317878,0.050643232,XRCC1/ERCC1/XRCC3,3
GO:0043175,MF,GO:0043175,RNA polymerase core enzyme binding,3/271,42/18522,0.071428571,4.881918819,3.068977041,0.023372729,0.077695061,0.053666706,ERBB2/NCOA3/BRD4,3
GO:0140299,MF,GO:0140299,small molecule sensor activity,3/271,43/18522,0.069767442,4.768385823,3.014559673,0.02486069,0.082189713,0.05677132,XRCC3/MLH1/MSH2,3
GO:0005149,MF,GO:0005149,interleukin-1 receptor binding,2/271,17/18522,0.117647059,8.040807467,3.538962113,0.025099416,0.082527972,0.057004967,IL1B/MYD88,2
GO:0003714,MF,GO:0003714,transcription corepressor activity,7/271,198/18522,0.035353535,2.416303254,2.44147474,0.026812955,0.087685611,0.060567529,CCND1/SMARCA4/EZH2/RB1/PAWR/TFAP2A/MED1,7
GO:0000400,MF,GO:0000400,four-way junction DNA binding,2/271,18/18522,0.111111111,7.594095941,3.410611351,0.027968341,0.090544172,0.062542038,XRCC3/MSH2,2
GO:0003925,MF,GO:0003925,G protein activity,3/271,45/18522,0.066666667,4.556457565,2.910594386,0.02798638,0.090544172,0.062542038,RHOA/KRAS/HRAS,3
GO:0032182,MF,GO:0032182,ubiquitin-like protein binding,5/271,119/18522,0.042016807,2.871716952,2.495990168,0.030708454,0.09882242,0.068260114,FBXW7/MAP3K7/HDAC6/SQSTM1/SMAD3,5
GO:0015459,MF,GO:0015459,potassium channel regulator activity,3/271,48/18522,0.0625,4.271678967,2.765568117,0.033047585,0.105787244,0.073070963,AKT1/CAV1/LRRC26,3
GO:0051117,MF,GO:0051117,ATPase binding,4/271,84/18522,0.047619048,3.254612546,2.523644552,0.034801768,0.110336004,0.076212951,AR/CAV1/EGFR/ESR1,4
GO:0005504,MF,GO:0005504,fatty acid binding,3/271,49/18522,0.06122449,4.184501845,2.719846275,0.03483335,0.110336004,0.076212951,PPARG/GSTP1/RBP1,3
GO:0046982,MF,GO:0046982,protein heterodimerization activity,10/271,353/18522,0.028328612,1.93617177,2.163968376,0.035563032,0.112060597,0.077404188,TP53/ERBB2/AURKA/HIF1A/TENM1/TLR4/KATNB1/CAV1/BAX/ZHX2,10
GO:0017046,MF,GO:0017046,peptide hormone binding,3/271,50/18522,0.06,4.100811808,2.675327663,0.036668095,0.114750655,0.079262305,EDNRB/IGF1R/CRHR2,3
GO:0016616,MF,GO:0016616,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",5/271,125/18522,0.04,2.733874539,2.370132908,0.036796078,0.114750655,0.079262305,SRD5A2/HSD3B1/FASN/HSD3B2/AKR1C3,5
GO:0016500,MF,GO:0016500,protein-hormone receptor activity,2/271,21/18522,0.095238095,6.509225092,3.078052985,0.037305885,0.1157439,0.079948375,IGF1R/LGR4,2
GO:0008528,MF,GO:0008528,G protein-coupled peptide receptor activity,5/271,126/18522,0.03968254,2.712177122,2.349880571,0.037877661,0.116918291,0.080759567,EDNRB/MC1R/GRPR/CRHR2/LGR4,5
GO:0010485,MF,GO:0010485,histone H4 acetyltransferase activity,2/271,22/18522,0.090909091,6.213351224,2.981370771,0.040648205,0.12483332,0.086226756,BRCA2/MEAF6,2
GO:0061980,MF,GO:0061980,regulatory RNA binding,3/271,53/18522,0.056603774,3.868690385,2.548434353,0.042463477,0.129749514,0.089622544,YBX1/MALAT1/SOX2,3
GO:0004602,MF,GO:0004602,glutathione peroxidase activity,2/271,23/18522,0.086956522,5.943205519,2.890493437,0.044098769,0.134069122,0.092606249,GPX1/GSTP1,2
GO:0001653,MF,GO:0001653,peptide receptor activity,5/271,132/18522,0.037878788,2.588896344,2.232364951,0.044774419,0.135442617,0.09355497,EDNRB/MC1R/GRPR/CRHR2/LGR4,5
GO:0051087,MF,GO:0051087,protein-folding chaperone binding,5/271,133/18522,0.037593985,2.569430957,2.213413262,0.045992161,0.138434115,0.095621303,TP53/CYP1A1/BAX/HSPA5/CLU,5
GO:0051213,MF,GO:0051213,dioxygenase activity,4/271,93/18522,0.043010753,2.939650042,2.285006807,0.047649904,0.139953889,0.096671064,ALOX12/PTGS2/ALOX15B/KDM4B,4
GO:0005385,MF,GO:0005385,zinc ion transmembrane transporter activity,2/271,24/18522,0.083333333,5.695571956,2.804821722,0.047653721,0.139953889,0.096671064,SLC39A9/SLC39A11,2
GO:0005540,MF,GO:0005540,hyaluronic acid binding,2/271,24/18522,0.083333333,5.695571956,2.804821722,0.047653721,0.139953889,0.096671064,CD44/LYVE1,2
GO:0016505,MF,GO:0016505,peptidase activator activity involved in apoptotic process,2/271,24/18522,0.083333333,5.695571956,2.804821722,0.047653721,0.139953889,0.096671064,NKX3-1/MAL,2
GO:0106222,MF,GO:0106222,lncRNA binding,2/271,24/18522,0.083333333,5.695571956,2.804821722,0.047653721,0.139953889,0.096671064,EZH2/BRD3,2
GO:0016614,MF,GO:0016614,"oxidoreductase activity, acting on CH-OH group of donors",5/271,135/18522,0.037037037,2.531365314,2.1760245,0.048486463,0.141711642,0.097885206,SRD5A2/HSD3B1/FASN/HSD3B2/AKR1C3,5
GO:0000287,MF,GO:0000287,magnesium ion binding,7/271,227/18522,0.030837004,2.10761253,2.046011689,0.049960486,0.145056642,0.100195714,MAP3K7/CDK2/SRPK1/REXO2/SPHK1/MSH2/MAP2K7,7
GO:0004601,MF,GO:0004601,peroxidase activity,3/271,57/18522,0.052631579,3.59720334,2.392997547,0.050857796,0.145056642,0.100195714,GPX1/PTGS2/GSTP1,3
GO:0015026,MF,GO:0015026,coreceptor activity,3/271,57/18522,0.052631579,3.59720334,2.392997547,0.050857796,0.145056642,0.100195714,ERBB2/KDR/CD8A,3
GO:0003707,MF,GO:0003707,nuclear steroid receptor activity,2/271,25/18522,0.08,5.467749077,2.72384041,0.051309291,0.145056642,0.100195714,ESR1/ESR2,2
GO:0005104,MF,GO:0005104,fibroblast growth factor receptor binding,2/271,25/18522,0.08,5.467749077,2.72384041,0.051309291,0.145056642,0.100195714,FGF2/FGF3,2
GO:0017025,MF,GO:0017025,TBP-class protein binding,2/271,25/18522,0.08,5.467749077,2.72384041,0.051309291,0.145056642,0.100195714,HHEX/ESR1,2
GO:0070840,MF,GO:0070840,dynein complex binding,2/271,25/18522,0.08,5.467749077,2.72384041,0.051309291,0.145056642,0.100195714,HDAC6/KATNB1,2
GO:0005112,MF,GO:0005112,Notch binding,2/271,26/18522,0.076923077,5.257451036,2.647103708,0.0550618,0.15216858,0.105108179,NOTCH1/CUL3,2
GO:0050681,MF,GO:0050681,nuclear androgen receptor binding,2/271,26/18522,0.076923077,5.257451036,2.647103708,0.0550618,0.15216858,0.105108179,KDM1A/SMARCA4,2
GO:0070006,MF,GO:0070006,metalloaminopeptidase activity,2/271,26/18522,0.076923077,5.257451036,2.647103708,0.0550618,0.15216858,0.105108179,NPEPPS/MMP14,2
GO:0070330,MF,GO:0070330,aromatase activity,2/271,26/18522,0.076923077,5.257451036,2.647103708,0.0550618,0.15216858,0.105108179,CYP1A1/CYP19A1,2
GO:0016684,MF,GO:0016684,"oxidoreductase activity, acting on peroxide as acceptor",3/271,59/18522,0.050847458,3.475264244,2.320437996,0.055334029,0.15216858,0.105108179,GPX1/PTGS2/GSTP1,3
GO:0045309,MF,GO:0045309,protein phosphorylated amino acid binding,3/271,59/18522,0.050847458,3.475264244,2.320437996,0.055334029,0.15216858,0.105108179,FBXW7/MAPK1/IRS1,3
GO:0016627,MF,GO:0016627,"oxidoreductase activity, acting on the CH-CH group of donors",3/271,60/18522,0.05,3.417343173,2.285325624,0.057640415,0.157793895,0.108993782,SRD5A2/FASN/AKR1C3,3
GO:0046966,MF,GO:0046966,nuclear thyroid hormone receptor binding,2/271,28/18522,0.071428571,4.881918819,2.50486063,0.06284333,0.170494237,0.117766354,NCOA3/MED1,2
GO:0141052,MF,GO:0141052,histone H3 demethylase activity,2/271,28/18522,0.071428571,4.881918819,2.50486063,0.06284333,0.170494237,0.117766354,KDM1A/KDM4B,2
GO:0005507,MF,GO:0005507,copper ion binding,3/271,63/18522,0.047619048,3.254612546,2.184296742,0.064827003,0.17509079,0.120941354,TP53/COX2/SNCG,3
GO:0004497,MF,GO:0004497,monooxygenase activity,4/271,105/18522,0.038095238,2.603690037,2.008071468,0.068330078,0.183731987,0.126910133,CYP1A1/AKR1C3/CYP17A1/CYP19A1,4
GO:0043539,MF,GO:0043539,protein serine/threonine kinase activator activity,3/271,65/18522,0.046153846,3.154470622,2.120265405,0.069835921,0.186950143,0.129133026,CCND1/DAB2IP/IGF2,3
GO:0032452,MF,GO:0032452,histone demethylase activity,2/271,30/18522,0.066666667,4.556457565,2.37552631,0.070970543,0.188320958,0.130079896,KDM1A/KDM4B,2
GO:0140457,MF,GO:0140457,protein demethylase activity,2/271,30/18522,0.066666667,4.556457565,2.37552631,0.070970543,0.188320958,0.130079896,KDM1A/KDM4B,2
GO:0031492,MF,GO:0031492,nucleosomal DNA binding,3/271,66/18522,0.045454545,3.106675612,2.089172851,0.072404168,0.19128612,0.132128038,SMARCA4/MBD2/SMARCE1,3
GO:0005506,MF,GO:0005506,iron ion binding,5/271,153/18522,0.032679739,2.23355763,1.866963945,0.074468405,0.195884282,0.13530415,ALOX12/ALOX15B/CYP1A1/CYP17A1/CYP19A1,5
GO:0008327,MF,GO:0008327,methyl-CpG binding,2/271,31/18522,0.064516129,4.409475062,2.315057033,0.075155455,0.196835715,0.135961337,HOXB13/MBD2,2
GO:0042393,MF,GO:0042393,histone binding,7/271,252/18522,0.027777778,1.898523985,1.749984492,0.077801437,0.202887367,0.140141426,SMARCA4/SMARCA2/CBX8/BRD3/BRD2/BRD4/STAT1,7
GO:0005200,MF,GO:0005200,structural constituent of cytoskeleton,4/271,112/18522,0.035714286,2.44095941,1.863834701,0.082211659,0.212555786,0.146819743,EPB41L3/VIM/TUBA4B/CCDC6,4
GO:0035591,MF,GO:0035591,signaling adaptor activity,4/271,112/18522,0.035714286,2.44095941,1.863834701,0.082211659,0.212555786,0.146819743,STAT3/DAB2IP/IRS1/MYD88,4
GO:0140597,MF,GO:0140597,protein carrier chaperone,2/271,34/18522,0.058823529,4.020403733,2.14799378,0.088157318,0.226958203,0.156767997,MYD88/CLU,2
GO:0016811,MF,GO:0016811,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides",3/271,72/18522,0.041666667,2.847785978,1.914226212,0.088671533,0.227314734,0.157014266,KLK3/HDAC6/FHIT,3
GO:0043015,MF,GO:0043015,gamma-tubulin binding,2/271,35/18522,0.057142857,3.905535055,2.096526952,0.09263017,0.235467449,0.162645632,BRCA2/GIT1,2
GO:0140693,MF,GO:0140693,molecular condensate scaffold activity,2/271,35/18522,0.057142857,3.905535055,2.096526952,0.09263017,0.235467449,0.162645632,SQSTM1/BRD3,2
GO:0000993,MF,GO:0000993,RNA polymerase II complex binding,2/271,36/18522,0.055555556,3.79704797,2.046931077,0.097167578,0.24494327,0.169190915,NCOA3/BRD4,2
GO:0071855,MF,GO:0071855,neuropeptide receptor binding,2/271,36/18522,0.055555556,3.79704797,2.046931077,0.097167578,0.24494327,0.169190915,TAC1/UCN,2
GO:0023023,MF,GO:0023023,MHC protein complex binding,2/271,37/18522,0.054054054,3.694425052,1.999082748,0.101766714,0.255472457,0.176463793,HSP90AA1/CD8A,2
GO:0004866,MF,GO:0004866,endopeptidase inhibitor activity,5/271,169/18522,0.029585799,2.022096552,1.626504511,0.10279141,0.255921001,0.176773619,TIMP1/THBS1/A2M/SERPINE1/ROCK1,5
GO:0043021,MF,GO:0043021,ribonucleoprotein complex binding,5/271,169/18522,0.029585799,2.022096552,1.626504511,0.10279141,0.255921001,0.176773619,RNASEL/MTOR/EZH2/HSPA5/PIM1,5
GO:0016709,MF,GO:0016709,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen",2/271,38/18522,0.052631579,3.59720334,1.952869848,0.106424816,0.263881204,0.182272011,CYP1A1/AKR1C3,2
GO:0000217,MF,GO:0000217,DNA secondary structure binding,2/271,39/18522,0.051282051,3.504967357,1.908190245,0.111139191,0.272666402,0.188340255,XRCC3/MSH2,2
GO:0016799,MF,GO:0016799,"hydrolase activity, hydrolyzing N-glycosyl compounds",2/271,39/18522,0.051282051,3.504967357,1.908190245,0.111139191,0.272666402,0.188340255,TLR4/PCNA,2
GO:0004519,MF,GO:0004519,endonuclease activity,4/271,125/18522,0.032,2.187099631,1.622714815,0.111320002,0.272666402,0.188340255,XRCC1/ERCC1/XRCC3/RNASEL,4
GO:0004177,MF,GO:0004177,aminopeptidase activity,2/271,40/18522,0.05,3.417343173,1.864950676,0.11590721,0.281621937,0.194526157,NPEPPS/MMP14,2
GO:0140662,MF,GO:0140662,ATP-dependent protein folding chaperone,2/271,40/18522,0.05,3.417343173,1.864950676,0.11590721,0.281621937,0.194526157,HSPA5/HSP90AA1,2
GO:0030414,MF,GO:0030414,peptidase inhibitor activity,5/271,176/18522,0.028409091,1.941672258,1.529533326,0.116649118,0.282290865,0.19498821,TIMP1/THBS1/A2M/SERPINE1/ROCK1,5
GO:0001727,MF,GO:0001727,lipid kinase activity,2/271,41/18522,0.048780488,3.33399334,1.823065767,0.12072631,0.289838958,0.200201942,PIK3CA/SPHK1,2
GO:0042056,MF,GO:0042056,chemoattractant activity,2/271,41/18522,0.048780488,3.33399334,1.823065767,0.12072631,0.289838958,0.200201942,VEGFA/FGF2,2
GO:0046915,MF,GO:0046915,transition metal ion transmembrane transporter activity,2/271,42/18522,0.047619048,3.254612546,1.782457198,0.125593989,0.300333452,0.207450857,SLC39A9/SLC39A11,2
GO:0004197,MF,GO:0004197,cysteine-type endopeptidase activity,3/271,85/18522,0.035294118,2.41224224,1.590182834,0.128466274,0.302669426,0.209064397,CASP8/CASP3/CTSB,3
GO:0016712,MF,GO:0016712,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen",2/271,43/18522,0.046511628,3.178923882,1.743052961,0.130507808,0.302669426,0.209064397,CYP1A1/CYP19A1,2
GO:0044325,MF,GO:0044325,transmembrane transporter binding,4/271,133/18522,0.030075188,2.055544766,1.488664903,0.131211061,0.302669426,0.209064397,CTNNB1/CAV1/HSP90AA1/LRRC26,4
GO:0000182,MF,GO:0000182,rDNA binding,1/271,10/18522,0.1,6.834686347,2.248870113,0.137076732,0.302669426,0.209064397,MTOR,1
GO:0004955,MF,GO:0004955,prostaglandin receptor activity,1/271,10/18522,0.1,6.834686347,2.248870113,0.137076732,0.302669426,0.209064397,PPARG,1
GO:0008190,MF,GO:0008190,eukaryotic initiation factor 4E binding,1/271,10/18522,0.1,6.834686347,2.248870113,0.137076732,0.302669426,0.209064397,HHEX,1
GO:0008330,MF,GO:0008330,protein tyrosine/threonine phosphatase activity,1/271,10/18522,0.1,6.834686347,2.248870113,0.137076732,0.302669426,0.209064397,DUSP6,1
GO:0016303,MF,GO:0016303,1-phosphatidylinositol-3-kinase activity,1/271,10/18522,0.1,6.834686347,2.248870113,0.137076732,0.302669426,0.209064397,PIK3CA,1
GO:0016801,MF,GO:0016801,"hydrolase activity, acting on ether bonds",1/271,10/18522,0.1,6.834686347,2.248870113,0.137076732,0.302669426,0.209064397,ALOX12,1
GO:0016803,MF,GO:0016803,ether hydrolase activity,1/271,10/18522,0.1,6.834686347,2.248870113,0.137076732,0.302669426,0.209064397,ALOX12,1
GO:0016889,MF,GO:0016889,"DNA endonuclease activity, producing 3'-phosphomonoesters",1/271,10/18522,0.1,6.834686347,2.248870113,0.137076732,0.302669426,0.209064397,XRCC3,1
GO:0019203,MF,GO:0019203,carbohydrate phosphatase activity,1/271,10/18522,0.1,6.834686347,2.248870113,0.137076732,0.302669426,0.209064397,FBP1,1
GO:0030957,MF,GO:0030957,Tat protein binding,1/271,10/18522,0.1,6.834686347,2.248870113,0.137076732,0.302669426,0.209064397,SMARCA4,1
GO:0033550,MF,GO:0033550,MAP kinase tyrosine phosphatase activity,1/271,10/18522,0.1,6.834686347,2.248870113,0.137076732,0.302669426,0.209064397,DUSP6,1
GO:0034594,MF,GO:0034594,phosphatidylinositol trisphosphate phosphatase activity,1/271,10/18522,0.1,6.834686347,2.248870113,0.137076732,0.302669426,0.209064397,PTEN,1
GO:0036312,MF,GO:0036312,phosphatidylinositol 3-kinase regulatory subunit binding,1/271,10/18522,0.1,6.834686347,2.248870113,0.137076732,0.302669426,0.209064397,DAB2IP,1
GO:0043121,MF,GO:0043121,neurotrophin binding,1/271,10/18522,0.1,6.834686347,2.248870113,0.137076732,0.302669426,0.209064397,A2M,1
GO:0050308,MF,GO:0050308,sugar-phosphatase activity,1/271,10/18522,0.1,6.834686347,2.248870113,0.137076732,0.302669426,0.209064397,FBP1,1
GO:0051864,MF,GO:0051864,histone H3K36 demethylase activity,1/271,10/18522,0.1,6.834686347,2.248870113,0.137076732,0.302669426,0.209064397,KDM4B,1
GO:0051880,MF,GO:0051880,G-quadruplex DNA binding,1/271,10/18522,0.1,6.834686347,2.248870113,0.137076732,0.302669426,0.209064397,CNBP,1
GO:0099122,MF,GO:0099122,RNA polymerase II C-terminal domain binding,1/271,10/18522,0.1,6.834686347,2.248870113,0.137076732,0.302669426,0.209064397,BRD4,1
GO:0061135,MF,GO:0061135,endopeptidase regulator activity,5/271,186/18522,0.02688172,1.837281276,1.39845688,0.137887833,0.303353233,0.209536726,TIMP1/THBS1/A2M/SERPINE1/ROCK1,5
GO:0004715,MF,GO:0004715,non-membrane spanning protein tyrosine kinase activity,2/271,45/18522,0.044444444,3.037638376,1.66759724,0.140464413,0.307902065,0.212678764,PRKCD/PTK2,2
GO:0004954,MF,GO:0004954,prostanoid receptor activity,1/271,11/18522,0.090909091,6.213351224,2.107521022,0.149709197,0.31232436,0.215733399,PPARG,1
GO:0019911,MF,GO:0019911,structural constituent of myelin sheath,1/271,11/18522,0.090909091,6.213351224,2.107521022,0.149709197,0.31232436,0.215733399,MAL,1
GO:0031731,MF,GO:0031731,CCR6 chemokine receptor binding,1/271,11/18522,0.090909091,6.213351224,2.107521022,0.149709197,0.31232436,0.215733399,DEFB1,1
GO:0034713,MF,GO:0034713,type I transforming growth factor beta receptor binding,1/271,11/18522,0.090909091,6.213351224,2.107521022,0.149709197,0.31232436,0.215733399,TGFB1,1
GO:0042975,MF,GO:0042975,peroxisome proliferator activated receptor binding,1/271,11/18522,0.090909091,6.213351224,2.107521022,0.149709197,0.31232436,0.215733399,MED1,1
GO:0043522,MF,GO:0043522,leucine zipper domain binding,1/271,11/18522,0.090909091,6.213351224,2.107521022,0.149709197,0.31232436,0.215733399,PAWR,1
GO:0043995,MF,GO:0043995,histone H4K5 acetyltransferase activity,1/271,11/18522,0.090909091,6.213351224,2.107521022,0.149709197,0.31232436,0.215733399,MEAF6,1
GO:0043996,MF,GO:0043996,histone H4K8 acetyltransferase activity,1/271,11/18522,0.090909091,6.213351224,2.107521022,0.149709197,0.31232436,0.215733399,MEAF6,1
GO:0048185,MF,GO:0048185,activin binding,1/271,11/18522,0.090909091,6.213351224,2.107521022,0.149709197,0.31232436,0.215733399,TGFBR1,1
GO:0050998,MF,GO:0050998,nitric-oxide synthase binding,1/271,11/18522,0.090909091,6.213351224,2.107521022,0.149709197,0.31232436,0.215733399,CAV1,1
GO:0070513,MF,GO:0070513,death domain binding,1/271,11/18522,0.090909091,6.213351224,2.107521022,0.149709197,0.31232436,0.215733399,BAX,1
GO:0140666,MF,GO:0140666,annealing activity,1/271,11/18522,0.090909091,6.213351224,2.107521022,0.149709197,0.31232436,0.215733399,TP53,1
GO:0140996,MF,GO:0140996,histone H3 kinase activity,1/271,11/18522,0.090909091,6.213351224,2.107521022,0.149709197,0.31232436,0.215733399,AURKA,1
GO:1901612,MF,GO:1901612,cardiolipin binding,1/271,11/18522,0.090909091,6.213351224,2.107521022,0.149709197,0.31232436,0.215733399,MME,1
GO:0001784,MF,GO:0001784,phosphotyrosine residue binding,2/271,47/18522,0.042553191,2.908377169,1.596226242,0.150577799,0.313056937,0.216239415,MAPK1/IRS1,2
GO:0020037,MF,GO:0020037,heme binding,4/271,142/18522,0.028169014,1.92526376,1.348684914,0.155192321,0.321545734,0.222102926,PTGS2/CYP1A1/CYP17A1/CYP19A1,4
GO:0031406,MF,GO:0031406,carboxylic acid binding,5/271,196/18522,0.025510204,1.743542435,1.275185844,0.160696238,0.321656496,0.222179432,VDR/PPARG/GSTP1/AKR1C3/RBP1,5
GO:0016860,MF,GO:0016860,intramolecular oxidoreductase activity,2/271,49/18522,0.040816327,2.789667897,1.528534697,0.160830552,0.321656496,0.222179432,HSD3B1/HSD3B2,2
GO:0004032,MF,GO:0004032,alditol:NADP+ 1-oxidoreductase activity,1/271,12/18522,0.083333333,5.695571956,1.982665468,0.162157407,0.321656496,0.222179432,AKR1C3,1
GO:0016668,MF,GO:0016668,"oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor",1/271,12/18522,0.083333333,5.695571956,1.982665468,0.162157407,0.321656496,0.222179432,TXN,1
GO:0032794,MF,GO:0032794,GTPase activating protein binding,1/271,12/18522,0.083333333,5.695571956,1.982665468,0.162157407,0.321656496,0.222179432,CDH1,1
GO:0033130,MF,GO:0033130,acetylcholine receptor binding,1/271,12/18522,0.083333333,5.695571956,1.982665468,0.162157407,0.321656496,0.222179432,PSCA,1
GO:0035259,MF,GO:0035259,nuclear glucocorticoid receptor binding,1/271,12/18522,0.083333333,5.695571956,1.982665468,0.162157407,0.321656496,0.222179432,SMAD3,1
GO:0042301,MF,GO:0042301,phosphate ion binding,1/271,12/18522,0.083333333,5.695571956,1.982665468,0.162157407,0.321656496,0.222179432,RELA,1
GO:0043997,MF,GO:0043997,histone H4K12 acetyltransferase activity,1/271,12/18522,0.083333333,5.695571956,1.982665468,0.162157407,0.321656496,0.222179432,MEAF6,1
GO:0045295,MF,GO:0045295,gamma-catenin binding,1/271,12/18522,0.083333333,5.695571956,1.982665468,0.162157407,0.321656496,0.222179432,CDH1,1
GO:0070410,MF,GO:0070410,co-SMAD binding,1/271,12/18522,0.083333333,5.695571956,1.982665468,0.162157407,0.321656496,0.222179432,SMAD3,1
GO:0097677,MF,GO:0097677,STAT family protein binding,1/271,12/18522,0.083333333,5.695571956,1.982665468,0.162157407,0.321656496,0.222179432,PPARG,1
GO:0140713,MF,GO:0140713,histone chaperone activity,1/271,12/18522,0.083333333,5.695571956,1.982665468,0.162157407,0.321656496,0.222179432,MYD88,1
GO:0048020,MF,GO:0048020,CCR chemokine receptor binding,2/271,50/18522,0.04,2.733874539,1.495957447,0.166003987,0.328210498,0.226706512,DEFB1/STAT1,2
GO:0016830,MF,GO:0016830,carbon-carbon lyase activity,2/271,51/18522,0.039215686,2.680269156,1.464172575,0.171206127,0.332891303,0.229939708,SGPL1/CYP17A1,2
GO:0030544,MF,GO:0030544,Hsp70 protein binding,2/271,51/18522,0.039215686,2.680269156,1.464172575,0.171206127,0.332891303,0.229939708,CYP1A1/BAX,2
GO:0004725,MF,GO:0004725,protein tyrosine phosphatase activity,3/271,98/18522,0.030612245,2.092250923,1.321043213,0.173331868,0.332891303,0.229939708,PTEN/DUSP6/PTK2,3
GO:0004438,MF,GO:0004438,phosphatidylinositol-3-phosphate phosphatase activity,1/271,13/18522,0.076923077,5.257451036,1.871127532,0.174424038,0.332891303,0.229939708,PTEN,1
GO:0005024,MF,GO:0005024,transforming growth factor beta receptor activity,1/271,13/18522,0.076923077,5.257451036,1.871127532,0.174424038,0.332891303,0.229939708,TGFBR1,1
GO:0017017,MF,GO:0017017,MAP kinase tyrosine/serine/threonine phosphatase activity,1/271,13/18522,0.076923077,5.257451036,1.871127532,0.174424038,0.332891303,0.229939708,DUSP6,1
GO:0019104,MF,GO:0019104,DNA N-glycosylase activity,1/271,13/18522,0.076923077,5.257451036,1.871127532,0.174424038,0.332891303,0.229939708,PCNA,1
GO:0031994,MF,GO:0031994,insulin-like growth factor I binding,1/271,13/18522,0.076923077,5.257451036,1.871127532,0.174424038,0.332891303,0.229939708,IGF1R,1
GO:0035325,MF,GO:0035325,Toll-like receptor binding,1/271,13/18522,0.076923077,5.257451036,1.871127532,0.174424038,0.332891303,0.229939708,MYD88,1
GO:0052650,MF,GO:0052650,NADP-retinol dehydrogenase activity,1/271,13/18522,0.076923077,5.257451036,1.871127532,0.174424038,0.332891303,0.229939708,AKR1C3,1
GO:0071837,MF,GO:0071837,HMG box domain binding,1/271,13/18522,0.076923077,5.257451036,1.871127532,0.174424038,0.332891303,0.229939708,GATA3,1
GO:0051020,MF,GO:0051020,GTPase binding,7/271,313/18522,0.022364217,1.528524103,1.149125461,0.176277444,0.334618168,0.231132515,YBX1/RILP/CAV1/GIT1/BNIP3/HSP90AA1/ROCK1,7
GO:0005080,MF,GO:0005080,protein kinase C binding,2/271,52/18522,0.038461538,2.628725518,1.433143418,0.176435034,0.334618168,0.231132515,SQSTM1/IRS1,2
GO:0019842,MF,GO:0019842,vitamin binding,4/271,150/18522,0.026666667,1.822583026,1.2325958,0.177772392,0.336100929,0.232156709,VDR/FASN/SGPL1/RBP1,4
GO:0008238,MF,GO:0008238,exopeptidase activity,3/271,100/18522,0.03,2.050405904,1.283400765,0.180592968,0.340369924,0.235105454,NPEPPS/MMP14/MME,3
GO:0005516,MF,GO:0005516,calmodulin binding,5/271,205/18522,0.024390244,1.66699667,1.170164591,0.182434902,0.342773652,0.236765793,AKT1/EGFR/SPHK1/ESR1/CAMKK2,5
GO:0046906,MF,GO:0046906,tetrapyrrole binding,4/271,152/18522,0.026315789,1.79860167,1.204677943,0.183584263,0.343865261,0.237519806,PTGS2/CYP1A1/CYP17A1/CYP19A1,4
GO:0072341,MF,GO:0072341,modified amino acid binding,3/271,101/18522,0.02970297,2.030104856,1.264908318,0.184254221,0.34405495,0.237650831,THBS1/FASN/MME,3
GO:0005161,MF,GO:0005161,platelet-derived growth factor receptor binding,1/271,14/18522,0.071428571,4.881918819,1.770533915,0.18651173,0.345075219,0.238355566,VEGFA,1
GO:0044548,MF,GO:0044548,S100 protein binding,1/271,14/18522,0.071428571,4.881918819,1.770533915,0.18651173,0.345075219,0.238355566,S100A6,1
GO:0052744,MF,GO:0052744,phosphatidylinositol monophosphate phosphatase activity,1/271,14/18522,0.071428571,4.881918819,1.770533915,0.18651173,0.345075219,0.238355566,PTEN,1
GO:0043177,MF,GO:0043177,organic acid binding,5/271,208/18522,0.024038462,1.642953449,1.1363003,0.18991354,0.350297841,0.241963015,VDR/PPARG/GSTP1/AKR1C3/RBP1,5
GO:1990756,MF,GO:1990756,ubiquitin ligase-substrate adaptor activity,2/271,55/18522,0.036363636,2.48534049,1.344258276,0.192263729,0.353554881,0.244212767,FBXW7/VHL,2
GO:0004518,MF,GO:0004518,nuclease activity,5/271,211/18522,0.023696682,1.619593921,1.102975519,0.197500365,0.357279658,0.246785601,XRCC1/ERCC1/XRCC3/RNASEL/REXO2,5
GO:0004953,MF,GO:0004953,icosanoid receptor activity,1/271,15/18522,0.066666667,4.556457565,1.679069902,0.198423083,0.357279658,0.246785601,PPARG,1
GO:0005523,MF,GO:0005523,tropomyosin binding,1/271,15/18522,0.066666667,4.556457565,1.679069902,0.198423083,0.357279658,0.246785601,S100A6,1
GO:0015562,MF,GO:0015562,efflux transmembrane transporter activity,1/271,15/18522,0.066666667,4.556457565,1.679069902,0.198423083,0.357279658,0.246785601,SLC39A9,1
GO:0016208,MF,GO:0016208,AMP binding,1/271,15/18522,0.066666667,4.556457565,1.679069902,0.198423083,0.357279658,0.246785601,FBP1,1
GO:0042809,MF,GO:0042809,nuclear vitamin D receptor binding,1/271,15/18522,0.066666667,4.556457565,1.679069902,0.198423083,0.357279658,0.246785601,MED1,1
GO:1901611,MF,GO:1901611,phosphatidylglycerol binding,1/271,15/18522,0.066666667,4.556457565,1.679069902,0.198423083,0.357279658,0.246785601,MME,1
GO:0031593,MF,GO:0031593,polyubiquitin modification-dependent protein binding,2/271,57/18522,0.035087719,2.39813556,1.288206785,0.202916718,0.363277713,0.250928668,HDAC6/SQSTM1,2
GO:0004129,MF,GO:0004129,cytochrome-c oxidase activity,1/271,16/18522,0.0625,4.271678967,1.595320416,0.21016066,0.363277713,0.250928668,COX2,1
GO:0004697,MF,GO:0004697,diacylglycerol-dependent serine/threonine kinase activity,1/271,16/18522,0.0625,4.271678967,1.595320416,0.21016066,0.363277713,0.250928668,PRKCD,1
GO:0008142,MF,GO:0008142,oxysterol binding,1/271,16/18522,0.0625,4.271678967,1.595320416,0.21016066,0.363277713,0.250928668,CAV1,1
GO:0008191,MF,GO:0008191,metalloendopeptidase inhibitor activity,1/271,16/18522,0.0625,4.271678967,1.595320416,0.21016066,0.363277713,0.250928668,TIMP1,1
GO:0008296,MF,GO:0008296,3'-5'-DNA exonuclease activity,1/271,16/18522,0.0625,4.271678967,1.595320416,0.21016066,0.363277713,0.250928668,REXO2,1
GO:0019841,MF,GO:0019841,retinol binding,1/271,16/18522,0.0625,4.271678967,1.595320416,0.21016066,0.363277713,0.250928668,RBP1,1
GO:0030275,MF,GO:0030275,LRR domain binding,1/271,16/18522,0.0625,4.271678967,1.595320416,0.21016066,0.363277713,0.250928668,PAWR,1
GO:0031435,MF,GO:0031435,mitogen-activated protein kinase kinase kinase binding,1/271,16/18522,0.0625,4.271678967,1.595320416,0.21016066,0.363277713,0.250928668,DAB2IP,1
GO:0045125,MF,GO:0045125,bioactive lipid receptor activity,1/271,16/18522,0.0625,4.271678967,1.595320416,0.21016066,0.363277713,0.250928668,SPHK1,1
GO:0050135,MF,GO:0050135,NADP+ nucleosidase activity,1/271,16/18522,0.0625,4.271678967,1.595320416,0.21016066,0.363277713,0.250928668,TLR4,1
GO:0050664,MF,GO:0050664,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor",1/271,16/18522,0.0625,4.271678967,1.595320416,0.21016066,0.363277713,0.250928668,AIFM1,1
GO:0061575,MF,GO:0061575,cyclin-dependent protein serine/threonine kinase activator activity,1/271,16/18522,0.0625,4.271678967,1.595320416,0.21016066,0.363277713,0.250928668,CCND1,1
GO:0061809,MF,GO:0061809,"NAD+ nucleotidase, cyclic ADP-ribose generating",1/271,16/18522,0.0625,4.271678967,1.595320416,0.21016066,0.363277713,0.250928668,TLR4,1
GO:0043022,MF,GO:0043022,ribosome binding,3/271,110/18522,0.027272727,1.864005367,1.107479838,0.218013642,0.37159232,0.256671859,MTOR/HSPA5/PIM1,3
GO:0005068,MF,GO:0005068,transmembrane receptor protein tyrosine kinase adaptor activity,1/271,17/18522,0.058823529,4.020403733,1.518163141,0.221726988,0.37159232,0.256671859,IRS1,1
GO:0005132,MF,GO:0005132,type I interferon receptor binding,1/271,17/18522,0.058823529,4.020403733,1.518163141,0.221726988,0.37159232,0.256671859,IFNA1,1
GO:0016004,MF,GO:0016004,phospholipase activator activity,1/271,17/18522,0.058823529,4.020403733,1.518163141,0.221726988,0.37159232,0.256671859,CASP3,1
GO:0016675,MF,GO:0016675,"oxidoreductase activity, acting on a heme group of donors",1/271,17/18522,0.058823529,4.020403733,1.518163141,0.221726988,0.37159232,0.256671859,COX2,1
GO:0016854,MF,GO:0016854,racemase and epimerase activity,1/271,17/18522,0.058823529,4.020403733,1.518163141,0.221726988,0.37159232,0.256671859,AMACR,1
GO:0030169,MF,GO:0030169,low-density lipoprotein particle binding,1/271,17/18522,0.058823529,4.020403733,1.518163141,0.221726988,0.37159232,0.256671859,THBS1,1
GO:0036041,MF,GO:0036041,long-chain fatty acid binding,1/271,17/18522,0.058823529,4.020403733,1.518163141,0.221726988,0.37159232,0.256671859,PPARG,1
GO:0043024,MF,GO:0043024,ribosomal small subunit binding,1/271,17/18522,0.058823529,4.020403733,1.518163141,0.221726988,0.37159232,0.256671859,PIM1,1
GO:0070064,MF,GO:0070064,proline-rich region binding,1/271,17/18522,0.058823529,4.020403733,1.518163141,0.221726988,0.37159232,0.256671859,CCND1,1
GO:0140566,MF,GO:0140566,histone reader activity,1/271,17/18522,0.058823529,4.020403733,1.518163141,0.221726988,0.37159232,0.256671859,BRD4,1
GO:0016836,MF,GO:0016836,hydro-lyase activity,2/271,61/18522,0.032786885,2.240880769,1.182880546,0.224404066,0.375039944,0.259053254,FASN/CYP1A1,2
GO:0005201,MF,GO:0005201,extracellular matrix structural constituent,4/271,166/18522,0.024096386,1.646912373,1.020196915,0.225860995,0.376434992,0.260016862,THBS1/LAMB3/FN1/COL11A2,4
GO:0008301,MF,GO:0008301,"DNA binding, bending",1/271,18/18522,0.055555556,3.79704797,1.446694686,0.233124555,0.381190151,0.263301418,HHEX,1
GO:0008391,MF,GO:0008391,arachidonic acid monooxygenase activity,1/271,18/18522,0.055555556,3.79704797,1.446694686,0.233124555,0.381190151,0.263301418,CYP1A1,1
GO:0016894,MF,GO:0016894,"endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters",1/271,18/18522,0.055555556,3.79704797,1.446694686,0.233124555,0.381190151,0.263301418,XRCC3,1
GO:0033549,MF,GO:0033549,MAP kinase phosphatase activity,1/271,18/18522,0.055555556,3.79704797,1.446694686,0.233124555,0.381190151,0.263301418,DUSP6,1
GO:0052745,MF,GO:0052745,inositol phosphate phosphatase activity,1/271,18/18522,0.055555556,3.79704797,1.446694686,0.233124555,0.381190151,0.263301418,PTEN,1
GO:0098641,MF,GO:0098641,cadherin binding involved in cell-cell adhesion,1/271,18/18522,0.055555556,3.79704797,1.446694686,0.233124555,0.381190151,0.263301418,PKP3,1
GO:0140036,MF,GO:0140036,ubiquitin-dependent protein binding,1/271,18/18522,0.055555556,3.79704797,1.446694686,0.233124555,0.381190151,0.263301418,SQSTM1,1
GO:0050840,MF,GO:0050840,extracellular matrix binding,2/271,64/18522,0.03125,2.135839483,1.109144567,0.240629972,0.392401976,0.271045819,THBS1/VEGFA,2
GO:0004303,MF,GO:0004303,estradiol 17-beta-dehydrogenase [NAD(P)] activity,1/271,19/18522,0.052631579,3.59720334,1.38017834,0.244355816,0.393178906,0.271582472,AKR1C3,1
GO:0004675,MF,GO:0004675,transmembrane receptor protein serine/threonine kinase activity,1/271,19/18522,0.052631579,3.59720334,1.38017834,0.244355816,0.393178906,0.271582472,TGFBR1,1
GO:0005520,MF,GO:0005520,insulin-like growth factor binding,1/271,19/18522,0.052631579,3.59720334,1.38017834,0.244355816,0.393178906,0.271582472,IGF1R,1
GO:0016918,MF,GO:0016918,retinal binding,1/271,19/18522,0.052631579,3.59720334,1.38017834,0.244355816,0.393178906,0.271582472,RBP1,1
GO:0030506,MF,GO:0030506,ankyrin binding,1/271,19/18522,0.052631579,3.59720334,1.38017834,0.244355816,0.393178906,0.271582472,CDH1,1
GO:0030145,MF,GO:0030145,manganese ion binding,2/271,65/18522,0.030769231,2.102980414,1.085469067,0.246052006,0.394857993,0.272742276,SOD2/PIM1,2
GO:0008235,MF,GO:0008235,metalloexopeptidase activity,2/271,66/18522,0.03030303,2.071117075,1.06221798,0.2514785,0.402498658,0.278019952,NPEPPS/MMP14,2
GO:0004745,MF,GO:0004745,NAD-retinol dehydrogenase activity,1/271,20/18522,0.05,3.417343173,1.318006332,0.255423187,0.40347527,0.278694532,AKR1C3,1
GO:0042288,MF,GO:0042288,MHC class I protein binding,1/271,20/18522,0.05,3.417343173,1.318006332,0.255423187,0.40347527,0.278694532,CD8A,1
GO:0051428,MF,GO:0051428,peptide hormone receptor binding,1/271,20/18522,0.05,3.417343173,1.318006332,0.255423187,0.40347527,0.278694532,UCN,1
GO:0140035,MF,GO:0140035,ubiquitination-like modification-dependent protein binding,1/271,20/18522,0.05,3.417343173,1.318006332,0.255423187,0.40347527,0.278694532,SQSTM1,1
GO:0140517,MF,GO:0140517,protein-RNA adaptor activity,1/271,20/18522,0.05,3.417343173,1.318006332,0.255423187,0.40347527,0.278694532,YBX1,1
GO:0140767,MF,GO:0140767,enzyme-substrate adaptor activity,2/271,67/18522,0.029850746,2.04020488,1.039376258,0.256908171,0.404764175,0.279584824,FBXW7/VHL,2
GO:0017124,MF,GO:0017124,SH3 domain binding,3/271,122/18522,0.024590164,1.680660577,0.919126167,0.264732857,0.413151479,0.285378229,GPX1/DAB2IP/CCDC6,3
GO:0051082,MF,GO:0051082,unfolded protein binding,3/271,122/18522,0.024590164,1.680660577,0.919126167,0.264732857,0.413151479,0.285378229,HSPA5/HSP90AA1/CLU,3
GO:0004407,MF,GO:0004407,histone deacetylase activity,1/271,21/18522,0.047619048,3.254612546,1.259672052,0.266329053,0.413151479,0.285378229,HDAC6,1
GO:0008656,MF,GO:0008656,cysteine-type endopeptidase activator activity involved in apoptotic process,1/271,21/18522,0.047619048,3.254612546,1.259672052,0.266329053,0.413151479,0.285378229,NKX3-1,1
GO:0060229,MF,GO:0060229,lipase activator activity,1/271,21/18522,0.047619048,3.254612546,1.259672052,0.266329053,0.413151479,0.285378229,CASP3,1
GO:1990381,MF,GO:1990381,ubiquitin-specific protease binding,1/271,21/18522,0.047619048,3.254612546,1.259672052,0.266329053,0.413151479,0.285378229,PTEN,1
GO:0001786,MF,GO:0001786,phosphatidylserine binding,2/271,69/18522,0.028985507,1.981068506,0.994864463,0.267772075,0.413270677,0.285460563,THBS1/MME,2
GO:0044183,MF,GO:0044183,protein folding chaperone,2/271,69/18522,0.028985507,1.981068506,0.994864463,0.267772075,0.413270677,0.285460563,HSPA5/HSP90AA1,2
GO:0033558,MF,GO:0033558,protein lysine deacetylase activity,1/271,22/18522,0.045454545,3.106675612,1.204749272,0.27707576,0.42438186,0.293135447,HDAC6,1
GO:0050321,MF,GO:0050321,tau-protein kinase activity,1/271,22/18522,0.045454545,3.106675612,1.204749272,0.27707576,0.42438186,0.293135447,ROCK1,1
GO:0050699,MF,GO:0050699,WW domain binding,1/271,22/18522,0.045454545,3.106675612,1.204749272,0.27707576,0.42438186,0.293135447,TP63,1
GO:0005179,MF,GO:0005179,hormone activity,3/271,126/18522,0.023809524,1.627306273,0.860947623,0.280587534,0.428675399,0.296101146,IGF1/UCN/IGF2,3
GO:0008234,MF,GO:0008234,cysteine-type peptidase activity,4/271,184/18522,0.02173913,1.48580138,0.806984513,0.283312151,0.431747736,0.298223317,CASP8/CASP3/BAP1/CTSB,4
GO:0003950,MF,GO:0003950,NAD+ ADP-ribosyltransferase activity,1/271,23/18522,0.043478261,2.97160276,1.15287637,0.287665623,0.431855339,0.298297642,PARP1,1
GO:0005212,MF,GO:0005212,structural constituent of eye lens,1/271,23/18522,0.043478261,2.97160276,1.15287637,0.287665623,0.431855339,0.298297642,VIM,1
GO:0008106,MF,GO:0008106,alcohol dehydrogenase (NADP+) activity,1/271,23/18522,0.043478261,2.97160276,1.15287637,0.287665623,0.431855339,0.298297642,AKR1C3,1
GO:0016493,MF,GO:0016493,C-C chemokine receptor activity,1/271,23/18522,0.043478261,2.97160276,1.15287637,0.287665623,0.431855339,0.298297642,CXCR2,1
GO:0035255,MF,GO:0035255,ionotropic glutamate receptor binding,1/271,23/18522,0.043478261,2.97160276,1.15287637,0.287665623,0.431855339,0.298297642,SQSTM1,1
GO:1990404,MF,GO:1990404,NAD+-protein ADP-ribosyltransferase activity,1/271,23/18522,0.043478261,2.97160276,1.15287637,0.287665623,0.431855339,0.298297642,PARP1,1
GO:0042379,MF,GO:0042379,chemokine receptor binding,2/271,74/18522,0.027027027,1.847212526,0.88983014,0.294904194,0.440535895,0.304293607,DEFB1/STAT1,2
GO:0048029,MF,GO:0048029,monosaccharide binding,2/271,74/18522,0.027027027,1.847212526,0.88983014,0.294904194,0.440535895,0.304293607,BSG/FBP1,2
GO:0008093,MF,GO:0008093,cytoskeletal anchor activity,1/271,24/18522,0.041666667,2.847785978,1.103744187,0.298100923,0.442036908,0.305330409,EPB41L3,1
GO:0019957,MF,GO:0019957,C-C chemokine binding,1/271,24/18522,0.041666667,2.847785978,1.103744187,0.298100923,0.442036908,0.305330409,CXCR2,1
GO:0050750,MF,GO:0050750,low-density lipoprotein particle receptor binding,1/271,24/18522,0.041666667,2.847785978,1.103744187,0.298100923,0.442036908,0.305330409,CLU,1
GO:0017022,MF,GO:0017022,myosin binding,2/271,75/18522,0.026666667,1.822583026,0.869803258,0.300317176,0.443150955,0.306099921,RHOA/LMTK2,2
GO:0019003,MF,GO:0019003,GDP binding,2/271,75/18522,0.026666667,1.822583026,0.869803258,0.300317176,0.443150955,0.306099921,KRAS/HRAS,2
GO:0005537,MF,GO:0005537,mannose binding,1/271,25/18522,0.04,2.733874539,1.057086567,0.308383907,0.449571721,0.310534968,BSG,1
GO:0008139,MF,GO:0008139,nuclear localization sequence binding,1/271,25/18522,0.04,2.733874539,1.057086567,0.308383907,0.449571721,0.310534968,NFKBIA,1
GO:0015645,MF,GO:0015645,fatty acid ligase activity,1/271,25/18522,0.04,2.733874539,1.057086567,0.308383907,0.449571721,0.310534968,ACSS3,1
GO:0016895,MF,GO:0016895,"DNA exonuclease activity, producing 5'-phosphomonoesters",1/271,25/18522,0.04,2.733874539,1.057086567,0.308383907,0.449571721,0.310534968,REXO2,1
GO:0070530,MF,GO:0070530,K63-linked polyubiquitin modification-dependent protein binding,1/271,25/18522,0.04,2.733874539,1.057086567,0.308383907,0.449571721,0.310534968,SQSTM1,1
GO:0016810,MF,GO:0016810,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds",3/271,134/18522,0.02238806,1.53015366,0.750516845,0.312518521,0.454487403,0.313930403,KLK3/HDAC6/FHIT,3
GO:0016835,MF,GO:0016835,carbon-oxygen lyase activity,2/271,78/18522,0.025641026,1.752483679,0.811503426,0.316511218,0.454487403,0.313930403,FASN/CYP1A1,2
GO:0001637,MF,GO:0001637,G protein-coupled chemoattractant receptor activity,1/271,26/18522,0.038461538,2.628725518,1.012672916,0.318516792,0.454487403,0.313930403,CXCR2,1
GO:0004190,MF,GO:0004190,aspartic-type endopeptidase activity,1/271,26/18522,0.038461538,2.628725518,1.012672916,0.318516792,0.454487403,0.313930403,CASP3,1
GO:0004529,MF,GO:0004529,DNA exonuclease activity,1/271,26/18522,0.038461538,2.628725518,1.012672916,0.318516792,0.454487403,0.313930403,REXO2,1
GO:0004950,MF,GO:0004950,chemokine receptor activity,1/271,26/18522,0.038461538,2.628725518,1.012672916,0.318516792,0.454487403,0.313930403,CXCR2,1
GO:0034593,MF,GO:0034593,phosphatidylinositol bisphosphate phosphatase activity,1/271,26/18522,0.038461538,2.628725518,1.012672916,0.318516792,0.454487403,0.313930403,PTEN,1
GO:0052742,MF,GO:0052742,phosphatidylinositol kinase activity,1/271,26/18522,0.038461538,2.628725518,1.012672916,0.318516792,0.454487403,0.313930403,PIK3CA,1
GO:0140463,MF,GO:0140463,chromatin-protein adaptor activity,1/271,26/18522,0.038461538,2.628725518,1.012672916,0.318516792,0.454487403,0.313930403,BRD4,1
GO:0001618,MF,GO:0001618,virus receptor activity,2/271,79/18522,0.025316456,1.730300341,0.792634177,0.321891174,0.457145917,0.315766732,BSG/EGFR,2
GO:0048306,MF,GO:0048306,calcium-dependent protein binding,2/271,79/18522,0.025316456,1.730300341,0.792634177,0.321891174,0.457145917,0.315766732,S100A6/A2M,2
GO:0140272,MF,GO:0140272,exogenous protein binding,2/271,80/18522,0.025,1.708671587,0.774033102,0.32726063,0.460054546,0.317775824,BSG/EGFR,2
GO:0004364,MF,GO:0004364,glutathione transferase activity,1/271,27/18522,0.037037037,2.531365314,0.970302273,0.328501759,0.460054546,0.317775824,GSTP1,1
GO:0004683,MF,GO:0004683,calmodulin-dependent protein kinase activity,1/271,27/18522,0.037037037,2.531365314,0.970302273,0.328501759,0.460054546,0.317775824,CAMKK2,1
GO:0016405,MF,GO:0016405,CoA-ligase activity,1/271,27/18522,0.037037037,2.531365314,0.970302273,0.328501759,0.460054546,0.317775824,ACSS3,1
GO:0023026,MF,GO:0023026,MHC class II protein complex binding,1/271,27/18522,0.037037037,2.531365314,0.970302273,0.328501759,0.460054546,0.317775824,HSP90AA1,1
GO:0070001,MF,GO:0070001,aspartic-type peptidase activity,1/271,27/18522,0.037037037,2.531365314,0.970302273,0.328501759,0.460054546,0.317775824,CASP3,1
GO:0016829,MF,GO:0016829,lyase activity,4/271,198/18522,0.02020202,1.380744717,0.656341504,0.32938326,0.460223724,0.317892681,FASN/CYP1A1/SGPL1/CYP17A1,4
GO:0099106,MF,GO:0099106,ion channel regulator activity,3/271,140/18522,0.021428571,1.464575646,0.672353399,0.336540454,0.467343107,0.322810288,AKT1/CAV1/LRRC26,3
GO:0051019,MF,GO:0051019,mitogen-activated protein kinase binding,1/271,28/18522,0.035714286,2.44095941,0.929798551,0.33834096,0.467343107,0.322810288,MAPK14,1
GO:0051393,MF,GO:0051393,alpha-actinin binding,1/271,28/18522,0.035714286,2.44095941,0.929798551,0.33834096,0.467343107,0.322810288,PPARG,1
GO:0051959,MF,GO:0051959,dynein light intermediate chain binding,1/271,28/18522,0.035714286,2.44095941,0.929798551,0.33834096,0.467343107,0.322810288,RILP,1
GO:0070273,MF,GO:0070273,phosphatidylinositol-4-phosphate binding,1/271,28/18522,0.035714286,2.44095941,0.929798551,0.33834096,0.467343107,0.322810288,DAB2IP,1
GO:0017018,MF,GO:0017018,myosin phosphatase activity,2/271,83/18522,0.024096386,1.646912373,0.719762723,0.343297696,0.473109581,0.326793395,PTEN/DUSP6,2
GO:0001965,MF,GO:0001965,G-protein alpha-subunit binding,1/271,29/18522,0.034482759,2.356788395,0.891006687,0.348036515,0.474238945,0.327573486,IGF1R,1
GO:0043236,MF,GO:0043236,laminin binding,1/271,29/18522,0.034482759,2.356788395,0.891006687,0.348036515,0.474238945,0.327573486,THBS1,1
GO:0043325,MF,GO:0043325,"phosphatidylinositol-3,4-bisphosphate binding",1/271,29/18522,0.034482759,2.356788395,0.891006687,0.348036515,0.474238945,0.327573486,AKT1,1
GO:0070325,MF,GO:0070325,lipoprotein particle receptor binding,1/271,29/18522,0.034482759,2.356788395,0.891006687,0.348036515,0.474238945,0.327573486,CLU,1
GO:0070566,MF,GO:0070566,adenylyltransferase activity,1/271,29/18522,0.034482759,2.356788395,0.891006687,0.348036515,0.474238945,0.327573486,FHIT,1
GO:0001540,MF,GO:0001540,amyloid-beta binding,2/271,85/18522,0.023529412,1.608161493,0.684789011,0.353921821,0.479694592,0.331341893,TLR4/CLU,2
GO:0016247,MF,GO:0016247,channel regulator activity,3/271,145/18522,0.020689655,1.414073037,0.609954127,0.356530182,0.479694592,0.331341893,AKT1/CAV1/LRRC26,3
GO:0004033,MF,GO:0004033,aldo-keto reductase (NADP) activity,1/271,30/18522,0.033333333,2.278228782,0.853789494,0.357590514,0.479694592,0.331341893,AKR1C3,1
GO:0005184,MF,GO:0005184,neuropeptide hormone activity,1/271,30/18522,0.033333333,2.278228782,0.853789494,0.357590514,0.479694592,0.331341893,UCN,1
GO:0016417,MF,GO:0016417,S-acyltransferase activity,1/271,30/18522,0.033333333,2.278228782,0.853789494,0.357590514,0.479694592,0.331341893,FASN,1
GO:0052866,MF,GO:0052866,phosphatidylinositol phosphate phosphatase activity,1/271,30/18522,0.033333333,2.278228782,0.853789494,0.357590514,0.479694592,0.331341893,PTEN,1
GO:0160041,MF,GO:0160041,neuropeptide activity,1/271,30/18522,0.033333333,2.278228782,0.853789494,0.357590514,0.479694592,0.331341893,UCN,1
GO:0016651,MF,GO:0016651,"oxidoreductase activity, acting on NAD(P)H",2/271,86/18522,0.023255814,1.589461941,0.667644345,0.35921149,0.48080299,0.332107503,AIFM1/AKR1C3,2
GO:0141108,MF,GO:0141108,transporter regulator activity,3/271,146/18522,0.020547945,1.404387606,0.597753739,0.360520102,0.481489319,0.332581574,AKT1/CAV1/LRRC26,3
GO:0003727,MF,GO:0003727,single-stranded RNA binding,2/271,87/18522,0.022988506,1.571192264,0.650719619,0.364485301,0.484799203,0.334867827,CNBP/CBX8,2
GO:0016878,MF,GO:0016878,acid-thiol ligase activity,1/271,31/18522,0.032258065,2.204737531,0.818025075,0.367005016,0.484799203,0.334867827,ACSS3,1
GO:0048019,MF,GO:0048019,receptor antagonist activity,1/271,31/18522,0.032258065,2.204737531,0.818025075,0.367005016,0.484799203,0.334867827,ESR2,1
GO:0071813,MF,GO:0071813,lipoprotein particle binding,1/271,31/18522,0.032258065,2.204737531,0.818025075,0.367005016,0.484799203,0.334867827,THBS1,1
GO:0071814,MF,GO:0071814,protein-lipid complex binding,1/271,31/18522,0.032258065,2.204737531,0.818025075,0.367005016,0.484799203,0.334867827,THBS1,1
GO:0050660,MF,GO:0050660,flavin adenine dinucleotide binding,2/271,88/18522,0.022727273,1.553337806,0.634008992,0.369742586,0.487351339,0.336630677,KDM1A/AIFM1,2
GO:0031369,MF,GO:0031369,translation initiation factor binding,1/271,32/18522,0.03125,2.135839483,0.783604685,0.37628205,0.494892697,0.341839757,HHEX,1
GO:0043178,MF,GO:0043178,alcohol binding,2/271,90/18522,0.022222222,1.518819188,0.601207767,0.380205021,0.498967544,0.344654397,CAV1/RBP1,2
GO:0015035,MF,GO:0015035,protein-disulfide reductase activity,1/271,33/18522,0.03030303,2.071117075,0.750430937,0.385423617,0.50254588,0.34712608,TXN,1
GO:0042923,MF,GO:0042923,neuropeptide binding,1/271,33/18522,0.03030303,2.071117075,0.750430937,0.385423617,0.50254588,0.34712608,GRPR,1
GO:0051427,MF,GO:0051427,hormone receptor binding,1/271,33/18522,0.03030303,2.071117075,0.750430937,0.385423617,0.50254588,0.34712608,UCN,1
GO:0015020,MF,GO:0015020,glucuronosyltransferase activity,1/271,34/18522,0.029411765,2.010201867,0.718416317,0.394431687,0.512084057,0.353714433,UGT2B17,1
GO:0038187,MF,GO:0038187,pattern recognition receptor activity,1/271,34/18522,0.029411765,2.010201867,0.718416317,0.394431687,0.512084057,0.353714433,TLR4,1
GO:0005154,MF,GO:0005154,epidermal growth factor receptor binding,1/271,35/18522,0.028571429,1.952767528,0.687481914,0.403308202,0.522487071,0.36090016,TGFA,1
GO:0140104,MF,GO:0140104,molecular carrier activity,2/271,95/18522,0.021052632,1.438881336,0.522582817,0.406029431,0.524888474,0.362558894,MYD88/CLU,2
GO:0004896,MF,GO:0004896,cytokine receptor activity,2/271,96/18522,0.020833333,1.423892989,0.507399279,0.411133102,0.530352935,0.366333389,CXCR2/CD44,2
GO:0000175,MF,GO:0000175,3'-5'-RNA exonuclease activity,1/271,36/18522,0.027777778,1.898523985,0.657556355,0.412055077,0.530411322,0.366373719,REXO2,1
GO:0016853,MF,GO:0016853,isomerase activity,3/271,161/18522,0.01863354,1.27354404,0.424781465,0.419739531,0.536936476,0.370880872,AMACR/HSD3B1/HSD3B2,3
GO:0008200,MF,GO:0008200,ion channel inhibitor activity,1/271,37/18522,0.027027027,1.847212526,0.628574895,0.420674198,0.536936476,0.370880872,CAV1,1
GO:0019213,MF,GO:0019213,deacetylase activity,1/271,37/18522,0.027027027,1.847212526,0.628574895,0.420674198,0.536936476,0.370880872,HDAC6,1
GO:0030280,MF,GO:0030280,structural constituent of skin epidermis,1/271,37/18522,0.027027027,1.847212526,0.628574895,0.420674198,0.536936476,0.370880872,PKP1,1
GO:0001664,MF,GO:0001664,G protein-coupled receptor binding,5/271,291/18522,0.017182131,1.174344733,0.365278079,0.422112883,0.537638514,0.371365794,EDNRB/DEFB1/TAC1/STAT1/UCN,5
GO:0005501,MF,GO:0005501,retinoid binding,1/271,38/18522,0.026315789,1.79860167,0.600478637,0.429167424,0.540929775,0.373639183,RBP1,1
GO:0016248,MF,GO:0016248,channel inhibitor activity,1/271,38/18522,0.026315789,1.79860167,0.600478637,0.429167424,0.540929775,0.373639183,CAV1,1
GO:0019840,MF,GO:0019840,isoprenoid binding,1/271,38/18522,0.026315789,1.79860167,0.600478637,0.429167424,0.540929775,0.373639183,RBP1,1
GO:0043531,MF,GO:0043531,ADP binding,1/271,38/18522,0.026315789,1.79860167,0.600478637,0.429167424,0.540929775,0.373639183,MSH2,1
GO:0141110,MF,GO:0141110,transporter inhibitor activity,1/271,38/18522,0.026315789,1.79860167,0.600478637,0.429167424,0.540929775,0.373639183,CAV1,1
GO:0004867,MF,GO:0004867,serine-type endopeptidase inhibitor activity,2/271,101/18522,0.01980198,1.353403237,0.433958438,0.436318938,0.546920736,0.37777735,A2M/SERPINE1,2
GO:0001530,MF,GO:0001530,lipopolysaccharide binding,1/271,39/18522,0.025641026,1.752483679,0.573213863,0.437536588,0.546920736,0.37777735,TLR4,1
GO:0015036,MF,GO:0015036,disulfide oxidoreductase activity,1/271,39/18522,0.025641026,1.752483679,0.573213863,0.437536588,0.546920736,0.37777735,TXN,1
GO:0016620,MF,GO:0016620,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",1/271,39/18522,0.025641026,1.752483679,0.573213863,0.437536588,0.546920736,0.37777735,AKR1C3,1
GO:0005547,MF,GO:0005547,"phosphatidylinositol-3,4,5-trisphosphate binding",1/271,40/18522,0.025,1.708671587,0.546731457,0.445783496,0.551531728,0.380962324,AKT1,1
GO:0016896,MF,GO:0016896,"RNA exonuclease activity, producing 5'-phosphomonoesters",1/271,40/18522,0.025,1.708671587,0.546731457,0.445783496,0.551531728,0.380962324,REXO2,1
GO:0061650,MF,GO:0061650,ubiquitin-like protein conjugating enzyme activity,1/271,40/18522,0.025,1.708671587,0.546731457,0.445783496,0.551531728,0.380962324,UBE2M,1
GO:0071949,MF,GO:0071949,FAD binding,1/271,40/18522,0.025,1.708671587,0.546731457,0.445783496,0.551531728,0.380962324,AIFM1,1
GO:0140318,MF,GO:0140318,protein transporter activity,1/271,40/18522,0.025,1.708671587,0.546731457,0.445783496,0.551531728,0.380962324,IGF1R,1
GO:0003779,MF,GO:0003779,actin binding,7/271,434/18522,0.016129032,1.102368766,0.262960541,0.450766808,0.555896881,0.383977489,HDAC6/PTK2/FSCN1/EPB41L3/EGFR/PAWR/FRG1,7
GO:0004722,MF,GO:0004722,protein serine/threonine phosphatase activity,2/271,104/18522,0.019230769,1.314362759,0.391741927,0.451149369,0.555896881,0.383977489,PTEN/DUSP6,2
GO:0016877,MF,GO:0016877,"ligase activity, forming carbon-sulfur bonds",1/271,41/18522,0.024390244,1.66699667,0.520986403,0.453909925,0.557029421,0.384759774,ACSS3,1
GO:0048487,MF,GO:0048487,beta-tubulin binding,1/271,41/18522,0.024390244,1.66699667,0.520986403,0.453909925,0.557029421,0.384759774,HDAC6,1
GO:0004532,MF,GO:0004532,RNA exonuclease activity,1/271,42/18522,0.023809524,1.627306273,0.495937354,0.461917631,0.562294098,0.388396271,REXO2,1
GO:0042287,MF,GO:0042287,MHC protein binding,1/271,42/18522,0.023809524,1.627306273,0.495937354,0.461917631,0.562294098,0.388396271,CD8A,1
GO:0043028,MF,GO:0043028,cysteine-type endopeptidase regulator activity involved in apoptotic process,1/271,42/18522,0.023809524,1.627306273,0.495937354,0.461917631,0.562294098,0.388396271,NKX3-1,1
GO:0140938,MF,GO:0140938,histone H3 methyltransferase activity,1/271,42/18522,0.023809524,1.627306273,0.495937354,0.461917631,0.562294098,0.388396271,EZH2,1
GO:0008138,MF,GO:0008138,protein tyrosine/serine/threonine phosphatase activity,1/271,43/18522,0.023255814,1.589461941,0.471546248,0.469808341,0.567333426,0.391877112,DUSP6,1
GO:0016790,MF,GO:0016790,thiolester hydrolase activity,1/271,43/18522,0.023255814,1.589461941,0.471546248,0.469808341,0.567333426,0.391877112,FASN,1
GO:0030547,MF,GO:0030547,signaling receptor inhibitor activity,1/271,43/18522,0.023255814,1.589461941,0.471546248,0.469808341,0.567333426,0.391877112,ESR2,1
GO:0043014,MF,GO:0043014,alpha-tubulin binding,1/271,43/18522,0.023255814,1.589461941,0.471546248,0.469808341,0.567333426,0.391877112,HDAC6,1
GO:0003954,MF,GO:0003954,NADH dehydrogenase activity,1/271,44/18522,0.022727273,1.553337806,0.447777977,0.477583759,0.574429769,0.396778805,AIFM1,1
GO:0035254,MF,GO:0035254,glutamate receptor binding,1/271,44/18522,0.022727273,1.553337806,0.447777977,0.477583759,0.574429769,0.396778805,SQSTM1,1
GO:0004864,MF,GO:0004864,protein phosphatase inhibitor activity,1/271,45/18522,0.022222222,1.518819188,0.424600094,0.485245562,0.580184911,0.400754084,LMTK2,1
GO:0030020,MF,GO:0030020,extracellular matrix structural constituent conferring tensile strength,1/271,45/18522,0.022222222,1.518819188,0.424600094,0.485245562,0.580184911,0.400754084,COL11A2,1
GO:0032266,MF,GO:0032266,phosphatidylinositol-3-phosphate binding,1/271,45/18522,0.022222222,1.518819188,0.424600094,0.485245562,0.580184911,0.400754084,DAB2IP,1
GO:0004721,MF,GO:0004721,phosphoprotein phosphatase activity,3/271,180/18522,0.016666667,1.139114391,0.228538039,0.491900333,0.58698166,0.405448837,PTEN/DUSP6/PTK2,3
GO:0005048,MF,GO:0005048,signal sequence binding,1/271,47/18522,0.021276596,1.454188584,0.379897511,0.500234918,0.595752216,0.411506968,NFKBIA,1
GO:0008188,MF,GO:0008188,neuropeptide receptor activity,1/271,48/18522,0.020833333,1.423892989,0.358319061,0.507565708,0.600933959,0.41508618,GRPR,1
GO:0016903,MF,GO:0016903,"oxidoreductase activity, acting on the aldehyde or oxo group of donors",1/271,48/18522,0.020833333,1.423892989,0.358319061,0.507565708,0.600933959,0.41508618,AKR1C3,1
GO:0019212,MF,GO:0019212,phosphatase inhibitor activity,1/271,48/18522,0.020833333,1.423892989,0.358319061,0.507565708,0.600933959,0.41508618,LMTK2,1
GO:0009055,MF,GO:0009055,electron transfer activity,2/271,117/18522,0.017094017,1.168322452,0.222556662,0.512737342,0.605871273,0.418496556,COX2/CYP19A1,2
GO:0016763,MF,GO:0016763,pentosyltransferase activity,1/271,49/18522,0.020408163,1.394833948,0.337223119,0.514789357,0.605929107,0.418536504,PARP1,1
GO:0060590,MF,GO:0060590,ATPase regulator activity,1/271,49/18522,0.020408163,1.394833948,0.337223119,0.514789357,0.605929107,0.418536504,KATNB1,1
GO:0003730,MF,GO:0003730,mRNA 3'-UTR binding,4/271,259/18522,0.015444015,1.055550015,0.109703765,0.526684428,0.618726366,0.42737602,TP53/MIR200C/MIR145/MIR130B,4
GO:0030159,MF,GO:0030159,signaling receptor complex adaptor activity,1/271,51/18522,0.019607843,1.340134578,0.296390444,0.528921452,0.620150152,0.428359478,IRS1,1
GO:0098632,MF,GO:0098632,cell-cell adhesion mediator activity,1/271,52/18522,0.019230769,1.314362759,0.276613164,0.53583295,0.627038558,0.433117543,PKP3,1
GO:0004540,MF,GO:0004540,RNA nuclease activity,2/271,123/18522,0.016260163,1.111331113,0.150954313,0.539595576,0.630222632,0.435316894,RNASEL/REXO2,2
GO:0015485,MF,GO:0015485,cholesterol binding,1/271,53/18522,0.018867925,1.289563462,0.257237057,0.542643414,0.631344741,0.436091974,CAV1,1
GO:0051287,MF,GO:0051287,NAD binding,1/271,53/18522,0.018867925,1.289563462,0.257237057,0.542643414,0.631344741,0.436091974,PARP1,1
GO:0016667,MF,GO:0016667,"oxidoreductase activity, acting on a sulfur group of donors",1/271,54/18522,0.018518519,1.265682657,0.238244938,0.549354315,0.637925836,0.440637768,TXN,1
GO:0005096,MF,GO:0005096,GTPase activator activity,4/271,271/18522,0.014760148,1.008809793,0.017802481,0.562469612,0.650673693,0.44944316,DLC1/GIT1/DAB2IP/NPRL2,4
GO:0030170,MF,GO:0030170,pyridoxal phosphate binding,1/271,56/18522,0.017857143,1.220479705,0.201349124,0.562483209,0.650673693,0.44944316,SGPL1,1
GO:0016655,MF,GO:0016655,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor",1/271,57/18522,0.01754386,1.19906778,0.183416024,0.568904039,0.655594179,0.452841912,AKR1C3,1
GO:0070279,MF,GO:0070279,vitamin B6 binding,1/271,57/18522,0.01754386,1.19906778,0.183416024,0.568904039,0.655594179,0.452841912,SGPL1,1
GO:0016791,MF,GO:0016791,phosphatase activity,4/271,275/18522,0.014545455,0.994136196,-0.011937781,0.574068866,0.660288335,0.45608433,PTEN/DUSP6/PTK2/FBP1,4
GO:0016798,MF,GO:0016798,"hydrolase activity, acting on glycosyl bonds",2/271,133/18522,0.015037594,1.027772383,0.039168184,0.582046476,0.668193773,0.461544894,TLR4/PCNA,2
GO:0008408,MF,GO:0008408,3'-5' exonuclease activity,1/271,60/18522,0.016666667,1.139114391,0.131516984,0.587608659,0.670760828,0.463318049,REXO2,1
GO:0016706,MF,GO:0016706,2-oxoglutarate-dependent dioxygenase activity,1/271,60/18522,0.016666667,1.139114391,0.131516984,0.587608659,0.670760828,0.463318049,KDM4B,1
GO:0016765,MF,GO:0016765,"transferase activity, transferring alkyl or aryl (other than methyl) groups",1/271,60/18522,0.016666667,1.139114391,0.131516984,0.587608659,0.670760828,0.463318049,GSTP1,1
GO:0051015,MF,GO:0051015,actin filament binding,3/271,208/18522,0.014423077,0.985772069,-0.025145214,0.589431028,0.671573958,0.463879707,FSCN1/EGFR/FRG1,3
GO:0031267,MF,GO:0031267,small GTPase binding,4/271,281/18522,0.014234875,0.972909089,-0.055760413,0.591140671,0.672255839,0.464350705,RILP/CAV1/GIT1/ROCK1,4
GO:0016796,MF,GO:0016796,"exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters",1/271,62/18522,0.016129032,1.102368766,0.098383211,0.599626945,0.680627208,0.470133104,REXO2,1
GO:0016279,MF,GO:0016279,protein-lysine N-methyltransferase activity,1/271,64/18522,0.015625,1.067919742,0.066323467,0.611296238,0.692573453,0.478384795,EZH2,1
GO:0016278,MF,GO:0016278,lysine N-methyltransferase activity,1/271,65/18522,0.015384615,1.051490207,0.050672729,0.617003179,0.697732567,0.481948376,EZH2,1
GO:0042054,MF,GO:0042054,histone methyltransferase activity,1/271,66/18522,0.015151515,1.035558537,0.035263109,0.622626636,0.702778199,0.485433571,EZH2,1
GO:0019843,MF,GO:0019843,rRNA binding,1/271,67/18522,0.014925373,1.02010244,0.020086426,0.628167825,0.705086334,0.487027881,RNASEL,1
GO:0032934,MF,GO:0032934,sterol binding,1/271,67/18522,0.014925373,1.02010244,0.020086426,0.628167825,0.705086334,0.487027881,CAV1,1
GO:0098631,MF,GO:0098631,cell adhesion mediator activity,1/271,67/18522,0.014925373,1.02010244,0.020086426,0.628167825,0.705086334,0.487027881,PKP3,1
GO:1903231,MF,GO:1903231,mRNA base-pairing translational repressor activity,4/271,296/18522,0.013513514,0.923606263,-0.161447549,0.632016863,0.707278426,0.488542036,MIR25/MIR200C/MIR145/MIR130B,4
GO:0016779,MF,GO:0016779,nucleotidyltransferase activity,2/271,146/18522,0.01369863,0.936258404,-0.094220933,0.63283582,0.707278426,0.488542036,PARP1/FHIT,2
GO:0015453,MF,GO:0015453,oxidoreduction-driven active transmembrane transporter activity,1/271,68/18522,0.014705882,1.005100933,0.005134905,0.633627945,0.707278426,0.488542036,COX2,1
GO:0140375,MF,GO:0140375,immune receptor activity,2/271,151/18522,0.013245033,0.90525647,-0.14244433,0.651049874,0.72538706,0.501050305,CXCR2/CD44,2
GO:0005525,MF,GO:0005525,GTP binding,5/271,380/18522,0.013157895,0.899300835,-0.241684398,0.655970008,0.728377255,0.503115738,RHOA/KRAS/TUBA4B/HSP90AA1/HRAS,5
GO:0003725,MF,GO:0003725,double-stranded RNA binding,1/271,73/18522,0.01369863,0.936258404,-0.066492319,0.659753282,0.728377255,0.503115738,VIM,1
GO:0004521,MF,GO:0004521,RNA endonuclease activity,1/271,73/18522,0.01369863,0.936258404,-0.066492319,0.659753282,0.728377255,0.503115738,RNASEL,1
GO:0038024,MF,GO:0038024,cargo receptor activity,1/271,73/18522,0.01369863,0.936258404,-0.066492319,0.659753282,0.728377255,0.503115738,LYVE1,1
GO:0051540,MF,GO:0051540,metal cluster binding,1/271,73/18522,0.01369863,0.936258404,-0.066492319,0.659753282,0.728377255,0.503115738,GSTP1,1
GO:0004386,MF,GO:0004386,helicase activity,2/271,154/18522,0.012987013,0.887621603,-0.170641942,0.661630497,0.729015192,0.503556383,SMARCA4/SMARCA2,2
GO:0015631,MF,GO:0015631,tubulin binding,5/271,383/18522,0.01305483,0.892256703,-0.259630976,0.662741084,0.729015192,0.503556383,BRCA1/BRCA2/HDAC6/KATNB1/GIT1,5
GO:0035064,MF,GO:0035064,methylated histone binding,1/271,80/18522,0.0125,0.854335793,-0.159098967,0.69323949,0.761179477,0.525773384,CBX8,1
GO:0019001,MF,GO:0019001,guanyl nucleotide binding,5/271,401/18522,0.012468828,0.85220528,-0.364597388,0.701538456,0.766830958,0.52967706,RHOA/KRAS/TUBA4B/HSP90AA1/HRAS,5
GO:0032561,MF,GO:0032561,guanyl ribonucleotide binding,5/271,401/18522,0.012468828,0.85220528,-0.364597388,0.701538456,0.766830958,0.52967706,RHOA/KRAS/TUBA4B/HSP90AA1/HRAS,5
GO:0140034,MF,GO:0140034,methylation-dependent protein binding,1/271,82/18522,0.012195122,0.833498335,-0.184127466,0.70218901,0.766830958,0.52967706,CBX8,1
GO:0030371,MF,GO:0030371,translation repressor activity,4/271,327/18522,0.012232416,0.83604726,-0.364493724,0.707823128,0.771590977,0.532964972,MIR25/MIR200C/MIR145/MIR130B,4
GO:0030165,MF,GO:0030165,PDZ domain binding,1/271,85/18522,0.011764706,0.804080747,-0.220604812,0.715127851,0.778151709,0.5374967,PTEN,1
GO:0004527,MF,GO:0004527,exonuclease activity,1/271,86/18522,0.011627907,0.794730971,-0.23249458,0.719315102,0.780412244,0.539058131,REXO2,1
GO:0005244,MF,GO:0005244,voltage-gated monoatomic ion channel activity,2/271,172/18522,0.011627907,0.794730971,-0.329566566,0.719785178,0.780412244,0.539058131,TMEM37/LRRC26,2
GO:0022832,MF,GO:0022832,voltage-gated channel activity,2/271,173/18522,0.011560694,0.79013715,-0.337929376,0.722755927,0.782231369,0.540314665,TMEM37/LRRC26,2
GO:1901981,MF,GO:1901981,phosphatidylinositol phosphate binding,2/271,178/18522,0.011235955,0.767942286,-0.379081437,0.737214441,0.796454887,0.550139348,AKT1/DAB2IP,2
GO:0019888,MF,GO:0019888,protein phosphatase regulator activity,1/271,93/18522,0.010752688,0.73491251,-0.312286601,0.746958017,0.805542959,0.556416798,LMTK2,1
GO:0045182,MF,GO:0045182,translation regulator activity,5/271,432/18522,0.011574074,0.791051661,-0.535469875,0.760890707,0.818327611,0.565247606,CNBP/MIR25/MIR200C/MIR145/MIR130B,5
GO:0008276,MF,GO:0008276,protein methyltransferase activity,1/271,97/18522,0.010309278,0.70460684,-0.355431638,0.761518091,0.818327611,0.565247606,EZH2,1
GO:0005249,MF,GO:0005249,voltage-gated potassium channel activity,1/271,99/18522,0.01010101,0.690372358,-0.376400919,0.768482003,0.824346829,0.569405291,LRRC26,1
GO:0008170,MF,GO:0008170,N-methyltransferase activity,1/271,100/18522,0.01,0.683468635,-0.386742492,0.771887603,0.826534513,0.570916402,EZH2,1
GO:0042578,MF,GO:0042578,phosphoric ester hydrolase activity,4/271,363/18522,0.011019284,0.753133482,-0.578819387,0.780869901,0.834675424,0.576539614,PTEN/DUSP6/PTK2/FBP1,4
GO:0019208,MF,GO:0019208,phosphatase regulator activity,1/271,105/18522,0.00952381,0.650922509,-0.437099772,0.788181318,0.841004757,0.580911507,LMTK2,1
GO:0004842,MF,GO:0004842,ubiquitin-protein transferase activity,5/271,450/18522,0.011111111,0.759409594,-0.629585883,0.791058402,0.842588615,0.582005533,BRCA1/CUL3/VHL/MED1/UBE2M,5
GO:0004843,MF,GO:0004843,cysteine-type deubiquitinase activity,1/271,108/18522,0.009259259,0.632841328,-0.46629969,0.797395419,0.847845745,0.585636817,BAP1,1
GO:0005262,MF,GO:0005262,calcium channel activity,1/271,114/18522,0.00877193,0.59953389,-0.522622882,0.814642679,0.864664597,0.597254189,TMEM37,1
GO:0101005,MF,GO:0101005,deubiquitinase activity,1/271,115/18522,0.008695652,0.594320552,-0.531757899,0.817371483,0.866041589,0.598205325,BAP1,1
GO:0005267,MF,GO:0005267,potassium channel activity,1/271,122/18522,0.008196721,0.560220192,-0.59385418,0.835384528,0.882664274,0.609687198,LRRC26,1
GO:0019787,MF,GO:0019787,ubiquitin-like protein transferase activity,5/271,481/18522,0.01039501,0.710466356,-0.78399772,0.835977899,0.882664274,0.609687198,BRCA1/CUL3/VHL/MED1/UBE2M,5
GO:0019783,MF,GO:0019783,ubiquitin-like protein peptidase activity,1/271,127/18522,0.007874016,0.538164279,-0.636374859,0.847156402,0.892908752,0.616763418,BAP1,1
GO:0016755,MF,GO:0016755,aminoacyltransferase activity,5/271,498/18522,0.010040161,0.686213489,-0.864961708,0.857075636,0.901291752,0.622553851,BRCA1/CUL3/VHL/MED1/UBE2M,5
GO:0015085,MF,GO:0015085,calcium ion transmembrane transporter activity,1/271,132/18522,0.007575758,0.517779269,-0.677509684,0.858089338,0.901291752,0.622553851,TMEM37,1
GO:0016887,MF,GO:0016887,ATP hydrolysis activity,4/271,417/18522,0.009592326,0.655605405,-0.866759516,0.862498987,0.904353358,0.624668609,HSPA5/HSP90AA1/MLH1/MSH2,4
GO:0003924,MF,GO:0003924,GTPase activity,3/271,333/18522,0.009009009,0.615737509,-0.862222255,0.868423428,0.908989921,0.627871246,RHOA/KRAS/HRAS,3
GO:0015078,MF,GO:0015078,proton transmembrane transporter activity,1/271,143/18522,0.006993007,0.477950094,-0.763646966,0.879476136,0.91738459,0.633669739,COX2,1
GO:0022843,MF,GO:0022843,voltage-gated monoatomic cation channel activity,1/271,143/18522,0.006993007,0.477950094,-0.763646966,0.879476136,0.91738459,0.633669739,LRRC26,1
GO:0008194,MF,GO:0008194,UDP-glycosyltransferase activity,1/271,145/18522,0.006896552,0.471357679,-0.778721473,0.883004298,0.919479518,0.635116779,UGT2B17,1
GO:0046873,MF,GO:0046873,metal ion transmembrane transporter activity,4/271,437/18522,0.009153318,0.625600581,-0.965139648,0.885362099,0.920350636,0.63571849,SLC39A9/SLC39A11/TMEM37/LRRC26,4
GO:0015079,MF,GO:0015079,potassium ion transmembrane transporter activity,1/271,158/18522,0.006329114,0.432575085,-0.872824305,0.903558265,0.937654803,0.647671086,LRRC26,1
GO:0016757,MF,GO:0016757,glycosyltransferase activity,2/271,268/18522,0.007462687,0.51005122,-0.984492888,0.905768689,0.938339138,0.648143781,UGT2B17/PARP1,2
GO:0008757,MF,GO:0008757,S-adenosylmethionine-dependent methyltransferase activity,1/271,165/18522,0.006060606,0.414223415,-0.920972484,0.913091817,0.940254636,0.649466882,EZH2,1
GO:0015399,MF,GO:0015399,primary active transmembrane transporter activity,1/271,165/18522,0.006060606,0.414223415,-0.920972484,0.913091817,0.940254636,0.649466882,COX2,1
GO:0035091,MF,GO:0035091,phosphatidylinositol binding,2/271,276/18522,0.007246377,0.495267127,-1.029451346,0.914366753,0.940254636,0.649466882,AKT1/DAB2IP,2
GO:0016874,MF,GO:0016874,ligase activity,1/271,166/18522,0.006024096,0.411728093,-0.92771944,0.914374822,0.940254636,0.649466882,ACSS3,1
GO:0008017,MF,GO:0008017,microtubule binding,2/271,277/18522,0.007220217,0.493479159,-1.034996304,0.915388397,0.940254636,0.649466882,HDAC6/KATNB1,2
GO:0030246,MF,GO:0030246,carbohydrate binding,2/271,279/18522,0.007168459,0.489941674,-1.046037714,0.917397553,0.94072122,0.649789168,BSG/FBP1,2
GO:0003823,MF,GO:0003823,antigen binding,1/271,177/18522,0.005649718,0.386140472,-0.999931628,0.927301226,0.946520182,0.653794715,TGFB1,1
GO:0005543,MF,GO:0005543,phospholipid binding,4/271,487/18522,0.008213552,0.561370542,-1.195302235,0.928619282,0.946520182,0.653794715,THBS1/AKT1/DAB2IP/MME,4
GO:0030695,MF,GO:0030695,GTPase regulator activity,4/271,488/18522,0.008196721,0.560220192,-1.199700092,0.929310724,0.946520182,0.653794715,DLC1/GIT1/DAB2IP/NPRL2,4
GO:0060589,MF,GO:0060589,nucleoside-triphosphatase regulator activity,4/271,488/18522,0.008196721,0.560220192,-1.199700092,0.929310724,0.946520182,0.653794715,DLC1/GIT1/DAB2IP/NPRL2,4
GO:0022836,MF,GO:0022836,gated channel activity,2/271,301/18522,0.006644518,0.454131983,-1.163478391,0.936733769,0.952477194,0.657909432,TMEM37/LRRC26,2
GO:0016758,MF,GO:0016758,hexosyltransferase activity,1/271,196/18522,0.005102041,0.348708487,-1.116974201,0.945215081,0.959488463,0.662752362,UGT2B17,1
GO:0008168,MF,GO:0008168,methyltransferase activity,1/271,208/18522,0.004807692,0.32859069,-1.186590728,0.954186311,0.966939693,0.667899188,EZH2,1
GO:0005261,MF,GO:0005261,monoatomic cation channel activity,2/271,330/18522,0.006060606,0.414223415,-1.308345012,0.955751961,0.966939693,0.667899188,TMEM37/LRRC26,2
GO:0016741,MF,GO:0016741,"transferase activity, transferring one-carbon groups",1/271,219/18522,0.00456621,0.312086135,-1.247867602,0.961117284,0.970744502,0.670527303,EZH2,1
GO:0061630,MF,GO:0061630,ubiquitin protein ligase activity,2/271,352/18522,0.005681818,0.388334452,-1.411826784,0.96640052,0.974453858,0.673089485,CUL3/MED1,2
GO:0022853,MF,GO:0022853,active monoatomic ion transmembrane transporter activity,1/271,244/18522,0.004098361,0.280110096,-1.379336372,0.973227434,0.978429578,0.675835654,COX2,1
GO:0061659,MF,GO:0061659,ubiquitin-like protein ligase activity,2/271,371/18522,0.005390836,0.368446703,-1.497339259,0.973577861,0.978429578,0.675835654,CUL3/MED1,2
GO:0140098,MF,GO:0140098,"catalytic activity, acting on RNA",2/271,390/18522,0.005128205,0.350496736,-1.579662524,0.979267235,0.982515219,0.67865775,RNASEL/REXO2,2
GO:0005216,MF,GO:0005216,monoatomic ion channel activity,2/271,441/18522,0.004535147,0.3099631,-1.787120827,0.989290032,0.990927929,0.684468704,TMEM37/LRRC26,2
GO:0022804,MF,GO:0022804,active transmembrane transporter activity,1/271,454/18522,0.002202643,0.150543752,-2.232993348,0.998858576,0.998858576,0.689946681,COX2,1
